data_2i9h_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2i9h _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.679 0.276 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.0 m -150.11 161.77 41.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.884 0.373 . . . . 0.0 111.253 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.452 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 16.6 mt-30 -102.93 -172.68 2.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.39 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.531 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.2 m-85 -137.52 129.32 28.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.059 0.457 . . . . 0.0 111.461 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -112.98 -28.24 7.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.498 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.0 p -128.57 132.49 48.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.515 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.44 -25.34 50.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.51 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.3 t -59.74 -18.35 42.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.621 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -90.42 -64.94 1.06 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.277 0.561 . . . . 0.0 111.031 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.474 ' CZ ' ' CG2' ' A' ' 23' ' ' VAL . 1.2 t80 -53.54 -29.0 34.63 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.015 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -54.89 -35.29 63.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.018 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.3 p -82.5 -37.49 25.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.111 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.74 -49.12 20.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.66 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.5 pt -77.58 -49.91 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.501 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.454 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -40.74 95.43 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 85.1 mt-30 44.35 86.66 0.02 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.422 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 8.1 t0 -169.54 41.14 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.407 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.541 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 10.9 mptt 67.56 -155.41 0.21 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.694 0.283 . . . . 0.0 110.888 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.508 ' HB2' ' HD3' ' A' ' 79' ' ' LYS . 61.5 tp -98.1 115.21 27.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.222 0.534 . . . . 0.0 111.252 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -99.79 128.2 51.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.471 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -99.74 91.22 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 110.816 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.474 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 42.0 t -101.27 132.19 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.125 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 7.9 t70 -102.43 129.11 48.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.73 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.544 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 4.4 m-85 -98.98 51.6 0.96 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.206 0.527 . . . . 0.0 110.467 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.502 ' O ' ' HD1' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -50.99 139.44 17.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.111 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.45 ' CB ' ' HB3' ' A' ' 72' ' ' MET . . . -65.58 141.75 58.32 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.331 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.437 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.6 t -57.91 -18.13 21.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.069 0.461 . . . . 0.0 110.835 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -106.61 -128.74 0.27 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.315 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 72' ' ' MET . 30.2 t 61.08 156.08 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.805 0.336 . . . . 0.0 110.979 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.09 -82.1 1.19 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.488 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.97 60.85 3.79 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.627 2.218 . . . . 0.0 112.33 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.7 p -107.61 -20.83 13.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.024 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -85.71 -24.11 27.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.119 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.439 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 57.7 ttp -63.44 -12.69 33.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.982 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.477 ' CG2' HG13 ' A' ' 40' ' ' ILE . 2.7 mp -81.99 -30.22 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.669 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.523 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -49.5 -45.72 77.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 37.8 Cg_endo -70.86 -37.65 6.28 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.722 1.615 . . . . 0.0 111.012 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.489 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 66.4 mtm -63.92 -54.94 26.81 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.477 HG13 ' CG2' ' A' ' 36' ' ' ILE . 55.7 mt -44.74 -29.08 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.069 0.461 . . . . 0.0 110.542 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.59 -40.32 23.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.176 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -59.82 -27.9 67.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.627 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.489 ' HD1' ' O ' ' A' ' 39' ' ' MET . 10.4 m-85 -78.02 -22.43 49.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.625 0.25 . . . . 0.0 111.389 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.438 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 46.9 t -66.65 -11.32 53.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.206 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -87.44 -26.09 23.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.64 0.257 . . . . 0.0 111.096 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -89.98 -31.73 17.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.199 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.479 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 89.7 m-85 -124.39 51.61 4.85 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.02 0.438 . . . . 0.0 110.489 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 2.9 Cg_endo -48.95 -25.43 8.66 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.034 2.489 . . . . 0.0 112.484 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -65.77 -31.49 72.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.054 0.454 . . . . 0.0 110.229 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.77 144.48 26.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.86 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -89.96 129.98 36.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.709 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.48 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 8.8 m-85 -105.09 90.94 3.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.391 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.531 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 47.5 m-85 -101.01 -178.12 3.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.559 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 4' ' ' GLN . 20.1 mtpp -141.9 141.27 33.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.395 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.474 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 3.0 tm? -105.26 144.23 32.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.29 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.423 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 22.9 t70 -99.9 115.5 29.77 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.075 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 75.5 t -76.83 -4.0 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.919 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.437 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 38.6 t70 -96.21 -50.09 4.95 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.254 0.549 . . . . 0.0 110.215 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.419 ' HG3' HD13 ' A' ' 60' ' ' LEU . 5.1 tp10 -82.16 -40.28 22.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.652 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.434 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 4.1 mp -111.67 43.53 1.52 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.545 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.6 -24.05 16.45 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.762 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.516 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 56.6 m-20 -71.04 -50.09 37.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.688 0.28 . . . . 0.0 111.256 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.539 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 15.6 t -56.37 -23.85 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.142 0.496 . . . . 0.0 110.244 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 69' ' ' VAL . . . -80.35 -25.2 39.33 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 5.7 pt20 -90.21 -35.4 15.36 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.272 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 20.2 ptmt -57.79 -48.45 79.66 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.421 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.42 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 75.6 m-80 -85.48 2.18 45.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.048 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 63.92 38.94 8.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.905 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.451 ' N ' ' O ' ' A' ' 64' ' ' ALA . 43.8 t -116.39 99.82 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.899 0.38 . . . . 0.0 111.398 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.7 m -121.7 13.17 10.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.446 ' O ' ' HB1' ' A' ' 27' ' ' ALA . . . -60.9 -157.9 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.092 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.608 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -169.75 88.19 0.57 Allowed Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 40.3 Cg_endo -96.71 -164.57 0.99 Allowed 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 124.777 -0.926 . . . . 0.0 112.793 -0.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 88' ' ' VAL . 29.3 m -149.98 153.91 37.35 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.701 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.419 ' CD1' ' CD1' ' A' ' 95' ' ' ILE . 85.3 mt -114.33 126.58 55.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.819 0.342 . . . . 0.0 111.235 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.544 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 19.1 mt -121.76 128.68 52.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.014 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.46 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 3.6 mp -109.89 141.88 41.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.628 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.601 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 65.1 m-85 -141.88 127.13 18.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.697 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.508 ' HD3' ' HB2' ' A' ' 20' ' ' LEU . 8.9 mmmm -109.82 133.17 53.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.53 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 5.2 m120 42.88 65.17 0.99 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.01 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 53.96 21.02 15.65 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.155 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.601 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 28.1 mtpp -127.33 -160.82 1.03 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.431 ' O ' HG12 ' A' ' 84' ' ' VAL . 82.3 tt0 -109.47 178.06 4.55 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.439 HG13 ' CG ' ' A' ' 79' ' ' LYS . 4.8 m -162.38 -47.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 O-C-N 123.1 0.25 . . . . 0.0 111.144 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.96 162.07 17.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.125 0.488 . . . . 0.0 111.874 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -149.09 115.39 5.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.267 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.3 t -131.1 98.66 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.331 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.508 ' HA ' HG22 ' A' ' 74' ' ' THR . 3.3 p -62.33 98.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.696 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.98 108.52 0.81 Allowed Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.2 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.478 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -95.68 37.13 1.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 111.259 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 93' ' ' ALA . 75.9 m-80 -72.04 131.77 85.17 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.237 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -45.91 86.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.689 2.26 . . . . 0.0 112.637 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 178.51 -36.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.525 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.23 -45.62 2.44 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 5.0 tp -49.94 -18.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.302 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -91.76 -50.97 5.46 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.903 0.382 . . . . 0.0 111.049 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -69.9 -32.1 70.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.599 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.1 -28.46 69.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.748 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.48 HD11 ' CZ ' ' A' ' 52' ' ' PHE . 56.7 mt -90.22 -8.08 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.526 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.26 -69.39 0.73 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.866 0.365 . . . . 0.0 111.162 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.99 -29.61 30.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.177 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.411 ' HB2' ' CD2' ' A' ' 20' ' ' LEU . 5.6 m120 -80.75 -52.91 6.99 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.053 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.041 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.426 ' CG2' ' CG2' ' A' ' 40' ' ' ILE . 11.2 p . . . . . 0 N--CA 1.464 0.253 0 CA-C-O 121.23 0.538 . . . . 0.0 112.048 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 54' ' ' LYS . 88.9 m -150.17 162.42 40.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.133 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.52 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 59.5 mt-30 -101.04 178.77 4.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.631 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.52 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 18.4 m-85 -133.17 98.48 4.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.712 0.291 . . . . 0.0 111.598 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -83.52 -28.31 28.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.44 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.3 p -123.36 122.62 38.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.255 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.59 -26.4 8.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.687 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.9 t -59.22 -19.85 49.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.829 0.347 . . . . 0.0 110.426 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -90.73 -31.07 16.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.358 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.502 ' CD1' ' CE2' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -85.86 8.45 20.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.391 -179.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -87.7 -60.58 1.93 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.867 0.365 . . . . 0.0 110.923 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -67.01 -17.17 64.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.28 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.48 91.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.377 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.554 ' O ' ' N ' ' A' ' 81' ' ' GLY . 21.4 pt -88.89 -49.92 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.465 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.451 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -46.29 103.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.847 0.356 . . . . 0.0 111.955 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 44.01 87.45 0.02 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.29 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -168.84 40.67 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.035 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER 64.33 -156.88 0.31 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.281 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.42 ' CD1' ' HB3' ' A' ' 102' ' ' ASN . 3.4 tt -98.15 115.85 29.14 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.205 0.526 . . . . 0.0 110.782 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -104.73 127.87 58.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.135 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.6 t -103.69 95.21 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.552 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.47 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 40.5 t -99.85 136.73 29.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.204 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 74' ' ' THR . 38.8 t70 -100.01 128.1 46.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.825 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.502 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 5.2 m-85 -98.89 48.69 0.96 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.012 0.434 . . . . 0.0 110.683 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.515 ' O ' ' HD1' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -51.48 137.04 24.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.889 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 72' ' ' MET . . . -58.39 165.01 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.965 0.412 . . . . 0.0 111.042 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.479 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 3.7 t -98.67 19.24 15.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.066 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 15.4 p-90 -141.76 -38.71 0.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.8 t -36.87 -69.06 0.12 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.781 0.325 . . . . 0.0 111.801 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.87 -74.42 0.23 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.511 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.6 -26.95 9.86 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.666 2.244 . . . . 0.0 112.421 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.4 ' HB3' ' CB ' ' A' ' 26' ' ' TYR . 77.5 m -58.25 -21.21 47.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.203 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -75.32 -19.22 59.76 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.28 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.427 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 84.4 mtp -75.3 3.8 8.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.357 . . . . 0.0 110.691 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.517 ' CG2' HG13 ' A' ' 40' ' ' ILE . 55.1 mt -85.68 -17.8 9.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.487 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.568 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.51 -42.33 74.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 35.3 Cg_endo -68.93 -43.58 3.3 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.576 1.517 . . . . 0.0 111.324 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.589 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 23.9 mmt -61.23 -61.28 2.67 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.517 HG13 ' CG2' ' A' ' 36' ' ' ILE . 56.8 mt -43.73 -29.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.846 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -81.56 -37.8 27.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.822 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 39' ' ' MET . 99.3 mttt -71.6 -30.96 66.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.544 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.589 ' HD1' ' O ' ' A' ' 39' ' ' MET . 16.3 m-85 -73.15 -27.07 61.46 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.356 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.5 p -67.02 -9.7 41.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.147 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.402 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 56.2 mt-10 -87.26 -26.51 23.44 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.788 0.327 . . . . 0.0 111.222 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.4 -31.79 16.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.524 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.531 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 73.9 m-85 -122.78 45.19 1.02 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.401 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 80.3 Cg_exo -37.74 -32.32 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.286 2.657 . . . . 0.0 113.478 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -60.71 -35.1 75.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.604 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.8 138.54 31.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.543 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.68 122.32 32.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.888 0.375 . . . . 0.0 110.46 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.444 ' CE2' ' CD1' ' A' ' 99' ' ' ILE . 4.5 m-85 -99.32 90.33 4.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.577 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.52 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 41.0 m-85 -101.02 -177.76 3.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.572 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 4' ' ' GLN . 34.4 mtpt -139.96 131.5 27.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.369 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.456 ' HB3' ' HA ' ' A' ' 25' ' ' PHE . 3.2 tm? -95.73 126.39 40.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.138 0.494 . . . . 0.0 111.068 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.448 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 44.9 m-20 -85.29 113.08 21.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.716 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 96.4 t -81.85 -5.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.141 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.479 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 11.4 p-10 -84.52 -39.72 18.5 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.854 0.359 . . . . 0.0 110.854 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -100.4 -23.02 14.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.171 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 3.1 mp -119.57 48.44 1.52 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.822 0.344 . . . . 0.0 110.995 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -60.35 -18.24 49.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.444 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.67 -27.56 55.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.694 0.283 . . . . 0.0 111.507 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.7 t -75.53 -54.69 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.758 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.51 -26.74 22.12 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.954 0.407 . . . . 0.0 110.218 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.06 -26.84 20.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.69 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -70.44 -49.36 49.55 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.034 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -77.61 -1.1 29.16 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.116 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 67.55 37.61 3.34 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.344 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.5 t -115.25 68.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.854 0.359 . . . . 0.0 110.845 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.8 p -81.77 -7.95 59.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.15 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.415 ' CB ' HG23 ' A' ' 88' ' ' VAL . . . -57.56 -166.53 0.0 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.537 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -174.43 107.43 0.28 Allowed Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.476 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 37.2 Cg_endo -89.77 -166.68 2.99 Favored 'Cis proline' 0 C--N 1.35 0.642 0 C-N-CA 124.353 -1.103 . . . . 0.0 112.366 -0.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 53.4 m -160.88 142.69 12.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.227 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.487 HD12 ' CB ' ' A' ' 90' ' ' ALA . 36.7 mt -109.79 123.75 50.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.023 0.439 . . . . 0.0 111.551 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.502 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 29.1 mt -115.16 127.07 55.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.853 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.448 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 4.5 mp -109.68 131.52 54.98 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.477 ' HA ' HG23 ' A' ' 84' ' ' VAL . 51.9 m-85 -130.94 125.52 33.65 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.298 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.478 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 24.6 mtpp -109.78 126.53 53.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.719 0.295 . . . . 0.0 111.087 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.45 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 6.3 m120 50.41 55.62 9.2 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.941 0.4 . . . . 0.0 111.768 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 59.58 16.39 36.78 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.072 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 27.0 mtpp -115.57 -153.55 0.53 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 35.6 tt0 -108.87 171.51 7.39 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.478 ' CG2' ' HG3' ' A' ' 79' ' ' LYS . 38.4 t -144.0 -59.82 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.75 0.309 . . . . 0.0 111.203 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.08 157.42 6.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.442 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -118.3 114.67 23.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.708 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.4 t -136.96 80.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.036 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.415 HG23 ' CB ' ' A' ' 71' ' ' ALA . 3.8 p -59.64 85.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.998 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.54 123.41 2.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.703 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.487 ' CB ' HD12 ' A' ' 75' ' ' LEU . . . -84.45 55.23 3.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 110.83 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -51.59 131.89 35.86 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.725 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -44.96 -25.95 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.643 2.229 . . . . 0.0 112.776 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.411 ' HA ' ' HE2' ' A' ' 96' ' ' LYS . . . -123.32 49.19 1.72 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.724 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.445 ' C ' ' H ' ' A' ' 96' ' ' LYS . . . -152.39 -62.02 0.16 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.443 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 75' ' ' LEU . 3.5 tp -58.17 -5.45 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.184 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' A' ' 94' ' ' ALA . 64.5 pttt -90.95 -47.53 7.53 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.954 0.407 . . . . 0.0 110.469 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.431 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 25.7 mt-30 -74.7 -32.47 62.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.52 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.4 -30.94 70.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.578 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.444 ' CD1' ' CE2' ' A' ' 52' ' ' PHE . 56.4 mt -90.25 -6.4 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.528 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.64 -77.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.998 0.428 . . . . 0.0 111.651 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.21 -29.3 5.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.054 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.42 ' HB3' ' CD1' ' A' ' 20' ' ' LEU . 73.0 m-80 -88.05 -67.4 0.83 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.672 0.272 . . . . 0.0 111.707 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.292 -179.69 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.442 HG11 ' HB2' ' A' ' 41' ' ' GLU . 9.9 p . . . . . 0 CA--C 1.529 0.164 0 CA-C-O 120.554 0.216 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.4 m -150.29 157.69 43.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.0 111.481 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.518 ' HG3' ' HE2' ' A' ' 54' ' ' LYS . 10.8 mp0 -92.23 -177.14 4.57 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.525 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 14.7 m-85 -133.67 96.57 3.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.819 0.342 . . . . 0.0 111.073 178.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -75.54 -30.29 59.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.729 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.0 p -128.61 132.43 48.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.48 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.06 -25.32 58.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.389 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.8 m -59.08 -19.86 48.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.542 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -90.63 -35.75 14.8 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.2 0.524 . . . . 0.0 111.075 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.463 ' CZ ' ' CG2' ' A' ' 23' ' ' VAL . 1.1 t80 -73.67 -29.46 62.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.888 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -53.3 -57.02 12.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.218 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.8 p -61.13 -37.61 83.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.56 -51.9 33.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.649 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.6 pt -75.94 -48.86 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.529 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.454 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -43.14 97.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 84.7 mt-30 45.35 88.86 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.341 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 8.8 t70 -170.0 39.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.403 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 52.0 mttp 68.18 -154.35 0.18 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.731 0.301 . . . . 0.0 110.584 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.502 ' HB2' ' HD3' ' A' ' 79' ' ' LYS . 61.1 tp -97.8 114.28 26.28 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.089 0.471 . . . . 0.0 110.916 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -103.81 124.03 57.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.889 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.467 ' CG2' HG13 ' A' ' 99' ' ' ILE . 49.1 t -99.78 96.67 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.681 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.463 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 36.2 t -103.34 130.11 54.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.065 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.497 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.8 t70 -99.68 131.37 45.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.577 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.522 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 5.3 m-85 -98.9 50.88 0.96 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.036 0.446 . . . . 0.0 110.707 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.593 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -54.05 135.61 42.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.935 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -60.88 156.42 17.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 0.0 110.894 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 3.2 t -87.35 6.09 35.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.453 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.45 ' CZ2' ' CE ' ' A' ' 72' ' ' MET . 20.1 p-90 -127.52 -37.58 1.98 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 29' ' ' TRP . 53.9 t -28.51 -75.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.08 -80.81 0.35 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.898 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.96 -21.3 33.35 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.756 2.304 . . . . 0.0 112.326 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.5 p -53.44 -33.56 54.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.124 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -64.94 -22.74 67.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.321 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.0 mtp -68.76 -7.4 33.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.735 0.302 . . . . 0.0 111.016 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.5 ' CG2' HG13 ' A' ' 40' ' ' ILE . 57.0 mt -88.01 -19.25 7.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.303 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.511 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -53.09 -43.74 95.45 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.893 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 38.1 Cg_endo -71.67 -36.66 6.17 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.747 1.632 . . . . 0.0 111.459 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.466 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 1.1 mpt? -64.64 -55.95 16.94 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.5 HG13 ' CG2' ' A' ' 36' ' ' ILE . 55.7 mt -44.66 -27.4 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.841 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.442 ' HB2' HG11 ' A' ' 2' ' ' VAL . 43.1 tt0 -80.75 -39.83 26.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.138 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -64.12 -30.98 72.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.606 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.466 ' HD1' ' O ' ' A' ' 39' ' ' MET . 10.7 m-85 -75.47 -19.18 59.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.69 0.281 . . . . 0.0 111.377 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.424 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.6 t -72.77 -6.92 48.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.382 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -90.15 -26.9 19.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.701 0.286 . . . . 0.0 111.06 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -90.3 -28.99 18.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.568 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.52 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 80.0 m-85 -123.83 47.65 1.89 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.081 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 62.9 Cg_exo -35.26 -41.58 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.6 2.867 . . . . 0.0 113.919 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.411 ' O ' ' CD ' ' A' ' 19' ' ' LYS . 85.8 mt-30 -55.4 -34.92 64.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.978 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 20' ' ' LEU . . . -89.6 135.77 33.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.722 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.62 121.95 32.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.409 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.448 ' CE2' ' CB ' ' A' ' 43' ' ' PHE . 5.6 m-85 -98.26 84.59 3.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.586 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.525 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 48.2 m-85 -98.86 -174.71 2.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.515 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.593 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 34.4 mtmm -148.39 132.65 17.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.018 0.437 . . . . 0.0 111.033 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.474 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 2.1 tm? -91.87 130.74 37.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.187 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 60' ' ' LEU . 46.8 m-20 -86.44 126.32 34.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.411 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.48 ' O ' ' CG1' ' A' ' 57' ' ' VAL . 95.9 t -97.16 18.93 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.533 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.456 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 2.8 p30 -111.39 -38.99 4.81 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.242 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.428 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 17.6 tp10 -100.03 -13.94 18.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.805 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.514 HD13 ' N ' ' A' ' 60' ' ' LEU . 5.3 mp -104.74 -69.08 0.82 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.295 0.569 . . . . 0.0 110.926 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.84 -61.58 0.5 Allowed Glycine 0 C--N 1.314 -0.661 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.591 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -52.69 -43.43 65.59 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.575 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 16.0 t -59.83 -53.34 49.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.719 0.295 . . . . 0.0 110.844 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -51.25 -26.09 6.66 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 110.053 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -90.39 -38.02 13.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.157 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.575 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -61.15 -42.0 97.75 Favored 'General case' 0 C--O 1.23 0.055 0 CA-C-O 120.863 0.363 . . . . 0.0 110.414 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -84.95 -1.97 57.34 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.923 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 64.91 38.4 6.5 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.021 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.433 ' CG1' ' CB ' ' A' ' 74' ' ' THR . 40.2 t -114.75 69.12 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.852 0.358 . . . . 0.0 111.019 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.8 p -82.34 -11.46 58.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.067 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.32 -172.07 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.603 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.555 ' HG2' ' O ' ' A' ' 72' ' ' MET . 1.7 pmm? -171.59 107.57 0.38 Allowed Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.602 -0.439 . . . . 0.0 112.085 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 83.2 Cg_endo -93.78 171.23 18.28 Favored 'Cis proline' 0 N--CA 1.459 -0.55 0 C-N-CA 124.634 -0.986 . . . . 0.0 112.23 -0.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 34.5 m -136.16 153.69 51.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.953 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 90' ' ' ALA . 85.3 mt -115.09 125.55 53.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 111.056 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.522 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 28.5 mt -122.38 128.99 51.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.061 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.471 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 3.4 mp -109.79 146.03 35.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.441 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.619 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 67.9 m-85 -145.99 128.82 16.33 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.779 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.502 ' HD3' ' HB2' ' A' ' 20' ' ' LEU . 27.0 mmmt -109.69 132.92 53.7 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.458 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 5.2 m120 44.44 60.25 2.93 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.842 0.353 . . . . 0.0 111.845 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 57.29 18.61 29.28 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.245 -0.503 . . . . 0.0 113.072 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 96.5 mttt -122.12 -158.86 0.79 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.428 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 32.0 tt0 -109.35 176.73 4.98 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.461 HG12 ' CG ' ' A' ' 79' ' ' LYS . 3.3 m -165.01 -46.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 O-C-N 123.169 0.293 . . . . 0.0 111.292 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.26 158.17 16.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.147 0.499 . . . . 0.0 111.881 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -151.67 114.85 4.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.399 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.7 t -135.57 106.64 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.184 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 3.6 p -66.78 97.87 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.48 104.83 0.44 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.195 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.529 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -96.98 35.87 1.5 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.927 0.394 . . . . 0.0 111.524 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 93' ' ' ALA . 13.9 p-10 -76.7 134.45 69.1 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.236 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -44.79 87.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.591 2.194 . . . . 0.0 112.702 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 178.76 -36.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.551 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.9 -41.9 2.2 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.529 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 5.1 tp -51.02 -18.0 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.586 0.231 . . . . 0.0 111.329 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -92.25 -50.33 5.72 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.971 0.415 . . . . 0.0 110.837 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -68.02 -31.92 71.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.581 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.38 -30.38 64.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.174 0.512 . . . . 0.0 110.772 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.472 HG21 ' CG ' ' A' ' 47' ' ' TYR . 1.5 mp -90.09 -9.72 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.554 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.62 -65.64 1.0 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 111.184 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.91 -26.91 27.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.452 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -89.3 -59.95 2.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.536 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.102 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.6 t . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.763 0.316 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.9 m -149.98 147.06 27.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.977 0.417 . . . . 0.0 111.248 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.571 ' HG2' ' HE3' ' A' ' 54' ' ' LYS . 40.4 mt-30 -90.13 174.48 7.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.28 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.507 ' CD2' ' CG ' ' A' ' 11' ' ' PHE . 16.9 m-85 -123.02 124.52 43.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.931 0.396 . . . . 0.0 111.144 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -109.26 -25.21 10.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.643 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -129.92 123.28 30.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.29 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.1 -26.64 4.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.426 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -57.8 -20.94 39.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.069 0.461 . . . . 0.0 110.477 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -90.42 -45.73 8.8 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.557 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.507 ' CG ' ' CD2' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -76.46 -23.38 53.87 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.695 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -63.85 -38.06 89.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.966 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.0 m -87.94 -26.39 22.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.224 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.38 -31.8 35.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.834 0.349 . . . . 0.0 111.423 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.533 ' C ' ' HA2' ' A' ' 81' ' ' GLY . 20.4 pt -90.18 -47.71 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.361 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.439 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.1 97.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 45.65 86.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.33 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -167.36 41.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.44 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.53 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.9 mptp? 63.31 -156.67 0.33 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.432 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.44 ' HB2' ' HG2' ' A' ' 79' ' ' LYS . 66.0 tp -97.98 115.81 28.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.102 0.477 . . . . 0.0 110.637 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.8 t -102.74 133.84 45.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.126 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.31 103.38 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.481 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.461 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 23.7 t -113.93 126.36 71.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 0.0 111.462 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 74' ' ' THR . 34.6 t70 -99.76 135.19 41.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.662 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.525 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 6.6 m-85 -99.39 46.78 0.97 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.705 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.545 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -46.9 141.02 4.29 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.071 0.462 . . . . 0.0 111.755 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.598 ' CA ' ' HG3' ' A' ' 72' ' ' MET . . . -69.88 133.59 47.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.084 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.7 t -63.67 -20.48 65.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.743 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.482 ' CE3' ' N ' ' A' ' 30' ' ' CYS . 8.4 p-90 -96.28 -126.46 0.14 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.301 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.482 ' N ' ' CE3' ' A' ' 29' ' ' TRP . 51.8 t 48.67 -88.68 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.747 0.419 . . . . 0.0 111.654 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . 150.25 -77.83 0.22 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.675 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.23 -6.77 17.05 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.77 2.313 . . . . 0.0 113.419 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 85.5 m -50.44 -34.38 24.44 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.589 0.233 . . . . 0.0 111.445 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -76.64 -5.06 46.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.62 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.434 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 27.9 ttt -81.04 2.92 24.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.895 0.379 . . . . 0.0 110.676 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.476 ' CG2' HG13 ' A' ' 40' ' ' ILE . 58.2 mt -86.41 -14.98 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.588 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.538 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -53.76 -42.04 90.59 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 37.7 Cg_endo -70.92 -41.25 2.92 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.638 1.559 . . . . 0.0 111.766 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 70.5 mtm -63.05 -54.95 30.06 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.476 HG13 ' CG2' ' A' ' 36' ' ' ILE . 70.5 mt -47.42 -28.01 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.81 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -79.68 -33.12 41.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.168 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.53 -21.98 66.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.703 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.415 ' CZ ' HG23 ' A' ' 95' ' ' ILE . 4.2 m-85 -90.05 -18.13 26.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.616 0.246 . . . . 0.0 111.559 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.426 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.6 t -74.3 -6.88 50.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.187 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -90.07 -28.08 19.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.839 0.352 . . . . 0.0 111.069 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.51 -27.65 19.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.652 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.54 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 74.6 m-85 -123.53 44.38 0.95 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.529 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 96.0 Cg_exo -39.19 -31.85 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.093 2.529 . . . . 0.0 113.346 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -61.7 -35.68 78.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.863 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.01 140.82 29.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.072 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -89.83 127.28 35.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.639 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.426 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 4.6 m-85 -102.2 89.0 3.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.006 0.431 . . . . 0.0 111.577 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.483 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 39.5 m-85 -98.3 -174.56 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.207 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.571 ' HE3' ' HG2' ' A' ' 4' ' ' GLN . 42.2 mtmt -150.22 137.84 19.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.062 0.458 . . . . 0.0 111.395 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 25' ' ' PHE . 3.1 tm? -91.59 141.35 28.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.662 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -97.74 112.84 24.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.355 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 83.4 t -77.9 -4.51 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.933 0.397 . . . . 0.0 110.563 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.507 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 38.8 t70 -95.49 -35.0 11.85 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.174 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.418 ' HG3' HD13 ' A' ' 60' ' ' LEU . 5.3 tp10 -102.48 -46.48 4.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.613 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.418 HD13 ' HG3' ' A' ' 59' ' ' GLU . 6.1 mp -102.38 35.2 2.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.743 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -51.33 -25.12 11.59 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.411 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.63 -30.01 71.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.685 0.279 . . . . 0.0 111.198 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.405 HG13 ' CE2' ' A' ' 25' ' ' PHE . 11.1 t -74.06 -52.18 21.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.576 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.76 -29.83 41.7 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.991 0.424 . . . . 0.0 110.071 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -90.19 -28.31 18.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.001 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 67' ' ' ASN . 2.9 tptm -66.15 -50.67 63.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.015 0.436 . . . . 0.0 109.948 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.409 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 75.5 m-80 -79.67 0.43 30.37 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.84 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 62.61 40.61 10.23 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.445 ' CG1' ' CB ' ' A' ' 74' ' ' THR . 29.2 t -107.72 54.2 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 110.821 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 94.1 p -74.05 -13.29 60.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.018 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.407 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -88.44 62.58 6.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.112 0.482 . . . . 0.0 110.054 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.603 ' HB2' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -89.55 165.59 24.81 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.073 -179.128 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.603 ' HA ' ' HB2' ' A' ' 72' ' ' MET . 56.9 Cg_endo -72.59 134.47 34.6 Favored 'Cis proline' 0 C--N 1.353 0.773 0 C-N-CA 123.288 -1.547 . . . . 0.0 112.94 0.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 88' ' ' VAL . 53.0 m -117.77 154.38 31.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.565 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.412 ' CD1' ' HA ' ' A' ' 90' ' ' ALA . 75.9 mt -109.25 115.35 29.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 110.813 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.525 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 25.6 mt -109.77 126.72 54.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.889 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 3.8 mp -109.66 142.36 40.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.568 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.632 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 54.5 m-85 -141.86 127.01 18.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.984 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.501 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 9.5 mtpm? -116.38 132.19 56.74 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.668 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.437 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 74.0 m-20 49.31 68.75 0.67 Allowed 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.38 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.533 ' HA2' ' C ' ' A' ' 15' ' ' ILE . . . 46.55 28.54 3.54 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 116.095 -0.502 . . . . 0.0 113.098 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.632 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 68.2 mttm -136.42 -161.64 1.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.433 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 30.9 tt0 -109.1 -179.52 3.87 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.433 ' CG1' ' O ' ' A' ' 83' ' ' GLU . 5.0 m -162.76 -47.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.626 0.25 . . . . 0.0 111.309 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.13 166.15 13.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.098 0.475 . . . . 0.0 111.827 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.449 ' NZ ' ' HB2' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -141.76 115.42 9.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.522 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.9 t -116.05 85.42 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.13 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.482 ' HA ' HG23 ' A' ' 74' ' ' THR . 5.5 p -61.52 84.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.063 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.83 109.28 1.21 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.529 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.536 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -77.41 59.28 1.84 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.981 0.419 . . . . 0.0 111.075 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -62.63 133.98 95.08 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.342 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -43.7 -26.38 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.534 2.156 . . . . 0.0 112.803 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.22 53.12 0.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.605 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.407 ' C ' ' H ' ' A' ' 96' ' ' LYS . . . -167.69 -56.7 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.549 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.536 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 3.1 tp -54.72 -9.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.492 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 25.3 pttm -92.04 -50.28 5.77 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.919 0.39 . . . . 0.0 110.856 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.433 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 83.8 mt-30 -70.32 -32.24 69.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.782 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.22 -37.25 77.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.217 0.532 . . . . 0.0 110.394 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.521 ' CD1' ' N ' ' A' ' 99' ' ' ILE . 1.3 mp -90.21 -8.68 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.542 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.28 -62.52 1.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.941 0.4 . . . . 0.0 110.981 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.07 -28.54 58.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.073 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.409 ' CB ' ' CD2' ' A' ' 20' ' ' LEU . 3.6 m120 -84.64 -63.12 1.39 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.197 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.056 -179.995 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.43 HG21 ' NZ ' ' A' ' 54' ' ' LYS . 12.6 p . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.54 0.21 . . . . 0.0 110.724 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.3 m -150.08 161.27 42.69 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.147 0.498 . . . . 0.0 112.06 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.588 ' HG2' ' HD2' ' A' ' 54' ' ' LYS . 54.1 mt-30 -92.37 -170.68 2.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.952 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.514 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 15.4 m-85 -134.4 121.46 21.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.114 0.483 . . . . 0.0 111.488 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HB3' ' NZ ' ' A' ' 6' ' ' LYS . 2.4 mmmp? -109.14 -16.41 14.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.621 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.7 p -139.83 125.38 19.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.374 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.56 -26.11 4.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.525 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 m -58.78 -20.3 48.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.344 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -90.63 -39.09 12.7 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.151 0.5 . . . . 0.0 111.025 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 11' ' ' PHE . 1.0 OUTLIER -84.54 4.16 33.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.22 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -89.88 -31.54 17.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.906 0.384 . . . . 0.0 110.738 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.3 p -89.92 -37.07 14.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.5 -40.38 12.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.499 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.593 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.1 pt -86.8 -50.93 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.353 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.462 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.69 97.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 44.52 86.84 0.02 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.231 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 64.2 t0 -169.32 40.78 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.453 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 92.2 mttt 67.66 -156.64 0.21 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.669 0.271 . . . . 0.0 110.614 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.452 ' CD1' HG12 ' A' ' 84' ' ' VAL . 63.9 tp -98.04 114.96 27.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.042 0.449 . . . . 0.0 110.9 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.4 t -102.85 132.48 48.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.966 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.427 ' CG2' HG13 ' A' ' 99' ' ' ILE . 41.1 t -102.38 107.58 22.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.68 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.461 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 34.6 t -113.91 126.75 71.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.008 0.433 . . . . 0.0 111.367 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 7.2 t70 -99.87 129.01 45.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.668 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.545 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 5.9 m-85 -99.08 52.09 0.96 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.124 0.487 . . . . 0.0 110.602 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.58 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -57.48 137.41 56.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.961 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 72' ' ' MET . . . -61.01 143.74 54.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.019 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.528 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 5.2 t -63.04 -13.91 41.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.853 0.359 . . . . 0.0 110.948 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.445 ' CD1' ' HB1' ' A' ' 27' ' ' ALA . 11.7 p-90 -110.13 -132.33 0.33 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.644 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 40.8 t 62.2 -79.66 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.581 0.352 . . . . 0.0 111.437 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.71 -78.52 0.37 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.723 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -45.06 -30.55 4.82 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.637 2.225 . . . . 0.0 112.131 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 98.5 m -55.4 -36.88 66.91 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.596 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.12 -17.02 62.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.142 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.576 ' HA ' ' CE ' ' A' ' 35' ' ' MET . 1.7 tpt -76.16 -1.09 24.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.885 0.374 . . . . 0.0 110.68 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.483 HG21 HD13 ' A' ' 36' ' ' ILE . 65.1 mt -87.72 -12.72 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.695 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.538 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -58.41 -41.4 89.09 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 40.9 Cg_endo -71.97 -38.82 3.66 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.636 1.558 . . . . 0.0 111.367 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.429 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 90.1 mtp -62.87 -57.12 11.92 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.473 HG13 ' CG2' ' A' ' 36' ' ' ILE . 61.2 mt -46.59 -28.52 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.007 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -79.95 -29.38 39.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.603 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 57.2 mtpt -74.58 -15.65 60.83 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.429 ' HD1' ' O ' ' A' ' 39' ' ' MET . 4.4 m-85 -90.59 -20.08 22.99 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.433 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 79.3 p -67.59 -9.32 41.79 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 42' ' ' LYS . 12.5 pt-20 -90.02 -26.17 20.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.687 0.279 . . . . 0.0 111.058 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -90.56 -28.53 18.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.383 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.525 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 86.5 m-85 -123.13 46.14 1.28 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.328 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 84.7 Cg_exo -37.63 -38.66 0.64 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.177 2.585 . . . . 0.0 113.501 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.402 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 85.1 mt-30 -59.03 -33.17 70.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.622 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 20' ' ' LEU . . . -89.63 134.6 34.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.853 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -89.66 122.69 33.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.418 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.433 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 4.1 m-85 -97.33 100.91 12.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.07 0.462 . . . . 0.0 111.445 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.514 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 45.6 m-85 -115.82 -177.29 3.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.363 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.588 ' HD2' ' HG2' ' A' ' 4' ' ' GLN . 29.0 mttm -141.37 157.58 45.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.245 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.481 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 2.6 tm? -118.39 132.77 56.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.865 0.364 . . . . 0.0 111.033 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -85.25 114.98 22.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.222 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.467 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 55.8 t -74.12 -4.63 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.07 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.528 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 62.1 t0 -102.34 -50.89 3.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.048 0.451 . . . . 0.0 110.392 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.422 ' HG3' HD13 ' A' ' 60' ' ' LEU . 38.0 tp10 -75.11 -40.66 59.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.659 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 4.5 mp -113.44 37.75 3.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.707 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -53.12 -23.77 18.24 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.651 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -66.45 -29.79 70.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.635 0.255 . . . . 0.0 111.223 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.571 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 5.5 t -79.87 -27.47 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.051 0.453 . . . . 0.0 110.546 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.29 -26.08 60.93 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -90.17 -34.96 15.64 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.816 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 13.4 ptmm? -60.56 -48.53 81.37 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.073 0.463 . . . . 0.0 110.007 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.421 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.8 m-80 -80.93 -3.67 52.27 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.878 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 63.85 42.67 5.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.292 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.411 ' CG1' HG22 ' A' ' 74' ' ' THR . 55.1 t -103.38 109.23 26.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.754 0.311 . . . . 0.0 111.061 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -138.63 19.24 2.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.728 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.86 34.44 2.08 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.264 0.554 . . . . 0.0 109.918 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.494 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 1.2 pmm? -21.76 119.77 0.14 Allowed Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 85.8 Cg_endo -86.42 -163.88 2.83 Favored 'Cis proline' 0 C--N 1.353 0.812 0 C-N-CA 123.81 -1.329 . . . . 0.0 111.899 -0.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 98.6 m -161.91 162.44 29.16 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.987 0.422 . . . . 0.0 111.374 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.455 ' CD1' ' HA ' ' A' ' 90' ' ' ALA . 75.8 mt -126.38 121.25 31.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.862 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.545 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 26.5 mt -120.05 123.94 44.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.576 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.528 ' O ' HG11 ' A' ' 84' ' ' VAL . 3.5 mp -109.71 146.88 34.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.38 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.521 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 56.3 m-85 -143.77 129.33 19.12 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.193 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 51.8 mtmt -109.86 129.44 55.64 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.258 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.485 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.3 m120 45.69 63.79 1.68 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.882 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 52.46 22.09 10.22 Favored Glycine 0 N--CA 1.453 -0.218 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.484 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 97.5 mttt -125.55 -156.13 0.71 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 33.7 tt0 -108.7 174.83 5.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.528 HG11 ' O ' ' A' ' 77' ' ' LEU . 4.3 p -162.19 -59.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 120.881 0.372 . . . . 0.0 111.369 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.486 ' H ' ' CG1' ' A' ' 84' ' ' VAL . . . -155.76 167.29 30.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.432 ' HG2' HD21 ' A' ' 76' ' ' LEU . 36.5 mtmm -150.5 130.42 13.36 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.414 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.1 t -145.11 90.25 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.407 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 2.8 p -60.71 88.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.757 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.21 101.24 0.57 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.475 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.531 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -75.5 61.16 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.861 0.362 . . . . 0.0 111.071 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -76.7 133.33 70.41 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.057 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -44.02 -24.29 0.84 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.547 2.165 . . . . 0.0 112.843 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.425 ' HA ' ' NZ ' ' A' ' 96' ' ' LYS . . . -95.16 27.65 3.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.356 -0.384 . . . . 0.0 112.022 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -164.21 -53.05 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.531 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 4.5 tp -49.2 -16.94 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 25.6 pttm -92.47 -51.36 5.17 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.966 0.412 . . . . 0.0 111.097 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.459 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 72.5 mt-30 -69.31 -32.04 70.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.879 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.55 -33.95 70.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.17 0.51 . . . . 0.0 110.47 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.461 ' CD1' ' N ' ' A' ' 99' ' ' ILE . 1.6 mp -90.4 -11.78 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.457 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.18 -62.92 1.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.806 0.336 . . . . 0.0 111.035 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.78 -27.43 51.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.011 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -83.66 -51.84 6.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.859 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.03 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.429 ' CG1' ' HE3' ' A' ' 54' ' ' LYS . 51.2 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.81 0.338 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 51.0 m -150.1 158.86 44.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.019 0.438 . . . . 0.0 111.504 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.578 ' HG2' ' NZ ' ' A' ' 54' ' ' LYS . 48.7 mt-30 -89.98 166.27 13.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.128 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.473 ' CE2' ' CG ' ' A' ' 11' ' ' PHE . 12.9 m-30 -114.4 120.26 39.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.926 0.393 . . . . 0.0 110.488 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -97.51 -41.44 8.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.798 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -123.12 139.46 54.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.69 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.18 -24.68 43.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.4 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.5 m -63.1 -15.81 57.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.607 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -90.15 -46.69 8.29 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.158 0.504 . . . . 0.0 110.967 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.473 ' CG ' ' CE2' ' A' ' 5' ' ' PHE . 1.1 t80 -75.39 -35.41 61.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.615 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -52.36 -31.3 33.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.057 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 t -90.05 -26.22 20.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.27 -52.0 64.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.438 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.4 pt -73.77 -48.88 37.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.334 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.431 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -41.48 95.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 45.73 92.06 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.217 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -174.7 39.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.315 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.54 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 11.0 mptt 64.97 -155.61 0.29 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.243 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.426 ' CD2' ' CB ' ' A' ' 102' ' ' ASN . 65.1 tp -98.04 115.57 28.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.015 0.436 . . . . 0.0 111.006 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.4 t -101.26 133.48 44.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.807 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.1 t -99.78 91.44 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.586 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.461 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 22.3 t -100.67 123.34 53.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.904 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 7.7 t70 -99.98 133.25 44.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.095 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.504 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 4.6 m-85 -99.25 54.41 0.97 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.161 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.577 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -54.19 146.48 15.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.712 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.54 146.32 53.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.896 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.526 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 2.4 t -77.32 -1.16 28.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.723 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -125.38 -33.87 2.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.8 t -46.96 159.19 0.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.93 -64.09 0.71 Allowed Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.297 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.7 -24.3 4.58 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.869 2.379 . . . . 0.0 113.305 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.404 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 86.8 m -58.03 -54.98 40.76 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -51.83 -28.21 15.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.687 0.279 . . . . 0.0 111.74 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.401 ' O ' ' HG3' ' A' ' 35' ' ' MET . 43.8 tpp -75.09 1.25 13.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.886 0.374 . . . . 0.0 110.72 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.656 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 61.9 mt -87.12 -18.77 8.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.705 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.534 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -51.99 -43.51 89.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 38.4 Cg_endo -71.18 -39.17 4.16 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.724 1.616 . . . . 0.0 111.611 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.462 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 1.2 mpt? -63.24 -56.23 18.3 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.514 HG13 ' CG2' ' A' ' 36' ' ' ILE . 56.8 mt -44.02 -28.58 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.687 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.411 ' N ' HG23 ' A' ' 2' ' ' VAL . 43.7 tt0 -81.04 -41.35 22.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.852 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.32 -31.84 69.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.175 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.462 ' HD1' ' O ' ' A' ' 39' ' ' MET . 11.0 m-85 -74.43 -17.17 60.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.251 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.7 t -70.92 -10.41 59.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.151 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -87.05 -24.59 24.56 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.697 0.284 . . . . 0.0 111.007 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -90.44 -34.73 15.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.585 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.544 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 67.7 m-85 -122.95 43.33 0.74 Allowed Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.706 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 95.3 Cg_exo -39.38 -31.99 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.934 2.423 . . . . 0.0 113.201 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -61.06 -37.54 83.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.834 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.85 148.84 22.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.01 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.77 148.94 22.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.64 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -125.44 85.93 2.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.425 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.47 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 45.5 m-85 -99.12 -176.02 3.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.574 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.578 ' NZ ' ' HG2' ' A' ' 4' ' ' GLN . 9.8 mtmp? -146.43 133.84 20.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.98 0.419 . . . . 0.0 111.104 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.482 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 2.9 tm? -89.77 139.05 30.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.999 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -95.17 101.49 13.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.467 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 71.7 t -68.23 -12.72 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 0.0 110.466 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.526 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 61.8 t0 -86.74 -31.27 21.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.44 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.409 ' HG3' HD13 ' A' ' 60' ' ' LEU . 40.2 tp10 -103.16 -51.98 3.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.237 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.413 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 5.5 mp -93.62 51.86 1.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.895 0.378 . . . . 0.0 111.06 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.11 -19.86 47.32 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.501 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.95 -29.27 61.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.618 0.246 . . . . 0.0 111.38 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.574 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 5.5 t -78.45 -48.1 23.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.362 . . . . 0.0 110.343 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.31 -24.93 46.65 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -90.37 -38.84 13.06 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.025 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -60.99 -41.74 97.04 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.933 0.397 . . . . 0.0 110.241 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -85.31 0.6 51.51 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.736 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 61.35 39.86 14.86 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.46 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.402 ' CG1' ' CG2' ' A' ' 74' ' ' THR . 46.1 t -109.69 107.12 22.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.848 0.356 . . . . 0.0 111.054 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 84.3 p -124.0 20.91 9.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.032 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.472 ' CB ' ' CG2' ' A' ' 88' ' ' VAL . . . -73.02 -149.13 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.741 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.502 ' HG3' ' O ' ' A' ' 72' ' ' MET . 18.3 ptt? -175.88 84.73 0.29 Allowed Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.656 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 6.9 Cg_endo -95.76 -156.28 0.44 Allowed 'Cis proline' 0 CA--C 1.534 0.509 0 C-N-CA 125.217 -0.743 . . . . 0.0 112.834 -0.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.438 HG21 ' N ' ' A' ' 75' ' ' LEU . 91.6 m -150.68 146.77 26.68 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.362 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.438 ' N ' HG21 ' A' ' 74' ' ' THR . 77.3 mt -112.35 122.08 46.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.785 0.326 . . . . 0.0 111.382 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.504 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 27.9 mt -120.82 128.13 52.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.656 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 3.7 mp -109.9 145.36 36.98 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.66 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.581 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 54.8 m-85 -146.52 127.45 14.51 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.262 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.511 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 9.8 mtpm? -115.19 135.92 53.66 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.638 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.477 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.2 m120 48.59 59.94 4.01 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.641 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 52.37 23.02 11.78 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.022 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.581 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 52.1 mtmt -126.91 -158.48 0.87 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.461 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 82.0 tt0 -108.97 178.41 4.48 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.461 ' CG1' ' O ' ' A' ' 83' ' ' GLU . 4.3 m -164.54 -47.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.533 0.206 . . . . 0.0 111.251 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -169.98 154.37 5.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.038 0.447 . . . . 0.0 111.845 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -137.8 113.93 10.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.409 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.3 t -121.82 81.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.067 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.472 ' CG2' ' CB ' ' A' ' 71' ' ' ALA . 7.4 p -50.27 94.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.18 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.04 131.35 3.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.254 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.471 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -95.6 35.86 1.32 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.919 0.39 . . . . 0.0 111.133 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -59.04 108.04 1.19 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.97 179.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -33.02 90.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.138 2.559 . . . . 0.0 113.113 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 172.97 -30.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.122 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.99 -44.32 2.06 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.471 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 4.6 tp -49.35 -19.07 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.738 0.304 . . . . 0.0 111.179 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -91.2 -66.17 0.95 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.981 0.419 . . . . 0.0 111.22 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -60.79 -34.41 74.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.964 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.88 -31.29 68.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.06 0.457 . . . . 0.0 110.702 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.439 HG21 HD13 ' A' ' 99' ' ' ILE . 66.6 mt -90.25 -10.75 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.373 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.44 -68.68 0.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.839 0.352 . . . . 0.0 111.4 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.87 -28.21 34.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.367 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.426 ' CB ' ' CD2' ' A' ' 20' ' ' LEU . 3.6 m120 -83.48 -48.21 10.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.106 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.135 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.711 0.291 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.1 m -150.08 147.47 27.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.095 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.502 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 60.1 mt-30 -89.94 -176.9 5.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.39 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.51 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.9 m-85 -134.73 135.97 42.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.024 0.44 . . . . 0.0 111.375 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 34.5 mmtp -112.92 -33.76 5.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.536 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.9 m -124.54 165.55 17.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.82 52.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.77 0.319 . . . . 0.0 111.068 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.4 t -59.35 -16.42 22.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.791 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -90.09 -58.32 2.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.299 0.571 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.482 ' CZ ' ' CG2' ' A' ' 23' ' ' VAL . 1.1 t80 -66.42 -28.42 68.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.64 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -59.04 -42.73 90.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.817 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.5 m -79.23 -29.95 42.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.78 -32.4 67.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.194 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.8 pt -90.0 -49.15 13.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.275 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.456 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -42.95 101.9 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.1 mt-30 43.78 86.1 0.02 OUTLIER 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.211 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -166.24 39.26 0.05 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.62 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.544 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER 65.37 -153.29 0.27 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.729 0.299 . . . . 0.0 110.364 179.063 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.442 ' CD1' HG23 ' A' ' 84' ' ' VAL . 54.6 tp -97.7 114.18 26.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.06 0.457 . . . . 0.0 110.928 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 52.3 t -103.28 120.17 52.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.726 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.404 ' CG2' HG12 ' A' ' 99' ' ' ILE . 48.1 t -99.83 98.31 6.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.622 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.482 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 44.1 t -99.74 145.45 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.167 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 74' ' ' THR . 37.4 t70 -106.97 126.06 51.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.597 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.542 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 7.4 m-85 -98.88 50.42 0.96 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.152 0.501 . . . . 0.0 110.308 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.513 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -53.15 139.25 29.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.529 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.43 ' CB ' ' HB3' ' A' ' 72' ' ' MET . . . -63.13 149.16 45.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.572 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.4 t -74.53 -11.91 60.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.79 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.538 ' O ' ' C ' ' A' ' 30' ' ' CYS . 5.4 p-90 -112.18 -60.39 1.87 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.538 ' C ' ' O ' ' A' ' 29' ' ' TRP . 50.6 t 4.07 -80.95 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.431 0.692 . . . . 0.0 112.774 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.14 -78.48 0.35 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.582 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.02 -15.71 43.82 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.574 2.183 . . . . 0.0 112.567 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.9 p -52.9 -26.7 15.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.138 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -75.79 -16.84 60.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.553 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.419 ' O ' ' HG2' ' A' ' 35' ' ' MET . 48.0 ttm -74.17 2.07 9.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.038 0.447 . . . . 0.0 110.779 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.531 ' CG2' HG13 ' A' ' 40' ' ' ILE . 55.6 mt -83.74 -25.83 7.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.639 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.495 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -45.9 -45.02 36.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 40.4 Cg_endo -72.32 -37.69 4.23 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 121.694 1.596 . . . . 0.0 111.096 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.431 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 88.8 mtp -64.11 -54.9 26.66 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.531 HG13 ' CG2' ' A' ' 36' ' ' ILE . 67.2 mt -46.79 -27.62 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.703 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -81.19 -34.05 32.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.336 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -67.0 -22.74 65.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.739 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.435 ' CB ' ' CE2' ' A' ' 52' ' ' PHE . 5.9 m-85 -84.75 -21.91 29.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.716 0.294 . . . . 0.0 111.597 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.2 m -68.65 -12.06 60.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.015 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.406 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 39.4 tt0 -88.63 -23.81 22.97 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.826 0.346 . . . . 0.0 110.541 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -90.43 -38.23 13.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.371 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.536 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 60.5 m-85 -123.92 43.87 0.9 Allowed Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 89.6 Cg_exo -38.59 -29.03 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.046 2.497 . . . . 0.0 113.014 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.474 ' OE1' ' N ' ' A' ' 49' ' ' GLN . 0.3 OUTLIER -57.17 -37.8 72.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.692 179.548 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 20' ' ' LEU . . . -89.86 152.93 21.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.137 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.66 123.31 41.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.751 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.435 ' CE2' ' CB ' ' A' ' 43' ' ' PHE . 4.1 m-85 -100.93 104.43 15.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.111 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.51 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 46.5 m-85 -113.89 -178.81 3.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.212 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.513 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 32.9 mtpt -137.62 142.92 41.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.212 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.458 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 2.7 tm? -107.82 138.54 43.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.803 0.335 . . . . 0.0 110.733 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.414 ' HB3' HD11 ' A' ' 60' ' ' LEU . 26.4 t70 -93.03 113.39 25.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.909 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 52.6 t -73.5 -6.12 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.411 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.506 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 38.6 t70 -97.6 -46.39 6.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.085 0.469 . . . . 0.0 110.613 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 6' ' ' LYS . 38.2 tp10 -83.72 -32.54 25.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.101 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.451 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 3.6 mp -119.72 59.92 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.905 0.383 . . . . 0.0 110.929 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.21 -8.07 64.65 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.708 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -83.91 -28.31 27.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.674 0.273 . . . . 0.0 111.448 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.618 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 7.3 t -78.01 -45.28 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.869 0.366 . . . . 0.0 110.544 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.22 -24.92 45.33 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -90.45 -40.2 12.16 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.299 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -57.86 -48.92 78.4 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.892 0.377 . . . . 0.0 110.458 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.6 m-80 -78.14 -3.79 44.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.963 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 66.55 40.42 3.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.225 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.454 HG13 ' CB ' ' A' ' 74' ' ' THR . 58.0 t -83.45 -77.39 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 120.761 0.315 . . . . 0.0 110.869 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.7 p 47.91 25.45 0.76 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.756 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.91 -159.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.589 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -172.74 90.4 0.4 Allowed Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.484 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 22.5 Cg_endo -91.99 -160.41 1.07 Allowed 'Cis proline' 0 C--N 1.349 0.577 0 C-N-CA 124.625 -0.99 . . . . 0.0 112.42 -0.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.454 ' CB ' HG13 ' A' ' 69' ' ' VAL . 98.5 m -156.31 155.49 32.35 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.849 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.425 ' CD1' ' CD1' ' A' ' 95' ' ' ILE . 72.6 mt -120.22 121.38 38.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.935 0.398 . . . . 0.0 111.288 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.542 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 20.1 mt -118.99 128.57 54.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.875 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 4.3 mp -109.7 138.31 46.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.723 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.486 ' CE1' ' OE2' ' A' ' 83' ' ' GLU . 73.7 m-85 -137.51 126.91 24.87 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.542 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.47 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 59.5 mttm -109.84 128.71 55.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.728 0.299 . . . . 0.0 111.275 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 6.0 m120 44.27 58.04 3.98 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 61.64 13.55 39.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.372 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -111.71 -156.81 0.6 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.486 ' OE2' ' CE1' ' A' ' 78' ' ' PHE . 10.9 tp10 -108.78 173.82 6.15 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.47 ' CG2' ' HG3' ' A' ' 79' ' ' LYS . 56.8 t -146.64 -62.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.748 0.309 . . . . 0.0 111.317 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.13 159.26 7.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.357 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -122.29 115.44 22.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.611 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.57 80.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.419 ' HA ' HG23 ' A' ' 74' ' ' THR . 2.7 p -57.18 95.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.017 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.6 114.27 1.27 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.611 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.463 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -98.66 33.85 2.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 110.908 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -62.07 108.58 1.67 Allowed Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.968 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -31.91 88.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.229 2.62 . . . . 0.0 113.216 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 176.17 -35.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.85 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.62 -43.33 2.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.577 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 4.6 tp -53.26 -15.53 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.704 -0.226 . . . . 0.0 111.277 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.42 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 64.5 pttt -91.2 -49.25 6.48 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.78 0.324 . . . . 0.0 110.642 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.42 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 72.7 mt-30 -71.85 -32.15 67.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.366 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.24 -31.53 71.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.441 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.431 HG23 ' CG ' ' A' ' 47' ' ' TYR . 56.5 mt -90.08 -6.57 10.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.305 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.38 -65.29 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.921 0.391 . . . . 0.0 111.036 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.82 -29.78 8.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.944 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.415 ' HB2' ' CD2' ' A' ' 20' ' ' LEU . 67.5 m-20 -90.07 -67.79 0.82 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.948 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.126 -179.983 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.41 ' CG1' ' HD2' ' A' ' 54' ' ' LYS . 44.1 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.775 0.321 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.5 m -149.95 164.84 34.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.864 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.508 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -105.61 -177.35 3.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.339 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.481 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.9 m-85 -130.33 131.43 45.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.984 0.421 . . . . 0.0 111.483 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 59' ' ' GLU . 34.5 mmtp -114.49 -19.74 11.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.774 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -141.23 136.96 32.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.466 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.07 -28.42 17.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.242 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.9 m -59.32 -19.83 49.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.244 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.43 ' HG3' ' CE1' ' A' ' 5' ' ' PHE . 17.6 tp10 -90.49 -37.93 13.57 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.334 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.487 ' CD1' ' O ' ' A' ' 11' ' ' PHE . 1.1 t80 -90.2 15.83 9.64 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.06 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -89.79 -45.98 8.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.875 0.369 . . . . 0.0 110.662 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -79.6 -23.36 42.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.97 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.83 -50.48 68.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.205 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.7 pt -83.12 -50.02 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.334 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.431 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -40.06 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 79.9 mt-30 39.19 85.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.662 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 9.1 t70 -162.49 40.52 0.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.668 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.534 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 10.9 mptt 67.2 -156.52 0.22 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.458 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.425 ' CD2' ' CB ' ' A' ' 102' ' ' ASN . 64.3 tp -98.18 116.42 30.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.203 0.525 . . . . 0.0 110.977 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.9 t -103.12 134.69 43.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.748 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.2 t -99.7 92.32 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.65 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.485 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 48.0 t -99.83 124.34 53.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.044 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 8.1 t70 -99.98 129.17 46.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.921 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.541 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 5.7 m-85 -98.99 48.57 0.96 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.185 0.516 . . . . 0.0 110.348 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.541 ' O ' ' HD1' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -50.14 134.55 22.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.139 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.443 ' CB ' ' HB3' ' A' ' 72' ' ' MET . . . -60.72 153.04 25.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.196 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.416 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 3.3 t -76.89 2.25 15.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.514 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.419 ' CD1' ' HB1' ' A' ' 27' ' ' ALA . 5.4 p-90 -127.35 -125.3 0.23 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.746 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 48.8 t 62.49 -77.58 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.931 0.492 . . . . 0.0 111.421 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.11 -80.18 0.27 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.979 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.26 51.0 3.33 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.744 2.296 . . . . 0.0 112.523 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 99.5 m -112.5 -28.25 7.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.734 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -79.94 -15.9 56.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.495 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.4 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 66.1 mtt -74.7 4.16 6.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.764 0.316 . . . . 0.0 111.102 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.517 ' CG2' HG13 ' A' ' 40' ' ' ILE . 52.7 mt -83.53 -26.27 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.534 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.485 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -45.67 -45.39 34.74 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 44.1 Cg_endo -73.1 -36.36 4.36 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.773 1.649 . . . . 0.0 111.268 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 49.6 ttm -65.24 -53.11 49.21 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.517 HG13 ' CG2' ' A' ' 36' ' ' ILE . 79.0 mt -46.91 -30.44 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.593 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -76.79 -37.01 56.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.938 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.97 -22.74 62.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.367 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -90.1 -16.48 29.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.488 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.4 t -74.84 -6.88 51.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.236 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -90.12 -27.94 19.3 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.785 0.326 . . . . 0.0 111.052 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -90.47 -28.33 18.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.723 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.539 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 76.0 m-85 -123.14 43.93 0.85 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.698 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 98.5 Cg_exo -39.76 -31.62 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.977 2.451 . . . . 0.0 113.098 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -62.26 -37.82 86.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.941 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 20' ' ' LEU . . . -89.88 147.75 23.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.172 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -89.84 153.67 20.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.54 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -128.55 93.88 3.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.025 0.44 . . . . 0.0 111.479 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.481 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 49.6 m-85 -107.44 178.59 4.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.596 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.508 ' HB2' ' HA ' ' A' ' 4' ' ' GLN . 16.5 mtpp -139.09 146.92 41.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.51 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 25' ' ' PHE . 2.8 tm? -108.19 140.9 40.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.072 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.409 ' N ' HD13 ' A' ' 55' ' ' LEU . 27.8 t70 -95.43 116.04 28.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.55 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 60.6 t -76.88 -1.85 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.649 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.416 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 8.1 t70 -103.5 -43.57 5.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.024 0.44 . . . . 0.0 110.575 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.408 ' HG3' HD13 ' A' ' 60' ' ' LEU . 38.5 tp10 -86.12 -39.69 16.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.022 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.413 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 4.8 mp -111.4 44.01 1.4 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.849 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.15 -28.02 53.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.379 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.51 -29.1 70.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.739 0.304 . . . . 0.0 111.158 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.481 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 6.8 t -79.3 -45.42 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.438 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.36 -22.85 55.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.409 . . . . 0.0 110.058 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -90.16 -38.13 13.71 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.205 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 15.6 pttp -60.89 -47.1 87.93 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.972 0.415 . . . . 0.0 110.084 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.401 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.6 m-20 -77.93 -4.44 46.89 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.917 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 66.94 39.51 3.27 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.034 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.3 t -110.18 107.71 23.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.756 0.313 . . . . 0.0 110.97 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.5 t -121.87 -1.82 9.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.779 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.466 ' CB ' HG21 ' A' ' 88' ' ' VAL . . . -61.01 -157.75 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.578 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -175.26 100.92 0.26 Allowed Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 32.6 Cg_endo -88.54 -162.06 1.92 Allowed 'Cis proline' 0 C--N 1.353 0.795 0 C-N-CA 124.701 -0.958 . . . . 0.0 112.669 -0.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.415 HG23 ' HA ' ' A' ' 88' ' ' VAL . 42.8 m -158.58 146.86 18.41 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.098 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.403 HD11 ' HA ' ' A' ' 90' ' ' ALA . 84.3 mt -113.97 123.04 48.75 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.804 0.335 . . . . 0.0 111.701 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.541 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 18.2 mt -116.94 129.87 56.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.493 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 3.9 mp -109.78 142.01 41.62 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.719 0.295 . . . . 0.0 111.017 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.571 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 63.8 m-85 -143.71 126.58 16.26 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.274 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.501 ' HE2' HG12 ' A' ' 84' ' ' VAL . 41.6 mtmt -118.91 136.76 53.89 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.379 178.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 78.3 m-20 50.81 60.92 3.52 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.569 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 50.04 26.19 8.5 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.849 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.571 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 98.9 mttt -132.34 -159.55 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.488 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 28.7 tt0 -109.05 -179.75 3.94 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.501 HG12 ' HE2' ' A' ' 79' ' ' LYS . 12.2 m -163.75 -49.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.588 0.232 . . . . 0.0 111.217 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.14 156.54 14.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.054 0.454 . . . . 0.0 111.726 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -138.81 113.63 9.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.33 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.63 91.1 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.075 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.466 HG21 ' CB ' ' A' ' 71' ' ' ALA . 7.2 p -61.66 83.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.983 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.7 113.17 0.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.236 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.483 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -95.36 37.76 1.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.355 . . . . 0.0 111.387 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 93' ' ' ALA . 5.5 m120 -73.69 131.88 81.51 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.325 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -46.7 86.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.674 2.249 . . . . 0.0 112.665 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 174.35 -35.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.425 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.39 -46.55 2.87 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.781 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 4.9 tp -53.45 -14.8 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.526 0.203 . . . . 0.0 111.278 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -91.03 -49.52 6.37 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.883 0.373 . . . . 0.0 110.864 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -73.13 -32.38 64.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.447 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.33 -30.27 70.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.681 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.442 ' CG2' ' CD2' ' A' ' 47' ' ' TYR . 67.6 mt -90.19 -14.91 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.25 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.38 -70.51 0.67 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.84 0.352 . . . . 0.0 111.182 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.69 -28.69 6.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.272 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.425 ' CB ' ' CD2' ' A' ' 20' ' ' LEU . 5.7 m120 -83.18 -48.3 10.67 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.061 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.121 -179.953 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.401 ' CG1' ' HE2' ' A' ' 54' ' ' LYS . 47.4 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.838 0.351 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.8 m -147.89 154.49 40.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.03 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.527 ' HG2' ' HE3' ' A' ' 54' ' ' LYS . 16.2 mt-30 -93.74 177.25 6.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.624 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.525 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 14.4 m-85 -127.98 136.17 50.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.0 111.241 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HB3' ' HG2' ' A' ' 59' ' ' GLU . 34.4 mmtp -115.95 -46.34 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.513 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.1 p -114.81 134.11 55.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.534 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.09 -24.68 18.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.431 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.2 m -62.37 -16.58 55.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.556 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -90.21 -58.01 2.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.347 0.594 . . . . 0.0 111.076 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.523 ' CD1' ' CE2' ' A' ' 5' ' ' PHE . 1.1 t80 -61.28 -31.47 71.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.667 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -55.54 -23.32 25.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.1 t -80.37 -45.99 16.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.191 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.96 -46.52 68.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.29 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.853 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 24.1 pt -78.16 -4.63 6.88 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.833 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.901 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.18 81.82 6.1 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.682 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 74.9 mt-30 48.14 91.76 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.608 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 63.9 t0 -168.91 39.62 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.533 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 88.0 mttt 76.12 -156.83 0.04 OUTLIER 'General case' 0 C--O 1.23 0.065 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.564 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.491 ' CD1' HG22 ' A' ' 84' ' ' VAL . 59.7 tp -98.07 116.95 31.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.216 0.531 . . . . 0.0 110.79 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.89 124.22 56.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.801 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.4 HG21 ' CD1' ' A' ' 99' ' ' ILE . 46.0 t -99.79 97.88 6.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.665 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.477 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 40.2 t -105.12 131.04 55.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.424 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 7.8 t70 -99.87 130.67 46.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.453 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.535 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 6.3 m-85 -99.06 49.48 0.95 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.975 0.417 . . . . 0.0 110.69 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.568 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -51.05 140.74 15.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.067 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 72' ' ' MET . . . -62.27 157.35 19.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.754 0.311 . . . . 0.0 110.505 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.524 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 5.0 t -83.58 4.12 29.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.406 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 18.2 p-90 -124.64 -46.6 1.87 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.419 ' HB2' ' HG3' ' A' ' 72' ' ' MET . 22.3 t -43.96 127.97 5.5 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 111.414 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.41 -64.14 2.23 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.98 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -41.5 -28.26 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.389 2.726 . . . . 0.0 113.176 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.9 m -61.5 -14.57 30.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.418 ' C ' ' HD2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -78.8 -25.85 44.29 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.163 -179.497 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.445 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 66.0 mtm -75.39 1.52 13.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 110.301 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.481 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 28.1 mm -79.2 -44.37 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.873 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.472 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -41.7 -47.16 9.61 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.04 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.481 ' HD2' ' C ' ' A' ' 36' ' ' ILE . 45.6 Cg_endo -73.91 -27.77 11.91 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.79 1.66 . . . . 0.0 111.233 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.402 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 14.2 tpt -74.16 -50.02 21.16 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.459 HG23 HD13 ' A' ' 40' ' ' ILE . 63.8 mt -50.96 -32.72 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.389 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -72.37 -39.56 67.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.113 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.452 ' HB3' ' NZ ' ' A' ' 42' ' ' LYS . 9.6 mtpm? -57.88 -23.94 55.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.712 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.402 ' HD1' ' O ' ' A' ' 39' ' ' MET . 6.0 m-85 -90.43 -16.88 28.18 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.1 t -72.95 -7.66 52.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.523 0.201 . . . . 0.0 111.456 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -90.15 -26.53 20.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.757 0.313 . . . . 0.0 111.081 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.07 -30.07 17.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.531 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.504 ' CG ' HG22 ' A' ' 99' ' ' ILE . 79.6 m-85 -125.44 51.86 5.97 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.088 0.47 . . . . 0.0 110.745 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 1.4 Cg_endo -46.79 -26.5 4.68 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.085 2.523 . . . . 0.0 112.987 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.416 ' O ' ' HD3' ' A' ' 19' ' ' LYS . 73.8 mt-30 -69.04 -29.24 67.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.122 0.487 . . . . 0.0 110.394 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 20' ' ' LEU . . . -89.58 139.06 30.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.781 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -89.56 121.69 32.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.268 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.446 ' CE2' HD11 ' A' ' 99' ' ' ILE . 6.2 m-85 -99.02 81.77 2.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.596 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.525 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 47.4 m-85 -94.47 -175.12 3.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.357 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.568 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 47.0 mtmt -148.47 138.2 22.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.994 0.426 . . . . 0.0 110.75 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.429 ' CD1' ' N ' ' A' ' 56' ' ' ASP . 2.2 tm? -98.35 141.95 30.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.325 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.429 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 9.9 t70 -92.74 125.09 37.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.949 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 92.1 t -93.14 42.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.436 0.636 . . . . 0.0 110.621 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.524 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 64.5 t0 -152.97 -48.78 0.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.035 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.408 ' HG2' ' HB3' ' A' ' 6' ' ' LYS . 5.3 tp10 -75.56 -27.35 58.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.171 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' A' ' 60' ' ' LEU . 2.5 mm? -103.16 -64.43 1.08 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.376 0.608 . . . . 0.0 111.007 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.5 -61.25 0.64 Allowed Glycine 0 C--N 1.314 -0.658 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.644 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -51.17 -36.79 42.85 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.532 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 6.6 t -70.51 -58.25 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 110.589 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.49 -24.84 8.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.002 0.43 . . . . 0.0 110.074 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -90.14 -37.49 14.17 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.259 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 17.4 pttp -60.71 -48.77 80.28 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.1 m-20 -76.71 -7.72 55.88 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.676 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 66.09 43.53 2.88 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.24 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.434 ' CG1' HG22 ' A' ' 74' ' ' THR . 49.0 t -107.37 74.6 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.885 0.374 . . . . 0.0 111.011 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.9 p -83.38 -11.32 57.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.996 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.438 ' CB ' HG23 ' A' ' 88' ' ' VAL . . . -58.14 -163.73 0.0 OUTLIER 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.728 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.547 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -178.1 106.64 0.21 Allowed Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 42.8 Cg_endo -89.72 -165.35 2.64 Favored 'Cis proline' 0 C--N 1.351 0.687 0 C-N-CA 124.485 -1.048 . . . . 0.0 112.612 -0.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 91.7 m -152.59 163.24 39.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.811 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' A' ' 90' ' ' ALA . 80.9 mt -128.02 120.73 28.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.098 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.535 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 21.8 mt -118.93 124.11 46.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.758 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 4.3 mp -109.82 135.4 50.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.474 ' HA ' HG23 ' A' ' 84' ' ' VAL . 42.4 m-85 -136.05 129.05 31.37 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.602 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.441 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 9.2 mtpm? -114.65 124.04 50.83 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.99 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 6.4 m120 43.9 82.46 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.652 0.263 . . . . 0.0 111.213 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.853 ' HA2' ' O ' ' A' ' 15' ' ' ILE . . . 33.83 46.77 0.45 Allowed Glycine 0 C--N 1.333 0.38 0 CA-C-N 116.024 -0.535 . . . . 0.0 114.202 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 34.5 mmtp -146.97 -158.73 0.94 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.421 ' C ' HG23 ' A' ' 84' ' ' VAL . 34.0 tt0 -108.69 174.01 6.06 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.491 HG22 ' CD1' ' A' ' 20' ' ' LEU . 59.2 t -145.08 -69.08 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 0.0 111.107 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.25 155.32 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.377 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -112.65 138.26 49.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.069 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -154.6 78.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.141 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 2.5 p -58.73 90.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.093 0.473 . . . . 0.0 110.611 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 136.35 124.3 2.35 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.08 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.476 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -87.85 47.37 1.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.871 0.367 . . . . 0.0 111.468 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -53.35 110.02 1.8 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -33.2 -31.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.167 2.578 . . . . 0.0 113.64 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -95.49 30.49 2.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.445 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -152.34 -60.13 0.15 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 4.3 tp -51.91 -11.97 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.338 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 64.8 pttt -91.13 -51.09 5.49 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.843 0.354 . . . . 0.0 110.669 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.43 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 9.7 mm-40 -69.52 -32.02 70.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.51 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.78 -32.15 73.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.613 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.504 HG22 ' CG ' ' A' ' 47' ' ' TYR . 50.5 mt -90.14 -7.92 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.488 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.09 -68.62 0.77 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.924 0.393 . . . . 0.0 111.259 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.67 -29.14 51.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.132 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -80.39 -52.5 7.6 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.037 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.071 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.444 ' CG1' ' NZ ' ' A' ' 54' ' ' LYS . 55.0 t . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.763 0.316 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 90.1 m -150.2 162.1 41.13 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.173 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.57 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -100.28 -177.68 3.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 179.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.511 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 23.8 m-85 -124.79 150.59 46.17 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.03 0.443 . . . . 0.0 111.671 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 72.7 mmtt -128.52 -37.21 1.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.974 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 m -116.65 164.0 15.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.13 -27.85 57.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.993 0.425 . . . . 0.0 110.933 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.2 m -64.13 -12.58 41.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.969 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -89.98 -69.35 0.73 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.226 0.536 . . . . 0.0 111.401 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.512 ' CZ ' ' CG2' ' A' ' 23' ' ' VAL . 1.1 t80 -56.9 -25.88 57.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.085 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -56.38 -42.71 78.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.23 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -82.06 -24.81 35.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.321 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.83 -46.09 81.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.476 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.8 pt -80.21 -49.59 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.46 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.439 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -43.55 98.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 45.58 90.49 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.223 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -171.42 39.5 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.267 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.535 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.7 mptp? 63.54 -154.98 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.233 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.445 ' CD1' HG22 ' A' ' 84' ' ' VAL . 43.7 tp -98.05 115.99 29.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.135 0.493 . . . . 0.0 110.848 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.2 t -103.08 134.34 44.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.983 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.418 ' CG2' HG13 ' A' ' 99' ' ' ILE . 46.3 t -99.78 92.61 2.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.479 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.512 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 38.5 t -99.91 125.29 53.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.081 0.467 . . . . 0.0 111.334 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 74' ' ' THR . 38.5 t70 -99.91 130.53 46.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.916 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.541 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 5.7 m-85 -98.96 49.45 0.96 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.096 0.474 . . . . 0.0 110.208 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.697 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -50.68 139.8 15.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.786 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.433 ' CB ' ' HB3' ' A' ' 72' ' ' MET . . . -60.59 142.12 55.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.525 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.47 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 5.8 t -69.05 -11.53 60.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.565 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.453 ' CH2' ' HG2' ' A' ' 72' ' ' MET . 21.5 p-90 -109.55 -45.3 3.71 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 24.6 t -42.38 139.54 1.45 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.657 0.265 . . . . 0.0 111.264 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.11 -57.19 1.72 Allowed Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.82 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -46.16 -27.67 4.77 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.7 2.266 . . . . 0.0 112.754 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.416 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . 84.8 m -65.68 -21.1 66.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.54 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -73.45 -29.6 62.65 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -78.86 5.96 10.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.041 0.448 . . . . 0.0 110.989 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.636 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 69.9 mt -83.29 -27.44 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.119 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.518 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -49.18 -45.79 75.85 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 47.6 Cg_endo -72.04 -37.51 4.76 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 121.699 1.599 . . . . 0.0 111.134 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 58.3 ttp -62.34 -53.1 59.9 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.484 HG13 ' CG2' ' A' ' 36' ' ' ILE . 58.6 mt -47.61 -29.35 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.638 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.4 ' HA ' HG21 ' A' ' 2' ' ' VAL . 87.8 tt0 -78.49 -35.79 46.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.767 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 38' ' ' PRO . 72.7 mmtt -60.76 -21.97 63.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.433 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -90.12 -20.29 23.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.664 0.268 . . . . 0.0 111.632 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.4 p -74.15 -6.59 48.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.1 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -90.11 -29.44 18.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.82 0.343 . . . . 0.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.5 -29.73 17.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.676 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.54 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 71.2 m-85 -122.93 43.66 0.79 Allowed Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.654 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 93.7 Cg_exo -39.26 -31.51 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.993 2.462 . . . . 0.0 113.252 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.71 -38.13 84.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.903 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.04 146.52 24.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.951 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.87 148.7 23.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.72 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.409 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . 5.6 m-85 -125.27 98.35 5.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.243 0.544 . . . . 0.0 111.058 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.511 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 52.3 m-85 -113.84 -176.29 2.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.879 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.697 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 29.5 mttp -134.9 165.3 25.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.203 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.488 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 2.1 tm? -130.93 117.19 18.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.465 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.494 ' HB3' HD12 ' A' ' 60' ' ' LEU . 59.3 t0 -70.26 117.59 12.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.898 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 29.6 t -72.51 -8.34 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.852 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 31.9 t70 -100.97 -59.57 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.975 0.416 . . . . 0.0 110.606 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 6' ' ' LYS . 36.7 tp10 -66.48 -33.61 76.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.862 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.494 HD12 ' HB3' ' A' ' 56' ' ' ASP . 4.3 mp -120.47 40.37 3.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.951 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.52 -20.81 32.24 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.415 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.65 -42.1 99.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.693 0.282 . . . . 0.0 111.475 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.583 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 4.4 t -69.59 -46.97 74.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.946 0.403 . . . . 0.0 110.546 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 69' ' ' VAL . . . -53.62 -25.87 19.61 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.57 -41.66 11.24 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.451 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 12.9 ptmm? -55.92 -48.81 75.01 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.853 0.359 . . . . 0.0 110.695 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.415 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.4 m-20 -80.32 0.96 30.66 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.196 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 65.06 38.8 5.98 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.895 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.466 HG12 ' HB ' ' A' ' 74' ' ' THR . 47.5 t -107.92 93.48 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.883 0.373 . . . . 0.0 111.024 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.2 p -112.94 21.47 15.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.46 ' CB ' HG23 ' A' ' 88' ' ' VAL . . . -77.83 -154.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.583 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.453 ' HG2' ' CH2' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -171.46 87.12 0.47 Allowed Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.636 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 3.4 Cg_endo -96.35 -156.3 0.4 Allowed 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 124.888 -0.88 . . . . 0.0 112.663 0.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.466 ' HB ' HG12 ' A' ' 69' ' ' VAL . 87.7 m -154.19 148.05 25.51 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.467 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.428 ' CD1' ' HA ' ' A' ' 90' ' ' ALA . 83.3 mt -110.02 122.18 46.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.941 0.4 . . . . 0.0 111.62 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.541 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 23.5 mt -116.99 129.19 55.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.525 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.448 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 4.4 mp -109.75 135.25 50.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.02 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.507 ' HA ' HG23 ' A' ' 84' ' ' VAL . 57.2 m-85 -136.22 124.14 22.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.991 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.479 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 26.0 mtpp -112.12 126.93 55.71 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.405 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.489 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.3 m120 50.3 64.58 1.74 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.846 0.355 . . . . 0.0 111.635 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 50.44 24.99 7.95 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 116.185 -0.461 . . . . 0.0 113.319 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 61.5 mttp -128.94 -157.0 0.79 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -108.74 174.64 5.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.507 HG23 ' HA ' ' A' ' 78' ' ' PHE . 1.7 t -151.09 -55.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.973 0.416 . . . . 0.0 110.687 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.13 -164.24 0.4 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.848 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.476 ' HD3' ' N ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -164.4 125.83 2.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.027 0.441 . . . . 0.0 110.826 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.0 t -132.21 80.36 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.924 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.46 HG23 ' CB ' ' A' ' 71' ' ' ALA . 7.2 p -72.54 99.17 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.02 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.74 -23.1 0.33 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.213 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.533 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . 51.2 40.4 25.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.869 0.366 . . . . 0.0 111.101 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -59.5 134.26 88.76 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.916 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -47.67 -25.36 5.53 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.636 2.224 . . . . 0.0 112.733 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.75 26.45 10.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.625 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -137.5 -57.32 0.69 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.362 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 3.2 tp -54.81 -11.48 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.715 0.293 . . . . 0.0 110.867 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -92.0 -59.49 2.09 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.055 0.455 . . . . 0.0 110.801 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -63.32 -33.32 75.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.101 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.44 -31.06 65.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.115 0.483 . . . . 0.0 110.664 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.49 ' CD1' ' N ' ' A' ' 99' ' ' ILE . 1.4 mp -90.18 -8.29 10.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.542 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.57 -71.78 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.789 0.328 . . . . 0.0 111.34 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.2 -30.04 48.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.334 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.438 ' CB ' ' CD2' ' A' ' 20' ' ' LEU . 3.0 m120 -77.37 -50.02 13.67 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.986 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.167 -0.921 . . . . 0.0 111.131 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.683 0.278 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 92.2 m -150.04 161.72 41.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.028 0.442 . . . . 0.0 111.702 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.628 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 51.0 mt-30 -96.19 178.7 5.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.135 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.477 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 17.3 m-85 -124.66 127.58 47.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.925 0.393 . . . . 0.0 111.133 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -107.92 -26.7 10.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.691 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.8 p -134.05 129.25 35.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.35 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.28 -26.02 6.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.57 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -61.62 -16.76 51.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.56 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -90.4 -41.72 11.32 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.107 0.48 . . . . 0.0 111.281 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.459 ' CG ' ' CE2' ' A' ' 5' ' ' PHE . 1.1 t80 -78.38 -27.63 46.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.055 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -51.9 -57.47 9.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.391 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 t -71.32 -23.06 61.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.499 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' A' ' 11' ' ' PHE . . . -56.56 -44.19 80.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.474 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.1 pt -81.08 -49.93 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.483 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.483 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -45.58 101.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 44.78 89.08 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.223 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -171.72 40.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.313 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.544 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 3.1 mppt? 62.45 -156.67 0.34 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.25 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.467 ' CD1' HG21 ' A' ' 84' ' ' VAL . 54.7 tp -98.06 116.51 30.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.089 0.471 . . . . 0.0 110.863 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.96 134.78 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.638 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.82 84.24 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.951 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.453 HG21 ' CE1' ' A' ' 11' ' ' PHE . 38.8 t -101.11 120.17 50.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.098 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.448 ' OD1' HD21 ' A' ' 75' ' ' LEU . 2.9 m-20 -99.31 137.91 37.15 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.009 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.536 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 4.8 m-85 -99.35 53.21 0.95 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.646 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.555 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -52.64 137.38 30.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.439 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.418 ' CB ' ' HB3' ' A' ' 72' ' ' MET . . . -66.1 134.82 53.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.549 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.439 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.6 t -57.59 -17.77 16.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.334 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.444 ' CZ3' ' SD ' ' A' ' 72' ' ' MET . 6.4 p-90 -109.12 -125.98 0.26 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 40.0 t 61.58 -82.24 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 122.448 0.299 . . . . 0.0 110.951 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.45 -77.77 0.29 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.067 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.03 -18.69 51.97 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.916 2.41 . . . . 0.0 112.98 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.439 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 95.0 m -52.88 -26.14 13.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.666 0.269 . . . . 0.0 111.711 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -79.47 -24.75 42.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.667 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 89.6 mmm -72.55 -2.22 18.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.729 0.299 . . . . 0.0 111.099 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.514 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 44.0 mt -85.58 -22.88 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.822 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.497 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -51.7 -44.73 91.07 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 47.2 Cg_endo -72.82 -34.42 6.8 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 121.802 1.668 . . . . 0.0 111.322 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.407 ' HE2' ' CZ ' ' A' ' 43' ' ' PHE . 27.7 ttt -65.9 -52.21 51.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.493 HG13 ' CG2' ' A' ' 36' ' ' ILE . 75.9 mt -48.77 -29.34 2.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.581 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -76.9 -32.71 57.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.062 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -66.73 -19.61 65.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.72 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.407 ' CZ ' ' HE2' ' A' ' 39' ' ' MET . 3.6 m-85 -90.18 -26.65 20.03 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.403 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 53.9 m -59.87 -16.14 26.76 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.16 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.454 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 56.2 mt-10 -86.19 -20.32 28.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.821 0.344 . . . . 0.0 110.853 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -90.54 -37.29 13.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.552 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.586 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 72.4 m-85 -122.45 41.24 0.51 Allowed Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.723 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 75.5 Cg_exo -34.94 -33.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.5 2.8 . . . . 0.0 113.704 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -57.26 -36.8 71.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.035 0.445 . . . . 0.0 110.594 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 20' ' ' LEU . . . -89.8 143.01 27.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.561 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -89.68 121.86 32.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.911 0.386 . . . . 0.0 110.694 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.403 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 5.5 m-85 -95.21 85.79 4.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.594 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.477 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 34.7 m-85 -97.82 -176.87 3.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.27 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.628 ' HE2' ' HG2' ' A' ' 4' ' ' GLN . 35.1 mtmm -150.03 136.17 18.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.052 0.453 . . . . 0.0 110.982 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.447 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 2.4 tm? -93.04 139.94 30.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.963 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.408 ' HB3' HD12 ' A' ' 60' ' ' LEU . 9.2 t0 -95.27 112.57 24.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.856 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 53.5 t -73.2 -7.38 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.423 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.439 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 9.2 t70 -97.6 -59.84 1.69 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.972 0.415 . . . . 0.0 110.521 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.446 ' HG3' HD13 ' A' ' 60' ' ' LEU . 16.9 tp10 -67.55 -32.92 74.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.882 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.446 HD13 ' HG3' ' A' ' 59' ' ' GLU . 4.7 mp -120.03 58.3 0.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.928 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.35 -15.26 58.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.647 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.92 -27.05 43.7 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.68 0.276 . . . . 0.0 111.452 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.511 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 11.7 t -77.59 -51.49 18.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.477 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.21 -23.22 46.39 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.18 -37.98 13.79 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.229 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.511 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 17.2 pttp -59.88 -48.52 81.35 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.918 0.389 . . . . 0.0 110.131 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.413 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.0 m-20 -77.86 -6.33 53.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.871 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 66.38 42.51 2.94 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.117 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.415 HG13 ' CB ' ' A' ' 74' ' ' THR . 48.5 t -110.44 78.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.81 0.338 . . . . 0.0 111.196 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 81.4 p -90.53 10.26 26.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.096 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.415 ' HB3' HG21 ' A' ' 88' ' ' VAL . . . -61.46 -156.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.747 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 72' ' ' MET . 9.5 ptt? -176.68 86.93 0.26 Allowed Pre-proline 0 CA--C 1.53 0.185 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.514 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 43.0 Cg_endo -98.06 -159.58 0.46 Allowed 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 125.131 -0.779 . . . . 0.0 112.467 -0.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 88' ' ' VAL . 83.6 m -149.9 161.22 42.71 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.825 0.345 . . . . 0.0 111.269 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.481 ' CD1' ' HA ' ' A' ' 90' ' ' ALA . 37.3 mt -122.1 124.1 43.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.305 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.536 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 22.2 mt -123.64 125.5 44.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.761 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.446 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 4.6 mp -109.75 136.36 49.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.484 ' HA ' HG22 ' A' ' 84' ' ' VAL . 53.2 m-85 -137.13 125.11 22.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.054 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.467 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 54.1 mtpt -112.43 131.21 55.68 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.514 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.476 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.4 m120 48.94 54.85 10.16 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.883 0.373 . . . . 0.0 111.719 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 58.4 17.56 32.93 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 121.276 -0.488 . . . . 0.0 113.02 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 31.0 mmmt -115.62 -153.76 0.53 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 88.1 tt0 -108.79 172.72 6.68 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.484 HG22 ' HA ' ' A' ' 78' ' ' PHE . 44.8 t -146.45 -64.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.756 0.312 . . . . 0.0 111.276 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.08 150.08 3.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.299 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -119.3 120.25 36.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.611 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.6 t -145.49 94.87 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.277 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.45 ' HA ' HG22 ' A' ' 74' ' ' THR . 4.3 p -64.56 102.33 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.735 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.99 103.07 0.54 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.42 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.502 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -96.31 36.99 1.28 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.953 0.406 . . . . 0.0 111.273 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 93' ' ' ALA . 21.2 p30 -80.06 141.52 54.52 Favored Pre-proline 0 N--CA 1.44 -0.94 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.532 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -46.95 87.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.624 2.216 . . . . 0.0 112.669 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -179.54 -38.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.407 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.69 -40.8 2.04 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 4.5 tp -50.51 -18.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.642 0.258 . . . . 0.0 111.441 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -91.21 -50.18 5.97 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.894 0.378 . . . . 0.0 111.15 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -71.02 -31.73 68.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.464 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.82 -32.39 73.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.786 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.429 HG21 ' CD2' ' A' ' 47' ' ' TYR . 58.1 mt -90.1 -7.75 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.455 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.47 -74.26 0.5 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.973 0.416 . . . . 0.0 111.383 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -50.07 -30.44 10.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.53 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.434 ' CB ' ' CD2' ' A' ' 20' ' ' LEU . 3.9 m120 -82.38 -48.58 10.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.11 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.041 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.435 HG23 ' N ' ' A' ' 41' ' ' GLU . 57.5 t . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.981 0.419 . . . . 0.0 111.303 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.0 m -150.16 147.39 27.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.915 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.487 ' HG2' ' HE3' ' A' ' 54' ' ' LYS . 63.2 mt-30 -89.95 164.76 14.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.329 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.459 ' CE2' ' CG ' ' A' ' 11' ' ' PHE . 18.2 m-85 -117.53 123.3 45.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.926 0.393 . . . . 0.0 111.448 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.626 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -103.79 -33.06 9.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.145 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.9 p -127.09 131.13 50.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.398 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.02 -24.45 9.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.657 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.1 m -61.67 -17.02 53.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.662 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.27 -39.08 12.98 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.105 0.478 . . . . 0.0 111.224 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.46 ' CZ ' ' CG2' ' A' ' 23' ' ' VAL . 1.1 t80 -82.17 -30.95 30.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.911 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -55.55 -37.81 68.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.248 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.4 m -90.04 -0.13 57.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.64 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.6 -44.61 15.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.689 0.28 . . . . 0.0 111.39 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.2 pt -79.56 -49.67 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.551 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -41.93 97.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 85.0 mt-30 45.77 88.52 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.219 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 9.1 t70 -170.37 41.07 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.126 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 91.6 mttt 66.17 -155.49 0.25 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.699 0.285 . . . . 0.0 110.404 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.489 ' CD1' HG23 ' A' ' 84' ' ' VAL . 57.9 tp -98.06 116.12 29.63 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.29 0.567 . . . . 0.0 110.917 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.55 122.29 58.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.722 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.417 ' CG2' HG12 ' A' ' 99' ' ' ILE . 46.8 t -99.98 97.68 6.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.779 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.46 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 45.5 t -99.91 134.79 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.224 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 74' ' ' THR . 37.5 t70 -99.79 128.03 45.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.673 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.542 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 5.3 m-85 -99.08 51.37 0.95 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.656 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.571 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -50.9 128.65 21.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.061 0.457 . . . . 0.0 111.035 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.413 ' CB ' ' HB3' ' A' ' 72' ' ' MET . . . -56.07 157.2 4.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.256 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.483 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 4.2 t -95.4 21.59 7.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.202 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 26.0 p-90 -138.53 -43.62 0.49 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.834 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 72' ' ' MET . 35.9 t -43.75 129.6 5.55 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.546 0.213 . . . . 0.0 110.984 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.07 -67.85 1.34 Allowed Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.786 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 33' ' ' CYS . 56.5 Cg_endo -67.76 -145.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.56 2.173 . . . . 0.0 110.937 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 32' ' ' PRO . 58.9 m 73.9 4.69 4.7 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -111.46 -29.11 7.91 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.692 0.282 . . . . 0.0 111.056 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.472 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 86.0 mmm -78.44 5.29 11.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.127 0.489 . . . . 0.0 110.538 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.519 ' CG2' HG13 ' A' ' 40' ' ' ILE . 71.3 mt -81.49 -24.07 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.701 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.506 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -47.36 -45.79 56.39 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 50.0 Cg_endo -72.77 -35.58 5.62 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.904 1.736 . . . . 0.0 111.199 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.5 ttt -65.12 -51.79 59.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.519 HG13 ' CG2' ' A' ' 36' ' ' ILE . 69.7 mt -48.88 -28.67 2.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.459 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.435 ' N ' HG23 ' A' ' 2' ' ' VAL . 38.8 tt0 -78.24 -33.32 49.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.898 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.453 ' HB3' ' NZ ' ' A' ' 42' ' ' LYS . 9.0 mtpm? -64.35 -22.36 66.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.437 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -90.14 -16.97 28.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.665 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.423 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 45.8 t -74.67 -6.53 49.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.252 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -90.17 -29.07 18.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.937 0.399 . . . . 0.0 111.109 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.31 -26.41 20.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.791 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.523 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 80.1 m-85 -123.61 46.37 1.41 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.473 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 81.9 Cg_exo -37.44 -44.32 1.41 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.207 2.604 . . . . 0.0 113.64 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -56.37 -31.29 63.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.923 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.66 133.44 34.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.803 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.55 121.91 32.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.482 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.423 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 4.5 m-85 -96.46 103.58 15.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.375 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.451 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 40.7 m-85 -114.17 -176.73 2.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.316 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.571 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 44.3 mtmt -145.54 130.51 18.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 111.206 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.435 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 3.0 tm? -90.75 138.27 31.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.401 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.451 ' OD2' ' N ' ' A' ' 59' ' ' GLU . 25.4 t70 -94.98 108.34 20.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.422 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 91.1 t -71.15 -11.29 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.547 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.483 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 9.7 t70 -88.9 -41.35 12.48 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.434 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.451 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 38.4 tp10 -93.06 -47.51 6.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.824 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.408 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 5.2 mp -101.82 46.68 0.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.07 -20.78 36.03 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.462 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -71.35 -25.41 62.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.576 0.227 . . . . 0.0 111.517 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.0 t -79.61 -51.79 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.711 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.92 -27.4 51.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.99 0.424 . . . . 0.0 110.122 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.03 -26.31 20.37 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.756 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -70.51 -50.44 37.75 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.999 0.428 . . . . 0.0 109.96 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -76.24 -2.6 32.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.915 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 67.48 38.97 2.99 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.167 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.424 HG13 ' HB ' ' A' ' 74' ' ' THR . 48.3 t -112.04 83.49 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.868 0.366 . . . . 0.0 111.054 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.6 p -93.15 3.34 55.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.272 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.49 -163.07 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.616 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -173.82 94.39 0.33 Allowed Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.496 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 18.9 Cg_endo -91.93 -161.1 1.16 Allowed 'Cis proline' 0 C--N 1.349 0.562 0 C-N-CA 124.835 -0.902 . . . . 0.0 112.513 -0.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.424 ' HB ' HG13 ' A' ' 69' ' ' VAL . 29.0 m -155.92 148.53 23.91 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.671 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.419 ' CD1' ' CD1' ' A' ' 95' ' ' ILE . 83.2 mt -109.78 125.26 52.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 111.334 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.542 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 21.8 mt -121.37 127.37 51.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.782 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.442 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 4.7 mp -109.87 140.57 43.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.024 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.49 ' HA ' HG21 ' A' ' 84' ' ' VAL . 52.5 m-85 -140.61 125.7 18.48 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.853 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.472 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 54.9 mtpt -109.87 129.01 55.69 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.789 0.328 . . . . 0.0 111.47 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.495 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 25.8 t-20 45.79 61.28 2.72 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.079 0.466 . . . . 0.0 111.6 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 55.59 17.89 14.73 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-N 116.088 -0.506 . . . . 0.0 113.542 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 60.0 mttp -115.18 -155.85 0.59 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.425 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 34.7 tt0 -108.78 173.0 6.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.49 HG21 ' HA ' ' A' ' 78' ' ' PHE . 47.9 t -147.79 -68.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.939 0.4 . . . . 0.0 111.038 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.63 154.99 4.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.254 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -114.52 114.99 26.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.414 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.35 82.18 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.311 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -60.89 85.14 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.721 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.6 115.39 1.37 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.367 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.509 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -96.79 38.45 1.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.804 0.335 . . . . 0.0 111.186 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 93' ' ' ALA . 46.2 t30 -68.84 129.28 92.48 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.194 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -45.62 88.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.667 2.245 . . . . 0.0 112.659 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 172.52 -33.16 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.411 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.43 -44.68 2.46 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.509 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 3.8 tp -50.83 -17.9 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.298 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.406 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 7.0 ptpp? -91.63 -48.99 6.53 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.949 0.404 . . . . 0.0 110.792 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.406 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 80.2 mt-30 -69.96 -31.6 69.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.575 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.21 -31.68 72.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.023 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.458 HG23 ' CG ' ' A' ' 47' ' ' TYR . 46.4 mt -90.19 -8.24 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.56 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.2 -69.65 0.71 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.842 0.353 . . . . 0.0 111.174 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.99 -29.0 18.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.221 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -82.63 -51.76 7.45 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.032 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.188 179.957 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 52' ' ' PHE . 14.6 p . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.605 0.241 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.3 m -141.88 162.84 34.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.959 0.409 . . . . 0.0 111.51 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.554 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 19.2 mt-30 -97.29 -176.97 3.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.777 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.504 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 20.3 m-85 -135.14 101.77 4.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.328 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -83.19 -25.4 31.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.731 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.5 p -130.42 123.21 29.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.261 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.83 -25.77 4.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.583 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m -59.5 -18.9 43.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.572 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -90.47 -44.1 9.83 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.206 0.527 . . . . 0.0 111.452 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.503 ' CD1' ' CE2' ' A' ' 5' ' ' PHE . 1.2 t80 -69.39 -30.51 68.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.031 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -50.83 -66.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.404 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.9 m -60.78 -20.48 61.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.467 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.41 -66.42 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.795 0.331 . . . . 0.0 111.676 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' GLY . 21.0 pt -54.6 -48.14 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.753 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.472 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.07 103.0 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.7 mt-30 45.18 92.11 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.236 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -171.51 38.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.384 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.547 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 61.61 -152.5 0.37 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.439 ' CD1' HG23 ' A' ' 84' ' ' VAL . 59.3 tp -97.55 115.92 28.78 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.244 0.545 . . . . 0.0 110.437 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.9 t -104.05 126.97 58.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.871 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.414 ' CG2' HG12 ' A' ' 99' ' ' ILE . 48.6 t -99.74 93.15 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.495 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.469 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 43.4 t -99.76 128.14 51.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.114 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.7 t70 -99.72 130.73 45.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.752 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.536 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 3.4 m-85 -99.07 53.01 0.97 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.968 0.413 . . . . 0.0 110.406 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.552 ' O ' ' HD1' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -50.98 124.77 12.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.301 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.438 ' CB ' ' HB3' ' A' ' 72' ' ' MET . . . -51.69 154.1 2.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.25 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.0 t -96.47 23.82 6.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.085 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 27.3 p-90 -141.53 -38.05 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.61 ' HB2' ' HB2' ' A' ' 72' ' ' MET . 51.3 t -35.21 150.98 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.0 0.429 . . . . 0.0 111.938 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.36 -79.29 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.453 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.438 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 3.3 Cg_exo -73.01 -76.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.43 2.087 . . . . 0.0 112.021 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.9 p 37.92 31.33 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 28.3 mtpp -132.04 -35.98 1.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.214 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.483 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 15.2 tmm? -58.41 -16.03 13.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.852 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.428 HG22 ' CD1' ' A' ' 40' ' ' ILE . 2.4 mp -75.26 -38.13 40.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.345 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.499 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -45.6 -49.28 36.04 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 41.0 Cg_endo -70.88 -32.73 13.44 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 121.988 1.792 . . . . 0.0 110.999 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 49.3 ttm -66.59 -51.13 59.78 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.428 ' CD1' HG22 ' A' ' 36' ' ' ILE . 61.6 mt -49.54 -28.38 3.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.515 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -79.16 -30.93 43.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.183 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.464 ' HB3' ' NZ ' ' A' ' 42' ' ' LYS . 9.1 mtpm? -69.37 -16.11 63.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.73 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.453 ' CB ' ' CE2' ' A' ' 52' ' ' PHE . 3.9 m-85 -90.11 -20.85 22.66 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.5 t -66.74 -14.28 62.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.777 0.322 . . . . 0.0 110.713 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.409 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 5.1 tm-20 -90.04 -20.95 22.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.295 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -90.12 -36.35 14.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.315 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.538 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 81.6 m-85 -124.11 45.4 1.22 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.373 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 75.1 Cg_exo -36.91 -33.03 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.429 2.753 . . . . 0.0 113.628 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -59.57 -37.64 79.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.652 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.83 141.26 28.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.801 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -90.08 123.41 33.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.824 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.453 ' CE2' ' CB ' ' A' ' 43' ' ' PHE . 5.4 m-85 -97.09 106.58 18.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.303 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.504 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 40.9 m-85 -116.11 -178.45 3.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.523 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 4' ' ' GLN . 69.9 mttt -142.13 145.36 34.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.393 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.454 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 2.7 tm? -107.25 125.13 50.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.76 108.18 15.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.693 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 85.1 t -72.34 -10.12 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.44 -60.52 2.34 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.424 ' HB3' HD13 ' A' ' 60' ' ' LEU . 2.2 tm-20 -77.9 -39.83 41.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.572 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' A' ' 59' ' ' GLU . 4.5 mp -97.76 44.85 1.03 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.014 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.13 -19.88 40.44 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.627 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -78.93 -29.32 44.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.783 0.325 . . . . 0.0 111.432 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.506 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 21.4 t -73.27 -54.83 14.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.788 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.86 -25.08 10.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.918 0.389 . . . . 0.0 110.142 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -90.17 -38.36 13.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.158 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 51.5 pttt -60.83 -46.97 88.48 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.945 0.403 . . . . 0.0 110.185 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.402 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.8 m-20 -79.16 -2.09 39.2 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.025 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 64.72 37.7 7.36 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.456 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.402 ' CG1' ' CB ' ' A' ' 74' ' ' THR . 41.9 t -111.45 68.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.992 0.425 . . . . 0.0 110.546 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.2 t -85.01 8.24 18.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.733 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.41 ' HB2' HG21 ' A' ' 88' ' ' VAL . . . -59.76 -161.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.61 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -173.71 89.46 0.36 Allowed Pre-proline 0 N--CA 1.454 -0.228 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 65.0 Cg_endo -96.13 -165.76 1.25 Allowed 'Cis proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.577 -1.01 . . . . 0.0 112.437 -0.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 29.5 m -147.35 163.63 35.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.477 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.421 ' CD1' ' HA ' ' A' ' 90' ' ' ALA . 78.9 mt -122.34 127.74 50.16 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.835 0.35 . . . . 0.0 111.191 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.536 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 26.5 mt -123.97 128.5 49.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.608 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.442 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 4.7 mp -109.64 136.9 48.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.028 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.475 ' HA ' HG21 ' A' ' 84' ' ' VAL . 51.1 m-85 -138.72 126.42 22.11 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.877 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.479 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 9.8 mtpm? -109.77 129.77 55.59 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.368 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.428 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 6.3 m120 45.78 56.75 5.64 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.865 0.365 . . . . 0.0 111.92 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 60.61 14.65 36.74 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.066 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 49.1 mtmt -110.93 -155.37 0.56 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.42 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 88.2 tt0 -109.04 172.6 6.75 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.479 ' CG2' ' HG3' ' A' ' 79' ' ' LYS . 64.5 t -146.18 -68.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 0.0 111.25 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.39 -168.31 0.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 0.0 111.551 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.45 ' HB3' ' NZ ' ' A' ' 86' ' ' LYS . 9.7 mtpm? -142.51 140.03 31.68 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.994 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.7 t -154.46 82.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.532 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 71' ' ' ALA . 5.5 p -78.67 109.57 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.826 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.91 -25.79 0.72 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.134 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.454 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . 44.48 39.8 3.46 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 111.357 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -62.4 135.61 95.39 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.664 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -47.78 -25.18 5.59 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.663 2.242 . . . . 0.0 112.82 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.34 30.05 7.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.626 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.432 ' C ' ' H ' ' A' ' 96' ' ' LYS . . . -139.67 -59.57 0.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.2 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 3.9 tp -57.02 -7.28 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.337 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 94' ' ' ALA . 14.8 ptmm? -91.3 -49.16 6.51 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.928 0.394 . . . . 0.0 110.659 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.403 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 73.0 mt-30 -69.52 -31.85 70.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.28 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.75 -28.32 69.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.695 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.423 HG21 ' CG ' ' A' ' 47' ' ' TYR . 59.0 mt -90.17 -10.82 10.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.523 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.84 -71.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.997 0.427 . . . . 0.0 111.349 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -47.43 -29.09 2.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.46 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -90.05 -48.04 7.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.324 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.078 -179.971 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.426 ' CG1' ' HE3' ' A' ' 54' ' ' LYS . 32.7 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.739 0.304 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.5 m -144.25 161.19 39.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.057 0.456 . . . . 0.0 111.411 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.577 ' HG2' ' NZ ' ' A' ' 54' ' ' LYS . 55.3 mt-30 -91.71 172.55 8.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.443 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.521 ' CE2' ' CG ' ' A' ' 11' ' ' PHE . 17.1 m-85 -126.68 131.96 51.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.19 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 47.5 mmtm -120.98 -32.61 3.92 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.2 p -126.2 148.06 49.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.908 0.385 . . . . 0.0 111.657 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 9' ' ' SER . . . -74.21 99.51 3.43 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.405 0.621 . . . . 0.0 110.337 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 31.3 t 160.55 -24.97 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.018 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -84.67 -32.68 23.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.294 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.521 ' CG ' ' CE2' ' A' ' 5' ' ' PHE . 1.1 t80 -90.34 -43.33 10.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.401 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -47.29 -37.91 11.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.12 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.7 m -74.81 -30.95 61.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.834 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.423 ' HB1' ' CE2' ' A' ' 53' ' ' TYR . . . -60.49 -34.9 74.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.062 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.1 pt -90.07 -49.71 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.417 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.438 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -43.62 95.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 45.23 83.17 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.177 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.3 t70 -164.67 42.25 0.08 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.588 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.533 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.7 mptp? 64.86 -157.2 0.29 Allowed 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 120.701 0.286 . . . . 0.0 110.657 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.448 ' HB2' ' HG2' ' A' ' 79' ' ' LYS . 65.9 tp -98.24 117.14 31.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.062 0.458 . . . . 0.0 110.856 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 46.6 t -113.93 124.02 70.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.742 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.401 ' CG2' HG13 ' A' ' 99' ' ' ILE . 58.8 t -99.84 111.56 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.933 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.472 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 41.5 t -109.45 137.77 40.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.197 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -99.84 128.96 45.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.824 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.544 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 6.8 m-85 -99.15 48.29 0.96 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.052 0.453 . . . . 0.0 110.175 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.568 ' O ' ' HD1' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -48.88 132.04 18.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.243 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . . . -60.78 145.31 50.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.808 0.337 . . . . 0.0 110.718 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.462 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 7.7 t -72.79 -21.19 61.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.391 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -95.87 -39.24 9.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.806 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.433 ' HB2' ' HG3' ' A' ' 72' ' ' MET . 49.1 t -41.23 139.49 0.98 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.914 0.387 . . . . 0.0 111.717 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.71 -58.18 1.85 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.785 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.93 52.5 4.28 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.619 2.212 . . . . 0.0 112.755 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.3 p -127.13 -13.05 5.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.38 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -78.47 -25.44 45.82 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.738 0.304 . . . . 0.0 111.251 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.4 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 65.9 mtt -73.75 3.83 5.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.828 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.521 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 62.2 mt -79.14 -38.78 20.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.933 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.546 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -42.79 -45.42 11.47 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 23.9 Cg_endo -66.36 -43.49 8.17 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.595 1.53 . . . . 0.0 111.669 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.508 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 12.2 mmt -62.1 -59.87 4.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.529 HD13 ' HG2' ' A' ' 54' ' ' LYS . 43.2 mt -43.08 -29.27 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.019 0.438 . . . . 0.0 110.751 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -80.42 -43.34 21.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.767 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -59.78 -29.94 68.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.183 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.508 ' HD1' ' O ' ' A' ' 39' ' ' MET . 16.0 m-85 -76.14 -22.6 55.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.473 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 98.9 p -77.31 -4.05 43.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.71 0.29 . . . . 0.0 110.711 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.419 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 50.3 mt-10 -90.08 -28.32 19.09 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.855 0.36 . . . . 0.0 110.712 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -90.24 -28.31 18.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.362 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.539 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 70.3 m-85 -123.97 45.54 1.25 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.133 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 74.2 Cg_exo -37.41 -32.43 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.376 2.718 . . . . 0.0 113.54 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -60.79 -38.45 85.37 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.674 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.0 138.69 31.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.956 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 58.2 m-20 -90.71 138.72 31.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.663 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.413 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . 2.7 m-85 -114.74 98.39 6.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.516 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.518 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 43.5 m-85 -102.41 -173.25 2.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.562 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.577 ' NZ ' ' HG2' ' A' ' 4' ' ' GLN . 10.2 mtmp? -147.84 135.38 20.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.954 0.406 . . . . 0.0 111.04 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.482 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 2.1 tm? -98.25 145.62 26.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.698 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.459 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 9.9 t70 -93.85 126.04 38.82 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.7 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 98.3 t -93.38 30.33 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 121.286 0.565 . . . . 0.0 110.814 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.462 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 65.8 t0 -137.94 -46.73 0.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.58 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 6' ' ' LYS . 5.2 tp10 -81.56 -32.24 32.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.414 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.422 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 4.5 mp -118.52 72.78 0.89 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.64 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -77.84 -1.72 79.32 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.88 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -90.04 -38.39 13.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.741 0.305 . . . . 0.0 111.39 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.504 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 6.0 t -71.73 -54.88 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.345 . . . . 0.0 110.608 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.37 -25.44 15.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.019 0.438 . . . . 0.0 110.226 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -90.24 -38.36 13.49 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.109 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 16.5 pttp -60.7 -48.4 81.97 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-O 120.865 0.364 . . . . 0.0 110.129 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.417 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.5 m-20 -76.81 -6.08 50.89 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.869 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 66.3 41.66 3.3 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.019 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.425 ' CG1' HG23 ' A' ' 74' ' ' THR . 59.6 t -104.63 84.6 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.153 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 91.3 p -95.56 -17.46 21.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.922 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.99 -171.01 0.0 OUTLIER 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.501 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.564 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -167.84 108.31 0.58 Allowed Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.349 -0.54 . . . . 0.0 112.372 -179.506 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.471 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 42.1 Cg_endo -87.85 -162.15 2.07 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.394 -1.086 . . . . 0.0 112.286 -0.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.427 HG21 ' HA ' ' A' ' 88' ' ' VAL . 84.9 m -153.76 163.81 39.39 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.803 0.335 . . . . 0.0 110.797 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.406 ' CD1' ' CD1' ' A' ' 95' ' ' ILE . 71.0 mt -129.0 123.45 32.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 110.913 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.544 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 20.7 mt -121.05 129.15 53.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.803 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.461 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 3.5 mp -109.7 143.71 39.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.7 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.588 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 64.7 m-85 -144.41 127.09 16.15 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.001 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.449 ' HD3' HG12 ' A' ' 84' ' ' VAL . 49.3 mtpt -117.24 136.69 52.9 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.831 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.443 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.2 m120 45.78 67.69 0.7 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.569 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 46.29 33.97 5.99 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 113.048 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.588 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 68.1 mttm -141.78 -160.57 1.1 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.452 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 28.9 tt0 -109.14 -179.91 3.98 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.452 ' CG1' ' O ' ' A' ' 83' ' ' GLU . 4.6 m -164.2 -46.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.51 0.195 . . . . 0.0 111.38 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.47 158.68 24.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.046 0.451 . . . . 0.0 112.012 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.468 ' CD ' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -148.03 113.67 5.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.872 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.7 t -139.41 107.37 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.412 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.427 ' HA ' HG21 ' A' ' 74' ' ' THR . 3.2 p -69.45 110.45 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.063 0.458 . . . . 0.0 110.659 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.2 105.14 0.91 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.164 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.498 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -94.0 38.35 1.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.847 0.356 . . . . 0.0 111.39 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' A' ' 93' ' ' ALA . 5.4 m120 -72.38 134.83 82.12 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.437 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -48.48 84.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.722 2.282 . . . . 0.0 112.625 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 178.66 -38.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.43 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.33 -45.68 2.92 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.7 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 4.9 tp -52.83 -16.49 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.148 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.479 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -92.21 -49.3 6.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.982 0.42 . . . . 0.0 110.901 179.509 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.425 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 25.8 mt-30 -71.53 -32.05 67.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.661 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.89 -32.93 68.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.429 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.497 HG22 ' CG ' ' A' ' 47' ' ' TYR . 1.5 mp -90.24 -12.25 9.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.423 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.47 -64.42 1.14 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.911 0.386 . . . . 0.0 111.095 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.31 -30.36 38.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.064 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -90.15 -66.42 0.93 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.301 -0.856 . . . . 0.0 111.117 179.923 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.432 HG23 HG23 ' A' ' 40' ' ' ILE . 6.0 p . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.654 0.264 . . . . 0.0 110.668 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 54' ' ' LYS . 92.5 m -150.3 162.01 41.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.198 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.532 ' HG3' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -105.4 -173.37 2.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.878 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.51 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.8 m-85 -135.79 105.75 6.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.762 0.315 . . . . 0.0 111.698 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -88.93 -27.71 20.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.763 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.7 p -126.35 128.52 47.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 110.705 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.79 -24.04 20.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.415 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -62.29 -16.59 54.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.627 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -90.14 -56.74 3.1 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.246 0.546 . . . . 0.0 111.111 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.463 ' CE1' HG23 ' A' ' 23' ' ' VAL . 1.1 t80 -60.49 -33.1 72.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.7 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -51.46 -56.69 11.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.256 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.4 m -65.85 -25.3 67.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.39 -72.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 0.0 111.322 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.4 pt -52.8 -48.52 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.674 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.467 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -44.43 96.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 44.68 91.16 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.541 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -174.54 40.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.487 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.519 ' NZ ' ' HB2' ' A' ' 19' ' ' LYS . 8.1 mtmp? 69.36 -158.26 0.17 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.498 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.438 ' HB2' ' HG2' ' A' ' 79' ' ' LYS . 61.6 tp -98.16 113.76 25.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.205 0.526 . . . . 0.0 111.19 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.74 125.45 53.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.524 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.8 t -99.71 96.3 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.665 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.463 HG23 ' CE1' ' A' ' 11' ' ' PHE . 30.1 t -104.95 131.84 53.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.368 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.6 t70 -99.99 132.23 45.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.507 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.553 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 4.8 m-85 -99.14 54.6 0.98 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.137 0.494 . . . . 0.0 110.643 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.591 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -58.35 140.92 52.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.098 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.46 ' HB1' ' HB3' ' A' ' 72' ' ' MET . . . -67.42 136.44 54.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.774 0.321 . . . . 0.0 110.253 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 3.3 t -53.39 -49.35 67.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.222 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 32.0 p-90 -68.2 -42.62 79.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.79 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 53.1 t -45.75 135.14 7.07 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 111.146 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.27 -56.3 0.94 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.117 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -48.57 -26.02 8.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.617 2.211 . . . . 0.0 112.729 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.9 p -63.92 -32.21 73.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.071 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -61.87 -25.32 67.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.383 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 66.1 mtt -68.85 -5.85 23.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.962 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.505 ' CG2' HG13 ' A' ' 40' ' ' ILE . 60.0 mt -86.51 -23.63 6.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.447 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.28 -44.48 81.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 45.6 Cg_endo -72.7 -36.61 4.67 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.669 1.579 . . . . 0.0 111.447 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.522 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 67.5 mtm -64.96 -51.46 61.63 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.505 HG13 ' CG2' ' A' ' 36' ' ' ILE . 68.0 mt -48.71 -25.53 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.716 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.425 ' HB2' HG11 ' A' ' 2' ' ' VAL . 38.0 tt0 -85.06 -23.38 28.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.972 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.432 ' NZ ' ' HB2' ' A' ' 42' ' ' LYS . 10.5 mtmp? -82.28 -15.71 52.03 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.522 ' HD1' ' O ' ' A' ' 39' ' ' MET . 3.5 m-85 -90.04 -19.27 24.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.652 0.263 . . . . 0.0 111.323 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.445 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.6 t -69.62 -8.84 50.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.484 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -87.99 -27.18 22.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.739 0.304 . . . . 0.0 111.098 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -90.6 -30.4 17.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.904 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.511 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 72.9 m-85 -123.03 47.3 1.56 Allowed Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.167 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 80.7 Cg_exo -38.01 -27.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.254 2.636 . . . . 0.0 113.594 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.487 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 13.4 mp0 -65.63 -36.22 83.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.105 0.479 . . . . 0.0 110.472 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 20' ' ' LEU . . . -89.48 138.27 31.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.109 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.406 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.5 m-20 -89.53 122.21 32.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.026 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.464 ' CE2' ' CB ' ' A' ' 43' ' ' PHE . 4.2 m-85 -97.37 83.96 3.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.221 0.534 . . . . 0.0 111.624 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.51 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 54.2 m-85 -102.31 -174.75 2.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.495 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.591 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 28.6 mttp -141.98 148.59 38.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.307 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.468 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 2.8 tm? -106.21 130.23 54.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.127 0.489 . . . . 0.0 110.943 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 56.9 m-20 -83.89 117.03 23.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.619 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 69.9 t -87.22 5.56 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.111 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.473 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 11.5 p-10 -99.63 -40.73 7.65 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.92 0.39 . . . . 0.0 110.631 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -99.66 -28.5 13.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.979 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.461 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 3.1 mp -114.17 41.79 2.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.032 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.51 -21.44 34.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.55 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -72.38 -25.83 61.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.687 0.28 . . . . 0.0 111.511 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.7 t -77.82 -49.56 21.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.75 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.47 -28.4 59.6 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.971 0.415 . . . . 0.0 110.321 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -90.03 -23.93 21.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.724 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -73.03 -49.54 28.19 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.98 0.419 . . . . 0.0 110.052 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -77.75 -0.75 28.14 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.146 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 68.09 37.33 2.98 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.306 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.2 t -116.18 72.97 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.758 0.313 . . . . 0.0 110.983 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.2 p -84.12 -15.13 48.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.929 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.36 -172.62 0.0 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.524 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.516 ' HG2' ' O ' ' A' ' 72' ' ' MET . 1.7 pmm? -170.08 112.74 0.47 Allowed Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.513 -0.475 . . . . 0.0 112.209 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.473 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 68.4 Cg_endo -87.64 -167.39 4.06 Favored 'Cis proline' 0 C--N 1.349 0.571 0 C-N-CA 124.151 -1.187 . . . . 0.0 112.086 -0.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 29.0 m -161.36 151.67 17.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.681 0.277 . . . . 0.0 110.837 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.401 HD12 ' CB ' ' A' ' 90' ' ' ALA . 81.7 mt -114.22 124.84 53.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.282 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.553 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 22.7 mt -120.05 128.76 53.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.282 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.469 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 3.1 mp -109.6 141.19 42.47 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.833 0.349 . . . . 0.0 110.838 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.611 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 55.1 m-85 -143.19 126.21 16.32 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.96 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.461 ' HD3' HG12 ' A' ' 84' ' ' VAL . 48.5 mtpt -117.04 136.11 53.21 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.701 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.447 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.2 m120 49.12 62.4 2.63 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.484 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 50.61 25.54 9.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.069 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.611 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 75.2 mmtt -132.45 -160.09 1.02 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.468 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 32.2 tt0 -108.94 -179.93 4.0 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 83' ' ' GLU . 4.6 m -164.16 -47.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -164.81 165.24 20.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.155 0.502 . . . . 0.0 111.814 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.413 ' HG2' HD21 ' A' ' 76' ' ' LEU . 36.5 mtmm -151.19 135.15 16.6 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.923 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.4 t -154.21 105.99 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.469 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 2.8 p -68.03 78.68 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.841 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.52 106.27 0.2 Allowed Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.339 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.525 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -97.11 38.53 1.24 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.875 0.369 . . . . 0.0 111.183 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 93' ' ' ALA . 22.9 t-20 -85.8 141.08 35.6 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.147 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -45.52 87.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.657 2.238 . . . . 0.0 112.636 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -179.6 -40.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.336 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.11 -42.14 2.29 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.525 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 5.3 tp -50.39 -17.92 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.081 -0.247 . . . . 0.0 111.133 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.45 ' CD ' ' CE2' ' A' ' 43' ' ' PHE . 29.6 mmmt -90.64 -66.76 0.9 Allowed 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.787 0.327 . . . . 0.0 111.104 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.469 ' OE1' ' N ' ' A' ' 97' ' ' GLN . 1.3 mp0 -59.93 -34.82 73.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.705 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.97 -30.87 66.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.616 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.413 HG23 ' CG ' ' A' ' 47' ' ' TYR . 57.8 mt -90.22 -14.67 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.343 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.43 -68.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.865 0.364 . . . . 0.0 111.142 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.07 -28.76 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.148 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.417 ' CB ' ' CD2' ' A' ' 20' ' ' LEU . 5.8 m120 -83.15 -51.92 7.07 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.996 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.056 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.5 p . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.564 0.221 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 54' ' ' LYS . 85.3 m -148.67 162.59 39.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.958 0.409 . . . . 0.0 111.543 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.631 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 43.1 mt-30 -107.62 -179.92 4.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.219 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.508 ' CE2' ' CD1' ' A' ' 11' ' ' PHE . 22.6 m-85 -129.49 129.73 44.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.564 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.418 ' CA ' HD12 ' A' ' 60' ' ' LEU . 47.4 mmtm -110.95 -18.77 12.99 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.5 m -147.94 165.77 29.68 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.18 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.55 ' O ' ' OG ' ' A' ' 9' ' ' SER . . . -84.63 101.46 12.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.473 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.55 ' OG ' ' O ' ' A' ' 8' ' ' ALA . 13.2 m 160.26 -25.33 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.044 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -87.24 -30.77 20.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.481 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.508 ' CD1' ' CE2' ' A' ' 5' ' ' PHE . 1.1 t80 -90.05 -40.8 12.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.556 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -48.64 -40.35 27.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.22 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 m -76.21 -27.12 56.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.096 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.47 -62.16 1.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.36 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.1 pt -63.72 -48.71 85.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.602 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.444 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -40.49 94.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 24.6 mt-30 44.16 88.96 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.385 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 8.9 t70 -170.64 40.47 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.324 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 53.1 mttp 70.82 -151.47 0.1 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.729 0.3 . . . . 0.0 110.635 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 77' ' ' LEU . 28.0 tp -97.47 111.49 23.73 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.15 0.5 . . . . 0.0 110.998 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -99.96 113.91 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.918 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.445 ' CG2' HG12 ' A' ' 99' ' ' ILE . 43.6 t -99.9 102.39 13.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.6 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.493 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 39.9 t -104.84 138.42 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.604 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -104.42 130.96 52.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.823 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.54 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 4.4 m-85 -99.1 49.39 0.95 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.047 0.451 . . . . 0.0 109.832 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -47.18 134.56 10.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.508 -179.106 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.0 128.72 37.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.445 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.526 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 5.2 t -59.44 -28.02 66.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.766 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.403 ' CH2' ' SD ' ' A' ' 72' ' ' MET . 31.4 p-90 -93.83 -36.97 11.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 72' ' ' MET . 33.2 t -46.58 158.72 0.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.577 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.71 -66.39 0.81 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.304 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -46.77 -26.68 4.8 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.892 2.394 . . . . 0.0 113.08 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 86.3 m -60.43 -17.86 47.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -73.81 -44.34 56.12 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.403 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 65.2 mtt -70.77 1.7 5.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.796 0.331 . . . . 0.0 111.522 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.709 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 36.3 mt -75.74 -39.4 38.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.728 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.496 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -44.53 -50.39 23.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 41.6 Cg_endo -69.58 -31.26 21.69 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 121.806 1.671 . . . . 0.0 111.194 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 47.1 tpp -68.93 -51.19 42.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 40' ' ' ILE . 62.6 mt -50.32 -29.07 5.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.411 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -75.71 -35.63 60.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.889 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -62.42 -20.58 64.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.675 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.26 -24.54 20.91 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.413 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 50.5 m -62.21 -13.21 25.38 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.611 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -85.59 -25.2 26.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.729 0.3 . . . . 0.0 111.31 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -90.42 -30.74 17.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.525 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 80.8 m-85 -123.1 46.47 1.35 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.747 0.308 . . . . 0.0 111.482 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 79.3 Cg_exo -37.18 -33.2 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.321 2.68 . . . . 0.0 114.025 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.413 ' O ' ' CD ' ' A' ' 19' ' ' LYS . 9.6 mm-40 -66.17 -30.92 71.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.931 0.396 . . . . 0.0 110.86 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.34 138.45 31.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.475 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.49 121.59 31.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.006 0.431 . . . . 0.0 110.383 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.427 ' CE2' HD11 ' A' ' 99' ' ' ILE . 5.2 m-85 -97.44 82.99 3.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.594 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.432 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 43.0 m-85 -97.04 -178.16 4.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.898 178.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.631 ' HE2' ' HG2' ' A' ' 4' ' ' GLN . 33.4 mtmm -146.31 139.13 25.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.163 0.506 . . . . 0.0 111.398 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -102.09 135.44 43.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.967 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.419 ' HB3' HD13 ' A' ' 60' ' ' LEU . 9.9 t0 -88.43 128.68 35.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.308 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 41.4 t -85.66 -11.17 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.526 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 2.1 p30 -105.1 -41.25 5.62 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.336 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 6' ' ' LYS . 15.8 tp10 -76.84 -31.17 56.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.97 0.414 . . . . 0.0 110.608 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 4.2 mp -125.35 42.73 3.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.765 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -48.44 -27.42 5.77 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.486 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.45 -25.78 68.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.63 0.252 . . . . 0.0 111.447 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.499 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 11.0 t -81.16 -55.58 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.745 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.83 -26.72 6.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.069 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.427 ' N ' ' OE1' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -90.33 -37.14 14.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.669 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 52.6 pttt -59.74 -48.12 82.94 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.051 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.41 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.0 m-20 -78.41 -5.22 51.73 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.867 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 67.01 41.49 2.65 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.256 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.442 HG13 ' HB ' ' A' ' 74' ' ' THR . 41.7 t -112.63 97.6 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-O 120.805 0.336 . . . . 0.0 110.99 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.8 p -112.31 28.68 8.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.983 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.469 ' CB ' ' CG2' ' A' ' 88' ' ' VAL . . . -76.12 -153.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.823 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.477 ' HG3' ' O ' ' A' ' 72' ' ' MET . 16.5 ptt? -173.04 79.65 0.41 Allowed Pre-proline 0 CA--C 1.529 0.141 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.709 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 1.3 Cg_endo -97.52 -155.61 0.33 Allowed 'Cis proline' 0 C--N 1.348 0.524 0 C-N-CA 125.242 -0.733 . . . . 0.0 112.783 -0.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.442 ' HB ' HG13 ' A' ' 69' ' ' VAL . 86.6 m -151.22 147.09 26.57 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.027 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 89' ' ' GLY . 88.4 mt -109.67 122.7 48.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.941 0.4 . . . . 0.0 111.458 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.54 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 29.2 mt -120.23 125.87 49.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.441 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.472 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 3.3 mp -109.8 147.47 33.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.8 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.614 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 47.0 m-85 -148.45 126.83 12.28 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.339 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.452 ' HD3' HG11 ' A' ' 84' ' ' VAL . 50.3 mtpt -115.55 140.16 49.42 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.463 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 6.0 m120 49.1 52.12 14.96 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.634 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 57.62 19.32 34.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.706 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.614 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 54.7 mtpt -122.5 -155.83 0.67 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.494 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 83.1 tt0 -108.85 177.73 4.68 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.494 ' CG1' ' O ' ' A' ' 83' ' ' GLU . 4.2 m -166.55 -47.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.644 0.259 . . . . 0.0 111.369 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -163.93 174.68 11.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 111.612 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.402 ' HB2' ' CD2' ' A' ' 76' ' ' LEU . 14.3 ptmm? -170.05 115.57 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.649 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 87' ' ' VAL . 9.1 p -122.88 103.82 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.129 0.49 . . . . 0.0 111.547 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.469 ' CG2' ' CB ' ' A' ' 71' ' ' ALA . 2.1 p -59.92 88.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.838 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 90' ' ' ALA . . . 158.65 -128.93 2.15 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.169 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . 158.54 39.42 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.825 0.345 . . . . 0.0 110.894 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -70.91 139.71 85.73 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.744 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.75 -18.41 2.74 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.764 2.309 . . . . 0.0 113.198 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.44 21.63 12.89 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.59 -60.06 0.17 Allowed 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.829 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 3.9 tp -50.69 -15.15 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.138 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.482 ' HD2' ' N ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -92.34 -41.03 10.58 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.0 0.429 . . . . 0.0 110.677 179.351 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.482 ' N ' ' HD2' ' A' ' 96' ' ' LYS . 72.1 mt-30 -76.45 -32.13 58.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.18 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.39 -32.33 73.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.52 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.465 HG22 ' CG ' ' A' ' 47' ' ' TYR . 38.9 mt -90.25 -13.47 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.258 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.402 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . . . -90.4 -72.05 0.59 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.9 0.381 . . . . 0.0 111.186 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -48.45 -29.34 3.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.264 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.412 ' HB2' ' CD2' ' A' ' 20' ' ' LEU . 3.7 m120 -83.82 -41.69 17.26 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.146 179.934 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.452 ' CG1' ' HD3' ' A' ' 54' ' ' LYS . 49.9 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.886 0.374 . . . . 0.0 111.345 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.41 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 87.0 m -150.12 153.86 37.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.535 ' HG2' ' HG3' ' A' ' 54' ' ' LYS . 57.3 mt-30 -89.42 -179.21 5.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.178 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.543 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 17.0 m-85 -130.02 140.03 50.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.016 0.436 . . . . 0.0 111.309 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -112.72 -55.94 2.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.489 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.2 p -105.75 169.39 8.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.559 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.78 -27.84 40.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.1 m -60.85 -16.16 38.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.621 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -90.34 -62.59 1.43 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.227 0.537 . . . . 0.0 111.087 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.518 ' CZ ' ' CG2' ' A' ' 23' ' ' VAL . 1.1 t80 -59.85 -24.14 63.97 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.992 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -54.96 -55.7 27.86 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.447 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.1 m -72.01 -23.41 61.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.487 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.98 -38.63 68.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 111.598 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 81' ' ' GLY . 21.3 pt -88.01 -48.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.437 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.37 102.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 85.1 mt-30 44.5 87.52 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.216 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 8.8 t70 -168.37 39.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.352 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.535 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.6 mptp? 62.54 -154.51 0.34 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.686 0.279 . . . . 0.0 110.43 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.46 ' HB2' ' HD3' ' A' ' 79' ' ' LYS . 62.3 tp -97.92 115.27 27.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.071 0.462 . . . . 0.0 110.882 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.8 t -106.89 130.71 58.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.632 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.4 t -99.81 97.96 6.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.547 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.518 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 24.8 t -101.4 126.03 55.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.053 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.553 ' HB3' ' NZ ' ' A' ' 54' ' ' LYS . 38.0 t70 -99.97 131.67 45.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.015 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.532 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 4.1 m-85 -99.25 50.26 0.95 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.077 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.668 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -53.79 129.58 33.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.352 -179.559 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.44 ' CB ' ' HB3' ' A' ' 72' ' ' MET . . . -50.39 153.34 1.57 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.724 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.591 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 7.9 t -92.6 21.57 5.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.042 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.462 ' CH2' ' CE ' ' A' ' 72' ' ' MET . 23.7 p-90 -143.58 -42.24 0.28 Allowed 'General case' 0 C--O 1.232 0.167 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 29' ' ' TRP . 50.1 t -29.97 -76.2 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.54 -78.92 0.38 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.446 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -46.98 -29.34 8.33 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.667 2.245 . . . . 0.0 112.217 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.409 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 82.5 m -60.19 -20.15 57.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.784 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -74.09 -37.27 64.22 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.6 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.424 ' O ' ' HG2' ' A' ' 35' ' ' MET . 48.6 ttm -72.21 0.88 8.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.381 . . . . 0.0 111.074 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.593 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 59.1 mt -83.2 -25.23 8.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.011 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.543 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.88 -45.84 87.31 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 38.4 Cg_endo -69.91 -37.4 8.85 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.896 1.731 . . . . 0.0 111.588 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 57.1 ttp -64.49 -51.25 63.97 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.494 ' CD1' ' NZ ' ' A' ' 54' ' ' LYS . 55.2 mt -51.73 -27.35 8.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.652 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.402 ' HA ' ' CG2' ' A' ' 2' ' ' VAL . 87.7 tt0 -77.48 -29.39 52.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.336 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -66.82 -17.98 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.221 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -89.97 -18.45 26.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.425 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.5 t -67.31 -12.32 59.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.158 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 5.5 tp10 -85.71 -24.39 26.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.707 0.289 . . . . 0.0 111.042 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -90.26 -35.06 15.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.556 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.539 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 69.0 m-85 -122.33 43.9 0.78 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.539 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 90.4 Cg_exo -38.63 -32.45 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.104 2.536 . . . . 0.0 113.224 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -59.41 -38.28 80.21 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.715 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 20' ' ' LEU . . . -89.78 145.77 24.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -89.98 148.88 22.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.732 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 52' ' ' PHE . 2.6 m-85 -123.39 94.58 4.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.979 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.543 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 53.5 m-85 -108.8 173.78 6.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.997 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.668 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -124.61 162.26 24.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 25' ' ' PHE . 2.1 tm? -127.2 108.69 11.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.753 0.311 . . . . 0.0 110.485 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.404 ' HB3' HD23 ' A' ' 60' ' ' LEU . 8.5 t0 -64.01 112.15 2.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.62 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 55.5 t -69.27 -11.15 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.744 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.591 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 4.5 t70 -99.69 -59.92 1.63 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.138 0.495 . . . . 0.0 110.374 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.42 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -53.41 -45.45 69.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.582 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.416 HD21 ' N ' ' A' ' 60' ' ' LEU . 3.3 mm? -81.64 -67.71 0.76 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.378 0.609 . . . . 0.0 110.83 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.11 -64.38 0.52 Allowed Glycine 0 C--N 1.314 -0.66 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.481 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -56.91 -28.82 62.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.615 0.245 . . . . 0.0 111.386 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.5 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 16.3 t -73.03 -52.78 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.434 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.92 -24.68 39.22 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.086 0.469 . . . . 0.0 109.806 178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -90.34 -38.91 13.03 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.169 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 17.3 pttp -59.72 -48.38 81.89 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.893 0.378 . . . . 0.0 110.206 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.414 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.5 m-80 -77.55 -5.1 48.94 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.897 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 66.32 41.74 3.25 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.129 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.427 HG12 ' HB ' ' A' ' 74' ' ' THR . 53.8 t -113.87 86.16 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.122 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 93.3 p -91.46 -21.88 20.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.838 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.48 -173.64 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.514 ' O ' ' SD ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -172.76 119.38 0.41 Allowed Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.593 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 50.6 Cg_endo -83.89 -179.23 21.14 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.939 -1.275 . . . . 0.0 112.158 -0.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 37.0 m -147.03 143.65 28.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.469 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.404 ' CD1' ' HA ' ' A' ' 90' ' ' ALA . 79.5 mt -109.78 124.55 51.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.06 0.457 . . . . 0.0 111.812 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.532 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 25.1 mt -119.38 127.61 53.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.468 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 4.5 mp -109.71 134.08 52.4 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.212 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.462 ' HA ' HG22 ' A' ' 84' ' ' VAL . 53.1 m-85 -133.91 127.99 33.62 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.111 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HD3' ' HB2' ' A' ' 20' ' ' LEU . 7.4 mmmm -109.79 127.74 54.85 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.728 0.299 . . . . 0.0 111.47 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.424 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.3 m120 45.32 56.43 5.62 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.909 0.385 . . . . 0.0 111.832 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 61.6 14.15 41.61 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.199 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 34.3 mmtp -111.74 -154.18 0.54 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.415 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 35.8 tt0 -108.77 171.37 7.47 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 78' ' ' PHE . 59.6 t -144.03 -66.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.745 0.307 . . . . 0.0 111.35 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.17 161.7 8.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.003 0.43 . . . . 0.0 111.524 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -116.69 129.14 55.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.09 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.4 t -154.49 81.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.261 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 73' ' ' PRO . 6.8 p -61.74 85.38 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.009 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.81 110.69 0.26 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.566 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.506 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -100.78 38.9 1.45 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.884 0.374 . . . . 0.0 111.318 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 93' ' ' ALA . 47.4 t30 -79.6 132.01 62.93 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.208 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -44.37 87.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.737 2.292 . . . . 0.0 112.886 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 173.26 -38.14 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.21 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.58 -46.24 3.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.643 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.506 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 5.0 tp -52.77 -16.12 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.703 0.287 . . . . 0.0 111.148 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.443 ' NZ ' ' HB2' ' A' ' 96' ' ' LYS . 10.4 mtmp? -90.78 -63.06 1.32 Allowed 'General case' 0 CA--C 1.523 -0.091 0 CA-C-O 121.024 0.44 . . . . 0.0 110.623 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -58.8 -33.39 70.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.639 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.62 -30.1 69.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 99' ' ' ILE . 59.9 mt -89.9 -7.8 10.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.468 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.32 -72.16 0.58 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.971 0.415 . . . . 0.0 111.273 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.44 -30.73 31.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.337 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -80.83 -53.57 6.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.0 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.074 179.985 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.411 ' CG2' ' HD2' ' A' ' 54' ' ' LYS . 11.0 p . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 120.533 0.206 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.0 m -150.18 152.2 34.28 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.177 0.513 . . . . 0.0 111.803 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.42 ' OE1' ' HE3' ' A' ' 54' ' ' LYS . 9.3 mm-40 -90.13 159.03 16.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.003 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.518 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 15.0 m-85 -116.61 99.12 6.92 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.824 -0.351 . . . . 0.0 111.543 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -85.92 -27.51 24.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.8 p -127.74 124.23 37.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.479 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.88 -25.15 7.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.364 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.8 m -60.07 -18.69 48.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.574 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -90.33 -40.51 12.06 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.134 0.493 . . . . 0.0 111.207 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.489 ' CZ ' ' CG2' ' A' ' 23' ' ' VAL . 1.2 t80 -75.69 -30.88 59.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.812 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -54.57 -49.57 70.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.084 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -71.93 -25.47 61.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.164 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.88 -67.67 0.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.311 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 81' ' ' GLY . 17.8 pt -54.13 -49.47 61.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.776 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.444 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -44.78 99.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 44.66 89.66 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.55 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 63.9 t0 -169.38 39.66 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.284 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.539 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.6 mptp? 65.82 -154.56 0.26 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.37 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 103' ' ' ALA . 54.0 tp -97.78 115.84 28.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.14 0.495 . . . . 0.0 110.774 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -105.94 128.56 60.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.032 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.47 ' CG2' HG13 ' A' ' 99' ' ' ILE . 44.5 t -99.97 96.81 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.361 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.489 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 41.2 t -101.37 129.42 52.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.085 0.469 . . . . 0.0 111.678 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -99.76 130.06 45.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.327 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.542 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 3.6 m-85 -99.12 50.18 0.95 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.011 0.434 . . . . 0.0 110.849 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -51.05 136.79 22.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.831 179.499 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.423 ' HB1' ' HB2' ' A' ' 30' ' ' CYS . . . -62.09 150.3 38.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.905 0.383 . . . . 0.0 110.973 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.438 ' HB ' ' N ' ' A' ' 58' ' ' ASP . 5.1 t -78.76 -22.67 46.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.339 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.441 ' CH2' ' SD ' ' A' ' 72' ' ' MET . 21.8 p-90 -104.18 -34.91 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.868 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 72' ' ' MET . 42.2 t -39.47 156.33 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.727 0.299 . . . . 0.0 111.425 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' A' ' 32' ' ' PRO . . . -86.98 -87.97 1.06 Allowed Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.756 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' A' ' 31' ' ' GLY . 18.0 Cg_exo -66.72 61.92 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.896 2.397 . . . . 0.0 112.645 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.8 p -129.45 -4.1 4.83 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.376 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -99.02 -24.96 14.72 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.673 0.273 . . . . 0.0 111.433 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.8 mmt -68.74 -0.25 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.318 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.532 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 64.5 mt -82.66 -27.63 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.867 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.485 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -47.54 -46.04 58.86 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 41.5 Cg_endo -72.51 -36.81 4.74 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.788 1.659 . . . . 0.0 110.763 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.477 ' CE ' ' CE1' ' A' ' 43' ' ' PHE . 1.7 tmt? -62.26 -51.88 65.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.196 178.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.503 HG13 ' CG2' ' A' ' 36' ' ' ILE . 55.9 mt -51.45 -29.25 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.629 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -76.31 -40.02 52.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.484 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -55.36 -24.63 30.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.371 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.477 ' CE1' ' CE ' ' A' ' 39' ' ' MET . 5.1 m-85 -90.29 -22.85 21.37 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.447 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 87.1 p -70.09 -8.36 48.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.156 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.405 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 5.4 tp10 -90.02 -25.88 20.6 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.739 0.304 . . . . 0.0 110.998 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -90.4 -29.53 17.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.582 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.53 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 78.1 m-85 -122.86 44.94 0.98 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.356 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 84.1 Cg_exo -38.18 -32.02 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.088 2.525 . . . . 0.0 113.262 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -59.01 -40.86 86.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.561 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.88 141.37 28.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.709 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -89.98 125.44 35.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.909 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 4.6 m-85 -99.84 93.87 6.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.52 ' C ' ' HD3' ' A' ' 54' ' ' LYS . 47.2 m-85 -107.42 179.43 4.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.917 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.604 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -137.9 153.88 49.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.691 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.443 ' HB3' ' HA ' ' A' ' 25' ' ' PHE . 2.8 tm? -112.33 118.83 36.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -78.25 108.37 11.52 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.566 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 90.6 t -75.46 -5.03 6.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.024 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.438 ' N ' ' HB ' ' A' ' 28' ' ' THR . 67.1 t0 -80.34 -46.8 15.48 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.795 0.331 . . . . 0.0 110.826 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -97.99 -24.56 15.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.115 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 3.4 mp -113.47 52.64 0.8 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.86 0.362 . . . . 0.0 111.055 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.82 -15.55 58.04 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.707 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.36 -26.36 32.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.664 0.269 . . . . 0.0 111.486 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.579 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 11.7 t -78.76 -22.75 12.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.865 0.364 . . . . 0.0 110.889 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.58 -24.85 38.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -90.22 -31.72 16.89 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.779 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -59.35 -47.96 83.45 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.043 0.449 . . . . 0.0 110.077 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.411 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.4 m-80 -86.86 -0.01 55.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.064 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 62.15 41.32 10.85 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.056 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.425 ' CG1' ' CB ' ' A' ' 74' ' ' THR . 47.5 t -106.27 116.54 50.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.116 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.8 p -149.87 18.69 0.89 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.695 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 72' ' ' MET . . . -70.15 -16.58 63.11 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.908 0.385 . . . . 0.0 110.779 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.53 ' HG3' ' O ' ' A' ' 72' ' ' MET . 11.4 ptt? 43.54 93.31 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.206 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.532 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 13.2 Cg_endo -92.6 -156.43 0.64 Allowed 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 125.077 -0.801 . . . . 0.0 112.319 -0.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.425 ' CB ' ' CG1' ' A' ' 69' ' ' VAL . 89.2 m -164.63 162.53 21.54 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.958 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 68.5 mt -123.46 123.62 41.05 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.68 0.276 . . . . 0.0 110.796 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.542 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 23.4 mt -118.74 131.5 56.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.0 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 3.5 mp -109.75 137.04 48.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.039 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.505 ' HA ' HG23 ' A' ' 84' ' ' VAL . 67.8 m-85 -136.88 126.03 24.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.276 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.463 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 8.6 mtmp? -113.39 126.71 55.66 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.64 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 74.6 m-80 46.26 75.43 0.12 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.617 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 40.95 39.5 1.99 Allowed Glycine 0 C--N 1.331 0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.619 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 31.9 mmmt -143.51 -158.58 0.89 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.402 ' C ' HG23 ' A' ' 84' ' ' VAL . 86.5 tt0 -108.82 175.17 5.56 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.505 HG23 ' HA ' ' A' ' 78' ' ' PHE . 14.3 t -149.14 -66.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 110.946 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.13 154.42 4.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.138 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -117.79 120.63 38.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.735 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.417 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 49.1 t -139.06 93.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.138 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.436 HG23 ' CB ' ' A' ' 71' ' ' ALA . 4.6 p -67.56 120.85 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.964 0.411 . . . . 0.0 110.878 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.93 102.22 1.61 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.236 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.468 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -94.41 37.58 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 111.208 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 93' ' ' ALA . 46.1 t30 -83.47 134.37 45.39 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.017 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -40.73 89.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.75 2.3 . . . . 0.0 112.693 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 179.56 -32.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.301 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.11 -42.47 0.98 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.468 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 6.4 tp -53.73 -14.76 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.471 0.177 . . . . 0.0 111.449 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.42 ' HG2' ' N ' ' A' ' 97' ' ' GLN . 14.2 tttm -92.02 -61.87 1.53 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.92 0.39 . . . . 0.0 111.004 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.445 ' NE2' ' H ' ' A' ' 97' ' ' GLN . 0.3 OUTLIER -66.64 -34.83 78.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.991 -179.531 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.42 -30.26 62.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.094 0.473 . . . . 0.0 110.646 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.47 HG13 ' CG2' ' A' ' 22' ' ' VAL . 1.5 mp -90.18 -8.43 10.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.627 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.23 -75.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.319 . . . . 0.0 111.34 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.88 -29.52 8.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.356 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.429 ' CB ' ' CD2' ' A' ' 20' ' ' LEU . 2.4 m120 -78.54 -50.66 11.18 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.916 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.03 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.1 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.74 0.305 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.6 m -150.15 161.69 41.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.964 0.411 . . . . 0.0 111.433 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.58 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 17.1 mt-30 -96.88 -179.34 4.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.375 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.52 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 18.1 m-85 -132.31 95.94 3.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.188 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -80.77 -19.53 44.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.6 p -134.37 122.71 22.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.375 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.47 -25.41 6.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.599 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.1 t -60.63 -17.23 45.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.769 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -90.5 -45.78 8.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.158 0.504 . . . . 0.0 111.476 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.479 ' CZ ' ' CG2' ' A' ' 23' ' ' VAL . 1.2 t80 -69.08 -23.26 64.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.087 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -57.37 -40.09 77.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.394 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -86.48 -24.46 25.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.528 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.94 -38.61 73.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.542 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.542 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.1 pt -86.76 -49.41 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.543 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.474 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -44.3 100.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 44.98 90.19 0.01 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.4 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 8.5 t0 -173.66 40.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.063 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.8 mptp? 63.92 -157.28 0.31 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.447 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.455 ' CD1' HG21 ' A' ' 84' ' ' VAL . 59.1 tp -98.19 117.87 33.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.112 0.482 . . . . 0.0 110.914 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.4 t -101.66 137.58 28.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.617 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.4 HG23 ' CD1' ' A' ' 99' ' ' ILE . 45.7 t -99.93 87.5 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.368 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.479 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 29.0 t -99.91 121.6 50.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.357 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -100.0 134.38 43.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.61 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.521 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 4.2 m-85 -99.19 52.36 0.95 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.931 0.395 . . . . 0.0 110.577 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -51.81 138.15 24.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 72' ' ' MET . . . -68.23 138.08 55.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.549 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -58.41 -14.37 7.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.403 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.431 ' CZ2' ' HE3' ' A' ' 72' ' ' MET . 5.7 p-90 -112.25 -123.83 0.28 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.092 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 36.8 t 60.74 -83.18 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.561 0.344 . . . . 0.0 110.824 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.64 -79.8 0.22 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.145 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.65 -22.15 73.66 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.884 2.389 . . . . 0.0 113.254 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 98.4 m -50.04 -27.66 5.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.615 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -77.7 -28.25 50.95 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.524 -179.55 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.4 mtp -76.58 4.43 9.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.859 0.361 . . . . 0.0 110.85 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.579 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 70.8 mt -86.31 -20.44 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.023 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.526 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -52.15 -44.07 91.77 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 46.4 Cg_endo -72.36 -35.15 6.83 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.835 1.69 . . . . 0.0 111.417 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.9 ttt -65.84 -52.13 53.06 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.493 HG13 ' CG2' ' A' ' 36' ' ' ILE . 63.8 mt -49.92 -28.41 4.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.536 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -76.69 -36.55 57.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.364 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.454 ' HB3' ' NZ ' ' A' ' 42' ' ' LYS . 9.3 mtpm? -58.56 -21.45 52.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.145 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.13 -22.34 21.8 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.36 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.454 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.2 t -65.6 -11.73 46.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.312 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -86.28 -25.17 25.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.661 0.267 . . . . 0.0 111.366 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.27 -28.68 18.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.792 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.528 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 80.4 m-85 -122.78 45.2 1.02 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.5 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 86.1 Cg_exo -37.98 -32.79 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.163 2.575 . . . . 0.0 113.601 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -63.69 -37.09 86.04 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.751 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 47' ' ' TYR . . . -89.84 138.79 31.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.789 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -89.76 127.11 35.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.916 0.388 . . . . 0.0 110.579 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 4.9 m-85 -98.58 86.59 3.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.717 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.52 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 36.6 m-85 -96.48 -175.73 3.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.88 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.58 ' HE2' ' HG2' ' A' ' 4' ' ' GLN . 34.4 mtmm -150.1 138.78 20.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.952 0.406 . . . . 0.0 111.293 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.428 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 3.0 tm? -95.22 129.72 42.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.07 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -86.98 110.46 20.06 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.888 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 84.2 t -78.81 -4.51 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.012 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -84.63 -55.29 4.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.977 0.418 . . . . 0.0 110.827 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -87.26 -17.31 32.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.398 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.472 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 2.3 mp -127.09 57.93 1.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.929 0.395 . . . . 0.0 111.092 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.64 -16.11 55.04 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.384 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -79.95 -29.63 39.7 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.575 0.226 . . . . 0.0 111.57 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.548 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 21.8 t -73.49 -27.56 23.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.961 0.41 . . . . 0.0 110.956 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 69' ' ' VAL . . . -80.01 -26.83 39.7 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -90.4 -31.0 17.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.823 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 13.9 ptmm? -60.31 -48.06 83.35 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.969 0.414 . . . . 0.0 109.984 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.42 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 75.3 m-80 -84.95 1.65 46.44 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.784 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 65.41 37.74 6.07 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.332 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 64' ' ' ALA . 48.9 t -111.61 75.19 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.815 0.341 . . . . 0.0 111.053 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.6 p -89.35 5.59 44.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.136 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HB1' HG22 ' A' ' 88' ' ' VAL . . . -60.68 -159.01 0.01 OUTLIER 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.575 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.613 ' HG2' ' O ' ' A' ' 72' ' ' MET . 1.5 pmm? -174.98 93.2 0.29 Allowed Pre-proline 0 CA--C 1.53 0.192 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.579 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 8.0 Cg_endo -94.04 -156.69 0.57 Allowed 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 124.904 -0.873 . . . . 0.0 112.502 -0.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.428 ' CB ' ' CG1' ' A' ' 69' ' ' VAL . 53.4 m -158.09 148.44 20.4 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.81 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 89' ' ' GLY . 90.5 mt -109.89 123.31 49.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.185 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.521 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 20.2 mt -122.76 128.96 51.17 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.837 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 4.5 mp -109.96 144.66 38.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.959 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.502 ' HA ' HG22 ' A' ' 84' ' ' VAL . 65.5 m-85 -145.04 126.09 14.57 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.471 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 51.8 mtmt -113.46 132.96 55.46 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.694 0.283 . . . . 0.0 111.493 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.454 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.3 m120 47.96 53.34 11.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.9 0.381 . . . . 0.0 111.742 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 59.43 16.07 34.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.978 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 74.7 mmtt -111.19 -153.92 0.53 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.416 ' C ' HG22 ' A' ' 84' ' ' VAL . 10.5 tp10 -108.81 173.79 6.16 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' A' ' 78' ' ' PHE . 58.0 t -149.18 -63.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.853 0.358 . . . . 0.0 111.165 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.49 162.8 8.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.2 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -138.53 115.16 10.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.543 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.5 t -136.41 98.89 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.17 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.445 HG22 ' HB1' ' A' ' 71' ' ' ALA . 2.4 p -56.92 116.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.967 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 90' ' ' ALA . . . 141.52 -140.26 10.09 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.989 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 89' ' ' GLY . . . 147.61 36.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.818 0.447 . . . . 0.0 110.867 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 93' ' ' ALA . 75.3 m-80 -86.94 143.46 35.2 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.576 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -48.87 85.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.581 2.187 . . . . 0.0 112.478 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -179.48 -37.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.487 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.46 -44.34 2.13 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 3.2 tp -50.1 -18.61 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.464 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.45 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 7.8 ptpp? -91.71 -49.52 6.23 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.971 0.415 . . . . 0.0 110.974 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.45 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 25.7 mt-30 -69.22 -32.11 71.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.48 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.65 -27.76 68.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.534 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.448 HG22 ' CG ' ' A' ' 47' ' ' TYR . 58.4 mt -90.22 -11.54 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.511 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.43 -74.21 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.917 0.389 . . . . 0.0 111.492 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -45.93 -29.5 1.44 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.378 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.408 ' CB ' ' CD2' ' A' ' 20' ' ' LEU . 69.8 m-20 -90.14 -42.34 11.12 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.269 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.081 179.896 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 41' ' ' GLU . 12.5 p . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.652 0.263 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.3 m -150.26 156.54 41.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.946 0.403 . . . . 0.0 111.403 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -99.57 -173.44 2.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.621 179.368 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.527 ' CE2' ' CD1' ' A' ' 11' ' ' PHE . 21.4 m-85 -137.5 101.33 4.47 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -83.19 -20.41 34.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.283 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -133.03 122.84 24.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.147 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.12 -26.49 27.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.49 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -55.33 -23.41 23.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.188 0.518 . . . . 0.0 110.392 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -90.69 -35.19 15.07 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.627 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.527 ' CD1' ' CE2' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -74.76 -24.11 58.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.948 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -58.75 -68.68 0.24 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.066 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.4 t -56.74 -23.56 43.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.447 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.46 -64.36 0.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.36 . . . . 0.0 111.472 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.7 pt -61.03 -47.23 94.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.486 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.514 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -40.28 97.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.7 mt-30 43.14 88.58 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.309 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 63.9 t0 -167.11 38.5 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.671 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 28.7 mtmt 70.07 -155.46 0.14 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.799 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.418 ' CD2' ' HB3' ' A' ' 103' ' ' ALA . 36.4 tp -97.6 112.07 24.09 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.144 0.497 . . . . 0.0 110.574 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -101.44 124.73 55.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.536 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.4 t -103.51 98.79 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.141 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.47 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 38.2 t -105.74 131.69 54.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.775 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.529 ' HA ' ' O ' ' A' ' 74' ' ' THR . 62.2 t0 -100.1 132.53 45.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.53 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.527 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 5.2 m-85 -99.11 49.13 0.95 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.069 0.462 . . . . 0.0 110.524 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.534 ' HB2' ' HB3' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -50.42 145.87 5.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.44 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' A' ' 72' ' ' MET . . . -59.99 164.91 3.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.77 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.464 ' HB ' ' N ' ' A' ' 58' ' ' ASP . 3.1 t -96.75 22.74 7.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.913 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -148.82 -44.77 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 39.1 t -43.3 156.11 0.05 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.836 0.35 . . . . 0.0 111.373 -179.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -93.41 -69.34 1.1 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.239 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -47.07 -25.95 4.64 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.983 2.456 . . . . 0.0 112.955 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 98.7 m -61.8 -63.07 1.38 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.704 0.288 . . . . 0.0 111.623 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 61.9 pttt -55.45 -22.02 18.68 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.602 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.42 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 44.4 tpp -76.43 1.43 16.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 110.776 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.539 ' CG2' HG13 ' A' ' 40' ' ' ILE . 63.1 mt -85.93 -18.08 9.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.401 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.501 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.32 -44.4 81.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 53.9 Cg_endo -73.36 -35.4 4.98 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.837 1.691 . . . . 0.0 111.438 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 57.3 ttp -65.33 -52.04 56.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.539 HG13 ' CG2' ' A' ' 36' ' ' ILE . 73.1 mt -48.18 -29.51 2.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.56 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.416 ' HB2' HG12 ' A' ' 2' ' ' VAL . 87.1 tt0 -76.92 -34.31 57.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.977 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -63.91 -22.89 67.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.62 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -90.37 -22.51 21.46 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.455 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 80.2 p -67.29 -9.17 38.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.486 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -88.62 -26.22 22.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.78 0.324 . . . . 0.0 111.174 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -90.53 -29.79 17.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.842 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.529 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 78.6 m-85 -122.79 45.63 1.12 Allowed Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.502 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 84.0 Cg_exo -38.05 -32.16 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.22 2.613 . . . . 0.0 113.952 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.499 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 3.9 mm100 -66.91 -16.83 64.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.927 0.394 . . . . 0.0 111.31 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.04 139.89 38.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.559 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -89.44 120.99 31.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.907 0.384 . . . . 0.0 110.359 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.455 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 5.3 m-85 -97.92 83.88 3.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.313 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.493 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 46.5 m-85 -99.52 -174.53 2.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.354 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 32.6 mtmm -150.21 141.69 23.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.943 0.401 . . . . 0.0 110.964 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.452 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 2.5 tm? -100.41 130.34 46.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.866 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -87.87 114.07 24.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.856 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 78.3 t -77.54 -3.08 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.65 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.464 ' N ' ' HB ' ' A' ' 28' ' ' THR . 64.9 t0 -82.05 -55.53 4.51 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.899 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -89.82 -28.46 19.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.391 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 3.8 mp -108.23 52.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.848 0.356 . . . . 0.0 111.116 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.9 -15.21 59.9 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.447 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -82.94 -29.12 29.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.716 0.293 . . . . 0.0 111.448 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.588 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 15.4 t -73.33 -51.1 27.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.454 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 69' ' ' VAL . . . -54.47 -26.02 28.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.114 0.483 . . . . 0.0 109.718 178.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.415 ' NE2' ' C ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -90.46 -37.82 13.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.07 179.649 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -61.64 -42.53 99.02 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.903 0.382 . . . . 0.0 110.352 -179.581 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -83.68 -0.46 50.83 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 65.67 35.45 6.96 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.334 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 64' ' ' ALA . 31.2 t -113.16 63.51 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 121.03 0.443 . . . . 0.0 110.867 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.2 p -74.57 -13.85 60.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.074 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.79 -168.77 0.0 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.414 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.539 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -174.29 111.82 0.3 Allowed Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.207 -179.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.499 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 57.3 Cg_endo -88.99 -166.73 3.19 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.275 -1.136 . . . . 0.0 112.398 -0.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 34.1 m -159.81 150.07 18.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.604 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.407 ' CD1' ' CD1' ' A' ' 95' ' ' ILE . 71.8 mt -110.78 124.8 52.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.888 0.375 . . . . 0.0 111.591 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.527 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 29.4 mt -124.72 124.14 41.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.465 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 3.3 mp -109.91 149.19 30.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.786 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.597 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 40.5 m-85 -149.29 128.55 12.87 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.128 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.505 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 9.8 mtpm? -114.99 137.33 52.12 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.477 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 6.2 m120 49.93 52.35 14.83 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.721 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 16' ' ' ALA . . . 57.78 18.7 33.17 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.732 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.597 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 67.1 mttm -120.01 -155.56 0.63 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.468 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 85.8 tt0 -109.13 176.93 4.92 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 83' ' ' GLU . 3.5 m -165.38 -47.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.44 0.162 . . . . 0.0 111.301 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.69 170.37 9.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.142 0.496 . . . . 0.0 112.019 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.477 ' N ' ' HD2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -160.12 132.19 6.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.355 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.4 t -146.02 109.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.147 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 6.5 p -69.55 69.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.814 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.2 118.29 0.56 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.349 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.466 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -95.96 38.0 1.2 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.914 0.388 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 93' ' ' ALA . 5.5 m120 -65.89 132.21 94.71 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.545 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -48.4 86.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.66 2.24 . . . . 0.0 112.668 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 176.8 -36.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.267 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.04 -46.87 2.7 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 4.7 tp -53.58 -15.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.211 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -91.38 -50.95 5.53 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.791 0.329 . . . . 0.0 111.086 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -73.79 -32.97 64.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.478 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.02 -26.44 66.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.59 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.437 HG22 ' CG ' ' A' ' 47' ' ' TYR . 63.7 mt -90.24 -18.27 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.107 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.74 -65.49 1.01 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.007 0.432 . . . . 0.0 111.104 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -48.96 -28.26 3.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.217 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -90.23 -38.71 13.26 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.34 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.418 ' HB3' ' CD2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.197 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.798 0.332 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.7 p -167.7 135.91 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.802 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.0 m -150.11 161.77 41.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.884 0.373 . . . . 0.0 111.253 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.452 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 16.6 mt-30 -102.93 -172.68 2.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.39 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.531 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.2 m-85 -137.52 129.32 28.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.059 0.457 . . . . 0.0 111.461 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -112.98 -28.24 7.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.498 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.0 p -128.57 132.49 48.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.515 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.44 -25.34 50.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.51 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.3 t -59.74 -18.35 42.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.621 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -90.42 -64.94 1.06 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.277 0.561 . . . . 0.0 111.031 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.474 ' CZ ' ' CG2' ' A' ' 23' ' ' VAL . 1.2 t80 -53.54 -29.0 34.63 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.015 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -54.89 -35.29 63.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.018 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.3 p -82.5 -37.49 25.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.111 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.74 -49.12 20.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.66 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.55 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.5 pt -77.58 -49.91 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.501 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.454 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -40.74 95.43 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 85.1 mt-30 44.35 86.66 0.02 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.422 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 8.1 t0 -169.54 41.14 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.407 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.541 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 10.9 mptt 67.56 -155.41 0.21 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.694 0.283 . . . . 0.0 110.888 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.508 ' HB2' ' HD3' ' A' ' 79' ' ' LYS . 61.5 tp -98.1 115.21 27.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.222 0.534 . . . . 0.0 111.252 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -99.79 128.2 51.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.471 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.8 t -99.74 91.22 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 110.816 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.474 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 42.0 t -101.27 132.19 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.125 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 7.9 t70 -102.43 129.11 48.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.73 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.544 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 4.4 m-85 -98.98 51.6 0.96 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.206 0.527 . . . . 0.0 110.467 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.502 ' O ' ' HD1' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -50.99 139.44 17.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.111 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.45 ' CB ' ' HB3' ' A' ' 72' ' ' MET . . . -65.58 141.75 58.32 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.331 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.437 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.6 t -57.91 -18.13 21.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.069 0.461 . . . . 0.0 110.835 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -106.61 -128.74 0.27 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.315 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 72' ' ' MET . 30.2 t 61.08 156.08 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.805 0.336 . . . . 0.0 110.979 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.09 -82.1 1.19 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.488 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.97 60.85 3.79 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.627 2.218 . . . . 0.0 112.33 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.7 p -107.61 -20.83 13.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.024 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -85.71 -24.11 27.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.119 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.439 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 57.7 ttp -63.44 -12.69 33.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.982 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.477 ' CG2' HG13 ' A' ' 40' ' ' ILE . 2.7 mp -81.99 -30.22 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.669 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -49.5 -45.72 77.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 37.8 Cg_endo -70.86 -37.65 6.28 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.722 1.615 . . . . 0.0 111.012 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.489 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 66.4 mtm -63.92 -54.94 26.81 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.477 HG13 ' CG2' ' A' ' 36' ' ' ILE . 55.7 mt -44.74 -29.08 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.069 0.461 . . . . 0.0 110.542 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -81.59 -40.32 23.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.176 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -59.82 -27.9 67.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.627 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.489 ' HD1' ' O ' ' A' ' 39' ' ' MET . 10.4 m-85 -78.02 -22.43 49.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.625 0.25 . . . . 0.0 111.389 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.438 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 46.9 t -66.65 -11.32 53.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.206 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -87.44 -26.09 23.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.64 0.257 . . . . 0.0 111.096 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -89.98 -31.73 17.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.199 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.479 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 89.7 m-85 -124.39 51.61 4.85 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.02 0.438 . . . . 0.0 110.489 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 2.9 Cg_endo -48.95 -25.43 8.66 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.034 2.489 . . . . 0.0 112.484 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -65.77 -31.49 72.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.054 0.454 . . . . 0.0 110.229 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -95.77 144.48 26.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.86 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -89.96 129.98 36.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.709 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.48 ' CZ ' HD11 ' A' ' 99' ' ' ILE . 8.8 m-85 -105.09 90.94 3.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.391 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.531 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 47.5 m-85 -101.01 -178.12 3.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.559 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 4' ' ' GLN . 20.1 mtpp -141.9 141.27 33.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.395 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.474 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 3.0 tm? -105.26 144.23 32.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.29 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.423 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 22.9 t70 -99.9 115.5 29.77 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.075 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 75.5 t -76.83 -4.0 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.919 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.437 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 38.6 t70 -96.21 -50.09 4.95 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.254 0.549 . . . . 0.0 110.215 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.419 ' HG3' HD13 ' A' ' 60' ' ' LEU . 5.1 tp10 -82.16 -40.28 22.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.652 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.434 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 4.1 mp -111.67 43.53 1.52 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.545 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.6 -24.05 16.45 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.762 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.516 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 56.6 m-20 -71.04 -50.09 37.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.688 0.28 . . . . 0.0 111.256 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.539 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 15.6 t -56.37 -23.85 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.142 0.496 . . . . 0.0 110.244 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 69' ' ' VAL . . . -80.35 -25.2 39.33 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 5.7 pt20 -90.21 -35.4 15.36 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.272 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 20.2 ptmt -57.79 -48.45 79.66 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.421 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.42 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 75.6 m-80 -85.48 2.18 45.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.048 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 63.92 38.94 8.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.905 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.451 ' N ' ' O ' ' A' ' 64' ' ' ALA . 43.8 t -116.39 99.82 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.899 0.38 . . . . 0.0 111.398 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.7 m -121.7 13.17 10.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.446 ' O ' ' HB1' ' A' ' 27' ' ' ALA . . . -60.9 -157.9 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.092 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.608 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -169.75 88.19 0.57 Allowed Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 40.3 Cg_endo -96.71 -164.57 0.99 Allowed 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 124.777 -0.926 . . . . 0.0 112.793 -0.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.508 HG22 ' HA ' ' A' ' 88' ' ' VAL . 29.3 m -149.98 153.91 37.35 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.701 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.419 ' CD1' ' CD1' ' A' ' 95' ' ' ILE . 85.3 mt -114.33 126.58 55.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.819 0.342 . . . . 0.0 111.235 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.544 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 19.1 mt -121.76 128.68 52.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.014 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.46 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 3.6 mp -109.89 141.88 41.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.628 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.601 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 65.1 m-85 -141.88 127.13 18.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.697 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.508 ' HD3' ' HB2' ' A' ' 20' ' ' LEU . 8.9 mmmm -109.82 133.17 53.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.53 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 5.2 m120 42.88 65.17 0.99 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.01 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 53.96 21.02 15.65 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.155 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.601 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 28.1 mtpp -127.33 -160.82 1.03 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.431 ' O ' HG12 ' A' ' 84' ' ' VAL . 82.3 tt0 -109.47 178.06 4.55 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.439 HG13 ' CG ' ' A' ' 79' ' ' LYS . 4.8 m -162.38 -47.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 O-C-N 123.1 0.25 . . . . 0.0 111.144 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.96 162.07 17.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.125 0.488 . . . . 0.0 111.874 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -149.09 115.39 5.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.267 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.3 t -131.1 98.66 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.331 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.508 ' HA ' HG22 ' A' ' 74' ' ' THR . 3.3 p -62.33 98.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.696 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.98 108.52 0.81 Allowed Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.2 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.478 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -95.68 37.13 1.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 111.259 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 93' ' ' ALA . 75.9 m-80 -72.04 131.77 85.17 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.237 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -45.91 86.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.689 2.26 . . . . 0.0 112.637 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 178.51 -36.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.525 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.23 -45.62 2.44 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 5.0 tp -49.94 -18.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.302 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -91.76 -50.97 5.46 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.903 0.382 . . . . 0.0 111.049 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -69.9 -32.1 70.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.599 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.1 -28.46 69.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.748 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.48 HD11 ' CZ ' ' A' ' 52' ' ' PHE . 56.7 mt -90.22 -8.08 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.526 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.26 -69.39 0.73 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.866 0.365 . . . . 0.0 111.162 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.99 -29.61 30.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.177 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.411 ' HB2' ' CD2' ' A' ' 20' ' ' LEU . 5.6 m120 -80.75 -52.91 6.99 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.053 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.041 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.506 ' O ' ' CG1' ' A' ' 2' ' ' VAL . 26.5 ptt? . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.506 ' CG1' ' O ' ' A' ' 1' ' ' MET . 11.2 p 52.03 131.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.23 0.538 . . . . 0.0 112.048 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 54' ' ' LYS . 88.9 m -150.17 162.42 40.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.133 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.52 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 59.5 mt-30 -101.04 178.77 4.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.631 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.52 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 18.4 m-85 -133.17 98.48 4.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.712 0.291 . . . . 0.0 111.598 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -83.52 -28.31 28.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.44 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.3 p -123.36 122.62 38.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.255 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.59 -26.4 8.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.687 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.9 t -59.22 -19.85 49.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.829 0.347 . . . . 0.0 110.426 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -90.73 -31.07 16.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.358 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.502 ' CD1' ' CE2' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -85.86 8.45 20.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.391 -179.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -87.7 -60.58 1.93 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.867 0.365 . . . . 0.0 110.923 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -67.01 -17.17 64.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.28 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.48 91.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.377 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.554 ' O ' ' N ' ' A' ' 81' ' ' GLY . 21.4 pt -88.89 -49.92 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.465 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.451 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -46.29 103.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.847 0.356 . . . . 0.0 111.955 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 44.01 87.45 0.02 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.29 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -168.84 40.67 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.035 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER 64.33 -156.88 0.31 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.281 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.42 ' CD1' ' HB3' ' A' ' 102' ' ' ASN . 3.4 tt -98.15 115.85 29.14 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.205 0.526 . . . . 0.0 110.782 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -104.73 127.87 58.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.135 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.6 t -103.69 95.21 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.552 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.47 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 40.5 t -99.85 136.73 29.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.204 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 74' ' ' THR . 38.8 t70 -100.01 128.1 46.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.825 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.502 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 5.2 m-85 -98.89 48.69 0.96 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.012 0.434 . . . . 0.0 110.683 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.515 ' O ' ' HD1' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -51.48 137.04 24.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.889 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 72' ' ' MET . . . -58.39 165.01 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.965 0.412 . . . . 0.0 111.042 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.479 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 3.7 t -98.67 19.24 15.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.066 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 15.4 p-90 -141.76 -38.71 0.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.8 t -36.87 -69.06 0.12 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.781 0.325 . . . . 0.0 111.801 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.87 -74.42 0.23 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.511 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.6 -26.95 9.86 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.666 2.244 . . . . 0.0 112.421 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.4 ' HB3' ' CB ' ' A' ' 26' ' ' TYR . 77.5 m -58.25 -21.21 47.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.203 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -75.32 -19.22 59.76 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.28 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.427 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 84.4 mtp -75.3 3.8 8.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.357 . . . . 0.0 110.691 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.517 ' CG2' HG13 ' A' ' 40' ' ' ILE . 55.1 mt -85.68 -17.8 9.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.487 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.568 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.51 -42.33 74.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 35.3 Cg_endo -68.93 -43.58 3.3 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.576 1.517 . . . . 0.0 111.324 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.589 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 23.9 mmt -61.23 -61.28 2.67 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.517 HG13 ' CG2' ' A' ' 36' ' ' ILE . 56.8 mt -43.73 -29.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.846 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -81.56 -37.8 27.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.822 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 39' ' ' MET . 99.3 mttt -71.6 -30.96 66.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.544 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.589 ' HD1' ' O ' ' A' ' 39' ' ' MET . 16.3 m-85 -73.15 -27.07 61.46 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.356 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.5 p -67.02 -9.7 41.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.147 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.402 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 56.2 mt-10 -87.26 -26.51 23.44 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.788 0.327 . . . . 0.0 111.222 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.4 -31.79 16.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.524 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.531 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 73.9 m-85 -122.78 45.19 1.02 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.401 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 80.3 Cg_exo -37.74 -32.32 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.286 2.657 . . . . 0.0 113.478 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -60.71 -35.1 75.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.604 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.8 138.54 31.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.543 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.68 122.32 32.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.888 0.375 . . . . 0.0 110.46 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.444 ' CE2' ' CD1' ' A' ' 99' ' ' ILE . 4.5 m-85 -99.32 90.33 4.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.577 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.52 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 41.0 m-85 -101.02 -177.76 3.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.572 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 4' ' ' GLN . 34.4 mtpt -139.96 131.5 27.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.369 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.456 ' HB3' ' HA ' ' A' ' 25' ' ' PHE . 3.2 tm? -95.73 126.39 40.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.138 0.494 . . . . 0.0 111.068 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.448 ' HB3' ' OD1' ' A' ' 58' ' ' ASP . 44.9 m-20 -85.29 113.08 21.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.716 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 96.4 t -81.85 -5.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.141 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.479 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 11.4 p-10 -84.52 -39.72 18.5 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.854 0.359 . . . . 0.0 110.854 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -100.4 -23.02 14.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.171 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.473 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 3.1 mp -119.57 48.44 1.52 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.822 0.344 . . . . 0.0 110.995 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -60.35 -18.24 49.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.444 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.67 -27.56 55.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.694 0.283 . . . . 0.0 111.507 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.7 t -75.53 -54.69 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.758 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.51 -26.74 22.12 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.954 0.407 . . . . 0.0 110.218 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.06 -26.84 20.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.69 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -70.44 -49.36 49.55 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.034 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -77.61 -1.1 29.16 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.116 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 67.55 37.61 3.34 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.344 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.5 t -115.25 68.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.854 0.359 . . . . 0.0 110.845 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.8 p -81.77 -7.95 59.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.15 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.415 ' CB ' HG23 ' A' ' 88' ' ' VAL . . . -57.56 -166.53 0.0 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.537 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -174.43 107.43 0.28 Allowed Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.476 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 37.2 Cg_endo -89.77 -166.68 2.99 Favored 'Cis proline' 0 C--N 1.35 0.642 0 C-N-CA 124.353 -1.103 . . . . 0.0 112.366 -0.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 53.4 m -160.88 142.69 12.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.227 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.487 HD12 ' CB ' ' A' ' 90' ' ' ALA . 36.7 mt -109.79 123.75 50.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.023 0.439 . . . . 0.0 111.551 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.502 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 29.1 mt -115.16 127.07 55.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.853 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.448 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 4.5 mp -109.68 131.52 54.98 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.477 ' HA ' HG23 ' A' ' 84' ' ' VAL . 51.9 m-85 -130.94 125.52 33.65 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.298 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.478 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 24.6 mtpp -109.78 126.53 53.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.719 0.295 . . . . 0.0 111.087 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.45 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 6.3 m120 50.41 55.62 9.2 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.941 0.4 . . . . 0.0 111.768 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 59.58 16.39 36.78 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.072 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 27.0 mtpp -115.57 -153.55 0.53 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 35.6 tt0 -108.87 171.51 7.39 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.478 ' CG2' ' HG3' ' A' ' 79' ' ' LYS . 38.4 t -144.0 -59.82 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.75 0.309 . . . . 0.0 111.203 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.08 157.42 6.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.442 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -118.3 114.67 23.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.708 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.4 t -136.96 80.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.036 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.415 HG23 ' CB ' ' A' ' 71' ' ' ALA . 3.8 p -59.64 85.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.998 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.54 123.41 2.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.703 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.487 ' CB ' HD12 ' A' ' 75' ' ' LEU . . . -84.45 55.23 3.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 110.83 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -51.59 131.89 35.86 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.725 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -44.96 -25.95 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.643 2.229 . . . . 0.0 112.776 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.411 ' HA ' ' HE2' ' A' ' 96' ' ' LYS . . . -123.32 49.19 1.72 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.724 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.445 ' C ' ' H ' ' A' ' 96' ' ' LYS . . . -152.39 -62.02 0.16 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.443 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.433 ' CD1' ' CD1' ' A' ' 75' ' ' LEU . 3.5 tp -58.17 -5.45 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.184 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.445 ' H ' ' C ' ' A' ' 94' ' ' ALA . 64.5 pttt -90.95 -47.53 7.53 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.954 0.407 . . . . 0.0 110.469 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.431 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 25.7 mt-30 -74.7 -32.47 62.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.52 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.4 -30.94 70.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.578 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.444 ' CD1' ' CE2' ' A' ' 52' ' ' PHE . 56.4 mt -90.25 -6.4 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.528 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.64 -77.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.998 0.428 . . . . 0.0 111.651 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.21 -29.3 5.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.054 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.42 ' HB3' ' CD1' ' A' ' 20' ' ' LEU . 73.0 m-80 -88.05 -67.4 0.83 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.672 0.272 . . . . 0.0 111.707 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.292 -179.69 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.815 0.34 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.442 HG11 ' HB2' ' A' ' 41' ' ' GLU . 9.9 p -153.73 132.98 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.56 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.4 m -150.29 157.69 43.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.0 111.481 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.518 ' HG3' ' HE2' ' A' ' 54' ' ' LYS . 10.8 mp0 -92.23 -177.14 4.57 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.525 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 14.7 m-85 -133.67 96.57 3.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.819 0.342 . . . . 0.0 111.073 178.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -75.54 -30.29 59.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.729 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.0 p -128.61 132.43 48.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.48 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.06 -25.32 58.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.389 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.8 m -59.08 -19.86 48.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.542 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -90.63 -35.75 14.8 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.2 0.524 . . . . 0.0 111.075 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.463 ' CZ ' ' CG2' ' A' ' 23' ' ' VAL . 1.1 t80 -73.67 -29.46 62.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.888 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -53.3 -57.02 12.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.218 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.8 p -61.13 -37.61 83.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.56 -51.9 33.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.649 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.6 pt -75.94 -48.86 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.529 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.454 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -43.14 97.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 84.7 mt-30 45.35 88.86 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.341 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 8.8 t70 -170.0 39.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.403 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 52.0 mttp 68.18 -154.35 0.18 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.731 0.301 . . . . 0.0 110.584 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.502 ' HB2' ' HD3' ' A' ' 79' ' ' LYS . 61.1 tp -97.8 114.28 26.28 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.089 0.471 . . . . 0.0 110.916 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -103.81 124.03 57.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.889 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.467 ' CG2' HG13 ' A' ' 99' ' ' ILE . 49.1 t -99.78 96.67 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.681 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.463 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 36.2 t -103.34 130.11 54.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.065 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.497 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.8 t70 -99.68 131.37 45.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.577 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.522 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 5.3 m-85 -98.9 50.88 0.96 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.036 0.446 . . . . 0.0 110.707 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.593 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -54.05 135.61 42.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.935 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -60.88 156.42 17.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 0.0 110.894 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 3.2 t -87.35 6.09 35.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.453 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.45 ' CZ2' ' CE ' ' A' ' 72' ' ' MET . 20.1 p-90 -127.52 -37.58 1.98 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 29' ' ' TRP . 53.9 t -28.51 -75.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.08 -80.81 0.35 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.898 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.96 -21.3 33.35 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.756 2.304 . . . . 0.0 112.326 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.5 p -53.44 -33.56 54.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.124 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -64.94 -22.74 67.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.321 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.0 mtp -68.76 -7.4 33.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.735 0.302 . . . . 0.0 111.016 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.5 ' CG2' HG13 ' A' ' 40' ' ' ILE . 57.0 mt -88.01 -19.25 7.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.303 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.511 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -53.09 -43.74 95.45 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.893 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 38.1 Cg_endo -71.67 -36.66 6.17 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.747 1.632 . . . . 0.0 111.459 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.466 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 1.1 mpt? -64.64 -55.95 16.94 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.5 HG13 ' CG2' ' A' ' 36' ' ' ILE . 55.7 mt -44.66 -27.4 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.841 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.442 ' HB2' HG11 ' A' ' 2' ' ' VAL . 43.1 tt0 -80.75 -39.83 26.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.138 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -64.12 -30.98 72.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.606 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.466 ' HD1' ' O ' ' A' ' 39' ' ' MET . 10.7 m-85 -75.47 -19.18 59.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.69 0.281 . . . . 0.0 111.377 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.424 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.6 t -72.77 -6.92 48.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.382 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -90.15 -26.9 19.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.701 0.286 . . . . 0.0 111.06 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -90.3 -28.99 18.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.568 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.52 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 80.0 m-85 -123.83 47.65 1.89 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.081 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 62.9 Cg_exo -35.26 -41.58 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.6 2.867 . . . . 0.0 113.919 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.411 ' O ' ' CD ' ' A' ' 19' ' ' LYS . 85.8 mt-30 -55.4 -34.92 64.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.978 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 20' ' ' LEU . . . -89.6 135.77 33.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.722 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.62 121.95 32.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.409 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.448 ' CE2' ' CB ' ' A' ' 43' ' ' PHE . 5.6 m-85 -98.26 84.59 3.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.586 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.525 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 48.2 m-85 -98.86 -174.71 2.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.515 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.593 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 34.4 mtmm -148.39 132.65 17.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.018 0.437 . . . . 0.0 111.033 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.474 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 2.1 tm? -91.87 130.74 37.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.187 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.403 ' O ' ' CD1' ' A' ' 60' ' ' LEU . 46.8 m-20 -86.44 126.32 34.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.411 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.48 ' O ' ' CG1' ' A' ' 57' ' ' VAL . 95.9 t -97.16 18.93 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.533 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.456 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 2.8 p30 -111.39 -38.99 4.81 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.242 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.428 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 17.6 tp10 -100.03 -13.94 18.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.805 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.514 HD13 ' N ' ' A' ' 60' ' ' LEU . 5.3 mp -104.74 -69.08 0.82 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.295 0.569 . . . . 0.0 110.926 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.84 -61.58 0.5 Allowed Glycine 0 C--N 1.314 -0.661 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.591 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -52.69 -43.43 65.59 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.575 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 16.0 t -59.83 -53.34 49.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.719 0.295 . . . . 0.0 110.844 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -51.25 -26.09 6.66 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 110.053 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -90.39 -38.02 13.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.157 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.575 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -61.15 -42.0 97.75 Favored 'General case' 0 C--O 1.23 0.055 0 CA-C-O 120.863 0.363 . . . . 0.0 110.414 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -84.95 -1.97 57.34 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.923 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 64.91 38.4 6.5 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.021 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.433 ' CG1' ' CB ' ' A' ' 74' ' ' THR . 40.2 t -114.75 69.12 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.852 0.358 . . . . 0.0 111.019 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.8 p -82.34 -11.46 58.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.067 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.32 -172.07 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.603 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.555 ' HG2' ' O ' ' A' ' 72' ' ' MET . 1.7 pmm? -171.59 107.57 0.38 Allowed Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.602 -0.439 . . . . 0.0 112.085 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 83.2 Cg_endo -93.78 171.23 18.28 Favored 'Cis proline' 0 N--CA 1.459 -0.55 0 C-N-CA 124.634 -0.986 . . . . 0.0 112.23 -0.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 34.5 m -136.16 153.69 51.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.953 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 90' ' ' ALA . 85.3 mt -115.09 125.55 53.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 111.056 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.522 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 28.5 mt -122.38 128.99 51.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.061 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.471 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 3.4 mp -109.79 146.03 35.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.441 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.619 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 67.9 m-85 -145.99 128.82 16.33 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.779 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.502 ' HD3' ' HB2' ' A' ' 20' ' ' LEU . 27.0 mmmt -109.69 132.92 53.7 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.458 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.485 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 5.2 m120 44.44 60.25 2.93 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.842 0.353 . . . . 0.0 111.845 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 57.29 18.61 29.28 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.245 -0.503 . . . . 0.0 113.072 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.619 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 96.5 mttt -122.12 -158.86 0.79 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.428 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 32.0 tt0 -109.35 176.73 4.98 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.461 HG12 ' CG ' ' A' ' 79' ' ' LYS . 3.3 m -165.01 -46.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 O-C-N 123.169 0.293 . . . . 0.0 111.292 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.26 158.17 16.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.147 0.499 . . . . 0.0 111.881 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -151.67 114.85 4.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.399 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.7 t -135.57 106.64 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.184 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 3.6 p -66.78 97.87 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.48 104.83 0.44 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.195 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.529 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -96.98 35.87 1.5 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.927 0.394 . . . . 0.0 111.524 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 93' ' ' ALA . 13.9 p-10 -76.7 134.45 69.1 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.236 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -44.79 87.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.591 2.194 . . . . 0.0 112.702 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 178.76 -36.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.551 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.9 -41.9 2.2 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.529 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 5.1 tp -51.02 -18.0 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.586 0.231 . . . . 0.0 111.329 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -92.25 -50.33 5.72 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.971 0.415 . . . . 0.0 110.837 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -68.02 -31.92 71.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.581 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.38 -30.38 64.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.174 0.512 . . . . 0.0 110.772 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.472 HG21 ' CG ' ' A' ' 47' ' ' TYR . 1.5 mp -90.09 -9.72 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.554 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.62 -65.64 1.0 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 111.184 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.91 -26.91 27.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.452 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -89.3 -59.95 2.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.536 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.102 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.846 0.355 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.6 t -104.54 143.89 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.9 m -149.98 147.06 27.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.977 0.417 . . . . 0.0 111.248 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.571 ' HG2' ' HE3' ' A' ' 54' ' ' LYS . 40.4 mt-30 -90.13 174.48 7.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.28 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.507 ' CD2' ' CG ' ' A' ' 11' ' ' PHE . 16.9 m-85 -123.02 124.52 43.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.931 0.396 . . . . 0.0 111.144 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -109.26 -25.21 10.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.643 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -129.92 123.28 30.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.29 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.1 -26.64 4.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.426 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -57.8 -20.94 39.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.069 0.461 . . . . 0.0 110.477 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -90.42 -45.73 8.8 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.557 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.507 ' CG ' ' CD2' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -76.46 -23.38 53.87 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.695 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -63.85 -38.06 89.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.966 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.0 m -87.94 -26.39 22.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.224 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.38 -31.8 35.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.834 0.349 . . . . 0.0 111.423 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.533 ' C ' ' HA2' ' A' ' 81' ' ' GLY . 20.4 pt -90.18 -47.71 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.361 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.439 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.1 97.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 45.65 86.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.33 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -167.36 41.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.44 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.53 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.9 mptp? 63.31 -156.67 0.33 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.432 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.44 ' HB2' ' HG2' ' A' ' 79' ' ' LYS . 66.0 tp -97.98 115.81 28.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.102 0.477 . . . . 0.0 110.637 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.8 t -102.74 133.84 45.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.126 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.8 t -100.31 103.38 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.481 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.461 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 23.7 t -113.93 126.36 71.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 0.0 111.462 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 74' ' ' THR . 34.6 t70 -99.76 135.19 41.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.662 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.525 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 6.6 m-85 -99.39 46.78 0.97 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.705 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.545 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -46.9 141.02 4.29 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.071 0.462 . . . . 0.0 111.755 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.598 ' CA ' ' HG3' ' A' ' 72' ' ' MET . . . -69.88 133.59 47.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.084 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.7 t -63.67 -20.48 65.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.743 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.482 ' CE3' ' N ' ' A' ' 30' ' ' CYS . 8.4 p-90 -96.28 -126.46 0.14 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.301 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.482 ' N ' ' CE3' ' A' ' 29' ' ' TRP . 51.8 t 48.67 -88.68 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.747 0.419 . . . . 0.0 111.654 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . 150.25 -77.83 0.22 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.675 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.23 -6.77 17.05 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.77 2.313 . . . . 0.0 113.419 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 85.5 m -50.44 -34.38 24.44 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.589 0.233 . . . . 0.0 111.445 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -76.64 -5.06 46.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.62 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.434 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 27.9 ttt -81.04 2.92 24.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.895 0.379 . . . . 0.0 110.676 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.476 ' CG2' HG13 ' A' ' 40' ' ' ILE . 58.2 mt -86.41 -14.98 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.588 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.538 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -53.76 -42.04 90.59 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 37.7 Cg_endo -70.92 -41.25 2.92 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.638 1.559 . . . . 0.0 111.766 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 70.5 mtm -63.05 -54.95 30.06 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.476 HG13 ' CG2' ' A' ' 36' ' ' ILE . 70.5 mt -47.42 -28.01 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.81 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -79.68 -33.12 41.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.168 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.53 -21.98 66.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.703 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.415 ' CZ ' HG23 ' A' ' 95' ' ' ILE . 4.2 m-85 -90.05 -18.13 26.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.616 0.246 . . . . 0.0 111.559 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.426 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.6 t -74.3 -6.88 50.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.187 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -90.07 -28.08 19.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.839 0.352 . . . . 0.0 111.069 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.51 -27.65 19.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.652 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.54 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 74.6 m-85 -123.53 44.38 0.95 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.529 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 96.0 Cg_exo -39.19 -31.85 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.093 2.529 . . . . 0.0 113.346 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -61.7 -35.68 78.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.863 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.01 140.82 29.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.072 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -89.83 127.28 35.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.639 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.426 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 4.6 m-85 -102.2 89.0 3.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.006 0.431 . . . . 0.0 111.577 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.483 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 39.5 m-85 -98.3 -174.56 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.207 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.571 ' HE3' ' HG2' ' A' ' 4' ' ' GLN . 42.2 mtmt -150.22 137.84 19.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.062 0.458 . . . . 0.0 111.395 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.462 ' HB3' ' HA ' ' A' ' 25' ' ' PHE . 3.1 tm? -91.59 141.35 28.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.662 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -97.74 112.84 24.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.355 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 83.4 t -77.9 -4.51 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.933 0.397 . . . . 0.0 110.563 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.507 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 38.8 t70 -95.49 -35.0 11.85 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.174 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.418 ' HG3' HD13 ' A' ' 60' ' ' LEU . 5.3 tp10 -102.48 -46.48 4.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.613 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.418 HD13 ' HG3' ' A' ' 59' ' ' GLU . 6.1 mp -102.38 35.2 2.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.743 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -51.33 -25.12 11.59 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.411 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.63 -30.01 71.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.685 0.279 . . . . 0.0 111.198 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.405 HG13 ' CE2' ' A' ' 25' ' ' PHE . 11.1 t -74.06 -52.18 21.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.576 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.76 -29.83 41.7 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.991 0.424 . . . . 0.0 110.071 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -90.19 -28.31 18.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.001 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 67' ' ' ASN . 2.9 tptm -66.15 -50.67 63.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.015 0.436 . . . . 0.0 109.948 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.409 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 75.5 m-80 -79.67 0.43 30.37 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.84 179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 62.61 40.61 10.23 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.445 ' CG1' ' CB ' ' A' ' 74' ' ' THR . 29.2 t -107.72 54.2 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 110.821 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 94.1 p -74.05 -13.29 60.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.018 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.407 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -88.44 62.58 6.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.112 0.482 . . . . 0.0 110.054 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.603 ' HB2' ' HA ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -89.55 165.59 24.81 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.073 -179.128 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.603 ' HA ' ' HB2' ' A' ' 72' ' ' MET . 56.9 Cg_endo -72.59 134.47 34.6 Favored 'Cis proline' 0 C--N 1.353 0.773 0 C-N-CA 123.288 -1.547 . . . . 0.0 112.94 0.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 88' ' ' VAL . 53.0 m -117.77 154.38 31.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.565 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.412 ' CD1' ' HA ' ' A' ' 90' ' ' ALA . 75.9 mt -109.25 115.35 29.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 110.813 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.525 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 25.6 mt -109.77 126.72 54.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.889 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 3.8 mp -109.66 142.36 40.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.568 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.632 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 54.5 m-85 -141.86 127.01 18.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.984 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.501 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 9.5 mtpm? -116.38 132.19 56.74 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.668 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.437 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 74.0 m-20 49.31 68.75 0.67 Allowed 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.38 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.533 ' HA2' ' C ' ' A' ' 15' ' ' ILE . . . 46.55 28.54 3.54 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 116.095 -0.502 . . . . 0.0 113.098 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.632 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 68.2 mttm -136.42 -161.64 1.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.433 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 30.9 tt0 -109.1 -179.52 3.87 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.433 ' CG1' ' O ' ' A' ' 83' ' ' GLU . 5.0 m -162.76 -47.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.626 0.25 . . . . 0.0 111.309 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.13 166.15 13.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.098 0.475 . . . . 0.0 111.827 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.449 ' NZ ' ' HB2' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -141.76 115.42 9.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.522 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.9 t -116.05 85.42 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.13 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.482 ' HA ' HG23 ' A' ' 74' ' ' THR . 5.5 p -61.52 84.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.063 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.83 109.28 1.21 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.529 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.536 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -77.41 59.28 1.84 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.981 0.419 . . . . 0.0 111.075 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -62.63 133.98 95.08 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.342 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -43.7 -26.38 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.534 2.156 . . . . 0.0 112.803 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.22 53.12 0.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.605 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.407 ' C ' ' H ' ' A' ' 96' ' ' LYS . . . -167.69 -56.7 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.549 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.536 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 3.1 tp -54.72 -9.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.492 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.433 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 25.3 pttm -92.04 -50.28 5.77 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.919 0.39 . . . . 0.0 110.856 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.433 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 83.8 mt-30 -70.32 -32.24 69.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.782 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.22 -37.25 77.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.217 0.532 . . . . 0.0 110.394 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.521 ' CD1' ' N ' ' A' ' 99' ' ' ILE . 1.3 mp -90.21 -8.68 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.542 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.28 -62.52 1.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.941 0.4 . . . . 0.0 110.981 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.07 -28.54 58.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.073 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.409 ' CB ' ' CD2' ' A' ' 20' ' ' LEU . 3.6 m120 -84.64 -63.12 1.39 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.197 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.056 -179.995 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptp . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.828 0.347 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.43 HG21 ' NZ ' ' A' ' 54' ' ' LYS . 12.6 p -133.58 144.4 36.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.724 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.3 m -150.08 161.27 42.69 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.147 0.498 . . . . 0.0 112.06 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.588 ' HG2' ' HD2' ' A' ' 54' ' ' LYS . 54.1 mt-30 -92.37 -170.68 2.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.952 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.514 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 15.4 m-85 -134.4 121.46 21.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.114 0.483 . . . . 0.0 111.488 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HB3' ' NZ ' ' A' ' 6' ' ' LYS . 2.4 mmmp? -109.14 -16.41 14.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.621 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.7 p -139.83 125.38 19.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.374 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.56 -26.11 4.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.525 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 m -58.78 -20.3 48.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.344 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -90.63 -39.09 12.7 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.151 0.5 . . . . 0.0 111.025 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 11' ' ' PHE . 1.0 OUTLIER -84.54 4.16 33.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.22 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -89.88 -31.54 17.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.906 0.384 . . . . 0.0 110.738 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.3 p -89.92 -37.07 14.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.5 -40.38 12.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.499 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.593 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.1 pt -86.8 -50.93 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.353 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.462 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.69 97.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 44.52 86.84 0.02 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.231 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 64.2 t0 -169.32 40.78 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.453 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 92.2 mttt 67.66 -156.64 0.21 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.669 0.271 . . . . 0.0 110.614 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.452 ' CD1' HG12 ' A' ' 84' ' ' VAL . 63.9 tp -98.04 114.96 27.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.042 0.449 . . . . 0.0 110.9 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.4 t -102.85 132.48 48.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.966 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.427 ' CG2' HG13 ' A' ' 99' ' ' ILE . 41.1 t -102.38 107.58 22.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.68 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.461 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 34.6 t -113.91 126.75 71.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.008 0.433 . . . . 0.0 111.367 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 7.2 t70 -99.87 129.01 45.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.668 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.545 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 5.9 m-85 -99.08 52.09 0.96 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.124 0.487 . . . . 0.0 110.602 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.58 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -57.48 137.41 56.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.961 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.494 ' HB3' ' HB3' ' A' ' 72' ' ' MET . . . -61.01 143.74 54.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.019 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.528 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 5.2 t -63.04 -13.91 41.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.853 0.359 . . . . 0.0 110.948 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.445 ' CD1' ' HB1' ' A' ' 27' ' ' ALA . 11.7 p-90 -110.13 -132.33 0.33 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.644 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 40.8 t 62.2 -79.66 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.581 0.352 . . . . 0.0 111.437 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.71 -78.52 0.37 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.723 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -45.06 -30.55 4.82 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.637 2.225 . . . . 0.0 112.131 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 98.5 m -55.4 -36.88 66.91 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.596 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.12 -17.02 62.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.142 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.576 ' HA ' ' CE ' ' A' ' 35' ' ' MET . 1.7 tpt -76.16 -1.09 24.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.885 0.374 . . . . 0.0 110.68 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.483 HG21 HD13 ' A' ' 36' ' ' ILE . 65.1 mt -87.72 -12.72 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.695 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.538 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -58.41 -41.4 89.09 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 40.9 Cg_endo -71.97 -38.82 3.66 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.636 1.558 . . . . 0.0 111.367 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.429 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 90.1 mtp -62.87 -57.12 11.92 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.473 HG13 ' CG2' ' A' ' 36' ' ' ILE . 61.2 mt -46.59 -28.52 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.007 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -79.95 -29.38 39.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.603 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 57.2 mtpt -74.58 -15.65 60.83 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.429 ' HD1' ' O ' ' A' ' 39' ' ' MET . 4.4 m-85 -90.59 -20.08 22.99 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.433 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 79.3 p -67.59 -9.32 41.79 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 42' ' ' LYS . 12.5 pt-20 -90.02 -26.17 20.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.687 0.279 . . . . 0.0 111.058 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -90.56 -28.53 18.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.383 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.525 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 86.5 m-85 -123.13 46.14 1.28 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.328 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 84.7 Cg_exo -37.63 -38.66 0.64 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.177 2.585 . . . . 0.0 113.501 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 85.1 mt-30 -59.03 -33.17 70.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.622 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 20' ' ' LEU . . . -89.63 134.6 34.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.853 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -89.66 122.69 33.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.418 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.433 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 4.1 m-85 -97.33 100.91 12.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.07 0.462 . . . . 0.0 111.445 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.514 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 45.6 m-85 -115.82 -177.29 3.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.363 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.588 ' HD2' ' HG2' ' A' ' 4' ' ' GLN . 29.0 mttm -141.37 157.58 45.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.245 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.481 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 2.6 tm? -118.39 132.77 56.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.865 0.364 . . . . 0.0 111.033 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -85.25 114.98 22.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.222 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.467 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 55.8 t -74.12 -4.63 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.07 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.528 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 62.1 t0 -102.34 -50.89 3.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.048 0.451 . . . . 0.0 110.392 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.422 ' HG3' HD13 ' A' ' 60' ' ' LEU . 38.0 tp10 -75.11 -40.66 59.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.659 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 4.5 mp -113.44 37.75 3.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.707 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -53.12 -23.77 18.24 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.651 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -66.45 -29.79 70.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.635 0.255 . . . . 0.0 111.223 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.571 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 5.5 t -79.87 -27.47 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.051 0.453 . . . . 0.0 110.546 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.29 -26.08 60.93 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -90.17 -34.96 15.64 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.816 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 13.4 ptmm? -60.56 -48.53 81.37 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.073 0.463 . . . . 0.0 110.007 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.421 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.8 m-80 -80.93 -3.67 52.27 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.878 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 63.85 42.67 5.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.292 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.411 ' CG1' HG22 ' A' ' 74' ' ' THR . 55.1 t -103.38 109.23 26.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.754 0.311 . . . . 0.0 111.061 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -138.63 19.24 2.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.728 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.86 34.44 2.08 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.264 0.554 . . . . 0.0 109.918 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.494 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 1.2 pmm? -21.76 119.77 0.14 Allowed Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 85.8 Cg_endo -86.42 -163.88 2.83 Favored 'Cis proline' 0 C--N 1.353 0.812 0 C-N-CA 123.81 -1.329 . . . . 0.0 111.899 -0.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 98.6 m -161.91 162.44 29.16 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.987 0.422 . . . . 0.0 111.374 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.455 ' CD1' ' HA ' ' A' ' 90' ' ' ALA . 75.8 mt -126.38 121.25 31.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.862 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.545 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 26.5 mt -120.05 123.94 44.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.576 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.528 ' O ' HG11 ' A' ' 84' ' ' VAL . 3.5 mp -109.71 146.88 34.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.38 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.521 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 56.3 m-85 -143.77 129.33 19.12 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.193 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HG3' ' HB ' ' A' ' 84' ' ' VAL . 51.8 mtmt -109.86 129.44 55.64 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.258 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.485 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.3 m120 45.69 63.79 1.68 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.882 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 52.46 22.09 10.22 Favored Glycine 0 N--CA 1.453 -0.218 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.484 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.521 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 97.5 mttt -125.55 -156.13 0.71 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 33.7 tt0 -108.7 174.83 5.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.528 HG11 ' O ' ' A' ' 77' ' ' LEU . 4.3 p -162.19 -59.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 120.881 0.372 . . . . 0.0 111.369 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.486 ' H ' ' CG1' ' A' ' 84' ' ' VAL . . . -155.76 167.29 30.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.432 ' HG2' HD21 ' A' ' 76' ' ' LEU . 36.5 mtmm -150.5 130.42 13.36 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.414 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.1 t -145.11 90.25 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.407 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 2.8 p -60.71 88.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.757 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.21 101.24 0.57 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.475 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.531 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -75.5 61.16 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.861 0.362 . . . . 0.0 111.071 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -76.7 133.33 70.41 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.057 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -44.02 -24.29 0.84 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.547 2.165 . . . . 0.0 112.843 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.425 ' HA ' ' NZ ' ' A' ' 96' ' ' LYS . . . -95.16 27.65 3.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.356 -0.384 . . . . 0.0 112.022 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -164.21 -53.05 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.531 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 4.5 tp -49.2 -16.94 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 25.6 pttm -92.47 -51.36 5.17 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.966 0.412 . . . . 0.0 111.097 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.459 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 72.5 mt-30 -69.31 -32.04 70.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.879 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.55 -33.95 70.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.17 0.51 . . . . 0.0 110.47 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.461 ' CD1' ' N ' ' A' ' 99' ' ' ILE . 1.6 mp -90.4 -11.78 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.457 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.18 -62.92 1.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.806 0.336 . . . . 0.0 111.035 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.78 -27.43 51.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.011 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -83.66 -51.84 6.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.859 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.03 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ppp? . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.888 0.375 . . . . 0.0 111.397 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.429 ' CG1' ' HE3' ' A' ' 54' ' ' LYS . 51.2 t -132.37 126.36 55.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.911 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 51.0 m -150.1 158.86 44.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.019 0.438 . . . . 0.0 111.504 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.578 ' HG2' ' NZ ' ' A' ' 54' ' ' LYS . 48.7 mt-30 -89.98 166.27 13.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.128 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.473 ' CE2' ' CG ' ' A' ' 11' ' ' PHE . 12.9 m-30 -114.4 120.26 39.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.926 0.393 . . . . 0.0 110.488 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -97.51 -41.44 8.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.798 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -123.12 139.46 54.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.69 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.18 -24.68 43.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.4 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.5 m -63.1 -15.81 57.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.607 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -90.15 -46.69 8.29 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.158 0.504 . . . . 0.0 110.967 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.473 ' CG ' ' CE2' ' A' ' 5' ' ' PHE . 1.1 t80 -75.39 -35.41 61.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.615 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -52.36 -31.3 33.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.057 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 t -90.05 -26.22 20.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.27 -52.0 64.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.438 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.4 pt -73.77 -48.88 37.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.334 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.431 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -41.48 95.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 45.73 92.06 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.217 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -174.7 39.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.315 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.54 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 11.0 mptt 64.97 -155.61 0.29 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.243 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.426 ' CD2' ' CB ' ' A' ' 102' ' ' ASN . 65.1 tp -98.04 115.57 28.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.015 0.436 . . . . 0.0 111.006 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.4 t -101.26 133.48 44.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.807 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 48.1 t -99.78 91.44 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.586 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.461 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 22.3 t -100.67 123.34 53.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.904 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 7.7 t70 -99.98 133.25 44.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.095 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.504 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 4.6 m-85 -99.25 54.41 0.97 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.161 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.577 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -54.19 146.48 15.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.712 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.54 146.32 53.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.896 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.526 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 2.4 t -77.32 -1.16 28.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.723 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -125.38 -33.87 2.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.8 t -46.96 159.19 0.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.93 -64.09 0.71 Allowed Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.297 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.7 -24.3 4.58 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.869 2.379 . . . . 0.0 113.305 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.404 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 86.8 m -58.03 -54.98 40.76 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -51.83 -28.21 15.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.687 0.279 . . . . 0.0 111.74 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.401 ' O ' ' HG3' ' A' ' 35' ' ' MET . 43.8 tpp -75.09 1.25 13.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.886 0.374 . . . . 0.0 110.72 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.656 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 61.9 mt -87.12 -18.77 8.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.705 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.534 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -51.99 -43.51 89.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 38.4 Cg_endo -71.18 -39.17 4.16 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.724 1.616 . . . . 0.0 111.611 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.462 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 1.2 mpt? -63.24 -56.23 18.3 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.514 HG13 ' CG2' ' A' ' 36' ' ' ILE . 56.8 mt -44.02 -28.58 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.687 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.411 ' N ' HG23 ' A' ' 2' ' ' VAL . 43.7 tt0 -81.04 -41.35 22.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.852 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.32 -31.84 69.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.175 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.462 ' HD1' ' O ' ' A' ' 39' ' ' MET . 11.0 m-85 -74.43 -17.17 60.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.251 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.7 t -70.92 -10.41 59.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.151 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -87.05 -24.59 24.56 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.697 0.284 . . . . 0.0 111.007 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -90.44 -34.73 15.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.585 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.544 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 67.7 m-85 -122.95 43.33 0.74 Allowed Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.706 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 95.3 Cg_exo -39.38 -31.99 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.934 2.423 . . . . 0.0 113.201 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -61.06 -37.54 83.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.834 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.85 148.84 22.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.01 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.77 148.94 22.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.64 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -125.44 85.93 2.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.425 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.47 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 45.5 m-85 -99.12 -176.02 3.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.574 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.578 ' NZ ' ' HG2' ' A' ' 4' ' ' GLN . 9.8 mtmp? -146.43 133.84 20.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.98 0.419 . . . . 0.0 111.104 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.482 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 2.9 tm? -89.77 139.05 30.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.999 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -95.17 101.49 13.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.467 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 71.7 t -68.23 -12.72 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 0.0 110.466 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.526 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 61.8 t0 -86.74 -31.27 21.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.44 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.409 ' HG3' HD13 ' A' ' 60' ' ' LEU . 40.2 tp10 -103.16 -51.98 3.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.237 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.413 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 5.5 mp -93.62 51.86 1.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.895 0.378 . . . . 0.0 111.06 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.11 -19.86 47.32 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.501 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.95 -29.27 61.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.618 0.246 . . . . 0.0 111.38 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.574 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 5.5 t -78.45 -48.1 23.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.362 . . . . 0.0 110.343 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.31 -24.93 46.65 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -90.37 -38.84 13.06 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.025 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -60.99 -41.74 97.04 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.933 0.397 . . . . 0.0 110.241 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -85.31 0.6 51.51 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.736 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 61.35 39.86 14.86 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.46 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.402 ' CG1' ' CG2' ' A' ' 74' ' ' THR . 46.1 t -109.69 107.12 22.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.848 0.356 . . . . 0.0 111.054 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 84.3 p -124.0 20.91 9.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.032 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.472 ' CB ' ' CG2' ' A' ' 88' ' ' VAL . . . -73.02 -149.13 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.741 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.502 ' HG3' ' O ' ' A' ' 72' ' ' MET . 18.3 ptt? -175.88 84.73 0.29 Allowed Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.656 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 6.9 Cg_endo -95.76 -156.28 0.44 Allowed 'Cis proline' 0 CA--C 1.534 0.509 0 C-N-CA 125.217 -0.743 . . . . 0.0 112.834 -0.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.438 HG21 ' N ' ' A' ' 75' ' ' LEU . 91.6 m -150.68 146.77 26.68 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.362 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.438 ' N ' HG21 ' A' ' 74' ' ' THR . 77.3 mt -112.35 122.08 46.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.785 0.326 . . . . 0.0 111.382 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.504 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 27.9 mt -120.82 128.13 52.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.656 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 3.7 mp -109.9 145.36 36.98 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.66 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.581 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 54.8 m-85 -146.52 127.45 14.51 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.262 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.511 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 9.8 mtpm? -115.19 135.92 53.66 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.638 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.477 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.2 m120 48.59 59.94 4.01 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.641 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 52.37 23.02 11.78 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.022 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.581 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 52.1 mtmt -126.91 -158.48 0.87 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.461 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 82.0 tt0 -108.97 178.41 4.48 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.461 ' CG1' ' O ' ' A' ' 83' ' ' GLU . 4.3 m -164.54 -47.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.533 0.206 . . . . 0.0 111.251 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -169.98 154.37 5.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.038 0.447 . . . . 0.0 111.845 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -137.8 113.93 10.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.409 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.3 t -121.82 81.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.067 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.472 ' CG2' ' CB ' ' A' ' 71' ' ' ALA . 7.4 p -50.27 94.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.18 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.04 131.35 3.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.254 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.471 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -95.6 35.86 1.32 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.919 0.39 . . . . 0.0 111.133 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -59.04 108.04 1.19 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.97 179.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -33.02 90.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.138 2.559 . . . . 0.0 113.113 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 172.97 -30.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.122 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.99 -44.32 2.06 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.471 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 4.6 tp -49.35 -19.07 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.738 0.304 . . . . 0.0 111.179 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -91.2 -66.17 0.95 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.981 0.419 . . . . 0.0 111.22 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -60.79 -34.41 74.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.964 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.88 -31.29 68.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.06 0.457 . . . . 0.0 110.702 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.439 HG21 HD13 ' A' ' 99' ' ' ILE . 66.6 mt -90.25 -10.75 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.373 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.44 -68.68 0.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.839 0.352 . . . . 0.0 111.4 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.87 -28.21 34.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.367 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.426 ' CB ' ' CD2' ' A' ' 20' ' ' LEU . 3.6 m120 -83.48 -48.21 10.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.106 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.135 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.823 0.344 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.5 t -154.15 144.55 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.99 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.1 m -150.08 147.47 27.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.095 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.502 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 60.1 mt-30 -89.94 -176.9 5.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.39 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.51 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.9 m-85 -134.73 135.97 42.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.024 0.44 . . . . 0.0 111.375 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 34.5 mmtp -112.92 -33.76 5.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.536 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.9 m -124.54 165.55 17.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.82 52.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.77 0.319 . . . . 0.0 111.068 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.4 t -59.35 -16.42 22.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.791 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -90.09 -58.32 2.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.299 0.571 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.482 ' CZ ' ' CG2' ' A' ' 23' ' ' VAL . 1.1 t80 -66.42 -28.42 68.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.64 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -59.04 -42.73 90.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.817 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.5 m -79.23 -29.95 42.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.78 -32.4 67.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.194 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.8 pt -90.0 -49.15 13.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.275 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.456 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -42.95 101.9 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.1 mt-30 43.78 86.1 0.02 OUTLIER 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.211 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -166.24 39.26 0.05 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.62 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.544 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER 65.37 -153.29 0.27 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.729 0.299 . . . . 0.0 110.364 179.063 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.442 ' CD1' HG23 ' A' ' 84' ' ' VAL . 54.6 tp -97.7 114.18 26.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.06 0.457 . . . . 0.0 110.928 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 52.3 t -103.28 120.17 52.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.726 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.404 ' CG2' HG12 ' A' ' 99' ' ' ILE . 48.1 t -99.83 98.31 6.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.622 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.482 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 44.1 t -99.74 145.45 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.167 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 74' ' ' THR . 37.4 t70 -106.97 126.06 51.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.597 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.542 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 7.4 m-85 -98.88 50.42 0.96 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.152 0.501 . . . . 0.0 110.308 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.513 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -53.15 139.25 29.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.529 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.43 ' CB ' ' HB3' ' A' ' 72' ' ' MET . . . -63.13 149.16 45.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.572 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.4 t -74.53 -11.91 60.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.79 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.538 ' O ' ' C ' ' A' ' 30' ' ' CYS . 5.4 p-90 -112.18 -60.39 1.87 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.538 ' C ' ' O ' ' A' ' 29' ' ' TRP . 50.6 t 4.07 -80.95 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.431 0.692 . . . . 0.0 112.774 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.14 -78.48 0.35 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.582 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.02 -15.71 43.82 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.574 2.183 . . . . 0.0 112.567 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 31.9 p -52.9 -26.7 15.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.138 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -75.79 -16.84 60.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.553 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.419 ' O ' ' HG2' ' A' ' 35' ' ' MET . 48.0 ttm -74.17 2.07 9.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.038 0.447 . . . . 0.0 110.779 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.531 ' CG2' HG13 ' A' ' 40' ' ' ILE . 55.6 mt -83.74 -25.83 7.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.639 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.495 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -45.9 -45.02 36.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 40.4 Cg_endo -72.32 -37.69 4.23 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 121.694 1.596 . . . . 0.0 111.096 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.431 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 88.8 mtp -64.11 -54.9 26.66 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.531 HG13 ' CG2' ' A' ' 36' ' ' ILE . 67.2 mt -46.79 -27.62 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.703 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -81.19 -34.05 32.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.336 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -67.0 -22.74 65.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.739 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.435 ' CB ' ' CE2' ' A' ' 52' ' ' PHE . 5.9 m-85 -84.75 -21.91 29.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.716 0.294 . . . . 0.0 111.597 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.2 m -68.65 -12.06 60.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.015 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.406 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 39.4 tt0 -88.63 -23.81 22.97 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.826 0.346 . . . . 0.0 110.541 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -90.43 -38.23 13.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.371 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.536 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 60.5 m-85 -123.92 43.87 0.9 Allowed Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 89.6 Cg_exo -38.59 -29.03 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.046 2.497 . . . . 0.0 113.014 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.474 ' OE1' ' N ' ' A' ' 49' ' ' GLN . 0.3 OUTLIER -57.17 -37.8 72.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.692 179.548 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 20' ' ' LEU . . . -89.86 152.93 21.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.137 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -97.66 123.31 41.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.751 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.435 ' CE2' ' CB ' ' A' ' 43' ' ' PHE . 4.1 m-85 -100.93 104.43 15.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.111 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.51 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 46.5 m-85 -113.89 -178.81 3.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.212 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.513 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 32.9 mtpt -137.62 142.92 41.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.212 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.458 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 2.7 tm? -107.82 138.54 43.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.803 0.335 . . . . 0.0 110.733 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.414 ' HB3' HD11 ' A' ' 60' ' ' LEU . 26.4 t70 -93.03 113.39 25.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.909 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 52.6 t -73.5 -6.12 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.411 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.506 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 38.6 t70 -97.6 -46.39 6.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.085 0.469 . . . . 0.0 110.613 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 6' ' ' LYS . 38.2 tp10 -83.72 -32.54 25.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.101 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.451 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 3.6 mp -119.72 59.92 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.905 0.383 . . . . 0.0 110.929 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.21 -8.07 64.65 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.708 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -83.91 -28.31 27.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.674 0.273 . . . . 0.0 111.448 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.618 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 7.3 t -78.01 -45.28 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.869 0.366 . . . . 0.0 110.544 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.22 -24.92 45.33 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -90.45 -40.2 12.16 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.299 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -57.86 -48.92 78.4 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.892 0.377 . . . . 0.0 110.458 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.6 m-80 -78.14 -3.79 44.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.963 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 66.55 40.42 3.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.225 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.454 HG13 ' CB ' ' A' ' 74' ' ' THR . 58.0 t -83.45 -77.39 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 120.761 0.315 . . . . 0.0 110.869 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.7 p 47.91 25.45 0.76 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.756 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.91 -159.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.589 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -172.74 90.4 0.4 Allowed Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.484 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 22.5 Cg_endo -91.99 -160.41 1.07 Allowed 'Cis proline' 0 C--N 1.349 0.577 0 C-N-CA 124.625 -0.99 . . . . 0.0 112.42 -0.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.454 ' CB ' HG13 ' A' ' 69' ' ' VAL . 98.5 m -156.31 155.49 32.35 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.849 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.425 ' CD1' ' CD1' ' A' ' 95' ' ' ILE . 72.6 mt -120.22 121.38 38.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.935 0.398 . . . . 0.0 111.288 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.542 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 20.1 mt -118.99 128.57 54.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.875 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 4.3 mp -109.7 138.31 46.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.723 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.486 ' CE1' ' OE2' ' A' ' 83' ' ' GLU . 73.7 m-85 -137.51 126.91 24.87 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.542 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.47 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 59.5 mttm -109.84 128.71 55.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.728 0.299 . . . . 0.0 111.275 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 6.0 m120 44.27 58.04 3.98 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 61.64 13.55 39.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.372 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -111.71 -156.81 0.6 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.486 ' OE2' ' CE1' ' A' ' 78' ' ' PHE . 10.9 tp10 -108.78 173.82 6.15 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.47 ' CG2' ' HG3' ' A' ' 79' ' ' LYS . 56.8 t -146.64 -62.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.748 0.309 . . . . 0.0 111.317 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.13 159.26 7.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.357 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -122.29 115.44 22.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.611 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.57 80.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.419 ' HA ' HG23 ' A' ' 74' ' ' THR . 2.7 p -57.18 95.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.017 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.6 114.27 1.27 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.611 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.463 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -98.66 33.85 2.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 110.908 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -62.07 108.58 1.67 Allowed Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.968 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -31.91 88.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.229 2.62 . . . . 0.0 113.216 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 176.17 -35.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.85 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.62 -43.33 2.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.577 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 4.6 tp -53.26 -15.53 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.704 -0.226 . . . . 0.0 111.277 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.42 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 64.5 pttt -91.2 -49.25 6.48 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.78 0.324 . . . . 0.0 110.642 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.42 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 72.7 mt-30 -71.85 -32.15 67.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.366 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.24 -31.53 71.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.441 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.431 HG23 ' CG ' ' A' ' 47' ' ' TYR . 56.5 mt -90.08 -6.57 10.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.305 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.38 -65.29 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.921 0.391 . . . . 0.0 111.036 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.82 -29.78 8.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.944 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.415 ' HB2' ' CD2' ' A' ' 20' ' ' LEU . 67.5 m-20 -90.07 -67.79 0.82 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.948 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.126 -179.983 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptm . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.766 0.317 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.41 ' CG1' ' HD2' ' A' ' 54' ' ' LYS . 44.1 t -136.5 143.17 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.5 m -149.95 164.84 34.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.864 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.508 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -105.61 -177.35 3.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.339 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.481 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.9 m-85 -130.33 131.43 45.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.984 0.421 . . . . 0.0 111.483 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 59' ' ' GLU . 34.5 mmtp -114.49 -19.74 11.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.774 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -141.23 136.96 32.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.466 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.07 -28.42 17.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.242 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.9 m -59.32 -19.83 49.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.244 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.43 ' HG3' ' CE1' ' A' ' 5' ' ' PHE . 17.6 tp10 -90.49 -37.93 13.57 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.334 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.487 ' CD1' ' O ' ' A' ' 11' ' ' PHE . 1.1 t80 -90.2 15.83 9.64 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.06 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -89.79 -45.98 8.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.875 0.369 . . . . 0.0 110.662 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -79.6 -23.36 42.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.97 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.83 -50.48 68.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.205 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.7 pt -83.12 -50.02 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.334 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.431 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -40.06 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 79.9 mt-30 39.19 85.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.662 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 9.1 t70 -162.49 40.52 0.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.668 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.534 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 10.9 mptt 67.2 -156.52 0.22 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.458 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.425 ' CD2' ' CB ' ' A' ' 102' ' ' ASN . 64.3 tp -98.18 116.42 30.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.203 0.525 . . . . 0.0 110.977 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.9 t -103.12 134.69 43.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.748 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.2 t -99.7 92.32 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.65 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.485 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 48.0 t -99.83 124.34 53.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.044 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 8.1 t70 -99.98 129.17 46.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.921 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.541 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 5.7 m-85 -98.99 48.57 0.96 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.185 0.516 . . . . 0.0 110.348 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.541 ' O ' ' HD1' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -50.14 134.55 22.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.139 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.443 ' CB ' ' HB3' ' A' ' 72' ' ' MET . . . -60.72 153.04 25.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.196 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.416 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 3.3 t -76.89 2.25 15.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.514 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.419 ' CD1' ' HB1' ' A' ' 27' ' ' ALA . 5.4 p-90 -127.35 -125.3 0.23 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.746 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 48.8 t 62.49 -77.58 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.931 0.492 . . . . 0.0 111.421 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.11 -80.18 0.27 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.979 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.26 51.0 3.33 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.744 2.296 . . . . 0.0 112.523 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 99.5 m -112.5 -28.25 7.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.734 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -79.94 -15.9 56.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.495 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.4 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 66.1 mtt -74.7 4.16 6.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.764 0.316 . . . . 0.0 111.102 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.517 ' CG2' HG13 ' A' ' 40' ' ' ILE . 52.7 mt -83.53 -26.27 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.534 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.485 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -45.67 -45.39 34.74 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 44.1 Cg_endo -73.1 -36.36 4.36 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.773 1.649 . . . . 0.0 111.268 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 49.6 ttm -65.24 -53.11 49.21 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.517 HG13 ' CG2' ' A' ' 36' ' ' ILE . 79.0 mt -46.91 -30.44 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.593 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -76.79 -37.01 56.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.938 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.97 -22.74 62.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.367 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -90.1 -16.48 29.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.488 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.4 t -74.84 -6.88 51.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.236 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -90.12 -27.94 19.3 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.785 0.326 . . . . 0.0 111.052 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -90.47 -28.33 18.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.723 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.539 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 76.0 m-85 -123.14 43.93 0.85 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.698 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 98.5 Cg_exo -39.76 -31.62 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.977 2.451 . . . . 0.0 113.098 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -62.26 -37.82 86.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.941 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 20' ' ' LEU . . . -89.88 147.75 23.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.172 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -89.84 153.67 20.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.54 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -128.55 93.88 3.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.025 0.44 . . . . 0.0 111.479 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.481 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 49.6 m-85 -107.44 178.59 4.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.596 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.508 ' HB2' ' HA ' ' A' ' 4' ' ' GLN . 16.5 mtpp -139.09 146.92 41.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.51 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 25' ' ' PHE . 2.8 tm? -108.19 140.9 40.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.072 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.409 ' N ' HD13 ' A' ' 55' ' ' LEU . 27.8 t70 -95.43 116.04 28.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.55 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 60.6 t -76.88 -1.85 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.649 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.416 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 8.1 t70 -103.5 -43.57 5.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.024 0.44 . . . . 0.0 110.575 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.408 ' HG3' HD13 ' A' ' 60' ' ' LEU . 38.5 tp10 -86.12 -39.69 16.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.022 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.413 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 4.8 mp -111.4 44.01 1.4 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.849 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.15 -28.02 53.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.379 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.51 -29.1 70.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.739 0.304 . . . . 0.0 111.158 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.481 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 6.8 t -79.3 -45.42 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.438 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.36 -22.85 55.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.409 . . . . 0.0 110.058 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -90.16 -38.13 13.71 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.205 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 15.6 pttp -60.89 -47.1 87.93 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.972 0.415 . . . . 0.0 110.084 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.401 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.6 m-20 -77.93 -4.44 46.89 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.917 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 66.94 39.51 3.27 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.034 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.3 t -110.18 107.71 23.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.756 0.313 . . . . 0.0 110.97 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.5 t -121.87 -1.82 9.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.779 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.466 ' CB ' HG21 ' A' ' 88' ' ' VAL . . . -61.01 -157.75 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.578 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -175.26 100.92 0.26 Allowed Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.432 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 32.6 Cg_endo -88.54 -162.06 1.92 Allowed 'Cis proline' 0 C--N 1.353 0.795 0 C-N-CA 124.701 -0.958 . . . . 0.0 112.669 -0.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.415 HG23 ' HA ' ' A' ' 88' ' ' VAL . 42.8 m -158.58 146.86 18.41 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.098 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.403 HD11 ' HA ' ' A' ' 90' ' ' ALA . 84.3 mt -113.97 123.04 48.75 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.804 0.335 . . . . 0.0 111.701 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.541 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 18.2 mt -116.94 129.87 56.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.493 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 3.9 mp -109.78 142.01 41.62 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.719 0.295 . . . . 0.0 111.017 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.571 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 63.8 m-85 -143.71 126.58 16.26 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.274 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.501 ' HE2' HG12 ' A' ' 84' ' ' VAL . 41.6 mtmt -118.91 136.76 53.89 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.379 178.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 78.3 m-20 50.81 60.92 3.52 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.569 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 50.04 26.19 8.5 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.849 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.571 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 98.9 mttt -132.34 -159.55 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.488 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 28.7 tt0 -109.05 -179.75 3.94 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.501 HG12 ' HE2' ' A' ' 79' ' ' LYS . 12.2 m -163.75 -49.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.588 0.232 . . . . 0.0 111.217 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.14 156.54 14.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.054 0.454 . . . . 0.0 111.726 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -138.81 113.63 9.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.33 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.63 91.1 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.075 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.466 HG21 ' CB ' ' A' ' 71' ' ' ALA . 7.2 p -61.66 83.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.983 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.7 113.17 0.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.236 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.483 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -95.36 37.76 1.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.355 . . . . 0.0 111.387 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 93' ' ' ALA . 5.5 m120 -73.69 131.88 81.51 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.325 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -46.7 86.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.674 2.249 . . . . 0.0 112.665 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 174.35 -35.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.425 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.39 -46.55 2.87 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.781 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.483 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 4.9 tp -53.45 -14.8 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.526 0.203 . . . . 0.0 111.278 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -91.03 -49.52 6.37 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.883 0.373 . . . . 0.0 110.864 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -73.13 -32.38 64.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.447 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.33 -30.27 70.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.681 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.442 ' CG2' ' CD2' ' A' ' 47' ' ' TYR . 67.6 mt -90.19 -14.91 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.25 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.38 -70.51 0.67 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.84 0.352 . . . . 0.0 111.182 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.69 -28.69 6.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.272 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.425 ' CB ' ' CD2' ' A' ' 20' ' ' LEU . 5.7 m120 -83.18 -48.3 10.67 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.061 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.121 -179.953 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.714 0.292 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.401 ' CG1' ' HE2' ' A' ' 54' ' ' LYS . 47.4 t -152.36 138.61 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.002 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.8 m -147.89 154.49 40.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.03 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.527 ' HG2' ' HE3' ' A' ' 54' ' ' LYS . 16.2 mt-30 -93.74 177.25 6.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.624 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.525 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 14.4 m-85 -127.98 136.17 50.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.0 111.241 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HB3' ' HG2' ' A' ' 59' ' ' GLU . 34.4 mmtp -115.95 -46.34 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.513 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.1 p -114.81 134.11 55.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.534 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.09 -24.68 18.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.431 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.2 m -62.37 -16.58 55.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.556 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -90.21 -58.01 2.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.347 0.594 . . . . 0.0 111.076 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.523 ' CD1' ' CE2' ' A' ' 5' ' ' PHE . 1.1 t80 -61.28 -31.47 71.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.667 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -55.54 -23.32 25.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.1 t -80.37 -45.99 16.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.191 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.96 -46.52 68.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.29 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.853 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 24.1 pt -78.16 -4.63 6.88 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.833 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.901 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.18 81.82 6.1 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.682 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 74.9 mt-30 48.14 91.76 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.608 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 63.9 t0 -168.91 39.62 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.533 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 88.0 mttt 76.12 -156.83 0.04 OUTLIER 'General case' 0 C--O 1.23 0.065 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.564 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.491 ' CD1' HG22 ' A' ' 84' ' ' VAL . 59.7 tp -98.07 116.95 31.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.216 0.531 . . . . 0.0 110.79 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.6 t -102.89 124.22 56.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.801 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.4 HG21 ' CD1' ' A' ' 99' ' ' ILE . 46.0 t -99.79 97.88 6.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.665 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.477 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 40.2 t -105.12 131.04 55.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.424 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 7.8 t70 -99.87 130.67 46.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.453 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.535 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 6.3 m-85 -99.06 49.48 0.95 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.975 0.417 . . . . 0.0 110.69 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.568 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -51.05 140.74 15.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.067 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 72' ' ' MET . . . -62.27 157.35 19.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.754 0.311 . . . . 0.0 110.505 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.524 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 5.0 t -83.58 4.12 29.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.406 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 18.2 p-90 -124.64 -46.6 1.87 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.419 ' HB2' ' HG3' ' A' ' 72' ' ' MET . 22.3 t -43.96 127.97 5.5 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 111.414 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.41 -64.14 2.23 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.98 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -41.5 -28.26 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.389 2.726 . . . . 0.0 113.176 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.9 m -61.5 -14.57 30.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.418 ' C ' ' HD2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -78.8 -25.85 44.29 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.163 -179.497 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.445 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 66.0 mtm -75.39 1.52 13.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 110.301 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.481 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 28.1 mm -79.2 -44.37 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.873 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.472 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -41.7 -47.16 9.61 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.04 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.481 ' HD2' ' C ' ' A' ' 36' ' ' ILE . 45.6 Cg_endo -73.91 -27.77 11.91 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.79 1.66 . . . . 0.0 111.233 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.402 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 14.2 tpt -74.16 -50.02 21.16 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.459 HG23 HD13 ' A' ' 40' ' ' ILE . 63.8 mt -50.96 -32.72 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.389 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -72.37 -39.56 67.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.113 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.452 ' HB3' ' NZ ' ' A' ' 42' ' ' LYS . 9.6 mtpm? -57.88 -23.94 55.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.712 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.402 ' HD1' ' O ' ' A' ' 39' ' ' MET . 6.0 m-85 -90.43 -16.88 28.18 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.1 t -72.95 -7.66 52.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.523 0.201 . . . . 0.0 111.456 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -90.15 -26.53 20.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.757 0.313 . . . . 0.0 111.081 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.07 -30.07 17.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.531 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.504 ' CG ' HG22 ' A' ' 99' ' ' ILE . 79.6 m-85 -125.44 51.86 5.97 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.088 0.47 . . . . 0.0 110.745 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 1.4 Cg_endo -46.79 -26.5 4.68 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.085 2.523 . . . . 0.0 112.987 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.416 ' O ' ' HD3' ' A' ' 19' ' ' LYS . 73.8 mt-30 -69.04 -29.24 67.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.122 0.487 . . . . 0.0 110.394 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 20' ' ' LEU . . . -89.58 139.06 30.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.781 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -89.56 121.69 32.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.268 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.446 ' CE2' HD11 ' A' ' 99' ' ' ILE . 6.2 m-85 -99.02 81.77 2.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.596 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.525 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 47.4 m-85 -94.47 -175.12 3.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.357 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.568 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 47.0 mtmt -148.47 138.2 22.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.994 0.426 . . . . 0.0 110.75 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.429 ' CD1' ' N ' ' A' ' 56' ' ' ASP . 2.2 tm? -98.35 141.95 30.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.325 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.429 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 9.9 t70 -92.74 125.09 37.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.949 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 92.1 t -93.14 42.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.436 0.636 . . . . 0.0 110.621 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.524 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 64.5 t0 -152.97 -48.78 0.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.035 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.408 ' HG2' ' HB3' ' A' ' 6' ' ' LYS . 5.3 tp10 -75.56 -27.35 58.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.171 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' A' ' 60' ' ' LEU . 2.5 mm? -103.16 -64.43 1.08 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.376 0.608 . . . . 0.0 111.007 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.5 -61.25 0.64 Allowed Glycine 0 C--N 1.314 -0.658 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.644 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -51.17 -36.79 42.85 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.532 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 6.6 t -70.51 -58.25 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 110.589 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.49 -24.84 8.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.002 0.43 . . . . 0.0 110.074 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -90.14 -37.49 14.17 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.259 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 17.4 pttp -60.71 -48.77 80.28 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.1 m-20 -76.71 -7.72 55.88 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.676 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 66.09 43.53 2.88 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.24 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.434 ' CG1' HG22 ' A' ' 74' ' ' THR . 49.0 t -107.37 74.6 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.885 0.374 . . . . 0.0 111.011 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.9 p -83.38 -11.32 57.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.996 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.438 ' CB ' HG23 ' A' ' 88' ' ' VAL . . . -58.14 -163.73 0.0 OUTLIER 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.728 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.547 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -178.1 106.64 0.21 Allowed Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 42.8 Cg_endo -89.72 -165.35 2.64 Favored 'Cis proline' 0 C--N 1.351 0.687 0 C-N-CA 124.485 -1.048 . . . . 0.0 112.612 -0.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 91.7 m -152.59 163.24 39.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.811 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' A' ' 90' ' ' ALA . 80.9 mt -128.02 120.73 28.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.098 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.535 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 21.8 mt -118.93 124.11 46.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.758 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 4.3 mp -109.82 135.4 50.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.474 ' HA ' HG23 ' A' ' 84' ' ' VAL . 42.4 m-85 -136.05 129.05 31.37 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.602 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.441 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 9.2 mtpm? -114.65 124.04 50.83 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.99 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 6.4 m120 43.9 82.46 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.652 0.263 . . . . 0.0 111.213 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.853 ' HA2' ' O ' ' A' ' 15' ' ' ILE . . . 33.83 46.77 0.45 Allowed Glycine 0 C--N 1.333 0.38 0 CA-C-N 116.024 -0.535 . . . . 0.0 114.202 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 34.5 mmtp -146.97 -158.73 0.94 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.421 ' C ' HG23 ' A' ' 84' ' ' VAL . 34.0 tt0 -108.69 174.01 6.06 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.491 HG22 ' CD1' ' A' ' 20' ' ' LEU . 59.2 t -145.08 -69.08 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 0.0 111.107 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.25 155.32 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.377 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -112.65 138.26 49.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.069 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -154.6 78.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.141 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 2.5 p -58.73 90.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.093 0.473 . . . . 0.0 110.611 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 136.35 124.3 2.35 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.08 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.476 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -87.85 47.37 1.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.871 0.367 . . . . 0.0 111.468 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -53.35 110.02 1.8 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -33.2 -31.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.167 2.578 . . . . 0.0 113.64 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -95.49 30.49 2.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.445 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -152.34 -60.13 0.15 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.476 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 4.3 tp -51.91 -11.97 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.338 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.43 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 64.8 pttt -91.13 -51.09 5.49 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.843 0.354 . . . . 0.0 110.669 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.43 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 9.7 mm-40 -69.52 -32.02 70.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.51 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.78 -32.15 73.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.613 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.504 HG22 ' CG ' ' A' ' 47' ' ' TYR . 50.5 mt -90.14 -7.92 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.488 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.09 -68.62 0.77 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.924 0.393 . . . . 0.0 111.259 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.67 -29.14 51.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.132 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -80.39 -52.5 7.6 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.037 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.071 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.801 0.334 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.444 ' CG1' ' NZ ' ' A' ' 54' ' ' LYS . 55.0 t -155.24 136.56 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.145 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 90.1 m -150.2 162.1 41.13 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.173 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.57 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -100.28 -177.68 3.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 179.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.511 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 23.8 m-85 -124.79 150.59 46.17 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.03 0.443 . . . . 0.0 111.671 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 72.7 mmtt -128.52 -37.21 1.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.974 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 m -116.65 164.0 15.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.13 -27.85 57.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.993 0.425 . . . . 0.0 110.933 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.2 m -64.13 -12.58 41.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.969 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -89.98 -69.35 0.73 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.226 0.536 . . . . 0.0 111.401 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.512 ' CZ ' ' CG2' ' A' ' 23' ' ' VAL . 1.1 t80 -56.9 -25.88 57.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.085 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -56.38 -42.71 78.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.23 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -82.06 -24.81 35.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.321 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.83 -46.09 81.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.476 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.8 pt -80.21 -49.59 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.46 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.439 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -43.55 98.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 45.58 90.49 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.223 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -171.42 39.5 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.267 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.535 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.7 mptp? 63.54 -154.98 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.233 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.445 ' CD1' HG22 ' A' ' 84' ' ' VAL . 43.7 tp -98.05 115.99 29.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.135 0.493 . . . . 0.0 110.848 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.2 t -103.08 134.34 44.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.983 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.418 ' CG2' HG13 ' A' ' 99' ' ' ILE . 46.3 t -99.78 92.61 2.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.479 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.512 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 38.5 t -99.91 125.29 53.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.081 0.467 . . . . 0.0 111.334 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 74' ' ' THR . 38.5 t70 -99.91 130.53 46.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.916 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.541 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 5.7 m-85 -98.96 49.45 0.96 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.096 0.474 . . . . 0.0 110.208 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.697 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -50.68 139.8 15.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.786 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.433 ' CB ' ' HB3' ' A' ' 72' ' ' MET . . . -60.59 142.12 55.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.525 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.47 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 5.8 t -69.05 -11.53 60.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.565 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.453 ' CH2' ' HG2' ' A' ' 72' ' ' MET . 21.5 p-90 -109.55 -45.3 3.71 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 24.6 t -42.38 139.54 1.45 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.657 0.265 . . . . 0.0 111.264 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.11 -57.19 1.72 Allowed Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.82 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -46.16 -27.67 4.77 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.7 2.266 . . . . 0.0 112.754 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.416 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . 84.8 m -65.68 -21.1 66.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.54 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -73.45 -29.6 62.65 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -78.86 5.96 10.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.041 0.448 . . . . 0.0 110.989 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.636 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 69.9 mt -83.29 -27.44 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.119 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.518 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -49.18 -45.79 75.85 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 47.6 Cg_endo -72.04 -37.51 4.76 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 121.699 1.599 . . . . 0.0 111.134 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 58.3 ttp -62.34 -53.1 59.9 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.484 HG13 ' CG2' ' A' ' 36' ' ' ILE . 58.6 mt -47.61 -29.35 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.638 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.4 ' HA ' HG21 ' A' ' 2' ' ' VAL . 87.8 tt0 -78.49 -35.79 46.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.767 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 38' ' ' PRO . 72.7 mmtt -60.76 -21.97 63.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.433 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -90.12 -20.29 23.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.664 0.268 . . . . 0.0 111.632 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.4 p -74.15 -6.59 48.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.1 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -90.11 -29.44 18.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.82 0.343 . . . . 0.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.5 -29.73 17.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.676 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.54 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 71.2 m-85 -122.93 43.66 0.79 Allowed Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.654 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 93.7 Cg_exo -39.26 -31.51 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.993 2.462 . . . . 0.0 113.252 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.71 -38.13 84.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.903 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.04 146.52 24.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.951 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.87 148.7 23.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.72 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.409 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . 5.6 m-85 -125.27 98.35 5.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.243 0.544 . . . . 0.0 111.058 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.511 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 52.3 m-85 -113.84 -176.29 2.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.879 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.697 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 29.5 mttp -134.9 165.3 25.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.203 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.488 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 2.1 tm? -130.93 117.19 18.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.465 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.494 ' HB3' HD12 ' A' ' 60' ' ' LEU . 59.3 t0 -70.26 117.59 12.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.898 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 29.6 t -72.51 -8.34 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.852 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 31.9 t70 -100.97 -59.57 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.975 0.416 . . . . 0.0 110.606 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 6' ' ' LYS . 36.7 tp10 -66.48 -33.61 76.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.862 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.494 HD12 ' HB3' ' A' ' 56' ' ' ASP . 4.3 mp -120.47 40.37 3.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.951 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.52 -20.81 32.24 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.415 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.65 -42.1 99.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.693 0.282 . . . . 0.0 111.475 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.583 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 4.4 t -69.59 -46.97 74.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.946 0.403 . . . . 0.0 110.546 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 69' ' ' VAL . . . -53.62 -25.87 19.61 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.57 -41.66 11.24 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.451 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 12.9 ptmm? -55.92 -48.81 75.01 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.853 0.359 . . . . 0.0 110.695 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.415 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.4 m-20 -80.32 0.96 30.66 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.196 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 65.06 38.8 5.98 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.895 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.466 HG12 ' HB ' ' A' ' 74' ' ' THR . 47.5 t -107.92 93.48 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.883 0.373 . . . . 0.0 111.024 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.2 p -112.94 21.47 15.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.46 ' CB ' HG23 ' A' ' 88' ' ' VAL . . . -77.83 -154.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.583 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.453 ' HG2' ' CH2' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -171.46 87.12 0.47 Allowed Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.636 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 3.4 Cg_endo -96.35 -156.3 0.4 Allowed 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 124.888 -0.88 . . . . 0.0 112.663 0.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.466 ' HB ' HG12 ' A' ' 69' ' ' VAL . 87.7 m -154.19 148.05 25.51 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.467 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.428 ' CD1' ' HA ' ' A' ' 90' ' ' ALA . 83.3 mt -110.02 122.18 46.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.941 0.4 . . . . 0.0 111.62 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.541 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 23.5 mt -116.99 129.19 55.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.525 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.448 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 4.4 mp -109.75 135.25 50.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.02 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.507 ' HA ' HG23 ' A' ' 84' ' ' VAL . 57.2 m-85 -136.22 124.14 22.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.991 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.479 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 26.0 mtpp -112.12 126.93 55.71 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.405 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.489 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.3 m120 50.3 64.58 1.74 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.846 0.355 . . . . 0.0 111.635 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 50.44 24.99 7.95 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 116.185 -0.461 . . . . 0.0 113.319 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 61.5 mttp -128.94 -157.0 0.79 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -108.74 174.64 5.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.507 HG23 ' HA ' ' A' ' 78' ' ' PHE . 1.7 t -151.09 -55.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.973 0.416 . . . . 0.0 110.687 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.13 -164.24 0.4 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.848 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.476 ' HD3' ' N ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -164.4 125.83 2.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.027 0.441 . . . . 0.0 110.826 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.0 t -132.21 80.36 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.924 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.46 HG23 ' CB ' ' A' ' 71' ' ' ALA . 7.2 p -72.54 99.17 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.02 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.74 -23.1 0.33 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.213 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.533 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . 51.2 40.4 25.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.869 0.366 . . . . 0.0 111.101 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -59.5 134.26 88.76 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.916 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -47.67 -25.36 5.53 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.636 2.224 . . . . 0.0 112.733 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.75 26.45 10.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.625 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -137.5 -57.32 0.69 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.362 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.533 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 3.2 tp -54.81 -11.48 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.715 0.293 . . . . 0.0 110.867 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -92.0 -59.49 2.09 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.055 0.455 . . . . 0.0 110.801 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -63.32 -33.32 75.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.101 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.44 -31.06 65.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.115 0.483 . . . . 0.0 110.664 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.49 ' CD1' ' N ' ' A' ' 99' ' ' ILE . 1.4 mp -90.18 -8.29 10.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.542 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.57 -71.78 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.789 0.328 . . . . 0.0 111.34 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.2 -30.04 48.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.334 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.438 ' CB ' ' CD2' ' A' ' 20' ' ' LEU . 3.0 m120 -77.37 -50.02 13.67 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.986 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.167 -0.921 . . . . 0.0 111.131 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.868 0.366 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 p -153.38 138.0 9.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 92.2 m -150.04 161.72 41.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.028 0.442 . . . . 0.0 111.702 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.628 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 51.0 mt-30 -96.19 178.7 5.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.135 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.477 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 17.3 m-85 -124.66 127.58 47.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.925 0.393 . . . . 0.0 111.133 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -107.92 -26.7 10.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.691 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.8 p -134.05 129.25 35.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.35 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.28 -26.02 6.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.57 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -61.62 -16.76 51.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.56 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -90.4 -41.72 11.32 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.107 0.48 . . . . 0.0 111.281 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.459 ' CG ' ' CE2' ' A' ' 5' ' ' PHE . 1.1 t80 -78.38 -27.63 46.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.055 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -51.9 -57.47 9.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.391 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 t -71.32 -23.06 61.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.499 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' A' ' 11' ' ' PHE . . . -56.56 -44.19 80.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.474 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.1 pt -81.08 -49.93 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.483 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.483 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -45.58 101.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 44.78 89.08 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.223 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -171.72 40.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.313 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.544 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 3.1 mppt? 62.45 -156.67 0.34 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.25 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.467 ' CD1' HG21 ' A' ' 84' ' ' VAL . 54.7 tp -98.06 116.51 30.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.089 0.471 . . . . 0.0 110.863 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.96 134.78 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.638 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.5 t -99.82 84.24 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.951 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.453 HG21 ' CE1' ' A' ' 11' ' ' PHE . 38.8 t -101.11 120.17 50.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.098 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.448 ' OD1' HD21 ' A' ' 75' ' ' LEU . 2.9 m-20 -99.31 137.91 37.15 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.009 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.536 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 4.8 m-85 -99.35 53.21 0.95 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.646 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.555 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -52.64 137.38 30.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.439 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.418 ' CB ' ' HB3' ' A' ' 72' ' ' MET . . . -66.1 134.82 53.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.549 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.439 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.6 t -57.59 -17.77 16.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.334 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.444 ' CZ3' ' SD ' ' A' ' 72' ' ' MET . 6.4 p-90 -109.12 -125.98 0.26 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 40.0 t 61.58 -82.24 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 122.448 0.299 . . . . 0.0 110.951 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.45 -77.77 0.29 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.067 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.03 -18.69 51.97 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.916 2.41 . . . . 0.0 112.98 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.439 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 95.0 m -52.88 -26.14 13.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.666 0.269 . . . . 0.0 111.711 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -79.47 -24.75 42.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.667 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 89.6 mmm -72.55 -2.22 18.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.729 0.299 . . . . 0.0 111.099 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.514 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 44.0 mt -85.58 -22.88 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.822 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.497 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -51.7 -44.73 91.07 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 47.2 Cg_endo -72.82 -34.42 6.8 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 121.802 1.668 . . . . 0.0 111.322 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.407 ' HE2' ' CZ ' ' A' ' 43' ' ' PHE . 27.7 ttt -65.9 -52.21 51.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.493 HG13 ' CG2' ' A' ' 36' ' ' ILE . 75.9 mt -48.77 -29.34 2.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.581 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -76.9 -32.71 57.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.062 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -66.73 -19.61 65.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.72 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.407 ' CZ ' ' HE2' ' A' ' 39' ' ' MET . 3.6 m-85 -90.18 -26.65 20.03 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.403 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 53.9 m -59.87 -16.14 26.76 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.16 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.454 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 56.2 mt-10 -86.19 -20.32 28.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.821 0.344 . . . . 0.0 110.853 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -90.54 -37.29 13.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.552 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.586 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 72.4 m-85 -122.45 41.24 0.51 Allowed Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.723 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 75.5 Cg_exo -34.94 -33.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.5 2.8 . . . . 0.0 113.704 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -57.26 -36.8 71.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.035 0.445 . . . . 0.0 110.594 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 20' ' ' LEU . . . -89.8 143.01 27.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.561 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -89.68 121.86 32.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.911 0.386 . . . . 0.0 110.694 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.403 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 5.5 m-85 -95.21 85.79 4.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.594 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.477 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 34.7 m-85 -97.82 -176.87 3.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.27 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.628 ' HE2' ' HG2' ' A' ' 4' ' ' GLN . 35.1 mtmm -150.03 136.17 18.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.052 0.453 . . . . 0.0 110.982 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.447 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 2.4 tm? -93.04 139.94 30.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.963 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.408 ' HB3' HD12 ' A' ' 60' ' ' LEU . 9.2 t0 -95.27 112.57 24.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.856 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 53.5 t -73.2 -7.38 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.423 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.439 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 9.2 t70 -97.6 -59.84 1.69 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.972 0.415 . . . . 0.0 110.521 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.446 ' HG3' HD13 ' A' ' 60' ' ' LEU . 16.9 tp10 -67.55 -32.92 74.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.882 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.446 HD13 ' HG3' ' A' ' 59' ' ' GLU . 4.7 mp -120.03 58.3 0.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.928 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.35 -15.26 58.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.647 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.92 -27.05 43.7 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.68 0.276 . . . . 0.0 111.452 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.511 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 11.7 t -77.59 -51.49 18.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.477 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.21 -23.22 46.39 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.18 -37.98 13.79 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.229 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.511 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 17.2 pttp -59.88 -48.52 81.35 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.918 0.389 . . . . 0.0 110.131 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.413 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.0 m-20 -77.86 -6.33 53.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.871 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 66.38 42.51 2.94 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.117 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.415 HG13 ' CB ' ' A' ' 74' ' ' THR . 48.5 t -110.44 78.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.81 0.338 . . . . 0.0 111.196 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 81.4 p -90.53 10.26 26.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.096 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.415 ' HB3' HG21 ' A' ' 88' ' ' VAL . . . -61.46 -156.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.747 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.451 ' HG3' ' O ' ' A' ' 72' ' ' MET . 9.5 ptt? -176.68 86.93 0.26 Allowed Pre-proline 0 CA--C 1.53 0.185 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.514 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 43.0 Cg_endo -98.06 -159.58 0.46 Allowed 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 125.131 -0.779 . . . . 0.0 112.467 -0.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' ' 88' ' ' VAL . 83.6 m -149.9 161.22 42.71 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.825 0.345 . . . . 0.0 111.269 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.481 ' CD1' ' HA ' ' A' ' 90' ' ' ALA . 37.3 mt -122.1 124.1 43.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.305 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.536 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 22.2 mt -123.64 125.5 44.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.761 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.446 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 4.6 mp -109.75 136.36 49.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.484 ' HA ' HG22 ' A' ' 84' ' ' VAL . 53.2 m-85 -137.13 125.11 22.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.054 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.467 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 54.1 mtpt -112.43 131.21 55.68 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.514 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.476 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.4 m120 48.94 54.85 10.16 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.883 0.373 . . . . 0.0 111.719 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 58.4 17.56 32.93 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 121.276 -0.488 . . . . 0.0 113.02 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 31.0 mmmt -115.62 -153.76 0.53 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 88.1 tt0 -108.79 172.72 6.68 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.484 HG22 ' HA ' ' A' ' 78' ' ' PHE . 44.8 t -146.45 -64.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.756 0.312 . . . . 0.0 111.276 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.08 150.08 3.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.299 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -119.3 120.25 36.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.611 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.6 t -145.49 94.87 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.277 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.45 ' HA ' HG22 ' A' ' 74' ' ' THR . 4.3 p -64.56 102.33 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.735 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.99 103.07 0.54 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.42 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.502 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -96.31 36.99 1.28 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.953 0.406 . . . . 0.0 111.273 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 93' ' ' ALA . 21.2 p30 -80.06 141.52 54.52 Favored Pre-proline 0 N--CA 1.44 -0.94 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.532 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -46.95 87.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.624 2.216 . . . . 0.0 112.669 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -179.54 -38.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.407 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.69 -40.8 2.04 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.502 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 4.5 tp -50.51 -18.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.642 0.258 . . . . 0.0 111.441 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -91.21 -50.18 5.97 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.894 0.378 . . . . 0.0 111.15 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -71.02 -31.73 68.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.464 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.82 -32.39 73.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.786 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.429 HG21 ' CD2' ' A' ' 47' ' ' TYR . 58.1 mt -90.1 -7.75 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.455 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.47 -74.26 0.5 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.973 0.416 . . . . 0.0 111.383 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -50.07 -30.44 10.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.53 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.434 ' CB ' ' CD2' ' A' ' 20' ' ' LEU . 3.9 m120 -82.38 -48.58 10.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.11 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.041 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 tpt . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.744 0.306 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.435 HG23 ' N ' ' A' ' 41' ' ' GLU . 57.5 t 66.64 123.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.303 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.0 m -150.16 147.39 27.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.915 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.487 ' HG2' ' HE3' ' A' ' 54' ' ' LYS . 63.2 mt-30 -89.95 164.76 14.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.329 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.459 ' CE2' ' CG ' ' A' ' 11' ' ' PHE . 18.2 m-85 -117.53 123.3 45.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.926 0.393 . . . . 0.0 111.448 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.626 ' HA ' ' HE3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -103.79 -33.06 9.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.145 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.9 p -127.09 131.13 50.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.398 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.02 -24.45 9.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.657 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.1 m -61.67 -17.02 53.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.662 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.27 -39.08 12.98 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.105 0.478 . . . . 0.0 111.224 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.46 ' CZ ' ' CG2' ' A' ' 23' ' ' VAL . 1.1 t80 -82.17 -30.95 30.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.911 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -55.55 -37.81 68.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.248 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.4 m -90.04 -0.13 57.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.64 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -82.6 -44.61 15.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.689 0.28 . . . . 0.0 111.39 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.2 pt -79.56 -49.67 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.551 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -41.93 97.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 85.0 mt-30 45.77 88.52 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.219 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 9.1 t70 -170.37 41.07 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.126 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 91.6 mttt 66.17 -155.49 0.25 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.699 0.285 . . . . 0.0 110.404 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.489 ' CD1' HG23 ' A' ' 84' ' ' VAL . 57.9 tp -98.06 116.12 29.63 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.29 0.567 . . . . 0.0 110.917 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -105.55 122.29 58.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.722 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.417 ' CG2' HG12 ' A' ' 99' ' ' ILE . 46.8 t -99.98 97.68 6.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.779 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.46 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 45.5 t -99.91 134.79 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.224 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 74' ' ' THR . 37.5 t70 -99.79 128.03 45.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.673 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.542 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 5.3 m-85 -99.08 51.37 0.95 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.656 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.571 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -50.9 128.65 21.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.061 0.457 . . . . 0.0 111.035 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.413 ' CB ' ' HB3' ' A' ' 72' ' ' MET . . . -56.07 157.2 4.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.256 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.483 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 4.2 t -95.4 21.59 7.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.202 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 26.0 p-90 -138.53 -43.62 0.49 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.834 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 72' ' ' MET . 35.9 t -43.75 129.6 5.55 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.546 0.213 . . . . 0.0 110.984 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.07 -67.85 1.34 Allowed Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.786 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 33' ' ' CYS . 56.5 Cg_endo -67.76 -145.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.56 2.173 . . . . 0.0 110.937 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 32' ' ' PRO . 58.9 m 73.9 4.69 4.7 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -111.46 -29.11 7.91 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.692 0.282 . . . . 0.0 111.056 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.472 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 86.0 mmm -78.44 5.29 11.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.127 0.489 . . . . 0.0 110.538 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.519 ' CG2' HG13 ' A' ' 40' ' ' ILE . 71.3 mt -81.49 -24.07 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.701 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.506 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -47.36 -45.79 56.39 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 50.0 Cg_endo -72.77 -35.58 5.62 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.904 1.736 . . . . 0.0 111.199 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.5 ttt -65.12 -51.79 59.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.519 HG13 ' CG2' ' A' ' 36' ' ' ILE . 69.7 mt -48.88 -28.67 2.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.459 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.435 ' N ' HG23 ' A' ' 2' ' ' VAL . 38.8 tt0 -78.24 -33.32 49.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.898 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.453 ' HB3' ' NZ ' ' A' ' 42' ' ' LYS . 9.0 mtpm? -64.35 -22.36 66.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.437 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -90.14 -16.97 28.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.665 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.423 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 45.8 t -74.67 -6.53 49.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.252 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -90.17 -29.07 18.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.937 0.399 . . . . 0.0 111.109 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.31 -26.41 20.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.791 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.523 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 80.1 m-85 -123.61 46.37 1.41 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.473 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 81.9 Cg_exo -37.44 -44.32 1.41 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.207 2.604 . . . . 0.0 113.64 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -56.37 -31.29 63.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.923 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.66 133.44 34.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.803 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.55 121.91 32.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.482 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.423 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 4.5 m-85 -96.46 103.58 15.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.375 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.451 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 40.7 m-85 -114.17 -176.73 2.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.316 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.571 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 44.3 mtmt -145.54 130.51 18.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 111.206 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.435 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 3.0 tm? -90.75 138.27 31.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.401 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.451 ' OD2' ' N ' ' A' ' 59' ' ' GLU . 25.4 t70 -94.98 108.34 20.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.422 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 91.1 t -71.15 -11.29 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.547 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.483 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 9.7 t70 -88.9 -41.35 12.48 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.434 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.451 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 38.4 tp10 -93.06 -47.51 6.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.824 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.408 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 5.2 mp -101.82 46.68 0.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.07 -20.78 36.03 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.462 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -71.35 -25.41 62.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.576 0.227 . . . . 0.0 111.517 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.0 t -79.61 -51.79 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.711 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.92 -27.4 51.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.99 0.424 . . . . 0.0 110.122 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.03 -26.31 20.37 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.756 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -70.51 -50.44 37.75 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.999 0.428 . . . . 0.0 109.96 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -76.24 -2.6 32.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.915 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 67.48 38.97 2.99 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.167 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.424 HG13 ' HB ' ' A' ' 74' ' ' THR . 48.3 t -112.04 83.49 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.868 0.366 . . . . 0.0 111.054 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.6 p -93.15 3.34 55.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.272 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.49 -163.07 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.616 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -173.82 94.39 0.33 Allowed Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.496 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 18.9 Cg_endo -91.93 -161.1 1.16 Allowed 'Cis proline' 0 C--N 1.349 0.562 0 C-N-CA 124.835 -0.902 . . . . 0.0 112.513 -0.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.424 ' HB ' HG13 ' A' ' 69' ' ' VAL . 29.0 m -155.92 148.53 23.91 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.671 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.419 ' CD1' ' CD1' ' A' ' 95' ' ' ILE . 83.2 mt -109.78 125.26 52.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 111.334 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.542 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 21.8 mt -121.37 127.37 51.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.782 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.442 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 4.7 mp -109.87 140.57 43.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.024 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.49 ' HA ' HG21 ' A' ' 84' ' ' VAL . 52.5 m-85 -140.61 125.7 18.48 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.853 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.472 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 54.9 mtpt -109.87 129.01 55.69 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.789 0.328 . . . . 0.0 111.47 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.495 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 25.8 t-20 45.79 61.28 2.72 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.079 0.466 . . . . 0.0 111.6 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 55.59 17.89 14.73 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-N 116.088 -0.506 . . . . 0.0 113.542 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 60.0 mttp -115.18 -155.85 0.59 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.425 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 34.7 tt0 -108.78 173.0 6.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.49 HG21 ' HA ' ' A' ' 78' ' ' PHE . 47.9 t -147.79 -68.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.939 0.4 . . . . 0.0 111.038 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.63 154.99 4.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.254 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -114.52 114.99 26.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.414 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.35 82.18 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.311 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -60.89 85.14 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.721 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.6 115.39 1.37 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.367 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.509 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -96.79 38.45 1.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.804 0.335 . . . . 0.0 111.186 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 93' ' ' ALA . 46.2 t30 -68.84 129.28 92.48 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.194 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -45.62 88.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.667 2.245 . . . . 0.0 112.659 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 172.52 -33.16 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.411 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.43 -44.68 2.46 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.509 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 3.8 tp -50.83 -17.9 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.298 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.406 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 7.0 ptpp? -91.63 -48.99 6.53 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.949 0.404 . . . . 0.0 110.792 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.406 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 80.2 mt-30 -69.96 -31.6 69.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.575 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.21 -31.68 72.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.023 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.458 HG23 ' CG ' ' A' ' 47' ' ' TYR . 46.4 mt -90.19 -8.24 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.56 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.2 -69.65 0.71 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.842 0.353 . . . . 0.0 111.174 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.99 -29.0 18.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.221 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -82.63 -51.76 7.45 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.032 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.188 179.957 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.9 tpp . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.809 0.338 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 52' ' ' PHE . 14.6 p -178.04 139.73 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.3 m -141.88 162.84 34.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.959 0.409 . . . . 0.0 111.51 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.554 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 19.2 mt-30 -97.29 -176.97 3.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.777 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.504 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 20.3 m-85 -135.14 101.77 4.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.328 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -83.19 -25.4 31.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.731 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.5 p -130.42 123.21 29.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.261 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.83 -25.77 4.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.583 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m -59.5 -18.9 43.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.572 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -90.47 -44.1 9.83 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.206 0.527 . . . . 0.0 111.452 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.503 ' CD1' ' CE2' ' A' ' 5' ' ' PHE . 1.2 t80 -69.39 -30.51 68.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.031 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -50.83 -66.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.404 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.9 m -60.78 -20.48 61.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.467 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.41 -66.42 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.795 0.331 . . . . 0.0 111.676 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' GLY . 21.0 pt -54.6 -48.14 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.753 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.472 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.07 103.0 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.7 mt-30 45.18 92.11 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.236 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -171.51 38.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.384 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.547 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 61.61 -152.5 0.37 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.439 ' CD1' HG23 ' A' ' 84' ' ' VAL . 59.3 tp -97.55 115.92 28.78 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.244 0.545 . . . . 0.0 110.437 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.9 t -104.05 126.97 58.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.871 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.414 ' CG2' HG12 ' A' ' 99' ' ' ILE . 48.6 t -99.74 93.15 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.495 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.469 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 43.4 t -99.76 128.14 51.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.114 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.7 t70 -99.72 130.73 45.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.752 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.536 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 3.4 m-85 -99.07 53.01 0.97 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.968 0.413 . . . . 0.0 110.406 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.552 ' O ' ' HD1' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -50.98 124.77 12.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.301 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.438 ' CB ' ' HB3' ' A' ' 72' ' ' MET . . . -51.69 154.1 2.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.25 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.0 t -96.47 23.82 6.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.085 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 27.3 p-90 -141.53 -38.05 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.61 ' HB2' ' HB2' ' A' ' 72' ' ' MET . 51.3 t -35.21 150.98 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.0 0.429 . . . . 0.0 111.938 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.36 -79.29 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.453 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.438 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 3.3 Cg_exo -73.01 -76.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.43 2.087 . . . . 0.0 112.021 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.9 p 37.92 31.33 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 28.3 mtpp -132.04 -35.98 1.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.214 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.483 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 15.2 tmm? -58.41 -16.03 13.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.852 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.428 HG22 ' CD1' ' A' ' 40' ' ' ILE . 2.4 mp -75.26 -38.13 40.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.345 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.499 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -45.6 -49.28 36.04 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 41.0 Cg_endo -70.88 -32.73 13.44 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 121.988 1.792 . . . . 0.0 110.999 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 49.3 ttm -66.59 -51.13 59.78 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.428 ' CD1' HG22 ' A' ' 36' ' ' ILE . 61.6 mt -49.54 -28.38 3.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.515 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -79.16 -30.93 43.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.183 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.464 ' HB3' ' NZ ' ' A' ' 42' ' ' LYS . 9.1 mtpm? -69.37 -16.11 63.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.73 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.453 ' CB ' ' CE2' ' A' ' 52' ' ' PHE . 3.9 m-85 -90.11 -20.85 22.66 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.5 t -66.74 -14.28 62.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.777 0.322 . . . . 0.0 110.713 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.409 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 5.1 tm-20 -90.04 -20.95 22.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.295 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -90.12 -36.35 14.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.315 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.538 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 81.6 m-85 -124.11 45.4 1.22 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.373 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 75.1 Cg_exo -36.91 -33.03 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.429 2.753 . . . . 0.0 113.628 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -59.57 -37.64 79.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.652 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.83 141.26 28.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.801 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -90.08 123.41 33.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.824 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.453 ' CE2' ' CB ' ' A' ' 43' ' ' PHE . 5.4 m-85 -97.09 106.58 18.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.303 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.504 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 40.9 m-85 -116.11 -178.45 3.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.523 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 4' ' ' GLN . 69.9 mttt -142.13 145.36 34.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.393 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.454 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 2.7 tm? -107.25 125.13 50.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -81.76 108.18 15.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.693 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.442 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 85.1 t -72.34 -10.12 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.44 -60.52 2.34 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.424 ' HB3' HD13 ' A' ' 60' ' ' LEU . 2.2 tm-20 -77.9 -39.83 41.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.572 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' A' ' 59' ' ' GLU . 4.5 mp -97.76 44.85 1.03 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.014 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.13 -19.88 40.44 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.627 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -78.93 -29.32 44.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.783 0.325 . . . . 0.0 111.432 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.506 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 21.4 t -73.27 -54.83 14.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.788 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.86 -25.08 10.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.918 0.389 . . . . 0.0 110.142 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -90.17 -38.36 13.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.158 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 51.5 pttt -60.83 -46.97 88.48 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.945 0.403 . . . . 0.0 110.185 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.402 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.8 m-20 -79.16 -2.09 39.2 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.025 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 64.72 37.7 7.36 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.456 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.402 ' CG1' ' CB ' ' A' ' 74' ' ' THR . 41.9 t -111.45 68.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.992 0.425 . . . . 0.0 110.546 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.2 t -85.01 8.24 18.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.733 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.41 ' HB2' HG21 ' A' ' 88' ' ' VAL . . . -59.76 -161.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.61 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -173.71 89.46 0.36 Allowed Pre-proline 0 N--CA 1.454 -0.228 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 65.0 Cg_endo -96.13 -165.76 1.25 Allowed 'Cis proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.577 -1.01 . . . . 0.0 112.437 -0.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 29.5 m -147.35 163.63 35.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.477 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.421 ' CD1' ' HA ' ' A' ' 90' ' ' ALA . 78.9 mt -122.34 127.74 50.16 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.835 0.35 . . . . 0.0 111.191 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.536 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 26.5 mt -123.97 128.5 49.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.608 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.442 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 4.7 mp -109.64 136.9 48.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.028 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.475 ' HA ' HG21 ' A' ' 84' ' ' VAL . 51.1 m-85 -138.72 126.42 22.11 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.877 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.479 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 9.8 mtpm? -109.77 129.77 55.59 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.368 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.428 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 6.3 m120 45.78 56.75 5.64 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.865 0.365 . . . . 0.0 111.92 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 60.61 14.65 36.74 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.066 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 49.1 mtmt -110.93 -155.37 0.56 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.42 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 88.2 tt0 -109.04 172.6 6.75 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.479 ' CG2' ' HG3' ' A' ' 79' ' ' LYS . 64.5 t -146.18 -68.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 0.0 111.25 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.39 -168.31 0.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 0.0 111.551 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.45 ' HB3' ' NZ ' ' A' ' 86' ' ' LYS . 9.7 mtpm? -142.51 140.03 31.68 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.994 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.7 t -154.46 82.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.532 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 71' ' ' ALA . 5.5 p -78.67 109.57 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.826 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.91 -25.79 0.72 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.134 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.454 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . 44.48 39.8 3.46 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 111.357 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -62.4 135.61 95.39 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.664 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -47.78 -25.18 5.59 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.663 2.242 . . . . 0.0 112.82 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.34 30.05 7.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.626 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.432 ' C ' ' H ' ' A' ' 96' ' ' LYS . . . -139.67 -59.57 0.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.2 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.454 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 3.9 tp -57.02 -7.28 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.337 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 94' ' ' ALA . 14.8 ptmm? -91.3 -49.16 6.51 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.928 0.394 . . . . 0.0 110.659 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.403 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 73.0 mt-30 -69.52 -31.85 70.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.28 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.75 -28.32 69.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.695 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.423 HG21 ' CG ' ' A' ' 47' ' ' TYR . 59.0 mt -90.17 -10.82 10.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.523 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.84 -71.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.997 0.427 . . . . 0.0 111.349 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -47.43 -29.09 2.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.46 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -90.05 -48.04 7.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.324 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.078 -179.971 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.826 0.346 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.426 ' CG1' ' HE3' ' A' ' 54' ' ' LYS . 32.7 t -142.35 141.3 28.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.867 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 95.5 m -144.25 161.19 39.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.057 0.456 . . . . 0.0 111.411 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.577 ' HG2' ' NZ ' ' A' ' 54' ' ' LYS . 55.3 mt-30 -91.71 172.55 8.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.443 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.521 ' CE2' ' CG ' ' A' ' 11' ' ' PHE . 17.1 m-85 -126.68 131.96 51.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.19 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 47.5 mmtm -120.98 -32.61 3.92 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.2 p -126.2 148.06 49.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.908 0.385 . . . . 0.0 111.657 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 9' ' ' SER . . . -74.21 99.51 3.43 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.405 0.621 . . . . 0.0 110.337 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 31.3 t 160.55 -24.97 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.018 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -84.67 -32.68 23.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.294 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.521 ' CG ' ' CE2' ' A' ' 5' ' ' PHE . 1.1 t80 -90.34 -43.33 10.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.401 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -47.29 -37.91 11.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.12 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.7 m -74.81 -30.95 61.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.834 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.423 ' HB1' ' CE2' ' A' ' 53' ' ' TYR . . . -60.49 -34.9 74.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.062 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.1 pt -90.07 -49.71 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.417 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.438 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -43.62 95.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 45.23 83.17 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.177 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.3 t70 -164.67 42.25 0.08 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.588 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.533 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.7 mptp? 64.86 -157.2 0.29 Allowed 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 120.701 0.286 . . . . 0.0 110.657 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.448 ' HB2' ' HG2' ' A' ' 79' ' ' LYS . 65.9 tp -98.24 117.14 31.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.062 0.458 . . . . 0.0 110.856 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 51' ' ' ASP . 46.6 t -113.93 124.02 70.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.742 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.401 ' CG2' HG13 ' A' ' 99' ' ' ILE . 58.8 t -99.84 111.56 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.933 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.472 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 41.5 t -109.45 137.77 40.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.197 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -99.84 128.96 45.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.824 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.544 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 6.8 m-85 -99.15 48.29 0.96 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.052 0.453 . . . . 0.0 110.175 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.568 ' O ' ' HD1' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -48.88 132.04 18.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.243 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . . . -60.78 145.31 50.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.808 0.337 . . . . 0.0 110.718 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.462 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 7.7 t -72.79 -21.19 61.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.391 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -95.87 -39.24 9.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.806 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.433 ' HB2' ' HG3' ' A' ' 72' ' ' MET . 49.1 t -41.23 139.49 0.98 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.914 0.387 . . . . 0.0 111.717 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.71 -58.18 1.85 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.785 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.93 52.5 4.28 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.619 2.212 . . . . 0.0 112.755 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.3 p -127.13 -13.05 5.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.38 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -78.47 -25.44 45.82 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.738 0.304 . . . . 0.0 111.251 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.4 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 65.9 mtt -73.75 3.83 5.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.828 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.521 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 62.2 mt -79.14 -38.78 20.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.933 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.546 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -42.79 -45.42 11.47 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 23.9 Cg_endo -66.36 -43.49 8.17 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.595 1.53 . . . . 0.0 111.669 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.508 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 12.2 mmt -62.1 -59.87 4.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.529 HD13 ' HG2' ' A' ' 54' ' ' LYS . 43.2 mt -43.08 -29.27 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.019 0.438 . . . . 0.0 110.751 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -80.42 -43.34 21.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.767 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -59.78 -29.94 68.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.183 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.508 ' HD1' ' O ' ' A' ' 39' ' ' MET . 16.0 m-85 -76.14 -22.6 55.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.473 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 98.9 p -77.31 -4.05 43.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.71 0.29 . . . . 0.0 110.711 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.419 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 50.3 mt-10 -90.08 -28.32 19.09 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.855 0.36 . . . . 0.0 110.712 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -90.24 -28.31 18.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.362 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.539 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 70.3 m-85 -123.97 45.54 1.25 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.133 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 74.2 Cg_exo -37.41 -32.43 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.376 2.718 . . . . 0.0 113.54 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -60.79 -38.45 85.37 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.674 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.0 138.69 31.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.956 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 58.2 m-20 -90.71 138.72 31.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.663 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.413 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . 2.7 m-85 -114.74 98.39 6.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.516 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.518 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 43.5 m-85 -102.41 -173.25 2.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.562 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.577 ' NZ ' ' HG2' ' A' ' 4' ' ' GLN . 10.2 mtmp? -147.84 135.38 20.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.954 0.406 . . . . 0.0 111.04 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.482 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 2.1 tm? -98.25 145.62 26.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.698 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.459 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 9.9 t70 -93.85 126.04 38.82 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.7 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 98.3 t -93.38 30.33 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 121.286 0.565 . . . . 0.0 110.814 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.462 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 65.8 t0 -137.94 -46.73 0.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.58 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 6' ' ' LYS . 5.2 tp10 -81.56 -32.24 32.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.414 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.422 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 4.5 mp -118.52 72.78 0.89 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.64 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -77.84 -1.72 79.32 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.88 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -90.04 -38.39 13.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.741 0.305 . . . . 0.0 111.39 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.504 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 6.0 t -71.73 -54.88 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.345 . . . . 0.0 110.608 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.37 -25.44 15.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.019 0.438 . . . . 0.0 110.226 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -90.24 -38.36 13.49 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.109 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 16.5 pttp -60.7 -48.4 81.97 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-O 120.865 0.364 . . . . 0.0 110.129 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.417 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.5 m-20 -76.81 -6.08 50.89 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.869 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 66.3 41.66 3.3 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.019 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.425 ' CG1' HG23 ' A' ' 74' ' ' THR . 59.6 t -104.63 84.6 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.153 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 91.3 p -95.56 -17.46 21.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.922 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.99 -171.01 0.0 OUTLIER 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.501 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.564 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -167.84 108.31 0.58 Allowed Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.349 -0.54 . . . . 0.0 112.372 -179.506 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.471 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 42.1 Cg_endo -87.85 -162.15 2.07 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.394 -1.086 . . . . 0.0 112.286 -0.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.427 HG21 ' HA ' ' A' ' 88' ' ' VAL . 84.9 m -153.76 163.81 39.39 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.803 0.335 . . . . 0.0 110.797 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.406 ' CD1' ' CD1' ' A' ' 95' ' ' ILE . 71.0 mt -129.0 123.45 32.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 110.913 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.544 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 20.7 mt -121.05 129.15 53.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.803 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.461 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 3.5 mp -109.7 143.71 39.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.7 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.588 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 64.7 m-85 -144.41 127.09 16.15 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.001 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.449 ' HD3' HG12 ' A' ' 84' ' ' VAL . 49.3 mtpt -117.24 136.69 52.9 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.831 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.443 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.2 m120 45.78 67.69 0.7 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.569 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 46.29 33.97 5.99 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 113.048 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.588 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 68.1 mttm -141.78 -160.57 1.1 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.452 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 28.9 tt0 -109.14 -179.91 3.98 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.452 ' CG1' ' O ' ' A' ' 83' ' ' GLU . 4.6 m -164.2 -46.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.51 0.195 . . . . 0.0 111.38 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.47 158.68 24.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.046 0.451 . . . . 0.0 112.012 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.468 ' CD ' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -148.03 113.67 5.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.872 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.7 t -139.41 107.37 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.412 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.427 ' HA ' HG21 ' A' ' 74' ' ' THR . 3.2 p -69.45 110.45 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.063 0.458 . . . . 0.0 110.659 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.2 105.14 0.91 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.164 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.498 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -94.0 38.35 1.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.847 0.356 . . . . 0.0 111.39 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' A' ' 93' ' ' ALA . 5.4 m120 -72.38 134.83 82.12 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.437 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -48.48 84.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.722 2.282 . . . . 0.0 112.625 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 178.66 -38.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.43 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.33 -45.68 2.92 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.7 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.498 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 4.9 tp -52.83 -16.49 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.148 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.479 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -92.21 -49.3 6.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.982 0.42 . . . . 0.0 110.901 179.509 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.425 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 25.8 mt-30 -71.53 -32.05 67.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.661 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.89 -32.93 68.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.429 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.497 HG22 ' CG ' ' A' ' 47' ' ' TYR . 1.5 mp -90.24 -12.25 9.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.423 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.47 -64.42 1.14 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.911 0.386 . . . . 0.0 111.095 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.31 -30.36 38.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.064 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -90.15 -66.42 0.93 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.301 -0.856 . . . . 0.0 111.117 179.923 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.867 0.365 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.432 HG23 HG23 ' A' ' 40' ' ' ILE . 6.0 p -177.31 127.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.668 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 54' ' ' LYS . 92.5 m -150.3 162.01 41.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.198 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.532 ' HG3' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -105.4 -173.37 2.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.878 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.51 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.8 m-85 -135.79 105.75 6.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.762 0.315 . . . . 0.0 111.698 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.2 mmmm -88.93 -27.71 20.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.763 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.7 p -126.35 128.52 47.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 110.705 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.79 -24.04 20.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.415 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -62.29 -16.59 54.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.627 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -90.14 -56.74 3.1 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.246 0.546 . . . . 0.0 111.111 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.463 ' CE1' HG23 ' A' ' 23' ' ' VAL . 1.1 t80 -60.49 -33.1 72.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.7 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -51.46 -56.69 11.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.256 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.4 m -65.85 -25.3 67.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.39 -72.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 0.0 111.322 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.4 pt -52.8 -48.52 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.674 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.467 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -44.43 96.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 44.68 91.16 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.541 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -174.54 40.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.487 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.519 ' NZ ' ' HB2' ' A' ' 19' ' ' LYS . 8.1 mtmp? 69.36 -158.26 0.17 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.498 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.438 ' HB2' ' HG2' ' A' ' 79' ' ' LYS . 61.6 tp -98.16 113.76 25.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.205 0.526 . . . . 0.0 111.19 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.74 125.45 53.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.524 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.8 t -99.71 96.3 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.665 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.463 HG23 ' CE1' ' A' ' 11' ' ' PHE . 30.1 t -104.95 131.84 53.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.368 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.6 t70 -99.99 132.23 45.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.507 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.553 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 4.8 m-85 -99.14 54.6 0.98 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.137 0.494 . . . . 0.0 110.643 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.591 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -58.35 140.92 52.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.098 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.46 ' HB1' ' HB3' ' A' ' 72' ' ' MET . . . -67.42 136.44 54.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.774 0.321 . . . . 0.0 110.253 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 3.3 t -53.39 -49.35 67.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.222 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 32.0 p-90 -68.2 -42.62 79.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.79 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 53.1 t -45.75 135.14 7.07 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 111.146 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.27 -56.3 0.94 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.117 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -48.57 -26.02 8.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.617 2.211 . . . . 0.0 112.729 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.9 p -63.92 -32.21 73.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.071 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -61.87 -25.32 67.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.383 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 66.1 mtt -68.85 -5.85 23.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.962 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.505 ' CG2' HG13 ' A' ' 40' ' ' ILE . 60.0 mt -86.51 -23.63 6.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.447 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.28 -44.48 81.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 45.6 Cg_endo -72.7 -36.61 4.67 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.669 1.579 . . . . 0.0 111.447 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.522 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 67.5 mtm -64.96 -51.46 61.63 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.505 HG13 ' CG2' ' A' ' 36' ' ' ILE . 68.0 mt -48.71 -25.53 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.716 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.425 ' HB2' HG11 ' A' ' 2' ' ' VAL . 38.0 tt0 -85.06 -23.38 28.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.972 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.432 ' NZ ' ' HB2' ' A' ' 42' ' ' LYS . 10.5 mtmp? -82.28 -15.71 52.03 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.522 ' HD1' ' O ' ' A' ' 39' ' ' MET . 3.5 m-85 -90.04 -19.27 24.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.652 0.263 . . . . 0.0 111.323 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.445 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.6 t -69.62 -8.84 50.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.484 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -87.99 -27.18 22.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.739 0.304 . . . . 0.0 111.098 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -90.6 -30.4 17.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.904 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.511 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 72.9 m-85 -123.03 47.3 1.56 Allowed Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.167 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 80.7 Cg_exo -38.01 -27.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.254 2.636 . . . . 0.0 113.594 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.487 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 13.4 mp0 -65.63 -36.22 83.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.105 0.479 . . . . 0.0 110.472 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 20' ' ' LEU . . . -89.48 138.27 31.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.109 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.406 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.5 m-20 -89.53 122.21 32.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.026 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.464 ' CE2' ' CB ' ' A' ' 43' ' ' PHE . 4.2 m-85 -97.37 83.96 3.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.221 0.534 . . . . 0.0 111.624 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.51 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 54.2 m-85 -102.31 -174.75 2.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.495 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.591 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 28.6 mttp -141.98 148.59 38.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.307 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.468 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 2.8 tm? -106.21 130.23 54.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.127 0.489 . . . . 0.0 110.943 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 5' ' ' PHE . 56.9 m-20 -83.89 117.03 23.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.619 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 69.9 t -87.22 5.56 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.111 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.473 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 11.5 p-10 -99.63 -40.73 7.65 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.92 0.39 . . . . 0.0 110.631 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -99.66 -28.5 13.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.979 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.461 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 3.1 mp -114.17 41.79 2.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.032 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.51 -21.44 34.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.55 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -72.38 -25.83 61.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.687 0.28 . . . . 0.0 111.511 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.7 t -77.82 -49.56 21.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.75 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.47 -28.4 59.6 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.971 0.415 . . . . 0.0 110.321 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -90.03 -23.93 21.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.724 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -73.03 -49.54 28.19 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.98 0.419 . . . . 0.0 110.052 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -77.75 -0.75 28.14 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.146 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 68.09 37.33 2.98 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.306 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.2 t -116.18 72.97 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.758 0.313 . . . . 0.0 110.983 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.2 p -84.12 -15.13 48.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.929 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.36 -172.62 0.0 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.524 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.516 ' HG2' ' O ' ' A' ' 72' ' ' MET . 1.7 pmm? -170.08 112.74 0.47 Allowed Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.513 -0.475 . . . . 0.0 112.209 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.473 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 68.4 Cg_endo -87.64 -167.39 4.06 Favored 'Cis proline' 0 C--N 1.349 0.571 0 C-N-CA 124.151 -1.187 . . . . 0.0 112.086 -0.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 29.0 m -161.36 151.67 17.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.681 0.277 . . . . 0.0 110.837 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.401 HD12 ' CB ' ' A' ' 90' ' ' ALA . 81.7 mt -114.22 124.84 53.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.282 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.553 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 22.7 mt -120.05 128.76 53.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.282 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.469 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 3.1 mp -109.6 141.19 42.47 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.833 0.349 . . . . 0.0 110.838 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.611 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 55.1 m-85 -143.19 126.21 16.32 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.96 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.461 ' HD3' HG12 ' A' ' 84' ' ' VAL . 48.5 mtpt -117.04 136.11 53.21 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.701 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.447 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.2 m120 49.12 62.4 2.63 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.484 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 50.61 25.54 9.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.069 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.611 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 75.2 mmtt -132.45 -160.09 1.02 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.468 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 32.2 tt0 -108.94 -179.93 4.0 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 83' ' ' GLU . 4.6 m -164.16 -47.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -164.81 165.24 20.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.155 0.502 . . . . 0.0 111.814 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.413 ' HG2' HD21 ' A' ' 76' ' ' LEU . 36.5 mtmm -151.19 135.15 16.6 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.923 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.4 t -154.21 105.99 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.469 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 2.8 p -68.03 78.68 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.841 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.52 106.27 0.2 Allowed Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.339 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.525 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -97.11 38.53 1.24 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.875 0.369 . . . . 0.0 111.183 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 93' ' ' ALA . 22.9 t-20 -85.8 141.08 35.6 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.147 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -45.52 87.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.657 2.238 . . . . 0.0 112.636 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -179.6 -40.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.336 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.11 -42.14 2.29 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.525 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 5.3 tp -50.39 -17.92 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.081 -0.247 . . . . 0.0 111.133 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.45 ' CD ' ' CE2' ' A' ' 43' ' ' PHE . 29.6 mmmt -90.64 -66.76 0.9 Allowed 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.787 0.327 . . . . 0.0 111.104 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.469 ' OE1' ' N ' ' A' ' 97' ' ' GLN . 1.3 mp0 -59.93 -34.82 73.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.705 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.97 -30.87 66.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.616 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.413 HG23 ' CG ' ' A' ' 47' ' ' TYR . 57.8 mt -90.22 -14.67 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.343 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.43 -68.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.865 0.364 . . . . 0.0 111.142 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.07 -28.76 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.148 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.417 ' CB ' ' CD2' ' A' ' 20' ' ' LEU . 5.8 m120 -83.15 -51.92 7.07 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.996 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.056 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 tpp . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.792 0.33 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.5 p -139.07 137.7 41.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.464 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 54' ' ' LYS . 85.3 m -148.67 162.59 39.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.958 0.409 . . . . 0.0 111.543 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.631 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 43.1 mt-30 -107.62 -179.92 4.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.219 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.508 ' CE2' ' CD1' ' A' ' 11' ' ' PHE . 22.6 m-85 -129.49 129.73 44.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.564 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.418 ' CA ' HD12 ' A' ' 60' ' ' LEU . 47.4 mmtm -110.95 -18.77 12.99 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.5 m -147.94 165.77 29.68 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.18 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.55 ' O ' ' OG ' ' A' ' 9' ' ' SER . . . -84.63 101.46 12.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.473 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.55 ' OG ' ' O ' ' A' ' 8' ' ' ALA . 13.2 m 160.26 -25.33 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.044 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -87.24 -30.77 20.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.481 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.508 ' CD1' ' CE2' ' A' ' 5' ' ' PHE . 1.1 t80 -90.05 -40.8 12.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.556 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -48.64 -40.35 27.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.22 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 m -76.21 -27.12 56.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.096 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.47 -62.16 1.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.36 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.1 pt -63.72 -48.71 85.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.602 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.444 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -40.49 94.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 24.6 mt-30 44.16 88.96 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.385 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 8.9 t70 -170.64 40.47 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.324 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 53.1 mttp 70.82 -151.47 0.1 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.729 0.3 . . . . 0.0 110.635 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 77' ' ' LEU . 28.0 tp -97.47 111.49 23.73 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.15 0.5 . . . . 0.0 110.998 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.0 t -99.96 113.91 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.918 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.445 ' CG2' HG12 ' A' ' 99' ' ' ILE . 43.6 t -99.9 102.39 13.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.6 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.493 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 39.9 t -104.84 138.42 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.604 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -104.42 130.96 52.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.823 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.54 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 4.4 m-85 -99.1 49.39 0.95 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.047 0.451 . . . . 0.0 109.832 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -47.18 134.56 10.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.508 -179.106 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.0 128.72 37.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.445 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.526 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 5.2 t -59.44 -28.02 66.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.766 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.403 ' CH2' ' SD ' ' A' ' 72' ' ' MET . 31.4 p-90 -93.83 -36.97 11.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 72' ' ' MET . 33.2 t -46.58 158.72 0.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.577 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.71 -66.39 0.81 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.304 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -46.77 -26.68 4.8 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.892 2.394 . . . . 0.0 113.08 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 86.3 m -60.43 -17.86 47.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -73.81 -44.34 56.12 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.403 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 65.2 mtt -70.77 1.7 5.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.796 0.331 . . . . 0.0 111.522 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.709 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 36.3 mt -75.74 -39.4 38.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.728 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.496 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -44.53 -50.39 23.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 41.6 Cg_endo -69.58 -31.26 21.69 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 121.806 1.671 . . . . 0.0 111.194 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 47.1 tpp -68.93 -51.19 42.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.456 HG22 HD11 ' A' ' 40' ' ' ILE . 62.6 mt -50.32 -29.07 5.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.411 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -75.71 -35.63 60.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.889 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -62.42 -20.58 64.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.675 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.26 -24.54 20.91 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.413 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 50.5 m -62.21 -13.21 25.38 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.611 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -85.59 -25.2 26.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.729 0.3 . . . . 0.0 111.31 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -90.42 -30.74 17.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.525 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 80.8 m-85 -123.1 46.47 1.35 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.747 0.308 . . . . 0.0 111.482 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 79.3 Cg_exo -37.18 -33.2 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.321 2.68 . . . . 0.0 114.025 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.413 ' O ' ' CD ' ' A' ' 19' ' ' LYS . 9.6 mm-40 -66.17 -30.92 71.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.931 0.396 . . . . 0.0 110.86 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.34 138.45 31.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.475 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -89.49 121.59 31.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.006 0.431 . . . . 0.0 110.383 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.427 ' CE2' HD11 ' A' ' 99' ' ' ILE . 5.2 m-85 -97.44 82.99 3.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.594 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.432 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 43.0 m-85 -97.04 -178.16 4.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.898 178.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.631 ' HE2' ' HG2' ' A' ' 4' ' ' GLN . 33.4 mtmm -146.31 139.13 25.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.163 0.506 . . . . 0.0 111.398 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -102.09 135.44 43.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.967 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.419 ' HB3' HD13 ' A' ' 60' ' ' LEU . 9.9 t0 -88.43 128.68 35.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.308 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 41.4 t -85.66 -11.17 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.526 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 2.1 p30 -105.1 -41.25 5.62 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.336 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 6' ' ' LYS . 15.8 tp10 -76.84 -31.17 56.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.97 0.414 . . . . 0.0 110.608 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 4.2 mp -125.35 42.73 3.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.765 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -48.44 -27.42 5.77 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.486 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.45 -25.78 68.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.63 0.252 . . . . 0.0 111.447 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.499 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 11.0 t -81.16 -55.58 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.745 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.83 -26.72 6.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.069 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.427 ' N ' ' OE1' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -90.33 -37.14 14.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.669 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 52.6 pttt -59.74 -48.12 82.94 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.051 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.41 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.0 m-20 -78.41 -5.22 51.73 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.867 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 67.01 41.49 2.65 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.256 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.442 HG13 ' HB ' ' A' ' 74' ' ' THR . 41.7 t -112.63 97.6 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-O 120.805 0.336 . . . . 0.0 110.99 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.8 p -112.31 28.68 8.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.983 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.469 ' CB ' ' CG2' ' A' ' 88' ' ' VAL . . . -76.12 -153.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.823 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.477 ' HG3' ' O ' ' A' ' 72' ' ' MET . 16.5 ptt? -173.04 79.65 0.41 Allowed Pre-proline 0 CA--C 1.529 0.141 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.709 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 1.3 Cg_endo -97.52 -155.61 0.33 Allowed 'Cis proline' 0 C--N 1.348 0.524 0 C-N-CA 125.242 -0.733 . . . . 0.0 112.783 -0.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.442 ' HB ' HG13 ' A' ' 69' ' ' VAL . 86.6 m -151.22 147.09 26.57 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.027 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 89' ' ' GLY . 88.4 mt -109.67 122.7 48.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.941 0.4 . . . . 0.0 111.458 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.54 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 29.2 mt -120.23 125.87 49.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.441 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.472 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 3.3 mp -109.8 147.47 33.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.8 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.614 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 47.0 m-85 -148.45 126.83 12.28 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.339 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.452 ' HD3' HG11 ' A' ' 84' ' ' VAL . 50.3 mtpt -115.55 140.16 49.42 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.463 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 6.0 m120 49.1 52.12 14.96 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.634 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 57.62 19.32 34.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.706 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.614 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 54.7 mtpt -122.5 -155.83 0.67 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.494 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 83.1 tt0 -108.85 177.73 4.68 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.494 ' CG1' ' O ' ' A' ' 83' ' ' GLU . 4.2 m -166.55 -47.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.644 0.259 . . . . 0.0 111.369 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -163.93 174.68 11.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 111.612 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.402 ' HB2' ' CD2' ' A' ' 76' ' ' LEU . 14.3 ptmm? -170.05 115.57 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.649 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 87' ' ' VAL . 9.1 p -122.88 103.82 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.129 0.49 . . . . 0.0 111.547 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.469 ' CG2' ' CB ' ' A' ' 71' ' ' ALA . 2.1 p -59.92 88.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.838 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 90' ' ' ALA . . . 158.65 -128.93 2.15 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.169 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . 158.54 39.42 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.825 0.345 . . . . 0.0 110.894 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -70.91 139.71 85.73 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.744 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.75 -18.41 2.74 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.764 2.309 . . . . 0.0 113.198 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.44 21.63 12.89 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.59 -60.06 0.17 Allowed 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.829 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 3.9 tp -50.69 -15.15 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.138 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.482 ' HD2' ' N ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -92.34 -41.03 10.58 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.0 0.429 . . . . 0.0 110.677 179.351 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.482 ' N ' ' HD2' ' A' ' 96' ' ' LYS . 72.1 mt-30 -76.45 -32.13 58.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.18 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.39 -32.33 73.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.52 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.465 HG22 ' CG ' ' A' ' 47' ' ' TYR . 38.9 mt -90.25 -13.47 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.258 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.402 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . . . -90.4 -72.05 0.59 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.9 0.381 . . . . 0.0 111.186 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -48.45 -29.34 3.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.264 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.412 ' HB2' ' CD2' ' A' ' 20' ' ' LEU . 3.7 m120 -83.82 -41.69 17.26 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.146 179.934 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptp . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.704 0.288 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.452 ' CG1' ' HD3' ' A' ' 54' ' ' LYS . 49.9 t 67.14 139.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.345 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.41 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 87.0 m -150.12 153.86 37.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.535 ' HG2' ' HG3' ' A' ' 54' ' ' LYS . 57.3 mt-30 -89.42 -179.21 5.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.178 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.543 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 17.0 m-85 -130.02 140.03 50.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.016 0.436 . . . . 0.0 111.309 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -112.72 -55.94 2.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.489 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.2 p -105.75 169.39 8.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.559 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.78 -27.84 40.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.1 m -60.85 -16.16 38.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.621 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -90.34 -62.59 1.43 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.227 0.537 . . . . 0.0 111.087 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.518 ' CZ ' ' CG2' ' A' ' 23' ' ' VAL . 1.1 t80 -59.85 -24.14 63.97 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.992 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -54.96 -55.7 27.86 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.447 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.1 m -72.01 -23.41 61.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.487 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.98 -38.63 68.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 111.598 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 81' ' ' GLY . 21.3 pt -88.01 -48.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.437 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.37 102.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 85.1 mt-30 44.5 87.52 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.216 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 8.8 t70 -168.37 39.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.352 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.535 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.6 mptp? 62.54 -154.51 0.34 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.686 0.279 . . . . 0.0 110.43 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.46 ' HB2' ' HD3' ' A' ' 79' ' ' LYS . 62.3 tp -97.92 115.27 27.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.071 0.462 . . . . 0.0 110.882 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 45.8 t -106.89 130.71 58.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.632 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 56.4 t -99.81 97.96 6.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.547 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.518 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 24.8 t -101.4 126.03 55.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.053 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.553 ' HB3' ' NZ ' ' A' ' 54' ' ' LYS . 38.0 t70 -99.97 131.67 45.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.015 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.532 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 4.1 m-85 -99.25 50.26 0.95 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.077 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.668 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -53.79 129.58 33.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.352 -179.559 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.44 ' CB ' ' HB3' ' A' ' 72' ' ' MET . . . -50.39 153.34 1.57 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.724 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.591 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 7.9 t -92.6 21.57 5.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.042 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.462 ' CH2' ' CE ' ' A' ' 72' ' ' MET . 23.7 p-90 -143.58 -42.24 0.28 Allowed 'General case' 0 C--O 1.232 0.167 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 29' ' ' TRP . 50.1 t -29.97 -76.2 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.54 -78.92 0.38 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.446 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -46.98 -29.34 8.33 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.667 2.245 . . . . 0.0 112.217 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.409 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 82.5 m -60.19 -20.15 57.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.784 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -74.09 -37.27 64.22 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.6 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.424 ' O ' ' HG2' ' A' ' 35' ' ' MET . 48.6 ttm -72.21 0.88 8.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.381 . . . . 0.0 111.074 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.593 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 59.1 mt -83.2 -25.23 8.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.011 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.543 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.88 -45.84 87.31 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 38.4 Cg_endo -69.91 -37.4 8.85 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.896 1.731 . . . . 0.0 111.588 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 57.1 ttp -64.49 -51.25 63.97 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.494 ' CD1' ' NZ ' ' A' ' 54' ' ' LYS . 55.2 mt -51.73 -27.35 8.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.652 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.402 ' HA ' ' CG2' ' A' ' 2' ' ' VAL . 87.7 tt0 -77.48 -29.39 52.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.336 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -66.82 -17.98 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.221 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -89.97 -18.45 26.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.425 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.5 t -67.31 -12.32 59.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.158 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 5.5 tp10 -85.71 -24.39 26.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.707 0.289 . . . . 0.0 111.042 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -90.26 -35.06 15.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.556 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.539 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 69.0 m-85 -122.33 43.9 0.78 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.539 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 90.4 Cg_exo -38.63 -32.45 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.104 2.536 . . . . 0.0 113.224 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -59.41 -38.28 80.21 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.715 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' A' ' 20' ' ' LEU . . . -89.78 145.77 24.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -89.98 148.88 22.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.732 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 52' ' ' PHE . 2.6 m-85 -123.39 94.58 4.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.979 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.543 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 53.5 m-85 -108.8 173.78 6.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.997 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.668 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -124.61 162.26 24.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 25' ' ' PHE . 2.1 tm? -127.2 108.69 11.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.753 0.311 . . . . 0.0 110.485 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.404 ' HB3' HD23 ' A' ' 60' ' ' LEU . 8.5 t0 -64.01 112.15 2.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.62 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 55.5 t -69.27 -11.15 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.744 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.591 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 4.5 t70 -99.69 -59.92 1.63 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.138 0.495 . . . . 0.0 110.374 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.42 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -53.41 -45.45 69.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.582 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.416 HD21 ' N ' ' A' ' 60' ' ' LEU . 3.3 mm? -81.64 -67.71 0.76 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.378 0.609 . . . . 0.0 110.83 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.11 -64.38 0.52 Allowed Glycine 0 C--N 1.314 -0.66 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.481 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -56.91 -28.82 62.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.615 0.245 . . . . 0.0 111.386 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.5 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 16.3 t -73.03 -52.78 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.434 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.92 -24.68 39.22 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.086 0.469 . . . . 0.0 109.806 178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -90.34 -38.91 13.03 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.169 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 17.3 pttp -59.72 -48.38 81.89 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.893 0.378 . . . . 0.0 110.206 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.414 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.5 m-80 -77.55 -5.1 48.94 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.897 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 66.32 41.74 3.25 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.129 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.427 HG12 ' HB ' ' A' ' 74' ' ' THR . 53.8 t -113.87 86.16 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.122 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 93.3 p -91.46 -21.88 20.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.838 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.48 -173.64 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.514 ' O ' ' SD ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -172.76 119.38 0.41 Allowed Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.593 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 50.6 Cg_endo -83.89 -179.23 21.14 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.939 -1.275 . . . . 0.0 112.158 -0.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 37.0 m -147.03 143.65 28.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.469 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.404 ' CD1' ' HA ' ' A' ' 90' ' ' ALA . 79.5 mt -109.78 124.55 51.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.06 0.457 . . . . 0.0 111.812 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.532 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 25.1 mt -119.38 127.61 53.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.468 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 4.5 mp -109.71 134.08 52.4 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.212 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.462 ' HA ' HG22 ' A' ' 84' ' ' VAL . 53.1 m-85 -133.91 127.99 33.62 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.111 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HD3' ' HB2' ' A' ' 20' ' ' LEU . 7.4 mmmm -109.79 127.74 54.85 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.728 0.299 . . . . 0.0 111.47 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.424 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.3 m120 45.32 56.43 5.62 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.909 0.385 . . . . 0.0 111.832 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 61.6 14.15 41.61 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.199 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 34.3 mmtp -111.74 -154.18 0.54 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.415 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 35.8 tt0 -108.77 171.37 7.47 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 78' ' ' PHE . 59.6 t -144.03 -66.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.745 0.307 . . . . 0.0 111.35 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.17 161.7 8.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.003 0.43 . . . . 0.0 111.524 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -116.69 129.14 55.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.09 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.4 t -154.49 81.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.261 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 73' ' ' PRO . 6.8 p -61.74 85.38 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.009 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.81 110.69 0.26 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.566 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.506 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -100.78 38.9 1.45 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.884 0.374 . . . . 0.0 111.318 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 93' ' ' ALA . 47.4 t30 -79.6 132.01 62.93 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.208 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -44.37 87.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.737 2.292 . . . . 0.0 112.886 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 173.26 -38.14 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.21 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.58 -46.24 3.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.643 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.506 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 5.0 tp -52.77 -16.12 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.703 0.287 . . . . 0.0 111.148 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.443 ' NZ ' ' HB2' ' A' ' 96' ' ' LYS . 10.4 mtmp? -90.78 -63.06 1.32 Allowed 'General case' 0 CA--C 1.523 -0.091 0 CA-C-O 121.024 0.44 . . . . 0.0 110.623 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -58.8 -33.39 70.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.639 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.62 -30.1 69.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 99' ' ' ILE . 59.9 mt -89.9 -7.8 10.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.468 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.32 -72.16 0.58 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.971 0.415 . . . . 0.0 111.273 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.44 -30.73 31.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.337 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -80.83 -53.57 6.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.0 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.074 179.985 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.729 0.3 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.411 ' CG2' ' HD2' ' A' ' 54' ' ' LYS . 11.0 p -148.06 135.94 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.814 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.0 m -150.18 152.2 34.28 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.177 0.513 . . . . 0.0 111.803 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.42 ' OE1' ' HE3' ' A' ' 54' ' ' LYS . 9.3 mm-40 -90.13 159.03 16.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.003 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.518 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 15.0 m-85 -116.61 99.12 6.92 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.824 -0.351 . . . . 0.0 111.543 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -85.92 -27.51 24.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.8 p -127.74 124.23 37.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.479 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.88 -25.15 7.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.364 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.8 m -60.07 -18.69 48.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.574 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -90.33 -40.51 12.06 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.134 0.493 . . . . 0.0 111.207 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.489 ' CZ ' ' CG2' ' A' ' 23' ' ' VAL . 1.2 t80 -75.69 -30.88 59.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.812 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -54.57 -49.57 70.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.084 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -71.93 -25.47 61.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.164 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.88 -67.67 0.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.311 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 81' ' ' GLY . 17.8 pt -54.13 -49.47 61.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.776 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.444 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -44.78 99.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 44.66 89.66 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.55 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 63.9 t0 -169.38 39.66 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.284 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.539 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.6 mptp? 65.82 -154.56 0.26 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.37 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 103' ' ' ALA . 54.0 tp -97.78 115.84 28.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.14 0.495 . . . . 0.0 110.774 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.1 t -105.94 128.56 60.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.032 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.47 ' CG2' HG13 ' A' ' 99' ' ' ILE . 44.5 t -99.97 96.81 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.361 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.489 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 41.2 t -101.37 129.42 52.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.085 0.469 . . . . 0.0 111.678 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -99.76 130.06 45.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.327 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.542 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 3.6 m-85 -99.12 50.18 0.95 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.011 0.434 . . . . 0.0 110.849 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -51.05 136.79 22.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.831 179.499 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.423 ' HB1' ' HB2' ' A' ' 30' ' ' CYS . . . -62.09 150.3 38.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.905 0.383 . . . . 0.0 110.973 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.438 ' HB ' ' N ' ' A' ' 58' ' ' ASP . 5.1 t -78.76 -22.67 46.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.339 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.441 ' CH2' ' SD ' ' A' ' 72' ' ' MET . 21.8 p-90 -104.18 -34.91 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.868 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 72' ' ' MET . 42.2 t -39.47 156.33 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.727 0.299 . . . . 0.0 111.425 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' A' ' 32' ' ' PRO . . . -86.98 -87.97 1.06 Allowed Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.756 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' A' ' 31' ' ' GLY . 18.0 Cg_exo -66.72 61.92 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.896 2.397 . . . . 0.0 112.645 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.8 p -129.45 -4.1 4.83 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.376 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -99.02 -24.96 14.72 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.673 0.273 . . . . 0.0 111.433 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.8 mmt -68.74 -0.25 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.318 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.532 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 64.5 mt -82.66 -27.63 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.867 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.485 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -47.54 -46.04 58.86 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 41.5 Cg_endo -72.51 -36.81 4.74 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.788 1.659 . . . . 0.0 110.763 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.477 ' CE ' ' CE1' ' A' ' 43' ' ' PHE . 1.7 tmt? -62.26 -51.88 65.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.196 178.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.503 HG13 ' CG2' ' A' ' 36' ' ' ILE . 55.9 mt -51.45 -29.25 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.629 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -76.31 -40.02 52.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.484 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -55.36 -24.63 30.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.371 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.477 ' CE1' ' CE ' ' A' ' 39' ' ' MET . 5.1 m-85 -90.29 -22.85 21.37 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.447 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 87.1 p -70.09 -8.36 48.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.156 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 5.4 tp10 -90.02 -25.88 20.6 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.739 0.304 . . . . 0.0 110.998 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -90.4 -29.53 17.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.582 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.53 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 78.1 m-85 -122.86 44.94 0.98 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.356 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 84.1 Cg_exo -38.18 -32.02 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.088 2.525 . . . . 0.0 113.262 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -59.01 -40.86 86.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.561 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.88 141.37 28.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.709 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -89.98 125.44 35.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.909 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 4.6 m-85 -99.84 93.87 6.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.52 ' C ' ' HD3' ' A' ' 54' ' ' LYS . 47.2 m-85 -107.42 179.43 4.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.917 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.604 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 0.0 OUTLIER -137.9 153.88 49.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.691 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.443 ' HB3' ' HA ' ' A' ' 25' ' ' PHE . 2.8 tm? -112.33 118.83 36.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -78.25 108.37 11.52 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.566 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.455 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 90.6 t -75.46 -5.03 6.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.024 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.438 ' N ' ' HB ' ' A' ' 28' ' ' THR . 67.1 t0 -80.34 -46.8 15.48 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.795 0.331 . . . . 0.0 110.826 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -97.99 -24.56 15.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.115 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 3.4 mp -113.47 52.64 0.8 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.86 0.362 . . . . 0.0 111.055 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.82 -15.55 58.04 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.707 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.36 -26.36 32.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.664 0.269 . . . . 0.0 111.486 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.579 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 11.7 t -78.76 -22.75 12.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.865 0.364 . . . . 0.0 110.889 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.58 -24.85 38.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -90.22 -31.72 16.89 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.779 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -59.35 -47.96 83.45 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.043 0.449 . . . . 0.0 110.077 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.411 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.4 m-80 -86.86 -0.01 55.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.064 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 62.15 41.32 10.85 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.056 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.425 ' CG1' ' CB ' ' A' ' 74' ' ' THR . 47.5 t -106.27 116.54 50.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.116 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.8 p -149.87 18.69 0.89 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.695 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 72' ' ' MET . . . -70.15 -16.58 63.11 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.908 0.385 . . . . 0.0 110.779 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.53 ' HG3' ' O ' ' A' ' 72' ' ' MET . 11.4 ptt? 43.54 93.31 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.206 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.532 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 13.2 Cg_endo -92.6 -156.43 0.64 Allowed 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 125.077 -0.801 . . . . 0.0 112.319 -0.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.425 ' CB ' ' CG1' ' A' ' 69' ' ' VAL . 89.2 m -164.63 162.53 21.54 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.958 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 68.5 mt -123.46 123.62 41.05 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.68 0.276 . . . . 0.0 110.796 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.542 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 23.4 mt -118.74 131.5 56.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.0 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 3.5 mp -109.75 137.04 48.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.039 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.505 ' HA ' HG23 ' A' ' 84' ' ' VAL . 67.8 m-85 -136.88 126.03 24.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.276 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.463 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 8.6 mtmp? -113.39 126.71 55.66 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.64 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 74.6 m-80 46.26 75.43 0.12 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.617 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 40.95 39.5 1.99 Allowed Glycine 0 C--N 1.331 0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.619 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 31.9 mmmt -143.51 -158.58 0.89 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.402 ' C ' HG23 ' A' ' 84' ' ' VAL . 86.5 tt0 -108.82 175.17 5.56 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.505 HG23 ' HA ' ' A' ' 78' ' ' PHE . 14.3 t -149.14 -66.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 110.946 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.13 154.42 4.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.138 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -117.79 120.63 38.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.735 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.417 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 49.1 t -139.06 93.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.138 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.436 HG23 ' CB ' ' A' ' 71' ' ' ALA . 4.6 p -67.56 120.85 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.964 0.411 . . . . 0.0 110.878 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.93 102.22 1.61 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.236 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.468 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -94.41 37.58 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 111.208 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 93' ' ' ALA . 46.1 t30 -83.47 134.37 45.39 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.017 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -40.73 89.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.75 2.3 . . . . 0.0 112.693 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 179.56 -32.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.301 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.11 -42.47 0.98 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.468 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 6.4 tp -53.73 -14.76 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.471 0.177 . . . . 0.0 111.449 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.42 ' HG2' ' N ' ' A' ' 97' ' ' GLN . 14.2 tttm -92.02 -61.87 1.53 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.92 0.39 . . . . 0.0 111.004 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.445 ' NE2' ' H ' ' A' ' 97' ' ' GLN . 0.3 OUTLIER -66.64 -34.83 78.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.991 -179.531 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.42 -30.26 62.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.094 0.473 . . . . 0.0 110.646 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.47 HG13 ' CG2' ' A' ' 22' ' ' VAL . 1.5 mp -90.18 -8.43 10.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.627 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.23 -75.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.319 . . . . 0.0 111.34 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.88 -29.52 8.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.356 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.429 ' CB ' ' CD2' ' A' ' 20' ' ' LEU . 2.4 m120 -78.54 -50.66 11.18 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.916 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.43 ' HB3' ' HB3' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.03 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.845 0.355 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.1 p -133.49 138.66 50.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.813 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.6 m -150.15 161.69 41.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.964 0.411 . . . . 0.0 111.433 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.58 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 17.1 mt-30 -96.88 -179.34 4.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.375 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.52 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 18.1 m-85 -132.31 95.94 3.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.188 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -80.77 -19.53 44.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.6 p -134.37 122.71 22.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.375 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.47 -25.41 6.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.599 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.1 t -60.63 -17.23 45.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.769 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -90.5 -45.78 8.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.158 0.504 . . . . 0.0 111.476 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.479 ' CZ ' ' CG2' ' A' ' 23' ' ' VAL . 1.2 t80 -69.08 -23.26 64.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.087 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -57.37 -40.09 77.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.394 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -86.48 -24.46 25.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.528 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.94 -38.61 73.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.542 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.542 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.1 pt -86.76 -49.41 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.543 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.474 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -44.3 100.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 44.98 90.19 0.01 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.4 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 8.5 t0 -173.66 40.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.063 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.542 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.8 mptp? 63.92 -157.28 0.31 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.447 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.455 ' CD1' HG21 ' A' ' 84' ' ' VAL . 59.1 tp -98.19 117.87 33.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.112 0.482 . . . . 0.0 110.914 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.4 t -101.66 137.58 28.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.617 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.4 HG23 ' CD1' ' A' ' 99' ' ' ILE . 45.7 t -99.93 87.5 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.368 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.479 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 29.0 t -99.91 121.6 50.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.357 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -100.0 134.38 43.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.61 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.521 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 4.2 m-85 -99.19 52.36 0.95 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.931 0.395 . . . . 0.0 110.577 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -51.81 138.15 24.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 72' ' ' MET . . . -68.23 138.08 55.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.549 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -58.41 -14.37 7.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.403 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.431 ' CZ2' ' HE3' ' A' ' 72' ' ' MET . 5.7 p-90 -112.25 -123.83 0.28 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.092 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 36.8 t 60.74 -83.18 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.561 0.344 . . . . 0.0 110.824 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.64 -79.8 0.22 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.145 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.65 -22.15 73.66 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.884 2.389 . . . . 0.0 113.254 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 98.4 m -50.04 -27.66 5.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.615 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -77.7 -28.25 50.95 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.524 -179.55 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.4 mtp -76.58 4.43 9.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.859 0.361 . . . . 0.0 110.85 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.579 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 70.8 mt -86.31 -20.44 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.023 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.526 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -52.15 -44.07 91.77 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 46.4 Cg_endo -72.36 -35.15 6.83 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.835 1.69 . . . . 0.0 111.417 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.9 ttt -65.84 -52.13 53.06 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.493 HG13 ' CG2' ' A' ' 36' ' ' ILE . 63.8 mt -49.92 -28.41 4.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.536 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -76.69 -36.55 57.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.364 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.454 ' HB3' ' NZ ' ' A' ' 42' ' ' LYS . 9.3 mtpm? -58.56 -21.45 52.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.145 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.13 -22.34 21.8 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.36 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.454 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.2 t -65.6 -11.73 46.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.312 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -86.28 -25.17 25.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.661 0.267 . . . . 0.0 111.366 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.27 -28.68 18.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.792 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.528 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 80.4 m-85 -122.78 45.2 1.02 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.5 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 86.1 Cg_exo -37.98 -32.79 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.163 2.575 . . . . 0.0 113.601 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -63.69 -37.09 86.04 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.751 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 47' ' ' TYR . . . -89.84 138.79 31.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.789 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -89.76 127.11 35.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.916 0.388 . . . . 0.0 110.579 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 4.9 m-85 -98.58 86.59 3.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.717 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.52 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 36.6 m-85 -96.48 -175.73 3.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.88 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.58 ' HE2' ' HG2' ' A' ' 4' ' ' GLN . 34.4 mtmm -150.1 138.78 20.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.952 0.406 . . . . 0.0 111.293 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.428 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 3.0 tm? -95.22 129.72 42.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.07 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -86.98 110.46 20.06 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.888 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 84.2 t -78.81 -4.51 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.012 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -84.63 -55.29 4.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.977 0.418 . . . . 0.0 110.827 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -87.26 -17.31 32.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.398 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.472 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 2.3 mp -127.09 57.93 1.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.929 0.395 . . . . 0.0 111.092 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.64 -16.11 55.04 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.384 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -79.95 -29.63 39.7 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.575 0.226 . . . . 0.0 111.57 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.548 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 21.8 t -73.49 -27.56 23.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.961 0.41 . . . . 0.0 110.956 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' A' ' 69' ' ' VAL . . . -80.01 -26.83 39.7 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -90.4 -31.0 17.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.823 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 13.9 ptmm? -60.31 -48.06 83.35 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.969 0.414 . . . . 0.0 109.984 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.42 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 75.3 m-80 -84.95 1.65 46.44 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.784 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 65.41 37.74 6.07 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.332 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 64' ' ' ALA . 48.9 t -111.61 75.19 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.815 0.341 . . . . 0.0 111.053 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.6 p -89.35 5.59 44.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.136 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HB1' HG22 ' A' ' 88' ' ' VAL . . . -60.68 -159.01 0.01 OUTLIER 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.575 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.613 ' HG2' ' O ' ' A' ' 72' ' ' MET . 1.5 pmm? -174.98 93.2 0.29 Allowed Pre-proline 0 CA--C 1.53 0.192 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.579 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 8.0 Cg_endo -94.04 -156.69 0.57 Allowed 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 124.904 -0.873 . . . . 0.0 112.502 -0.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.428 ' CB ' ' CG1' ' A' ' 69' ' ' VAL . 53.4 m -158.09 148.44 20.4 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.81 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 89' ' ' GLY . 90.5 mt -109.89 123.31 49.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.185 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.521 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 20.2 mt -122.76 128.96 51.17 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.837 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 4.5 mp -109.96 144.66 38.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.959 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.502 ' HA ' HG22 ' A' ' 84' ' ' VAL . 65.5 m-85 -145.04 126.09 14.57 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.471 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 51.8 mtmt -113.46 132.96 55.46 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.694 0.283 . . . . 0.0 111.493 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.454 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.3 m120 47.96 53.34 11.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.9 0.381 . . . . 0.0 111.742 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 59.43 16.07 34.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.978 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 74.7 mmtt -111.19 -153.92 0.53 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.416 ' C ' HG22 ' A' ' 84' ' ' VAL . 10.5 tp10 -108.81 173.79 6.16 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.502 HG22 ' HA ' ' A' ' 78' ' ' PHE . 58.0 t -149.18 -63.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.853 0.358 . . . . 0.0 111.165 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.49 162.8 8.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.2 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -138.53 115.16 10.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.543 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.5 t -136.41 98.89 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.17 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.445 HG22 ' HB1' ' A' ' 71' ' ' ALA . 2.4 p -56.92 116.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.967 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 90' ' ' ALA . . . 141.52 -140.26 10.09 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.989 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 89' ' ' GLY . . . 147.61 36.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.818 0.447 . . . . 0.0 110.867 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 93' ' ' ALA . 75.3 m-80 -86.94 143.46 35.2 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.576 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -48.87 85.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.581 2.187 . . . . 0.0 112.478 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -179.48 -37.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.487 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.46 -44.34 2.13 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 3.2 tp -50.1 -18.61 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.464 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.45 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 7.8 ptpp? -91.71 -49.52 6.23 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.971 0.415 . . . . 0.0 110.974 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.45 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 25.7 mt-30 -69.22 -32.11 71.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.48 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.65 -27.76 68.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.534 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.448 HG22 ' CG ' ' A' ' 47' ' ' TYR . 58.4 mt -90.22 -11.54 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.511 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.43 -74.21 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.917 0.389 . . . . 0.0 111.492 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -45.93 -29.5 1.44 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.378 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.408 ' CB ' ' CD2' ' A' ' 20' ' ' LEU . 69.8 m-20 -90.14 -42.34 11.12 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.269 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.081 179.896 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 120.795 0.331 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 41' ' ' GLU . 12.5 p -167.89 132.15 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.3 m -150.26 156.54 41.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.946 0.403 . . . . 0.0 111.403 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -99.57 -173.44 2.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.621 179.368 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.527 ' CE2' ' CD1' ' A' ' 11' ' ' PHE . 21.4 m-85 -137.5 101.33 4.47 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -83.19 -20.41 34.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.283 178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -133.03 122.84 24.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.147 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.12 -26.49 27.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.49 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -55.33 -23.41 23.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.188 0.518 . . . . 0.0 110.392 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -90.69 -35.19 15.07 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.627 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.527 ' CD1' ' CE2' ' A' ' 5' ' ' PHE . 1.0 OUTLIER -74.76 -24.11 58.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.948 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -58.75 -68.68 0.24 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.066 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.4 t -56.74 -23.56 43.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.447 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.46 -64.36 0.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.36 . . . . 0.0 111.472 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.7 pt -61.03 -47.23 94.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.486 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.514 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -40.28 97.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.7 mt-30 43.14 88.58 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.309 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 63.9 t0 -167.11 38.5 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.671 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 28.7 mtmt 70.07 -155.46 0.14 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.799 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.418 ' CD2' ' HB3' ' A' ' 103' ' ' ALA . 36.4 tp -97.6 112.07 24.09 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.144 0.497 . . . . 0.0 110.574 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 47.3 t -101.44 124.73 55.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.536 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 50.4 t -103.51 98.79 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.141 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.47 ' CG2' ' CZ ' ' A' ' 11' ' ' PHE . 38.2 t -105.74 131.69 54.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.775 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.529 ' HA ' ' O ' ' A' ' 74' ' ' THR . 62.2 t0 -100.1 132.53 45.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.53 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.527 ' CE1' ' CD1' ' A' ' 76' ' ' LEU . 5.2 m-85 -99.11 49.13 0.95 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.069 0.462 . . . . 0.0 110.524 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.534 ' HB2' ' HB3' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -50.42 145.87 5.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.44 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' A' ' 72' ' ' MET . . . -59.99 164.91 3.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.77 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.464 ' HB ' ' N ' ' A' ' 58' ' ' ASP . 3.1 t -96.75 22.74 7.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.913 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -148.82 -44.77 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 39.1 t -43.3 156.11 0.05 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.836 0.35 . . . . 0.0 111.373 -179.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -93.41 -69.34 1.1 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.239 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -47.07 -25.95 4.64 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.983 2.456 . . . . 0.0 112.955 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 98.7 m -61.8 -63.07 1.38 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.704 0.288 . . . . 0.0 111.623 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 61.9 pttt -55.45 -22.02 18.68 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.602 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.42 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 44.4 tpp -76.43 1.43 16.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 110.776 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.539 ' CG2' HG13 ' A' ' 40' ' ' ILE . 63.1 mt -85.93 -18.08 9.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.401 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.501 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.32 -44.4 81.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 53.9 Cg_endo -73.36 -35.4 4.98 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.837 1.691 . . . . 0.0 111.438 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 57.3 ttp -65.33 -52.04 56.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.539 HG13 ' CG2' ' A' ' 36' ' ' ILE . 73.1 mt -48.18 -29.51 2.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.56 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.416 ' HB2' HG12 ' A' ' 2' ' ' VAL . 87.1 tt0 -76.92 -34.31 57.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.977 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -63.91 -22.89 67.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.62 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -90.37 -22.51 21.46 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.455 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 80.2 p -67.29 -9.17 38.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.486 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -88.62 -26.22 22.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.78 0.324 . . . . 0.0 111.174 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -90.53 -29.79 17.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.842 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.529 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 78.6 m-85 -122.79 45.63 1.12 Allowed Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.502 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 84.0 Cg_exo -38.05 -32.16 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.22 2.613 . . . . 0.0 113.952 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.499 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 3.9 mm100 -66.91 -16.83 64.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.927 0.394 . . . . 0.0 111.31 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -104.04 139.89 38.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.559 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -89.44 120.99 31.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.907 0.384 . . . . 0.0 110.359 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.455 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 5.3 m-85 -97.92 83.88 3.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.313 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.493 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 46.5 m-85 -99.52 -174.53 2.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.354 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 32.6 mtmm -150.21 141.69 23.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.943 0.401 . . . . 0.0 110.964 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.452 ' HG ' ' CE2' ' A' ' 25' ' ' PHE . 2.5 tm? -100.41 130.34 46.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.866 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -87.87 114.07 24.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.856 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 78.3 t -77.54 -3.08 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.65 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.464 ' N ' ' HB ' ' A' ' 28' ' ' THR . 64.9 t0 -82.05 -55.53 4.51 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.899 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -89.82 -28.46 19.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.391 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' A' ' 60' ' ' LEU . 3.8 mp -108.23 52.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.848 0.356 . . . . 0.0 111.116 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.9 -15.21 59.9 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.447 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -82.94 -29.12 29.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.716 0.293 . . . . 0.0 111.448 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.588 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 15.4 t -73.33 -51.1 27.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.454 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 69' ' ' VAL . . . -54.47 -26.02 28.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.114 0.483 . . . . 0.0 109.718 178.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.415 ' NE2' ' C ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -90.46 -37.82 13.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.07 179.649 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -61.64 -42.53 99.02 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.903 0.382 . . . . 0.0 110.352 -179.581 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -83.68 -0.46 50.83 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 65.67 35.45 6.96 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.334 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 64' ' ' ALA . 31.2 t -113.16 63.51 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 121.03 0.443 . . . . 0.0 110.867 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.2 p -74.57 -13.85 60.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.074 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.79 -168.77 0.0 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.414 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.539 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -174.29 111.82 0.3 Allowed Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.207 -179.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.499 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 57.3 Cg_endo -88.99 -166.73 3.19 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.275 -1.136 . . . . 0.0 112.398 -0.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 24' ' ' ASP . 34.1 m -159.81 150.07 18.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.604 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.407 ' CD1' ' CD1' ' A' ' 95' ' ' ILE . 71.8 mt -110.78 124.8 52.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.888 0.375 . . . . 0.0 111.591 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.527 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 29.4 mt -124.72 124.14 41.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.465 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 77' ' ' LEU . 3.3 mp -109.91 149.19 30.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.786 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.597 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 40.5 m-85 -149.29 128.55 12.87 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.128 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.505 ' NZ ' ' HB3' ' A' ' 79' ' ' LYS . 9.8 mtpm? -114.99 137.33 52.12 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.477 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 6.2 m120 49.93 52.35 14.83 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.721 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 16' ' ' ALA . . . 57.78 18.7 33.17 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.732 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.597 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 67.1 mttm -120.01 -155.56 0.63 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.468 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 85.8 tt0 -109.13 176.93 4.92 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 83' ' ' GLU . 3.5 m -165.38 -47.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.44 0.162 . . . . 0.0 111.301 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.69 170.37 9.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.142 0.496 . . . . 0.0 112.019 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.477 ' N ' ' HD2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -160.12 132.19 6.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.355 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.4 t -146.02 109.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.147 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 6.5 p -69.55 69.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.814 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.2 118.29 0.56 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.349 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.466 ' HA ' ' HB ' ' A' ' 95' ' ' ILE . . . -95.96 38.0 1.2 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.914 0.388 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 93' ' ' ALA . 5.5 m120 -65.89 132.21 94.71 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.545 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -48.4 86.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.66 2.24 . . . . 0.0 112.668 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 176.8 -36.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.267 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.04 -46.87 2.7 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 90' ' ' ALA . 4.7 tp -53.58 -15.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.211 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -91.38 -50.95 5.53 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.791 0.329 . . . . 0.0 111.086 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -73.79 -32.97 64.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.478 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.02 -26.44 66.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.59 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.437 HG22 ' CG ' ' A' ' 47' ' ' TYR . 63.7 mt -90.24 -18.27 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.107 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.74 -65.49 1.01 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.007 0.432 . . . . 0.0 111.104 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -48.96 -28.26 3.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.217 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 -90.23 -38.71 13.26 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.34 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.418 ' HB3' ' CD2' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.197 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.492 HG11 ' HB2' ' A' ' 41' ' ' GLU . 10.7 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.679 0.276 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.449 HG22 ' N ' ' A' ' 4' ' ' GLN . 86.0 m -150.11 161.77 41.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.884 0.373 . . . . 0.0 111.253 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.462 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 61.5 mt-30 -102.93 -172.68 2.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.39 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.531 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.2 m-85 -137.52 129.32 28.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.059 0.457 . . . . 0.0 111.461 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.716 ' C ' HD11 ' A' ' 60' ' ' LEU . 75.2 mmtt -112.98 -28.24 7.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.498 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.0 p -128.57 132.49 48.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.515 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.44 -25.34 50.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.51 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.3 t -59.74 -18.35 42.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.621 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -90.42 -64.94 1.06 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.277 0.561 . . . . 0.0 111.031 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.897 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.2 t80 -53.54 -29.0 34.63 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.015 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -54.89 -35.29 63.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.018 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.3 p -82.5 -37.49 25.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.111 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.594 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -46.74 -49.12 20.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.66 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.5 pt -77.58 -49.91 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.501 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.48 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -40.74 95.43 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 85.1 mt-30 44.35 86.66 0.02 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.422 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 8.1 t0 -169.54 41.14 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.407 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.56 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 10.9 mptt 67.56 -155.41 0.21 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.694 0.283 . . . . 0.0 110.888 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.898 HD11 ' HB3' ' A' ' 77' ' ' LEU . 61.5 tp -98.1 115.21 27.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.222 0.534 . . . . 0.0 111.252 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.511 HG12 HG23 ' A' ' 23' ' ' VAL . 59.9 t -99.79 128.2 51.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.471 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.678 HG21 ' CD1' ' A' ' 99' ' ' ILE . 48.8 t -99.74 91.22 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 110.816 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.897 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 42.0 t -101.27 132.19 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.125 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.9 t70 -102.43 129.11 48.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.73 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.071 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.4 m-85 -98.98 51.6 0.96 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.206 0.527 . . . . 0.0 110.467 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.533 ' O ' HG23 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -50.99 139.44 17.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.111 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 71' ' ' ALA . . . -65.58 141.75 58.32 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.331 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.6 t -57.91 -18.13 21.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.069 0.461 . . . . 0.0 110.835 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.422 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 8.2 p-90 -106.61 -128.74 0.27 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.315 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 72' ' ' MET . 30.2 t 61.08 156.08 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.805 0.336 . . . . 0.0 110.979 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.09 -82.1 1.19 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.488 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.97 60.85 3.79 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.627 2.218 . . . . 0.0 112.33 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.7 p -107.61 -20.83 13.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.024 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -85.71 -24.11 27.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.119 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.454 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 57.7 ttp -63.44 -12.69 33.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.982 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.772 HG22 HG13 ' A' ' 40' ' ' ILE . 2.7 mp -81.99 -30.22 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.669 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -49.5 -45.72 77.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 37.8 Cg_endo -70.86 -37.65 6.28 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.722 1.615 . . . . 0.0 111.012 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.494 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 66.4 mtm -63.92 -54.94 26.81 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.772 HG13 HG22 ' A' ' 36' ' ' ILE . 55.7 mt -44.74 -29.08 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.069 0.461 . . . . 0.0 110.542 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.492 ' HB2' HG11 ' A' ' 2' ' ' VAL . 38.3 tt0 -81.59 -40.32 23.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.176 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -59.82 -27.9 67.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.627 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.616 ' CE2' HG23 ' A' ' 95' ' ' ILE . 10.4 m-85 -78.02 -22.43 49.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.625 0.25 . . . . 0.0 111.389 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.446 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 46.9 t -66.65 -11.32 53.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.206 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -87.44 -26.09 23.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.64 0.257 . . . . 0.0 111.096 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -89.98 -31.73 17.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.199 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.479 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 89.7 m-85 -124.39 51.61 4.85 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.02 0.438 . . . . 0.0 110.489 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 2.9 Cg_endo -48.95 -25.43 8.66 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.034 2.489 . . . . 0.0 112.484 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -65.77 -31.49 72.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.054 0.454 . . . . 0.0 110.229 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.742 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -95.77 144.48 26.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.86 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.489 ' HB2' HG22 ' A' ' 21' ' ' VAL . 58.9 m-20 -89.96 129.98 36.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.709 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.479 ' CZ ' HD13 ' A' ' 99' ' ' ILE . 8.8 m-85 -105.09 90.94 3.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.391 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.628 ' HB2' HG22 ' A' ' 23' ' ' VAL . 47.5 m-85 -101.01 -178.12 3.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.559 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HZ2' HD12 ' A' ' 40' ' ' ILE . 20.1 mtpp -141.9 141.27 33.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.395 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.911 HD13 ' N ' ' A' ' 56' ' ' ASP . 3.0 tm? -105.26 144.23 32.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.29 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.911 ' N ' HD13 ' A' ' 55' ' ' LEU . 22.9 t70 -99.9 115.5 29.77 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.075 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 26' ' ' TYR . 75.5 t -76.83 -4.0 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.919 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.442 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 38.6 t70 -96.21 -50.09 4.95 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.254 0.549 . . . . 0.0 110.215 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.494 ' C ' HD12 ' A' ' 60' ' ' LEU . 5.1 tp10 -82.16 -40.28 22.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.652 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.724 HD22 ' CD2' ' A' ' 55' ' ' LEU . 4.1 mp -111.67 43.53 1.52 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.545 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.6 -24.05 16.45 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.762 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 56.6 m-20 -71.04 -50.09 37.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.688 0.28 . . . . 0.0 111.256 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.756 HG12 ' HE2' ' A' ' 25' ' ' PHE . 15.6 t -56.37 -23.85 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.142 0.496 . . . . 0.0 110.244 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -80.35 -25.2 39.33 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 3.2 pt20 -90.21 -35.4 15.36 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.272 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 20.2 ptmt -57.79 -48.45 79.66 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.421 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.435 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 75.6 m-80 -85.48 2.18 45.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.048 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 63.92 38.94 8.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.905 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.765 HG13 HG21 ' A' ' 74' ' ' THR . 43.8 t -116.39 99.82 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.899 0.38 . . . . 0.0 111.398 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.7 m -121.7 13.17 10.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.816 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -60.9 -157.9 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.092 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.604 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -169.75 88.19 0.57 Allowed Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.457 ' O ' HG23 ' A' ' 88' ' ' VAL . 40.3 Cg_endo -96.71 -164.57 0.99 Allowed 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 124.777 -0.926 . . . . 0.0 112.793 -0.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.816 ' OG1' ' HB3' ' A' ' 71' ' ' ALA . 29.3 m -149.98 153.91 37.35 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.701 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.016 HD13 HD13 ' A' ' 95' ' ' ILE . 85.3 mt -114.33 126.58 55.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.819 0.342 . . . . 0.0 111.235 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.071 HD12 ' CE1' ' A' ' 25' ' ' PHE . 19.1 mt -121.76 128.68 52.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.014 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.898 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.6 mp -109.89 141.88 41.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.628 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.607 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 65.1 m-85 -141.88 127.13 18.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.697 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.838 ' CG ' HG11 ' A' ' 84' ' ' VAL . 8.9 mmmm -109.82 133.17 53.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.53 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 5.2 m120 42.88 65.17 0.99 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.01 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 53.96 21.02 15.65 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.155 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.607 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 28.1 mtpp -127.33 -160.82 1.03 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.633 ' O ' HG13 ' A' ' 84' ' ' VAL . 82.3 tt0 -109.47 178.06 4.55 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.838 HG11 ' CG ' ' A' ' 79' ' ' LYS . 4.8 m -162.38 -47.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 O-C-N 123.1 0.25 . . . . 0.0 111.144 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.96 162.07 17.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.125 0.488 . . . . 0.0 111.874 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -149.09 115.39 5.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.267 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.3 t -131.1 98.66 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.331 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.597 HG21 ' CB ' ' A' ' 71' ' ' ALA . 3.3 p -62.33 98.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.696 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.98 108.52 0.81 Allowed Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.2 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.683 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -95.68 37.13 1.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 111.259 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 93' ' ' ALA . 75.9 m-80 -72.04 131.77 85.17 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.237 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -45.91 86.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.689 2.26 . . . . 0.0 112.637 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 178.51 -36.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.525 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.23 -45.62 2.44 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.016 HD13 HD13 ' A' ' 75' ' ' LEU . 5.0 tp -49.94 -18.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.302 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 22.4 pttp -91.76 -50.97 5.46 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.903 0.382 . . . . 0.0 111.049 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.405 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 61.7 mt-30 -69.9 -32.1 70.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.599 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.1 -28.46 69.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.748 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.678 ' CD1' HG21 ' A' ' 22' ' ' VAL . 56.7 mt -90.22 -8.08 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.526 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.26 -69.39 0.73 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.866 0.365 . . . . 0.0 111.162 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.99 -29.61 30.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.177 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.623 ' CB ' HD22 ' A' ' 20' ' ' LEU . 5.6 m120 -80.75 -52.91 6.99 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.053 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.041 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.618 HG11 ' HB2' ' A' ' 41' ' ' GLU . 11.2 p . . . . . 0 N--CA 1.464 0.253 0 CA-C-O 121.23 0.538 . . . . 0.0 112.048 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 4' ' ' GLN . 88.9 m -150.17 162.42 40.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.133 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.532 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 59.5 mt-30 -101.04 178.77 4.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.631 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.52 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 18.4 m-85 -133.17 98.48 4.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.712 0.291 . . . . 0.0 111.598 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.728 ' O ' HD11 ' A' ' 60' ' ' LEU . 45.8 mmtm -83.52 -28.31 28.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.44 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.3 p -123.36 122.62 38.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.255 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.59 -26.4 8.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.687 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.9 t -59.22 -19.85 49.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.829 0.347 . . . . 0.0 110.426 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -90.73 -31.07 16.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.358 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.88 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -85.86 8.45 20.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.391 -179.303 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -87.7 -60.58 1.93 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.867 0.365 . . . . 0.0 110.923 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -67.01 -17.17 64.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.28 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.48 91.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.377 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.554 ' O ' ' N ' ' A' ' 81' ' ' GLY . 21.4 pt -88.89 -49.92 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.465 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.478 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -46.29 103.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.847 0.356 . . . . 0.0 111.955 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.9 mt-30 44.01 87.45 0.02 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.29 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -168.84 40.67 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.035 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.555 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER 64.33 -156.88 0.31 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.281 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.764 HD13 ' N ' ' A' ' 103' ' ' ALA . 3.4 tt -98.15 115.85 29.14 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.205 0.526 . . . . 0.0 110.782 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.794 HG22 ' HB2' ' A' ' 51' ' ' ASP . 47.3 t -104.73 127.87 58.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.135 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.779 HG22 ' HG ' ' A' ' 77' ' ' LEU . 61.6 t -103.69 95.21 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.552 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.88 HG21 ' CE1' ' A' ' 11' ' ' PHE . 40.5 t -99.85 136.73 29.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.204 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 74' ' ' THR . 38.8 t70 -100.01 128.1 46.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.825 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.996 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.2 m-85 -98.89 48.69 0.96 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.012 0.434 . . . . 0.0 110.683 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.521 ' O ' ' HD1' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -51.48 137.04 24.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.889 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.789 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -58.39 165.01 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.965 0.412 . . . . 0.0 111.042 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.5 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 3.7 t -98.67 19.24 15.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.066 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.428 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 15.4 p-90 -141.76 -38.71 0.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.8 t -36.87 -69.06 0.12 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.781 0.325 . . . . 0.0 111.801 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.87 -74.42 0.23 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.511 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.6 -26.95 9.86 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.666 2.244 . . . . 0.0 112.421 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.417 ' HB3' ' CB ' ' A' ' 26' ' ' TYR . 77.5 m -58.25 -21.21 47.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.203 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -75.32 -19.22 59.76 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.28 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.425 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 84.4 mtp -75.3 3.8 8.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.357 . . . . 0.0 110.691 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.039 HG22 HG13 ' A' ' 40' ' ' ILE . 55.1 mt -85.68 -17.8 9.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.487 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.592 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.51 -42.33 74.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 35.3 Cg_endo -68.93 -43.58 3.3 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.576 1.517 . . . . 0.0 111.324 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.589 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 23.9 mmt -61.23 -61.28 2.67 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.039 HG13 HG22 ' A' ' 36' ' ' ILE . 56.8 mt -43.73 -29.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.846 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.618 ' HB2' HG11 ' A' ' 2' ' ' VAL . 4.0 tm-20 -81.56 -37.8 27.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.822 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 39' ' ' MET . 99.3 mttt -71.6 -30.96 66.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.544 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.589 ' HD1' ' O ' ' A' ' 39' ' ' MET . 16.3 m-85 -73.15 -27.07 61.46 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.356 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.5 p -67.02 -9.7 41.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.147 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.409 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 56.2 mt-10 -87.26 -26.51 23.44 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.788 0.327 . . . . 0.0 111.222 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.4 -31.79 16.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.524 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.531 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 73.9 m-85 -122.78 45.19 1.02 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.401 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 80.3 Cg_exo -37.74 -32.32 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.286 2.657 . . . . 0.0 113.478 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -60.71 -35.1 75.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.604 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.44 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.8 138.54 31.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.543 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.794 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.68 122.32 32.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.888 0.375 . . . . 0.0 110.46 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.65 ' CZ ' HD13 ' A' ' 99' ' ' ILE . 4.5 m-85 -99.32 90.33 4.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.577 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.733 ' HB2' HG22 ' A' ' 23' ' ' VAL . 41.0 m-85 -101.02 -177.76 3.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.572 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 4' ' ' GLN . 34.4 mtpt -139.96 131.5 27.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.369 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.667 HD23 ' CD2' ' A' ' 11' ' ' PHE . 3.2 tm? -95.73 126.39 40.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.138 0.494 . . . . 0.0 111.068 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.569 ' N ' HD13 ' A' ' 55' ' ' LEU . 44.9 m-20 -85.29 113.08 21.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.716 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 96.4 t -81.85 -5.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.141 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.5 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 11.4 p-10 -84.52 -39.72 18.5 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.854 0.359 . . . . 0.0 110.854 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.662 ' C ' HD12 ' A' ' 60' ' ' LEU . 17.6 tp10 -100.4 -23.02 14.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.171 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.728 HD11 ' O ' ' A' ' 6' ' ' LYS . 3.1 mp -119.57 48.44 1.52 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.822 0.344 . . . . 0.0 110.995 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -60.35 -18.24 49.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.444 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.67 -27.56 55.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.694 0.283 . . . . 0.0 111.507 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.717 HG12 ' HE2' ' A' ' 25' ' ' PHE . 15.7 t -75.53 -54.69 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.758 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.428 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -53.51 -26.74 22.12 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.954 0.407 . . . . 0.0 110.218 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.06 -26.84 20.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.69 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -70.44 -49.36 49.55 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.034 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -77.61 -1.1 29.16 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.116 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 67.55 37.61 3.34 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.344 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.654 ' CG1' HG21 ' A' ' 74' ' ' THR . 40.5 t -115.25 68.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.854 0.359 . . . . 0.0 110.845 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.8 p -81.77 -7.95 59.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.15 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.56 -166.53 0.0 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.537 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.789 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -174.43 107.43 0.28 Allowed Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.85 ' HG3' HD11 ' A' ' 36' ' ' ILE . 37.2 Cg_endo -89.77 -166.68 2.99 Favored 'Cis proline' 0 C--N 1.35 0.642 0 C-N-CA 124.353 -1.103 . . . . 0.0 112.366 -0.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.713 HG23 ' HA ' ' A' ' 88' ' ' VAL . 53.4 m -160.88 142.69 12.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.227 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.734 HD13 HD13 ' A' ' 95' ' ' ILE . 36.7 mt -109.79 123.75 50.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.023 0.439 . . . . 0.0 111.551 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.996 HD12 ' CE1' ' A' ' 25' ' ' PHE . 29.1 mt -115.16 127.07 55.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.853 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.779 ' HG ' HG22 ' A' ' 22' ' ' VAL . 4.5 mp -109.68 131.52 54.98 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.563 ' HA ' HG23 ' A' ' 84' ' ' VAL . 51.9 m-85 -130.94 125.52 33.65 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.298 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.481 ' HG3' HG21 ' A' ' 84' ' ' VAL . 24.6 mtpp -109.78 126.53 53.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.719 0.295 . . . . 0.0 111.087 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 6.3 m120 50.41 55.62 9.2 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.941 0.4 . . . . 0.0 111.768 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 59.58 16.39 36.78 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.072 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 27.0 mtpp -115.57 -153.55 0.53 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 35.6 tt0 -108.87 171.51 7.39 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.563 HG23 ' HA ' ' A' ' 78' ' ' PHE . 38.4 t -144.0 -59.82 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.75 0.309 . . . . 0.0 111.203 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.08 157.42 6.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.442 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -118.3 114.67 23.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.708 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.4 t -136.96 80.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.036 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.713 ' HA ' HG23 ' A' ' 74' ' ' THR . 3.8 p -59.64 85.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.998 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.54 123.41 2.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.703 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.604 ' HB2' HD11 ' A' ' 75' ' ' LEU . . . -84.45 55.23 3.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 110.83 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 46.6 t30 -51.59 131.89 35.86 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.725 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -44.96 -25.95 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.643 2.229 . . . . 0.0 112.776 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.403 ' HA ' ' HE2' ' A' ' 96' ' ' LYS . . . -123.32 49.19 1.72 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.724 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -152.39 -62.02 0.16 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.443 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.759 HD11 HG11 ' A' ' 22' ' ' VAL . 3.5 tp -58.17 -5.45 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.184 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.447 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 64.5 pttt -90.95 -47.53 7.53 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.954 0.407 . . . . 0.0 110.469 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.447 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 83.9 mt-30 -74.7 -32.47 62.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.52 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.4 -30.94 70.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.578 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.78 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 56.4 mt -90.25 -6.4 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.528 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.64 -77.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.998 0.428 . . . . 0.0 111.651 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.21 -29.3 5.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.054 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.604 ' HB3' HD12 ' A' ' 20' ' ' LEU . 73.0 m-80 -88.05 -67.4 0.83 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.672 0.272 . . . . 0.0 111.707 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.78 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.292 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.659 HG22 ' NZ ' ' A' ' 54' ' ' LYS . 9.9 p . . . . . 0 CA--C 1.529 0.164 0 CA-C-O 120.554 0.216 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 4' ' ' GLN . 95.4 m -150.29 157.69 43.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.0 111.481 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.546 ' HG3' ' HE2' ' A' ' 54' ' ' LYS . 1.7 mp0 -92.23 -177.14 4.57 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.771 ' O ' HD11 ' A' ' 60' ' ' LEU . 14.7 m-85 -133.67 96.57 3.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.819 0.342 . . . . 0.0 111.073 178.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -75.54 -30.29 59.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.729 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.0 p -128.61 132.43 48.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.48 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.06 -25.32 58.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.389 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.8 m -59.08 -19.86 48.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.542 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -90.63 -35.75 14.8 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.2 0.524 . . . . 0.0 111.075 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.944 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -73.67 -29.46 62.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.888 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -53.3 -57.02 12.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.218 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.8 p -61.13 -37.61 83.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.436 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -49.56 -51.9 33.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.649 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.6 pt -75.94 -48.86 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.529 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.479 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -43.14 97.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 84.7 mt-30 45.35 88.86 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.341 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 8.8 t70 -170.0 39.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.403 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 52.0 mttp 68.18 -154.35 0.18 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.731 0.301 . . . . 0.0 110.584 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.924 HD11 ' HB3' ' A' ' 77' ' ' LEU . 61.1 tp -97.8 114.28 26.28 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.089 0.471 . . . . 0.0 110.916 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.77 HG22 ' HB2' ' A' ' 51' ' ' ASP . 60.0 t -103.81 124.03 57.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.665 HG21 ' CG1' ' A' ' 99' ' ' ILE . 49.1 t -99.78 96.67 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.681 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.944 HG21 ' CE1' ' A' ' 11' ' ' PHE . 36.2 t -103.34 130.11 54.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.065 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.8 t70 -99.68 131.37 45.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.577 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.062 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.3 m-85 -98.9 50.88 0.96 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.036 0.446 . . . . 0.0 110.707 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -54.05 135.61 42.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.935 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.707 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -60.88 156.42 17.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 0.0 110.894 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 3.2 t -87.35 6.09 35.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.453 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.45 ' CZ2' ' CE ' ' A' ' 72' ' ' MET . 20.1 p-90 -127.52 -37.58 1.98 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 29' ' ' TRP . 53.9 t -28.51 -75.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.08 -80.81 0.35 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.898 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.96 -21.3 33.35 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.756 2.304 . . . . 0.0 112.326 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.5 p -53.44 -33.56 54.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.124 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -64.94 -22.74 67.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.321 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.0 mtp -68.76 -7.4 33.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.735 0.302 . . . . 0.0 111.016 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.776 HG22 HG13 ' A' ' 40' ' ' ILE . 57.0 mt -88.01 -19.25 7.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.303 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.536 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -53.09 -43.74 95.45 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.893 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 38.1 Cg_endo -71.67 -36.66 6.17 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.747 1.632 . . . . 0.0 111.459 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.468 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 1.1 mpt? -64.64 -55.95 16.94 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.776 HG13 HG22 ' A' ' 36' ' ' ILE . 55.7 mt -44.66 -27.4 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.841 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.509 ' HB2' HG11 ' A' ' 2' ' ' VAL . 43.1 tt0 -80.75 -39.83 26.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.138 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -64.12 -30.98 72.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.606 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.468 ' HD1' ' O ' ' A' ' 39' ' ' MET . 10.7 m-85 -75.47 -19.18 59.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.69 0.281 . . . . 0.0 111.377 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.43 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.6 t -72.77 -6.92 48.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.382 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -90.15 -26.9 19.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.701 0.286 . . . . 0.0 111.06 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -90.3 -28.99 18.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.568 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.52 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 80.0 m-85 -123.83 47.65 1.89 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.081 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 62.9 Cg_exo -35.26 -41.58 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.6 2.867 . . . . 0.0 113.919 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.411 ' O ' ' CD ' ' A' ' 19' ' ' LYS . 85.8 mt-30 -55.4 -34.92 64.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.978 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.6 135.77 33.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.722 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.77 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.62 121.95 32.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.409 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.451 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . 5.6 m-85 -98.26 84.59 3.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.586 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.556 ' HB2' HG22 ' A' ' 23' ' ' VAL . 48.2 m-85 -98.86 -174.71 2.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.515 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.659 ' NZ ' HG22 ' A' ' 2' ' ' VAL . 34.4 mtmm -148.39 132.65 17.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.018 0.437 . . . . 0.0 111.033 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.748 HD21 HD22 ' A' ' 60' ' ' LEU . 2.1 tm? -91.87 130.74 37.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.187 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.838 ' O ' HD13 ' A' ' 60' ' ' LEU . 46.8 m-20 -86.44 126.32 34.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.411 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.719 ' O ' HG12 ' A' ' 57' ' ' VAL . 95.9 t -97.16 18.93 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.533 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 2.8 p30 -111.39 -38.99 4.81 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.242 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.428 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 17.6 tp10 -100.03 -13.94 18.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.805 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.838 HD13 ' O ' ' A' ' 56' ' ' ASP . 5.3 mp -104.74 -69.08 0.82 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.295 0.569 . . . . 0.0 110.926 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.84 -61.58 0.5 Allowed Glycine 0 C--N 1.314 -0.661 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.591 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -52.69 -43.43 65.59 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.735 HG12 ' HE2' ' A' ' 25' ' ' PHE . 16.0 t -59.83 -53.34 49.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.719 0.295 . . . . 0.0 110.844 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -51.25 -26.09 6.66 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 110.053 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -90.39 -38.02 13.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.157 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -61.15 -42.0 97.75 Favored 'General case' 0 C--O 1.23 0.055 0 CA-C-O 120.863 0.363 . . . . 0.0 110.414 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -84.95 -1.97 57.34 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.923 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 64.91 38.4 6.5 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.021 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.809 HG13 HG21 ' A' ' 74' ' ' THR . 40.2 t -114.75 69.12 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.852 0.358 . . . . 0.0 111.019 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.8 p -82.34 -11.46 58.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.067 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.524 ' CB ' HG21 ' A' ' 88' ' ' VAL . . . -55.32 -172.07 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.603 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.707 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 1.7 pmm? -171.59 107.57 0.38 Allowed Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.602 -0.439 . . . . 0.0 112.085 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.553 ' HG3' HD12 ' A' ' 36' ' ' ILE . 83.2 Cg_endo -93.78 171.23 18.28 Favored 'Cis proline' 0 N--CA 1.459 -0.55 0 C-N-CA 124.634 -0.986 . . . . 0.0 112.23 -0.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.809 HG21 HG13 ' A' ' 69' ' ' VAL . 34.5 m -136.16 153.69 51.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.953 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.071 HD13 HD13 ' A' ' 95' ' ' ILE . 85.3 mt -115.09 125.55 53.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 111.056 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.062 HD12 ' CE1' ' A' ' 25' ' ' PHE . 28.5 mt -122.38 128.99 51.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.061 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.924 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.4 mp -109.79 146.03 35.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.441 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.626 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 67.9 m-85 -145.99 128.82 16.33 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.779 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.888 ' CG ' HG11 ' A' ' 84' ' ' VAL . 27.0 mmmt -109.69 132.92 53.7 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.458 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 5.2 m120 44.44 60.25 2.93 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.842 0.353 . . . . 0.0 111.845 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 57.29 18.61 29.28 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.245 -0.503 . . . . 0.0 113.072 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.626 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 96.5 mttt -122.12 -158.86 0.79 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.72 ' O ' HG13 ' A' ' 84' ' ' VAL . 32.0 tt0 -109.35 176.73 4.98 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.888 HG11 ' CG ' ' A' ' 79' ' ' LYS . 3.3 m -165.01 -46.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 O-C-N 123.169 0.293 . . . . 0.0 111.292 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.26 158.17 16.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.147 0.499 . . . . 0.0 111.881 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 60.8 pttt -151.67 114.85 4.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.399 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.7 t -135.57 106.64 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.184 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.56 ' HB ' HG23 ' A' ' 74' ' ' THR . 3.6 p -66.78 97.87 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.48 104.83 0.44 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.195 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.788 ' HB2' HD21 ' A' ' 75' ' ' LEU . . . -96.98 35.87 1.5 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.927 0.394 . . . . 0.0 111.524 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 93' ' ' ALA . 13.9 p-10 -76.7 134.45 69.1 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.236 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 80.0 Cg_exo -44.79 87.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.591 2.194 . . . . 0.0 112.702 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 178.76 -36.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.551 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.9 -41.9 2.2 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.071 HD13 HD13 ' A' ' 75' ' ' LEU . 5.1 tp -51.02 -18.0 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.586 0.231 . . . . 0.0 111.329 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.407 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 21.4 ptmt -92.25 -50.33 5.72 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.971 0.415 . . . . 0.0 110.837 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.407 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 84.2 mt-30 -68.02 -31.92 71.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.581 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.607 ' HB1' HD21 ' A' ' 77' ' ' LEU . . . -57.38 -30.38 64.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.174 0.512 . . . . 0.0 110.772 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.874 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.5 mp -90.09 -9.72 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.554 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.62 -65.64 1.0 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 111.184 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.91 -26.91 27.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.452 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.662 ' HB3' HD22 ' A' ' 20' ' ' LEU . 52.4 m-80 -89.3 -59.95 2.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.536 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.102 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.434 HG22 HG22 ' A' ' 40' ' ' ILE . 49.6 t . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.763 0.316 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.9 m -149.98 147.06 27.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.977 0.417 . . . . 0.0 111.248 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.611 ' HG2' ' HE3' ' A' ' 54' ' ' LYS . 40.4 mt-30 -90.13 174.48 7.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.28 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.631 ' O ' HD13 ' A' ' 60' ' ' LEU . 16.9 m-85 -123.02 124.52 43.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.931 0.396 . . . . 0.0 111.144 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.699 ' C ' HD11 ' A' ' 60' ' ' LEU . 46.7 mmtm -109.26 -25.21 10.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.643 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -129.92 123.28 30.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.29 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.1 -26.64 4.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.426 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -57.8 -20.94 39.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.069 0.461 . . . . 0.0 110.477 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -90.42 -45.73 8.8 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.557 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.915 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -76.46 -23.38 53.87 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.695 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -63.85 -38.06 89.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.966 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.0 m -87.94 -26.39 22.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.224 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.408 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -52.38 -31.8 35.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.834 0.349 . . . . 0.0 111.423 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.538 ' C ' ' HA2' ' A' ' 81' ' ' GLY . 20.4 pt -90.18 -47.71 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.361 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.472 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.1 97.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.7 mm100 45.65 86.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.33 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -167.36 41.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.44 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.547 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.9 mptp? 63.31 -156.67 0.33 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.432 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.881 HD11 ' HB3' ' A' ' 77' ' ' LEU . 66.0 tp -97.98 115.81 28.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.102 0.477 . . . . 0.0 110.637 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 51' ' ' ASP . 54.8 t -102.74 133.84 45.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.126 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.412 ' CG2' HG13 ' A' ' 99' ' ' ILE . 42.8 t -100.31 103.38 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.481 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.915 HG21 ' CE1' ' A' ' 11' ' ' PHE . 23.7 t -113.93 126.36 71.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 0.0 111.462 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 74' ' ' THR . 34.6 t70 -99.76 135.19 41.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.662 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.06 ' CE1' HD12 ' A' ' 76' ' ' LEU . 6.6 m-85 -99.39 46.78 0.97 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.705 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.562 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -46.9 141.02 4.29 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.071 0.462 . . . . 0.0 111.755 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.726 ' HB1' ' CE2' ' A' ' 29' ' ' TRP . . . -69.88 133.59 47.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.084 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.7 t -63.67 -20.48 65.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.743 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.726 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 8.4 p-90 -96.28 -126.46 0.14 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.301 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.553 ' H ' ' HE3' ' A' ' 29' ' ' TRP . 51.8 t 48.67 -88.68 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.747 0.419 . . . . 0.0 111.654 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . 150.25 -77.83 0.22 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.675 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.23 -6.77 17.05 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.77 2.313 . . . . 0.0 113.419 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 85.5 m -50.44 -34.38 24.44 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.589 0.233 . . . . 0.0 111.445 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -76.64 -5.06 46.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.62 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.437 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 27.9 ttt -81.04 2.92 24.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.895 0.379 . . . . 0.0 110.676 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.891 HG22 HG13 ' A' ' 40' ' ' ILE . 58.2 mt -86.41 -14.98 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.588 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.57 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -53.76 -42.04 90.59 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 37.7 Cg_endo -70.92 -41.25 2.92 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.638 1.559 . . . . 0.0 111.766 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.479 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 70.5 mtm -63.05 -54.95 30.06 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.891 HG13 HG22 ' A' ' 36' ' ' ILE . 70.5 mt -47.42 -28.01 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.81 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -79.68 -33.12 41.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.168 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.53 -21.98 66.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.703 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.662 ' CE2' HG23 ' A' ' 95' ' ' ILE . 4.2 m-85 -90.05 -18.13 26.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.616 0.246 . . . . 0.0 111.559 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.432 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.6 t -74.3 -6.88 50.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.187 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.402 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 95.0 mt-10 -90.07 -28.08 19.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.839 0.352 . . . . 0.0 111.069 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.51 -27.65 19.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.652 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.745 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 74.6 m-85 -123.53 44.38 0.95 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.529 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 96.0 Cg_exo -39.19 -31.85 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.093 2.529 . . . . 0.0 113.346 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -61.7 -35.68 78.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.863 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -90.01 140.82 29.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.072 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.507 ' O ' HG13 ' A' ' 21' ' ' VAL . 25.7 m-20 -89.83 127.28 35.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.639 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.432 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 4.6 m-85 -102.2 89.0 3.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.006 0.431 . . . . 0.0 111.577 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.505 ' HB2' HG22 ' A' ' 23' ' ' VAL . 39.5 m-85 -98.3 -174.56 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.207 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.611 ' HE3' ' HG2' ' A' ' 4' ' ' GLN . 42.2 mtmt -150.22 137.84 19.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.062 0.458 . . . . 0.0 111.395 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.851 HD13 ' N ' ' A' ' 56' ' ' ASP . 3.1 tm? -91.59 141.35 28.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.662 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.851 ' N ' HD13 ' A' ' 55' ' ' LEU . 54.1 t0 -97.74 112.84 24.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.355 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 83.4 t -77.9 -4.51 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.933 0.397 . . . . 0.0 110.563 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.501 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 38.8 t70 -95.49 -35.0 11.85 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.174 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -102.48 -46.48 4.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.613 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.699 HD11 ' C ' ' A' ' 6' ' ' LYS . 6.1 mp -102.38 35.2 2.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.743 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -51.33 -25.12 11.59 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.411 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.63 -30.01 71.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.685 0.279 . . . . 0.0 111.198 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.715 HG12 ' HE2' ' A' ' 25' ' ' PHE . 11.1 t -74.06 -52.18 21.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.576 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.76 -29.83 41.7 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.991 0.424 . . . . 0.0 110.071 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -90.19 -28.31 18.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.001 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -66.15 -50.67 63.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.015 0.436 . . . . 0.0 109.948 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -79.67 0.43 30.37 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.84 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 62.61 40.61 10.23 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.491 ' O ' HG12 ' A' ' 69' ' ' VAL . 29.2 t -107.72 54.2 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 110.821 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 94.1 p -74.05 -13.29 60.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.018 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.407 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -88.44 62.58 6.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.112 0.482 . . . . 0.0 110.054 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.692 ' CG ' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -89.55 165.59 24.81 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.073 -179.128 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.769 ' HG3' HD11 ' A' ' 36' ' ' ILE . 56.9 Cg_endo -72.59 134.47 34.6 Favored 'Cis proline' 0 C--N 1.353 0.773 0 C-N-CA 123.288 -1.547 . . . . 0.0 112.94 0.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.792 ' OG1' HG23 ' A' ' 88' ' ' VAL . 53.0 m -117.77 154.38 31.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.565 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.982 HD13 HD13 ' A' ' 95' ' ' ILE . 75.9 mt -109.25 115.35 29.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 110.813 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.06 HD12 ' CE1' ' A' ' 25' ' ' PHE . 25.6 mt -109.77 126.72 54.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.889 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.881 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.8 mp -109.66 142.36 40.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.568 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.638 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 54.5 m-85 -141.86 127.01 18.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.984 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.785 ' HG3' HG11 ' A' ' 84' ' ' VAL . 9.5 mtpm? -116.38 132.19 56.74 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.668 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.434 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 74.0 m-20 49.31 68.75 0.67 Allowed 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.38 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.538 ' HA2' ' C ' ' A' ' 15' ' ' ILE . . . 46.55 28.54 3.54 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 116.095 -0.502 . . . . 0.0 113.098 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.638 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 68.2 mttm -136.42 -161.64 1.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.665 ' O ' HG13 ' A' ' 84' ' ' VAL . 30.9 tt0 -109.1 -179.52 3.87 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.785 HG11 ' HG3' ' A' ' 79' ' ' LYS . 5.0 m -162.76 -47.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.626 0.25 . . . . 0.0 111.309 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.13 166.15 13.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.098 0.475 . . . . 0.0 111.827 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.461 ' NZ ' ' HB2' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -141.76 115.42 9.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.522 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.9 t -116.05 85.42 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.13 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.792 HG23 ' OG1' ' A' ' 74' ' ' THR . 5.5 p -61.52 84.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.063 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.83 109.28 1.21 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.529 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.715 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -77.41 59.28 1.84 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.981 0.419 . . . . 0.0 111.075 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.509 ' O ' HG22 ' A' ' 95' ' ' ILE . 45.8 t30 -62.63 133.98 95.08 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.342 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -43.7 -26.38 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.534 2.156 . . . . 0.0 112.803 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.22 53.12 0.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.605 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -167.69 -56.7 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.549 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.982 HD13 HD13 ' A' ' 75' ' ' LEU . 3.1 tp -54.72 -9.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.492 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.451 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 25.3 pttm -92.04 -50.28 5.77 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.919 0.39 . . . . 0.0 110.856 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.451 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 83.8 mt-30 -70.32 -32.24 69.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.782 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.22 -37.25 77.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.217 0.532 . . . . 0.0 110.394 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.663 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.3 mp -90.21 -8.68 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.542 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.745 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.28 -62.52 1.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.941 0.4 . . . . 0.0 110.981 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.07 -28.54 58.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.073 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.643 ' HB3' HD22 ' A' ' 20' ' ' LEU . 3.6 m120 -84.64 -63.12 1.39 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.197 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.585 ' HB2' HD23 ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.056 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 52' ' ' PHE . 12.6 p . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.54 0.21 . . . . 0.0 110.724 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 4' ' ' GLN . 97.3 m -150.08 161.27 42.69 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.147 0.498 . . . . 0.0 112.06 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.644 ' HG2' ' HD2' ' A' ' 54' ' ' LYS . 21.0 mt-30 -92.37 -170.68 2.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.952 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.514 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 15.4 m-85 -134.4 121.46 21.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.114 0.483 . . . . 0.0 111.488 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.625 ' C ' HD11 ' A' ' 60' ' ' LEU . 2.4 mmmp? -109.14 -16.41 14.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.621 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.7 p -139.83 125.38 19.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.374 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.56 -26.11 4.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.525 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 m -58.78 -20.3 48.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.344 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -90.63 -39.09 12.7 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.151 0.5 . . . . 0.0 111.025 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.877 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -84.54 4.16 33.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.22 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -89.88 -31.54 17.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.906 0.384 . . . . 0.0 110.738 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.3 p -89.92 -37.07 14.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.56 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -46.5 -40.38 12.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.499 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.593 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.1 pt -86.8 -50.93 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.353 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.69 97.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 44.52 86.84 0.02 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.231 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 64.2 t0 -169.32 40.78 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.453 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 92.2 mttt 67.66 -156.64 0.21 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.669 0.271 . . . . 0.0 110.614 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.913 HD11 ' HB3' ' A' ' 77' ' ' LEU . 63.9 tp -98.04 114.96 27.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.042 0.449 . . . . 0.0 110.9 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.774 HG22 ' HB2' ' A' ' 51' ' ' ASP . 61.4 t -102.85 132.48 48.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.966 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.525 HG21 ' CG1' ' A' ' 99' ' ' ILE . 41.1 t -102.38 107.58 22.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.68 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.877 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 34.6 t -113.91 126.75 71.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.008 0.433 . . . . 0.0 111.367 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 7.2 t70 -99.87 129.01 45.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.668 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.083 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.9 m-85 -99.08 52.09 0.96 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.124 0.487 . . . . 0.0 110.602 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -57.48 137.41 56.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.961 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.838 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -61.01 143.74 54.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.019 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.55 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 5.2 t -63.04 -13.91 41.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.853 0.359 . . . . 0.0 110.948 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.443 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 11.7 p-90 -110.13 -132.33 0.33 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.644 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 40.8 t 62.2 -79.66 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.581 0.352 . . . . 0.0 111.437 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.71 -78.52 0.37 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.723 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -45.06 -30.55 4.82 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.637 2.225 . . . . 0.0 112.131 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 98.5 m -55.4 -36.88 66.91 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.596 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.12 -17.02 62.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.142 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.597 ' HA ' ' CE ' ' A' ' 35' ' ' MET . 1.7 tpt -76.16 -1.09 24.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.885 0.374 . . . . 0.0 110.68 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.743 HG22 HG13 ' A' ' 40' ' ' ILE . 65.1 mt -87.72 -12.72 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.695 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.565 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -58.41 -41.4 89.09 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 40.9 Cg_endo -71.97 -38.82 3.66 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.636 1.558 . . . . 0.0 111.367 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.433 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 90.1 mtp -62.87 -57.12 11.92 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.743 HG13 HG22 ' A' ' 36' ' ' ILE . 61.2 mt -46.59 -28.52 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.007 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.621 ' HB2' HG11 ' A' ' 2' ' ' VAL . 44.6 tt0 -79.95 -29.38 39.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.603 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 57.2 mtpt -74.58 -15.65 60.83 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.449 ' HB2' ' CE2' ' A' ' 52' ' ' PHE . 4.4 m-85 -90.59 -20.08 22.99 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.439 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 79.3 p -67.59 -9.32 41.79 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 42' ' ' LYS . 12.5 pt-20 -90.02 -26.17 20.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.687 0.279 . . . . 0.0 111.058 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -90.56 -28.53 18.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.383 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.635 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 86.5 m-85 -123.13 46.14 1.28 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.328 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 84.7 Cg_exo -37.63 -38.66 0.64 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.177 2.585 . . . . 0.0 113.501 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.411 ' O ' ' HD3' ' A' ' 19' ' ' LYS . 85.1 mt-30 -59.03 -33.17 70.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.622 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.63 134.6 34.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.853 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.774 ' HB2' HG22 ' A' ' 21' ' ' VAL . 28.0 m-20 -89.66 122.69 33.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.418 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.75 ' O ' HG23 ' A' ' 2' ' ' VAL . 4.1 m-85 -97.33 100.91 12.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.07 0.462 . . . . 0.0 111.445 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.514 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 45.6 m-85 -115.82 -177.29 3.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.363 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.644 ' HD2' ' HG2' ' A' ' 4' ' ' GLN . 29.0 mttm -141.37 157.58 45.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.245 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.776 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.6 tm? -118.39 132.77 56.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.865 0.364 . . . . 0.0 111.033 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.776 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.9 t0 -85.25 114.98 22.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.222 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 26' ' ' TYR . 55.8 t -74.12 -4.63 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.07 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.55 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 62.1 t0 -102.34 -50.89 3.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.048 0.451 . . . . 0.0 110.392 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.535 ' C ' HD12 ' A' ' 60' ' ' LEU . 38.0 tp10 -75.11 -40.66 59.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.659 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.625 HD11 ' C ' ' A' ' 6' ' ' LYS . 4.5 mp -113.44 37.75 3.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.707 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -53.12 -23.77 18.24 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.651 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -66.45 -29.79 70.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.635 0.255 . . . . 0.0 111.223 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.671 HG13 ' HD3' ' A' ' 66' ' ' LYS . 5.5 t -79.87 -27.47 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.051 0.453 . . . . 0.0 110.546 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.29 -26.08 60.93 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -90.17 -34.96 15.64 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.816 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.671 ' HD3' HG13 ' A' ' 63' ' ' VAL . 13.4 ptmm? -60.56 -48.53 81.37 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.073 0.463 . . . . 0.0 110.007 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.421 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.8 m-80 -80.93 -3.67 52.27 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.878 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 63.85 42.67 5.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.292 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.425 ' CG1' HG21 ' A' ' 74' ' ' THR . 55.1 t -103.38 109.23 26.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.754 0.311 . . . . 0.0 111.061 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -138.63 19.24 2.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.728 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 1.07 ' HB3' HG21 ' A' ' 88' ' ' VAL . . . -98.86 34.44 2.08 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.264 0.554 . . . . 0.0 109.918 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.838 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 1.2 pmm? -21.76 119.77 0.14 Allowed Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.519 ' O ' HG23 ' A' ' 88' ' ' VAL . 85.8 Cg_endo -86.42 -163.88 2.83 Favored 'Cis proline' 0 C--N 1.353 0.812 0 C-N-CA 123.81 -1.329 . . . . 0.0 111.899 -0.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 98.6 m -161.91 162.44 29.16 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.987 0.422 . . . . 0.0 111.374 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.994 HD13 HD13 ' A' ' 95' ' ' ILE . 75.8 mt -126.38 121.25 31.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.862 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.083 HD12 ' CE1' ' A' ' 25' ' ' PHE . 26.5 mt -120.05 123.94 44.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.576 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.913 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.5 mp -109.71 146.88 34.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.38 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.524 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 56.3 m-85 -143.77 129.33 19.12 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.193 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HE2' HG23 ' A' ' 84' ' ' VAL . 51.8 mtmt -109.86 129.44 55.64 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.258 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.487 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.3 m120 45.69 63.79 1.68 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.882 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 52.46 22.09 10.22 Favored Glycine 0 N--CA 1.453 -0.218 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.484 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 97.5 mttt -125.55 -156.13 0.71 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 33.7 tt0 -108.7 174.83 5.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.745 HG11 ' CD1' ' A' ' 20' ' ' LEU . 4.3 p -162.19 -59.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 120.881 0.372 . . . . 0.0 111.369 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.667 ' H ' HG13 ' A' ' 84' ' ' VAL . . . -155.76 167.29 30.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.515 ' HG2' HD22 ' A' ' 76' ' ' LEU . 36.5 mtmm -150.5 130.42 13.36 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.414 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.1 t -145.11 90.25 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.407 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.07 HG21 ' HB3' ' A' ' 71' ' ' ALA . 2.8 p -60.71 88.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.757 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.21 101.24 0.57 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.475 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.756 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -75.5 61.16 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.861 0.362 . . . . 0.0 111.071 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.563 ' O ' HG22 ' A' ' 95' ' ' ILE . 17.5 t-20 -76.7 133.33 70.41 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.057 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.519 ' HD2' ' ND2' ' A' ' 91' ' ' ASN . 75.7 Cg_exo -44.02 -24.29 0.84 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.547 2.165 . . . . 0.0 112.843 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.448 ' HA ' ' NZ ' ' A' ' 96' ' ' LYS . . . -95.16 27.65 3.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.356 -0.384 . . . . 0.0 112.022 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -164.21 -53.05 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.994 HD13 HD13 ' A' ' 75' ' ' LEU . 4.5 tp -49.2 -16.94 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 25.6 pttm -92.47 -51.36 5.17 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.966 0.412 . . . . 0.0 111.097 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.476 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 35.3 mt-30 -69.31 -32.04 70.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.879 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.55 -33.95 70.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.17 0.51 . . . . 0.0 110.47 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.886 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.6 mp -90.4 -11.78 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.457 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.635 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.18 -62.92 1.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.806 0.336 . . . . 0.0 111.035 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.78 -27.43 51.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.011 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.619 ' OD1' HD22 ' A' ' 77' ' ' LEU . 3.7 m120 -83.66 -51.84 6.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.859 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.03 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.796 HG12 ' HE3' ' A' ' 54' ' ' LYS . 51.2 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.81 0.338 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 4' ' ' GLN . 51.0 m -150.1 158.86 44.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.019 0.438 . . . . 0.0 111.504 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.612 ' HG2' ' NZ ' ' A' ' 54' ' ' LYS . 48.7 mt-30 -89.98 166.27 13.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.128 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.556 ' O ' HD13 ' A' ' 60' ' ' LEU . 12.9 m-30 -114.4 120.26 39.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.926 0.393 . . . . 0.0 110.488 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.576 ' C ' HD11 ' A' ' 60' ' ' LEU . 2.1 tppt? -97.51 -41.44 8.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.798 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -123.12 139.46 54.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.69 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.18 -24.68 43.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.4 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.5 m -63.1 -15.81 57.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.607 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -90.15 -46.69 8.29 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.158 0.504 . . . . 0.0 110.967 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.902 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -75.39 -35.41 61.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.615 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -52.36 -31.3 33.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.057 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 t -90.05 -26.22 20.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.653 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -55.27 -52.0 64.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.438 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.4 pt -73.77 -48.88 37.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.334 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.466 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -41.48 95.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 45.73 92.06 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.217 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -174.7 39.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.315 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.559 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 11.0 mptt 64.97 -155.61 0.29 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.243 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.903 HD11 ' HB3' ' A' ' 77' ' ' LEU . 65.1 tp -98.04 115.57 28.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.015 0.436 . . . . 0.0 111.006 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.765 HG22 ' HB2' ' A' ' 51' ' ' ASP . 49.4 t -101.26 133.48 44.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.807 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.622 HG21 ' CD1' ' A' ' 99' ' ' ILE . 48.1 t -99.78 91.44 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.586 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.902 HG21 ' CE1' ' A' ' 11' ' ' PHE . 22.3 t -100.67 123.34 53.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.904 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 7.7 t70 -99.98 133.25 44.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.095 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.019 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.6 m-85 -99.25 54.41 0.97 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.161 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.594 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -54.19 146.48 15.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.712 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . . . -63.54 146.32 53.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.896 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.519 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 2.4 t -77.32 -1.16 28.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.723 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -125.38 -33.87 2.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 30.8 t -46.96 159.19 0.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.93 -64.09 0.71 Allowed Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.297 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.7 -24.3 4.58 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.869 2.379 . . . . 0.0 113.305 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 86.8 m -58.03 -54.98 40.76 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -51.83 -28.21 15.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.687 0.279 . . . . 0.0 111.74 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.8 tpp -75.09 1.25 13.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.886 0.374 . . . . 0.0 110.72 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.868 HG22 HG13 ' A' ' 40' ' ' ILE . 61.9 mt -87.12 -18.77 8.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.705 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.563 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -51.99 -43.51 89.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 38.4 Cg_endo -71.18 -39.17 4.16 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.724 1.616 . . . . 0.0 111.611 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.463 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 1.2 mpt? -63.24 -56.23 18.3 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.868 HG13 HG22 ' A' ' 36' ' ' ILE . 56.8 mt -44.02 -28.58 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.687 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.5 ' N ' HG21 ' A' ' 2' ' ' VAL . 43.7 tt0 -81.04 -41.35 22.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.852 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.32 -31.84 69.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.175 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.463 ' HD1' ' O ' ' A' ' 39' ' ' MET . 11.0 m-85 -74.43 -17.17 60.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.251 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.7 t -70.92 -10.41 59.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.151 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -87.05 -24.59 24.56 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.697 0.284 . . . . 0.0 111.007 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -90.44 -34.73 15.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.585 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.579 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 67.7 m-85 -122.95 43.33 0.74 Allowed Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.706 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 95.3 Cg_exo -39.38 -31.99 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.934 2.423 . . . . 0.0 113.201 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -61.06 -37.54 83.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.834 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.754 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.85 148.84 22.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.01 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.765 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.77 148.94 22.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.64 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -125.44 85.93 2.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.425 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.47 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 45.5 m-85 -99.12 -176.02 3.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.574 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.806 ' HD3' HD12 ' A' ' 40' ' ' ILE . 9.8 mtmp? -146.43 133.84 20.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.98 0.419 . . . . 0.0 111.104 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.812 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.9 tm? -89.77 139.05 30.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.999 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.812 ' N ' HD13 ' A' ' 55' ' ' LEU . 61.8 t0 -95.17 101.49 13.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.467 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 71.7 t -68.23 -12.72 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 0.0 110.466 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.519 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 61.8 t0 -86.74 -31.27 21.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.44 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -103.16 -51.98 3.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.237 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.668 HD22 ' CD2' ' A' ' 55' ' ' LEU . 5.5 mp -93.62 51.86 1.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.895 0.378 . . . . 0.0 111.06 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.11 -19.86 47.32 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.501 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.95 -29.27 61.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.618 0.246 . . . . 0.0 111.38 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.72 HG12 ' HE2' ' A' ' 25' ' ' PHE . 5.5 t -78.45 -48.1 23.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.362 . . . . 0.0 110.343 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.41 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -56.31 -24.93 46.65 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -90.37 -38.84 13.06 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.025 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -60.99 -41.74 97.04 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.933 0.397 . . . . 0.0 110.241 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -85.31 0.6 51.51 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.736 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 61.35 39.86 14.86 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.46 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.672 ' CG1' HG21 ' A' ' 74' ' ' THR . 46.1 t -109.69 107.12 22.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.848 0.356 . . . . 0.0 111.054 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 84.3 p -124.0 20.91 9.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.032 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.542 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -73.02 -149.13 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.741 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 72' ' ' MET . 18.3 ptt? -175.88 84.73 0.29 Allowed Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.674 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 6.9 Cg_endo -95.76 -156.28 0.44 Allowed 'Cis proline' 0 CA--C 1.534 0.509 0 C-N-CA 125.217 -0.743 . . . . 0.0 112.834 -0.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.719 HG23 ' HA ' ' A' ' 88' ' ' VAL . 91.6 m -150.68 146.77 26.68 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.362 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.02 HD13 HD13 ' A' ' 95' ' ' ILE . 77.3 mt -112.35 122.08 46.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.785 0.326 . . . . 0.0 111.382 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.019 HD12 ' CE1' ' A' ' 25' ' ' PHE . 27.9 mt -120.82 128.13 52.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.656 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.903 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.7 mp -109.9 145.36 36.98 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.66 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.582 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 54.8 m-85 -146.52 127.45 14.51 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.262 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.817 ' HG3' HG11 ' A' ' 84' ' ' VAL . 9.8 mtpm? -115.19 135.92 53.66 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.638 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.479 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.2 m120 48.59 59.94 4.01 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.641 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 52.37 23.02 11.78 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.022 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.582 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 52.1 mtmt -126.91 -158.48 0.87 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.713 ' O ' HG13 ' A' ' 84' ' ' VAL . 82.0 tt0 -108.97 178.41 4.48 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.817 HG11 ' HG3' ' A' ' 79' ' ' LYS . 4.3 m -164.54 -47.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.533 0.206 . . . . 0.0 111.251 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -169.98 154.37 5.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.038 0.447 . . . . 0.0 111.845 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -137.8 113.93 10.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.409 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.427 HG11 ' HB3' ' A' ' 94' ' ' ALA . 48.3 t -121.82 81.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.067 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.719 ' HA ' HG23 ' A' ' 74' ' ' THR . 7.4 p -50.27 94.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.18 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.04 131.35 3.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.254 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.577 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -95.6 35.86 1.32 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.919 0.39 . . . . 0.0 111.133 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 93' ' ' ALA . 47.2 t-20 -59.04 108.04 1.19 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.97 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 19.5 Cg_exo -33.02 90.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.138 2.559 . . . . 0.0 113.113 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.488 ' O ' ' NE2' ' A' ' 97' ' ' GLN . . . 172.97 -30.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.122 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.427 ' HB3' HG11 ' A' ' 87' ' ' VAL . . . -123.99 -44.32 2.06 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.02 HD13 HD13 ' A' ' 75' ' ' LEU . 4.6 tp -49.35 -19.07 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.738 0.304 . . . . 0.0 111.179 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -91.2 -66.17 0.95 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.981 0.419 . . . . 0.0 111.22 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 4.5 mp0 -60.79 -34.41 74.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.964 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.88 -31.29 68.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.06 0.457 . . . . 0.0 110.702 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.622 ' CD1' HG21 ' A' ' 22' ' ' VAL . 66.6 mt -90.25 -10.75 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.373 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.579 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.44 -68.68 0.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.839 0.352 . . . . 0.0 111.4 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.87 -28.21 34.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.367 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.683 ' HB3' HD22 ' A' ' 20' ' ' LEU . 3.6 m120 -83.48 -48.21 10.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.106 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.135 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.419 ' CG2' HG22 ' A' ' 40' ' ' ILE . 41.5 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.711 0.291 . . . . 0.0 110.99 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.1 m -150.08 147.47 27.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.095 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.507 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 24.1 mt-30 -89.94 -176.9 5.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.39 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.51 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.9 m-85 -134.73 135.97 42.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.024 0.44 . . . . 0.0 111.375 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.707 ' C ' HD11 ' A' ' 60' ' ' LEU . 34.5 mmtp -112.92 -33.76 5.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.536 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 8' ' ' ALA . 11.9 m -124.54 165.55 17.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.401 ' N ' HG22 ' A' ' 7' ' ' THR . . . -77.48 -29.82 52.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.77 0.319 . . . . 0.0 111.068 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.4 t -59.35 -16.42 22.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.791 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -90.09 -58.32 2.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.299 0.571 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.866 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -66.42 -28.42 68.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.64 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -59.04 -42.73 90.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.817 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.5 m -79.23 -29.95 42.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.462 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -57.78 -32.4 67.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.194 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.8 pt -90.0 -49.15 13.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.275 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.486 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -42.95 101.9 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.1 mt-30 43.78 86.1 0.02 OUTLIER 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.211 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -166.24 39.26 0.05 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.62 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.56 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER 65.37 -153.29 0.27 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.729 0.299 . . . . 0.0 110.364 179.063 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.882 HD11 ' HB3' ' A' ' 77' ' ' LEU . 54.6 tp -97.7 114.18 26.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.06 0.457 . . . . 0.0 110.928 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.637 HG22 ' HB2' ' A' ' 51' ' ' ASP . 52.3 t -103.28 120.17 52.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.726 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.741 HG21 HG12 ' A' ' 99' ' ' ILE . 48.1 t -99.83 98.31 6.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.622 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.866 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 44.1 t -99.74 145.45 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.167 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.458 ' HA ' ' O ' ' A' ' 74' ' ' THR . 37.4 t70 -106.97 126.06 51.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.597 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.062 ' CE1' HD12 ' A' ' 76' ' ' LEU . 7.4 m-85 -98.88 50.42 0.96 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.152 0.501 . . . . 0.0 110.308 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.53 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -53.15 139.25 29.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.529 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.732 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -63.13 149.16 45.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.572 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.514 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.4 t -74.53 -11.91 60.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.79 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.538 ' O ' ' C ' ' A' ' 30' ' ' CYS . 5.4 p-90 -112.18 -60.39 1.87 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.538 ' C ' ' O ' ' A' ' 29' ' ' TRP . 50.6 t 4.07 -80.95 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.431 0.692 . . . . 0.0 112.774 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.14 -78.48 0.35 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.582 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.02 -15.71 43.82 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.574 2.183 . . . . 0.0 112.567 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 31.9 p -52.9 -26.7 15.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.138 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -75.79 -16.84 60.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.553 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 35' ' ' MET . 48.0 ttm -74.17 2.07 9.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.038 0.447 . . . . 0.0 110.779 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.017 HG22 HG13 ' A' ' 40' ' ' ILE . 55.6 mt -83.74 -25.83 7.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.639 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.524 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -45.9 -45.02 36.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 40.4 Cg_endo -72.32 -37.69 4.23 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 121.694 1.596 . . . . 0.0 111.096 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.434 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 88.8 mtp -64.11 -54.9 26.66 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.017 HG13 HG22 ' A' ' 36' ' ' ILE . 67.2 mt -46.79 -27.62 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.703 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -81.19 -34.05 32.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.336 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -67.0 -22.74 65.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.739 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.435 ' CB ' ' CE2' ' A' ' 52' ' ' PHE . 5.9 m-85 -84.75 -21.91 29.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.716 0.294 . . . . 0.0 111.597 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.2 m -68.65 -12.06 60.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.015 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 39.4 tt0 -88.63 -23.81 22.97 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.826 0.346 . . . . 0.0 110.541 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -90.43 -38.23 13.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.371 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.536 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 60.5 m-85 -123.92 43.87 0.9 Allowed Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 89.6 Cg_exo -38.59 -29.03 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.046 2.497 . . . . 0.0 113.014 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.474 ' OE1' ' N ' ' A' ' 49' ' ' GLN . 0.3 OUTLIER -57.17 -37.8 72.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.692 179.548 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.777 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.86 152.93 21.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.137 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.637 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -97.66 123.31 41.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.751 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.435 ' CE2' ' CB ' ' A' ' 43' ' ' PHE . 4.1 m-85 -100.93 104.43 15.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.111 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.63 ' HB2' HG22 ' A' ' 23' ' ' VAL . 46.5 m-85 -113.89 -178.81 3.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.212 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 32.9 mtpt -137.62 142.92 41.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.212 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.872 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.7 tm? -107.82 138.54 43.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.803 0.335 . . . . 0.0 110.733 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.872 ' N ' HD13 ' A' ' 55' ' ' LEU . 26.4 t70 -93.03 113.39 25.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.909 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 52.6 t -73.5 -6.12 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.411 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.514 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 38.6 t70 -97.6 -46.39 6.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.085 0.469 . . . . 0.0 110.613 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.658 ' C ' HD12 ' A' ' 60' ' ' LEU . 38.2 tp10 -83.72 -32.54 25.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.101 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.707 HD11 ' C ' ' A' ' 6' ' ' LYS . 3.6 mp -119.72 59.92 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.905 0.383 . . . . 0.0 110.929 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.21 -8.07 64.65 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.708 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -83.91 -28.31 27.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.674 0.273 . . . . 0.0 111.448 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.654 HG13 ' HD3' ' A' ' 66' ' ' LYS . 7.3 t -78.01 -45.28 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.869 0.366 . . . . 0.0 110.544 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.22 -24.92 45.33 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -90.45 -40.2 12.16 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.299 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.654 ' HD3' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -57.86 -48.92 78.4 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.892 0.377 . . . . 0.0 110.458 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 33.7 m120 -78.14 -3.79 44.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.963 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 66.55 40.42 3.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.225 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.876 HG13 HG21 ' A' ' 74' ' ' THR . 58.0 t -83.45 -77.39 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 120.761 0.315 . . . . 0.0 110.869 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.7 p 47.91 25.45 0.76 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.756 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.9 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -98.91 -159.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.732 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -172.74 90.4 0.4 Allowed Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.798 ' HG3' HD11 ' A' ' 36' ' ' ILE . 22.5 Cg_endo -91.99 -160.41 1.07 Allowed 'Cis proline' 0 C--N 1.349 0.577 0 C-N-CA 124.625 -0.99 . . . . 0.0 112.42 -0.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.9 ' OG1' ' HB3' ' A' ' 71' ' ' ALA . 98.5 m -156.31 155.49 32.35 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.849 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 95' ' ' ILE . 72.6 mt -120.22 121.38 38.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.935 0.398 . . . . 0.0 111.288 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.062 HD12 ' CE1' ' A' ' 25' ' ' PHE . 20.1 mt -118.99 128.57 54.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.875 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.882 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.3 mp -109.7 138.31 46.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.723 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.562 ' HA ' HG23 ' A' ' 84' ' ' VAL . 73.7 m-85 -137.51 126.91 24.87 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.542 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.468 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 59.5 mttm -109.84 128.71 55.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.728 0.299 . . . . 0.0 111.275 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 6.0 m120 44.27 58.04 3.98 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 61.64 13.55 39.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.372 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 30.8 mmmt -111.71 -156.81 0.6 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.486 ' OE2' ' CE1' ' A' ' 78' ' ' PHE . 10.9 tp10 -108.78 173.82 6.15 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.562 HG23 ' HA ' ' A' ' 78' ' ' PHE . 56.8 t -146.64 -62.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.748 0.309 . . . . 0.0 111.317 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.13 159.26 7.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.357 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -122.29 115.44 22.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.611 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.57 80.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.473 HG21 ' CB ' ' A' ' 71' ' ' ALA . 2.7 p -57.18 95.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.017 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.6 114.27 1.27 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.611 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.677 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -98.66 33.85 2.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 110.908 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 93' ' ' ALA . 47.5 t-20 -62.07 108.58 1.67 Allowed Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.968 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 17.8 Cg_exo -31.91 88.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.229 2.62 . . . . 0.0 113.216 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 176.17 -35.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.85 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.62 -43.33 2.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.577 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.977 HD13 HD13 ' A' ' 75' ' ' LEU . 4.6 tp -53.26 -15.53 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.704 -0.226 . . . . 0.0 111.277 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.437 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 64.5 pttt -91.2 -49.25 6.48 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.78 0.324 . . . . 0.0 110.642 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.437 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 72.7 mt-30 -71.85 -32.15 67.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.366 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.24 -31.53 71.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.441 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.798 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 56.5 mt -90.08 -6.57 10.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.305 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.38 -65.29 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.921 0.391 . . . . 0.0 111.036 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.82 -29.78 8.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.944 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.816 ' CB ' HD22 ' A' ' 20' ' ' LEU . 67.5 m-20 -90.07 -67.79 0.82 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.948 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.798 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.126 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.43 ' CG1' ' HD2' ' A' ' 54' ' ' LYS . 44.1 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.775 0.321 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.477 HG22 ' N ' ' A' ' 4' ' ' GLN . 87.5 m -149.95 164.84 34.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.864 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.527 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -105.61 -177.35 3.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.339 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.481 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.9 m-85 -130.33 131.43 45.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.984 0.421 . . . . 0.0 111.483 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.706 ' C ' HD11 ' A' ' 60' ' ' LEU . 34.5 mmtp -114.49 -19.74 11.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.774 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -141.23 136.96 32.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.466 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.07 -28.42 17.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.242 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.9 m -59.32 -19.83 49.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.244 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.452 ' HG3' ' CE1' ' A' ' 5' ' ' PHE . 17.6 tp10 -90.49 -37.93 13.57 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.334 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.942 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -90.2 15.83 9.64 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.06 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -89.79 -45.98 8.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.875 0.369 . . . . 0.0 110.662 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -79.6 -23.36 42.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.97 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.535 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -54.83 -50.48 68.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.205 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.7 pt -83.12 -50.02 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.334 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.457 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -40.06 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 79.9 mt-30 39.19 85.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.662 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 9.1 t70 -162.49 40.52 0.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.668 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 10.9 mptt 67.2 -156.52 0.22 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.458 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.787 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 64.3 tp -98.18 116.42 30.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.203 0.525 . . . . 0.0 110.977 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.801 HG22 ' HB2' ' A' ' 51' ' ' ASP . 54.9 t -103.12 134.69 43.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.748 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.516 HG21 ' CD1' ' A' ' 99' ' ' ILE . 49.2 t -99.7 92.32 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.65 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.942 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 48.0 t -99.83 124.34 53.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.044 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 8.1 t70 -99.98 129.17 46.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.921 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.052 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.7 m-85 -98.99 48.57 0.96 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.185 0.516 . . . . 0.0 110.348 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.547 ' O ' ' HD1' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -50.14 134.55 22.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.139 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.507 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -60.72 153.04 25.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.196 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.428 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 3.3 t -76.89 2.25 15.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.514 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.452 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 5.4 p-90 -127.35 -125.3 0.23 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.746 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 48.8 t 62.49 -77.58 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.931 0.492 . . . . 0.0 111.421 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.11 -80.18 0.27 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.979 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.26 51.0 3.33 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.744 2.296 . . . . 0.0 112.523 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 99.5 m -112.5 -28.25 7.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.734 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -79.94 -15.9 56.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.495 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 66.1 mtt -74.7 4.16 6.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.764 0.316 . . . . 0.0 111.102 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.007 HG22 HG13 ' A' ' 40' ' ' ILE . 52.7 mt -83.53 -26.27 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.534 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.513 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -45.67 -45.39 34.74 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 44.1 Cg_endo -73.1 -36.36 4.36 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.773 1.649 . . . . 0.0 111.268 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 49.6 ttm -65.24 -53.11 49.21 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.007 HG13 HG22 ' A' ' 36' ' ' ILE . 79.0 mt -46.91 -30.44 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.593 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -76.79 -37.01 56.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.938 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.97 -22.74 62.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.367 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -90.1 -16.48 29.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.488 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.4 t -74.84 -6.88 51.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.236 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 44.7 tt0 -90.12 -27.94 19.3 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.785 0.326 . . . . 0.0 111.052 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -90.47 -28.33 18.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.723 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.848 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 76.0 m-85 -123.14 43.93 0.85 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.698 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 98.5 Cg_exo -39.76 -31.62 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.977 2.451 . . . . 0.0 113.098 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -62.26 -37.82 86.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.941 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.787 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.88 147.75 23.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.172 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.801 ' HB2' HG22 ' A' ' 21' ' ' VAL . 28.9 m-20 -89.84 153.67 20.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.54 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.487 ' CE2' HD13 ' A' ' 99' ' ' ILE . 6.0 m-85 -128.55 93.88 3.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.025 0.44 . . . . 0.0 111.479 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.481 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 49.6 m-85 -107.44 178.59 4.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.596 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HB2' ' HA ' ' A' ' 4' ' ' GLN . 16.5 mtpp -139.09 146.92 41.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.51 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.9 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.8 tm? -108.19 140.9 40.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.072 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.9 ' N ' HD13 ' A' ' 55' ' ' LEU . 27.8 t70 -95.43 116.04 28.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.55 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 57' ' ' VAL . 60.6 t -76.88 -1.85 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.649 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 8.1 t70 -103.5 -43.57 5.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.024 0.44 . . . . 0.0 110.575 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.492 ' C ' HD12 ' A' ' 60' ' ' LEU . 38.5 tp10 -86.12 -39.69 16.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.022 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.706 HD11 ' C ' ' A' ' 6' ' ' LYS . 4.8 mp -111.4 44.01 1.4 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.849 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.15 -28.02 53.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.379 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.51 -29.1 70.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.739 0.304 . . . . 0.0 111.158 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.705 HG12 ' HE2' ' A' ' 25' ' ' PHE . 6.8 t -79.3 -45.42 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.438 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.36 -22.85 55.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.409 . . . . 0.0 110.058 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -90.16 -38.13 13.71 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.205 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.705 ' HE3' HG13 ' A' ' 63' ' ' VAL . 15.6 pttp -60.89 -47.1 87.93 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.972 0.415 . . . . 0.0 110.084 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.401 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.6 m-20 -77.93 -4.44 46.89 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.917 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 66.94 39.51 3.27 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.034 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.709 ' CG1' HG21 ' A' ' 74' ' ' THR . 45.3 t -110.18 107.71 23.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.756 0.313 . . . . 0.0 110.97 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.5 t -121.87 -1.82 9.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.779 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.645 ' CB ' HG21 ' A' ' 88' ' ' VAL . . . -61.01 -157.75 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.575 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -175.26 100.92 0.26 Allowed Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.79 ' HG3' HD11 ' A' ' 36' ' ' ILE . 32.6 Cg_endo -88.54 -162.06 1.92 Allowed 'Cis proline' 0 C--N 1.353 0.795 0 C-N-CA 124.701 -0.958 . . . . 0.0 112.669 -0.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.777 ' OG1' HG23 ' A' ' 88' ' ' VAL . 42.8 m -158.58 146.86 18.41 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.098 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.029 HD13 HD13 ' A' ' 95' ' ' ILE . 84.3 mt -113.97 123.04 48.75 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.804 0.335 . . . . 0.0 111.701 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.052 HD12 ' CE1' ' A' ' 25' ' ' PHE . 18.2 mt -116.94 129.87 56.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.493 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.704 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.9 mp -109.78 142.01 41.62 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.719 0.295 . . . . 0.0 111.017 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.578 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 63.8 m-85 -143.71 126.58 16.26 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.274 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.825 ' HG3' HG11 ' A' ' 84' ' ' VAL . 41.6 mtmt -118.91 136.76 53.89 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.379 178.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 78.3 m-20 50.81 60.92 3.52 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.569 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 50.04 26.19 8.5 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.849 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.578 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 98.9 mttt -132.34 -159.55 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.69 ' O ' HG13 ' A' ' 84' ' ' VAL . 28.7 tt0 -109.05 -179.75 3.94 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.825 HG11 ' HG3' ' A' ' 79' ' ' LYS . 12.2 m -163.75 -49.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.588 0.232 . . . . 0.0 111.217 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.462 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -165.14 156.54 14.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.054 0.454 . . . . 0.0 111.726 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -138.81 113.63 9.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.33 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.63 91.1 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.075 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.777 HG23 ' OG1' ' A' ' 74' ' ' THR . 7.2 p -61.66 83.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.983 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.7 113.17 0.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.236 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.646 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -95.36 37.76 1.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.355 . . . . 0.0 111.387 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 93' ' ' ALA . 5.5 m120 -73.69 131.88 81.51 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.325 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 98.7 Cg_exo -46.7 86.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.674 2.249 . . . . 0.0 112.665 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 92' ' ' PRO . . . 174.35 -35.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.425 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.39 -46.55 2.87 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.781 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.029 HD13 HD13 ' A' ' 75' ' ' LEU . 4.9 tp -53.45 -14.8 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.526 0.203 . . . . 0.0 111.278 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.415 ' HG3' ' HG3' ' A' ' 97' ' ' GLN . 21.3 ptmt -91.03 -49.52 6.37 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.883 0.373 . . . . 0.0 110.864 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.415 ' HG3' ' HG3' ' A' ' 96' ' ' LYS . 73.0 mt-30 -73.13 -32.38 64.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.447 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.454 ' HB1' HD21 ' A' ' 77' ' ' LEU . . . -61.33 -30.27 70.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.681 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.516 ' CD1' HG21 ' A' ' 22' ' ' VAL . 67.6 mt -90.19 -14.91 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.25 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.848 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.38 -70.51 0.67 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.84 0.352 . . . . 0.0 111.182 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.69 -28.69 6.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.272 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.572 ' HB3' HD22 ' A' ' 20' ' ' LEU . 5.7 m120 -83.18 -48.3 10.67 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.061 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.121 -179.953 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.851 HG12 ' HE2' ' A' ' 54' ' ' LYS . 47.4 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.838 0.351 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.8 m -147.89 154.49 40.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.03 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.565 ' HG2' ' HE3' ' A' ' 54' ' ' LYS . 61.3 mt-30 -93.74 177.25 6.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.624 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.525 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 14.4 m-85 -127.98 136.17 50.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.0 111.241 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 34.4 mmtp -115.95 -46.34 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.513 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.1 p -114.81 134.11 55.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.534 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.09 -24.68 18.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.431 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.2 m -62.37 -16.58 55.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.556 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -90.21 -58.01 2.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.347 0.594 . . . . 0.0 111.076 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.913 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -61.28 -31.47 71.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.667 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -55.54 -23.32 25.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.1 t -80.37 -45.99 16.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.191 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.96 -46.52 68.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.29 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.853 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 24.1 pt -78.16 -4.63 6.88 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.833 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.901 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.18 81.82 6.1 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.682 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 74.9 mt-30 48.14 91.76 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 63.9 t0 -168.91 39.62 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.533 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 88.0 mttt 76.12 -156.83 0.04 OUTLIER 'General case' 0 C--O 1.23 0.065 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.564 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.895 HD11 ' HB3' ' A' ' 77' ' ' LEU . 59.7 tp -98.07 116.95 31.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.216 0.531 . . . . 0.0 110.79 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.767 HG22 ' HB2' ' A' ' 51' ' ' ASP . 60.6 t -102.89 124.22 56.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.801 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.646 HG21 ' CD1' ' A' ' 99' ' ' ILE . 46.0 t -99.79 97.88 6.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.665 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.913 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 40.2 t -105.12 131.04 55.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.424 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 7.8 t70 -99.87 130.67 46.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.453 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.056 ' CE1' HD12 ' A' ' 76' ' ' LEU . 6.3 m-85 -99.06 49.48 0.95 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.975 0.417 . . . . 0.0 110.69 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.586 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -51.05 140.74 15.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.067 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.775 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -62.27 157.35 19.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.754 0.311 . . . . 0.0 110.505 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.545 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 5.0 t -83.58 4.12 29.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.406 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.449 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 18.2 p-90 -124.64 -46.6 1.87 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.431 ' HB2' ' HG3' ' A' ' 72' ' ' MET . 22.3 t -43.96 127.97 5.5 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 111.414 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . -76.41 -64.14 2.23 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.98 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -41.5 -28.26 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.389 2.726 . . . . 0.0 113.176 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.9 m -61.5 -14.57 30.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.429 ' C ' ' HD2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -78.8 -25.85 44.29 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.163 -179.497 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.458 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 66.0 mtm -75.39 1.52 13.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 110.301 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.856 HG22 HG13 ' A' ' 40' ' ' ILE . 28.1 mm -79.2 -44.37 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.873 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.499 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -41.7 -47.16 9.61 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.04 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 45.6 Cg_endo -73.91 -27.77 11.91 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.79 1.66 . . . . 0.0 111.233 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.406 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 14.2 tpt -74.16 -50.02 21.16 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.856 HG13 HG22 ' A' ' 36' ' ' ILE . 63.8 mt -50.96 -32.72 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.389 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -72.37 -39.56 67.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.113 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.465 ' HB3' ' NZ ' ' A' ' 42' ' ' LYS . 9.6 mtpm? -57.88 -23.94 55.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.712 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.75 ' CE2' HG23 ' A' ' 95' ' ' ILE . 6.0 m-85 -90.43 -16.88 28.18 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.1 t -72.95 -7.66 52.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.523 0.201 . . . . 0.0 111.456 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -90.15 -26.53 20.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.757 0.313 . . . . 0.0 111.081 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.07 -30.07 17.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.531 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.581 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 79.6 m-85 -125.44 51.86 5.97 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.088 0.47 . . . . 0.0 110.745 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 1.4 Cg_endo -46.79 -26.5 4.68 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.085 2.523 . . . . 0.0 112.987 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.444 ' O ' ' HD3' ' A' ' 19' ' ' LYS . 73.8 mt-30 -69.04 -29.24 67.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.122 0.487 . . . . 0.0 110.394 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.58 139.06 30.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.781 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.767 ' HB2' HG22 ' A' ' 21' ' ' VAL . 28.2 m-20 -89.56 121.69 32.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.268 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.518 ' CE2' HD13 ' A' ' 99' ' ' ILE . 6.2 m-85 -99.02 81.77 2.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.596 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.654 ' HB2' HG22 ' A' ' 23' ' ' VAL . 47.4 m-85 -94.47 -175.12 3.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.357 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.851 ' HE2' HG12 ' A' ' 2' ' ' VAL . 47.0 mtmt -148.47 138.2 22.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.994 0.426 . . . . 0.0 110.75 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.926 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.2 tm? -98.35 141.95 30.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.325 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.926 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.9 t70 -92.74 125.09 37.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.949 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.742 ' O ' HG12 ' A' ' 57' ' ' VAL . 92.1 t -93.14 42.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.436 0.636 . . . . 0.0 110.621 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.545 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 64.5 t0 -152.97 -48.78 0.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.035 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 6' ' ' LYS . 5.3 tp10 -75.56 -27.35 58.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.171 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.578 HD22 ' N ' ' A' ' 60' ' ' LEU . 2.5 mm? -103.16 -64.43 1.08 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.376 0.608 . . . . 0.0 111.007 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.5 -61.25 0.64 Allowed Glycine 0 C--N 1.314 -0.658 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.644 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -51.17 -36.79 42.85 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.788 HG12 ' HE2' ' A' ' 25' ' ' PHE . 6.6 t -70.51 -58.25 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 110.589 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.49 -24.84 8.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.002 0.43 . . . . 0.0 110.074 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -90.14 -37.49 14.17 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.259 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.785 ' HE3' HG13 ' A' ' 63' ' ' VAL . 17.4 pttp -60.71 -48.77 80.28 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.1 m-20 -76.71 -7.72 55.88 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.676 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 66.09 43.53 2.88 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.24 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.479 ' CG1' HG21 ' A' ' 74' ' ' THR . 49.0 t -107.37 74.6 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.885 0.374 . . . . 0.0 111.011 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.9 p -83.38 -11.32 57.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.996 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.512 ' CB ' HG21 ' A' ' 88' ' ' VAL . . . -58.14 -163.73 0.0 OUTLIER 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.728 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.775 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -178.1 106.64 0.21 Allowed Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 42.8 Cg_endo -89.72 -165.35 2.64 Favored 'Cis proline' 0 C--N 1.351 0.687 0 C-N-CA 124.485 -1.048 . . . . 0.0 112.612 -0.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 91.7 m -152.59 163.24 39.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.811 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.984 HD13 HD13 ' A' ' 95' ' ' ILE . 80.9 mt -128.02 120.73 28.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.098 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.056 HD12 ' CE1' ' A' ' 25' ' ' PHE . 21.8 mt -118.93 124.11 46.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.758 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.895 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.3 mp -109.82 135.4 50.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.692 ' HA ' HG23 ' A' ' 84' ' ' VAL . 42.4 m-85 -136.05 129.05 31.37 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.602 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.666 ' HG3' HD13 ' A' ' 20' ' ' LEU . 9.2 mtpm? -114.65 124.04 50.83 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.99 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 6.4 m120 43.9 82.46 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.652 0.263 . . . . 0.0 111.213 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.853 ' HA2' ' O ' ' A' ' 15' ' ' ILE . . . 33.83 46.77 0.45 Allowed Glycine 0 C--N 1.333 0.38 0 CA-C-N 116.024 -0.535 . . . . 0.0 114.202 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 34.5 mmtp -146.97 -158.73 0.94 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 34.0 tt0 -108.69 174.01 6.06 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.692 HG23 ' HA ' ' A' ' 78' ' ' PHE . 59.2 t -145.08 -69.08 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 0.0 111.107 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.25 155.32 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.377 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -112.65 138.26 49.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.069 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -154.6 78.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.141 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 2.5 p -58.73 90.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.093 0.473 . . . . 0.0 110.611 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 136.35 124.3 2.35 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.08 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.741 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -87.85 47.37 1.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.871 0.367 . . . . 0.0 111.468 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 94' ' ' ALA . 46.2 t-20 -53.35 110.02 1.8 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -33.2 -31.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.167 2.578 . . . . 0.0 113.64 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -95.49 30.49 2.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.445 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -152.34 -60.13 0.15 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.984 HD13 HD13 ' A' ' 75' ' ' LEU . 4.3 tp -51.91 -11.97 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.338 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.446 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 64.8 pttt -91.13 -51.09 5.49 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.843 0.354 . . . . 0.0 110.669 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.446 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 9.7 mm-40 -69.52 -32.02 70.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.51 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.78 -32.15 73.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.613 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.646 ' CD1' HG21 ' A' ' 22' ' ' VAL . 50.5 mt -90.14 -7.92 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.488 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.581 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.09 -68.62 0.77 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.924 0.393 . . . . 0.0 111.259 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.67 -29.14 51.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.132 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.552 ' CB ' HD22 ' A' ' 20' ' ' LEU . 3.9 m120 -80.39 -52.5 7.6 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.037 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.071 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.533 HG11 ' CG2' ' A' ' 40' ' ' ILE . 55.0 t . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.763 0.316 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 4' ' ' GLN . 90.1 m -150.2 162.1 41.13 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.173 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.581 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -100.28 -177.68 3.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 179.593 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.511 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 23.8 m-85 -124.79 150.59 46.17 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.03 0.443 . . . . 0.0 111.671 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.687 ' C ' HD11 ' A' ' 60' ' ' LEU . 72.7 mmtt -128.52 -37.21 1.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.974 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 m -116.65 164.0 15.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 12' ' ' ASP . . . -76.13 -27.85 57.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.993 0.425 . . . . 0.0 110.933 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.2 m -64.13 -12.58 41.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.969 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -89.98 -69.35 0.73 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.226 0.536 . . . . 0.0 111.401 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.965 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -56.9 -25.88 57.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.085 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 64.2 t0 -56.38 -42.71 78.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.23 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -82.06 -24.81 35.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.321 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.679 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -56.83 -46.09 81.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.476 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.8 pt -80.21 -49.59 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.46 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.466 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -43.55 98.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 45.58 90.49 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.223 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -171.42 39.5 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.267 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.554 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.7 mptp? 63.54 -154.98 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.233 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.788 HD11 ' HB3' ' A' ' 77' ' ' LEU . 43.7 tp -98.05 115.99 29.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.135 0.493 . . . . 0.0 110.848 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.816 HG22 ' HB2' ' A' ' 51' ' ' ASP . 48.2 t -103.08 134.34 44.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.983 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.441 ' CG2' HG13 ' A' ' 99' ' ' ILE . 46.3 t -99.78 92.61 2.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.479 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.965 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 38.5 t -99.91 125.29 53.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.081 0.467 . . . . 0.0 111.334 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 74' ' ' THR . 38.5 t70 -99.91 130.53 46.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.916 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.057 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.7 m-85 -98.96 49.45 0.96 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.096 0.474 . . . . 0.0 110.208 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.71 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -50.68 139.8 15.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.786 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.72 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -60.59 142.12 55.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.525 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.491 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 5.8 t -69.05 -11.53 60.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.565 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.469 ' CH2' ' HG2' ' A' ' 72' ' ' MET . 21.5 p-90 -109.55 -45.3 3.71 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 24.6 t -42.38 139.54 1.45 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.657 0.265 . . . . 0.0 111.264 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.11 -57.19 1.72 Allowed Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.82 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -46.16 -27.67 4.77 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.7 2.266 . . . . 0.0 112.754 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.443 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 84.8 m -65.68 -21.1 66.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.54 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -73.45 -29.6 62.65 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -78.86 5.96 10.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.041 0.448 . . . . 0.0 110.989 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.73 HG22 HG13 ' A' ' 40' ' ' ILE . 69.9 mt -83.29 -27.44 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.119 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.542 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -49.18 -45.79 75.85 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 47.6 Cg_endo -72.04 -37.51 4.76 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 121.699 1.599 . . . . 0.0 111.134 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 58.3 ttp -62.34 -53.1 59.9 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.73 HG13 HG22 ' A' ' 36' ' ' ILE . 58.6 mt -47.61 -29.35 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.638 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.533 ' HA ' HG21 ' A' ' 2' ' ' VAL . 87.8 tt0 -78.49 -35.79 46.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.767 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 38' ' ' PRO . 72.7 mmtt -60.76 -21.97 63.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.433 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -90.12 -20.29 23.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.664 0.268 . . . . 0.0 111.632 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.4 p -74.15 -6.59 48.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.1 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.406 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 4.4 mm-40 -90.11 -29.44 18.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.82 0.343 . . . . 0.0 110.921 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.5 -29.73 17.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.676 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.54 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 71.2 m-85 -122.93 43.66 0.79 Allowed Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.654 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 93.7 Cg_exo -39.26 -31.51 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.993 2.462 . . . . 0.0 113.252 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.71 -38.13 84.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.903 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.715 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -90.04 146.52 24.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.951 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.816 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.87 148.7 23.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.72 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.49 ' O ' HG13 ' A' ' 2' ' ' VAL . 5.6 m-85 -125.27 98.35 5.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.243 0.544 . . . . 0.0 111.058 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.511 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 52.3 m-85 -113.84 -176.29 2.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.879 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.71 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 29.5 mttp -134.9 165.3 25.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.203 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.577 HD22 HD22 ' A' ' 60' ' ' LEU . 2.1 tm? -130.93 117.19 18.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.465 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.487 ' N ' HD13 ' A' ' 55' ' ' LEU . 59.3 t0 -70.26 117.59 12.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.898 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 26' ' ' TYR . 29.6 t -72.51 -8.34 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.852 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.491 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 31.9 t70 -100.97 -59.57 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.975 0.416 . . . . 0.0 110.606 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.681 ' C ' HD12 ' A' ' 60' ' ' LEU . 36.7 tp10 -66.48 -33.61 76.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.862 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.687 HD11 ' C ' ' A' ' 6' ' ' LYS . 4.3 mp -120.47 40.37 3.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.951 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.52 -20.81 32.24 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.415 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.65 -42.1 99.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.693 0.282 . . . . 0.0 111.475 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.599 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 4.4 t -69.59 -46.97 74.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.946 0.403 . . . . 0.0 110.546 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 69' ' ' VAL . . . -53.62 -25.87 19.61 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.57 -41.66 11.24 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.451 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 12.9 ptmm? -55.92 -48.81 75.01 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.853 0.359 . . . . 0.0 110.695 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.415 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 33.7 m120 -80.32 0.96 30.66 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.196 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 65.06 38.8 5.98 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.895 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.727 HG13 HG21 ' A' ' 74' ' ' THR . 47.5 t -107.92 93.48 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.883 0.373 . . . . 0.0 111.024 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.2 p -112.94 21.47 15.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.609 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -77.83 -154.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.583 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.72 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -171.46 87.12 0.47 Allowed Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.653 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 3.4 Cg_endo -96.35 -156.3 0.4 Allowed 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 124.888 -0.88 . . . . 0.0 112.663 0.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.859 HG23 ' HB ' ' A' ' 88' ' ' VAL . 87.7 m -154.19 148.05 25.51 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.467 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.056 HD13 HD13 ' A' ' 95' ' ' ILE . 83.3 mt -110.02 122.18 46.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.941 0.4 . . . . 0.0 111.62 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.057 HD12 ' CE1' ' A' ' 25' ' ' PHE . 23.5 mt -116.99 129.19 55.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.525 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.788 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.4 mp -109.75 135.25 50.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.02 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.532 ' HA ' HG23 ' A' ' 84' ' ' VAL . 57.2 m-85 -136.22 124.14 22.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.991 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.686 ' HG3' HG21 ' A' ' 84' ' ' VAL . 26.0 mtpp -112.12 126.93 55.71 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.405 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.494 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.3 m120 50.3 64.58 1.74 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.846 0.355 . . . . 0.0 111.635 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 50.44 24.99 7.95 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 116.185 -0.461 . . . . 0.0 113.319 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 61.5 mttp -128.94 -157.0 0.79 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 33.9 tt0 -108.74 174.64 5.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.686 HG21 ' HG3' ' A' ' 79' ' ' LYS . 1.7 t -151.09 -55.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.973 0.416 . . . . 0.0 110.687 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.13 -164.24 0.4 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.848 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.495 ' HD3' ' N ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -164.4 125.83 2.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.027 0.441 . . . . 0.0 110.826 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.494 HG11 ' HB1' ' A' ' 94' ' ' ALA . 49.0 t -132.21 80.36 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.924 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.859 ' HB ' HG23 ' A' ' 74' ' ' THR . 7.2 p -72.54 99.17 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.02 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.74 -23.1 0.33 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.213 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.668 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . 51.2 40.4 25.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.869 0.366 . . . . 0.0 111.101 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.593 ' O ' HG22 ' A' ' 95' ' ' ILE . 75.1 m-20 -59.5 134.26 88.76 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.916 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -47.67 -25.36 5.53 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.636 2.224 . . . . 0.0 112.733 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.75 26.45 10.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.625 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -137.5 -57.32 0.69 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.362 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.056 HD13 HD13 ' A' ' 75' ' ' LEU . 3.2 tp -54.81 -11.48 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.715 0.293 . . . . 0.0 110.867 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -92.0 -59.49 2.09 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.055 0.455 . . . . 0.0 110.801 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -63.32 -33.32 75.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.101 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.44 -31.06 65.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.115 0.483 . . . . 0.0 110.664 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.88 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.4 mp -90.18 -8.29 10.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.542 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.57 -71.78 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.789 0.328 . . . . 0.0 111.34 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.2 -30.04 48.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.334 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.639 ' CB ' HD22 ' A' ' 20' ' ' LEU . 1.1 m-80 -77.37 -50.02 13.67 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.986 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.577 ' HB2' HD23 ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.167 -0.921 . . . . 0.0 111.131 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 52' ' ' PHE . 14.0 p . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.683 0.278 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.449 HG22 ' N ' ' A' ' 4' ' ' GLN . 92.2 m -150.04 161.72 41.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.028 0.442 . . . . 0.0 111.702 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.672 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 51.0 mt-30 -96.19 178.7 5.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.135 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.477 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 17.3 m-85 -124.66 127.58 47.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.925 0.393 . . . . 0.0 111.133 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.749 ' C ' HD11 ' A' ' 60' ' ' LEU . 34.5 mmtp -107.92 -26.7 10.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.691 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.8 p -134.05 129.25 35.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.35 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.28 -26.02 6.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.57 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -61.62 -16.76 51.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.56 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -90.4 -41.72 11.32 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.107 0.48 . . . . 0.0 111.281 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.751 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -78.38 -27.63 46.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.055 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -51.9 -57.47 9.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.391 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 t -71.32 -23.06 61.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.499 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.651 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -56.56 -44.19 80.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.474 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.1 pt -81.08 -49.93 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.483 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -45.58 101.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 44.78 89.08 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.223 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -171.72 40.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.313 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.538 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 3.1 mppt? 62.45 -156.67 0.34 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.25 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.827 HD11 ' HB3' ' A' ' 77' ' ' LEU . 54.7 tp -98.06 116.51 30.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.089 0.471 . . . . 0.0 110.863 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 51' ' ' ASP . 45.2 t -99.96 134.78 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.638 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.614 HG21 HD13 ' A' ' 99' ' ' ILE . 40.5 t -99.82 84.24 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.951 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.799 HG22 ' HB2' ' A' ' 53' ' ' TYR . 38.8 t -101.11 120.17 50.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.098 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.532 ' CG ' HD23 ' A' ' 75' ' ' LEU . 2.9 m-20 -99.31 137.91 37.15 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.009 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.045 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.8 m-85 -99.35 53.21 0.95 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.646 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.575 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -52.64 137.38 30.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.439 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 72' ' ' MET . . . -66.1 134.82 53.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.549 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.441 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.6 t -57.59 -17.77 16.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.334 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.444 ' CZ3' ' SD ' ' A' ' 72' ' ' MET . 6.4 p-90 -109.12 -125.98 0.26 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 40.0 t 61.58 -82.24 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 122.448 0.299 . . . . 0.0 110.951 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.45 -77.77 0.29 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.067 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.03 -18.69 51.97 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.916 2.41 . . . . 0.0 112.98 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 95.0 m -52.88 -26.14 13.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.666 0.269 . . . . 0.0 111.711 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -79.47 -24.75 42.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.667 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 89.6 mmm -72.55 -2.22 18.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.729 0.299 . . . . 0.0 111.099 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.766 HG22 HG13 ' A' ' 40' ' ' ILE . 44.0 mt -85.58 -22.88 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.822 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.528 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -51.7 -44.73 91.07 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 47.2 Cg_endo -72.82 -34.42 6.8 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 121.802 1.668 . . . . 0.0 111.322 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.7 ttt -65.9 -52.21 51.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.766 HG13 HG22 ' A' ' 36' ' ' ILE . 75.9 mt -48.77 -29.34 2.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.581 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.531 ' HB2' HG11 ' A' ' 2' ' ' VAL . 37.7 tt0 -76.9 -32.71 57.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.062 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -66.73 -19.61 65.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.72 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -90.18 -26.65 20.03 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.406 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 53.9 m -59.87 -16.14 26.76 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.16 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.473 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 56.2 mt-10 -86.19 -20.32 28.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.821 0.344 . . . . 0.0 110.853 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -90.54 -37.29 13.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.552 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.586 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 72.4 m-85 -122.45 41.24 0.51 Allowed Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.723 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 75.5 Cg_exo -34.94 -33.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.5 2.8 . . . . 0.0 113.704 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -57.26 -36.8 71.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.035 0.445 . . . . 0.0 110.594 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.8 143.01 27.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.561 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.567 ' O ' HG13 ' A' ' 21' ' ' VAL . 29.9 m-20 -89.68 121.86 32.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.911 0.386 . . . . 0.0 110.694 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.662 ' O ' HG23 ' A' ' 2' ' ' VAL . 5.5 m-85 -95.21 85.79 4.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.594 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.799 ' HB2' HG22 ' A' ' 23' ' ' VAL . 34.7 m-85 -97.82 -176.87 3.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.27 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.672 ' HE2' ' HG2' ' A' ' 4' ' ' GLN . 35.1 mtmm -150.03 136.17 18.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.052 0.453 . . . . 0.0 110.982 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.4 tm? -93.04 139.94 30.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.963 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.876 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.2 t0 -95.27 112.57 24.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.856 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 53.5 t -73.2 -7.38 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.423 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.441 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 9.2 t70 -97.6 -59.84 1.69 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.972 0.415 . . . . 0.0 110.521 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.671 ' C ' HD12 ' A' ' 60' ' ' LEU . 16.9 tp10 -67.55 -32.92 74.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.882 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.749 HD11 ' C ' ' A' ' 6' ' ' LYS . 4.7 mp -120.03 58.3 0.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.928 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.35 -15.26 58.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.647 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.92 -27.05 43.7 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.68 0.276 . . . . 0.0 111.452 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.813 HG12 ' HE2' ' A' ' 25' ' ' PHE . 11.7 t -77.59 -51.49 18.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.477 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.44 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -57.21 -23.22 46.39 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.18 -37.98 13.79 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.229 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.709 ' HE3' HG13 ' A' ' 63' ' ' VAL . 17.2 pttp -59.88 -48.52 81.35 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.918 0.389 . . . . 0.0 110.131 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.413 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.0 m-20 -77.86 -6.33 53.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.871 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 66.38 42.51 2.94 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.117 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.513 ' CG1' HG21 ' A' ' 74' ' ' THR . 48.5 t -110.44 78.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.81 0.338 . . . . 0.0 111.196 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 81.4 p -90.53 10.26 26.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.096 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.645 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -61.46 -156.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.747 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 72' ' ' MET . 9.5 ptt? -176.68 86.93 0.26 Allowed Pre-proline 0 CA--C 1.53 0.185 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.613 ' HG3' HD12 ' A' ' 36' ' ' ILE . 43.0 Cg_endo -98.06 -159.58 0.46 Allowed 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 125.131 -0.779 . . . . 0.0 112.467 -0.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.645 ' OG1' ' HB3' ' A' ' 71' ' ' ALA . 83.6 m -149.9 161.22 42.71 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.825 0.345 . . . . 0.0 111.269 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.669 ' CD1' HD13 ' A' ' 95' ' ' ILE . 37.3 mt -122.1 124.1 43.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.305 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.045 HD12 ' CE1' ' A' ' 25' ' ' PHE . 22.2 mt -123.64 125.5 44.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.761 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.827 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.6 mp -109.75 136.36 49.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.635 ' HA ' HG23 ' A' ' 84' ' ' VAL . 53.2 m-85 -137.13 125.11 22.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.054 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.583 ' HG3' HD13 ' A' ' 20' ' ' LEU . 54.1 mtpt -112.43 131.21 55.68 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.514 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.4 m120 48.94 54.85 10.16 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.883 0.373 . . . . 0.0 111.719 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 58.4 17.56 32.93 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 121.276 -0.488 . . . . 0.0 113.02 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 31.0 mmmt -115.62 -153.76 0.53 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 88.1 tt0 -108.79 172.72 6.68 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 78' ' ' PHE . 44.8 t -146.45 -64.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.756 0.312 . . . . 0.0 111.276 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.08 150.08 3.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.299 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -119.3 120.25 36.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.611 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 48.6 t -145.49 94.87 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.277 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.63 HG21 ' CB ' ' A' ' 71' ' ' ALA . 4.3 p -64.56 102.33 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.735 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.99 103.07 0.54 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.42 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.615 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -96.31 36.99 1.28 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.953 0.406 . . . . 0.0 111.273 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 93' ' ' ALA . 21.2 p30 -80.06 141.52 54.52 Favored Pre-proline 0 N--CA 1.44 -0.94 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.532 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -46.95 87.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.624 2.216 . . . . 0.0 112.669 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -179.54 -38.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.407 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.69 -40.8 2.04 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.669 HD13 ' CD1' ' A' ' 75' ' ' LEU . 4.5 tp -50.51 -18.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.642 0.258 . . . . 0.0 111.441 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 18.0 ptpt -91.21 -50.18 5.97 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.894 0.378 . . . . 0.0 111.15 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.409 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 85.3 mt-30 -71.02 -31.73 68.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.464 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.82 -32.39 73.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.786 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.687 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 58.1 mt -90.1 -7.75 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.455 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.47 -74.26 0.5 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.973 0.416 . . . . 0.0 111.383 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -50.07 -30.44 10.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.53 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.686 ' HB3' HD22 ' A' ' 20' ' ' LEU . 3.9 m120 -82.38 -48.58 10.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.11 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.714 ' HB2' HD23 ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.041 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.83 HG22 HG22 ' A' ' 40' ' ' ILE . 57.5 t . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.981 0.419 . . . . 0.0 111.303 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.0 m -150.16 147.39 27.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.915 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.517 ' HG2' ' HE3' ' A' ' 54' ' ' LYS . 63.2 mt-30 -89.95 164.76 14.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.329 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.592 ' O ' HD13 ' A' ' 60' ' ' LEU . 18.2 m-85 -117.53 123.3 45.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.926 0.393 . . . . 0.0 111.448 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.679 ' C ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -103.79 -33.06 9.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.145 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.9 p -127.09 131.13 50.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.398 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.02 -24.45 9.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.657 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.1 m -61.67 -17.02 53.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.662 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.27 -39.08 12.98 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.105 0.478 . . . . 0.0 111.224 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.899 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -82.17 -30.95 30.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.911 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -55.55 -37.81 68.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.248 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.4 m -90.04 -0.13 57.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.64 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.671 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -82.6 -44.61 15.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.689 0.28 . . . . 0.0 111.39 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.2 pt -79.56 -49.67 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.551 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -41.93 97.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 85.0 mt-30 45.77 88.52 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.219 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 9.1 t70 -170.37 41.07 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.126 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 91.6 mttt 66.17 -155.49 0.25 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.699 0.285 . . . . 0.0 110.404 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.882 HD11 ' HB3' ' A' ' 77' ' ' LEU . 57.9 tp -98.06 116.12 29.63 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.29 0.567 . . . . 0.0 110.917 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.678 HG22 ' HB2' ' A' ' 51' ' ' ASP . 59.9 t -105.55 122.29 58.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.722 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.739 HG21 HG12 ' A' ' 99' ' ' ILE . 46.8 t -99.98 97.68 6.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.779 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.899 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 45.5 t -99.91 134.79 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.224 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 74' ' ' THR . 37.5 t70 -99.79 128.03 45.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.673 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.037 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.3 m-85 -99.08 51.37 0.95 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.656 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.588 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -50.9 128.65 21.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.061 0.457 . . . . 0.0 111.035 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.569 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -56.07 157.2 4.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.256 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.571 HG22 HG12 ' A' ' 57' ' ' VAL . 4.2 t -95.4 21.59 7.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.202 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.515 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 26.0 p-90 -138.53 -43.62 0.49 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.834 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.441 ' HG ' ' HG ' ' A' ' 33' ' ' CYS . 35.9 t -43.75 129.6 5.55 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.546 0.213 . . . . 0.0 110.984 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.07 -67.85 1.34 Allowed Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.786 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 33' ' ' CYS . 56.5 Cg_endo -67.76 -145.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.56 2.173 . . . . 0.0 110.937 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 32' ' ' PRO . 58.9 m 73.9 4.69 4.7 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -111.46 -29.11 7.91 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.692 0.282 . . . . 0.0 111.056 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.477 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 86.0 mmm -78.44 5.29 11.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.127 0.489 . . . . 0.0 110.538 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.909 HG22 HG13 ' A' ' 40' ' ' ILE . 71.3 mt -81.49 -24.07 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.701 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.53 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -47.36 -45.79 56.39 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 50.0 Cg_endo -72.77 -35.58 5.62 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.904 1.736 . . . . 0.0 111.199 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.5 ttt -65.12 -51.79 59.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.909 HG13 HG22 ' A' ' 36' ' ' ILE . 69.7 mt -48.88 -28.67 2.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.459 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.501 ' N ' HG21 ' A' ' 2' ' ' VAL . 38.8 tt0 -78.24 -33.32 49.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.898 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.464 ' HB3' ' NZ ' ' A' ' 42' ' ' LYS . 9.0 mtpm? -64.35 -22.36 66.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.437 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.483 ' HE2' HG23 ' A' ' 95' ' ' ILE . 4.0 m-85 -90.14 -16.97 28.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.665 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.43 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 45.8 t -74.67 -6.53 49.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.252 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -90.17 -29.07 18.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.937 0.399 . . . . 0.0 111.109 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.31 -26.41 20.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.791 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.571 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 80.1 m-85 -123.61 46.37 1.41 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.473 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 81.9 Cg_exo -37.44 -44.32 1.41 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.207 2.604 . . . . 0.0 113.64 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.415 ' O ' ' HD3' ' A' ' 19' ' ' LYS . 98.0 mm-40 -56.37 -31.29 63.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.923 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.66 133.44 34.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.803 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.678 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.55 121.91 32.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.482 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.547 ' CE2' HD13 ' A' ' 99' ' ' ILE . 4.5 m-85 -96.46 103.58 15.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.375 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.623 ' HB2' HG22 ' A' ' 23' ' ' VAL . 40.7 m-85 -114.17 -176.73 2.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.316 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.709 ' HE2' HG12 ' A' ' 2' ' ' VAL . 44.3 mtmt -145.54 130.51 18.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 111.206 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.811 HD13 ' N ' ' A' ' 56' ' ' ASP . 3.0 tm? -90.75 138.27 31.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.401 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.811 ' N ' HD13 ' A' ' 55' ' ' LEU . 25.4 t70 -94.98 108.34 20.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.422 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.571 HG12 HG22 ' A' ' 28' ' ' THR . 91.1 t -71.15 -11.29 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.547 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 9.7 t70 -88.9 -41.35 12.48 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.434 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.451 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 38.4 tp10 -93.06 -47.51 6.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.824 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.679 HD11 ' C ' ' A' ' 6' ' ' LYS . 5.2 mp -101.82 46.68 0.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.07 -20.78 36.03 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.462 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -71.35 -25.41 62.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.576 0.227 . . . . 0.0 111.517 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.738 HG12 ' HE2' ' A' ' 25' ' ' PHE . 8.0 t -79.61 -51.79 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.711 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.92 -27.4 51.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.99 0.424 . . . . 0.0 110.122 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.03 -26.31 20.37 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.756 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -70.51 -50.44 37.75 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.999 0.428 . . . . 0.0 109.96 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -76.24 -2.6 32.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.915 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 67.48 38.97 2.99 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.167 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.71 ' CG1' HG21 ' A' ' 74' ' ' THR . 48.3 t -112.04 83.49 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.868 0.366 . . . . 0.0 111.054 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.6 p -93.15 3.34 55.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.272 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.636 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -59.49 -163.07 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.612 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -173.82 94.39 0.33 Allowed Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.51 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 18.9 Cg_endo -91.93 -161.1 1.16 Allowed 'Cis proline' 0 C--N 1.349 0.562 0 C-N-CA 124.835 -0.902 . . . . 0.0 112.513 -0.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.719 HG23 ' HA ' ' A' ' 88' ' ' VAL . 29.0 m -155.92 148.53 23.91 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.671 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.006 HD13 HD13 ' A' ' 95' ' ' ILE . 83.2 mt -109.78 125.26 52.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 111.334 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.037 HD12 ' CE1' ' A' ' 25' ' ' PHE . 21.8 mt -121.37 127.37 51.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.782 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.882 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.7 mp -109.87 140.57 43.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.024 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.626 ' HA ' HG23 ' A' ' 84' ' ' VAL . 52.5 m-85 -140.61 125.7 18.48 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.853 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.584 ' HG3' HD13 ' A' ' 20' ' ' LEU . 54.9 mtpt -109.87 129.01 55.69 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.789 0.328 . . . . 0.0 111.47 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.523 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 0.4 OUTLIER 45.79 61.28 2.72 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.079 0.466 . . . . 0.0 111.6 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 55.59 17.89 14.73 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-N 116.088 -0.506 . . . . 0.0 113.542 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 60.0 mttp -115.18 -155.85 0.59 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 34.7 tt0 -108.78 173.0 6.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.626 HG23 ' HA ' ' A' ' 78' ' ' PHE . 47.9 t -147.79 -68.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.939 0.4 . . . . 0.0 111.038 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.63 154.99 4.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.254 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -114.52 114.99 26.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.414 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.35 82.18 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.311 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.719 ' HA ' HG23 ' A' ' 74' ' ' THR . 2.7 p -60.89 85.14 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.721 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.6 115.39 1.37 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.367 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.727 ' HB2' HD21 ' A' ' 75' ' ' LEU . . . -96.79 38.45 1.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.804 0.335 . . . . 0.0 111.186 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 93' ' ' ALA . 46.2 t30 -68.84 129.28 92.48 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.194 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 85.3 Cg_exo -45.62 88.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.667 2.245 . . . . 0.0 112.659 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 92' ' ' PRO . . . 172.52 -33.16 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.411 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.43 -44.68 2.46 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.006 HD13 HD13 ' A' ' 75' ' ' LEU . 3.8 tp -50.83 -17.9 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.298 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 7.0 ptpp? -91.63 -48.99 6.53 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.949 0.404 . . . . 0.0 110.792 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.418 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 80.2 mt-30 -69.96 -31.6 69.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.575 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.21 -31.68 72.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.023 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.739 HG12 HG21 ' A' ' 22' ' ' VAL . 46.4 mt -90.19 -8.24 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.56 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.571 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.2 -69.65 0.71 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.842 0.353 . . . . 0.0 111.174 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.99 -29.0 18.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.221 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.572 ' CB ' HD22 ' A' ' 20' ' ' LEU . 3.8 m120 -82.63 -51.76 7.45 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.032 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.616 ' HB2' HD23 ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.188 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 52' ' ' PHE . 14.6 p . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.605 0.241 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 4' ' ' GLN . 87.3 m -141.88 162.84 34.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.959 0.409 . . . . 0.0 111.51 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.596 ' HG2' ' HD2' ' A' ' 54' ' ' LYS . 71.5 mt-30 -97.29 -176.97 3.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.777 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.504 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 20.3 m-85 -135.14 101.77 4.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.328 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.559 ' C ' HD11 ' A' ' 60' ' ' LEU . 32.7 mmtp -83.19 -25.4 31.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.731 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.5 p -130.42 123.21 29.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.261 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.83 -25.77 4.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.583 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m -59.5 -18.9 43.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.572 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -90.47 -44.1 9.83 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.206 0.527 . . . . 0.0 111.452 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.885 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.2 t80 -69.39 -30.51 68.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.031 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -50.83 -66.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.404 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.9 m -60.78 -20.48 61.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.467 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 11' ' ' PHE . . . -56.41 -66.42 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.795 0.331 . . . . 0.0 111.676 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' GLY . 21.0 pt -54.6 -48.14 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.753 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.07 103.0 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.7 mt-30 45.18 92.11 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.236 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -171.51 38.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.384 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.538 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 61.61 -152.5 0.37 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.871 HD11 ' HB3' ' A' ' 77' ' ' LEU . 59.3 tp -97.55 115.92 28.78 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.244 0.545 . . . . 0.0 110.437 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 51' ' ' ASP . 58.9 t -104.05 126.97 58.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.871 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.783 HG11 HD11 ' A' ' 95' ' ' ILE . 48.6 t -99.74 93.15 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.495 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.885 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 43.4 t -99.76 128.14 51.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.114 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.7 t70 -99.72 130.73 45.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.752 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.044 ' CE1' HD12 ' A' ' 76' ' ' LEU . 3.4 m-85 -99.07 53.01 0.97 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.968 0.413 . . . . 0.0 110.406 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -50.98 124.77 12.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.301 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -51.69 154.1 2.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.25 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.468 HG22 HG12 ' A' ' 57' ' ' VAL . 7.0 t -96.47 23.82 6.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.085 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.506 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 27.3 p-90 -141.53 -38.05 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.63 ' HB2' ' HB2' ' A' ' 72' ' ' MET . 51.3 t -35.21 150.98 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.0 0.429 . . . . 0.0 111.938 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.36 -79.29 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.453 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 3.3 Cg_exo -73.01 -76.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.43 2.087 . . . . 0.0 112.021 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.9 p 37.92 31.33 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 28.3 mtpp -132.04 -35.98 1.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.214 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.491 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 15.2 tmm? -58.41 -16.03 13.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.852 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.691 HG22 HG13 ' A' ' 40' ' ' ILE . 2.4 mp -75.26 -38.13 40.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.345 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.522 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -45.6 -49.28 36.04 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 41.0 Cg_endo -70.88 -32.73 13.44 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 121.988 1.792 . . . . 0.0 110.999 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 49.3 ttm -66.59 -51.13 59.78 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.718 HG22 HG21 ' A' ' 2' ' ' VAL . 61.6 mt -49.54 -28.38 3.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.515 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.482 ' HB2' HG11 ' A' ' 2' ' ' VAL . 37.8 tt0 -79.16 -30.93 43.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.183 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.478 ' HB3' ' NZ ' ' A' ' 42' ' ' LYS . 9.1 mtpm? -69.37 -16.11 63.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.73 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.49 ' CE2' HG23 ' A' ' 95' ' ' ILE . 3.9 m-85 -90.11 -20.85 22.66 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.5 t -66.74 -14.28 62.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.777 0.322 . . . . 0.0 110.713 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.419 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 5.1 tm-20 -90.04 -20.95 22.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.295 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -90.12 -36.35 14.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.315 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.538 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 81.6 m-85 -124.11 45.4 1.22 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.373 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 75.1 Cg_exo -36.91 -33.03 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.429 2.753 . . . . 0.0 113.628 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -59.57 -37.64 79.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.652 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.83 141.26 28.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.801 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.546 ' O ' HG13 ' A' ' 21' ' ' VAL . 33.9 m-20 -90.08 123.41 33.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.824 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.799 ' O ' HG23 ' A' ' 2' ' ' VAL . 5.4 m-85 -97.09 106.58 18.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.303 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.561 ' HB2' HG22 ' A' ' 23' ' ' VAL . 40.9 m-85 -116.11 -178.45 3.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.523 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.726 ' HE3' HG22 ' A' ' 2' ' ' VAL . 69.9 mttt -142.13 145.36 34.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.393 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.677 ' CD2' HD22 ' A' ' 60' ' ' LEU . 2.7 tm? -107.25 125.13 50.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.607 ' N ' HD13 ' A' ' 55' ' ' LEU . 1.6 m-20 -81.76 108.18 15.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.693 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.468 HG12 HG22 ' A' ' 28' ' ' THR . 85.1 t -72.34 -10.12 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.44 -60.52 2.34 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.556 ' HB3' HD12 ' A' ' 60' ' ' LEU . 2.2 tm-20 -77.9 -39.83 41.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.572 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.677 HD22 ' CD2' ' A' ' 55' ' ' LEU . 4.5 mp -97.76 44.85 1.03 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.014 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.13 -19.88 40.44 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.627 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -78.93 -29.32 44.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.783 0.325 . . . . 0.0 111.432 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.86 HG13 ' HE2' ' A' ' 66' ' ' LYS . 21.4 t -73.27 -54.83 14.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.788 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.86 -25.08 10.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.918 0.389 . . . . 0.0 110.142 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -90.17 -38.36 13.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.158 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.86 ' HE2' HG13 ' A' ' 63' ' ' VAL . 51.5 pttt -60.83 -46.97 88.48 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.945 0.403 . . . . 0.0 110.185 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.402 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 34.0 m120 -79.16 -2.09 39.2 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.025 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 64.72 37.7 7.36 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.456 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.746 HG13 HG21 ' A' ' 74' ' ' THR . 41.9 t -111.45 68.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.992 0.425 . . . . 0.0 110.546 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.2 t -85.01 8.24 18.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.733 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.834 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -59.76 -161.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.63 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -173.71 89.46 0.36 Allowed Pre-proline 0 N--CA 1.454 -0.228 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.545 ' O ' HG23 ' A' ' 88' ' ' VAL . 65.0 Cg_endo -96.13 -165.76 1.25 Allowed 'Cis proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.577 -1.01 . . . . 0.0 112.437 -0.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.876 HG23 ' HB ' ' A' ' 88' ' ' VAL . 29.5 m -147.35 163.63 35.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.477 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.915 HD13 HD13 ' A' ' 95' ' ' ILE . 78.9 mt -122.34 127.74 50.16 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.835 0.35 . . . . 0.0 111.191 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.044 HD12 ' CE1' ' A' ' 25' ' ' PHE . 26.5 mt -123.97 128.5 49.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.608 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.871 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.7 mp -109.64 136.9 48.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.028 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.605 ' HA ' HG23 ' A' ' 84' ' ' VAL . 51.1 m-85 -138.72 126.42 22.11 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.877 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.476 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 9.8 mtpm? -109.77 129.77 55.59 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.368 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.442 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 6.3 m120 45.78 56.75 5.64 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.865 0.365 . . . . 0.0 111.92 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 60.61 14.65 36.74 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.066 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 49.1 mtmt -110.93 -155.37 0.56 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.441 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 88.2 tt0 -109.04 172.6 6.75 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 78' ' ' PHE . 64.5 t -146.18 -68.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 0.0 111.25 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.39 -168.31 0.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 0.0 111.551 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.462 ' HB3' ' NZ ' ' A' ' 86' ' ' LYS . 9.7 mtpm? -142.51 140.03 31.68 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.994 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.7 t -154.46 82.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.532 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.876 ' HB ' HG23 ' A' ' 74' ' ' THR . 5.5 p -78.67 109.57 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.826 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.91 -25.79 0.72 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.134 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.772 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . 44.48 39.8 3.46 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 111.357 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.481 ' O ' HG22 ' A' ' 95' ' ' ILE . 24.3 t-20 -62.4 135.61 95.39 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.664 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -47.78 -25.18 5.59 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.663 2.242 . . . . 0.0 112.82 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.34 30.05 7.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.626 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -139.67 -59.57 0.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.2 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.915 HD13 HD13 ' A' ' 75' ' ' LEU . 3.9 tp -57.02 -7.28 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.337 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 14.8 ptmm? -91.3 -49.16 6.51 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.928 0.394 . . . . 0.0 110.659 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.416 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 73.0 mt-30 -69.52 -31.85 70.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.28 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.75 -28.32 69.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.695 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.8 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 59.0 mt -90.17 -10.82 10.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.523 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.84 -71.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.997 0.427 . . . . 0.0 111.349 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -47.43 -29.09 2.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.46 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.679 ' CB ' HD22 ' A' ' 20' ' ' LEU . 68.5 m-20 -90.05 -48.04 7.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.324 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.8 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.078 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.791 HG12 ' HE3' ' A' ' 54' ' ' LYS . 32.7 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.739 0.304 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 4' ' ' GLN . 95.5 m -144.25 161.19 39.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.057 0.456 . . . . 0.0 111.411 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.613 ' HG2' ' NZ ' ' A' ' 54' ' ' LYS . 55.3 mt-30 -91.71 172.55 8.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.443 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.521 ' CE2' ' CG ' ' A' ' 11' ' ' PHE . 17.1 m-85 -126.68 131.96 51.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.19 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.589 ' C ' HD11 ' A' ' 60' ' ' LEU . 47.5 mmtm -120.98 -32.61 3.92 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.2 p -126.2 148.06 49.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.908 0.385 . . . . 0.0 111.657 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 9' ' ' SER . . . -74.21 99.51 3.43 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.405 0.621 . . . . 0.0 110.337 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 31.3 t 160.55 -24.97 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.018 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -84.67 -32.68 23.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.294 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.853 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -90.34 -43.33 10.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.401 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -47.29 -37.91 11.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.12 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.7 m -74.81 -30.95 61.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.834 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.491 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -60.49 -34.9 74.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.062 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.1 pt -90.07 -49.71 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.417 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.465 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -43.62 95.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 45.23 83.17 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.177 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -164.67 42.25 0.08 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.588 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.7 mptp? 64.86 -157.2 0.29 Allowed 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 120.701 0.286 . . . . 0.0 110.657 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.841 HD13 ' HG3' ' A' ' 79' ' ' LYS . 65.9 tp -98.24 117.14 31.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.062 0.458 . . . . 0.0 110.856 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 51' ' ' ASP . 46.6 t -113.93 124.02 70.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.742 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.72 HG22 ' HG ' ' A' ' 77' ' ' LEU . 58.8 t -99.84 111.56 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.933 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.853 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 41.5 t -109.45 137.77 40.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.197 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.45 ' OD2' HG21 ' A' ' 36' ' ' ILE . 61.8 t0 -99.84 128.96 45.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.824 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.067 ' CE1' HD12 ' A' ' 76' ' ' LEU . 6.8 m-85 -99.15 48.29 0.96 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.052 0.453 . . . . 0.0 110.175 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.582 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -48.88 132.04 18.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.243 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.563 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -60.78 145.31 50.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.808 0.337 . . . . 0.0 110.718 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.477 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 7.7 t -72.79 -21.19 61.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.391 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -95.87 -39.24 9.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.806 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 49.1 t -41.23 139.49 0.98 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.914 0.387 . . . . 0.0 111.717 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.71 -58.18 1.85 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.785 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.93 52.5 4.28 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.619 2.212 . . . . 0.0 112.755 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.442 ' O ' HD12 ' A' ' 36' ' ' ILE . 27.3 p -127.13 -13.05 5.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.38 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -78.47 -25.44 45.82 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.738 0.304 . . . . 0.0 111.251 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.409 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 65.9 mtt -73.75 3.83 5.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.828 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.797 HG22 HG13 ' A' ' 40' ' ' ILE . 62.2 mt -79.14 -38.78 20.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.933 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.572 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -42.79 -45.42 11.47 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 23.9 Cg_endo -66.36 -43.49 8.17 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.595 1.53 . . . . 0.0 111.669 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.509 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 12.2 mmt -62.1 -59.87 4.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.797 HG13 HG22 ' A' ' 36' ' ' ILE . 43.2 mt -43.08 -29.27 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.019 0.438 . . . . 0.0 110.751 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -80.42 -43.34 21.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.767 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -59.78 -29.94 68.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.183 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.605 ' CE2' HG23 ' A' ' 95' ' ' ILE . 16.0 m-85 -76.14 -22.6 55.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.473 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.401 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 98.9 p -77.31 -4.05 43.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.71 0.29 . . . . 0.0 110.711 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.424 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 50.3 mt-10 -90.08 -28.32 19.09 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.855 0.36 . . . . 0.0 110.712 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -90.24 -28.31 18.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.362 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.539 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 70.3 m-85 -123.97 45.54 1.25 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.133 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 74.2 Cg_exo -37.41 -32.43 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.376 2.718 . . . . 0.0 113.54 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -60.79 -38.45 85.37 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.674 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -90.0 138.69 31.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.956 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.657 ' O ' HG13 ' A' ' 21' ' ' VAL . 58.2 m-20 -90.71 138.72 31.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.663 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.602 ' O ' HG13 ' A' ' 2' ' ' VAL . 2.7 m-85 -114.74 98.39 6.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.516 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.672 ' HB2' HG22 ' A' ' 23' ' ' VAL . 43.5 m-85 -102.41 -173.25 2.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.562 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.791 ' HE3' HG12 ' A' ' 2' ' ' VAL . 10.2 mtmp? -147.84 135.38 20.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.954 0.406 . . . . 0.0 111.04 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.954 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.1 tm? -98.25 145.62 26.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.698 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.954 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.9 t70 -93.85 126.04 38.82 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.7 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.759 ' O ' HG12 ' A' ' 57' ' ' VAL . 98.3 t -93.38 30.33 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 121.286 0.565 . . . . 0.0 110.814 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.477 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 65.8 t0 -137.94 -46.73 0.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.58 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.614 ' C ' HD12 ' A' ' 60' ' ' LEU . 5.2 tp10 -81.56 -32.24 32.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.414 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.675 HD22 HD21 ' A' ' 55' ' ' LEU . 4.5 mp -118.52 72.78 0.89 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.64 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -77.84 -1.72 79.32 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.88 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -90.04 -38.39 13.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.741 0.305 . . . . 0.0 111.39 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.801 HG13 ' HE3' ' A' ' 66' ' ' LYS . 6.0 t -71.73 -54.88 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.345 . . . . 0.0 110.608 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.37 -25.44 15.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.019 0.438 . . . . 0.0 110.226 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -90.24 -38.36 13.49 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.109 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.801 ' HE3' HG13 ' A' ' 63' ' ' VAL . 16.5 pttp -60.7 -48.4 81.97 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-O 120.865 0.364 . . . . 0.0 110.129 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.417 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.5 m-20 -76.81 -6.08 50.89 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.869 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 66.3 41.66 3.3 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.019 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.561 HG13 HG21 ' A' ' 74' ' ' THR . 59.6 t -104.63 84.6 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.153 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 91.3 p -95.56 -17.46 21.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.922 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.774 ' CB ' HG21 ' A' ' 88' ' ' VAL . . . -55.99 -171.01 0.0 OUTLIER 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.501 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.563 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -167.84 108.31 0.58 Allowed Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.349 -0.54 . . . . 0.0 112.372 -179.506 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.733 ' O ' HG23 ' A' ' 88' ' ' VAL . 42.1 Cg_endo -87.85 -162.15 2.07 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.394 -1.086 . . . . 0.0 112.286 -0.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.561 HG21 HG13 ' A' ' 69' ' ' VAL . 84.9 m -153.76 163.81 39.39 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.803 0.335 . . . . 0.0 110.797 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.026 HD13 HD13 ' A' ' 95' ' ' ILE . 71.0 mt -129.0 123.45 32.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 110.913 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.067 HD12 ' CE1' ' A' ' 25' ' ' PHE . 20.7 mt -121.05 129.15 53.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.803 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.79 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.5 mp -109.7 143.71 39.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.7 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.585 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 64.7 m-85 -144.41 127.09 16.15 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.001 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.841 ' HG3' HD13 ' A' ' 20' ' ' LEU . 49.3 mtpt -117.24 136.69 52.9 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.831 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.444 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.2 m120 45.78 67.69 0.7 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.569 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 46.29 33.97 5.99 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 113.048 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.585 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 68.1 mttm -141.78 -160.57 1.1 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.718 ' O ' HG13 ' A' ' 84' ' ' VAL . 28.9 tt0 -109.14 -179.91 3.98 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.811 HG11 ' HG3' ' A' ' 79' ' ' LYS . 4.6 m -164.2 -46.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.51 0.195 . . . . 0.0 111.38 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.47 158.68 24.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.046 0.451 . . . . 0.0 112.012 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.468 ' CD ' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -148.03 113.67 5.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.872 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.7 t -139.41 107.37 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.412 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.774 HG21 ' CB ' ' A' ' 71' ' ' ALA . 3.2 p -69.45 110.45 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.063 0.458 . . . . 0.0 110.659 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.2 105.14 0.91 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.164 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.667 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -94.0 38.35 1.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.847 0.356 . . . . 0.0 111.39 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' A' ' 93' ' ' ALA . 5.4 m120 -72.38 134.83 82.12 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.437 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 85.6 Cg_exo -48.48 84.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.722 2.282 . . . . 0.0 112.625 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 178.66 -38.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.43 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.33 -45.68 2.92 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.7 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.026 HD13 HD13 ' A' ' 75' ' ' LEU . 4.9 tp -52.83 -16.49 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.148 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.491 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -92.21 -49.3 6.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.982 0.42 . . . . 0.0 110.901 179.509 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.442 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 84.0 mt-30 -71.53 -32.05 67.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.661 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.679 ' HB1' HD21 ' A' ' 77' ' ' LEU . . . -57.89 -32.93 68.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.429 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.872 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.5 mp -90.24 -12.25 9.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.423 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.47 -64.42 1.14 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.911 0.386 . . . . 0.0 111.095 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.31 -30.36 38.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.064 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.78 ' HB3' HD22 ' A' ' 20' ' ' LEU . 64.9 m-20 -90.15 -66.42 0.93 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.301 -0.856 . . . . 0.0 111.117 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.07 HG22 ' HZ2' ' A' ' 54' ' ' LYS . 6.0 p . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.654 0.264 . . . . 0.0 110.668 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 4' ' ' GLN . 92.5 m -150.3 162.01 41.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.198 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.546 ' HG3' ' HD2' ' A' ' 54' ' ' LYS . 14.5 mp0 -105.4 -173.37 2.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.878 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.51 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.8 m-85 -135.79 105.75 6.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.762 0.315 . . . . 0.0 111.698 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.661 ' O ' HD11 ' A' ' 60' ' ' LEU . 8.2 mmmm -88.93 -27.71 20.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.763 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.7 p -126.35 128.52 47.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 110.705 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.79 -24.04 20.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.415 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -62.29 -16.59 54.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.627 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -90.14 -56.74 3.1 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.246 0.546 . . . . 0.0 111.111 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.659 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -60.49 -33.1 72.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.7 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -51.46 -56.69 11.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.256 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.4 m -65.85 -25.3 67.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.526 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -56.39 -72.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 0.0 111.322 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.545 HG23 ' CE1' ' A' ' 11' ' ' PHE . 19.4 pt -52.8 -48.52 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.674 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -44.43 96.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 44.68 91.16 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.541 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -174.54 40.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.487 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.537 ' NZ ' ' HB2' ' A' ' 19' ' ' LYS . 8.1 mtmp? 69.36 -158.26 0.17 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.498 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.829 HD13 ' HG3' ' A' ' 79' ' ' LYS . 61.6 tp -98.16 113.76 25.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.205 0.526 . . . . 0.0 111.19 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.7 HG22 ' HB2' ' A' ' 51' ' ' ASP . 59.1 t -99.74 125.45 53.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.524 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.647 HG21 HG12 ' A' ' 99' ' ' ILE . 50.8 t -99.71 96.3 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.665 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.659 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 30.1 t -104.95 131.84 53.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.368 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.6 t70 -99.99 132.23 45.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.507 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.08 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.8 m-85 -99.14 54.6 0.98 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.137 0.494 . . . . 0.0 110.643 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.613 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -58.35 140.92 52.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.098 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.708 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -67.42 136.44 54.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.774 0.321 . . . . 0.0 110.253 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 3.3 t -53.39 -49.35 67.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.222 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 32.0 p-90 -68.2 -42.62 79.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.79 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 53.1 t -45.75 135.14 7.07 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 111.146 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.27 -56.3 0.94 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.117 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -48.57 -26.02 8.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.617 2.211 . . . . 0.0 112.729 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.9 p -63.92 -32.21 73.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.071 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -61.87 -25.32 67.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.383 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 66.1 mtt -68.85 -5.85 23.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.962 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.857 HG22 HG13 ' A' ' 40' ' ' ILE . 60.0 mt -86.51 -23.63 6.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.447 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.28 -44.48 81.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 45.6 Cg_endo -72.7 -36.61 4.67 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.669 1.579 . . . . 0.0 111.447 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.527 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 67.5 mtm -64.96 -51.46 61.63 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.857 HG13 HG22 ' A' ' 36' ' ' ILE . 68.0 mt -48.71 -25.53 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.716 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.404 ' HB2' HG11 ' A' ' 2' ' ' VAL . 38.0 tt0 -85.06 -23.38 28.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.972 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.447 ' NZ ' ' HB2' ' A' ' 42' ' ' LYS . 10.5 mtmp? -82.28 -15.71 52.03 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.527 ' HD1' ' O ' ' A' ' 39' ' ' MET . 3.5 m-85 -90.04 -19.27 24.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.652 0.263 . . . . 0.0 111.323 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.452 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.6 t -69.62 -8.84 50.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.484 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -87.99 -27.18 22.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.739 0.304 . . . . 0.0 111.098 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -90.6 -30.4 17.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.904 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.511 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 72.9 m-85 -123.03 47.3 1.56 Allowed Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.167 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 80.7 Cg_exo -38.01 -27.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.254 2.636 . . . . 0.0 113.594 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.491 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 13.4 mp0 -65.63 -36.22 83.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.105 0.479 . . . . 0.0 110.472 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.48 138.27 31.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.109 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.7 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.53 122.21 32.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.026 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.624 ' CE2' HD13 ' A' ' 99' ' ' ILE . 4.2 m-85 -97.37 83.96 3.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.221 0.534 . . . . 0.0 111.624 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.51 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 54.2 m-85 -102.31 -174.75 2.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.495 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 1.07 ' HZ2' HG22 ' A' ' 2' ' ' VAL . 28.6 mttp -141.98 148.59 38.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.307 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.727 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.8 tm? -106.21 130.23 54.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.127 0.489 . . . . 0.0 110.943 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.727 ' N ' HD13 ' A' ' 55' ' ' LEU . 56.9 m-20 -83.89 117.03 23.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.619 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 57' ' ' VAL . 69.9 t -87.22 5.56 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.111 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.492 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 11.5 p-10 -99.63 -40.73 7.65 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.92 0.39 . . . . 0.0 110.631 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.563 ' C ' HD12 ' A' ' 60' ' ' LEU . 5.4 tp10 -99.66 -28.5 13.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.979 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.672 ' N ' HD12 ' A' ' 60' ' ' LEU . 3.1 mp -114.17 41.79 2.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.032 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.51 -21.44 34.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.55 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -72.38 -25.83 61.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.687 0.28 . . . . 0.0 111.511 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.737 HG12 ' HE2' ' A' ' 25' ' ' PHE . 11.7 t -77.82 -49.56 21.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.75 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.47 -28.4 59.6 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.971 0.415 . . . . 0.0 110.321 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -90.03 -23.93 21.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.724 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -73.03 -49.54 28.19 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.98 0.419 . . . . 0.0 110.052 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -77.75 -0.75 28.14 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.146 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 68.09 37.33 2.98 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.306 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.766 HG13 HG21 ' A' ' 74' ' ' THR . 44.2 t -116.18 72.97 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.758 0.313 . . . . 0.0 110.983 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.2 p -84.12 -15.13 48.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.929 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.36 -172.62 0.0 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.524 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.708 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 1.7 pmm? -170.08 112.74 0.47 Allowed Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.513 -0.475 . . . . 0.0 112.209 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.562 ' O ' HG23 ' A' ' 88' ' ' VAL . 68.4 Cg_endo -87.64 -167.39 4.06 Favored 'Cis proline' 0 C--N 1.349 0.571 0 C-N-CA 124.151 -1.187 . . . . 0.0 112.086 -0.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.766 HG21 HG13 ' A' ' 69' ' ' VAL . 29.0 m -161.36 151.67 17.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.681 0.277 . . . . 0.0 110.837 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.988 HD13 HD13 ' A' ' 95' ' ' ILE . 81.7 mt -114.22 124.84 53.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.282 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.08 HD12 ' CE1' ' A' ' 25' ' ' PHE . 22.7 mt -120.05 128.76 53.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.282 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.787 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.1 mp -109.6 141.19 42.47 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.833 0.349 . . . . 0.0 110.838 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.611 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 55.1 m-85 -143.19 126.21 16.32 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.96 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.829 ' HG3' HD13 ' A' ' 20' ' ' LEU . 48.5 mtpt -117.04 136.11 53.21 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.701 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.2 m120 49.12 62.4 2.63 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.484 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 50.61 25.54 9.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.069 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.611 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 75.2 mmtt -132.45 -160.09 1.02 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.722 ' O ' HG13 ' A' ' 84' ' ' VAL . 32.2 tt0 -108.94 -179.93 4.0 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.792 HG11 ' HG3' ' A' ' 79' ' ' LYS . 4.6 m -164.16 -47.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -164.81 165.24 20.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.155 0.502 . . . . 0.0 111.814 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.534 ' HG2' HD22 ' A' ' 76' ' ' LEU . 36.5 mtmm -151.19 135.15 16.6 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.923 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.4 t -154.21 105.99 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.469 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.58 ' HA ' HG23 ' A' ' 74' ' ' THR . 2.8 p -68.03 78.68 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.841 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.52 106.27 0.2 Allowed Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.339 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.666 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -97.11 38.53 1.24 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.875 0.369 . . . . 0.0 111.183 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 93' ' ' ALA . 22.9 t-20 -85.8 141.08 35.6 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.147 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -45.52 87.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.657 2.238 . . . . 0.0 112.636 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -179.6 -40.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.336 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.11 -42.14 2.29 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.988 HD13 HD13 ' A' ' 75' ' ' LEU . 5.3 tp -50.39 -17.92 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.081 -0.247 . . . . 0.0 111.133 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.45 ' CD ' ' CE2' ' A' ' 43' ' ' PHE . 29.6 mmmt -90.64 -66.76 0.9 Allowed 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.787 0.327 . . . . 0.0 111.104 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.469 ' OE1' ' N ' ' A' ' 97' ' ' GLN . 1.3 mp0 -59.93 -34.82 73.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.705 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.97 -30.87 66.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.616 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.647 HG12 HG21 ' A' ' 22' ' ' VAL . 57.8 mt -90.22 -14.67 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.343 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.43 -68.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.865 0.364 . . . . 0.0 111.142 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.07 -28.76 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.148 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.591 ' HB3' HD22 ' A' ' 20' ' ' LEU . 5.8 m120 -83.15 -51.92 7.07 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.996 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.056 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.484 HG11 ' HB2' ' A' ' 41' ' ' GLU . 10.5 p . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.564 0.221 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.451 HG22 ' N ' ' A' ' 4' ' ' GLN . 85.3 m -148.67 162.59 39.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.958 0.409 . . . . 0.0 111.543 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.649 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 43.1 mt-30 -107.62 -179.92 4.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.219 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.508 ' CE2' ' CD1' ' A' ' 11' ' ' PHE . 22.6 m-85 -129.49 129.73 44.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.564 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.794 ' C ' HD11 ' A' ' 60' ' ' LEU . 47.4 mmtm -110.95 -18.77 12.99 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 8' ' ' ALA . 25.5 m -147.94 165.77 29.68 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.18 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.55 ' O ' ' OG ' ' A' ' 9' ' ' SER . . . -84.63 101.46 12.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.473 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.55 ' OG ' ' O ' ' A' ' 8' ' ' ALA . 13.2 m 160.26 -25.33 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.044 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -87.24 -30.77 20.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.481 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.911 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -90.05 -40.8 12.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.556 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -48.64 -40.35 27.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.22 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 m -76.21 -27.12 56.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.096 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.51 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -57.47 -62.16 1.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.36 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.65 HG22 ' HB2' ' A' ' 78' ' ' PHE . 19.1 pt -63.72 -48.71 85.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.602 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.48 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -40.49 94.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 81.7 mt-30 44.16 88.96 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.385 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.515 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 8.9 t70 -170.64 40.47 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.324 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 53.1 mttp 70.82 -151.47 0.1 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.729 0.3 . . . . 0.0 110.635 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.652 ' CD1' HG21 ' A' ' 84' ' ' VAL . 28.0 tp -97.47 111.49 23.73 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.15 0.5 . . . . 0.0 110.998 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.731 HG22 ' HB2' ' A' ' 51' ' ' ASP . 60.0 t -99.96 113.91 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.918 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.932 HG21 HG12 ' A' ' 99' ' ' ILE . 43.6 t -99.9 102.39 13.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.6 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.911 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 39.9 t -104.84 138.42 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.604 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -104.42 130.96 52.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.823 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.048 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.4 m-85 -99.1 49.39 0.95 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.047 0.451 . . . . 0.0 109.832 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.565 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -47.18 134.56 10.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.508 -179.106 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . . . -62.0 128.72 37.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.445 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.531 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 5.2 t -59.44 -28.02 66.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.766 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.403 ' CH2' ' SD ' ' A' ' 72' ' ' MET . 31.4 p-90 -93.83 -36.97 11.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 33.2 t -46.58 158.72 0.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.577 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.71 -66.39 0.81 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.304 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -46.77 -26.68 4.8 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.892 2.394 . . . . 0.0 113.08 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 86.3 m -60.43 -17.86 47.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -73.81 -44.34 56.12 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.406 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 65.2 mtt -70.77 1.7 5.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.796 0.331 . . . . 0.0 111.522 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.724 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 36.3 mt -75.74 -39.4 38.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.728 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.511 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -44.53 -50.39 23.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 41.6 Cg_endo -69.58 -31.26 21.69 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 121.806 1.671 . . . . 0.0 111.194 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 47.1 tpp -68.93 -51.19 42.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.779 HD12 ' CD ' ' A' ' 54' ' ' LYS . 62.6 mt -50.32 -29.07 5.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.411 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.484 ' HB2' HG11 ' A' ' 2' ' ' VAL . 43.6 tt0 -75.71 -35.63 60.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.889 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -62.42 -20.58 64.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.675 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.26 -24.54 20.91 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.414 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 50.5 m -62.21 -13.21 25.38 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.611 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -85.59 -25.2 26.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.729 0.3 . . . . 0.0 111.31 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -90.42 -30.74 17.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.556 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 80.8 m-85 -123.1 46.47 1.35 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.747 0.308 . . . . 0.0 111.482 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 79.3 Cg_exo -37.18 -33.2 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.321 2.68 . . . . 0.0 114.025 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.413 ' O ' ' CD ' ' A' ' 19' ' ' LYS . 9.6 mm-40 -66.17 -30.92 71.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.931 0.396 . . . . 0.0 110.86 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.34 138.45 31.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.475 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.731 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.49 121.59 31.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.006 0.431 . . . . 0.0 110.383 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.698 ' CE2' HD13 ' A' ' 99' ' ' ILE . 5.2 m-85 -97.44 82.99 3.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.594 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.609 ' HB2' HG22 ' A' ' 23' ' ' VAL . 43.0 m-85 -97.04 -178.16 4.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.898 178.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.779 ' CD ' HD12 ' A' ' 40' ' ' ILE . 33.4 mtmm -146.31 139.13 25.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.163 0.506 . . . . 0.0 111.398 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.831 HD13 ' N ' ' A' ' 56' ' ' ASP . 1.8 tm? -102.09 135.44 43.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.967 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.831 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.9 t0 -88.43 128.68 35.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.308 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 41.4 t -85.66 -11.17 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.531 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 2.1 p30 -105.1 -41.25 5.62 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.336 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.738 ' C ' HD12 ' A' ' 60' ' ' LEU . 15.8 tp10 -76.84 -31.17 56.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.97 0.414 . . . . 0.0 110.608 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.794 HD11 ' C ' ' A' ' 6' ' ' LYS . 4.2 mp -125.35 42.73 3.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.765 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -48.44 -27.42 5.77 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.486 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.45 -25.78 68.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.63 0.252 . . . . 0.0 111.447 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.812 HG13 ' HE2' ' A' ' 66' ' ' LYS . 11.0 t -81.16 -55.58 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.745 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.83 -26.72 6.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.069 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.427 ' N ' ' OE1' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -90.33 -37.14 14.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.669 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.812 ' HE2' HG13 ' A' ' 63' ' ' VAL . 52.6 pttt -59.74 -48.12 82.94 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.051 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.414 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 76.0 m-20 -78.41 -5.22 51.73 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.867 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 67.01 41.49 2.65 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.256 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.673 ' CG1' HG21 ' A' ' 74' ' ' THR . 41.7 t -112.63 97.6 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-O 120.805 0.336 . . . . 0.0 110.99 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.8 p -112.31 28.68 8.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.983 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.856 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -76.12 -153.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.823 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 72' ' ' MET . 16.5 ptt? -173.04 79.65 0.41 Allowed Pre-proline 0 CA--C 1.529 0.141 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.724 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 1.3 Cg_endo -97.52 -155.61 0.33 Allowed 'Cis proline' 0 C--N 1.348 0.524 0 C-N-CA 125.242 -0.733 . . . . 0.0 112.783 -0.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.856 ' OG1' ' HB3' ' A' ' 71' ' ' ALA . 86.6 m -151.22 147.09 26.57 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.027 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.047 HD13 HD13 ' A' ' 95' ' ' ILE . 88.4 mt -109.67 122.7 48.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.941 0.4 . . . . 0.0 111.458 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.048 HD12 ' CE1' ' A' ' 25' ' ' PHE . 29.2 mt -120.23 125.87 49.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.441 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.671 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.3 mp -109.8 147.47 33.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.8 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.65 ' HB2' HG22 ' A' ' 15' ' ' ILE . 47.0 m-85 -148.45 126.83 12.28 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.339 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.832 ' HG3' HG11 ' A' ' 84' ' ' VAL . 50.3 mtpt -115.55 140.16 49.42 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.463 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 6.0 m120 49.1 52.12 14.96 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.634 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 57.62 19.32 34.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.706 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.616 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 54.7 mtpt -122.5 -155.83 0.67 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.765 ' O ' HG13 ' A' ' 84' ' ' VAL . 83.1 tt0 -108.85 177.73 4.68 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.832 HG11 ' HG3' ' A' ' 79' ' ' LYS . 4.2 m -166.55 -47.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.644 0.259 . . . . 0.0 111.369 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.452 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -163.93 174.68 11.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 111.612 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.426 ' HB2' ' CD2' ' A' ' 76' ' ' LEU . 14.3 ptmm? -170.05 115.57 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.649 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.1 p -122.88 103.82 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.129 0.49 . . . . 0.0 111.547 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.786 ' HA ' HG23 ' A' ' 74' ' ' THR . 2.1 p -59.92 88.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.838 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.636 ' O ' ' HB2' ' A' ' 90' ' ' ALA . . . 158.65 -128.93 2.15 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.169 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.675 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . 158.54 39.42 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.825 0.345 . . . . 0.0 110.894 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.626 ' O ' HG22 ' A' ' 95' ' ' ILE . 23.2 p30 -70.91 139.71 85.73 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.744 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.75 -18.41 2.74 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.764 2.309 . . . . 0.0 113.198 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.44 21.63 12.89 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.59 -60.06 0.17 Allowed 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.829 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.047 HD13 HD13 ' A' ' 75' ' ' LEU . 3.9 tp -50.69 -15.15 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.138 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.502 ' HE2' ' HG3' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -92.34 -41.03 10.58 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.0 0.429 . . . . 0.0 110.677 179.351 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.502 ' HG3' ' HE2' ' A' ' 96' ' ' LYS . 72.1 mt-30 -76.45 -32.13 58.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.18 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.39 -32.33 73.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.52 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.932 HG12 HG21 ' A' ' 22' ' ' VAL . 38.9 mt -90.25 -13.47 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.258 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.556 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.4 -72.05 0.59 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.9 0.381 . . . . 0.0 111.186 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -48.45 -29.34 3.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.264 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.509 ' OD1' HD22 ' A' ' 77' ' ' LEU . 3.7 m120 -83.82 -41.69 17.26 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.146 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 52' ' ' PHE . 49.9 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.886 0.374 . . . . 0.0 111.345 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.419 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 87.0 m -150.12 153.86 37.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.573 ' HG2' ' HG3' ' A' ' 54' ' ' LYS . 57.3 mt-30 -89.42 -179.21 5.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.178 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.543 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 17.0 m-85 -130.02 140.03 50.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.016 0.436 . . . . 0.0 111.309 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HD2' ' HG3' ' A' ' 59' ' ' GLU . 34.3 mmtp -112.72 -55.94 2.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.489 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.2 p -105.75 169.39 8.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.559 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.78 -27.84 40.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.1 m -60.85 -16.16 38.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.621 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -90.34 -62.59 1.43 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.227 0.537 . . . . 0.0 111.087 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.95 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -59.85 -24.14 63.97 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.992 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -54.96 -55.7 27.86 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.447 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.1 m -72.01 -23.41 61.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.487 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.63 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -54.98 -38.63 68.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 111.598 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 81' ' ' GLY . 21.3 pt -88.01 -48.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.437 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.37 102.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 85.1 mt-30 44.5 87.52 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.216 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 8.8 t70 -168.37 39.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.352 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.552 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.6 mptp? 62.54 -154.51 0.34 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.686 0.279 . . . . 0.0 110.43 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.861 HD11 ' HB3' ' A' ' 77' ' ' LEU . 62.3 tp -97.92 115.27 27.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.071 0.462 . . . . 0.0 110.882 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.688 HG22 ' HB2' ' A' ' 51' ' ' ASP . 45.8 t -106.89 130.71 58.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.632 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.684 HG11 HD11 ' A' ' 95' ' ' ILE . 56.4 t -99.81 97.96 6.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.547 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.95 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 24.8 t -101.4 126.03 55.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.053 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.573 ' HB3' ' NZ ' ' A' ' 54' ' ' LYS . 38.0 t70 -99.97 131.67 45.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.015 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.069 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.1 m-85 -99.25 50.26 0.95 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.077 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.682 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -53.79 129.58 33.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.352 -179.559 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.762 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -50.39 153.34 1.57 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.724 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.623 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 7.9 t -92.6 21.57 5.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.042 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.462 ' CH2' ' CE ' ' A' ' 72' ' ' MET . 23.7 p-90 -143.58 -42.24 0.28 Allowed 'General case' 0 C--O 1.232 0.167 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 29' ' ' TRP . 50.1 t -29.97 -76.2 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.54 -78.92 0.38 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.446 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -46.98 -29.34 8.33 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.667 2.245 . . . . 0.0 112.217 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.46 ' HA ' HD12 ' A' ' 36' ' ' ILE . 82.5 m -60.19 -20.15 57.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.784 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -74.09 -37.27 64.22 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.6 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.44 ' O ' ' HG2' ' A' ' 35' ' ' MET . 48.6 ttm -72.21 0.88 8.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.381 . . . . 0.0 111.074 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.601 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 59.1 mt -83.2 -25.23 8.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.011 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.566 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.88 -45.84 87.31 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 38.4 Cg_endo -69.91 -37.4 8.85 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.896 1.731 . . . . 0.0 111.588 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 57.1 ttp -64.49 -51.25 63.97 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.838 HD12 ' HE2' ' A' ' 54' ' ' LYS . 55.2 mt -51.73 -27.35 8.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.652 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.635 ' HA ' HG21 ' A' ' 2' ' ' VAL . 87.7 tt0 -77.48 -29.39 52.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.336 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -66.82 -17.98 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.221 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -89.97 -18.45 26.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.425 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.5 t -67.31 -12.32 59.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.158 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.411 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 5.5 tp10 -85.71 -24.39 26.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.707 0.289 . . . . 0.0 111.042 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -90.26 -35.06 15.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.556 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.539 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 69.0 m-85 -122.33 43.9 0.78 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.539 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 90.4 Cg_exo -38.63 -32.45 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.104 2.536 . . . . 0.0 113.224 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -59.41 -38.28 80.21 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.715 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.755 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.78 145.77 24.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.688 ' HB2' HG22 ' A' ' 21' ' ' VAL . 32.7 m-20 -89.98 148.88 22.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.732 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.702 ' O ' HG13 ' A' ' 2' ' ' VAL . 2.6 m-85 -123.39 94.58 4.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.979 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.543 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 53.5 m-85 -108.8 173.78 6.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.997 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.838 ' HE2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -124.61 162.26 24.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.549 HD13 ' C ' ' A' ' 55' ' ' LEU . 2.1 tm? -127.2 108.69 11.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.753 0.311 . . . . 0.0 110.485 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -64.01 112.15 2.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.62 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 26' ' ' TYR . 55.5 t -69.27 -11.15 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.744 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.623 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 4.5 t70 -99.69 -59.92 1.63 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.138 0.495 . . . . 0.0 110.374 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.42 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -53.41 -45.45 69.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.582 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.52 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.3 mm? -81.64 -67.71 0.76 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.378 0.609 . . . . 0.0 110.83 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.11 -64.38 0.52 Allowed Glycine 0 C--N 1.314 -0.66 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.481 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -56.91 -28.82 62.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.615 0.245 . . . . 0.0 111.386 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.848 HG12 ' HE2' ' A' ' 25' ' ' PHE . 16.3 t -73.03 -52.78 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.434 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.92 -24.68 39.22 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.086 0.469 . . . . 0.0 109.806 178.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -90.34 -38.91 13.03 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.169 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.846 ' HE3' HG13 ' A' ' 63' ' ' VAL . 17.3 pttp -59.72 -48.38 81.89 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.893 0.378 . . . . 0.0 110.206 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.414 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.5 m-80 -77.55 -5.1 48.94 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.897 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 66.32 41.74 3.25 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.129 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.687 ' CG1' HG21 ' A' ' 74' ' ' THR . 53.8 t -113.87 86.16 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.122 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 93.3 p -91.46 -21.88 20.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.838 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.48 -173.64 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.762 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -172.76 119.38 0.41 Allowed Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.569 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.601 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 50.6 Cg_endo -83.89 -179.23 21.14 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.939 -1.275 . . . . 0.0 112.158 -0.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.687 HG21 ' CG1' ' A' ' 69' ' ' VAL . 37.0 m -147.03 143.65 28.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.469 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.04 HD13 HD13 ' A' ' 95' ' ' ILE . 79.5 mt -109.78 124.55 51.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.06 0.457 . . . . 0.0 111.812 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.069 HD12 ' CE1' ' A' ' 25' ' ' PHE . 25.1 mt -119.38 127.61 53.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.468 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.861 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.5 mp -109.71 134.08 52.4 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.212 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.593 ' HA ' HG23 ' A' ' 84' ' ' VAL . 53.1 m-85 -133.91 127.99 33.62 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.111 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.49 ' HD3' ' HB2' ' A' ' 20' ' ' LEU . 7.4 mmmm -109.79 127.74 54.85 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.728 0.299 . . . . 0.0 111.47 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.3 m120 45.32 56.43 5.62 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.909 0.385 . . . . 0.0 111.832 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 61.6 14.15 41.61 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.199 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 34.3 mmtp -111.74 -154.18 0.54 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 35.8 tt0 -108.77 171.37 7.47 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 78' ' ' PHE . 59.6 t -144.03 -66.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.745 0.307 . . . . 0.0 111.35 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.17 161.7 8.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.003 0.43 . . . . 0.0 111.524 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -116.69 129.14 55.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.09 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.4 t -154.49 81.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.261 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 88' ' ' VAL . 6.8 p -61.74 85.38 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.009 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.81 110.69 0.26 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.566 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.649 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -100.78 38.9 1.45 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.884 0.374 . . . . 0.0 111.318 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 93' ' ' ALA . 47.4 t30 -79.6 132.01 62.93 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.208 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.491 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 76.0 Cg_exo -44.37 87.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.737 2.292 . . . . 0.0 112.886 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 92' ' ' PRO . . . 173.26 -38.14 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.21 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.58 -46.24 3.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.643 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.04 HD13 HD13 ' A' ' 75' ' ' LEU . 5.0 tp -52.77 -16.12 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.703 0.287 . . . . 0.0 111.148 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.459 ' NZ ' ' HB2' ' A' ' 96' ' ' LYS . 10.4 mtmp? -90.78 -63.06 1.32 Allowed 'General case' 0 CA--C 1.523 -0.091 0 CA-C-O 121.024 0.44 . . . . 0.0 110.623 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -58.8 -33.39 70.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.639 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.62 -30.1 69.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.682 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 59.9 mt -89.9 -7.8 10.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.468 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.32 -72.16 0.58 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.971 0.415 . . . . 0.0 111.273 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.44 -30.73 31.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.337 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.58 ' CB ' HD22 ' A' ' 20' ' ' LEU . 3.9 m120 -80.83 -53.57 6.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.0 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.074 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.851 HG22 ' HE2' ' A' ' 54' ' ' LYS . 11.0 p . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 120.533 0.206 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.0 m -150.18 152.2 34.28 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.177 0.513 . . . . 0.0 111.803 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.412 ' OE1' ' HB2' ' A' ' 54' ' ' LYS . 9.3 mm-40 -90.13 159.03 16.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.003 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.518 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 15.0 m-85 -116.61 99.12 6.92 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.824 -0.351 . . . . 0.0 111.543 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.629 ' O ' HD11 ' A' ' 60' ' ' LEU . 30.7 mmtp -85.92 -27.51 24.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.8 p -127.74 124.23 37.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.479 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.88 -25.15 7.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.364 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.8 m -60.07 -18.69 48.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.574 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -90.33 -40.51 12.06 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.134 0.493 . . . . 0.0 111.207 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.946 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.2 t80 -75.69 -30.88 59.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.812 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -54.57 -49.57 70.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.084 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -71.93 -25.47 61.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.164 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.526 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -56.88 -67.67 0.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.311 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 81' ' ' GLY . 17.8 pt -54.13 -49.47 61.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.776 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -44.78 99.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 44.66 89.66 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.55 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 63.9 t0 -169.38 39.66 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.284 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.554 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.6 mptp? 65.82 -154.56 0.26 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.37 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.729 HD11 ' HB3' ' A' ' 77' ' ' LEU . 54.0 tp -97.78 115.84 28.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.14 0.495 . . . . 0.0 110.774 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.615 HG22 ' HB2' ' A' ' 51' ' ' ASP . 49.1 t -105.94 128.56 60.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.032 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.639 HG21 HG13 ' A' ' 99' ' ' ILE . 44.5 t -99.97 96.81 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.361 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.946 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 41.2 t -101.37 129.42 52.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.085 0.469 . . . . 0.0 111.678 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -99.76 130.06 45.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.327 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.049 ' CE1' HD12 ' A' ' 76' ' ' LEU . 3.6 m-85 -99.12 50.18 0.95 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.011 0.434 . . . . 0.0 110.849 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.621 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -51.05 136.79 22.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.831 179.499 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.739 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -62.09 150.3 38.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.905 0.383 . . . . 0.0 110.973 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.418 ' HB ' ' N ' ' A' ' 58' ' ' ASP . 5.1 t -78.76 -22.67 46.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.339 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.441 ' CH2' ' SD ' ' A' ' 72' ' ' MET . 21.8 p-90 -104.18 -34.91 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.868 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.607 ' CB ' ' HB3' ' A' ' 27' ' ' ALA . 42.2 t -39.47 156.33 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.727 0.299 . . . . 0.0 111.425 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 32' ' ' PRO . . . -86.98 -87.97 1.06 Allowed Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.756 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.411 ' HD3' ' HA3' ' A' ' 31' ' ' GLY . 18.0 Cg_exo -66.72 61.92 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.896 2.397 . . . . 0.0 112.645 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.8 p -129.45 -4.1 4.83 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.376 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -99.02 -24.96 14.72 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.673 0.273 . . . . 0.0 111.433 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.8 mmt -68.74 -0.25 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.318 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.89 HG22 HG13 ' A' ' 40' ' ' ILE . 64.5 mt -82.66 -27.63 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.867 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.511 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -47.54 -46.04 58.86 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 41.5 Cg_endo -72.51 -36.81 4.74 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.788 1.659 . . . . 0.0 110.763 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.653 ' HE3' ' HB1' ' A' ' 90' ' ' ALA . 1.7 tmt? -62.26 -51.88 65.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.196 178.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.89 HG13 HG22 ' A' ' 36' ' ' ILE . 55.9 mt -51.45 -29.25 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.629 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.501 ' HB2' HG11 ' A' ' 2' ' ' VAL . 39.2 tt0 -76.31 -40.02 52.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.484 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -55.36 -24.63 30.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.371 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.522 ' CZ ' ' HE1' ' A' ' 39' ' ' MET . 5.1 m-85 -90.29 -22.85 21.37 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.455 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 87.1 p -70.09 -8.36 48.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.156 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.41 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 5.4 tp10 -90.02 -25.88 20.6 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.739 0.304 . . . . 0.0 110.998 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -90.4 -29.53 17.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.582 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.53 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 78.1 m-85 -122.86 44.94 0.98 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.356 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 84.1 Cg_exo -38.18 -32.02 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.088 2.525 . . . . 0.0 113.262 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -59.01 -40.86 86.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.561 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.707 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.88 141.37 28.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.709 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.615 ' HB2' HG22 ' A' ' 21' ' ' VAL . 57.1 m-20 -89.98 125.44 35.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.909 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.455 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 4.6 m-85 -99.84 93.87 6.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.532 ' C ' ' HD3' ' A' ' 54' ' ' LYS . 47.2 m-85 -107.42 179.43 4.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.917 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.851 ' HE2' HG22 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -137.9 153.88 49.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.691 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.543 HD13 ' C ' ' A' ' 55' ' ' LEU . 2.8 tm? -112.33 118.83 36.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.445 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.1 m-20 -78.25 108.37 11.52 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.566 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 57' ' ' VAL . 90.6 t -75.46 -5.03 6.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.024 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.418 ' N ' ' HB ' ' A' ' 28' ' ' THR . 67.1 t0 -80.34 -46.8 15.48 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.795 0.331 . . . . 0.0 110.826 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.548 ' C ' HD12 ' A' ' 60' ' ' LEU . 5.5 tp10 -97.99 -24.56 15.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.115 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.672 ' N ' HD12 ' A' ' 60' ' ' LEU . 3.4 mp -113.47 52.64 0.8 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.86 0.362 . . . . 0.0 111.055 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.82 -15.55 58.04 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.707 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.36 -26.36 32.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.664 0.269 . . . . 0.0 111.486 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.839 HG12 ' HE2' ' A' ' 25' ' ' PHE . 11.7 t -78.76 -22.75 12.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.865 0.364 . . . . 0.0 110.889 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.58 -24.85 38.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -90.22 -31.72 16.89 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.779 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -59.35 -47.96 83.45 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.043 0.449 . . . . 0.0 110.077 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.411 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.4 m-80 -86.86 -0.01 55.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.064 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 62.15 41.32 10.85 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.056 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.513 HG13 HG21 ' A' ' 74' ' ' THR . 47.5 t -106.27 116.54 50.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.116 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.8 p -149.87 18.69 0.89 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.695 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 1.031 ' HB3' HG21 ' A' ' 88' ' ' VAL . . . -70.15 -16.58 63.11 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.908 0.385 . . . . 0.0 110.779 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.739 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 11.4 ptt? 43.54 93.31 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.206 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.701 ' HG3' HD11 ' A' ' 36' ' ' ILE . 13.2 Cg_endo -92.6 -156.43 0.64 Allowed 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 125.077 -0.801 . . . . 0.0 112.319 -0.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.513 HG21 HG13 ' A' ' 69' ' ' VAL . 89.2 m -164.63 162.53 21.54 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.958 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.039 HD13 HD13 ' A' ' 95' ' ' ILE . 68.5 mt -123.46 123.62 41.05 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.68 0.276 . . . . 0.0 110.796 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.049 HD12 ' CE1' ' A' ' 25' ' ' PHE . 23.4 mt -118.74 131.5 56.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.0 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.729 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.5 mp -109.75 137.04 48.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.039 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.613 ' HA ' HG23 ' A' ' 84' ' ' VAL . 67.8 m-85 -136.88 126.03 24.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.276 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.713 ' HG3' HD13 ' A' ' 20' ' ' LEU . 8.6 mtmp? -113.39 126.71 55.66 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.64 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.512 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 74.6 m-80 46.26 75.43 0.12 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.617 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 40.95 39.5 1.99 Allowed Glycine 0 C--N 1.331 0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.619 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 31.9 mmmt -143.51 -158.58 0.89 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.425 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 86.5 tt0 -108.82 175.17 5.56 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.684 HG13 ' HE3' ' A' ' 79' ' ' LYS . 14.3 t -149.14 -66.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 110.946 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.13 154.42 4.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.138 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -117.79 120.63 38.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.735 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 49.1 t -139.06 93.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.138 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 1.031 HG21 ' HB3' ' A' ' 71' ' ' ALA . 4.6 p -67.56 120.85 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.964 0.411 . . . . 0.0 110.878 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.93 102.22 1.61 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.236 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.7 ' HB2' HD21 ' A' ' 75' ' ' LEU . . . -94.41 37.58 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 111.208 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 93' ' ' ALA . 46.1 t30 -83.47 134.37 45.39 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.017 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -40.73 89.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.75 2.3 . . . . 0.0 112.693 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 179.56 -32.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.301 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.11 -42.47 0.98 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.039 HD13 HD13 ' A' ' 75' ' ' LEU . 6.4 tp -53.73 -14.76 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.471 0.177 . . . . 0.0 111.449 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.428 ' HG2' ' N ' ' A' ' 97' ' ' GLN . 14.2 tttm -92.02 -61.87 1.53 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.92 0.39 . . . . 0.0 111.004 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.512 ' NE2' ' H ' ' A' ' 97' ' ' GLN . 0.3 OUTLIER -66.64 -34.83 78.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.991 -179.531 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.42 -30.26 62.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.094 0.473 . . . . 0.0 110.646 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.917 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.5 mp -90.18 -8.43 10.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.627 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.23 -75.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.319 . . . . 0.0 111.34 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.88 -29.52 8.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.356 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.592 ' HB3' HD22 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -78.54 -50.66 11.18 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.916 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.543 ' HB2' HD23 ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.03 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 52' ' ' PHE . 13.1 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.74 0.305 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 4' ' ' GLN . 85.6 m -150.15 161.69 41.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.964 0.411 . . . . 0.0 111.433 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.609 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 64.5 mt-30 -96.88 -179.34 4.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.375 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.52 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 18.1 m-85 -132.31 95.94 3.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.188 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.79 ' O ' HD11 ' A' ' 60' ' ' LEU . 74.6 mmtt -80.77 -19.53 44.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.6 p -134.37 122.71 22.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.375 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.47 -25.41 6.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.599 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.1 t -60.63 -17.23 45.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.769 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -90.5 -45.78 8.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.158 0.504 . . . . 0.0 111.476 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.904 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.2 t80 -69.08 -23.26 64.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.087 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -57.37 -40.09 77.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.394 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -86.48 -24.46 25.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.528 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.683 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -56.94 -38.61 73.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.542 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.542 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.1 pt -86.76 -49.41 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.543 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.505 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -44.3 100.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 84.3 mt-30 44.98 90.19 0.01 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.4 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 8.5 t0 -173.66 40.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.063 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.559 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.8 mptp? 63.92 -157.28 0.31 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.447 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.851 HD11 ' HB3' ' A' ' 77' ' ' LEU . 59.1 tp -98.19 117.87 33.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.112 0.482 . . . . 0.0 110.914 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 51' ' ' ASP . 53.4 t -101.66 137.58 28.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.617 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.7 t -99.93 87.5 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.368 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.904 HG21 ' CE1' ' A' ' 11' ' ' PHE . 29.0 t -99.91 121.6 50.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.357 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -100.0 134.38 43.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.61 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.041 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.2 m-85 -99.19 52.36 0.95 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.931 0.395 . . . . 0.0 110.577 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -51.81 138.15 24.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -68.23 138.08 55.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.549 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -58.41 -14.37 7.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.403 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.519 ' CH2' ' HE2' ' A' ' 72' ' ' MET . 5.7 p-90 -112.25 -123.83 0.28 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.092 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 36.8 t 60.74 -83.18 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.561 0.344 . . . . 0.0 110.824 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.64 -79.8 0.22 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.145 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.65 -22.15 73.66 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.884 2.389 . . . . 0.0 113.254 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 98.4 m -50.04 -27.66 5.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.615 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -77.7 -28.25 50.95 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.524 -179.55 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.4 mtp -76.58 4.43 9.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.859 0.361 . . . . 0.0 110.85 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.805 HG22 HG13 ' A' ' 40' ' ' ILE . 70.8 mt -86.31 -20.44 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.023 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.554 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -52.15 -44.07 91.77 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 46.4 Cg_endo -72.36 -35.15 6.83 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.835 1.69 . . . . 0.0 111.417 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.9 ttt -65.84 -52.13 53.06 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.805 HG13 HG22 ' A' ' 36' ' ' ILE . 63.8 mt -49.92 -28.41 4.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.536 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.574 ' HB2' HG11 ' A' ' 2' ' ' VAL . 88.7 tt0 -76.69 -36.55 57.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.364 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.463 ' HB3' ' NZ ' ' A' ' 42' ' ' LYS . 9.3 mtpm? -58.56 -21.45 52.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.145 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.13 -22.34 21.8 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.36 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.461 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.2 t -65.6 -11.73 46.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.312 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -86.28 -25.17 25.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.661 0.267 . . . . 0.0 111.366 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.27 -28.68 18.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.792 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.528 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 80.4 m-85 -122.78 45.2 1.02 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.5 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 86.1 Cg_exo -37.98 -32.79 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.163 2.575 . . . . 0.0 113.601 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.5 mm-40 -63.69 -37.09 86.04 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.751 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.613 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.84 138.79 31.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.789 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.611 ' O ' HG13 ' A' ' 21' ' ' VAL . 59.0 m-20 -89.76 127.11 35.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.916 0.388 . . . . 0.0 110.579 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.821 ' O ' HG23 ' A' ' 2' ' ' VAL . 4.9 m-85 -98.58 86.59 3.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.717 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.52 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 36.6 m-85 -96.48 -175.73 3.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.88 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.75 ' CD ' HD12 ' A' ' 40' ' ' ILE . 34.4 mtmm -150.1 138.78 20.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.952 0.406 . . . . 0.0 111.293 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.633 HD13 ' N ' ' A' ' 56' ' ' ASP . 3.0 tm? -95.22 129.72 42.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.07 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.633 ' N ' HD13 ' A' ' 55' ' ' LEU . 41.4 m-20 -86.98 110.46 20.06 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.888 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 57' ' ' VAL . 84.2 t -78.81 -4.51 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.012 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -84.63 -55.29 4.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.977 0.418 . . . . 0.0 110.827 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.748 ' C ' HD12 ' A' ' 60' ' ' LEU . 41.6 tp10 -87.26 -17.31 32.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.398 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.79 HD11 ' O ' ' A' ' 6' ' ' LYS . 2.3 mp -127.09 57.93 1.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.929 0.395 . . . . 0.0 111.092 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.64 -16.11 55.04 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.384 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -79.95 -29.63 39.7 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.575 0.226 . . . . 0.0 111.57 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.851 HG12 ' HE2' ' A' ' 25' ' ' PHE . 21.8 t -73.49 -27.56 23.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.961 0.41 . . . . 0.0 110.956 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.518 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -80.01 -26.83 39.7 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -90.4 -31.0 17.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.823 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 13.9 ptmm? -60.31 -48.06 83.35 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.969 0.414 . . . . 0.0 109.984 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.438 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 75.3 m-80 -84.95 1.65 46.44 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.784 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 65.41 37.74 6.07 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.332 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.674 ' CG1' HG21 ' A' ' 74' ' ' THR . 48.9 t -111.61 75.19 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.815 0.341 . . . . 0.0 111.053 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.6 p -89.35 5.59 44.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.136 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -60.68 -159.01 0.01 OUTLIER 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.575 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.61 ' HG2' ' O ' ' A' ' 72' ' ' MET . 1.5 pmm? -174.98 93.2 0.29 Allowed Pre-proline 0 CA--C 1.53 0.192 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.593 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 8.0 Cg_endo -94.04 -156.69 0.57 Allowed 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 124.904 -0.873 . . . . 0.0 112.502 -0.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.674 HG21 ' CG1' ' A' ' 69' ' ' VAL . 53.4 m -158.09 148.44 20.4 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.81 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.109 HD13 HD13 ' A' ' 95' ' ' ILE . 90.5 mt -109.89 123.31 49.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.185 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.041 HD12 ' CE1' ' A' ' 25' ' ' PHE . 20.2 mt -122.76 128.96 51.17 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.837 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.851 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.5 mp -109.96 144.66 38.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.959 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.647 ' HA ' HG23 ' A' ' 84' ' ' VAL . 65.5 m-85 -145.04 126.09 14.57 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.577 ' HG3' HD13 ' A' ' 20' ' ' LEU . 51.8 mtmt -113.46 132.96 55.46 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.694 0.283 . . . . 0.0 111.493 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.3 m120 47.96 53.34 11.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.9 0.381 . . . . 0.0 111.742 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 59.43 16.07 34.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.978 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 74.7 mmtt -111.19 -153.92 0.53 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -108.81 173.79 6.16 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.647 HG23 ' HA ' ' A' ' 78' ' ' PHE . 58.0 t -149.18 -63.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.853 0.358 . . . . 0.0 111.165 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.49 162.8 8.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.2 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -138.53 115.16 10.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.543 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.5 t -136.41 98.89 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.17 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.613 ' HA ' HG23 ' A' ' 74' ' ' THR . 2.4 p -56.92 116.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.967 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.639 ' O ' ' HB2' ' A' ' 90' ' ' ALA . . . 141.52 -140.26 10.09 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.989 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 89' ' ' GLY . . . 147.61 36.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.818 0.447 . . . . 0.0 110.867 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 93' ' ' ALA . 75.3 m-80 -86.94 143.46 35.2 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.576 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -48.87 85.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.581 2.187 . . . . 0.0 112.478 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -179.48 -37.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.487 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.46 -44.34 2.13 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.109 HD13 HD13 ' A' ' 75' ' ' LEU . 3.2 tp -50.1 -18.61 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.464 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.463 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 7.8 ptpp? -91.71 -49.52 6.23 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.971 0.415 . . . . 0.0 110.974 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.463 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 84.2 mt-30 -69.22 -32.11 71.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.48 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.65 -27.76 68.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.534 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.833 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 58.4 mt -90.22 -11.54 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.511 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.43 -74.21 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.917 0.389 . . . . 0.0 111.492 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -45.93 -29.5 1.44 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.378 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.738 ' HB3' HD22 ' A' ' 20' ' ' LEU . 69.8 m-20 -90.14 -42.34 11.12 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.269 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.833 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.081 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.541 HG11 ' HB2' ' A' ' 41' ' ' GLU . 12.5 p . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.652 0.263 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.3 m -150.26 156.54 41.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.946 0.403 . . . . 0.0 111.403 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -99.57 -173.44 2.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.621 179.368 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.527 ' CE2' ' CD1' ' A' ' 11' ' ' PHE . 21.4 m-85 -137.5 101.33 4.47 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.61 ' C ' HD11 ' A' ' 60' ' ' LEU . 43.9 mmtm -83.19 -20.41 34.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.283 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -133.03 122.84 24.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.147 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.12 -26.49 27.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.49 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -55.33 -23.41 23.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.188 0.518 . . . . 0.0 110.392 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -90.69 -35.19 15.07 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.627 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.88 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -74.76 -24.11 58.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.948 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -58.75 -68.68 0.24 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.066 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.4 t -56.74 -23.56 43.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.447 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 11' ' ' PHE . . . -52.46 -64.36 0.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.36 . . . . 0.0 111.472 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.7 pt -61.03 -47.23 94.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.486 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -40.28 97.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.7 mt-30 43.14 88.58 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.309 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.509 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 63.9 t0 -167.11 38.5 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.671 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 28.7 mtmt 70.07 -155.46 0.14 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.799 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.537 ' CD1' HG21 ' A' ' 84' ' ' VAL . 36.4 tp -97.6 112.07 24.09 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.144 0.497 . . . . 0.0 110.574 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.776 HG22 ' HB2' ' A' ' 51' ' ' ASP . 47.3 t -101.44 124.73 55.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.536 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.724 HG21 HG12 ' A' ' 99' ' ' ILE . 50.4 t -103.51 98.79 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.141 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.88 HG21 ' CE1' ' A' ' 11' ' ' PHE . 38.2 t -105.74 131.69 54.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.775 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 74' ' ' THR . 62.2 t0 -100.1 132.53 45.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.53 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.056 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.2 m-85 -99.11 49.13 0.95 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.069 0.462 . . . . 0.0 110.524 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.58 ' HB2' ' HB3' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -50.42 145.87 5.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.44 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.792 ' HB2' ' CB ' ' A' ' 72' ' ' MET . . . -59.99 164.91 3.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.77 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.441 ' HB ' ' N ' ' A' ' 58' ' ' ASP . 3.1 t -96.75 22.74 7.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.913 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -148.82 -44.77 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 39.1 t -43.3 156.11 0.05 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.836 0.35 . . . . 0.0 111.373 -179.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -93.41 -69.34 1.1 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.239 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -47.07 -25.95 4.64 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.983 2.456 . . . . 0.0 112.955 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 98.7 m -61.8 -63.07 1.38 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.704 0.288 . . . . 0.0 111.623 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 61.9 pttt -55.45 -22.02 18.68 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.602 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.418 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 44.4 tpp -76.43 1.43 16.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 110.776 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.916 HG22 HG13 ' A' ' 40' ' ' ILE . 63.1 mt -85.93 -18.08 9.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.401 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.529 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.32 -44.4 81.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 53.9 Cg_endo -73.36 -35.4 4.98 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.837 1.691 . . . . 0.0 111.438 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.74 ' CE ' HG23 ' A' ' 36' ' ' ILE . 57.3 ttp -65.33 -52.04 56.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.916 HG13 HG22 ' A' ' 36' ' ' ILE . 73.1 mt -48.18 -29.51 2.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.56 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.541 ' HB2' HG11 ' A' ' 2' ' ' VAL . 87.1 tt0 -76.92 -34.31 57.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.977 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -63.91 -22.89 67.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.62 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -90.37 -22.51 21.46 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.463 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 80.2 p -67.29 -9.17 38.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.486 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -88.62 -26.22 22.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.78 0.324 . . . . 0.0 111.174 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -90.53 -29.79 17.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.842 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.529 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 78.6 m-85 -122.79 45.63 1.12 Allowed Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.502 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 84.0 Cg_exo -38.05 -32.16 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.22 2.613 . . . . 0.0 113.952 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.498 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 53.7 mm-40 -66.91 -16.83 64.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.927 0.394 . . . . 0.0 111.31 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -104.04 139.89 38.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.559 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.776 ' HB2' HG22 ' A' ' 21' ' ' VAL . 24.9 m-20 -89.44 120.99 31.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.907 0.384 . . . . 0.0 110.359 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.555 ' CE2' HD13 ' A' ' 99' ' ' ILE . 5.3 m-85 -97.92 83.88 3.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.313 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.599 ' HB2' HG22 ' A' ' 23' ' ' VAL . 46.5 m-85 -99.52 -174.53 2.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.354 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.655 ' CD ' HD12 ' A' ' 40' ' ' ILE . 32.6 mtmm -150.21 141.69 23.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.943 0.401 . . . . 0.0 110.964 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.711 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.5 tm? -100.41 130.34 46.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.866 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.711 ' N ' HD13 ' A' ' 55' ' ' LEU . 44.6 m-20 -87.87 114.07 24.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.856 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.521 ' O ' HG12 ' A' ' 57' ' ' VAL . 78.3 t -77.54 -3.08 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.65 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.441 ' N ' ' HB ' ' A' ' 28' ' ' THR . 64.9 t0 -82.05 -55.53 4.51 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.899 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.453 ' C ' HD12 ' A' ' 60' ' ' LEU . 41.0 tp10 -89.82 -28.46 19.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.391 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.659 ' N ' HD12 ' A' ' 60' ' ' LEU . 3.8 mp -108.23 52.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.848 0.356 . . . . 0.0 111.116 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.9 -15.21 59.9 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.447 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -82.94 -29.12 29.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.716 0.293 . . . . 0.0 111.448 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.756 HG12 ' HE2' ' A' ' 25' ' ' PHE . 15.4 t -73.33 -51.1 27.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.454 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -54.47 -26.02 28.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.114 0.483 . . . . 0.0 109.718 178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.7 tm0? -90.46 -37.82 13.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.07 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -61.64 -42.53 99.02 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.903 0.382 . . . . 0.0 110.352 -179.581 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -83.68 -0.46 50.83 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 65.67 35.45 6.96 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.334 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.68 ' CG1' HG21 ' A' ' 74' ' ' THR . 31.2 t -113.16 63.51 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 121.03 0.443 . . . . 0.0 110.867 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.2 p -74.57 -13.85 60.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.074 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.79 -168.77 0.0 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.414 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.792 ' CB ' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -174.29 111.82 0.3 Allowed Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.207 -179.838 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.517 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 57.3 Cg_endo -88.99 -166.73 3.19 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.275 -1.136 . . . . 0.0 112.398 -0.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.747 HG23 ' HA ' ' A' ' 88' ' ' VAL . 34.1 m -159.81 150.07 18.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.604 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.052 HD13 HD13 ' A' ' 95' ' ' ILE . 71.8 mt -110.78 124.8 52.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.888 0.375 . . . . 0.0 111.591 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.056 HD12 ' CE1' ' A' ' 25' ' ' PHE . 29.4 mt -124.72 124.14 41.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.465 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.667 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.3 mp -109.91 149.19 30.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.786 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.601 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 40.5 m-85 -149.29 128.55 12.87 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.128 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.823 ' HG3' HG11 ' A' ' 84' ' ' VAL . 9.8 mtpm? -114.99 137.33 52.12 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.477 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 6.2 m120 49.93 52.35 14.83 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.721 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 16' ' ' ALA . . . 57.78 18.7 33.17 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.732 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.601 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 67.1 mttm -120.01 -155.56 0.63 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.743 ' O ' HG13 ' A' ' 84' ' ' VAL . 85.8 tt0 -109.13 176.93 4.92 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.823 HG11 ' HG3' ' A' ' 79' ' ' LYS . 3.5 m -165.38 -47.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.44 0.162 . . . . 0.0 111.301 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.69 170.37 9.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.142 0.496 . . . . 0.0 112.019 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -160.12 132.19 6.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.355 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.4 t -146.02 109.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.147 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.747 ' HA ' HG23 ' A' ' 74' ' ' THR . 6.5 p -69.55 69.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.814 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.2 118.29 0.56 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.349 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.677 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -95.96 38.0 1.2 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.914 0.388 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 93' ' ' ALA . 5.5 m120 -65.89 132.21 94.71 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.545 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 86.5 Cg_exo -48.4 86.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.66 2.24 . . . . 0.0 112.668 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 92' ' ' PRO . . . 176.8 -36.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.267 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.04 -46.87 2.7 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 1.052 HD13 HD13 ' A' ' 75' ' ' LEU . 4.7 tp -53.58 -15.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.211 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HG3' ' HG3' ' A' ' 97' ' ' GLN . 21.3 ptmt -91.38 -50.95 5.53 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.791 0.329 . . . . 0.0 111.086 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.421 ' HG3' ' HG3' ' A' ' 96' ' ' LYS . 73.0 mt-30 -73.79 -32.97 64.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.478 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.02 -26.44 66.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.59 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.724 HG12 HG21 ' A' ' 22' ' ' VAL . 63.7 mt -90.24 -18.27 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.107 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.74 -65.49 1.01 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.007 0.432 . . . . 0.0 111.104 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -48.96 -28.26 3.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.217 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.526 ' CB ' HD22 ' A' ' 20' ' ' LEU . 50.8 m-20 -90.23 -38.71 13.26 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.34 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.197 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.798 0.332 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.492 HG11 ' HB2' ' A' ' 41' ' ' GLU . 10.7 p -167.7 135.91 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.802 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.449 HG22 ' N ' ' A' ' 4' ' ' GLN . 86.0 m -150.11 161.77 41.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.884 0.373 . . . . 0.0 111.253 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.462 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 61.5 mt-30 -102.93 -172.68 2.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.39 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.531 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.2 m-85 -137.52 129.32 28.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.059 0.457 . . . . 0.0 111.461 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.716 ' C ' HD11 ' A' ' 60' ' ' LEU . 75.2 mmtt -112.98 -28.24 7.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.498 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.0 p -128.57 132.49 48.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.515 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.44 -25.34 50.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.51 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.3 t -59.74 -18.35 42.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.621 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -90.42 -64.94 1.06 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.277 0.561 . . . . 0.0 111.031 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.897 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.2 t80 -53.54 -29.0 34.63 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.015 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -54.89 -35.29 63.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.018 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.3 p -82.5 -37.49 25.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.111 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.594 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -46.74 -49.12 20.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.66 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.5 pt -77.58 -49.91 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.501 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.48 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -40.74 95.43 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 85.1 mt-30 44.35 86.66 0.02 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.422 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 8.1 t0 -169.54 41.14 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.407 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.56 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 10.9 mptt 67.56 -155.41 0.21 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.694 0.283 . . . . 0.0 110.888 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.898 HD11 ' HB3' ' A' ' 77' ' ' LEU . 61.5 tp -98.1 115.21 27.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.222 0.534 . . . . 0.0 111.252 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.511 HG12 HG23 ' A' ' 23' ' ' VAL . 59.9 t -99.79 128.2 51.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.471 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.678 HG21 ' CD1' ' A' ' 99' ' ' ILE . 48.8 t -99.74 91.22 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 110.816 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.897 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 42.0 t -101.27 132.19 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.125 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.9 t70 -102.43 129.11 48.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.73 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.071 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.4 m-85 -98.98 51.6 0.96 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.206 0.527 . . . . 0.0 110.467 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.533 ' O ' HG23 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -50.99 139.44 17.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.111 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 71' ' ' ALA . . . -65.58 141.75 58.32 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.331 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.6 t -57.91 -18.13 21.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.069 0.461 . . . . 0.0 110.835 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.422 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 8.2 p-90 -106.61 -128.74 0.27 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.315 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 72' ' ' MET . 30.2 t 61.08 156.08 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.805 0.336 . . . . 0.0 110.979 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.09 -82.1 1.19 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.488 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.97 60.85 3.79 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.627 2.218 . . . . 0.0 112.33 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.7 p -107.61 -20.83 13.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.024 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -85.71 -24.11 27.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.119 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.454 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 57.7 ttp -63.44 -12.69 33.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.982 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.772 HG22 HG13 ' A' ' 40' ' ' ILE . 2.7 mp -81.99 -30.22 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.669 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -49.5 -45.72 77.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 37.8 Cg_endo -70.86 -37.65 6.28 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.722 1.615 . . . . 0.0 111.012 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.494 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 66.4 mtm -63.92 -54.94 26.81 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.772 HG13 HG22 ' A' ' 36' ' ' ILE . 55.7 mt -44.74 -29.08 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.069 0.461 . . . . 0.0 110.542 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.492 ' HB2' HG11 ' A' ' 2' ' ' VAL . 38.3 tt0 -81.59 -40.32 23.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.176 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -59.82 -27.9 67.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.627 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.616 ' CE2' HG23 ' A' ' 95' ' ' ILE . 10.4 m-85 -78.02 -22.43 49.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.625 0.25 . . . . 0.0 111.389 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.446 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 46.9 t -66.65 -11.32 53.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.206 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -87.44 -26.09 23.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.64 0.257 . . . . 0.0 111.096 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -89.98 -31.73 17.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.199 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.479 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 89.7 m-85 -124.39 51.61 4.85 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.02 0.438 . . . . 0.0 110.489 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 2.9 Cg_endo -48.95 -25.43 8.66 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.034 2.489 . . . . 0.0 112.484 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -65.77 -31.49 72.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.054 0.454 . . . . 0.0 110.229 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.742 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -95.77 144.48 26.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.86 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.489 ' HB2' HG22 ' A' ' 21' ' ' VAL . 58.9 m-20 -89.96 129.98 36.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.709 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.479 ' CZ ' HD13 ' A' ' 99' ' ' ILE . 8.8 m-85 -105.09 90.94 3.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.391 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.628 ' HB2' HG22 ' A' ' 23' ' ' VAL . 47.5 m-85 -101.01 -178.12 3.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.559 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HZ2' HD12 ' A' ' 40' ' ' ILE . 20.1 mtpp -141.9 141.27 33.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.395 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.911 HD13 ' N ' ' A' ' 56' ' ' ASP . 3.0 tm? -105.26 144.23 32.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.29 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.911 ' N ' HD13 ' A' ' 55' ' ' LEU . 22.9 t70 -99.9 115.5 29.77 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.075 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 26' ' ' TYR . 75.5 t -76.83 -4.0 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.919 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.442 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 38.6 t70 -96.21 -50.09 4.95 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.254 0.549 . . . . 0.0 110.215 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.494 ' C ' HD12 ' A' ' 60' ' ' LEU . 5.1 tp10 -82.16 -40.28 22.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.652 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.724 HD22 ' CD2' ' A' ' 55' ' ' LEU . 4.1 mp -111.67 43.53 1.52 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.545 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.6 -24.05 16.45 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.762 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 56.6 m-20 -71.04 -50.09 37.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.688 0.28 . . . . 0.0 111.256 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.756 HG12 ' HE2' ' A' ' 25' ' ' PHE . 15.6 t -56.37 -23.85 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.142 0.496 . . . . 0.0 110.244 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -80.35 -25.2 39.33 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 3.2 pt20 -90.21 -35.4 15.36 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.272 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 20.2 ptmt -57.79 -48.45 79.66 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.421 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.435 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 75.6 m-80 -85.48 2.18 45.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.048 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 63.92 38.94 8.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.905 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.765 HG13 HG21 ' A' ' 74' ' ' THR . 43.8 t -116.39 99.82 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.899 0.38 . . . . 0.0 111.398 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.7 m -121.7 13.17 10.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.816 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -60.9 -157.9 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.092 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.604 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -169.75 88.19 0.57 Allowed Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.457 ' O ' HG23 ' A' ' 88' ' ' VAL . 40.3 Cg_endo -96.71 -164.57 0.99 Allowed 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 124.777 -0.926 . . . . 0.0 112.793 -0.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.816 ' OG1' ' HB3' ' A' ' 71' ' ' ALA . 29.3 m -149.98 153.91 37.35 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.701 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.016 HD13 HD13 ' A' ' 95' ' ' ILE . 85.3 mt -114.33 126.58 55.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.819 0.342 . . . . 0.0 111.235 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.071 HD12 ' CE1' ' A' ' 25' ' ' PHE . 19.1 mt -121.76 128.68 52.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.014 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.898 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.6 mp -109.89 141.88 41.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.628 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.607 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 65.1 m-85 -141.88 127.13 18.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.697 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.838 ' CG ' HG11 ' A' ' 84' ' ' VAL . 8.9 mmmm -109.82 133.17 53.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.53 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 5.2 m120 42.88 65.17 0.99 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.01 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 53.96 21.02 15.65 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.155 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.607 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 28.1 mtpp -127.33 -160.82 1.03 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.633 ' O ' HG13 ' A' ' 84' ' ' VAL . 82.3 tt0 -109.47 178.06 4.55 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.838 HG11 ' CG ' ' A' ' 79' ' ' LYS . 4.8 m -162.38 -47.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 O-C-N 123.1 0.25 . . . . 0.0 111.144 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.96 162.07 17.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.125 0.488 . . . . 0.0 111.874 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -149.09 115.39 5.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.267 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.3 t -131.1 98.66 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.331 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.597 HG21 ' CB ' ' A' ' 71' ' ' ALA . 3.3 p -62.33 98.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.696 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.98 108.52 0.81 Allowed Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.2 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.683 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -95.68 37.13 1.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 111.259 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 93' ' ' ALA . 75.9 m-80 -72.04 131.77 85.17 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.237 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -45.91 86.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.689 2.26 . . . . 0.0 112.637 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 178.51 -36.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.525 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.23 -45.62 2.44 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.016 HD13 HD13 ' A' ' 75' ' ' LEU . 5.0 tp -49.94 -18.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.302 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 22.4 pttp -91.76 -50.97 5.46 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.903 0.382 . . . . 0.0 111.049 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.405 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 61.7 mt-30 -69.9 -32.1 70.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.599 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.1 -28.46 69.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.748 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.678 ' CD1' HG21 ' A' ' 22' ' ' VAL . 56.7 mt -90.22 -8.08 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.526 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.26 -69.39 0.73 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.866 0.365 . . . . 0.0 111.162 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.99 -29.61 30.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.177 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.623 ' CB ' HD22 ' A' ' 20' ' ' LEU . 5.6 m120 -80.75 -52.91 6.99 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.053 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.041 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.661 ' O ' HG12 ' A' ' 2' ' ' VAL . 26.5 ptt? . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 1' ' ' MET . 11.2 p 52.03 131.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.23 0.538 . . . . 0.0 112.048 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 4' ' ' GLN . 88.9 m -150.17 162.42 40.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.133 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.532 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 59.5 mt-30 -101.04 178.77 4.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.631 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.52 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 18.4 m-85 -133.17 98.48 4.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.712 0.291 . . . . 0.0 111.598 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.728 ' O ' HD11 ' A' ' 60' ' ' LEU . 45.8 mmtm -83.52 -28.31 28.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.44 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.3 p -123.36 122.62 38.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.255 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.59 -26.4 8.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.687 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.9 t -59.22 -19.85 49.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.829 0.347 . . . . 0.0 110.426 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -90.73 -31.07 16.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.358 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.88 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -85.86 8.45 20.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.391 -179.303 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -87.7 -60.58 1.93 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.867 0.365 . . . . 0.0 110.923 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -67.01 -17.17 64.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.28 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.48 91.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.377 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.554 ' O ' ' N ' ' A' ' 81' ' ' GLY . 21.4 pt -88.89 -49.92 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.465 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.478 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -46.29 103.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.847 0.356 . . . . 0.0 111.955 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.9 mt-30 44.01 87.45 0.02 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.29 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -168.84 40.67 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.035 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.555 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER 64.33 -156.88 0.31 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.281 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.764 HD13 ' N ' ' A' ' 103' ' ' ALA . 3.4 tt -98.15 115.85 29.14 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.205 0.526 . . . . 0.0 110.782 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.794 HG22 ' HB2' ' A' ' 51' ' ' ASP . 47.3 t -104.73 127.87 58.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.135 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.779 HG22 ' HG ' ' A' ' 77' ' ' LEU . 61.6 t -103.69 95.21 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.552 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.88 HG21 ' CE1' ' A' ' 11' ' ' PHE . 40.5 t -99.85 136.73 29.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.204 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 74' ' ' THR . 38.8 t70 -100.01 128.1 46.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.825 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.996 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.2 m-85 -98.89 48.69 0.96 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.012 0.434 . . . . 0.0 110.683 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.521 ' O ' ' HD1' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -51.48 137.04 24.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.889 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.789 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -58.39 165.01 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.965 0.412 . . . . 0.0 111.042 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.5 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 3.7 t -98.67 19.24 15.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.066 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.428 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 15.4 p-90 -141.76 -38.71 0.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.8 t -36.87 -69.06 0.12 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.781 0.325 . . . . 0.0 111.801 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.87 -74.42 0.23 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.511 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.6 -26.95 9.86 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.666 2.244 . . . . 0.0 112.421 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.417 ' HB3' ' CB ' ' A' ' 26' ' ' TYR . 77.5 m -58.25 -21.21 47.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.203 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -75.32 -19.22 59.76 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.28 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.425 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 84.4 mtp -75.3 3.8 8.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.357 . . . . 0.0 110.691 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.039 HG22 HG13 ' A' ' 40' ' ' ILE . 55.1 mt -85.68 -17.8 9.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.487 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.592 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.51 -42.33 74.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 35.3 Cg_endo -68.93 -43.58 3.3 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.576 1.517 . . . . 0.0 111.324 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.589 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 23.9 mmt -61.23 -61.28 2.67 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.039 HG13 HG22 ' A' ' 36' ' ' ILE . 56.8 mt -43.73 -29.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.846 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.618 ' HB2' HG11 ' A' ' 2' ' ' VAL . 4.0 tm-20 -81.56 -37.8 27.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.822 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 39' ' ' MET . 99.3 mttt -71.6 -30.96 66.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.544 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.589 ' HD1' ' O ' ' A' ' 39' ' ' MET . 16.3 m-85 -73.15 -27.07 61.46 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.356 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.5 p -67.02 -9.7 41.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.147 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.409 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 56.2 mt-10 -87.26 -26.51 23.44 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.788 0.327 . . . . 0.0 111.222 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.4 -31.79 16.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.524 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.531 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 73.9 m-85 -122.78 45.19 1.02 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.401 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 80.3 Cg_exo -37.74 -32.32 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.286 2.657 . . . . 0.0 113.478 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -60.71 -35.1 75.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.604 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.44 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.8 138.54 31.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.543 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.794 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.68 122.32 32.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.888 0.375 . . . . 0.0 110.46 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.65 ' CZ ' HD13 ' A' ' 99' ' ' ILE . 4.5 m-85 -99.32 90.33 4.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.577 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.733 ' HB2' HG22 ' A' ' 23' ' ' VAL . 41.0 m-85 -101.02 -177.76 3.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.572 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 4' ' ' GLN . 34.4 mtpt -139.96 131.5 27.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.369 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.667 HD23 ' CD2' ' A' ' 11' ' ' PHE . 3.2 tm? -95.73 126.39 40.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.138 0.494 . . . . 0.0 111.068 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.569 ' N ' HD13 ' A' ' 55' ' ' LEU . 44.9 m-20 -85.29 113.08 21.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.716 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 96.4 t -81.85 -5.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.141 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.5 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 11.4 p-10 -84.52 -39.72 18.5 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.854 0.359 . . . . 0.0 110.854 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.662 ' C ' HD12 ' A' ' 60' ' ' LEU . 17.6 tp10 -100.4 -23.02 14.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.171 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.728 HD11 ' O ' ' A' ' 6' ' ' LYS . 3.1 mp -119.57 48.44 1.52 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.822 0.344 . . . . 0.0 110.995 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -60.35 -18.24 49.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.444 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.67 -27.56 55.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.694 0.283 . . . . 0.0 111.507 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.717 HG12 ' HE2' ' A' ' 25' ' ' PHE . 15.7 t -75.53 -54.69 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.758 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.428 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -53.51 -26.74 22.12 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.954 0.407 . . . . 0.0 110.218 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.06 -26.84 20.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.69 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -70.44 -49.36 49.55 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.034 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -77.61 -1.1 29.16 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.116 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 67.55 37.61 3.34 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.344 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.654 ' CG1' HG21 ' A' ' 74' ' ' THR . 40.5 t -115.25 68.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.854 0.359 . . . . 0.0 110.845 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.8 p -81.77 -7.95 59.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.15 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.56 -166.53 0.0 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.537 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.789 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -174.43 107.43 0.28 Allowed Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.85 ' HG3' HD11 ' A' ' 36' ' ' ILE . 37.2 Cg_endo -89.77 -166.68 2.99 Favored 'Cis proline' 0 C--N 1.35 0.642 0 C-N-CA 124.353 -1.103 . . . . 0.0 112.366 -0.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.713 HG23 ' HA ' ' A' ' 88' ' ' VAL . 53.4 m -160.88 142.69 12.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.227 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.734 HD13 HD13 ' A' ' 95' ' ' ILE . 36.7 mt -109.79 123.75 50.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.023 0.439 . . . . 0.0 111.551 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.996 HD12 ' CE1' ' A' ' 25' ' ' PHE . 29.1 mt -115.16 127.07 55.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.853 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.779 ' HG ' HG22 ' A' ' 22' ' ' VAL . 4.5 mp -109.68 131.52 54.98 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.563 ' HA ' HG23 ' A' ' 84' ' ' VAL . 51.9 m-85 -130.94 125.52 33.65 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.298 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.481 ' HG3' HG21 ' A' ' 84' ' ' VAL . 24.6 mtpp -109.78 126.53 53.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.719 0.295 . . . . 0.0 111.087 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 6.3 m120 50.41 55.62 9.2 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.941 0.4 . . . . 0.0 111.768 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 59.58 16.39 36.78 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.072 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 27.0 mtpp -115.57 -153.55 0.53 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 35.6 tt0 -108.87 171.51 7.39 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.563 HG23 ' HA ' ' A' ' 78' ' ' PHE . 38.4 t -144.0 -59.82 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.75 0.309 . . . . 0.0 111.203 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.08 157.42 6.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.442 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -118.3 114.67 23.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.708 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.4 t -136.96 80.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.036 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.713 ' HA ' HG23 ' A' ' 74' ' ' THR . 3.8 p -59.64 85.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.998 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.54 123.41 2.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.703 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.604 ' HB2' HD11 ' A' ' 75' ' ' LEU . . . -84.45 55.23 3.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 110.83 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 46.6 t30 -51.59 131.89 35.86 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.725 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -44.96 -25.95 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.643 2.229 . . . . 0.0 112.776 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.403 ' HA ' ' HE2' ' A' ' 96' ' ' LYS . . . -123.32 49.19 1.72 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.724 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -152.39 -62.02 0.16 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.443 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.759 HD11 HG11 ' A' ' 22' ' ' VAL . 3.5 tp -58.17 -5.45 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.184 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.447 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 64.5 pttt -90.95 -47.53 7.53 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.954 0.407 . . . . 0.0 110.469 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.447 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 83.9 mt-30 -74.7 -32.47 62.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.52 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.4 -30.94 70.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.578 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.78 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 56.4 mt -90.25 -6.4 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.528 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.64 -77.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.998 0.428 . . . . 0.0 111.651 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.21 -29.3 5.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.054 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.604 ' HB3' HD12 ' A' ' 20' ' ' LEU . 73.0 m-80 -88.05 -67.4 0.83 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.672 0.272 . . . . 0.0 111.707 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.78 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.292 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.815 0.34 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.659 HG22 ' NZ ' ' A' ' 54' ' ' LYS . 9.9 p -153.73 132.98 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.56 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 4' ' ' GLN . 95.4 m -150.29 157.69 43.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.0 111.481 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.546 ' HG3' ' HE2' ' A' ' 54' ' ' LYS . 1.7 mp0 -92.23 -177.14 4.57 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.771 ' O ' HD11 ' A' ' 60' ' ' LEU . 14.7 m-85 -133.67 96.57 3.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.819 0.342 . . . . 0.0 111.073 178.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -75.54 -30.29 59.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.729 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.0 p -128.61 132.43 48.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.48 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.06 -25.32 58.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.389 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.8 m -59.08 -19.86 48.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.542 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -90.63 -35.75 14.8 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.2 0.524 . . . . 0.0 111.075 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.944 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -73.67 -29.46 62.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.888 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -53.3 -57.02 12.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.218 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.8 p -61.13 -37.61 83.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.436 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -49.56 -51.9 33.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.649 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.6 pt -75.94 -48.86 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.529 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.479 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -43.14 97.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 84.7 mt-30 45.35 88.86 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.341 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 8.8 t70 -170.0 39.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.403 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 52.0 mttp 68.18 -154.35 0.18 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.731 0.301 . . . . 0.0 110.584 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.924 HD11 ' HB3' ' A' ' 77' ' ' LEU . 61.1 tp -97.8 114.28 26.28 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.089 0.471 . . . . 0.0 110.916 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.77 HG22 ' HB2' ' A' ' 51' ' ' ASP . 60.0 t -103.81 124.03 57.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.665 HG21 ' CG1' ' A' ' 99' ' ' ILE . 49.1 t -99.78 96.67 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.681 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.944 HG21 ' CE1' ' A' ' 11' ' ' PHE . 36.2 t -103.34 130.11 54.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.065 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.8 t70 -99.68 131.37 45.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.577 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.062 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.3 m-85 -98.9 50.88 0.96 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.036 0.446 . . . . 0.0 110.707 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -54.05 135.61 42.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.935 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.707 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -60.88 156.42 17.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 0.0 110.894 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 3.2 t -87.35 6.09 35.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.453 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.45 ' CZ2' ' CE ' ' A' ' 72' ' ' MET . 20.1 p-90 -127.52 -37.58 1.98 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 29' ' ' TRP . 53.9 t -28.51 -75.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.08 -80.81 0.35 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.898 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.96 -21.3 33.35 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.756 2.304 . . . . 0.0 112.326 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.5 p -53.44 -33.56 54.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.124 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -64.94 -22.74 67.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.321 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.0 mtp -68.76 -7.4 33.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.735 0.302 . . . . 0.0 111.016 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.776 HG22 HG13 ' A' ' 40' ' ' ILE . 57.0 mt -88.01 -19.25 7.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.303 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.536 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -53.09 -43.74 95.45 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.893 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 38.1 Cg_endo -71.67 -36.66 6.17 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.747 1.632 . . . . 0.0 111.459 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.468 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 1.1 mpt? -64.64 -55.95 16.94 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.776 HG13 HG22 ' A' ' 36' ' ' ILE . 55.7 mt -44.66 -27.4 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.841 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.509 ' HB2' HG11 ' A' ' 2' ' ' VAL . 43.1 tt0 -80.75 -39.83 26.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.138 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -64.12 -30.98 72.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.606 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.468 ' HD1' ' O ' ' A' ' 39' ' ' MET . 10.7 m-85 -75.47 -19.18 59.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.69 0.281 . . . . 0.0 111.377 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.43 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.6 t -72.77 -6.92 48.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.382 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -90.15 -26.9 19.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.701 0.286 . . . . 0.0 111.06 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -90.3 -28.99 18.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.568 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.52 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 80.0 m-85 -123.83 47.65 1.89 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.081 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 62.9 Cg_exo -35.26 -41.58 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.6 2.867 . . . . 0.0 113.919 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.411 ' O ' ' CD ' ' A' ' 19' ' ' LYS . 85.8 mt-30 -55.4 -34.92 64.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.978 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.6 135.77 33.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.722 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.77 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.62 121.95 32.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.409 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.451 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . 5.6 m-85 -98.26 84.59 3.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.586 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.556 ' HB2' HG22 ' A' ' 23' ' ' VAL . 48.2 m-85 -98.86 -174.71 2.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.515 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.659 ' NZ ' HG22 ' A' ' 2' ' ' VAL . 34.4 mtmm -148.39 132.65 17.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.018 0.437 . . . . 0.0 111.033 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.748 HD21 HD22 ' A' ' 60' ' ' LEU . 2.1 tm? -91.87 130.74 37.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.187 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.838 ' O ' HD13 ' A' ' 60' ' ' LEU . 46.8 m-20 -86.44 126.32 34.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.411 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.719 ' O ' HG12 ' A' ' 57' ' ' VAL . 95.9 t -97.16 18.93 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.533 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 2.8 p30 -111.39 -38.99 4.81 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.242 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.428 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 17.6 tp10 -100.03 -13.94 18.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.805 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.838 HD13 ' O ' ' A' ' 56' ' ' ASP . 5.3 mp -104.74 -69.08 0.82 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.295 0.569 . . . . 0.0 110.926 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.84 -61.58 0.5 Allowed Glycine 0 C--N 1.314 -0.661 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.591 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -52.69 -43.43 65.59 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.735 HG12 ' HE2' ' A' ' 25' ' ' PHE . 16.0 t -59.83 -53.34 49.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.719 0.295 . . . . 0.0 110.844 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -51.25 -26.09 6.66 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 110.053 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -90.39 -38.02 13.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.157 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -61.15 -42.0 97.75 Favored 'General case' 0 C--O 1.23 0.055 0 CA-C-O 120.863 0.363 . . . . 0.0 110.414 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -84.95 -1.97 57.34 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.923 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 64.91 38.4 6.5 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.021 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.809 HG13 HG21 ' A' ' 74' ' ' THR . 40.2 t -114.75 69.12 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.852 0.358 . . . . 0.0 111.019 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.8 p -82.34 -11.46 58.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.067 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.524 ' CB ' HG21 ' A' ' 88' ' ' VAL . . . -55.32 -172.07 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.603 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.707 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 1.7 pmm? -171.59 107.57 0.38 Allowed Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.602 -0.439 . . . . 0.0 112.085 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.553 ' HG3' HD12 ' A' ' 36' ' ' ILE . 83.2 Cg_endo -93.78 171.23 18.28 Favored 'Cis proline' 0 N--CA 1.459 -0.55 0 C-N-CA 124.634 -0.986 . . . . 0.0 112.23 -0.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.809 HG21 HG13 ' A' ' 69' ' ' VAL . 34.5 m -136.16 153.69 51.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.953 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.071 HD13 HD13 ' A' ' 95' ' ' ILE . 85.3 mt -115.09 125.55 53.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 111.056 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.062 HD12 ' CE1' ' A' ' 25' ' ' PHE . 28.5 mt -122.38 128.99 51.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.061 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.924 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.4 mp -109.79 146.03 35.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.441 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.626 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 67.9 m-85 -145.99 128.82 16.33 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.779 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.888 ' CG ' HG11 ' A' ' 84' ' ' VAL . 27.0 mmmt -109.69 132.92 53.7 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.458 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 5.2 m120 44.44 60.25 2.93 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.842 0.353 . . . . 0.0 111.845 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 57.29 18.61 29.28 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.245 -0.503 . . . . 0.0 113.072 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.626 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 96.5 mttt -122.12 -158.86 0.79 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.72 ' O ' HG13 ' A' ' 84' ' ' VAL . 32.0 tt0 -109.35 176.73 4.98 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.888 HG11 ' CG ' ' A' ' 79' ' ' LYS . 3.3 m -165.01 -46.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 O-C-N 123.169 0.293 . . . . 0.0 111.292 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.26 158.17 16.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.147 0.499 . . . . 0.0 111.881 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 60.8 pttt -151.67 114.85 4.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.399 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.7 t -135.57 106.64 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.184 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.56 ' HB ' HG23 ' A' ' 74' ' ' THR . 3.6 p -66.78 97.87 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.48 104.83 0.44 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.195 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.788 ' HB2' HD21 ' A' ' 75' ' ' LEU . . . -96.98 35.87 1.5 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.927 0.394 . . . . 0.0 111.524 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 93' ' ' ALA . 13.9 p-10 -76.7 134.45 69.1 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.236 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 80.0 Cg_exo -44.79 87.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.591 2.194 . . . . 0.0 112.702 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 178.76 -36.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.551 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.9 -41.9 2.2 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.071 HD13 HD13 ' A' ' 75' ' ' LEU . 5.1 tp -51.02 -18.0 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.586 0.231 . . . . 0.0 111.329 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.407 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 21.4 ptmt -92.25 -50.33 5.72 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.971 0.415 . . . . 0.0 110.837 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.407 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 84.2 mt-30 -68.02 -31.92 71.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.581 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.607 ' HB1' HD21 ' A' ' 77' ' ' LEU . . . -57.38 -30.38 64.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.174 0.512 . . . . 0.0 110.772 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.874 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.5 mp -90.09 -9.72 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.554 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.62 -65.64 1.0 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 111.184 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.91 -26.91 27.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.452 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.662 ' HB3' HD22 ' A' ' 20' ' ' LEU . 52.4 m-80 -89.3 -59.95 2.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.536 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.102 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.846 0.355 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.434 HG22 HG22 ' A' ' 40' ' ' ILE . 49.6 t -104.54 143.89 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.9 m -149.98 147.06 27.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.977 0.417 . . . . 0.0 111.248 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.611 ' HG2' ' HE3' ' A' ' 54' ' ' LYS . 40.4 mt-30 -90.13 174.48 7.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.28 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.631 ' O ' HD13 ' A' ' 60' ' ' LEU . 16.9 m-85 -123.02 124.52 43.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.931 0.396 . . . . 0.0 111.144 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.699 ' C ' HD11 ' A' ' 60' ' ' LEU . 46.7 mmtm -109.26 -25.21 10.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.643 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -129.92 123.28 30.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.29 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.1 -26.64 4.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.426 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -57.8 -20.94 39.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.069 0.461 . . . . 0.0 110.477 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -90.42 -45.73 8.8 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.557 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.915 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -76.46 -23.38 53.87 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.695 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -63.85 -38.06 89.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.966 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.0 m -87.94 -26.39 22.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.224 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -52.38 -31.8 35.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.834 0.349 . . . . 0.0 111.423 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.538 ' C ' ' HA2' ' A' ' 81' ' ' GLY . 20.4 pt -90.18 -47.71 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.361 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.472 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.1 97.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.7 mm100 45.65 86.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.33 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -167.36 41.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.44 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.547 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.9 mptp? 63.31 -156.67 0.33 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.432 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.881 HD11 ' HB3' ' A' ' 77' ' ' LEU . 66.0 tp -97.98 115.81 28.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.102 0.477 . . . . 0.0 110.637 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 51' ' ' ASP . 54.8 t -102.74 133.84 45.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.126 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.412 ' CG2' HG13 ' A' ' 99' ' ' ILE . 42.8 t -100.31 103.38 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.481 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.915 HG21 ' CE1' ' A' ' 11' ' ' PHE . 23.7 t -113.93 126.36 71.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 0.0 111.462 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 74' ' ' THR . 34.6 t70 -99.76 135.19 41.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.662 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.06 ' CE1' HD12 ' A' ' 76' ' ' LEU . 6.6 m-85 -99.39 46.78 0.97 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.705 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.562 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -46.9 141.02 4.29 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.071 0.462 . . . . 0.0 111.755 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.726 ' HB1' ' CE2' ' A' ' 29' ' ' TRP . . . -69.88 133.59 47.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.084 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.7 t -63.67 -20.48 65.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.743 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.726 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 8.4 p-90 -96.28 -126.46 0.14 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.301 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.553 ' H ' ' HE3' ' A' ' 29' ' ' TRP . 51.8 t 48.67 -88.68 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.747 0.419 . . . . 0.0 111.654 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . 150.25 -77.83 0.22 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.675 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.23 -6.77 17.05 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.77 2.313 . . . . 0.0 113.419 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 85.5 m -50.44 -34.38 24.44 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.589 0.233 . . . . 0.0 111.445 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -76.64 -5.06 46.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.62 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.437 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 27.9 ttt -81.04 2.92 24.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.895 0.379 . . . . 0.0 110.676 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.891 HG22 HG13 ' A' ' 40' ' ' ILE . 58.2 mt -86.41 -14.98 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.588 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.57 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -53.76 -42.04 90.59 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 37.7 Cg_endo -70.92 -41.25 2.92 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.638 1.559 . . . . 0.0 111.766 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.479 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 70.5 mtm -63.05 -54.95 30.06 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.891 HG13 HG22 ' A' ' 36' ' ' ILE . 70.5 mt -47.42 -28.01 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.81 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -79.68 -33.12 41.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.168 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.53 -21.98 66.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.703 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.662 ' CE2' HG23 ' A' ' 95' ' ' ILE . 4.2 m-85 -90.05 -18.13 26.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.616 0.246 . . . . 0.0 111.559 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.432 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.6 t -74.3 -6.88 50.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.187 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.402 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 95.0 mt-10 -90.07 -28.08 19.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.839 0.352 . . . . 0.0 111.069 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.51 -27.65 19.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.652 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.745 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 74.6 m-85 -123.53 44.38 0.95 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.529 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 96.0 Cg_exo -39.19 -31.85 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.093 2.529 . . . . 0.0 113.346 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -61.7 -35.68 78.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.863 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -90.01 140.82 29.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.072 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.507 ' O ' HG13 ' A' ' 21' ' ' VAL . 25.7 m-20 -89.83 127.28 35.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.639 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.432 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 4.6 m-85 -102.2 89.0 3.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.006 0.431 . . . . 0.0 111.577 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.505 ' HB2' HG22 ' A' ' 23' ' ' VAL . 39.5 m-85 -98.3 -174.56 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.207 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.611 ' HE3' ' HG2' ' A' ' 4' ' ' GLN . 42.2 mtmt -150.22 137.84 19.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.062 0.458 . . . . 0.0 111.395 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.851 HD13 ' N ' ' A' ' 56' ' ' ASP . 3.1 tm? -91.59 141.35 28.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.662 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.851 ' N ' HD13 ' A' ' 55' ' ' LEU . 54.1 t0 -97.74 112.84 24.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.355 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 83.4 t -77.9 -4.51 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.933 0.397 . . . . 0.0 110.563 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.501 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 38.8 t70 -95.49 -35.0 11.85 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.174 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -102.48 -46.48 4.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.613 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.699 HD11 ' C ' ' A' ' 6' ' ' LYS . 6.1 mp -102.38 35.2 2.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.743 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -51.33 -25.12 11.59 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.411 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.63 -30.01 71.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.685 0.279 . . . . 0.0 111.198 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.715 HG12 ' HE2' ' A' ' 25' ' ' PHE . 11.1 t -74.06 -52.18 21.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.576 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.76 -29.83 41.7 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.991 0.424 . . . . 0.0 110.071 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 65.8 tt0 -90.19 -28.31 18.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.001 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -66.15 -50.67 63.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.015 0.436 . . . . 0.0 109.948 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -79.67 0.43 30.37 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.84 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 62.61 40.61 10.23 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.491 ' O ' HG12 ' A' ' 69' ' ' VAL . 29.2 t -107.72 54.2 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 110.821 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 94.1 p -74.05 -13.29 60.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.018 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.407 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -88.44 62.58 6.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.112 0.482 . . . . 0.0 110.054 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.692 ' CG ' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -89.55 165.59 24.81 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.073 -179.128 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.769 ' HG3' HD11 ' A' ' 36' ' ' ILE . 56.9 Cg_endo -72.59 134.47 34.6 Favored 'Cis proline' 0 C--N 1.353 0.773 0 C-N-CA 123.288 -1.547 . . . . 0.0 112.94 0.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.792 ' OG1' HG23 ' A' ' 88' ' ' VAL . 53.0 m -117.77 154.38 31.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.565 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.982 HD13 HD13 ' A' ' 95' ' ' ILE . 75.9 mt -109.25 115.35 29.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 110.813 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.06 HD12 ' CE1' ' A' ' 25' ' ' PHE . 25.6 mt -109.77 126.72 54.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.889 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.881 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.8 mp -109.66 142.36 40.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.568 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.638 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 54.5 m-85 -141.86 127.01 18.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.984 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.785 ' HG3' HG11 ' A' ' 84' ' ' VAL . 9.5 mtpm? -116.38 132.19 56.74 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.668 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.434 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 74.0 m-20 49.31 68.75 0.67 Allowed 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.38 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.538 ' HA2' ' C ' ' A' ' 15' ' ' ILE . . . 46.55 28.54 3.54 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 116.095 -0.502 . . . . 0.0 113.098 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.638 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 68.2 mttm -136.42 -161.64 1.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.665 ' O ' HG13 ' A' ' 84' ' ' VAL . 30.9 tt0 -109.1 -179.52 3.87 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.785 HG11 ' HG3' ' A' ' 79' ' ' LYS . 5.0 m -162.76 -47.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.626 0.25 . . . . 0.0 111.309 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.13 166.15 13.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.098 0.475 . . . . 0.0 111.827 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.461 ' NZ ' ' HB2' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -141.76 115.42 9.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.522 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.9 t -116.05 85.42 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.13 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.792 HG23 ' OG1' ' A' ' 74' ' ' THR . 5.5 p -61.52 84.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.063 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.83 109.28 1.21 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.529 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.715 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -77.41 59.28 1.84 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.981 0.419 . . . . 0.0 111.075 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.509 ' O ' HG22 ' A' ' 95' ' ' ILE . 45.8 t30 -62.63 133.98 95.08 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.342 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -43.7 -26.38 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.534 2.156 . . . . 0.0 112.803 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.22 53.12 0.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.605 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -167.69 -56.7 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.549 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.982 HD13 HD13 ' A' ' 75' ' ' LEU . 3.1 tp -54.72 -9.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.492 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.451 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 25.3 pttm -92.04 -50.28 5.77 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.919 0.39 . . . . 0.0 110.856 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.451 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 83.8 mt-30 -70.32 -32.24 69.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.782 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.22 -37.25 77.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.217 0.532 . . . . 0.0 110.394 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.663 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.3 mp -90.21 -8.68 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.542 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.745 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.28 -62.52 1.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.941 0.4 . . . . 0.0 110.981 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.07 -28.54 58.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.073 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.643 ' HB3' HD22 ' A' ' 20' ' ' LEU . 3.6 m120 -84.64 -63.12 1.39 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.197 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.585 ' HB2' HD23 ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.056 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptp . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.828 0.347 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 52' ' ' PHE . 12.6 p -133.58 144.4 36.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.724 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 4' ' ' GLN . 97.3 m -150.08 161.27 42.69 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.147 0.498 . . . . 0.0 112.06 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.644 ' HG2' ' HD2' ' A' ' 54' ' ' LYS . 21.0 mt-30 -92.37 -170.68 2.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.952 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.514 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 15.4 m-85 -134.4 121.46 21.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.114 0.483 . . . . 0.0 111.488 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.625 ' C ' HD11 ' A' ' 60' ' ' LEU . 2.4 mmmp? -109.14 -16.41 14.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.621 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.7 p -139.83 125.38 19.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.374 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.56 -26.11 4.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.525 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 m -58.78 -20.3 48.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.344 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -90.63 -39.09 12.7 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.151 0.5 . . . . 0.0 111.025 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.877 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -84.54 4.16 33.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.22 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -89.88 -31.54 17.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.906 0.384 . . . . 0.0 110.738 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.3 p -89.92 -37.07 14.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.56 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -46.5 -40.38 12.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.499 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.593 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.1 pt -86.8 -50.93 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.353 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.69 97.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 44.52 86.84 0.02 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.231 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 64.2 t0 -169.32 40.78 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.453 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 92.2 mttt 67.66 -156.64 0.21 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.669 0.271 . . . . 0.0 110.614 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.913 HD11 ' HB3' ' A' ' 77' ' ' LEU . 63.9 tp -98.04 114.96 27.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.042 0.449 . . . . 0.0 110.9 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.774 HG22 ' HB2' ' A' ' 51' ' ' ASP . 61.4 t -102.85 132.48 48.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.966 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.525 HG21 ' CG1' ' A' ' 99' ' ' ILE . 41.1 t -102.38 107.58 22.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.68 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.877 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 34.6 t -113.91 126.75 71.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.008 0.433 . . . . 0.0 111.367 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 7.2 t70 -99.87 129.01 45.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.668 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.083 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.9 m-85 -99.08 52.09 0.96 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.124 0.487 . . . . 0.0 110.602 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -57.48 137.41 56.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.961 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.838 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -61.01 143.74 54.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.019 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.55 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 5.2 t -63.04 -13.91 41.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.853 0.359 . . . . 0.0 110.948 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.443 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 11.7 p-90 -110.13 -132.33 0.33 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.644 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 40.8 t 62.2 -79.66 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.581 0.352 . . . . 0.0 111.437 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.71 -78.52 0.37 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.723 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -45.06 -30.55 4.82 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.637 2.225 . . . . 0.0 112.131 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 98.5 m -55.4 -36.88 66.91 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.596 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.12 -17.02 62.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.142 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.597 ' HA ' ' CE ' ' A' ' 35' ' ' MET . 1.7 tpt -76.16 -1.09 24.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.885 0.374 . . . . 0.0 110.68 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.743 HG22 HG13 ' A' ' 40' ' ' ILE . 65.1 mt -87.72 -12.72 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.695 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.565 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -58.41 -41.4 89.09 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 40.9 Cg_endo -71.97 -38.82 3.66 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.636 1.558 . . . . 0.0 111.367 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.433 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 90.1 mtp -62.87 -57.12 11.92 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.743 HG13 HG22 ' A' ' 36' ' ' ILE . 61.2 mt -46.59 -28.52 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.007 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.621 ' HB2' HG11 ' A' ' 2' ' ' VAL . 44.6 tt0 -79.95 -29.38 39.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.603 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 57.2 mtpt -74.58 -15.65 60.83 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.449 ' HB2' ' CE2' ' A' ' 52' ' ' PHE . 4.4 m-85 -90.59 -20.08 22.99 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.439 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 79.3 p -67.59 -9.32 41.79 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 42' ' ' LYS . 12.5 pt-20 -90.02 -26.17 20.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.687 0.279 . . . . 0.0 111.058 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -90.56 -28.53 18.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.383 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.635 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 86.5 m-85 -123.13 46.14 1.28 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.328 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 84.7 Cg_exo -37.63 -38.66 0.64 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.177 2.585 . . . . 0.0 113.501 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.411 ' O ' ' HD3' ' A' ' 19' ' ' LYS . 85.1 mt-30 -59.03 -33.17 70.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.622 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.63 134.6 34.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.853 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.774 ' HB2' HG22 ' A' ' 21' ' ' VAL . 28.0 m-20 -89.66 122.69 33.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.418 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.75 ' O ' HG23 ' A' ' 2' ' ' VAL . 4.1 m-85 -97.33 100.91 12.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.07 0.462 . . . . 0.0 111.445 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.514 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 45.6 m-85 -115.82 -177.29 3.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.363 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.644 ' HD2' ' HG2' ' A' ' 4' ' ' GLN . 29.0 mttm -141.37 157.58 45.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.245 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.776 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.6 tm? -118.39 132.77 56.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.865 0.364 . . . . 0.0 111.033 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.776 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.9 t0 -85.25 114.98 22.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.222 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 26' ' ' TYR . 55.8 t -74.12 -4.63 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.07 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.55 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 62.1 t0 -102.34 -50.89 3.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.048 0.451 . . . . 0.0 110.392 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.535 ' C ' HD12 ' A' ' 60' ' ' LEU . 38.0 tp10 -75.11 -40.66 59.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.659 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.625 HD11 ' C ' ' A' ' 6' ' ' LYS . 4.5 mp -113.44 37.75 3.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.707 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -53.12 -23.77 18.24 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.651 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -66.45 -29.79 70.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.635 0.255 . . . . 0.0 111.223 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.671 HG13 ' HD3' ' A' ' 66' ' ' LYS . 5.5 t -79.87 -27.47 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.051 0.453 . . . . 0.0 110.546 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.29 -26.08 60.93 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -90.17 -34.96 15.64 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.816 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.671 ' HD3' HG13 ' A' ' 63' ' ' VAL . 13.4 ptmm? -60.56 -48.53 81.37 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.073 0.463 . . . . 0.0 110.007 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.421 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.8 m-80 -80.93 -3.67 52.27 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.878 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 63.85 42.67 5.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.292 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.425 ' CG1' HG21 ' A' ' 74' ' ' THR . 55.1 t -103.38 109.23 26.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.754 0.311 . . . . 0.0 111.061 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -138.63 19.24 2.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.728 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 1.07 ' HB3' HG21 ' A' ' 88' ' ' VAL . . . -98.86 34.44 2.08 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.264 0.554 . . . . 0.0 109.918 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.838 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 1.2 pmm? -21.76 119.77 0.14 Allowed Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.519 ' O ' HG23 ' A' ' 88' ' ' VAL . 85.8 Cg_endo -86.42 -163.88 2.83 Favored 'Cis proline' 0 C--N 1.353 0.812 0 C-N-CA 123.81 -1.329 . . . . 0.0 111.899 -0.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 98.6 m -161.91 162.44 29.16 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.987 0.422 . . . . 0.0 111.374 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.994 HD13 HD13 ' A' ' 95' ' ' ILE . 75.8 mt -126.38 121.25 31.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.862 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.083 HD12 ' CE1' ' A' ' 25' ' ' PHE . 26.5 mt -120.05 123.94 44.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.576 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.913 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.5 mp -109.71 146.88 34.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.38 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.524 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 56.3 m-85 -143.77 129.33 19.12 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.193 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HE2' HG23 ' A' ' 84' ' ' VAL . 51.8 mtmt -109.86 129.44 55.64 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.258 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.487 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.3 m120 45.69 63.79 1.68 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.882 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 52.46 22.09 10.22 Favored Glycine 0 N--CA 1.453 -0.218 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.484 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 97.5 mttt -125.55 -156.13 0.71 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 33.7 tt0 -108.7 174.83 5.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.745 HG11 ' CD1' ' A' ' 20' ' ' LEU . 4.3 p -162.19 -59.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 120.881 0.372 . . . . 0.0 111.369 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.667 ' H ' HG13 ' A' ' 84' ' ' VAL . . . -155.76 167.29 30.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.515 ' HG2' HD22 ' A' ' 76' ' ' LEU . 36.5 mtmm -150.5 130.42 13.36 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.414 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.1 t -145.11 90.25 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.407 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.07 HG21 ' HB3' ' A' ' 71' ' ' ALA . 2.8 p -60.71 88.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.757 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.21 101.24 0.57 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.475 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.756 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -75.5 61.16 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.861 0.362 . . . . 0.0 111.071 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.563 ' O ' HG22 ' A' ' 95' ' ' ILE . 17.5 t-20 -76.7 133.33 70.41 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.057 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.519 ' HD2' ' ND2' ' A' ' 91' ' ' ASN . 75.7 Cg_exo -44.02 -24.29 0.84 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.547 2.165 . . . . 0.0 112.843 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.448 ' HA ' ' NZ ' ' A' ' 96' ' ' LYS . . . -95.16 27.65 3.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.356 -0.384 . . . . 0.0 112.022 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -164.21 -53.05 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.994 HD13 HD13 ' A' ' 75' ' ' LEU . 4.5 tp -49.2 -16.94 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 25.6 pttm -92.47 -51.36 5.17 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.966 0.412 . . . . 0.0 111.097 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.476 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 35.3 mt-30 -69.31 -32.04 70.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.879 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.55 -33.95 70.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.17 0.51 . . . . 0.0 110.47 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.886 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.6 mp -90.4 -11.78 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.457 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.635 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.18 -62.92 1.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.806 0.336 . . . . 0.0 111.035 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.78 -27.43 51.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.011 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.619 ' OD1' HD22 ' A' ' 77' ' ' LEU . 3.7 m120 -83.66 -51.84 6.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.859 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.03 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ppp? . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.888 0.375 . . . . 0.0 111.397 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.796 HG12 ' HE3' ' A' ' 54' ' ' LYS . 51.2 t -132.37 126.36 55.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.911 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 4' ' ' GLN . 51.0 m -150.1 158.86 44.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.019 0.438 . . . . 0.0 111.504 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.612 ' HG2' ' NZ ' ' A' ' 54' ' ' LYS . 48.7 mt-30 -89.98 166.27 13.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.128 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.556 ' O ' HD13 ' A' ' 60' ' ' LEU . 12.9 m-30 -114.4 120.26 39.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.926 0.393 . . . . 0.0 110.488 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.576 ' C ' HD11 ' A' ' 60' ' ' LEU . 2.1 tppt? -97.51 -41.44 8.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.798 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -123.12 139.46 54.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.69 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.18 -24.68 43.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.4 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.5 m -63.1 -15.81 57.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.607 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -90.15 -46.69 8.29 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.158 0.504 . . . . 0.0 110.967 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.902 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -75.39 -35.41 61.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.615 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -52.36 -31.3 33.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.057 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 t -90.05 -26.22 20.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.653 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -55.27 -52.0 64.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.438 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.4 pt -73.77 -48.88 37.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.334 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.466 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -41.48 95.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 45.73 92.06 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.217 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -174.7 39.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.315 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.559 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 11.0 mptt 64.97 -155.61 0.29 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.243 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.903 HD11 ' HB3' ' A' ' 77' ' ' LEU . 65.1 tp -98.04 115.57 28.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.015 0.436 . . . . 0.0 111.006 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.765 HG22 ' HB2' ' A' ' 51' ' ' ASP . 49.4 t -101.26 133.48 44.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.807 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.622 HG21 ' CD1' ' A' ' 99' ' ' ILE . 48.1 t -99.78 91.44 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.586 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.902 HG21 ' CE1' ' A' ' 11' ' ' PHE . 22.3 t -100.67 123.34 53.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.904 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 7.7 t70 -99.98 133.25 44.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.095 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.019 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.6 m-85 -99.25 54.41 0.97 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.161 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.594 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -54.19 146.48 15.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.712 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . . . -63.54 146.32 53.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.896 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.519 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 2.4 t -77.32 -1.16 28.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.723 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -125.38 -33.87 2.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 30.8 t -46.96 159.19 0.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.93 -64.09 0.71 Allowed Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.297 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.7 -24.3 4.58 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.869 2.379 . . . . 0.0 113.305 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 86.8 m -58.03 -54.98 40.76 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -51.83 -28.21 15.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.687 0.279 . . . . 0.0 111.74 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.8 tpp -75.09 1.25 13.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.886 0.374 . . . . 0.0 110.72 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.868 HG22 HG13 ' A' ' 40' ' ' ILE . 61.9 mt -87.12 -18.77 8.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.705 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.563 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -51.99 -43.51 89.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 38.4 Cg_endo -71.18 -39.17 4.16 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.724 1.616 . . . . 0.0 111.611 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.463 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 1.2 mpt? -63.24 -56.23 18.3 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.868 HG13 HG22 ' A' ' 36' ' ' ILE . 56.8 mt -44.02 -28.58 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.687 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.5 ' N ' HG21 ' A' ' 2' ' ' VAL . 43.7 tt0 -81.04 -41.35 22.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.852 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.32 -31.84 69.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.175 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.463 ' HD1' ' O ' ' A' ' 39' ' ' MET . 11.0 m-85 -74.43 -17.17 60.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.251 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.7 t -70.92 -10.41 59.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.151 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -87.05 -24.59 24.56 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.697 0.284 . . . . 0.0 111.007 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -90.44 -34.73 15.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.585 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.579 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 67.7 m-85 -122.95 43.33 0.74 Allowed Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.706 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 95.3 Cg_exo -39.38 -31.99 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.934 2.423 . . . . 0.0 113.201 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -61.06 -37.54 83.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.834 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.754 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.85 148.84 22.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.01 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.765 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.77 148.94 22.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.64 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -125.44 85.93 2.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.425 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.47 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 45.5 m-85 -99.12 -176.02 3.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.574 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.806 ' HD3' HD12 ' A' ' 40' ' ' ILE . 9.8 mtmp? -146.43 133.84 20.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.98 0.419 . . . . 0.0 111.104 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.812 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.9 tm? -89.77 139.05 30.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.999 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.812 ' N ' HD13 ' A' ' 55' ' ' LEU . 61.8 t0 -95.17 101.49 13.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.467 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 71.7 t -68.23 -12.72 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 0.0 110.466 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.519 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 61.8 t0 -86.74 -31.27 21.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.44 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -103.16 -51.98 3.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.237 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.668 HD22 ' CD2' ' A' ' 55' ' ' LEU . 5.5 mp -93.62 51.86 1.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.895 0.378 . . . . 0.0 111.06 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.11 -19.86 47.32 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.501 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.95 -29.27 61.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.618 0.246 . . . . 0.0 111.38 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.72 HG12 ' HE2' ' A' ' 25' ' ' PHE . 5.5 t -78.45 -48.1 23.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.362 . . . . 0.0 110.343 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.41 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -56.31 -24.93 46.65 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -90.37 -38.84 13.06 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.025 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -60.99 -41.74 97.04 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.933 0.397 . . . . 0.0 110.241 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -85.31 0.6 51.51 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.736 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 61.35 39.86 14.86 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.46 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.672 ' CG1' HG21 ' A' ' 74' ' ' THR . 46.1 t -109.69 107.12 22.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.848 0.356 . . . . 0.0 111.054 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 84.3 p -124.0 20.91 9.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.032 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.542 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -73.02 -149.13 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.741 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 72' ' ' MET . 18.3 ptt? -175.88 84.73 0.29 Allowed Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.674 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 6.9 Cg_endo -95.76 -156.28 0.44 Allowed 'Cis proline' 0 CA--C 1.534 0.509 0 C-N-CA 125.217 -0.743 . . . . 0.0 112.834 -0.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.719 HG23 ' HA ' ' A' ' 88' ' ' VAL . 91.6 m -150.68 146.77 26.68 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.362 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.02 HD13 HD13 ' A' ' 95' ' ' ILE . 77.3 mt -112.35 122.08 46.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.785 0.326 . . . . 0.0 111.382 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.019 HD12 ' CE1' ' A' ' 25' ' ' PHE . 27.9 mt -120.82 128.13 52.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.656 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.903 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.7 mp -109.9 145.36 36.98 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.66 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.582 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 54.8 m-85 -146.52 127.45 14.51 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.262 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.817 ' HG3' HG11 ' A' ' 84' ' ' VAL . 9.8 mtpm? -115.19 135.92 53.66 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.638 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.479 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.2 m120 48.59 59.94 4.01 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.641 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 52.37 23.02 11.78 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.022 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.582 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 52.1 mtmt -126.91 -158.48 0.87 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.713 ' O ' HG13 ' A' ' 84' ' ' VAL . 82.0 tt0 -108.97 178.41 4.48 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.817 HG11 ' HG3' ' A' ' 79' ' ' LYS . 4.3 m -164.54 -47.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.533 0.206 . . . . 0.0 111.251 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -169.98 154.37 5.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.038 0.447 . . . . 0.0 111.845 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -137.8 113.93 10.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.409 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.427 HG11 ' HB3' ' A' ' 94' ' ' ALA . 48.3 t -121.82 81.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.067 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.719 ' HA ' HG23 ' A' ' 74' ' ' THR . 7.4 p -50.27 94.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.18 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.04 131.35 3.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.254 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.577 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -95.6 35.86 1.32 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.919 0.39 . . . . 0.0 111.133 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 93' ' ' ALA . 47.2 t-20 -59.04 108.04 1.19 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.97 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 19.5 Cg_exo -33.02 90.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.138 2.559 . . . . 0.0 113.113 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.488 ' O ' ' NE2' ' A' ' 97' ' ' GLN . . . 172.97 -30.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.122 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.427 ' HB3' HG11 ' A' ' 87' ' ' VAL . . . -123.99 -44.32 2.06 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.02 HD13 HD13 ' A' ' 75' ' ' LEU . 4.6 tp -49.35 -19.07 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.738 0.304 . . . . 0.0 111.179 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -91.2 -66.17 0.95 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.981 0.419 . . . . 0.0 111.22 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 4.5 mp0 -60.79 -34.41 74.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.964 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.88 -31.29 68.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.06 0.457 . . . . 0.0 110.702 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.622 ' CD1' HG21 ' A' ' 22' ' ' VAL . 66.6 mt -90.25 -10.75 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.373 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.579 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.44 -68.68 0.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.839 0.352 . . . . 0.0 111.4 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.87 -28.21 34.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.367 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.683 ' HB3' HD22 ' A' ' 20' ' ' LEU . 3.6 m120 -83.48 -48.21 10.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.106 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.135 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.823 0.344 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.419 ' CG2' HG22 ' A' ' 40' ' ' ILE . 41.5 t -154.15 144.55 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.99 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.1 m -150.08 147.47 27.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.095 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.507 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 24.1 mt-30 -89.94 -176.9 5.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.39 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.51 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.9 m-85 -134.73 135.97 42.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.024 0.44 . . . . 0.0 111.375 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.707 ' C ' HD11 ' A' ' 60' ' ' LEU . 34.5 mmtp -112.92 -33.76 5.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.536 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 8' ' ' ALA . 11.9 m -124.54 165.55 17.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.401 ' N ' HG22 ' A' ' 7' ' ' THR . . . -77.48 -29.82 52.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.77 0.319 . . . . 0.0 111.068 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.4 t -59.35 -16.42 22.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.791 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -90.09 -58.32 2.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.299 0.571 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.866 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -66.42 -28.42 68.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.64 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -59.04 -42.73 90.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.817 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.5 m -79.23 -29.95 42.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.462 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -57.78 -32.4 67.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.194 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.8 pt -90.0 -49.15 13.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.275 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.486 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -42.95 101.9 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.1 mt-30 43.78 86.1 0.02 OUTLIER 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.211 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -166.24 39.26 0.05 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.62 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.56 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER 65.37 -153.29 0.27 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.729 0.299 . . . . 0.0 110.364 179.063 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.882 HD11 ' HB3' ' A' ' 77' ' ' LEU . 54.6 tp -97.7 114.18 26.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.06 0.457 . . . . 0.0 110.928 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.637 HG22 ' HB2' ' A' ' 51' ' ' ASP . 52.3 t -103.28 120.17 52.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.726 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.741 HG21 HG12 ' A' ' 99' ' ' ILE . 48.1 t -99.83 98.31 6.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.622 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.866 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 44.1 t -99.74 145.45 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.167 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.458 ' HA ' ' O ' ' A' ' 74' ' ' THR . 37.4 t70 -106.97 126.06 51.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.597 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.062 ' CE1' HD12 ' A' ' 76' ' ' LEU . 7.4 m-85 -98.88 50.42 0.96 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.152 0.501 . . . . 0.0 110.308 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.53 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -53.15 139.25 29.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.529 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.732 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -63.13 149.16 45.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.572 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.514 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.4 t -74.53 -11.91 60.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.79 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.538 ' O ' ' C ' ' A' ' 30' ' ' CYS . 5.4 p-90 -112.18 -60.39 1.87 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.538 ' C ' ' O ' ' A' ' 29' ' ' TRP . 50.6 t 4.07 -80.95 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.431 0.692 . . . . 0.0 112.774 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.14 -78.48 0.35 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.582 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.02 -15.71 43.82 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.574 2.183 . . . . 0.0 112.567 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 31.9 p -52.9 -26.7 15.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.138 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -75.79 -16.84 60.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.553 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 35' ' ' MET . 48.0 ttm -74.17 2.07 9.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.038 0.447 . . . . 0.0 110.779 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.017 HG22 HG13 ' A' ' 40' ' ' ILE . 55.6 mt -83.74 -25.83 7.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.639 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.524 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -45.9 -45.02 36.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 40.4 Cg_endo -72.32 -37.69 4.23 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 121.694 1.596 . . . . 0.0 111.096 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.434 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 88.8 mtp -64.11 -54.9 26.66 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.017 HG13 HG22 ' A' ' 36' ' ' ILE . 67.2 mt -46.79 -27.62 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.703 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -81.19 -34.05 32.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.336 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -67.0 -22.74 65.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.739 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.435 ' CB ' ' CE2' ' A' ' 52' ' ' PHE . 5.9 m-85 -84.75 -21.91 29.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.716 0.294 . . . . 0.0 111.597 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.2 m -68.65 -12.06 60.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.015 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 39.4 tt0 -88.63 -23.81 22.97 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.826 0.346 . . . . 0.0 110.541 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -90.43 -38.23 13.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.371 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.536 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 60.5 m-85 -123.92 43.87 0.9 Allowed Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 89.6 Cg_exo -38.59 -29.03 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.046 2.497 . . . . 0.0 113.014 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.474 ' OE1' ' N ' ' A' ' 49' ' ' GLN . 0.3 OUTLIER -57.17 -37.8 72.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.692 179.548 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.777 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.86 152.93 21.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.137 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.637 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -97.66 123.31 41.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.751 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.435 ' CE2' ' CB ' ' A' ' 43' ' ' PHE . 4.1 m-85 -100.93 104.43 15.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.111 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.63 ' HB2' HG22 ' A' ' 23' ' ' VAL . 46.5 m-85 -113.89 -178.81 3.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.212 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 32.9 mtpt -137.62 142.92 41.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.212 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.872 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.7 tm? -107.82 138.54 43.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.803 0.335 . . . . 0.0 110.733 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.872 ' N ' HD13 ' A' ' 55' ' ' LEU . 26.4 t70 -93.03 113.39 25.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.909 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 52.6 t -73.5 -6.12 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.411 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.514 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 38.6 t70 -97.6 -46.39 6.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.085 0.469 . . . . 0.0 110.613 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.658 ' C ' HD12 ' A' ' 60' ' ' LEU . 38.2 tp10 -83.72 -32.54 25.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.101 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.707 HD11 ' C ' ' A' ' 6' ' ' LYS . 3.6 mp -119.72 59.92 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.905 0.383 . . . . 0.0 110.929 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.21 -8.07 64.65 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.708 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -83.91 -28.31 27.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.674 0.273 . . . . 0.0 111.448 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.654 HG13 ' HD3' ' A' ' 66' ' ' LYS . 7.3 t -78.01 -45.28 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.869 0.366 . . . . 0.0 110.544 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.22 -24.92 45.33 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -90.45 -40.2 12.16 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.299 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.654 ' HD3' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -57.86 -48.92 78.4 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.892 0.377 . . . . 0.0 110.458 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 33.7 m120 -78.14 -3.79 44.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.963 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 66.55 40.42 3.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.225 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.876 HG13 HG21 ' A' ' 74' ' ' THR . 58.0 t -83.45 -77.39 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 120.761 0.315 . . . . 0.0 110.869 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.7 p 47.91 25.45 0.76 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.756 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.9 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -98.91 -159.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.732 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -172.74 90.4 0.4 Allowed Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.798 ' HG3' HD11 ' A' ' 36' ' ' ILE . 22.5 Cg_endo -91.99 -160.41 1.07 Allowed 'Cis proline' 0 C--N 1.349 0.577 0 C-N-CA 124.625 -0.99 . . . . 0.0 112.42 -0.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.9 ' OG1' ' HB3' ' A' ' 71' ' ' ALA . 98.5 m -156.31 155.49 32.35 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.849 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 95' ' ' ILE . 72.6 mt -120.22 121.38 38.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.935 0.398 . . . . 0.0 111.288 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.062 HD12 ' CE1' ' A' ' 25' ' ' PHE . 20.1 mt -118.99 128.57 54.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.875 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.882 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.3 mp -109.7 138.31 46.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.723 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.562 ' HA ' HG23 ' A' ' 84' ' ' VAL . 73.7 m-85 -137.51 126.91 24.87 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.542 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.468 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 59.5 mttm -109.84 128.71 55.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.728 0.299 . . . . 0.0 111.275 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 6.0 m120 44.27 58.04 3.98 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 61.64 13.55 39.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.372 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 30.8 mmmt -111.71 -156.81 0.6 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.486 ' OE2' ' CE1' ' A' ' 78' ' ' PHE . 10.9 tp10 -108.78 173.82 6.15 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.562 HG23 ' HA ' ' A' ' 78' ' ' PHE . 56.8 t -146.64 -62.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.748 0.309 . . . . 0.0 111.317 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.13 159.26 7.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.357 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -122.29 115.44 22.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.611 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.57 80.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.473 HG21 ' CB ' ' A' ' 71' ' ' ALA . 2.7 p -57.18 95.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.017 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.6 114.27 1.27 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.611 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.677 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -98.66 33.85 2.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 110.908 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 93' ' ' ALA . 47.5 t-20 -62.07 108.58 1.67 Allowed Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.968 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 17.8 Cg_exo -31.91 88.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.229 2.62 . . . . 0.0 113.216 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 176.17 -35.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.85 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.62 -43.33 2.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.577 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.977 HD13 HD13 ' A' ' 75' ' ' LEU . 4.6 tp -53.26 -15.53 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.704 -0.226 . . . . 0.0 111.277 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.437 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 64.5 pttt -91.2 -49.25 6.48 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.78 0.324 . . . . 0.0 110.642 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.437 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 72.7 mt-30 -71.85 -32.15 67.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.366 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.24 -31.53 71.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.441 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.798 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 56.5 mt -90.08 -6.57 10.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.305 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.38 -65.29 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.921 0.391 . . . . 0.0 111.036 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.82 -29.78 8.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.944 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.816 ' CB ' HD22 ' A' ' 20' ' ' LEU . 67.5 m-20 -90.07 -67.79 0.82 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.948 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.798 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.126 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptm . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.766 0.317 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.43 ' CG1' ' HD2' ' A' ' 54' ' ' LYS . 44.1 t -136.5 143.17 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.477 HG22 ' N ' ' A' ' 4' ' ' GLN . 87.5 m -149.95 164.84 34.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.864 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.527 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -105.61 -177.35 3.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.339 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.481 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.9 m-85 -130.33 131.43 45.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.984 0.421 . . . . 0.0 111.483 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.706 ' C ' HD11 ' A' ' 60' ' ' LEU . 34.5 mmtp -114.49 -19.74 11.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.774 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -141.23 136.96 32.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.466 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.07 -28.42 17.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.242 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.9 m -59.32 -19.83 49.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.244 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.452 ' HG3' ' CE1' ' A' ' 5' ' ' PHE . 17.6 tp10 -90.49 -37.93 13.57 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.334 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.942 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -90.2 15.83 9.64 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.06 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -89.79 -45.98 8.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.875 0.369 . . . . 0.0 110.662 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -79.6 -23.36 42.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.97 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.535 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -54.83 -50.48 68.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.205 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.7 pt -83.12 -50.02 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.334 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.457 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -40.06 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 79.9 mt-30 39.19 85.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.662 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 9.1 t70 -162.49 40.52 0.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.668 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 10.9 mptt 67.2 -156.52 0.22 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.458 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.787 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 64.3 tp -98.18 116.42 30.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.203 0.525 . . . . 0.0 110.977 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.801 HG22 ' HB2' ' A' ' 51' ' ' ASP . 54.9 t -103.12 134.69 43.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.748 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.516 HG21 ' CD1' ' A' ' 99' ' ' ILE . 49.2 t -99.7 92.32 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.65 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.942 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 48.0 t -99.83 124.34 53.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.044 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 8.1 t70 -99.98 129.17 46.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.921 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.052 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.7 m-85 -98.99 48.57 0.96 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.185 0.516 . . . . 0.0 110.348 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.547 ' O ' ' HD1' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -50.14 134.55 22.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.139 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.507 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -60.72 153.04 25.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.196 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.428 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 3.3 t -76.89 2.25 15.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.514 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.452 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 5.4 p-90 -127.35 -125.3 0.23 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.746 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 48.8 t 62.49 -77.58 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.931 0.492 . . . . 0.0 111.421 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.11 -80.18 0.27 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.979 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.26 51.0 3.33 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.744 2.296 . . . . 0.0 112.523 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 99.5 m -112.5 -28.25 7.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.734 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -79.94 -15.9 56.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.495 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 66.1 mtt -74.7 4.16 6.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.764 0.316 . . . . 0.0 111.102 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.007 HG22 HG13 ' A' ' 40' ' ' ILE . 52.7 mt -83.53 -26.27 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.534 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.513 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -45.67 -45.39 34.74 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 44.1 Cg_endo -73.1 -36.36 4.36 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.773 1.649 . . . . 0.0 111.268 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 49.6 ttm -65.24 -53.11 49.21 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.007 HG13 HG22 ' A' ' 36' ' ' ILE . 79.0 mt -46.91 -30.44 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.593 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -76.79 -37.01 56.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.938 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.97 -22.74 62.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.367 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -90.1 -16.48 29.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.488 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.4 t -74.84 -6.88 51.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.236 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 44.7 tt0 -90.12 -27.94 19.3 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.785 0.326 . . . . 0.0 111.052 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -90.47 -28.33 18.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.723 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.848 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 76.0 m-85 -123.14 43.93 0.85 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.698 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 98.5 Cg_exo -39.76 -31.62 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.977 2.451 . . . . 0.0 113.098 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -62.26 -37.82 86.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.941 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.787 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.88 147.75 23.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.172 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.801 ' HB2' HG22 ' A' ' 21' ' ' VAL . 28.9 m-20 -89.84 153.67 20.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.54 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.487 ' CE2' HD13 ' A' ' 99' ' ' ILE . 6.0 m-85 -128.55 93.88 3.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.025 0.44 . . . . 0.0 111.479 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.481 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 49.6 m-85 -107.44 178.59 4.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.596 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HB2' ' HA ' ' A' ' 4' ' ' GLN . 16.5 mtpp -139.09 146.92 41.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.51 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.9 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.8 tm? -108.19 140.9 40.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.072 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.9 ' N ' HD13 ' A' ' 55' ' ' LEU . 27.8 t70 -95.43 116.04 28.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.55 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 57' ' ' VAL . 60.6 t -76.88 -1.85 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.649 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 8.1 t70 -103.5 -43.57 5.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.024 0.44 . . . . 0.0 110.575 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.492 ' C ' HD12 ' A' ' 60' ' ' LEU . 38.5 tp10 -86.12 -39.69 16.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.022 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.706 HD11 ' C ' ' A' ' 6' ' ' LYS . 4.8 mp -111.4 44.01 1.4 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.849 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.15 -28.02 53.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.379 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.51 -29.1 70.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.739 0.304 . . . . 0.0 111.158 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.705 HG12 ' HE2' ' A' ' 25' ' ' PHE . 6.8 t -79.3 -45.42 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.438 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.36 -22.85 55.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.409 . . . . 0.0 110.058 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -90.16 -38.13 13.71 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.205 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.705 ' HE3' HG13 ' A' ' 63' ' ' VAL . 15.6 pttp -60.89 -47.1 87.93 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.972 0.415 . . . . 0.0 110.084 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.401 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.6 m-20 -77.93 -4.44 46.89 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.917 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 66.94 39.51 3.27 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.034 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.709 ' CG1' HG21 ' A' ' 74' ' ' THR . 45.3 t -110.18 107.71 23.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.756 0.313 . . . . 0.0 110.97 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.5 t -121.87 -1.82 9.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.779 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.645 ' CB ' HG21 ' A' ' 88' ' ' VAL . . . -61.01 -157.75 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.575 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -175.26 100.92 0.26 Allowed Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.79 ' HG3' HD11 ' A' ' 36' ' ' ILE . 32.6 Cg_endo -88.54 -162.06 1.92 Allowed 'Cis proline' 0 C--N 1.353 0.795 0 C-N-CA 124.701 -0.958 . . . . 0.0 112.669 -0.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.777 ' OG1' HG23 ' A' ' 88' ' ' VAL . 42.8 m -158.58 146.86 18.41 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.098 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.029 HD13 HD13 ' A' ' 95' ' ' ILE . 84.3 mt -113.97 123.04 48.75 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.804 0.335 . . . . 0.0 111.701 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.052 HD12 ' CE1' ' A' ' 25' ' ' PHE . 18.2 mt -116.94 129.87 56.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.493 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.704 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.9 mp -109.78 142.01 41.62 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.719 0.295 . . . . 0.0 111.017 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.578 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 63.8 m-85 -143.71 126.58 16.26 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.274 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.825 ' HG3' HG11 ' A' ' 84' ' ' VAL . 41.6 mtmt -118.91 136.76 53.89 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.379 178.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 78.3 m-20 50.81 60.92 3.52 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.569 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 50.04 26.19 8.5 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.849 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.578 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 98.9 mttt -132.34 -159.55 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.69 ' O ' HG13 ' A' ' 84' ' ' VAL . 28.7 tt0 -109.05 -179.75 3.94 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.825 HG11 ' HG3' ' A' ' 79' ' ' LYS . 12.2 m -163.75 -49.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.588 0.232 . . . . 0.0 111.217 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.462 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -165.14 156.54 14.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.054 0.454 . . . . 0.0 111.726 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -138.81 113.63 9.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.33 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.63 91.1 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.075 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.777 HG23 ' OG1' ' A' ' 74' ' ' THR . 7.2 p -61.66 83.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.983 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.7 113.17 0.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.236 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.646 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -95.36 37.76 1.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.355 . . . . 0.0 111.387 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 93' ' ' ALA . 5.5 m120 -73.69 131.88 81.51 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.325 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 98.7 Cg_exo -46.7 86.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.674 2.249 . . . . 0.0 112.665 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 92' ' ' PRO . . . 174.35 -35.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.425 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.39 -46.55 2.87 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.781 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.029 HD13 HD13 ' A' ' 75' ' ' LEU . 4.9 tp -53.45 -14.8 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.526 0.203 . . . . 0.0 111.278 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.415 ' HG3' ' HG3' ' A' ' 97' ' ' GLN . 21.3 ptmt -91.03 -49.52 6.37 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.883 0.373 . . . . 0.0 110.864 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.415 ' HG3' ' HG3' ' A' ' 96' ' ' LYS . 73.0 mt-30 -73.13 -32.38 64.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.447 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.454 ' HB1' HD21 ' A' ' 77' ' ' LEU . . . -61.33 -30.27 70.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.681 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.516 ' CD1' HG21 ' A' ' 22' ' ' VAL . 67.6 mt -90.19 -14.91 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.25 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.848 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.38 -70.51 0.67 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.84 0.352 . . . . 0.0 111.182 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.69 -28.69 6.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.272 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.572 ' HB3' HD22 ' A' ' 20' ' ' LEU . 5.7 m120 -83.18 -48.3 10.67 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.061 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.121 -179.953 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.714 0.292 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.851 HG12 ' HE2' ' A' ' 54' ' ' LYS . 47.4 t -152.36 138.61 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.002 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.8 m -147.89 154.49 40.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.03 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.565 ' HG2' ' HE3' ' A' ' 54' ' ' LYS . 61.3 mt-30 -93.74 177.25 6.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.624 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.525 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 14.4 m-85 -127.98 136.17 50.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.0 111.241 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 34.4 mmtp -115.95 -46.34 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.513 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.1 p -114.81 134.11 55.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.534 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.09 -24.68 18.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.431 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.2 m -62.37 -16.58 55.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.556 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -90.21 -58.01 2.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.347 0.594 . . . . 0.0 111.076 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.913 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -61.28 -31.47 71.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.667 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -55.54 -23.32 25.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.1 t -80.37 -45.99 16.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.191 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.96 -46.52 68.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.29 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.853 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 24.1 pt -78.16 -4.63 6.88 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.833 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.901 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.18 81.82 6.1 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.682 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 74.9 mt-30 48.14 91.76 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 63.9 t0 -168.91 39.62 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.533 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 88.0 mttt 76.12 -156.83 0.04 OUTLIER 'General case' 0 C--O 1.23 0.065 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.564 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.895 HD11 ' HB3' ' A' ' 77' ' ' LEU . 59.7 tp -98.07 116.95 31.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.216 0.531 . . . . 0.0 110.79 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.767 HG22 ' HB2' ' A' ' 51' ' ' ASP . 60.6 t -102.89 124.22 56.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.801 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.646 HG21 ' CD1' ' A' ' 99' ' ' ILE . 46.0 t -99.79 97.88 6.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.665 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.913 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 40.2 t -105.12 131.04 55.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.424 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 7.8 t70 -99.87 130.67 46.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.453 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.056 ' CE1' HD12 ' A' ' 76' ' ' LEU . 6.3 m-85 -99.06 49.48 0.95 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.975 0.417 . . . . 0.0 110.69 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.586 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -51.05 140.74 15.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.067 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.775 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -62.27 157.35 19.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.754 0.311 . . . . 0.0 110.505 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.545 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 5.0 t -83.58 4.12 29.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.406 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.449 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 18.2 p-90 -124.64 -46.6 1.87 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.431 ' HB2' ' HG3' ' A' ' 72' ' ' MET . 22.3 t -43.96 127.97 5.5 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 111.414 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . -76.41 -64.14 2.23 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.98 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -41.5 -28.26 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.389 2.726 . . . . 0.0 113.176 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.9 m -61.5 -14.57 30.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.429 ' C ' ' HD2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -78.8 -25.85 44.29 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.163 -179.497 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.458 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 66.0 mtm -75.39 1.52 13.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 110.301 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.856 HG22 HG13 ' A' ' 40' ' ' ILE . 28.1 mm -79.2 -44.37 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.873 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.499 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -41.7 -47.16 9.61 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.04 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 45.6 Cg_endo -73.91 -27.77 11.91 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.79 1.66 . . . . 0.0 111.233 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.406 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 14.2 tpt -74.16 -50.02 21.16 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.856 HG13 HG22 ' A' ' 36' ' ' ILE . 63.8 mt -50.96 -32.72 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.389 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -72.37 -39.56 67.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.113 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.465 ' HB3' ' NZ ' ' A' ' 42' ' ' LYS . 9.6 mtpm? -57.88 -23.94 55.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.712 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.75 ' CE2' HG23 ' A' ' 95' ' ' ILE . 6.0 m-85 -90.43 -16.88 28.18 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.1 t -72.95 -7.66 52.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.523 0.201 . . . . 0.0 111.456 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -90.15 -26.53 20.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.757 0.313 . . . . 0.0 111.081 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.07 -30.07 17.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.531 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.581 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 79.6 m-85 -125.44 51.86 5.97 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.088 0.47 . . . . 0.0 110.745 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 1.4 Cg_endo -46.79 -26.5 4.68 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.085 2.523 . . . . 0.0 112.987 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.444 ' O ' ' HD3' ' A' ' 19' ' ' LYS . 73.8 mt-30 -69.04 -29.24 67.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.122 0.487 . . . . 0.0 110.394 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.58 139.06 30.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.781 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.767 ' HB2' HG22 ' A' ' 21' ' ' VAL . 28.2 m-20 -89.56 121.69 32.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.268 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.518 ' CE2' HD13 ' A' ' 99' ' ' ILE . 6.2 m-85 -99.02 81.77 2.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.596 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.654 ' HB2' HG22 ' A' ' 23' ' ' VAL . 47.4 m-85 -94.47 -175.12 3.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.357 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.851 ' HE2' HG12 ' A' ' 2' ' ' VAL . 47.0 mtmt -148.47 138.2 22.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.994 0.426 . . . . 0.0 110.75 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.926 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.2 tm? -98.35 141.95 30.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.325 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.926 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.9 t70 -92.74 125.09 37.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.949 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.742 ' O ' HG12 ' A' ' 57' ' ' VAL . 92.1 t -93.14 42.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.436 0.636 . . . . 0.0 110.621 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.545 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 64.5 t0 -152.97 -48.78 0.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.035 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 6' ' ' LYS . 5.3 tp10 -75.56 -27.35 58.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.171 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.578 HD22 ' N ' ' A' ' 60' ' ' LEU . 2.5 mm? -103.16 -64.43 1.08 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.376 0.608 . . . . 0.0 111.007 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.5 -61.25 0.64 Allowed Glycine 0 C--N 1.314 -0.658 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.644 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -51.17 -36.79 42.85 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.788 HG12 ' HE2' ' A' ' 25' ' ' PHE . 6.6 t -70.51 -58.25 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 110.589 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.49 -24.84 8.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.002 0.43 . . . . 0.0 110.074 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -90.14 -37.49 14.17 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.259 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.785 ' HE3' HG13 ' A' ' 63' ' ' VAL . 17.4 pttp -60.71 -48.77 80.28 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.1 m-20 -76.71 -7.72 55.88 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.676 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 66.09 43.53 2.88 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.24 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.479 ' CG1' HG21 ' A' ' 74' ' ' THR . 49.0 t -107.37 74.6 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.885 0.374 . . . . 0.0 111.011 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.9 p -83.38 -11.32 57.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.996 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.512 ' CB ' HG21 ' A' ' 88' ' ' VAL . . . -58.14 -163.73 0.0 OUTLIER 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.728 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.775 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -178.1 106.64 0.21 Allowed Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 42.8 Cg_endo -89.72 -165.35 2.64 Favored 'Cis proline' 0 C--N 1.351 0.687 0 C-N-CA 124.485 -1.048 . . . . 0.0 112.612 -0.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 91.7 m -152.59 163.24 39.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.811 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.984 HD13 HD13 ' A' ' 95' ' ' ILE . 80.9 mt -128.02 120.73 28.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.098 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.056 HD12 ' CE1' ' A' ' 25' ' ' PHE . 21.8 mt -118.93 124.11 46.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.758 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.895 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.3 mp -109.82 135.4 50.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.692 ' HA ' HG23 ' A' ' 84' ' ' VAL . 42.4 m-85 -136.05 129.05 31.37 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.602 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.666 ' HG3' HD13 ' A' ' 20' ' ' LEU . 9.2 mtpm? -114.65 124.04 50.83 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.99 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 6.4 m120 43.9 82.46 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.652 0.263 . . . . 0.0 111.213 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.853 ' HA2' ' O ' ' A' ' 15' ' ' ILE . . . 33.83 46.77 0.45 Allowed Glycine 0 C--N 1.333 0.38 0 CA-C-N 116.024 -0.535 . . . . 0.0 114.202 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 34.5 mmtp -146.97 -158.73 0.94 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 34.0 tt0 -108.69 174.01 6.06 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.692 HG23 ' HA ' ' A' ' 78' ' ' PHE . 59.2 t -145.08 -69.08 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 0.0 111.107 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.25 155.32 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.377 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -112.65 138.26 49.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.069 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -154.6 78.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.141 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 2.5 p -58.73 90.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.093 0.473 . . . . 0.0 110.611 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 136.35 124.3 2.35 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.08 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.741 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -87.85 47.37 1.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.871 0.367 . . . . 0.0 111.468 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 94' ' ' ALA . 46.2 t-20 -53.35 110.02 1.8 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -33.2 -31.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.167 2.578 . . . . 0.0 113.64 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -95.49 30.49 2.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.445 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -152.34 -60.13 0.15 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.984 HD13 HD13 ' A' ' 75' ' ' LEU . 4.3 tp -51.91 -11.97 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.338 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.446 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 64.8 pttt -91.13 -51.09 5.49 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.843 0.354 . . . . 0.0 110.669 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.446 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 9.7 mm-40 -69.52 -32.02 70.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.51 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.78 -32.15 73.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.613 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.646 ' CD1' HG21 ' A' ' 22' ' ' VAL . 50.5 mt -90.14 -7.92 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.488 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.581 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.09 -68.62 0.77 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.924 0.393 . . . . 0.0 111.259 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.67 -29.14 51.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.132 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.552 ' CB ' HD22 ' A' ' 20' ' ' LEU . 3.9 m120 -80.39 -52.5 7.6 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.037 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.071 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.801 0.334 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.533 HG11 ' CG2' ' A' ' 40' ' ' ILE . 55.0 t -155.24 136.56 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.145 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 4' ' ' GLN . 90.1 m -150.2 162.1 41.13 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.173 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.581 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -100.28 -177.68 3.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 179.593 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.511 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 23.8 m-85 -124.79 150.59 46.17 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.03 0.443 . . . . 0.0 111.671 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.687 ' C ' HD11 ' A' ' 60' ' ' LEU . 72.7 mmtt -128.52 -37.21 1.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.974 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 m -116.65 164.0 15.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 12' ' ' ASP . . . -76.13 -27.85 57.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.993 0.425 . . . . 0.0 110.933 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.2 m -64.13 -12.58 41.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.969 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -89.98 -69.35 0.73 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.226 0.536 . . . . 0.0 111.401 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.965 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -56.9 -25.88 57.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.085 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 64.2 t0 -56.38 -42.71 78.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.23 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -82.06 -24.81 35.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.321 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.679 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -56.83 -46.09 81.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.476 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.8 pt -80.21 -49.59 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.46 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.466 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -43.55 98.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 45.58 90.49 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.223 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -171.42 39.5 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.267 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.554 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.7 mptp? 63.54 -154.98 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.233 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.788 HD11 ' HB3' ' A' ' 77' ' ' LEU . 43.7 tp -98.05 115.99 29.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.135 0.493 . . . . 0.0 110.848 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.816 HG22 ' HB2' ' A' ' 51' ' ' ASP . 48.2 t -103.08 134.34 44.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.983 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.441 ' CG2' HG13 ' A' ' 99' ' ' ILE . 46.3 t -99.78 92.61 2.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.479 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.965 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 38.5 t -99.91 125.29 53.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.081 0.467 . . . . 0.0 111.334 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 74' ' ' THR . 38.5 t70 -99.91 130.53 46.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.916 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.057 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.7 m-85 -98.96 49.45 0.96 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.096 0.474 . . . . 0.0 110.208 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.71 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -50.68 139.8 15.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.786 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.72 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -60.59 142.12 55.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.525 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.491 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 5.8 t -69.05 -11.53 60.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.565 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.469 ' CH2' ' HG2' ' A' ' 72' ' ' MET . 21.5 p-90 -109.55 -45.3 3.71 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 24.6 t -42.38 139.54 1.45 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.657 0.265 . . . . 0.0 111.264 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.11 -57.19 1.72 Allowed Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.82 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -46.16 -27.67 4.77 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.7 2.266 . . . . 0.0 112.754 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.443 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 84.8 m -65.68 -21.1 66.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.54 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -73.45 -29.6 62.65 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -78.86 5.96 10.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.041 0.448 . . . . 0.0 110.989 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.73 HG22 HG13 ' A' ' 40' ' ' ILE . 69.9 mt -83.29 -27.44 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.119 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.542 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -49.18 -45.79 75.85 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 47.6 Cg_endo -72.04 -37.51 4.76 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 121.699 1.599 . . . . 0.0 111.134 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 58.3 ttp -62.34 -53.1 59.9 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.73 HG13 HG22 ' A' ' 36' ' ' ILE . 58.6 mt -47.61 -29.35 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.638 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.533 ' HA ' HG21 ' A' ' 2' ' ' VAL . 87.8 tt0 -78.49 -35.79 46.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.767 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 38' ' ' PRO . 72.7 mmtt -60.76 -21.97 63.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.433 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -90.12 -20.29 23.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.664 0.268 . . . . 0.0 111.632 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.4 p -74.15 -6.59 48.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.1 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.406 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 4.4 mm-40 -90.11 -29.44 18.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.82 0.343 . . . . 0.0 110.921 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.5 -29.73 17.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.676 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.54 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 71.2 m-85 -122.93 43.66 0.79 Allowed Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.654 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 93.7 Cg_exo -39.26 -31.51 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.993 2.462 . . . . 0.0 113.252 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.71 -38.13 84.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.903 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.715 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -90.04 146.52 24.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.951 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.816 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.87 148.7 23.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.72 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.49 ' O ' HG13 ' A' ' 2' ' ' VAL . 5.6 m-85 -125.27 98.35 5.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.243 0.544 . . . . 0.0 111.058 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.511 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 52.3 m-85 -113.84 -176.29 2.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.879 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.71 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 29.5 mttp -134.9 165.3 25.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.203 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.577 HD22 HD22 ' A' ' 60' ' ' LEU . 2.1 tm? -130.93 117.19 18.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.465 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.487 ' N ' HD13 ' A' ' 55' ' ' LEU . 59.3 t0 -70.26 117.59 12.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.898 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 26' ' ' TYR . 29.6 t -72.51 -8.34 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.852 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.491 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 31.9 t70 -100.97 -59.57 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.975 0.416 . . . . 0.0 110.606 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.681 ' C ' HD12 ' A' ' 60' ' ' LEU . 36.7 tp10 -66.48 -33.61 76.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.862 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.687 HD11 ' C ' ' A' ' 6' ' ' LYS . 4.3 mp -120.47 40.37 3.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.951 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.52 -20.81 32.24 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.415 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.65 -42.1 99.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.693 0.282 . . . . 0.0 111.475 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.599 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 4.4 t -69.59 -46.97 74.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.946 0.403 . . . . 0.0 110.546 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 69' ' ' VAL . . . -53.62 -25.87 19.61 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.57 -41.66 11.24 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.451 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 12.9 ptmm? -55.92 -48.81 75.01 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.853 0.359 . . . . 0.0 110.695 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.415 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 33.7 m120 -80.32 0.96 30.66 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.196 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 65.06 38.8 5.98 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.895 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.727 HG13 HG21 ' A' ' 74' ' ' THR . 47.5 t -107.92 93.48 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.883 0.373 . . . . 0.0 111.024 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.2 p -112.94 21.47 15.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.609 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -77.83 -154.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.583 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.72 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -171.46 87.12 0.47 Allowed Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.653 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 3.4 Cg_endo -96.35 -156.3 0.4 Allowed 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 124.888 -0.88 . . . . 0.0 112.663 0.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.859 HG23 ' HB ' ' A' ' 88' ' ' VAL . 87.7 m -154.19 148.05 25.51 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.467 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.056 HD13 HD13 ' A' ' 95' ' ' ILE . 83.3 mt -110.02 122.18 46.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.941 0.4 . . . . 0.0 111.62 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.057 HD12 ' CE1' ' A' ' 25' ' ' PHE . 23.5 mt -116.99 129.19 55.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.525 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.788 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.4 mp -109.75 135.25 50.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.02 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.532 ' HA ' HG23 ' A' ' 84' ' ' VAL . 57.2 m-85 -136.22 124.14 22.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.991 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.686 ' HG3' HG21 ' A' ' 84' ' ' VAL . 26.0 mtpp -112.12 126.93 55.71 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.405 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.494 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.3 m120 50.3 64.58 1.74 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.846 0.355 . . . . 0.0 111.635 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 50.44 24.99 7.95 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 116.185 -0.461 . . . . 0.0 113.319 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 61.5 mttp -128.94 -157.0 0.79 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 33.9 tt0 -108.74 174.64 5.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.686 HG21 ' HG3' ' A' ' 79' ' ' LYS . 1.7 t -151.09 -55.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.973 0.416 . . . . 0.0 110.687 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.13 -164.24 0.4 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.848 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.495 ' HD3' ' N ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -164.4 125.83 2.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.027 0.441 . . . . 0.0 110.826 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.494 HG11 ' HB1' ' A' ' 94' ' ' ALA . 49.0 t -132.21 80.36 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.924 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.859 ' HB ' HG23 ' A' ' 74' ' ' THR . 7.2 p -72.54 99.17 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.02 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.74 -23.1 0.33 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.213 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.668 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . 51.2 40.4 25.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.869 0.366 . . . . 0.0 111.101 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.593 ' O ' HG22 ' A' ' 95' ' ' ILE . 75.1 m-20 -59.5 134.26 88.76 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.916 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -47.67 -25.36 5.53 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.636 2.224 . . . . 0.0 112.733 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.75 26.45 10.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.625 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -137.5 -57.32 0.69 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.362 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.056 HD13 HD13 ' A' ' 75' ' ' LEU . 3.2 tp -54.81 -11.48 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.715 0.293 . . . . 0.0 110.867 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -92.0 -59.49 2.09 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.055 0.455 . . . . 0.0 110.801 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -63.32 -33.32 75.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.101 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.44 -31.06 65.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.115 0.483 . . . . 0.0 110.664 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.88 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.4 mp -90.18 -8.29 10.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.542 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.57 -71.78 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.789 0.328 . . . . 0.0 111.34 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.2 -30.04 48.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.334 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.639 ' CB ' HD22 ' A' ' 20' ' ' LEU . 1.1 m-80 -77.37 -50.02 13.67 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.986 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.577 ' HB2' HD23 ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.167 -0.921 . . . . 0.0 111.131 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.868 0.366 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 52' ' ' PHE . 14.0 p -153.38 138.0 9.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.449 HG22 ' N ' ' A' ' 4' ' ' GLN . 92.2 m -150.04 161.72 41.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.028 0.442 . . . . 0.0 111.702 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.672 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 51.0 mt-30 -96.19 178.7 5.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.135 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.477 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 17.3 m-85 -124.66 127.58 47.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.925 0.393 . . . . 0.0 111.133 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.749 ' C ' HD11 ' A' ' 60' ' ' LEU . 34.5 mmtp -107.92 -26.7 10.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.691 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.8 p -134.05 129.25 35.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.35 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.28 -26.02 6.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.57 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -61.62 -16.76 51.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.56 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -90.4 -41.72 11.32 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.107 0.48 . . . . 0.0 111.281 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.751 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -78.38 -27.63 46.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.055 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -51.9 -57.47 9.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.391 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 t -71.32 -23.06 61.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.499 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.651 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -56.56 -44.19 80.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.474 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.1 pt -81.08 -49.93 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.483 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -45.58 101.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 44.78 89.08 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.223 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -171.72 40.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.313 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.538 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 3.1 mppt? 62.45 -156.67 0.34 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.25 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.827 HD11 ' HB3' ' A' ' 77' ' ' LEU . 54.7 tp -98.06 116.51 30.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.089 0.471 . . . . 0.0 110.863 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 51' ' ' ASP . 45.2 t -99.96 134.78 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.638 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.614 HG21 HD13 ' A' ' 99' ' ' ILE . 40.5 t -99.82 84.24 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.951 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.799 HG22 ' HB2' ' A' ' 53' ' ' TYR . 38.8 t -101.11 120.17 50.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.098 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.532 ' CG ' HD23 ' A' ' 75' ' ' LEU . 2.9 m-20 -99.31 137.91 37.15 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.009 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.045 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.8 m-85 -99.35 53.21 0.95 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.646 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.575 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -52.64 137.38 30.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.439 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 72' ' ' MET . . . -66.1 134.82 53.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.549 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.441 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.6 t -57.59 -17.77 16.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.334 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.444 ' CZ3' ' SD ' ' A' ' 72' ' ' MET . 6.4 p-90 -109.12 -125.98 0.26 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 40.0 t 61.58 -82.24 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 122.448 0.299 . . . . 0.0 110.951 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.45 -77.77 0.29 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.067 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.03 -18.69 51.97 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.916 2.41 . . . . 0.0 112.98 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 95.0 m -52.88 -26.14 13.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.666 0.269 . . . . 0.0 111.711 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -79.47 -24.75 42.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.667 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 89.6 mmm -72.55 -2.22 18.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.729 0.299 . . . . 0.0 111.099 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.766 HG22 HG13 ' A' ' 40' ' ' ILE . 44.0 mt -85.58 -22.88 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.822 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.528 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -51.7 -44.73 91.07 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 47.2 Cg_endo -72.82 -34.42 6.8 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 121.802 1.668 . . . . 0.0 111.322 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.7 ttt -65.9 -52.21 51.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.766 HG13 HG22 ' A' ' 36' ' ' ILE . 75.9 mt -48.77 -29.34 2.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.581 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.531 ' HB2' HG11 ' A' ' 2' ' ' VAL . 37.7 tt0 -76.9 -32.71 57.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.062 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -66.73 -19.61 65.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.72 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -90.18 -26.65 20.03 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.406 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 53.9 m -59.87 -16.14 26.76 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.16 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.473 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 56.2 mt-10 -86.19 -20.32 28.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.821 0.344 . . . . 0.0 110.853 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -90.54 -37.29 13.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.552 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.586 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 72.4 m-85 -122.45 41.24 0.51 Allowed Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.723 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 75.5 Cg_exo -34.94 -33.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.5 2.8 . . . . 0.0 113.704 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -57.26 -36.8 71.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.035 0.445 . . . . 0.0 110.594 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.8 143.01 27.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.561 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.567 ' O ' HG13 ' A' ' 21' ' ' VAL . 29.9 m-20 -89.68 121.86 32.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.911 0.386 . . . . 0.0 110.694 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.662 ' O ' HG23 ' A' ' 2' ' ' VAL . 5.5 m-85 -95.21 85.79 4.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.594 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.799 ' HB2' HG22 ' A' ' 23' ' ' VAL . 34.7 m-85 -97.82 -176.87 3.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.27 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.672 ' HE2' ' HG2' ' A' ' 4' ' ' GLN . 35.1 mtmm -150.03 136.17 18.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.052 0.453 . . . . 0.0 110.982 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.4 tm? -93.04 139.94 30.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.963 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.876 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.2 t0 -95.27 112.57 24.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.856 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 53.5 t -73.2 -7.38 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.423 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.441 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 9.2 t70 -97.6 -59.84 1.69 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.972 0.415 . . . . 0.0 110.521 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.671 ' C ' HD12 ' A' ' 60' ' ' LEU . 16.9 tp10 -67.55 -32.92 74.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.882 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.749 HD11 ' C ' ' A' ' 6' ' ' LYS . 4.7 mp -120.03 58.3 0.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.928 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.35 -15.26 58.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.647 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.92 -27.05 43.7 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.68 0.276 . . . . 0.0 111.452 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.813 HG12 ' HE2' ' A' ' 25' ' ' PHE . 11.7 t -77.59 -51.49 18.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.477 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.44 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -57.21 -23.22 46.39 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.18 -37.98 13.79 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.229 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.709 ' HE3' HG13 ' A' ' 63' ' ' VAL . 17.2 pttp -59.88 -48.52 81.35 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.918 0.389 . . . . 0.0 110.131 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.413 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.0 m-20 -77.86 -6.33 53.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.871 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 66.38 42.51 2.94 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.117 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.513 ' CG1' HG21 ' A' ' 74' ' ' THR . 48.5 t -110.44 78.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.81 0.338 . . . . 0.0 111.196 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 81.4 p -90.53 10.26 26.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.096 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.645 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -61.46 -156.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.747 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 72' ' ' MET . 9.5 ptt? -176.68 86.93 0.26 Allowed Pre-proline 0 CA--C 1.53 0.185 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.613 ' HG3' HD12 ' A' ' 36' ' ' ILE . 43.0 Cg_endo -98.06 -159.58 0.46 Allowed 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 125.131 -0.779 . . . . 0.0 112.467 -0.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.645 ' OG1' ' HB3' ' A' ' 71' ' ' ALA . 83.6 m -149.9 161.22 42.71 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.825 0.345 . . . . 0.0 111.269 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.669 ' CD1' HD13 ' A' ' 95' ' ' ILE . 37.3 mt -122.1 124.1 43.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.305 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.045 HD12 ' CE1' ' A' ' 25' ' ' PHE . 22.2 mt -123.64 125.5 44.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.761 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.827 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.6 mp -109.75 136.36 49.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.635 ' HA ' HG23 ' A' ' 84' ' ' VAL . 53.2 m-85 -137.13 125.11 22.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.054 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.583 ' HG3' HD13 ' A' ' 20' ' ' LEU . 54.1 mtpt -112.43 131.21 55.68 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.514 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.4 m120 48.94 54.85 10.16 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.883 0.373 . . . . 0.0 111.719 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 58.4 17.56 32.93 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 121.276 -0.488 . . . . 0.0 113.02 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 31.0 mmmt -115.62 -153.76 0.53 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 88.1 tt0 -108.79 172.72 6.68 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 78' ' ' PHE . 44.8 t -146.45 -64.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.756 0.312 . . . . 0.0 111.276 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.08 150.08 3.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.299 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -119.3 120.25 36.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.611 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 48.6 t -145.49 94.87 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.277 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.63 HG21 ' CB ' ' A' ' 71' ' ' ALA . 4.3 p -64.56 102.33 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.735 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.99 103.07 0.54 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.42 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.615 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -96.31 36.99 1.28 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.953 0.406 . . . . 0.0 111.273 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 93' ' ' ALA . 21.2 p30 -80.06 141.52 54.52 Favored Pre-proline 0 N--CA 1.44 -0.94 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.532 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -46.95 87.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.624 2.216 . . . . 0.0 112.669 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -179.54 -38.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.407 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.69 -40.8 2.04 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.669 HD13 ' CD1' ' A' ' 75' ' ' LEU . 4.5 tp -50.51 -18.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.642 0.258 . . . . 0.0 111.441 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 18.0 ptpt -91.21 -50.18 5.97 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.894 0.378 . . . . 0.0 111.15 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.409 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 85.3 mt-30 -71.02 -31.73 68.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.464 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.82 -32.39 73.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.786 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.687 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 58.1 mt -90.1 -7.75 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.455 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.47 -74.26 0.5 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.973 0.416 . . . . 0.0 111.383 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -50.07 -30.44 10.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.53 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.686 ' HB3' HD22 ' A' ' 20' ' ' LEU . 3.9 m120 -82.38 -48.58 10.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.11 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.714 ' HB2' HD23 ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.041 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 tpt . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.744 0.306 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.83 HG22 HG22 ' A' ' 40' ' ' ILE . 57.5 t 66.64 123.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.303 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.0 m -150.16 147.39 27.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.915 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.517 ' HG2' ' HE3' ' A' ' 54' ' ' LYS . 63.2 mt-30 -89.95 164.76 14.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.329 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.592 ' O ' HD13 ' A' ' 60' ' ' LEU . 18.2 m-85 -117.53 123.3 45.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.926 0.393 . . . . 0.0 111.448 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.679 ' C ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -103.79 -33.06 9.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.145 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.9 p -127.09 131.13 50.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.398 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.02 -24.45 9.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.657 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.1 m -61.67 -17.02 53.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.662 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.27 -39.08 12.98 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.105 0.478 . . . . 0.0 111.224 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.899 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -82.17 -30.95 30.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.911 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -55.55 -37.81 68.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.248 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.4 m -90.04 -0.13 57.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.64 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.671 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -82.6 -44.61 15.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.689 0.28 . . . . 0.0 111.39 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.2 pt -79.56 -49.67 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.551 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -41.93 97.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 85.0 mt-30 45.77 88.52 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.219 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 9.1 t70 -170.37 41.07 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.126 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 91.6 mttt 66.17 -155.49 0.25 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.699 0.285 . . . . 0.0 110.404 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.882 HD11 ' HB3' ' A' ' 77' ' ' LEU . 57.9 tp -98.06 116.12 29.63 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.29 0.567 . . . . 0.0 110.917 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.678 HG22 ' HB2' ' A' ' 51' ' ' ASP . 59.9 t -105.55 122.29 58.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.722 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.739 HG21 HG12 ' A' ' 99' ' ' ILE . 46.8 t -99.98 97.68 6.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.779 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.899 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 45.5 t -99.91 134.79 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.224 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 74' ' ' THR . 37.5 t70 -99.79 128.03 45.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.673 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.037 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.3 m-85 -99.08 51.37 0.95 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.656 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.588 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -50.9 128.65 21.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.061 0.457 . . . . 0.0 111.035 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.569 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -56.07 157.2 4.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.256 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.571 HG22 HG12 ' A' ' 57' ' ' VAL . 4.2 t -95.4 21.59 7.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.202 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.515 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 26.0 p-90 -138.53 -43.62 0.49 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.834 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.441 ' HG ' ' HG ' ' A' ' 33' ' ' CYS . 35.9 t -43.75 129.6 5.55 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.546 0.213 . . . . 0.0 110.984 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.07 -67.85 1.34 Allowed Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.786 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 33' ' ' CYS . 56.5 Cg_endo -67.76 -145.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.56 2.173 . . . . 0.0 110.937 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 32' ' ' PRO . 58.9 m 73.9 4.69 4.7 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -111.46 -29.11 7.91 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.692 0.282 . . . . 0.0 111.056 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.477 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 86.0 mmm -78.44 5.29 11.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.127 0.489 . . . . 0.0 110.538 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.909 HG22 HG13 ' A' ' 40' ' ' ILE . 71.3 mt -81.49 -24.07 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.701 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.53 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -47.36 -45.79 56.39 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 50.0 Cg_endo -72.77 -35.58 5.62 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.904 1.736 . . . . 0.0 111.199 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.5 ttt -65.12 -51.79 59.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.909 HG13 HG22 ' A' ' 36' ' ' ILE . 69.7 mt -48.88 -28.67 2.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.459 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.501 ' N ' HG21 ' A' ' 2' ' ' VAL . 38.8 tt0 -78.24 -33.32 49.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.898 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.464 ' HB3' ' NZ ' ' A' ' 42' ' ' LYS . 9.0 mtpm? -64.35 -22.36 66.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.437 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.483 ' HE2' HG23 ' A' ' 95' ' ' ILE . 4.0 m-85 -90.14 -16.97 28.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.665 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.43 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 45.8 t -74.67 -6.53 49.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.252 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -90.17 -29.07 18.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.937 0.399 . . . . 0.0 111.109 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.31 -26.41 20.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.791 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.571 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 80.1 m-85 -123.61 46.37 1.41 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.473 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 81.9 Cg_exo -37.44 -44.32 1.41 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.207 2.604 . . . . 0.0 113.64 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.415 ' O ' ' HD3' ' A' ' 19' ' ' LYS . 98.0 mm-40 -56.37 -31.29 63.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.923 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.66 133.44 34.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.803 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.678 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.55 121.91 32.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.482 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.547 ' CE2' HD13 ' A' ' 99' ' ' ILE . 4.5 m-85 -96.46 103.58 15.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.375 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.623 ' HB2' HG22 ' A' ' 23' ' ' VAL . 40.7 m-85 -114.17 -176.73 2.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.316 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.709 ' HE2' HG12 ' A' ' 2' ' ' VAL . 44.3 mtmt -145.54 130.51 18.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 111.206 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.811 HD13 ' N ' ' A' ' 56' ' ' ASP . 3.0 tm? -90.75 138.27 31.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.401 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.811 ' N ' HD13 ' A' ' 55' ' ' LEU . 25.4 t70 -94.98 108.34 20.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.422 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.571 HG12 HG22 ' A' ' 28' ' ' THR . 91.1 t -71.15 -11.29 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.547 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 9.7 t70 -88.9 -41.35 12.48 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.434 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.451 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 38.4 tp10 -93.06 -47.51 6.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.824 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.679 HD11 ' C ' ' A' ' 6' ' ' LYS . 5.2 mp -101.82 46.68 0.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.07 -20.78 36.03 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.462 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -71.35 -25.41 62.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.576 0.227 . . . . 0.0 111.517 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.738 HG12 ' HE2' ' A' ' 25' ' ' PHE . 8.0 t -79.61 -51.79 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.711 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.92 -27.4 51.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.99 0.424 . . . . 0.0 110.122 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.03 -26.31 20.37 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.756 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -70.51 -50.44 37.75 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.999 0.428 . . . . 0.0 109.96 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -76.24 -2.6 32.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.915 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 67.48 38.97 2.99 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.167 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.71 ' CG1' HG21 ' A' ' 74' ' ' THR . 48.3 t -112.04 83.49 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.868 0.366 . . . . 0.0 111.054 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.6 p -93.15 3.34 55.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.272 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.636 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -59.49 -163.07 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.612 ' HG2' ' O ' ' A' ' 72' ' ' MET . 0.0 OUTLIER -173.82 94.39 0.33 Allowed Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.51 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 18.9 Cg_endo -91.93 -161.1 1.16 Allowed 'Cis proline' 0 C--N 1.349 0.562 0 C-N-CA 124.835 -0.902 . . . . 0.0 112.513 -0.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.719 HG23 ' HA ' ' A' ' 88' ' ' VAL . 29.0 m -155.92 148.53 23.91 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.671 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.006 HD13 HD13 ' A' ' 95' ' ' ILE . 83.2 mt -109.78 125.26 52.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 111.334 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.037 HD12 ' CE1' ' A' ' 25' ' ' PHE . 21.8 mt -121.37 127.37 51.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.782 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.882 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.7 mp -109.87 140.57 43.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.024 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.626 ' HA ' HG23 ' A' ' 84' ' ' VAL . 52.5 m-85 -140.61 125.7 18.48 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.853 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.584 ' HG3' HD13 ' A' ' 20' ' ' LEU . 54.9 mtpt -109.87 129.01 55.69 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.789 0.328 . . . . 0.0 111.47 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.523 ' O ' ' ND2' ' A' ' 80' ' ' ASN . 0.4 OUTLIER 45.79 61.28 2.72 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.079 0.466 . . . . 0.0 111.6 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 55.59 17.89 14.73 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-N 116.088 -0.506 . . . . 0.0 113.542 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 60.0 mttp -115.18 -155.85 0.59 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 34.7 tt0 -108.78 173.0 6.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.626 HG23 ' HA ' ' A' ' 78' ' ' PHE . 47.9 t -147.79 -68.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.939 0.4 . . . . 0.0 111.038 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.63 154.99 4.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.254 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -114.52 114.99 26.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.414 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.35 82.18 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.311 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.719 ' HA ' HG23 ' A' ' 74' ' ' THR . 2.7 p -60.89 85.14 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.721 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.6 115.39 1.37 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.367 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.727 ' HB2' HD21 ' A' ' 75' ' ' LEU . . . -96.79 38.45 1.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.804 0.335 . . . . 0.0 111.186 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 93' ' ' ALA . 46.2 t30 -68.84 129.28 92.48 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.194 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 85.3 Cg_exo -45.62 88.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.667 2.245 . . . . 0.0 112.659 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 92' ' ' PRO . . . 172.52 -33.16 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.411 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.43 -44.68 2.46 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.006 HD13 HD13 ' A' ' 75' ' ' LEU . 3.8 tp -50.83 -17.9 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.298 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 7.0 ptpp? -91.63 -48.99 6.53 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.949 0.404 . . . . 0.0 110.792 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.418 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 80.2 mt-30 -69.96 -31.6 69.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.575 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.21 -31.68 72.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.023 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.739 HG12 HG21 ' A' ' 22' ' ' VAL . 46.4 mt -90.19 -8.24 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.56 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.571 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.2 -69.65 0.71 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.842 0.353 . . . . 0.0 111.174 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.99 -29.0 18.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.221 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.572 ' CB ' HD22 ' A' ' 20' ' ' LEU . 3.8 m120 -82.63 -51.76 7.45 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.032 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.616 ' HB2' HD23 ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.188 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.9 tpp . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.809 0.338 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 52' ' ' PHE . 14.6 p -178.04 139.73 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 4' ' ' GLN . 87.3 m -141.88 162.84 34.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.959 0.409 . . . . 0.0 111.51 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.596 ' HG2' ' HD2' ' A' ' 54' ' ' LYS . 71.5 mt-30 -97.29 -176.97 3.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.777 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.504 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 20.3 m-85 -135.14 101.77 4.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.328 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.559 ' C ' HD11 ' A' ' 60' ' ' LEU . 32.7 mmtp -83.19 -25.4 31.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.731 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.5 p -130.42 123.21 29.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.261 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.83 -25.77 4.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.583 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m -59.5 -18.9 43.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.572 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -90.47 -44.1 9.83 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.206 0.527 . . . . 0.0 111.452 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.885 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.2 t80 -69.39 -30.51 68.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.031 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -50.83 -66.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.404 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.9 m -60.78 -20.48 61.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.467 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 11' ' ' PHE . . . -56.41 -66.42 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.795 0.331 . . . . 0.0 111.676 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' GLY . 21.0 pt -54.6 -48.14 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.753 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.07 103.0 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.7 mt-30 45.18 92.11 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.236 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -171.51 38.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.384 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.538 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 61.61 -152.5 0.37 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.871 HD11 ' HB3' ' A' ' 77' ' ' LEU . 59.3 tp -97.55 115.92 28.78 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.244 0.545 . . . . 0.0 110.437 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 51' ' ' ASP . 58.9 t -104.05 126.97 58.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.871 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.783 HG11 HD11 ' A' ' 95' ' ' ILE . 48.6 t -99.74 93.15 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.495 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.885 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 43.4 t -99.76 128.14 51.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.114 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.7 t70 -99.72 130.73 45.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.752 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.044 ' CE1' HD12 ' A' ' 76' ' ' LEU . 3.4 m-85 -99.07 53.01 0.97 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.968 0.413 . . . . 0.0 110.406 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -50.98 124.77 12.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.301 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -51.69 154.1 2.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.25 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.468 HG22 HG12 ' A' ' 57' ' ' VAL . 7.0 t -96.47 23.82 6.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.085 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.506 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 27.3 p-90 -141.53 -38.05 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.63 ' HB2' ' HB2' ' A' ' 72' ' ' MET . 51.3 t -35.21 150.98 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.0 0.429 . . . . 0.0 111.938 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.36 -79.29 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.453 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 3.3 Cg_exo -73.01 -76.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.43 2.087 . . . . 0.0 112.021 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.9 p 37.92 31.33 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 28.3 mtpp -132.04 -35.98 1.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.214 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.491 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 15.2 tmm? -58.41 -16.03 13.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.852 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.691 HG22 HG13 ' A' ' 40' ' ' ILE . 2.4 mp -75.26 -38.13 40.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.345 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.522 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -45.6 -49.28 36.04 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 41.0 Cg_endo -70.88 -32.73 13.44 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 121.988 1.792 . . . . 0.0 110.999 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 49.3 ttm -66.59 -51.13 59.78 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.718 HG22 HG21 ' A' ' 2' ' ' VAL . 61.6 mt -49.54 -28.38 3.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.515 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.482 ' HB2' HG11 ' A' ' 2' ' ' VAL . 37.8 tt0 -79.16 -30.93 43.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.183 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.478 ' HB3' ' NZ ' ' A' ' 42' ' ' LYS . 9.1 mtpm? -69.37 -16.11 63.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.73 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.49 ' CE2' HG23 ' A' ' 95' ' ' ILE . 3.9 m-85 -90.11 -20.85 22.66 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.5 t -66.74 -14.28 62.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.777 0.322 . . . . 0.0 110.713 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.419 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 5.1 tm-20 -90.04 -20.95 22.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.295 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -90.12 -36.35 14.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.315 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.538 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 81.6 m-85 -124.11 45.4 1.22 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.373 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 75.1 Cg_exo -36.91 -33.03 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.429 2.753 . . . . 0.0 113.628 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -59.57 -37.64 79.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.652 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.83 141.26 28.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.801 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.546 ' O ' HG13 ' A' ' 21' ' ' VAL . 33.9 m-20 -90.08 123.41 33.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.824 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.799 ' O ' HG23 ' A' ' 2' ' ' VAL . 5.4 m-85 -97.09 106.58 18.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.303 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.561 ' HB2' HG22 ' A' ' 23' ' ' VAL . 40.9 m-85 -116.11 -178.45 3.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.523 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.726 ' HE3' HG22 ' A' ' 2' ' ' VAL . 69.9 mttt -142.13 145.36 34.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.393 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.677 ' CD2' HD22 ' A' ' 60' ' ' LEU . 2.7 tm? -107.25 125.13 50.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.607 ' N ' HD13 ' A' ' 55' ' ' LEU . 1.6 m-20 -81.76 108.18 15.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.693 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.468 HG12 HG22 ' A' ' 28' ' ' THR . 85.1 t -72.34 -10.12 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.44 -60.52 2.34 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.556 ' HB3' HD12 ' A' ' 60' ' ' LEU . 2.2 tm-20 -77.9 -39.83 41.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.572 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.677 HD22 ' CD2' ' A' ' 55' ' ' LEU . 4.5 mp -97.76 44.85 1.03 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.014 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.13 -19.88 40.44 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.627 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -78.93 -29.32 44.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.783 0.325 . . . . 0.0 111.432 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.86 HG13 ' HE2' ' A' ' 66' ' ' LYS . 21.4 t -73.27 -54.83 14.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.788 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.86 -25.08 10.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.918 0.389 . . . . 0.0 110.142 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -90.17 -38.36 13.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.158 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.86 ' HE2' HG13 ' A' ' 63' ' ' VAL . 51.5 pttt -60.83 -46.97 88.48 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.945 0.403 . . . . 0.0 110.185 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.402 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 34.0 m120 -79.16 -2.09 39.2 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.025 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 64.72 37.7 7.36 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.456 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.746 HG13 HG21 ' A' ' 74' ' ' THR . 41.9 t -111.45 68.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.992 0.425 . . . . 0.0 110.546 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.2 t -85.01 8.24 18.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.733 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.834 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -59.76 -161.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.63 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -173.71 89.46 0.36 Allowed Pre-proline 0 N--CA 1.454 -0.228 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.545 ' O ' HG23 ' A' ' 88' ' ' VAL . 65.0 Cg_endo -96.13 -165.76 1.25 Allowed 'Cis proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.577 -1.01 . . . . 0.0 112.437 -0.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.876 HG23 ' HB ' ' A' ' 88' ' ' VAL . 29.5 m -147.35 163.63 35.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.477 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.915 HD13 HD13 ' A' ' 95' ' ' ILE . 78.9 mt -122.34 127.74 50.16 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.835 0.35 . . . . 0.0 111.191 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.044 HD12 ' CE1' ' A' ' 25' ' ' PHE . 26.5 mt -123.97 128.5 49.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.608 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.871 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.7 mp -109.64 136.9 48.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.028 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.605 ' HA ' HG23 ' A' ' 84' ' ' VAL . 51.1 m-85 -138.72 126.42 22.11 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.877 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.476 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 9.8 mtpm? -109.77 129.77 55.59 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.368 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.442 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 6.3 m120 45.78 56.75 5.64 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.865 0.365 . . . . 0.0 111.92 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 60.61 14.65 36.74 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.066 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 49.1 mtmt -110.93 -155.37 0.56 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.441 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 88.2 tt0 -109.04 172.6 6.75 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 78' ' ' PHE . 64.5 t -146.18 -68.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 0.0 111.25 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.39 -168.31 0.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 0.0 111.551 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.462 ' HB3' ' NZ ' ' A' ' 86' ' ' LYS . 9.7 mtpm? -142.51 140.03 31.68 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.994 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.7 t -154.46 82.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.532 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.876 ' HB ' HG23 ' A' ' 74' ' ' THR . 5.5 p -78.67 109.57 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.826 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.91 -25.79 0.72 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.134 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.772 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . 44.48 39.8 3.46 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 111.357 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.481 ' O ' HG22 ' A' ' 95' ' ' ILE . 24.3 t-20 -62.4 135.61 95.39 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.664 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -47.78 -25.18 5.59 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.663 2.242 . . . . 0.0 112.82 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.34 30.05 7.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.626 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -139.67 -59.57 0.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.2 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.915 HD13 HD13 ' A' ' 75' ' ' LEU . 3.9 tp -57.02 -7.28 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.337 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 14.8 ptmm? -91.3 -49.16 6.51 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.928 0.394 . . . . 0.0 110.659 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.416 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 73.0 mt-30 -69.52 -31.85 70.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.28 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.75 -28.32 69.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.695 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.8 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 59.0 mt -90.17 -10.82 10.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.523 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.84 -71.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.997 0.427 . . . . 0.0 111.349 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -47.43 -29.09 2.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.46 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.679 ' CB ' HD22 ' A' ' 20' ' ' LEU . 68.5 m-20 -90.05 -48.04 7.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.324 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.8 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.078 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.826 0.346 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.791 HG12 ' HE3' ' A' ' 54' ' ' LYS . 32.7 t -142.35 141.3 28.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.867 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 4' ' ' GLN . 95.5 m -144.25 161.19 39.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.057 0.456 . . . . 0.0 111.411 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.613 ' HG2' ' NZ ' ' A' ' 54' ' ' LYS . 55.3 mt-30 -91.71 172.55 8.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.443 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.521 ' CE2' ' CG ' ' A' ' 11' ' ' PHE . 17.1 m-85 -126.68 131.96 51.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.19 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.589 ' C ' HD11 ' A' ' 60' ' ' LEU . 47.5 mmtm -120.98 -32.61 3.92 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.2 p -126.2 148.06 49.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.908 0.385 . . . . 0.0 111.657 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 9' ' ' SER . . . -74.21 99.51 3.43 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.405 0.621 . . . . 0.0 110.337 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 31.3 t 160.55 -24.97 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.018 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -84.67 -32.68 23.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.294 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.853 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -90.34 -43.33 10.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.401 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -47.29 -37.91 11.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.12 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.7 m -74.81 -30.95 61.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.834 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.491 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -60.49 -34.9 74.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.062 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.1 pt -90.07 -49.71 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.417 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.465 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -43.62 95.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 45.23 83.17 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.177 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -164.67 42.25 0.08 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.588 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.7 mptp? 64.86 -157.2 0.29 Allowed 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 120.701 0.286 . . . . 0.0 110.657 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.841 HD13 ' HG3' ' A' ' 79' ' ' LYS . 65.9 tp -98.24 117.14 31.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.062 0.458 . . . . 0.0 110.856 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 51' ' ' ASP . 46.6 t -113.93 124.02 70.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.742 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.72 HG22 ' HG ' ' A' ' 77' ' ' LEU . 58.8 t -99.84 111.56 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.933 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.853 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 41.5 t -109.45 137.77 40.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.197 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.45 ' OD2' HG21 ' A' ' 36' ' ' ILE . 61.8 t0 -99.84 128.96 45.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.824 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.067 ' CE1' HD12 ' A' ' 76' ' ' LEU . 6.8 m-85 -99.15 48.29 0.96 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.052 0.453 . . . . 0.0 110.175 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.582 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -48.88 132.04 18.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.243 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.563 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -60.78 145.31 50.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.808 0.337 . . . . 0.0 110.718 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.477 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 7.7 t -72.79 -21.19 61.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.391 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -95.87 -39.24 9.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.806 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 49.1 t -41.23 139.49 0.98 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.914 0.387 . . . . 0.0 111.717 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.71 -58.18 1.85 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.785 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.93 52.5 4.28 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.619 2.212 . . . . 0.0 112.755 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.442 ' O ' HD12 ' A' ' 36' ' ' ILE . 27.3 p -127.13 -13.05 5.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.38 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -78.47 -25.44 45.82 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.738 0.304 . . . . 0.0 111.251 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.409 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 65.9 mtt -73.75 3.83 5.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.828 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.797 HG22 HG13 ' A' ' 40' ' ' ILE . 62.2 mt -79.14 -38.78 20.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.933 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.572 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -42.79 -45.42 11.47 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 23.9 Cg_endo -66.36 -43.49 8.17 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.595 1.53 . . . . 0.0 111.669 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.509 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 12.2 mmt -62.1 -59.87 4.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.797 HG13 HG22 ' A' ' 36' ' ' ILE . 43.2 mt -43.08 -29.27 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.019 0.438 . . . . 0.0 110.751 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -80.42 -43.34 21.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.767 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -59.78 -29.94 68.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.183 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.605 ' CE2' HG23 ' A' ' 95' ' ' ILE . 16.0 m-85 -76.14 -22.6 55.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.473 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.401 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 98.9 p -77.31 -4.05 43.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.71 0.29 . . . . 0.0 110.711 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.424 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 50.3 mt-10 -90.08 -28.32 19.09 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.855 0.36 . . . . 0.0 110.712 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -90.24 -28.31 18.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.362 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.539 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 70.3 m-85 -123.97 45.54 1.25 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.133 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 74.2 Cg_exo -37.41 -32.43 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.376 2.718 . . . . 0.0 113.54 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -60.79 -38.45 85.37 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.674 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -90.0 138.69 31.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.956 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.657 ' O ' HG13 ' A' ' 21' ' ' VAL . 58.2 m-20 -90.71 138.72 31.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.663 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.602 ' O ' HG13 ' A' ' 2' ' ' VAL . 2.7 m-85 -114.74 98.39 6.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.516 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.672 ' HB2' HG22 ' A' ' 23' ' ' VAL . 43.5 m-85 -102.41 -173.25 2.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.562 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.791 ' HE3' HG12 ' A' ' 2' ' ' VAL . 10.2 mtmp? -147.84 135.38 20.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.954 0.406 . . . . 0.0 111.04 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.954 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.1 tm? -98.25 145.62 26.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.698 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.954 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.9 t70 -93.85 126.04 38.82 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.7 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.759 ' O ' HG12 ' A' ' 57' ' ' VAL . 98.3 t -93.38 30.33 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 121.286 0.565 . . . . 0.0 110.814 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.477 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 65.8 t0 -137.94 -46.73 0.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.58 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.614 ' C ' HD12 ' A' ' 60' ' ' LEU . 5.2 tp10 -81.56 -32.24 32.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.414 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.675 HD22 HD21 ' A' ' 55' ' ' LEU . 4.5 mp -118.52 72.78 0.89 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.64 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -77.84 -1.72 79.32 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.88 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -90.04 -38.39 13.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.741 0.305 . . . . 0.0 111.39 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.801 HG13 ' HE3' ' A' ' 66' ' ' LYS . 6.0 t -71.73 -54.88 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.345 . . . . 0.0 110.608 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.37 -25.44 15.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.019 0.438 . . . . 0.0 110.226 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -90.24 -38.36 13.49 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.109 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.801 ' HE3' HG13 ' A' ' 63' ' ' VAL . 16.5 pttp -60.7 -48.4 81.97 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-O 120.865 0.364 . . . . 0.0 110.129 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.417 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.5 m-20 -76.81 -6.08 50.89 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.869 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 66.3 41.66 3.3 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.019 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.561 HG13 HG21 ' A' ' 74' ' ' THR . 59.6 t -104.63 84.6 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.153 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 91.3 p -95.56 -17.46 21.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.922 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.774 ' CB ' HG21 ' A' ' 88' ' ' VAL . . . -55.99 -171.01 0.0 OUTLIER 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.501 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.563 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -167.84 108.31 0.58 Allowed Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.349 -0.54 . . . . 0.0 112.372 -179.506 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.733 ' O ' HG23 ' A' ' 88' ' ' VAL . 42.1 Cg_endo -87.85 -162.15 2.07 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.394 -1.086 . . . . 0.0 112.286 -0.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.561 HG21 HG13 ' A' ' 69' ' ' VAL . 84.9 m -153.76 163.81 39.39 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.803 0.335 . . . . 0.0 110.797 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.026 HD13 HD13 ' A' ' 95' ' ' ILE . 71.0 mt -129.0 123.45 32.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 110.913 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.067 HD12 ' CE1' ' A' ' 25' ' ' PHE . 20.7 mt -121.05 129.15 53.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.803 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.79 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.5 mp -109.7 143.71 39.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.7 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.585 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 64.7 m-85 -144.41 127.09 16.15 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.001 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.841 ' HG3' HD13 ' A' ' 20' ' ' LEU . 49.3 mtpt -117.24 136.69 52.9 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.831 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.444 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.2 m120 45.78 67.69 0.7 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.569 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 46.29 33.97 5.99 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 113.048 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.585 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 68.1 mttm -141.78 -160.57 1.1 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.718 ' O ' HG13 ' A' ' 84' ' ' VAL . 28.9 tt0 -109.14 -179.91 3.98 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.811 HG11 ' HG3' ' A' ' 79' ' ' LYS . 4.6 m -164.2 -46.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.51 0.195 . . . . 0.0 111.38 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.47 158.68 24.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.046 0.451 . . . . 0.0 112.012 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.468 ' CD ' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -148.03 113.67 5.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.872 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.7 t -139.41 107.37 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.412 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.774 HG21 ' CB ' ' A' ' 71' ' ' ALA . 3.2 p -69.45 110.45 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.063 0.458 . . . . 0.0 110.659 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.2 105.14 0.91 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.164 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.667 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -94.0 38.35 1.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.847 0.356 . . . . 0.0 111.39 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' A' ' 93' ' ' ALA . 5.4 m120 -72.38 134.83 82.12 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.437 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 85.6 Cg_exo -48.48 84.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.722 2.282 . . . . 0.0 112.625 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 178.66 -38.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.43 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.33 -45.68 2.92 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.7 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.026 HD13 HD13 ' A' ' 75' ' ' LEU . 4.9 tp -52.83 -16.49 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.148 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.491 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -92.21 -49.3 6.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.982 0.42 . . . . 0.0 110.901 179.509 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.442 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 84.0 mt-30 -71.53 -32.05 67.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.661 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.679 ' HB1' HD21 ' A' ' 77' ' ' LEU . . . -57.89 -32.93 68.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.429 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.872 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.5 mp -90.24 -12.25 9.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.423 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.47 -64.42 1.14 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.911 0.386 . . . . 0.0 111.095 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.31 -30.36 38.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.064 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.78 ' HB3' HD22 ' A' ' 20' ' ' LEU . 64.9 m-20 -90.15 -66.42 0.93 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.301 -0.856 . . . . 0.0 111.117 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.867 0.365 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.07 HG22 ' HZ2' ' A' ' 54' ' ' LYS . 6.0 p -177.31 127.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.668 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 4' ' ' GLN . 92.5 m -150.3 162.01 41.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.198 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.546 ' HG3' ' HD2' ' A' ' 54' ' ' LYS . 14.5 mp0 -105.4 -173.37 2.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.878 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.51 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.8 m-85 -135.79 105.75 6.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.762 0.315 . . . . 0.0 111.698 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.661 ' O ' HD11 ' A' ' 60' ' ' LEU . 8.2 mmmm -88.93 -27.71 20.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.763 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.7 p -126.35 128.52 47.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 110.705 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.79 -24.04 20.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.415 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -62.29 -16.59 54.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.627 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -90.14 -56.74 3.1 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.246 0.546 . . . . 0.0 111.111 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.659 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -60.49 -33.1 72.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.7 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -51.46 -56.69 11.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.256 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.4 m -65.85 -25.3 67.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.526 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -56.39 -72.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 0.0 111.322 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.545 HG23 ' CE1' ' A' ' 11' ' ' PHE . 19.4 pt -52.8 -48.52 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.674 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -44.43 96.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 44.68 91.16 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.541 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -174.54 40.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.487 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.537 ' NZ ' ' HB2' ' A' ' 19' ' ' LYS . 8.1 mtmp? 69.36 -158.26 0.17 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.498 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.829 HD13 ' HG3' ' A' ' 79' ' ' LYS . 61.6 tp -98.16 113.76 25.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.205 0.526 . . . . 0.0 111.19 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.7 HG22 ' HB2' ' A' ' 51' ' ' ASP . 59.1 t -99.74 125.45 53.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.524 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.647 HG21 HG12 ' A' ' 99' ' ' ILE . 50.8 t -99.71 96.3 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.665 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.659 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 30.1 t -104.95 131.84 53.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.368 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.6 t70 -99.99 132.23 45.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.507 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.08 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.8 m-85 -99.14 54.6 0.98 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.137 0.494 . . . . 0.0 110.643 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.613 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -58.35 140.92 52.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.098 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.708 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -67.42 136.44 54.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.774 0.321 . . . . 0.0 110.253 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 3.3 t -53.39 -49.35 67.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.222 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 32.0 p-90 -68.2 -42.62 79.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.79 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 53.1 t -45.75 135.14 7.07 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 111.146 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.27 -56.3 0.94 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.117 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -48.57 -26.02 8.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.617 2.211 . . . . 0.0 112.729 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.9 p -63.92 -32.21 73.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.071 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -61.87 -25.32 67.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.383 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 66.1 mtt -68.85 -5.85 23.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.962 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.857 HG22 HG13 ' A' ' 40' ' ' ILE . 60.0 mt -86.51 -23.63 6.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.447 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.28 -44.48 81.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 45.6 Cg_endo -72.7 -36.61 4.67 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.669 1.579 . . . . 0.0 111.447 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.527 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 67.5 mtm -64.96 -51.46 61.63 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.857 HG13 HG22 ' A' ' 36' ' ' ILE . 68.0 mt -48.71 -25.53 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.716 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.404 ' HB2' HG11 ' A' ' 2' ' ' VAL . 38.0 tt0 -85.06 -23.38 28.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.972 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.447 ' NZ ' ' HB2' ' A' ' 42' ' ' LYS . 10.5 mtmp? -82.28 -15.71 52.03 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.527 ' HD1' ' O ' ' A' ' 39' ' ' MET . 3.5 m-85 -90.04 -19.27 24.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.652 0.263 . . . . 0.0 111.323 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.452 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.6 t -69.62 -8.84 50.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.484 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -87.99 -27.18 22.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.739 0.304 . . . . 0.0 111.098 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -90.6 -30.4 17.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.904 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.511 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 72.9 m-85 -123.03 47.3 1.56 Allowed Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.167 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 80.7 Cg_exo -38.01 -27.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.254 2.636 . . . . 0.0 113.594 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.491 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 13.4 mp0 -65.63 -36.22 83.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.105 0.479 . . . . 0.0 110.472 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.48 138.27 31.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.109 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.7 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.53 122.21 32.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.026 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.624 ' CE2' HD13 ' A' ' 99' ' ' ILE . 4.2 m-85 -97.37 83.96 3.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.221 0.534 . . . . 0.0 111.624 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.51 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 54.2 m-85 -102.31 -174.75 2.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.495 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 1.07 ' HZ2' HG22 ' A' ' 2' ' ' VAL . 28.6 mttp -141.98 148.59 38.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.307 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.727 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.8 tm? -106.21 130.23 54.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.127 0.489 . . . . 0.0 110.943 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.727 ' N ' HD13 ' A' ' 55' ' ' LEU . 56.9 m-20 -83.89 117.03 23.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.619 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.626 ' O ' HG12 ' A' ' 57' ' ' VAL . 69.9 t -87.22 5.56 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.111 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.492 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 11.5 p-10 -99.63 -40.73 7.65 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.92 0.39 . . . . 0.0 110.631 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.563 ' C ' HD12 ' A' ' 60' ' ' LEU . 5.4 tp10 -99.66 -28.5 13.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.979 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.672 ' N ' HD12 ' A' ' 60' ' ' LEU . 3.1 mp -114.17 41.79 2.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.032 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.51 -21.44 34.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.55 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -72.38 -25.83 61.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.687 0.28 . . . . 0.0 111.511 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.737 HG12 ' HE2' ' A' ' 25' ' ' PHE . 11.7 t -77.82 -49.56 21.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.75 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.47 -28.4 59.6 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.971 0.415 . . . . 0.0 110.321 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -90.03 -23.93 21.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.724 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -73.03 -49.54 28.19 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.98 0.419 . . . . 0.0 110.052 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -77.75 -0.75 28.14 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.146 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 68.09 37.33 2.98 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.306 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.766 HG13 HG21 ' A' ' 74' ' ' THR . 44.2 t -116.18 72.97 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.758 0.313 . . . . 0.0 110.983 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.2 p -84.12 -15.13 48.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.929 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.36 -172.62 0.0 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.524 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.708 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 1.7 pmm? -170.08 112.74 0.47 Allowed Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.513 -0.475 . . . . 0.0 112.209 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.562 ' O ' HG23 ' A' ' 88' ' ' VAL . 68.4 Cg_endo -87.64 -167.39 4.06 Favored 'Cis proline' 0 C--N 1.349 0.571 0 C-N-CA 124.151 -1.187 . . . . 0.0 112.086 -0.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.766 HG21 HG13 ' A' ' 69' ' ' VAL . 29.0 m -161.36 151.67 17.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.681 0.277 . . . . 0.0 110.837 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.988 HD13 HD13 ' A' ' 95' ' ' ILE . 81.7 mt -114.22 124.84 53.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.282 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.08 HD12 ' CE1' ' A' ' 25' ' ' PHE . 22.7 mt -120.05 128.76 53.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.282 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.787 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.1 mp -109.6 141.19 42.47 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.833 0.349 . . . . 0.0 110.838 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.611 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 55.1 m-85 -143.19 126.21 16.32 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.96 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.829 ' HG3' HD13 ' A' ' 20' ' ' LEU . 48.5 mtpt -117.04 136.11 53.21 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.701 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.2 m120 49.12 62.4 2.63 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.484 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 50.61 25.54 9.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.069 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.611 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 75.2 mmtt -132.45 -160.09 1.02 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.722 ' O ' HG13 ' A' ' 84' ' ' VAL . 32.2 tt0 -108.94 -179.93 4.0 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.792 HG11 ' HG3' ' A' ' 79' ' ' LYS . 4.6 m -164.16 -47.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -164.81 165.24 20.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.155 0.502 . . . . 0.0 111.814 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.534 ' HG2' HD22 ' A' ' 76' ' ' LEU . 36.5 mtmm -151.19 135.15 16.6 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.923 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.4 t -154.21 105.99 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.469 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.58 ' HA ' HG23 ' A' ' 74' ' ' THR . 2.8 p -68.03 78.68 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.841 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.52 106.27 0.2 Allowed Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.339 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.666 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -97.11 38.53 1.24 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.875 0.369 . . . . 0.0 111.183 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 93' ' ' ALA . 22.9 t-20 -85.8 141.08 35.6 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.147 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -45.52 87.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.657 2.238 . . . . 0.0 112.636 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -179.6 -40.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.336 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.11 -42.14 2.29 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.988 HD13 HD13 ' A' ' 75' ' ' LEU . 5.3 tp -50.39 -17.92 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.081 -0.247 . . . . 0.0 111.133 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.45 ' CD ' ' CE2' ' A' ' 43' ' ' PHE . 29.6 mmmt -90.64 -66.76 0.9 Allowed 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.787 0.327 . . . . 0.0 111.104 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.469 ' OE1' ' N ' ' A' ' 97' ' ' GLN . 1.3 mp0 -59.93 -34.82 73.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.705 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.97 -30.87 66.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.616 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.647 HG12 HG21 ' A' ' 22' ' ' VAL . 57.8 mt -90.22 -14.67 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.343 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.43 -68.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.865 0.364 . . . . 0.0 111.142 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.07 -28.76 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.148 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.591 ' HB3' HD22 ' A' ' 20' ' ' LEU . 5.8 m120 -83.15 -51.92 7.07 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.996 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.056 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 tpp . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.792 0.33 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.484 HG11 ' HB2' ' A' ' 41' ' ' GLU . 10.5 p -139.07 137.7 41.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.464 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.451 HG22 ' N ' ' A' ' 4' ' ' GLN . 85.3 m -148.67 162.59 39.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.958 0.409 . . . . 0.0 111.543 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.649 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 43.1 mt-30 -107.62 -179.92 4.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.219 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.508 ' CE2' ' CD1' ' A' ' 11' ' ' PHE . 22.6 m-85 -129.49 129.73 44.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.564 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.794 ' C ' HD11 ' A' ' 60' ' ' LEU . 47.4 mmtm -110.95 -18.77 12.99 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 8' ' ' ALA . 25.5 m -147.94 165.77 29.68 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.18 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.55 ' O ' ' OG ' ' A' ' 9' ' ' SER . . . -84.63 101.46 12.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.473 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.55 ' OG ' ' O ' ' A' ' 8' ' ' ALA . 13.2 m 160.26 -25.33 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.044 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -87.24 -30.77 20.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.481 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.911 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -90.05 -40.8 12.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.556 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -48.64 -40.35 27.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.22 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 m -76.21 -27.12 56.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.096 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.51 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -57.47 -62.16 1.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.36 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.65 HG22 ' HB2' ' A' ' 78' ' ' PHE . 19.1 pt -63.72 -48.71 85.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.602 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.48 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -40.49 94.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 81.7 mt-30 44.16 88.96 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.385 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.515 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 8.9 t70 -170.64 40.47 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.324 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 53.1 mttp 70.82 -151.47 0.1 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.729 0.3 . . . . 0.0 110.635 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.652 ' CD1' HG21 ' A' ' 84' ' ' VAL . 28.0 tp -97.47 111.49 23.73 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.15 0.5 . . . . 0.0 110.998 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.731 HG22 ' HB2' ' A' ' 51' ' ' ASP . 60.0 t -99.96 113.91 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.918 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.932 HG21 HG12 ' A' ' 99' ' ' ILE . 43.6 t -99.9 102.39 13.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.6 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.911 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 39.9 t -104.84 138.42 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.604 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -104.42 130.96 52.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.823 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.048 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.4 m-85 -99.1 49.39 0.95 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.047 0.451 . . . . 0.0 109.832 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.565 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -47.18 134.56 10.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.508 -179.106 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . . . -62.0 128.72 37.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.445 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.531 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 5.2 t -59.44 -28.02 66.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.766 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.403 ' CH2' ' SD ' ' A' ' 72' ' ' MET . 31.4 p-90 -93.83 -36.97 11.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 33.2 t -46.58 158.72 0.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.577 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.71 -66.39 0.81 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.304 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -46.77 -26.68 4.8 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.892 2.394 . . . . 0.0 113.08 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 86.3 m -60.43 -17.86 47.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -73.81 -44.34 56.12 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.406 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 65.2 mtt -70.77 1.7 5.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.796 0.331 . . . . 0.0 111.522 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.724 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 36.3 mt -75.74 -39.4 38.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.728 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.511 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -44.53 -50.39 23.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 41.6 Cg_endo -69.58 -31.26 21.69 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 121.806 1.671 . . . . 0.0 111.194 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 47.1 tpp -68.93 -51.19 42.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.779 HD12 ' CD ' ' A' ' 54' ' ' LYS . 62.6 mt -50.32 -29.07 5.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.411 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.484 ' HB2' HG11 ' A' ' 2' ' ' VAL . 43.6 tt0 -75.71 -35.63 60.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.889 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -62.42 -20.58 64.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.675 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.26 -24.54 20.91 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.414 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 50.5 m -62.21 -13.21 25.38 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.611 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -85.59 -25.2 26.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.729 0.3 . . . . 0.0 111.31 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -90.42 -30.74 17.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.556 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 80.8 m-85 -123.1 46.47 1.35 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.747 0.308 . . . . 0.0 111.482 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 79.3 Cg_exo -37.18 -33.2 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.321 2.68 . . . . 0.0 114.025 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.413 ' O ' ' CD ' ' A' ' 19' ' ' LYS . 9.6 mm-40 -66.17 -30.92 71.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.931 0.396 . . . . 0.0 110.86 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.34 138.45 31.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.475 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.731 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.49 121.59 31.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.006 0.431 . . . . 0.0 110.383 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.698 ' CE2' HD13 ' A' ' 99' ' ' ILE . 5.2 m-85 -97.44 82.99 3.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.594 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.609 ' HB2' HG22 ' A' ' 23' ' ' VAL . 43.0 m-85 -97.04 -178.16 4.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.898 178.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.779 ' CD ' HD12 ' A' ' 40' ' ' ILE . 33.4 mtmm -146.31 139.13 25.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.163 0.506 . . . . 0.0 111.398 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.831 HD13 ' N ' ' A' ' 56' ' ' ASP . 1.8 tm? -102.09 135.44 43.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.967 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.831 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.9 t0 -88.43 128.68 35.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.308 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 41.4 t -85.66 -11.17 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.531 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 2.1 p30 -105.1 -41.25 5.62 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.336 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.738 ' C ' HD12 ' A' ' 60' ' ' LEU . 15.8 tp10 -76.84 -31.17 56.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.97 0.414 . . . . 0.0 110.608 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.794 HD11 ' C ' ' A' ' 6' ' ' LYS . 4.2 mp -125.35 42.73 3.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.765 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -48.44 -27.42 5.77 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.486 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.45 -25.78 68.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.63 0.252 . . . . 0.0 111.447 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.812 HG13 ' HE2' ' A' ' 66' ' ' LYS . 11.0 t -81.16 -55.58 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.745 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.83 -26.72 6.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.069 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.427 ' N ' ' OE1' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -90.33 -37.14 14.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.669 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.812 ' HE2' HG13 ' A' ' 63' ' ' VAL . 52.6 pttt -59.74 -48.12 82.94 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.051 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.414 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 76.0 m-20 -78.41 -5.22 51.73 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.867 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 67.01 41.49 2.65 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.256 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.673 ' CG1' HG21 ' A' ' 74' ' ' THR . 41.7 t -112.63 97.6 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-O 120.805 0.336 . . . . 0.0 110.99 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.8 p -112.31 28.68 8.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.983 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.856 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -76.12 -153.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.823 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 72' ' ' MET . 16.5 ptt? -173.04 79.65 0.41 Allowed Pre-proline 0 CA--C 1.529 0.141 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.724 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 1.3 Cg_endo -97.52 -155.61 0.33 Allowed 'Cis proline' 0 C--N 1.348 0.524 0 C-N-CA 125.242 -0.733 . . . . 0.0 112.783 -0.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.856 ' OG1' ' HB3' ' A' ' 71' ' ' ALA . 86.6 m -151.22 147.09 26.57 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.027 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.047 HD13 HD13 ' A' ' 95' ' ' ILE . 88.4 mt -109.67 122.7 48.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.941 0.4 . . . . 0.0 111.458 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.048 HD12 ' CE1' ' A' ' 25' ' ' PHE . 29.2 mt -120.23 125.87 49.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.441 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.671 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.3 mp -109.8 147.47 33.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.8 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.65 ' HB2' HG22 ' A' ' 15' ' ' ILE . 47.0 m-85 -148.45 126.83 12.28 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.339 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.832 ' HG3' HG11 ' A' ' 84' ' ' VAL . 50.3 mtpt -115.55 140.16 49.42 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.463 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 6.0 m120 49.1 52.12 14.96 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.634 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 57.62 19.32 34.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.706 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.616 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 54.7 mtpt -122.5 -155.83 0.67 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.765 ' O ' HG13 ' A' ' 84' ' ' VAL . 83.1 tt0 -108.85 177.73 4.68 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.832 HG11 ' HG3' ' A' ' 79' ' ' LYS . 4.2 m -166.55 -47.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.644 0.259 . . . . 0.0 111.369 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.452 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -163.93 174.68 11.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 111.612 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.426 ' HB2' ' CD2' ' A' ' 76' ' ' LEU . 14.3 ptmm? -170.05 115.57 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.649 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.1 p -122.88 103.82 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.129 0.49 . . . . 0.0 111.547 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.786 ' HA ' HG23 ' A' ' 74' ' ' THR . 2.1 p -59.92 88.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.838 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.636 ' O ' ' HB2' ' A' ' 90' ' ' ALA . . . 158.65 -128.93 2.15 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.169 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.675 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . 158.54 39.42 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.825 0.345 . . . . 0.0 110.894 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.626 ' O ' HG22 ' A' ' 95' ' ' ILE . 23.2 p30 -70.91 139.71 85.73 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.744 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.75 -18.41 2.74 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.764 2.309 . . . . 0.0 113.198 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.44 21.63 12.89 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.59 -60.06 0.17 Allowed 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.829 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.047 HD13 HD13 ' A' ' 75' ' ' LEU . 3.9 tp -50.69 -15.15 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.138 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.502 ' HE2' ' HG3' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -92.34 -41.03 10.58 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.0 0.429 . . . . 0.0 110.677 179.351 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.502 ' HG3' ' HE2' ' A' ' 96' ' ' LYS . 72.1 mt-30 -76.45 -32.13 58.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.18 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.39 -32.33 73.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.52 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.932 HG12 HG21 ' A' ' 22' ' ' VAL . 38.9 mt -90.25 -13.47 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.258 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.556 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.4 -72.05 0.59 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.9 0.381 . . . . 0.0 111.186 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -48.45 -29.34 3.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.264 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.509 ' OD1' HD22 ' A' ' 77' ' ' LEU . 3.7 m120 -83.82 -41.69 17.26 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.146 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptp . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.704 0.288 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 52' ' ' PHE . 49.9 t 67.14 139.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.345 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.419 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 87.0 m -150.12 153.86 37.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.573 ' HG2' ' HG3' ' A' ' 54' ' ' LYS . 57.3 mt-30 -89.42 -179.21 5.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.178 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.543 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 17.0 m-85 -130.02 140.03 50.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.016 0.436 . . . . 0.0 111.309 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HD2' ' HG3' ' A' ' 59' ' ' GLU . 34.3 mmtp -112.72 -55.94 2.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.489 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.2 p -105.75 169.39 8.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.559 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.78 -27.84 40.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.1 m -60.85 -16.16 38.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.621 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -90.34 -62.59 1.43 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.227 0.537 . . . . 0.0 111.087 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.95 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -59.85 -24.14 63.97 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.992 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -54.96 -55.7 27.86 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.447 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.1 m -72.01 -23.41 61.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.487 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.63 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -54.98 -38.63 68.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 111.598 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 81' ' ' GLY . 21.3 pt -88.01 -48.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.437 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.37 102.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 85.1 mt-30 44.5 87.52 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.216 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 8.8 t70 -168.37 39.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.352 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.552 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.6 mptp? 62.54 -154.51 0.34 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.686 0.279 . . . . 0.0 110.43 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.861 HD11 ' HB3' ' A' ' 77' ' ' LEU . 62.3 tp -97.92 115.27 27.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.071 0.462 . . . . 0.0 110.882 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.688 HG22 ' HB2' ' A' ' 51' ' ' ASP . 45.8 t -106.89 130.71 58.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.632 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.684 HG11 HD11 ' A' ' 95' ' ' ILE . 56.4 t -99.81 97.96 6.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.547 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.95 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 24.8 t -101.4 126.03 55.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.053 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.573 ' HB3' ' NZ ' ' A' ' 54' ' ' LYS . 38.0 t70 -99.97 131.67 45.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.015 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.069 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.1 m-85 -99.25 50.26 0.95 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.077 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.682 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -53.79 129.58 33.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.352 -179.559 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.762 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -50.39 153.34 1.57 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.724 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.623 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 7.9 t -92.6 21.57 5.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.042 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.462 ' CH2' ' CE ' ' A' ' 72' ' ' MET . 23.7 p-90 -143.58 -42.24 0.28 Allowed 'General case' 0 C--O 1.232 0.167 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 29' ' ' TRP . 50.1 t -29.97 -76.2 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.54 -78.92 0.38 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.446 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -46.98 -29.34 8.33 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.667 2.245 . . . . 0.0 112.217 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.46 ' HA ' HD12 ' A' ' 36' ' ' ILE . 82.5 m -60.19 -20.15 57.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.784 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -74.09 -37.27 64.22 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.6 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.44 ' O ' ' HG2' ' A' ' 35' ' ' MET . 48.6 ttm -72.21 0.88 8.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.381 . . . . 0.0 111.074 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.601 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 59.1 mt -83.2 -25.23 8.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.011 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.566 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.88 -45.84 87.31 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 38.4 Cg_endo -69.91 -37.4 8.85 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.896 1.731 . . . . 0.0 111.588 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 57.1 ttp -64.49 -51.25 63.97 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.838 HD12 ' HE2' ' A' ' 54' ' ' LYS . 55.2 mt -51.73 -27.35 8.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.652 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.635 ' HA ' HG21 ' A' ' 2' ' ' VAL . 87.7 tt0 -77.48 -29.39 52.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.336 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -66.82 -17.98 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.221 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -89.97 -18.45 26.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.425 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.5 t -67.31 -12.32 59.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.158 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.411 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 5.5 tp10 -85.71 -24.39 26.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.707 0.289 . . . . 0.0 111.042 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -90.26 -35.06 15.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.556 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.539 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 69.0 m-85 -122.33 43.9 0.78 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.539 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 90.4 Cg_exo -38.63 -32.45 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.104 2.536 . . . . 0.0 113.224 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -59.41 -38.28 80.21 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.715 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.755 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.78 145.77 24.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.688 ' HB2' HG22 ' A' ' 21' ' ' VAL . 32.7 m-20 -89.98 148.88 22.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.732 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.702 ' O ' HG13 ' A' ' 2' ' ' VAL . 2.6 m-85 -123.39 94.58 4.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.979 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.543 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 53.5 m-85 -108.8 173.78 6.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.997 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.838 ' HE2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -124.61 162.26 24.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.549 HD13 ' C ' ' A' ' 55' ' ' LEU . 2.1 tm? -127.2 108.69 11.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.753 0.311 . . . . 0.0 110.485 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -64.01 112.15 2.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.62 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 26' ' ' TYR . 55.5 t -69.27 -11.15 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.744 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.623 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 4.5 t70 -99.69 -59.92 1.63 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.138 0.495 . . . . 0.0 110.374 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.42 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -53.41 -45.45 69.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.582 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.52 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.3 mm? -81.64 -67.71 0.76 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.378 0.609 . . . . 0.0 110.83 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.11 -64.38 0.52 Allowed Glycine 0 C--N 1.314 -0.66 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.481 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -56.91 -28.82 62.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.615 0.245 . . . . 0.0 111.386 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.848 HG12 ' HE2' ' A' ' 25' ' ' PHE . 16.3 t -73.03 -52.78 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.434 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.92 -24.68 39.22 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.086 0.469 . . . . 0.0 109.806 178.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -90.34 -38.91 13.03 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.169 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.846 ' HE3' HG13 ' A' ' 63' ' ' VAL . 17.3 pttp -59.72 -48.38 81.89 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.893 0.378 . . . . 0.0 110.206 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.414 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.5 m-80 -77.55 -5.1 48.94 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.897 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 66.32 41.74 3.25 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.129 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.687 ' CG1' HG21 ' A' ' 74' ' ' THR . 53.8 t -113.87 86.16 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.122 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 93.3 p -91.46 -21.88 20.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.838 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.48 -173.64 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.762 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -172.76 119.38 0.41 Allowed Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.569 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.601 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 50.6 Cg_endo -83.89 -179.23 21.14 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.939 -1.275 . . . . 0.0 112.158 -0.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.687 HG21 ' CG1' ' A' ' 69' ' ' VAL . 37.0 m -147.03 143.65 28.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.469 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.04 HD13 HD13 ' A' ' 95' ' ' ILE . 79.5 mt -109.78 124.55 51.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.06 0.457 . . . . 0.0 111.812 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.069 HD12 ' CE1' ' A' ' 25' ' ' PHE . 25.1 mt -119.38 127.61 53.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.468 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.861 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.5 mp -109.71 134.08 52.4 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.212 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.593 ' HA ' HG23 ' A' ' 84' ' ' VAL . 53.1 m-85 -133.91 127.99 33.62 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.111 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.49 ' HD3' ' HB2' ' A' ' 20' ' ' LEU . 7.4 mmmm -109.79 127.74 54.85 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.728 0.299 . . . . 0.0 111.47 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.3 m120 45.32 56.43 5.62 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.909 0.385 . . . . 0.0 111.832 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 61.6 14.15 41.61 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.199 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 34.3 mmtp -111.74 -154.18 0.54 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 35.8 tt0 -108.77 171.37 7.47 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 78' ' ' PHE . 59.6 t -144.03 -66.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.745 0.307 . . . . 0.0 111.35 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.17 161.7 8.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.003 0.43 . . . . 0.0 111.524 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -116.69 129.14 55.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.09 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.4 t -154.49 81.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.261 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 88' ' ' VAL . 6.8 p -61.74 85.38 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.009 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.81 110.69 0.26 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.566 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.649 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -100.78 38.9 1.45 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.884 0.374 . . . . 0.0 111.318 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 93' ' ' ALA . 47.4 t30 -79.6 132.01 62.93 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.208 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.491 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 76.0 Cg_exo -44.37 87.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.737 2.292 . . . . 0.0 112.886 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 92' ' ' PRO . . . 173.26 -38.14 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.21 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.58 -46.24 3.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.643 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.04 HD13 HD13 ' A' ' 75' ' ' LEU . 5.0 tp -52.77 -16.12 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.703 0.287 . . . . 0.0 111.148 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.459 ' NZ ' ' HB2' ' A' ' 96' ' ' LYS . 10.4 mtmp? -90.78 -63.06 1.32 Allowed 'General case' 0 CA--C 1.523 -0.091 0 CA-C-O 121.024 0.44 . . . . 0.0 110.623 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -58.8 -33.39 70.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.639 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.62 -30.1 69.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.682 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 59.9 mt -89.9 -7.8 10.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.468 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.32 -72.16 0.58 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.971 0.415 . . . . 0.0 111.273 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.44 -30.73 31.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.337 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.58 ' CB ' HD22 ' A' ' 20' ' ' LEU . 3.9 m120 -80.83 -53.57 6.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.0 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.074 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.729 0.3 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.851 HG22 ' HE2' ' A' ' 54' ' ' LYS . 11.0 p -148.06 135.94 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.814 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.0 m -150.18 152.2 34.28 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.177 0.513 . . . . 0.0 111.803 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.412 ' OE1' ' HB2' ' A' ' 54' ' ' LYS . 9.3 mm-40 -90.13 159.03 16.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.003 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.518 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 15.0 m-85 -116.61 99.12 6.92 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.824 -0.351 . . . . 0.0 111.543 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.629 ' O ' HD11 ' A' ' 60' ' ' LEU . 30.7 mmtp -85.92 -27.51 24.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.8 p -127.74 124.23 37.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.479 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.88 -25.15 7.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.364 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.8 m -60.07 -18.69 48.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.574 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -90.33 -40.51 12.06 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.134 0.493 . . . . 0.0 111.207 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.946 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.2 t80 -75.69 -30.88 59.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.812 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -54.57 -49.57 70.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.084 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -71.93 -25.47 61.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.164 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.526 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -56.88 -67.67 0.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.311 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 81' ' ' GLY . 17.8 pt -54.13 -49.47 61.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.776 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -44.78 99.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 44.66 89.66 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.55 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 63.9 t0 -169.38 39.66 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.284 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.554 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.6 mptp? 65.82 -154.56 0.26 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.37 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.729 HD11 ' HB3' ' A' ' 77' ' ' LEU . 54.0 tp -97.78 115.84 28.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.14 0.495 . . . . 0.0 110.774 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.615 HG22 ' HB2' ' A' ' 51' ' ' ASP . 49.1 t -105.94 128.56 60.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.032 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.639 HG21 HG13 ' A' ' 99' ' ' ILE . 44.5 t -99.97 96.81 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.361 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.946 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 41.2 t -101.37 129.42 52.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.085 0.469 . . . . 0.0 111.678 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -99.76 130.06 45.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.327 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.049 ' CE1' HD12 ' A' ' 76' ' ' LEU . 3.6 m-85 -99.12 50.18 0.95 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.011 0.434 . . . . 0.0 110.849 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.621 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -51.05 136.79 22.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.831 179.499 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.739 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -62.09 150.3 38.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.905 0.383 . . . . 0.0 110.973 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.418 ' HB ' ' N ' ' A' ' 58' ' ' ASP . 5.1 t -78.76 -22.67 46.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.339 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.441 ' CH2' ' SD ' ' A' ' 72' ' ' MET . 21.8 p-90 -104.18 -34.91 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.868 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.607 ' CB ' ' HB3' ' A' ' 27' ' ' ALA . 42.2 t -39.47 156.33 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.727 0.299 . . . . 0.0 111.425 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 32' ' ' PRO . . . -86.98 -87.97 1.06 Allowed Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.756 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.411 ' HD3' ' HA3' ' A' ' 31' ' ' GLY . 18.0 Cg_exo -66.72 61.92 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.896 2.397 . . . . 0.0 112.645 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.8 p -129.45 -4.1 4.83 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.376 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -99.02 -24.96 14.72 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.673 0.273 . . . . 0.0 111.433 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.8 mmt -68.74 -0.25 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.318 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.89 HG22 HG13 ' A' ' 40' ' ' ILE . 64.5 mt -82.66 -27.63 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.867 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.511 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -47.54 -46.04 58.86 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 41.5 Cg_endo -72.51 -36.81 4.74 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.788 1.659 . . . . 0.0 110.763 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.653 ' HE3' ' HB1' ' A' ' 90' ' ' ALA . 1.7 tmt? -62.26 -51.88 65.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.196 178.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.89 HG13 HG22 ' A' ' 36' ' ' ILE . 55.9 mt -51.45 -29.25 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.629 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.501 ' HB2' HG11 ' A' ' 2' ' ' VAL . 39.2 tt0 -76.31 -40.02 52.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.484 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -55.36 -24.63 30.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.371 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.522 ' CZ ' ' HE1' ' A' ' 39' ' ' MET . 5.1 m-85 -90.29 -22.85 21.37 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.455 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 87.1 p -70.09 -8.36 48.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.156 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.41 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 5.4 tp10 -90.02 -25.88 20.6 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.739 0.304 . . . . 0.0 110.998 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -90.4 -29.53 17.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.582 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.53 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 78.1 m-85 -122.86 44.94 0.98 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.356 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 84.1 Cg_exo -38.18 -32.02 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.088 2.525 . . . . 0.0 113.262 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -59.01 -40.86 86.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.561 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.707 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.88 141.37 28.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.709 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.615 ' HB2' HG22 ' A' ' 21' ' ' VAL . 57.1 m-20 -89.98 125.44 35.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.909 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.455 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 4.6 m-85 -99.84 93.87 6.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.532 ' C ' ' HD3' ' A' ' 54' ' ' LYS . 47.2 m-85 -107.42 179.43 4.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.917 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.851 ' HE2' HG22 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -137.9 153.88 49.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.691 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.543 HD13 ' C ' ' A' ' 55' ' ' LEU . 2.8 tm? -112.33 118.83 36.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.445 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.1 m-20 -78.25 108.37 11.52 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.566 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 57' ' ' VAL . 90.6 t -75.46 -5.03 6.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.024 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.418 ' N ' ' HB ' ' A' ' 28' ' ' THR . 67.1 t0 -80.34 -46.8 15.48 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.795 0.331 . . . . 0.0 110.826 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.548 ' C ' HD12 ' A' ' 60' ' ' LEU . 5.5 tp10 -97.99 -24.56 15.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.115 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.672 ' N ' HD12 ' A' ' 60' ' ' LEU . 3.4 mp -113.47 52.64 0.8 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.86 0.362 . . . . 0.0 111.055 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.82 -15.55 58.04 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.707 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.36 -26.36 32.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.664 0.269 . . . . 0.0 111.486 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.839 HG12 ' HE2' ' A' ' 25' ' ' PHE . 11.7 t -78.76 -22.75 12.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.865 0.364 . . . . 0.0 110.889 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.58 -24.85 38.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -90.22 -31.72 16.89 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.779 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -59.35 -47.96 83.45 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.043 0.449 . . . . 0.0 110.077 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.411 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.4 m-80 -86.86 -0.01 55.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.064 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 62.15 41.32 10.85 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.056 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.513 HG13 HG21 ' A' ' 74' ' ' THR . 47.5 t -106.27 116.54 50.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.116 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.8 p -149.87 18.69 0.89 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.695 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 1.031 ' HB3' HG21 ' A' ' 88' ' ' VAL . . . -70.15 -16.58 63.11 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.908 0.385 . . . . 0.0 110.779 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.739 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 11.4 ptt? 43.54 93.31 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.206 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.701 ' HG3' HD11 ' A' ' 36' ' ' ILE . 13.2 Cg_endo -92.6 -156.43 0.64 Allowed 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 125.077 -0.801 . . . . 0.0 112.319 -0.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.513 HG21 HG13 ' A' ' 69' ' ' VAL . 89.2 m -164.63 162.53 21.54 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.958 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.039 HD13 HD13 ' A' ' 95' ' ' ILE . 68.5 mt -123.46 123.62 41.05 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.68 0.276 . . . . 0.0 110.796 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.049 HD12 ' CE1' ' A' ' 25' ' ' PHE . 23.4 mt -118.74 131.5 56.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.0 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.729 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.5 mp -109.75 137.04 48.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.039 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.613 ' HA ' HG23 ' A' ' 84' ' ' VAL . 67.8 m-85 -136.88 126.03 24.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.276 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.713 ' HG3' HD13 ' A' ' 20' ' ' LEU . 8.6 mtmp? -113.39 126.71 55.66 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.64 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.512 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 74.6 m-80 46.26 75.43 0.12 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.617 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 40.95 39.5 1.99 Allowed Glycine 0 C--N 1.331 0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.619 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 31.9 mmmt -143.51 -158.58 0.89 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.425 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 86.5 tt0 -108.82 175.17 5.56 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.684 HG13 ' HE3' ' A' ' 79' ' ' LYS . 14.3 t -149.14 -66.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 110.946 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.13 154.42 4.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.138 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -117.79 120.63 38.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.735 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 49.1 t -139.06 93.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.138 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.031 HG21 ' HB3' ' A' ' 71' ' ' ALA . 4.6 p -67.56 120.85 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.964 0.411 . . . . 0.0 110.878 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.93 102.22 1.61 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.236 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.7 ' HB2' HD21 ' A' ' 75' ' ' LEU . . . -94.41 37.58 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 111.208 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 93' ' ' ALA . 46.1 t30 -83.47 134.37 45.39 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.017 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -40.73 89.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.75 2.3 . . . . 0.0 112.693 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 179.56 -32.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.301 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.11 -42.47 0.98 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.039 HD13 HD13 ' A' ' 75' ' ' LEU . 6.4 tp -53.73 -14.76 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.471 0.177 . . . . 0.0 111.449 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.428 ' HG2' ' N ' ' A' ' 97' ' ' GLN . 14.2 tttm -92.02 -61.87 1.53 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.92 0.39 . . . . 0.0 111.004 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.512 ' NE2' ' H ' ' A' ' 97' ' ' GLN . 0.3 OUTLIER -66.64 -34.83 78.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.991 -179.531 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.42 -30.26 62.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.094 0.473 . . . . 0.0 110.646 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.917 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.5 mp -90.18 -8.43 10.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.627 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.23 -75.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.319 . . . . 0.0 111.34 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.88 -29.52 8.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.356 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.592 ' HB3' HD22 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -78.54 -50.66 11.18 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.916 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.543 ' HB2' HD23 ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.03 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.845 0.355 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 52' ' ' PHE . 13.1 p -133.49 138.66 50.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.813 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 4' ' ' GLN . 85.6 m -150.15 161.69 41.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.964 0.411 . . . . 0.0 111.433 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.609 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 64.5 mt-30 -96.88 -179.34 4.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.375 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.52 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 18.1 m-85 -132.31 95.94 3.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.188 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.79 ' O ' HD11 ' A' ' 60' ' ' LEU . 74.6 mmtt -80.77 -19.53 44.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.6 p -134.37 122.71 22.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.375 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.47 -25.41 6.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.599 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.1 t -60.63 -17.23 45.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.769 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -90.5 -45.78 8.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.158 0.504 . . . . 0.0 111.476 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.904 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.2 t80 -69.08 -23.26 64.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.087 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -57.37 -40.09 77.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.394 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -86.48 -24.46 25.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.528 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.683 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -56.94 -38.61 73.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.542 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.542 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.1 pt -86.76 -49.41 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.543 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.505 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -44.3 100.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 84.3 mt-30 44.98 90.19 0.01 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.4 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 8.5 t0 -173.66 40.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.063 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.559 ' N ' ' HD2' ' A' ' 19' ' ' LYS . 2.8 mptp? 63.92 -157.28 0.31 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.447 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.851 HD11 ' HB3' ' A' ' 77' ' ' LEU . 59.1 tp -98.19 117.87 33.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.112 0.482 . . . . 0.0 110.914 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 51' ' ' ASP . 53.4 t -101.66 137.58 28.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.617 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.7 t -99.93 87.5 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.368 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.904 HG21 ' CE1' ' A' ' 11' ' ' PHE . 29.0 t -99.91 121.6 50.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.357 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -100.0 134.38 43.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.61 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.041 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.2 m-85 -99.19 52.36 0.95 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.931 0.395 . . . . 0.0 110.577 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -51.81 138.15 24.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -68.23 138.08 55.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.549 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -58.41 -14.37 7.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.403 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.519 ' CH2' ' HE2' ' A' ' 72' ' ' MET . 5.7 p-90 -112.25 -123.83 0.28 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.092 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 36.8 t 60.74 -83.18 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.561 0.344 . . . . 0.0 110.824 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.64 -79.8 0.22 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.145 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.65 -22.15 73.66 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.884 2.389 . . . . 0.0 113.254 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 98.4 m -50.04 -27.66 5.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.615 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -77.7 -28.25 50.95 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.524 -179.55 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.4 mtp -76.58 4.43 9.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.859 0.361 . . . . 0.0 110.85 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.805 HG22 HG13 ' A' ' 40' ' ' ILE . 70.8 mt -86.31 -20.44 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.023 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.554 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -52.15 -44.07 91.77 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 46.4 Cg_endo -72.36 -35.15 6.83 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.835 1.69 . . . . 0.0 111.417 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.9 ttt -65.84 -52.13 53.06 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.805 HG13 HG22 ' A' ' 36' ' ' ILE . 63.8 mt -49.92 -28.41 4.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.536 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.574 ' HB2' HG11 ' A' ' 2' ' ' VAL . 88.7 tt0 -76.69 -36.55 57.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.364 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.463 ' HB3' ' NZ ' ' A' ' 42' ' ' LYS . 9.3 mtpm? -58.56 -21.45 52.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.145 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.13 -22.34 21.8 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.36 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.461 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.2 t -65.6 -11.73 46.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.312 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -86.28 -25.17 25.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.661 0.267 . . . . 0.0 111.366 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.27 -28.68 18.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.792 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.528 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 80.4 m-85 -122.78 45.2 1.02 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.5 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 86.1 Cg_exo -37.98 -32.79 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.163 2.575 . . . . 0.0 113.601 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.5 mm-40 -63.69 -37.09 86.04 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.751 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.613 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.84 138.79 31.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.789 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.611 ' O ' HG13 ' A' ' 21' ' ' VAL . 59.0 m-20 -89.76 127.11 35.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.916 0.388 . . . . 0.0 110.579 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.821 ' O ' HG23 ' A' ' 2' ' ' VAL . 4.9 m-85 -98.58 86.59 3.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.717 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.52 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 36.6 m-85 -96.48 -175.73 3.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.88 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.75 ' CD ' HD12 ' A' ' 40' ' ' ILE . 34.4 mtmm -150.1 138.78 20.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.952 0.406 . . . . 0.0 111.293 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.633 HD13 ' N ' ' A' ' 56' ' ' ASP . 3.0 tm? -95.22 129.72 42.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.07 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.633 ' N ' HD13 ' A' ' 55' ' ' LEU . 41.4 m-20 -86.98 110.46 20.06 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.888 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 57' ' ' VAL . 84.2 t -78.81 -4.51 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.012 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -84.63 -55.29 4.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.977 0.418 . . . . 0.0 110.827 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.748 ' C ' HD12 ' A' ' 60' ' ' LEU . 41.6 tp10 -87.26 -17.31 32.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.398 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.79 HD11 ' O ' ' A' ' 6' ' ' LYS . 2.3 mp -127.09 57.93 1.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.929 0.395 . . . . 0.0 111.092 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.64 -16.11 55.04 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.384 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -79.95 -29.63 39.7 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.575 0.226 . . . . 0.0 111.57 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.851 HG12 ' HE2' ' A' ' 25' ' ' PHE . 21.8 t -73.49 -27.56 23.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.961 0.41 . . . . 0.0 110.956 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.518 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -80.01 -26.83 39.7 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -90.4 -31.0 17.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.823 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 13.9 ptmm? -60.31 -48.06 83.35 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.969 0.414 . . . . 0.0 109.984 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.438 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 75.3 m-80 -84.95 1.65 46.44 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.784 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 65.41 37.74 6.07 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.332 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.674 ' CG1' HG21 ' A' ' 74' ' ' THR . 48.9 t -111.61 75.19 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.815 0.341 . . . . 0.0 111.053 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.6 p -89.35 5.59 44.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.136 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -60.68 -159.01 0.01 OUTLIER 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.575 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.61 ' HG2' ' O ' ' A' ' 72' ' ' MET . 1.5 pmm? -174.98 93.2 0.29 Allowed Pre-proline 0 CA--C 1.53 0.192 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.593 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 8.0 Cg_endo -94.04 -156.69 0.57 Allowed 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 124.904 -0.873 . . . . 0.0 112.502 -0.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.674 HG21 ' CG1' ' A' ' 69' ' ' VAL . 53.4 m -158.09 148.44 20.4 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.81 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.109 HD13 HD13 ' A' ' 95' ' ' ILE . 90.5 mt -109.89 123.31 49.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.185 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.041 HD12 ' CE1' ' A' ' 25' ' ' PHE . 20.2 mt -122.76 128.96 51.17 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.837 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.851 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.5 mp -109.96 144.66 38.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.959 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.647 ' HA ' HG23 ' A' ' 84' ' ' VAL . 65.5 m-85 -145.04 126.09 14.57 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.577 ' HG3' HD13 ' A' ' 20' ' ' LEU . 51.8 mtmt -113.46 132.96 55.46 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.694 0.283 . . . . 0.0 111.493 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.3 m120 47.96 53.34 11.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.9 0.381 . . . . 0.0 111.742 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 59.43 16.07 34.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.978 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 74.7 mmtt -111.19 -153.92 0.53 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -108.81 173.79 6.16 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.647 HG23 ' HA ' ' A' ' 78' ' ' PHE . 58.0 t -149.18 -63.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.853 0.358 . . . . 0.0 111.165 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.49 162.8 8.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.2 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -138.53 115.16 10.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.543 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.5 t -136.41 98.89 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.17 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.613 ' HA ' HG23 ' A' ' 74' ' ' THR . 2.4 p -56.92 116.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.967 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.639 ' O ' ' HB2' ' A' ' 90' ' ' ALA . . . 141.52 -140.26 10.09 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.989 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 89' ' ' GLY . . . 147.61 36.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.818 0.447 . . . . 0.0 110.867 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 93' ' ' ALA . 75.3 m-80 -86.94 143.46 35.2 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.576 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -48.87 85.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.581 2.187 . . . . 0.0 112.478 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -179.48 -37.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.487 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.46 -44.34 2.13 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.109 HD13 HD13 ' A' ' 75' ' ' LEU . 3.2 tp -50.1 -18.61 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.464 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.463 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 7.8 ptpp? -91.71 -49.52 6.23 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.971 0.415 . . . . 0.0 110.974 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.463 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 84.2 mt-30 -69.22 -32.11 71.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.48 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.65 -27.76 68.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.534 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.833 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 58.4 mt -90.22 -11.54 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.511 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.43 -74.21 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.917 0.389 . . . . 0.0 111.492 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -45.93 -29.5 1.44 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.378 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.738 ' HB3' HD22 ' A' ' 20' ' ' LEU . 69.8 m-20 -90.14 -42.34 11.12 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.269 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.833 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.081 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 120.795 0.331 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.541 HG11 ' HB2' ' A' ' 41' ' ' GLU . 12.5 p -167.89 132.15 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.3 m -150.26 156.54 41.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.946 0.403 . . . . 0.0 111.403 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -99.57 -173.44 2.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.621 179.368 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.527 ' CE2' ' CD1' ' A' ' 11' ' ' PHE . 21.4 m-85 -137.5 101.33 4.47 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.61 ' C ' HD11 ' A' ' 60' ' ' LEU . 43.9 mmtm -83.19 -20.41 34.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.283 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -133.03 122.84 24.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.147 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.12 -26.49 27.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.49 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -55.33 -23.41 23.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.188 0.518 . . . . 0.0 110.392 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -90.69 -35.19 15.07 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.627 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.88 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -74.76 -24.11 58.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.948 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -58.75 -68.68 0.24 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.066 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.4 t -56.74 -23.56 43.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.447 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 11' ' ' PHE . . . -52.46 -64.36 0.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.36 . . . . 0.0 111.472 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.7 pt -61.03 -47.23 94.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.486 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -40.28 97.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.7 mt-30 43.14 88.58 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.309 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.509 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 63.9 t0 -167.11 38.5 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.671 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 28.7 mtmt 70.07 -155.46 0.14 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.799 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.537 ' CD1' HG21 ' A' ' 84' ' ' VAL . 36.4 tp -97.6 112.07 24.09 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.144 0.497 . . . . 0.0 110.574 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.776 HG22 ' HB2' ' A' ' 51' ' ' ASP . 47.3 t -101.44 124.73 55.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.536 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.724 HG21 HG12 ' A' ' 99' ' ' ILE . 50.4 t -103.51 98.79 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.141 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.88 HG21 ' CE1' ' A' ' 11' ' ' PHE . 38.2 t -105.74 131.69 54.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.775 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 74' ' ' THR . 62.2 t0 -100.1 132.53 45.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.53 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.056 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.2 m-85 -99.11 49.13 0.95 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.069 0.462 . . . . 0.0 110.524 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.58 ' HB2' ' HB3' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -50.42 145.87 5.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.44 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.792 ' HB2' ' CB ' ' A' ' 72' ' ' MET . . . -59.99 164.91 3.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.77 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.441 ' HB ' ' N ' ' A' ' 58' ' ' ASP . 3.1 t -96.75 22.74 7.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.913 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -148.82 -44.77 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 39.1 t -43.3 156.11 0.05 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.836 0.35 . . . . 0.0 111.373 -179.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -93.41 -69.34 1.1 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.239 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -47.07 -25.95 4.64 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.983 2.456 . . . . 0.0 112.955 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 98.7 m -61.8 -63.07 1.38 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.704 0.288 . . . . 0.0 111.623 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 61.9 pttt -55.45 -22.02 18.68 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.602 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.418 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 44.4 tpp -76.43 1.43 16.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 110.776 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.916 HG22 HG13 ' A' ' 40' ' ' ILE . 63.1 mt -85.93 -18.08 9.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.401 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.529 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.32 -44.4 81.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 53.9 Cg_endo -73.36 -35.4 4.98 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.837 1.691 . . . . 0.0 111.438 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.74 ' CE ' HG23 ' A' ' 36' ' ' ILE . 57.3 ttp -65.33 -52.04 56.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.916 HG13 HG22 ' A' ' 36' ' ' ILE . 73.1 mt -48.18 -29.51 2.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.56 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.541 ' HB2' HG11 ' A' ' 2' ' ' VAL . 87.1 tt0 -76.92 -34.31 57.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.977 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -63.91 -22.89 67.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.62 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -90.37 -22.51 21.46 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.463 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 80.2 p -67.29 -9.17 38.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.486 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -88.62 -26.22 22.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.78 0.324 . . . . 0.0 111.174 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -90.53 -29.79 17.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.842 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.529 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 78.6 m-85 -122.79 45.63 1.12 Allowed Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.502 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 84.0 Cg_exo -38.05 -32.16 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.22 2.613 . . . . 0.0 113.952 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.498 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 53.7 mm-40 -66.91 -16.83 64.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.927 0.394 . . . . 0.0 111.31 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -104.04 139.89 38.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.559 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.776 ' HB2' HG22 ' A' ' 21' ' ' VAL . 24.9 m-20 -89.44 120.99 31.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.907 0.384 . . . . 0.0 110.359 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.555 ' CE2' HD13 ' A' ' 99' ' ' ILE . 5.3 m-85 -97.92 83.88 3.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.313 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.599 ' HB2' HG22 ' A' ' 23' ' ' VAL . 46.5 m-85 -99.52 -174.53 2.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.354 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.655 ' CD ' HD12 ' A' ' 40' ' ' ILE . 32.6 mtmm -150.21 141.69 23.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.943 0.401 . . . . 0.0 110.964 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.711 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.5 tm? -100.41 130.34 46.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.866 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.711 ' N ' HD13 ' A' ' 55' ' ' LEU . 44.6 m-20 -87.87 114.07 24.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.856 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.521 ' O ' HG12 ' A' ' 57' ' ' VAL . 78.3 t -77.54 -3.08 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.65 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.441 ' N ' ' HB ' ' A' ' 28' ' ' THR . 64.9 t0 -82.05 -55.53 4.51 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.899 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.453 ' C ' HD12 ' A' ' 60' ' ' LEU . 41.0 tp10 -89.82 -28.46 19.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.391 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.659 ' N ' HD12 ' A' ' 60' ' ' LEU . 3.8 mp -108.23 52.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.848 0.356 . . . . 0.0 111.116 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.9 -15.21 59.9 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.447 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -82.94 -29.12 29.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.716 0.293 . . . . 0.0 111.448 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.756 HG12 ' HE2' ' A' ' 25' ' ' PHE . 15.4 t -73.33 -51.1 27.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.454 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -54.47 -26.02 28.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.114 0.483 . . . . 0.0 109.718 178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.7 tm0? -90.46 -37.82 13.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.07 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -61.64 -42.53 99.02 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.903 0.382 . . . . 0.0 110.352 -179.581 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -83.68 -0.46 50.83 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 65.67 35.45 6.96 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.334 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.68 ' CG1' HG21 ' A' ' 74' ' ' THR . 31.2 t -113.16 63.51 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 121.03 0.443 . . . . 0.0 110.867 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.2 p -74.57 -13.85 60.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.074 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.79 -168.77 0.0 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.414 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.792 ' CB ' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -174.29 111.82 0.3 Allowed Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.207 -179.838 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.517 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 57.3 Cg_endo -88.99 -166.73 3.19 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.275 -1.136 . . . . 0.0 112.398 -0.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.747 HG23 ' HA ' ' A' ' 88' ' ' VAL . 34.1 m -159.81 150.07 18.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.604 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.052 HD13 HD13 ' A' ' 95' ' ' ILE . 71.8 mt -110.78 124.8 52.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.888 0.375 . . . . 0.0 111.591 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.056 HD12 ' CE1' ' A' ' 25' ' ' PHE . 29.4 mt -124.72 124.14 41.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.465 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.667 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.3 mp -109.91 149.19 30.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.786 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.601 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 40.5 m-85 -149.29 128.55 12.87 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.128 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.823 ' HG3' HG11 ' A' ' 84' ' ' VAL . 9.8 mtpm? -114.99 137.33 52.12 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.477 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 6.2 m120 49.93 52.35 14.83 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.721 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 16' ' ' ALA . . . 57.78 18.7 33.17 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.732 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.601 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 67.1 mttm -120.01 -155.56 0.63 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.743 ' O ' HG13 ' A' ' 84' ' ' VAL . 85.8 tt0 -109.13 176.93 4.92 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.823 HG11 ' HG3' ' A' ' 79' ' ' LYS . 3.5 m -165.38 -47.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.44 0.162 . . . . 0.0 111.301 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.69 170.37 9.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.142 0.496 . . . . 0.0 112.019 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -160.12 132.19 6.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.355 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.4 t -146.02 109.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.147 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.747 ' HA ' HG23 ' A' ' 74' ' ' THR . 6.5 p -69.55 69.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.814 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.2 118.29 0.56 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.349 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.677 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -95.96 38.0 1.2 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.914 0.388 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 93' ' ' ALA . 5.5 m120 -65.89 132.21 94.71 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.545 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 86.5 Cg_exo -48.4 86.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.66 2.24 . . . . 0.0 112.668 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 92' ' ' PRO . . . 176.8 -36.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.267 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.04 -46.87 2.7 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.052 HD13 HD13 ' A' ' 75' ' ' LEU . 4.7 tp -53.58 -15.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.211 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HG3' ' HG3' ' A' ' 97' ' ' GLN . 21.3 ptmt -91.38 -50.95 5.53 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.791 0.329 . . . . 0.0 111.086 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.421 ' HG3' ' HG3' ' A' ' 96' ' ' LYS . 73.0 mt-30 -73.79 -32.97 64.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.478 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.02 -26.44 66.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.59 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.724 HG12 HG21 ' A' ' 22' ' ' VAL . 63.7 mt -90.24 -18.27 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.107 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.74 -65.49 1.01 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.007 0.432 . . . . 0.0 111.104 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -48.96 -28.26 3.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.217 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.526 ' CB ' HD22 ' A' ' 20' ' ' LEU . 50.8 m-20 -90.23 -38.71 13.26 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.34 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.197 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.492 HG11 ' HB2' ' A' ' 41' ' ' GLU . 10.7 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.679 0.276 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.449 HG22 ' N ' ' A' ' 4' ' ' GLN . 86.0 m -150.11 161.77 41.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.884 0.373 . . . . 0.0 111.253 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.462 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 16.6 mt-30 -102.93 -172.68 2.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.39 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.531 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.2 m-85 -137.52 129.32 28.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.059 0.457 . . . . 0.0 111.461 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.716 ' C ' HD11 ' A' ' 60' ' ' LEU . 75.2 mmtt -112.98 -28.24 7.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.498 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.0 p -128.57 132.49 48.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.515 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.44 -25.34 50.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.51 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.3 t -59.74 -18.35 42.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.621 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -90.42 -64.94 1.06 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.277 0.561 . . . . 0.0 111.031 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.897 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.2 t80 -53.54 -29.0 34.63 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.015 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -54.89 -35.29 63.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.018 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.3 p -82.5 -37.49 25.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.111 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.594 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -46.74 -49.12 20.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.66 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.5 pt -77.58 -49.91 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.501 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.48 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -40.74 95.43 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 85.1 mt-30 44.35 86.66 0.02 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.422 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 8.1 t0 -169.54 41.14 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.407 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 10.9 mptt 67.56 -155.41 0.21 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.694 0.283 . . . . 0.0 110.888 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.898 HD11 ' HB3' ' A' ' 77' ' ' LEU . 61.5 tp -98.1 115.21 27.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.222 0.534 . . . . 0.0 111.252 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.511 HG12 HG23 ' A' ' 23' ' ' VAL . 59.9 t -99.79 128.2 51.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.471 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.678 HG21 ' CD1' ' A' ' 99' ' ' ILE . 48.8 t -99.74 91.22 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 110.816 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.897 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 42.0 t -101.27 132.19 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.125 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.9 t70 -102.43 129.11 48.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.73 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.071 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.4 m-85 -98.98 51.6 0.96 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.206 0.527 . . . . 0.0 110.467 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.533 ' O ' HG23 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -50.99 139.44 17.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.111 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 71' ' ' ALA . . . -65.58 141.75 58.32 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.331 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.6 t -57.91 -18.13 21.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.069 0.461 . . . . 0.0 110.835 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.422 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 8.2 p-90 -106.61 -128.74 0.27 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.315 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 72' ' ' MET . 30.2 t 61.08 156.08 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.805 0.336 . . . . 0.0 110.979 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.09 -82.1 1.19 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.488 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.97 60.85 3.79 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.627 2.218 . . . . 0.0 112.33 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.7 p -107.61 -20.83 13.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.024 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -85.71 -24.11 27.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.119 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.454 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 57.7 ttp -63.44 -12.69 33.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.982 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.772 HG22 HG13 ' A' ' 40' ' ' ILE . 2.7 mp -81.99 -30.22 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.669 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -49.5 -45.72 77.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 37.8 Cg_endo -70.86 -37.65 6.28 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.722 1.615 . . . . 0.0 111.012 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.494 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 66.4 mtm -63.92 -54.94 26.81 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.772 HG13 HG22 ' A' ' 36' ' ' ILE . 55.7 mt -44.74 -29.08 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.069 0.461 . . . . 0.0 110.542 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.492 ' HB2' HG11 ' A' ' 2' ' ' VAL . 38.3 tt0 -81.59 -40.32 23.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.176 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -59.82 -27.9 67.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.627 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.616 ' CE2' HG23 ' A' ' 95' ' ' ILE . 10.4 m-85 -78.02 -22.43 49.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.625 0.25 . . . . 0.0 111.389 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.446 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 46.9 t -66.65 -11.32 53.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.206 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -87.44 -26.09 23.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.64 0.257 . . . . 0.0 111.096 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -89.98 -31.73 17.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.199 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.479 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 89.7 m-85 -124.39 51.61 4.85 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.02 0.438 . . . . 0.0 110.489 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 2.9 Cg_endo -48.95 -25.43 8.66 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.034 2.489 . . . . 0.0 112.484 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -65.77 -31.49 72.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.054 0.454 . . . . 0.0 110.229 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.742 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -95.77 144.48 26.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.86 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.489 ' HB2' HG22 ' A' ' 21' ' ' VAL . 58.9 m-20 -89.96 129.98 36.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.709 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.479 ' CZ ' HD13 ' A' ' 99' ' ' ILE . 8.8 m-85 -105.09 90.94 3.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.391 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.628 ' HB2' HG22 ' A' ' 23' ' ' VAL . 47.5 m-85 -101.01 -178.12 3.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.559 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HZ2' HD12 ' A' ' 40' ' ' ILE . 20.1 mtpp -141.9 141.27 33.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.395 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.911 HD13 ' N ' ' A' ' 56' ' ' ASP . 3.0 tm? -105.26 144.23 32.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.29 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.911 ' N ' HD13 ' A' ' 55' ' ' LEU . 22.9 t70 -99.9 115.5 29.77 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.075 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 26' ' ' TYR . 75.5 t -76.83 -4.0 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.919 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.442 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 38.6 t70 -96.21 -50.09 4.95 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.254 0.549 . . . . 0.0 110.215 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.494 ' C ' HD12 ' A' ' 60' ' ' LEU . 5.1 tp10 -82.16 -40.28 22.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.652 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.724 HD22 ' CD2' ' A' ' 55' ' ' LEU . 4.1 mp -111.67 43.53 1.52 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.545 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.6 -24.05 16.45 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.762 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 56.6 m-20 -71.04 -50.09 37.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.688 0.28 . . . . 0.0 111.256 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.756 HG12 ' HE2' ' A' ' 25' ' ' PHE . 15.6 t -56.37 -23.85 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.142 0.496 . . . . 0.0 110.244 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -80.35 -25.2 39.33 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 5.7 pt20 -90.21 -35.4 15.36 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.272 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 20.2 ptmt -57.79 -48.45 79.66 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.421 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.435 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 75.6 m-80 -85.48 2.18 45.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.048 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 63.92 38.94 8.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.905 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.765 HG13 HG21 ' A' ' 74' ' ' THR . 43.8 t -116.39 99.82 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.899 0.38 . . . . 0.0 111.398 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.7 m -121.7 13.17 10.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.816 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -60.9 -157.9 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.092 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.604 ' O ' ' HG2' ' A' ' 72' ' ' MET . 0.0 OUTLIER -169.75 88.19 0.57 Allowed Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.457 ' O ' HG23 ' A' ' 88' ' ' VAL . 40.3 Cg_endo -96.71 -164.57 0.99 Allowed 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 124.777 -0.926 . . . . 0.0 112.793 -0.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.816 ' OG1' ' HB3' ' A' ' 71' ' ' ALA . 29.3 m -149.98 153.91 37.35 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.701 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.016 HD13 HD13 ' A' ' 95' ' ' ILE . 85.3 mt -114.33 126.58 55.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.819 0.342 . . . . 0.0 111.235 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.071 HD12 ' CE1' ' A' ' 25' ' ' PHE . 19.1 mt -121.76 128.68 52.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.014 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.898 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.6 mp -109.89 141.88 41.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.628 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.607 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 65.1 m-85 -141.88 127.13 18.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.697 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.838 ' CG ' HG11 ' A' ' 84' ' ' VAL . 8.9 mmmm -109.82 133.17 53.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.53 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 5.2 m120 42.88 65.17 0.99 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.01 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 53.96 21.02 15.65 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.155 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.607 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 28.1 mtpp -127.33 -160.82 1.03 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.633 ' O ' HG13 ' A' ' 84' ' ' VAL . 82.3 tt0 -109.47 178.06 4.55 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.838 HG11 ' CG ' ' A' ' 79' ' ' LYS . 4.8 m -162.38 -47.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 O-C-N 123.1 0.25 . . . . 0.0 111.144 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.96 162.07 17.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.125 0.488 . . . . 0.0 111.874 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -149.09 115.39 5.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.267 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.3 t -131.1 98.66 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.331 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.597 HG21 ' CB ' ' A' ' 71' ' ' ALA . 3.3 p -62.33 98.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.696 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.98 108.52 0.81 Allowed Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.2 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.683 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -95.68 37.13 1.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 111.259 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 93' ' ' ALA . 75.9 m-80 -72.04 131.77 85.17 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.237 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -45.91 86.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.689 2.26 . . . . 0.0 112.637 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 178.51 -36.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.525 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.23 -45.62 2.44 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.016 HD13 HD13 ' A' ' 75' ' ' LEU . 5.0 tp -49.94 -18.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.302 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 22.4 pttp -91.76 -50.97 5.46 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.903 0.382 . . . . 0.0 111.049 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.405 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 61.7 mt-30 -69.9 -32.1 70.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.599 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.1 -28.46 69.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.748 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.678 ' CD1' HG21 ' A' ' 22' ' ' VAL . 56.7 mt -90.22 -8.08 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.526 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.26 -69.39 0.73 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.866 0.365 . . . . 0.0 111.162 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.99 -29.61 30.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.177 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.623 ' CB ' HD22 ' A' ' 20' ' ' LEU . 5.6 m120 -80.75 -52.91 6.99 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.053 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.041 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.618 HG11 ' HB2' ' A' ' 41' ' ' GLU . 11.2 p . . . . . 0 N--CA 1.464 0.253 0 CA-C-O 121.23 0.538 . . . . 0.0 112.048 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 4' ' ' GLN . 88.9 m -150.17 162.42 40.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.133 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.532 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 59.5 mt-30 -101.04 178.77 4.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.631 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.52 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 18.4 m-85 -133.17 98.48 4.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.712 0.291 . . . . 0.0 111.598 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.728 ' O ' HD11 ' A' ' 60' ' ' LEU . 45.8 mmtm -83.52 -28.31 28.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.44 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.3 p -123.36 122.62 38.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.255 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.59 -26.4 8.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.687 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.9 t -59.22 -19.85 49.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.829 0.347 . . . . 0.0 110.426 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -90.73 -31.07 16.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.358 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.88 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -85.86 8.45 20.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.391 -179.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -87.7 -60.58 1.93 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.867 0.365 . . . . 0.0 110.923 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -67.01 -17.17 64.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.28 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.48 91.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.377 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.554 ' O ' ' N ' ' A' ' 81' ' ' GLY . 21.4 pt -88.89 -49.92 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.465 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.478 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -46.29 103.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.847 0.356 . . . . 0.0 111.955 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.9 mt-30 44.01 87.45 0.02 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.29 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -168.84 40.67 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.035 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.555 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER 64.33 -156.88 0.31 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.281 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.764 HD13 ' N ' ' A' ' 103' ' ' ALA . 3.4 tt -98.15 115.85 29.14 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.205 0.526 . . . . 0.0 110.782 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.794 HG22 ' HB2' ' A' ' 51' ' ' ASP . 47.3 t -104.73 127.87 58.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.135 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.779 HG22 ' HG ' ' A' ' 77' ' ' LEU . 61.6 t -103.69 95.21 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.552 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.88 HG21 ' CE1' ' A' ' 11' ' ' PHE . 40.5 t -99.85 136.73 29.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.204 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 74' ' ' THR . 38.8 t70 -100.01 128.1 46.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.825 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.996 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.2 m-85 -98.89 48.69 0.96 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.012 0.434 . . . . 0.0 110.683 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.521 ' HD1' ' O ' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -51.48 137.04 24.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.889 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.789 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -58.39 165.01 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.965 0.412 . . . . 0.0 111.042 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.5 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 3.7 t -98.67 19.24 15.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.066 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.428 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 15.4 p-90 -141.76 -38.71 0.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.8 t -36.87 -69.06 0.12 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.781 0.325 . . . . 0.0 111.801 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.87 -74.42 0.23 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.511 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.6 -26.95 9.86 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.666 2.244 . . . . 0.0 112.421 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.417 ' HB3' ' CB ' ' A' ' 26' ' ' TYR . 77.5 m -58.25 -21.21 47.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.203 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -75.32 -19.22 59.76 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.28 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.425 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 84.4 mtp -75.3 3.8 8.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.357 . . . . 0.0 110.691 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.039 HG22 HG13 ' A' ' 40' ' ' ILE . 55.1 mt -85.68 -17.8 9.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.487 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.592 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.51 -42.33 74.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 35.3 Cg_endo -68.93 -43.58 3.3 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.576 1.517 . . . . 0.0 111.324 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.589 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 23.9 mmt -61.23 -61.28 2.67 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.039 HG13 HG22 ' A' ' 36' ' ' ILE . 56.8 mt -43.73 -29.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.846 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.618 ' HB2' HG11 ' A' ' 2' ' ' VAL . 4.0 tm-20 -81.56 -37.8 27.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.822 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 39' ' ' MET . 99.3 mttt -71.6 -30.96 66.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.544 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.589 ' HD1' ' O ' ' A' ' 39' ' ' MET . 16.3 m-85 -73.15 -27.07 61.46 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.356 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.5 p -67.02 -9.7 41.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.147 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.409 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 56.2 mt-10 -87.26 -26.51 23.44 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.788 0.327 . . . . 0.0 111.222 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.4 -31.79 16.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.524 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.531 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 73.9 m-85 -122.78 45.19 1.02 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.401 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 80.3 Cg_exo -37.74 -32.32 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.286 2.657 . . . . 0.0 113.478 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -60.71 -35.1 75.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.604 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.44 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.8 138.54 31.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.543 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.794 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.68 122.32 32.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.888 0.375 . . . . 0.0 110.46 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.65 ' CZ ' HD13 ' A' ' 99' ' ' ILE . 4.5 m-85 -99.32 90.33 4.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.577 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.733 ' HB2' HG22 ' A' ' 23' ' ' VAL . 41.0 m-85 -101.02 -177.76 3.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.572 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 4' ' ' GLN . 34.4 mtpt -139.96 131.5 27.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.369 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.667 HD23 ' CD2' ' A' ' 11' ' ' PHE . 3.2 tm? -95.73 126.39 40.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.138 0.494 . . . . 0.0 111.068 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.569 ' N ' HD13 ' A' ' 55' ' ' LEU . 44.9 m-20 -85.29 113.08 21.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.716 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 96.4 t -81.85 -5.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.141 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.5 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 11.4 p-10 -84.52 -39.72 18.5 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.854 0.359 . . . . 0.0 110.854 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.662 ' C ' HD12 ' A' ' 60' ' ' LEU . 17.6 tp10 -100.4 -23.02 14.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.171 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.728 HD11 ' O ' ' A' ' 6' ' ' LYS . 3.1 mp -119.57 48.44 1.52 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.822 0.344 . . . . 0.0 110.995 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -60.35 -18.24 49.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.444 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.67 -27.56 55.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.694 0.283 . . . . 0.0 111.507 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.717 HG12 ' HE2' ' A' ' 25' ' ' PHE . 15.7 t -75.53 -54.69 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.758 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.428 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -53.51 -26.74 22.12 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.954 0.407 . . . . 0.0 110.218 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.06 -26.84 20.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.69 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -70.44 -49.36 49.55 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.034 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -77.61 -1.1 29.16 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.116 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 67.55 37.61 3.34 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.344 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.654 ' CG1' HG21 ' A' ' 74' ' ' THR . 40.5 t -115.25 68.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.854 0.359 . . . . 0.0 110.845 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.8 p -81.77 -7.95 59.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.15 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.56 -166.53 0.0 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.537 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.789 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -174.43 107.43 0.28 Allowed Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.85 ' HG3' HD11 ' A' ' 36' ' ' ILE . 37.2 Cg_endo -89.77 -166.68 2.99 Favored 'Cis proline' 0 C--N 1.35 0.642 0 C-N-CA 124.353 -1.103 . . . . 0.0 112.366 -0.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.713 HG23 ' HA ' ' A' ' 88' ' ' VAL . 53.4 m -160.88 142.69 12.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.227 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.734 HD13 HD13 ' A' ' 95' ' ' ILE . 36.7 mt -109.79 123.75 50.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.023 0.439 . . . . 0.0 111.551 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.996 HD12 ' CE1' ' A' ' 25' ' ' PHE . 29.1 mt -115.16 127.07 55.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.853 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.779 ' HG ' HG22 ' A' ' 22' ' ' VAL . 4.5 mp -109.68 131.52 54.98 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.563 ' HA ' HG23 ' A' ' 84' ' ' VAL . 51.9 m-85 -130.94 125.52 33.65 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.298 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.481 ' HG3' HG21 ' A' ' 84' ' ' VAL . 24.6 mtpp -109.78 126.53 53.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.719 0.295 . . . . 0.0 111.087 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 6.3 m120 50.41 55.62 9.2 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.941 0.4 . . . . 0.0 111.768 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 59.58 16.39 36.78 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.072 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 27.0 mtpp -115.57 -153.55 0.53 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 35.6 tt0 -108.87 171.51 7.39 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.563 HG23 ' HA ' ' A' ' 78' ' ' PHE . 38.4 t -144.0 -59.82 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.75 0.309 . . . . 0.0 111.203 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.08 157.42 6.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.442 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -118.3 114.67 23.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.708 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.4 t -136.96 80.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.036 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.713 ' HA ' HG23 ' A' ' 74' ' ' THR . 3.8 p -59.64 85.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.998 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.54 123.41 2.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.703 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.604 ' HB2' HD11 ' A' ' 75' ' ' LEU . . . -84.45 55.23 3.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 110.83 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 46.6 t30 -51.59 131.89 35.86 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.725 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -44.96 -25.95 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.643 2.229 . . . . 0.0 112.776 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.403 ' HA ' ' HE2' ' A' ' 96' ' ' LYS . . . -123.32 49.19 1.72 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.724 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -152.39 -62.02 0.16 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.443 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.759 HD11 HG11 ' A' ' 22' ' ' VAL . 3.5 tp -58.17 -5.45 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.184 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.447 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 64.5 pttt -90.95 -47.53 7.53 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.954 0.407 . . . . 0.0 110.469 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.447 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 25.7 mt-30 -74.7 -32.47 62.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.52 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.4 -30.94 70.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.578 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.78 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 56.4 mt -90.25 -6.4 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.528 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.64 -77.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.998 0.428 . . . . 0.0 111.651 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.21 -29.3 5.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.054 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.604 ' HB3' HD12 ' A' ' 20' ' ' LEU . 73.0 m-80 -88.05 -67.4 0.83 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.672 0.272 . . . . 0.0 111.707 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.78 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.292 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.659 HG22 ' NZ ' ' A' ' 54' ' ' LYS . 9.9 p . . . . . 0 CA--C 1.529 0.164 0 CA-C-O 120.554 0.216 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 4' ' ' GLN . 95.4 m -150.29 157.69 43.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.0 111.481 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.546 ' HG3' ' HE2' ' A' ' 54' ' ' LYS . 10.8 mp0 -92.23 -177.14 4.57 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.771 ' O ' HD11 ' A' ' 60' ' ' LEU . 14.7 m-85 -133.67 96.57 3.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.819 0.342 . . . . 0.0 111.073 178.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -75.54 -30.29 59.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.729 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.0 p -128.61 132.43 48.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.48 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.06 -25.32 58.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.389 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.8 m -59.08 -19.86 48.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.542 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -90.63 -35.75 14.8 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.2 0.524 . . . . 0.0 111.075 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.944 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -73.67 -29.46 62.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.888 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -53.3 -57.02 12.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.218 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.8 p -61.13 -37.61 83.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.436 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -49.56 -51.9 33.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.649 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.6 pt -75.94 -48.86 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.529 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.479 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -43.14 97.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 84.7 mt-30 45.35 88.86 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.341 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 8.8 t70 -170.0 39.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.403 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 52.0 mttp 68.18 -154.35 0.18 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.731 0.301 . . . . 0.0 110.584 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.924 HD11 ' HB3' ' A' ' 77' ' ' LEU . 61.1 tp -97.8 114.28 26.28 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.089 0.471 . . . . 0.0 110.916 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.77 HG22 ' HB2' ' A' ' 51' ' ' ASP . 60.0 t -103.81 124.03 57.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.665 HG21 ' CG1' ' A' ' 99' ' ' ILE . 49.1 t -99.78 96.67 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.681 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.944 HG21 ' CE1' ' A' ' 11' ' ' PHE . 36.2 t -103.34 130.11 54.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.065 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.8 t70 -99.68 131.37 45.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.577 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.062 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.3 m-85 -98.9 50.88 0.96 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.036 0.446 . . . . 0.0 110.707 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -54.05 135.61 42.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.935 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.707 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -60.88 156.42 17.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 0.0 110.894 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 3.2 t -87.35 6.09 35.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.453 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.45 ' CZ2' ' CE ' ' A' ' 72' ' ' MET . 20.1 p-90 -127.52 -37.58 1.98 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 29' ' ' TRP . 53.9 t -28.51 -75.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.08 -80.81 0.35 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.898 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.96 -21.3 33.35 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.756 2.304 . . . . 0.0 112.326 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.5 p -53.44 -33.56 54.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.124 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -64.94 -22.74 67.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.321 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.0 mtp -68.76 -7.4 33.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.735 0.302 . . . . 0.0 111.016 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.776 HG22 HG13 ' A' ' 40' ' ' ILE . 57.0 mt -88.01 -19.25 7.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.303 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.536 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -53.09 -43.74 95.45 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.893 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 38.1 Cg_endo -71.67 -36.66 6.17 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.747 1.632 . . . . 0.0 111.459 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.468 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 1.1 mpt? -64.64 -55.95 16.94 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.776 HG13 HG22 ' A' ' 36' ' ' ILE . 55.7 mt -44.66 -27.4 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.841 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.509 ' HB2' HG11 ' A' ' 2' ' ' VAL . 43.1 tt0 -80.75 -39.83 26.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.138 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -64.12 -30.98 72.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.606 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.468 ' HD1' ' O ' ' A' ' 39' ' ' MET . 10.7 m-85 -75.47 -19.18 59.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.69 0.281 . . . . 0.0 111.377 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.43 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.6 t -72.77 -6.92 48.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.382 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -90.15 -26.9 19.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.701 0.286 . . . . 0.0 111.06 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -90.3 -28.99 18.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.568 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.52 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 80.0 m-85 -123.83 47.65 1.89 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.081 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 62.9 Cg_exo -35.26 -41.58 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.6 2.867 . . . . 0.0 113.919 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.411 ' O ' ' CD ' ' A' ' 19' ' ' LYS . 85.8 mt-30 -55.4 -34.92 64.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.978 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.6 135.77 33.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.722 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.77 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.62 121.95 32.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.409 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.451 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . 5.6 m-85 -98.26 84.59 3.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.586 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.556 ' HB2' HG22 ' A' ' 23' ' ' VAL . 48.2 m-85 -98.86 -174.71 2.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.515 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.659 ' NZ ' HG22 ' A' ' 2' ' ' VAL . 34.4 mtmm -148.39 132.65 17.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.018 0.437 . . . . 0.0 111.033 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.748 HD21 HD22 ' A' ' 60' ' ' LEU . 2.1 tm? -91.87 130.74 37.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.187 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.838 ' O ' HD13 ' A' ' 60' ' ' LEU . 46.8 m-20 -86.44 126.32 34.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.411 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.719 HG12 ' O ' ' A' ' 57' ' ' VAL . 95.9 t -97.16 18.93 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.533 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 2.8 p30 -111.39 -38.99 4.81 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.242 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.428 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 17.6 tp10 -100.03 -13.94 18.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.805 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.838 HD13 ' O ' ' A' ' 56' ' ' ASP . 5.3 mp -104.74 -69.08 0.82 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.295 0.569 . . . . 0.0 110.926 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.84 -61.58 0.5 Allowed Glycine 0 C--N 1.314 -0.661 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.591 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -52.69 -43.43 65.59 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.735 HG12 ' HE2' ' A' ' 25' ' ' PHE . 16.0 t -59.83 -53.34 49.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.719 0.295 . . . . 0.0 110.844 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -51.25 -26.09 6.66 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 110.053 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -90.39 -38.02 13.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.157 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -61.15 -42.0 97.75 Favored 'General case' 0 C--O 1.23 0.055 0 CA-C-O 120.863 0.363 . . . . 0.0 110.414 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -84.95 -1.97 57.34 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.923 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 64.91 38.4 6.5 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.021 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.809 HG13 HG21 ' A' ' 74' ' ' THR . 40.2 t -114.75 69.12 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.852 0.358 . . . . 0.0 111.019 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.8 p -82.34 -11.46 58.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.067 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.524 ' CB ' HG21 ' A' ' 88' ' ' VAL . . . -55.32 -172.07 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.603 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.707 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 1.7 pmm? -171.59 107.57 0.38 Allowed Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.602 -0.439 . . . . 0.0 112.085 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.553 ' HG3' HD12 ' A' ' 36' ' ' ILE . 83.2 Cg_endo -93.78 171.23 18.28 Favored 'Cis proline' 0 N--CA 1.459 -0.55 0 C-N-CA 124.634 -0.986 . . . . 0.0 112.23 -0.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.809 HG21 HG13 ' A' ' 69' ' ' VAL . 34.5 m -136.16 153.69 51.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.953 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.071 HD13 HD13 ' A' ' 95' ' ' ILE . 85.3 mt -115.09 125.55 53.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 111.056 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.062 HD12 ' CE1' ' A' ' 25' ' ' PHE . 28.5 mt -122.38 128.99 51.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.061 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.924 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.4 mp -109.79 146.03 35.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.441 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.626 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 67.9 m-85 -145.99 128.82 16.33 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.779 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.888 ' CG ' HG11 ' A' ' 84' ' ' VAL . 27.0 mmmt -109.69 132.92 53.7 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.458 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 5.2 m120 44.44 60.25 2.93 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.842 0.353 . . . . 0.0 111.845 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 57.29 18.61 29.28 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.245 -0.503 . . . . 0.0 113.072 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.626 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 96.5 mttt -122.12 -158.86 0.79 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.72 ' O ' HG13 ' A' ' 84' ' ' VAL . 32.0 tt0 -109.35 176.73 4.98 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.888 HG11 ' CG ' ' A' ' 79' ' ' LYS . 3.3 m -165.01 -46.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 O-C-N 123.169 0.293 . . . . 0.0 111.292 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.26 158.17 16.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.147 0.499 . . . . 0.0 111.881 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 60.8 pttt -151.67 114.85 4.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.399 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.7 t -135.57 106.64 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.184 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.56 ' HB ' HG23 ' A' ' 74' ' ' THR . 3.6 p -66.78 97.87 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.48 104.83 0.44 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.195 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.788 ' HB2' HD21 ' A' ' 75' ' ' LEU . . . -96.98 35.87 1.5 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.927 0.394 . . . . 0.0 111.524 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 93' ' ' ALA . 13.9 p-10 -76.7 134.45 69.1 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.236 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 80.0 Cg_exo -44.79 87.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.591 2.194 . . . . 0.0 112.702 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 178.76 -36.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.551 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.9 -41.9 2.2 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.071 HD13 HD13 ' A' ' 75' ' ' LEU . 5.1 tp -51.02 -18.0 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.586 0.231 . . . . 0.0 111.329 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.407 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 21.4 ptmt -92.25 -50.33 5.72 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.971 0.415 . . . . 0.0 110.837 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.407 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 25.7 mt-30 -68.02 -31.92 71.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.581 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.607 ' HB1' HD21 ' A' ' 77' ' ' LEU . . . -57.38 -30.38 64.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.174 0.512 . . . . 0.0 110.772 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.874 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.5 mp -90.09 -9.72 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.554 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.62 -65.64 1.0 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 111.184 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.91 -26.91 27.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.452 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.662 ' HB3' HD22 ' A' ' 20' ' ' LEU . 52.4 m-80 -89.3 -59.95 2.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.536 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.102 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.434 HG22 HG22 ' A' ' 40' ' ' ILE . 49.6 t . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.763 0.316 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.9 m -149.98 147.06 27.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.977 0.417 . . . . 0.0 111.248 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.611 ' HG2' ' HE3' ' A' ' 54' ' ' LYS . 40.4 mt-30 -90.13 174.48 7.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.28 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.631 ' O ' HD13 ' A' ' 60' ' ' LEU . 16.9 m-85 -123.02 124.52 43.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.931 0.396 . . . . 0.0 111.144 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.699 ' C ' HD11 ' A' ' 60' ' ' LEU . 46.7 mmtm -109.26 -25.21 10.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.643 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -129.92 123.28 30.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.29 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.1 -26.64 4.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.426 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -57.8 -20.94 39.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.069 0.461 . . . . 0.0 110.477 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -90.42 -45.73 8.8 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.557 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.915 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -76.46 -23.38 53.87 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.695 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -63.85 -38.06 89.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.966 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.0 m -87.94 -26.39 22.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.224 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.408 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -52.38 -31.8 35.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.834 0.349 . . . . 0.0 111.423 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.538 ' C ' ' HA2' ' A' ' 81' ' ' GLY . 20.4 pt -90.18 -47.71 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.361 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.472 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.1 97.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 45.65 86.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.33 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -167.36 41.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.44 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.547 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 2.9 mptp? 63.31 -156.67 0.33 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.432 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.881 HD11 ' HB3' ' A' ' 77' ' ' LEU . 66.0 tp -97.98 115.81 28.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.102 0.477 . . . . 0.0 110.637 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 51' ' ' ASP . 54.8 t -102.74 133.84 45.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.126 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.412 ' CG2' HG13 ' A' ' 99' ' ' ILE . 42.8 t -100.31 103.38 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.481 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.915 HG21 ' CE1' ' A' ' 11' ' ' PHE . 23.7 t -113.93 126.36 71.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 0.0 111.462 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 74' ' ' THR . 34.6 t70 -99.76 135.19 41.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.662 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.06 ' CE1' HD12 ' A' ' 76' ' ' LEU . 6.6 m-85 -99.39 46.78 0.97 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.705 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.562 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -46.9 141.02 4.29 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.071 0.462 . . . . 0.0 111.755 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.726 ' HB1' ' CE2' ' A' ' 29' ' ' TRP . . . -69.88 133.59 47.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.084 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.7 t -63.67 -20.48 65.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.743 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.726 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 8.4 p-90 -96.28 -126.46 0.14 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.301 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.553 ' H ' ' HE3' ' A' ' 29' ' ' TRP . 51.8 t 48.67 -88.68 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.747 0.419 . . . . 0.0 111.654 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . 150.25 -77.83 0.22 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.675 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.23 -6.77 17.05 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.77 2.313 . . . . 0.0 113.419 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 85.5 m -50.44 -34.38 24.44 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.589 0.233 . . . . 0.0 111.445 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -76.64 -5.06 46.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.62 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.437 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 27.9 ttt -81.04 2.92 24.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.895 0.379 . . . . 0.0 110.676 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.891 HG22 HG13 ' A' ' 40' ' ' ILE . 58.2 mt -86.41 -14.98 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.588 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.57 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -53.76 -42.04 90.59 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 37.7 Cg_endo -70.92 -41.25 2.92 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.638 1.559 . . . . 0.0 111.766 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.479 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 70.5 mtm -63.05 -54.95 30.06 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.891 HG13 HG22 ' A' ' 36' ' ' ILE . 70.5 mt -47.42 -28.01 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.81 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -79.68 -33.12 41.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.168 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.53 -21.98 66.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.703 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.662 ' CE2' HG23 ' A' ' 95' ' ' ILE . 4.2 m-85 -90.05 -18.13 26.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.616 0.246 . . . . 0.0 111.559 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.432 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.6 t -74.3 -6.88 50.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.187 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.402 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 95.0 mt-10 -90.07 -28.08 19.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.839 0.352 . . . . 0.0 111.069 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.51 -27.65 19.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.652 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.745 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 74.6 m-85 -123.53 44.38 0.95 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.529 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 96.0 Cg_exo -39.19 -31.85 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.093 2.529 . . . . 0.0 113.346 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -61.7 -35.68 78.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.863 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -90.01 140.82 29.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.072 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.507 ' O ' HG13 ' A' ' 21' ' ' VAL . 25.7 m-20 -89.83 127.28 35.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.639 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.432 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 4.6 m-85 -102.2 89.0 3.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.006 0.431 . . . . 0.0 111.577 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.505 ' HB2' HG22 ' A' ' 23' ' ' VAL . 39.5 m-85 -98.3 -174.56 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.207 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.611 ' HE3' ' HG2' ' A' ' 4' ' ' GLN . 42.2 mtmt -150.22 137.84 19.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.062 0.458 . . . . 0.0 111.395 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.851 HD13 ' N ' ' A' ' 56' ' ' ASP . 3.1 tm? -91.59 141.35 28.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.662 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.851 ' N ' HD13 ' A' ' 55' ' ' LEU . 54.1 t0 -97.74 112.84 24.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.355 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 83.4 t -77.9 -4.51 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.933 0.397 . . . . 0.0 110.563 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.501 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 38.8 t70 -95.49 -35.0 11.85 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.174 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -102.48 -46.48 4.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.613 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.699 HD11 ' C ' ' A' ' 6' ' ' LYS . 6.1 mp -102.38 35.2 2.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.743 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -51.33 -25.12 11.59 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.411 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.63 -30.01 71.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.685 0.279 . . . . 0.0 111.198 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.715 HG12 ' HE2' ' A' ' 25' ' ' PHE . 11.1 t -74.06 -52.18 21.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.576 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.76 -29.83 41.7 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.991 0.424 . . . . 0.0 110.071 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -90.19 -28.31 18.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.001 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -66.15 -50.67 63.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.015 0.436 . . . . 0.0 109.948 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -79.67 0.43 30.37 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.84 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 62.61 40.61 10.23 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.491 ' O ' HG12 ' A' ' 69' ' ' VAL . 29.2 t -107.72 54.2 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 110.821 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 94.1 p -74.05 -13.29 60.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.018 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.407 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -88.44 62.58 6.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.112 0.482 . . . . 0.0 110.054 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.692 ' CG ' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -89.55 165.59 24.81 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.073 -179.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.769 ' HG3' HD11 ' A' ' 36' ' ' ILE . 56.9 Cg_endo -72.59 134.47 34.6 Favored 'Cis proline' 0 C--N 1.353 0.773 0 C-N-CA 123.288 -1.547 . . . . 0.0 112.94 0.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.792 ' OG1' HG23 ' A' ' 88' ' ' VAL . 53.0 m -117.77 154.38 31.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.565 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.982 HD13 HD13 ' A' ' 95' ' ' ILE . 75.9 mt -109.25 115.35 29.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 110.813 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.06 HD12 ' CE1' ' A' ' 25' ' ' PHE . 25.6 mt -109.77 126.72 54.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.889 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.881 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.8 mp -109.66 142.36 40.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.568 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.638 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 54.5 m-85 -141.86 127.01 18.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.984 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.785 ' CG ' HG11 ' A' ' 84' ' ' VAL . 9.5 mtpm? -116.38 132.19 56.74 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.668 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.434 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 74.0 m-20 49.31 68.75 0.67 Allowed 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.38 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.538 ' HA2' ' C ' ' A' ' 15' ' ' ILE . . . 46.55 28.54 3.54 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 116.095 -0.502 . . . . 0.0 113.098 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.638 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 68.2 mttm -136.42 -161.64 1.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.665 ' O ' HG13 ' A' ' 84' ' ' VAL . 30.9 tt0 -109.1 -179.52 3.87 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.785 HG11 ' CG ' ' A' ' 79' ' ' LYS . 5.0 m -162.76 -47.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.626 0.25 . . . . 0.0 111.309 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.13 166.15 13.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.098 0.475 . . . . 0.0 111.827 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.461 ' NZ ' ' HB2' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -141.76 115.42 9.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.522 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.9 t -116.05 85.42 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.13 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.792 HG23 ' OG1' ' A' ' 74' ' ' THR . 5.5 p -61.52 84.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.063 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.83 109.28 1.21 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.529 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.715 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -77.41 59.28 1.84 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.981 0.419 . . . . 0.0 111.075 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.509 ' O ' HG22 ' A' ' 95' ' ' ILE . 45.8 t30 -62.63 133.98 95.08 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.342 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -43.7 -26.38 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.534 2.156 . . . . 0.0 112.803 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.22 53.12 0.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.605 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -167.69 -56.7 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.549 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.982 HD13 HD13 ' A' ' 75' ' ' LEU . 3.1 tp -54.72 -9.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.492 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.451 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 25.3 pttm -92.04 -50.28 5.77 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.919 0.39 . . . . 0.0 110.856 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.451 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 83.8 mt-30 -70.32 -32.24 69.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.782 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.22 -37.25 77.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.217 0.532 . . . . 0.0 110.394 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.663 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.3 mp -90.21 -8.68 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.542 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.745 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.28 -62.52 1.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.941 0.4 . . . . 0.0 110.981 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.07 -28.54 58.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.073 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.643 ' HB3' HD22 ' A' ' 20' ' ' LEU . 3.6 m120 -84.64 -63.12 1.39 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.197 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.585 ' HB2' HD23 ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.056 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 52' ' ' PHE . 12.6 p . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.54 0.21 . . . . 0.0 110.724 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 4' ' ' GLN . 97.3 m -150.08 161.27 42.69 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.147 0.498 . . . . 0.0 112.06 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.644 ' HG2' ' HD2' ' A' ' 54' ' ' LYS . 54.1 mt-30 -92.37 -170.68 2.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.952 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.514 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 15.4 m-85 -134.4 121.46 21.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.114 0.483 . . . . 0.0 111.488 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.625 ' C ' HD11 ' A' ' 60' ' ' LEU . 2.4 mmmp? -109.14 -16.41 14.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.621 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.7 p -139.83 125.38 19.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.374 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.56 -26.11 4.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.525 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 m -58.78 -20.3 48.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.344 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -90.63 -39.09 12.7 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.151 0.5 . . . . 0.0 111.025 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.877 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -84.54 4.16 33.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.22 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -89.88 -31.54 17.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.906 0.384 . . . . 0.0 110.738 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.3 p -89.92 -37.07 14.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.56 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -46.5 -40.38 12.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.499 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.593 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.1 pt -86.8 -50.93 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.353 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.69 97.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 44.52 86.84 0.02 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.231 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 64.2 t0 -169.32 40.78 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.453 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 92.2 mttt 67.66 -156.64 0.21 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.669 0.271 . . . . 0.0 110.614 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.913 HD11 ' HB3' ' A' ' 77' ' ' LEU . 63.9 tp -98.04 114.96 27.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.042 0.449 . . . . 0.0 110.9 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.774 HG22 ' HB2' ' A' ' 51' ' ' ASP . 61.4 t -102.85 132.48 48.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.966 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.525 HG21 ' CG1' ' A' ' 99' ' ' ILE . 41.1 t -102.38 107.58 22.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.68 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.877 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 34.6 t -113.91 126.75 71.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.008 0.433 . . . . 0.0 111.367 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 7.2 t70 -99.87 129.01 45.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.668 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.083 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.9 m-85 -99.08 52.09 0.96 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.124 0.487 . . . . 0.0 110.602 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -57.48 137.41 56.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.961 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.838 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -61.01 143.74 54.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.019 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.55 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 5.2 t -63.04 -13.91 41.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.853 0.359 . . . . 0.0 110.948 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.443 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 11.7 p-90 -110.13 -132.33 0.33 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.644 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 40.8 t 62.2 -79.66 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.581 0.352 . . . . 0.0 111.437 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.71 -78.52 0.37 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.723 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -45.06 -30.55 4.82 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.637 2.225 . . . . 0.0 112.131 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 98.5 m -55.4 -36.88 66.91 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.596 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.12 -17.02 62.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.142 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.597 ' HA ' ' CE ' ' A' ' 35' ' ' MET . 1.7 tpt -76.16 -1.09 24.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.885 0.374 . . . . 0.0 110.68 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.743 HG22 HG13 ' A' ' 40' ' ' ILE . 65.1 mt -87.72 -12.72 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.695 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.565 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -58.41 -41.4 89.09 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 40.9 Cg_endo -71.97 -38.82 3.66 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.636 1.558 . . . . 0.0 111.367 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.433 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 90.1 mtp -62.87 -57.12 11.92 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.743 HG13 HG22 ' A' ' 36' ' ' ILE . 61.2 mt -46.59 -28.52 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.007 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.621 ' HB2' HG11 ' A' ' 2' ' ' VAL . 44.6 tt0 -79.95 -29.38 39.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.603 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 57.2 mtpt -74.58 -15.65 60.83 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.449 ' HB2' ' CE2' ' A' ' 52' ' ' PHE . 4.4 m-85 -90.59 -20.08 22.99 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.439 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 79.3 p -67.59 -9.32 41.79 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 42' ' ' LYS . 12.5 pt-20 -90.02 -26.17 20.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.687 0.279 . . . . 0.0 111.058 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -90.56 -28.53 18.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.383 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.635 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 86.5 m-85 -123.13 46.14 1.28 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.328 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 84.7 Cg_exo -37.63 -38.66 0.64 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.177 2.585 . . . . 0.0 113.501 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.411 ' O ' ' HD3' ' A' ' 19' ' ' LYS . 85.1 mt-30 -59.03 -33.17 70.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.622 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.63 134.6 34.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.853 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.774 ' HB2' HG22 ' A' ' 21' ' ' VAL . 28.0 m-20 -89.66 122.69 33.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.418 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.75 ' O ' HG23 ' A' ' 2' ' ' VAL . 4.1 m-85 -97.33 100.91 12.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.07 0.462 . . . . 0.0 111.445 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.514 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 45.6 m-85 -115.82 -177.29 3.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.363 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.644 ' HD2' ' HG2' ' A' ' 4' ' ' GLN . 29.0 mttm -141.37 157.58 45.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.245 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.776 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.6 tm? -118.39 132.77 56.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.865 0.364 . . . . 0.0 111.033 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.776 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.9 t0 -85.25 114.98 22.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.222 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 26' ' ' TYR . 55.8 t -74.12 -4.63 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.07 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.55 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 62.1 t0 -102.34 -50.89 3.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.048 0.451 . . . . 0.0 110.392 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.535 ' C ' HD12 ' A' ' 60' ' ' LEU . 38.0 tp10 -75.11 -40.66 59.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.659 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.625 HD11 ' C ' ' A' ' 6' ' ' LYS . 4.5 mp -113.44 37.75 3.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.707 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -53.12 -23.77 18.24 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.651 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -66.45 -29.79 70.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.635 0.255 . . . . 0.0 111.223 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.671 HG13 ' HD3' ' A' ' 66' ' ' LYS . 5.5 t -79.87 -27.47 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.051 0.453 . . . . 0.0 110.546 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.29 -26.08 60.93 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -90.17 -34.96 15.64 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.816 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.671 ' HD3' HG13 ' A' ' 63' ' ' VAL . 13.4 ptmm? -60.56 -48.53 81.37 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.073 0.463 . . . . 0.0 110.007 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.421 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.8 m-80 -80.93 -3.67 52.27 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.878 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 63.85 42.67 5.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.292 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.425 ' CG1' HG21 ' A' ' 74' ' ' THR . 55.1 t -103.38 109.23 26.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.754 0.311 . . . . 0.0 111.061 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -138.63 19.24 2.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.728 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 1.07 ' HB3' HG21 ' A' ' 88' ' ' VAL . . . -98.86 34.44 2.08 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.264 0.554 . . . . 0.0 109.918 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.838 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 1.2 pmm? -21.76 119.77 0.14 Allowed Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.519 ' O ' HG23 ' A' ' 88' ' ' VAL . 85.8 Cg_endo -86.42 -163.88 2.83 Favored 'Cis proline' 0 C--N 1.353 0.812 0 C-N-CA 123.81 -1.329 . . . . 0.0 111.899 -0.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 98.6 m -161.91 162.44 29.16 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.987 0.422 . . . . 0.0 111.374 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.994 HD13 HD13 ' A' ' 95' ' ' ILE . 75.8 mt -126.38 121.25 31.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.862 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.083 HD12 ' CE1' ' A' ' 25' ' ' PHE . 26.5 mt -120.05 123.94 44.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.576 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.913 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.5 mp -109.71 146.88 34.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.38 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.524 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 56.3 m-85 -143.77 129.33 19.12 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.193 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HE2' HG23 ' A' ' 84' ' ' VAL . 51.8 mtmt -109.86 129.44 55.64 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.258 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.487 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.3 m120 45.69 63.79 1.68 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.882 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 52.46 22.09 10.22 Favored Glycine 0 N--CA 1.453 -0.218 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.484 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 97.5 mttt -125.55 -156.13 0.71 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 33.7 tt0 -108.7 174.83 5.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.745 HG11 ' CD1' ' A' ' 20' ' ' LEU . 4.3 p -162.19 -59.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 120.881 0.372 . . . . 0.0 111.369 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.667 ' H ' HG13 ' A' ' 84' ' ' VAL . . . -155.76 167.29 30.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.515 ' HG2' HD22 ' A' ' 76' ' ' LEU . 36.5 mtmm -150.5 130.42 13.36 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.414 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.1 t -145.11 90.25 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.407 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.07 HG21 ' HB3' ' A' ' 71' ' ' ALA . 2.8 p -60.71 88.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.757 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.21 101.24 0.57 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.475 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.756 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -75.5 61.16 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.861 0.362 . . . . 0.0 111.071 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.563 ' O ' HG22 ' A' ' 95' ' ' ILE . 48.2 t30 -76.7 133.33 70.41 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.057 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -44.02 -24.29 0.84 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.547 2.165 . . . . 0.0 112.843 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.512 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . . . -95.16 27.65 3.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.356 -0.384 . . . . 0.0 112.022 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -164.21 -53.05 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.994 HD13 HD13 ' A' ' 75' ' ' LEU . 4.5 tp -49.2 -16.94 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 25.6 pttm -92.47 -51.36 5.17 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.966 0.412 . . . . 0.0 111.097 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.476 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 72.5 mt-30 -69.31 -32.04 70.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.879 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.55 -33.95 70.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.17 0.51 . . . . 0.0 110.47 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.886 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.6 mp -90.4 -11.78 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.457 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.635 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.18 -62.92 1.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.806 0.336 . . . . 0.0 111.035 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.78 -27.43 51.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.011 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.619 ' OD1' HD22 ' A' ' 77' ' ' LEU . 3.7 m120 -83.66 -51.84 6.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.859 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.03 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.796 HG12 ' HE3' ' A' ' 54' ' ' LYS . 51.2 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.81 0.338 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 4' ' ' GLN . 51.0 m -150.1 158.86 44.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.019 0.438 . . . . 0.0 111.504 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.612 ' HG2' ' NZ ' ' A' ' 54' ' ' LYS . 48.7 mt-30 -89.98 166.27 13.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.128 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.556 ' O ' HD13 ' A' ' 60' ' ' LEU . 12.9 m-30 -114.4 120.26 39.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.926 0.393 . . . . 0.0 110.488 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.576 ' C ' HD11 ' A' ' 60' ' ' LEU . 2.1 tppt? -97.51 -41.44 8.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.798 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -123.12 139.46 54.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.69 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.18 -24.68 43.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.4 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.5 m -63.1 -15.81 57.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.607 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -90.15 -46.69 8.29 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.158 0.504 . . . . 0.0 110.967 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.902 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -75.39 -35.41 61.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.615 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -52.36 -31.3 33.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.057 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 t -90.05 -26.22 20.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.653 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -55.27 -52.0 64.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.438 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.4 pt -73.77 -48.88 37.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.334 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.466 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -41.48 95.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 45.73 92.06 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.217 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -174.7 39.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.315 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.559 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 11.0 mptt 64.97 -155.61 0.29 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.243 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.903 HD11 ' HB3' ' A' ' 77' ' ' LEU . 65.1 tp -98.04 115.57 28.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.015 0.436 . . . . 0.0 111.006 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.765 HG22 ' HB2' ' A' ' 51' ' ' ASP . 49.4 t -101.26 133.48 44.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.807 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.622 HG21 ' CD1' ' A' ' 99' ' ' ILE . 48.1 t -99.78 91.44 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.586 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.902 HG21 ' CE1' ' A' ' 11' ' ' PHE . 22.3 t -100.67 123.34 53.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.904 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 7.7 t70 -99.98 133.25 44.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.095 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.019 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.6 m-85 -99.25 54.41 0.97 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.161 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.594 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -54.19 146.48 15.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.712 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . . . -63.54 146.32 53.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.896 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.519 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 2.4 t -77.32 -1.16 28.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.723 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -125.38 -33.87 2.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 30.8 t -46.96 159.19 0.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.93 -64.09 0.71 Allowed Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.297 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.7 -24.3 4.58 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.869 2.379 . . . . 0.0 113.305 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 86.8 m -58.03 -54.98 40.76 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -51.83 -28.21 15.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.687 0.279 . . . . 0.0 111.74 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.8 tpp -75.09 1.25 13.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.886 0.374 . . . . 0.0 110.72 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.868 HG22 HG13 ' A' ' 40' ' ' ILE . 61.9 mt -87.12 -18.77 8.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.705 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.563 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -51.99 -43.51 89.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 38.4 Cg_endo -71.18 -39.17 4.16 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.724 1.616 . . . . 0.0 111.611 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.463 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 1.2 mpt? -63.24 -56.23 18.3 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.868 HG13 HG22 ' A' ' 36' ' ' ILE . 56.8 mt -44.02 -28.58 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.687 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.5 ' N ' HG21 ' A' ' 2' ' ' VAL . 43.7 tt0 -81.04 -41.35 22.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.852 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.32 -31.84 69.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.175 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.463 ' HD1' ' O ' ' A' ' 39' ' ' MET . 11.0 m-85 -74.43 -17.17 60.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.251 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.7 t -70.92 -10.41 59.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.151 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -87.05 -24.59 24.56 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.697 0.284 . . . . 0.0 111.007 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -90.44 -34.73 15.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.585 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.579 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 67.7 m-85 -122.95 43.33 0.74 Allowed Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.706 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 95.3 Cg_exo -39.38 -31.99 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.934 2.423 . . . . 0.0 113.201 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -61.06 -37.54 83.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.834 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.754 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.85 148.84 22.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.01 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.765 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.77 148.94 22.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.64 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -125.44 85.93 2.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.425 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.47 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 45.5 m-85 -99.12 -176.02 3.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.574 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.806 ' HD3' HD12 ' A' ' 40' ' ' ILE . 9.8 mtmp? -146.43 133.84 20.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.98 0.419 . . . . 0.0 111.104 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.812 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.9 tm? -89.77 139.05 30.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.999 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.812 ' N ' HD13 ' A' ' 55' ' ' LEU . 61.8 t0 -95.17 101.49 13.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.467 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 71.7 t -68.23 -12.72 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 0.0 110.466 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.519 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 61.8 t0 -86.74 -31.27 21.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.44 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -103.16 -51.98 3.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.237 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.668 HD22 ' CD2' ' A' ' 55' ' ' LEU . 5.5 mp -93.62 51.86 1.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.895 0.378 . . . . 0.0 111.06 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.11 -19.86 47.32 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.501 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.95 -29.27 61.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.618 0.246 . . . . 0.0 111.38 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.72 HG12 ' HE2' ' A' ' 25' ' ' PHE . 5.5 t -78.45 -48.1 23.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.362 . . . . 0.0 110.343 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.41 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -56.31 -24.93 46.65 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -90.37 -38.84 13.06 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.025 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -60.99 -41.74 97.04 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.933 0.397 . . . . 0.0 110.241 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -85.31 0.6 51.51 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.736 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 61.35 39.86 14.86 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.46 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.672 ' CG1' HG21 ' A' ' 74' ' ' THR . 46.1 t -109.69 107.12 22.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.848 0.356 . . . . 0.0 111.054 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 84.3 p -124.0 20.91 9.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.032 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.542 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -73.02 -149.13 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.741 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.506 ' O ' ' HG3' ' A' ' 72' ' ' MET . 18.3 ptt? -175.88 84.73 0.29 Allowed Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.674 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 6.9 Cg_endo -95.76 -156.28 0.44 Allowed 'Cis proline' 0 CA--C 1.534 0.509 0 C-N-CA 125.217 -0.743 . . . . 0.0 112.834 -0.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.719 HG23 ' HA ' ' A' ' 88' ' ' VAL . 91.6 m -150.68 146.77 26.68 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.362 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.02 HD13 HD13 ' A' ' 95' ' ' ILE . 77.3 mt -112.35 122.08 46.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.785 0.326 . . . . 0.0 111.382 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.019 HD12 ' CE1' ' A' ' 25' ' ' PHE . 27.9 mt -120.82 128.13 52.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.656 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.903 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.7 mp -109.9 145.36 36.98 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.66 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.582 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 54.8 m-85 -146.52 127.45 14.51 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.262 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.817 ' HG3' HG11 ' A' ' 84' ' ' VAL . 9.8 mtpm? -115.19 135.92 53.66 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.638 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.479 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.2 m120 48.59 59.94 4.01 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.641 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 52.37 23.02 11.78 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.022 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.582 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 52.1 mtmt -126.91 -158.48 0.87 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.713 ' O ' HG13 ' A' ' 84' ' ' VAL . 82.0 tt0 -108.97 178.41 4.48 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.817 HG11 ' HG3' ' A' ' 79' ' ' LYS . 4.3 m -164.54 -47.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.533 0.206 . . . . 0.0 111.251 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -169.98 154.37 5.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.038 0.447 . . . . 0.0 111.845 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -137.8 113.93 10.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.409 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.427 HG11 ' HB3' ' A' ' 94' ' ' ALA . 48.3 t -121.82 81.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.067 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.719 ' HA ' HG23 ' A' ' 74' ' ' THR . 7.4 p -50.27 94.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.18 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.04 131.35 3.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.254 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.577 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -95.6 35.86 1.32 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.919 0.39 . . . . 0.0 111.133 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -59.04 108.04 1.19 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.97 179.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 19.5 Cg_exo -33.02 90.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.138 2.559 . . . . 0.0 113.113 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 92' ' ' PRO . . . 172.97 -30.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.122 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.427 ' HB3' HG11 ' A' ' 87' ' ' VAL . . . -123.99 -44.32 2.06 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.02 HD13 HD13 ' A' ' 75' ' ' LEU . 4.6 tp -49.35 -19.07 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.738 0.304 . . . . 0.0 111.179 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -91.2 -66.17 0.95 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.981 0.419 . . . . 0.0 111.22 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -60.79 -34.41 74.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.964 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.88 -31.29 68.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.06 0.457 . . . . 0.0 110.702 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.622 ' CD1' HG21 ' A' ' 22' ' ' VAL . 66.6 mt -90.25 -10.75 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.373 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.579 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.44 -68.68 0.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.839 0.352 . . . . 0.0 111.4 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.87 -28.21 34.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.367 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.683 ' HB3' HD22 ' A' ' 20' ' ' LEU . 3.6 m120 -83.48 -48.21 10.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.106 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.135 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.419 ' CG2' HG22 ' A' ' 40' ' ' ILE . 41.5 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.711 0.291 . . . . 0.0 110.99 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.1 m -150.08 147.47 27.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.095 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.507 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 60.1 mt-30 -89.94 -176.9 5.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.39 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.51 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.9 m-85 -134.73 135.97 42.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.024 0.44 . . . . 0.0 111.375 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.707 ' C ' HD11 ' A' ' 60' ' ' LEU . 34.5 mmtp -112.92 -33.76 5.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.536 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 8' ' ' ALA . 11.9 m -124.54 165.55 17.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.401 ' N ' HG22 ' A' ' 7' ' ' THR . . . -77.48 -29.82 52.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.77 0.319 . . . . 0.0 111.068 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.4 t -59.35 -16.42 22.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.791 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -90.09 -58.32 2.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.299 0.571 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.866 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -66.42 -28.42 68.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.64 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -59.04 -42.73 90.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.817 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.5 m -79.23 -29.95 42.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.462 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -57.78 -32.4 67.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.194 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.8 pt -90.0 -49.15 13.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.275 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.486 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -42.95 101.9 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.1 mt-30 43.78 86.1 0.02 OUTLIER 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.211 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -166.24 39.26 0.05 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.62 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER 65.37 -153.29 0.27 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.729 0.299 . . . . 0.0 110.364 179.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.882 HD11 ' HB3' ' A' ' 77' ' ' LEU . 54.6 tp -97.7 114.18 26.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.06 0.457 . . . . 0.0 110.928 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.637 HG22 ' HB2' ' A' ' 51' ' ' ASP . 52.3 t -103.28 120.17 52.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.726 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.741 HG21 HG12 ' A' ' 99' ' ' ILE . 48.1 t -99.83 98.31 6.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.622 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.866 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 44.1 t -99.74 145.45 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.167 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.458 ' HA ' ' O ' ' A' ' 74' ' ' THR . 37.4 t70 -106.97 126.06 51.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.597 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.062 ' CE1' HD12 ' A' ' 76' ' ' LEU . 7.4 m-85 -98.88 50.42 0.96 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.152 0.501 . . . . 0.0 110.308 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.53 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -53.15 139.25 29.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.529 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.732 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -63.13 149.16 45.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.572 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.514 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.4 t -74.53 -11.91 60.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.79 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.538 ' O ' ' C ' ' A' ' 30' ' ' CYS . 5.4 p-90 -112.18 -60.39 1.87 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.538 ' C ' ' O ' ' A' ' 29' ' ' TRP . 50.6 t 4.07 -80.95 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.431 0.692 . . . . 0.0 112.774 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.14 -78.48 0.35 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.582 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.02 -15.71 43.82 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.574 2.183 . . . . 0.0 112.567 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 31.9 p -52.9 -26.7 15.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.138 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -75.79 -16.84 60.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.553 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 35' ' ' MET . 48.0 ttm -74.17 2.07 9.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.038 0.447 . . . . 0.0 110.779 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.017 HG22 HG13 ' A' ' 40' ' ' ILE . 55.6 mt -83.74 -25.83 7.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.639 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.524 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -45.9 -45.02 36.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 40.4 Cg_endo -72.32 -37.69 4.23 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 121.694 1.596 . . . . 0.0 111.096 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.434 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 88.8 mtp -64.11 -54.9 26.66 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.017 HG13 HG22 ' A' ' 36' ' ' ILE . 67.2 mt -46.79 -27.62 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.703 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -81.19 -34.05 32.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.336 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -67.0 -22.74 65.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.739 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.435 ' CB ' ' CE2' ' A' ' 52' ' ' PHE . 5.9 m-85 -84.75 -21.91 29.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.716 0.294 . . . . 0.0 111.597 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.2 m -68.65 -12.06 60.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.015 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.417 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 39.4 tt0 -88.63 -23.81 22.97 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.826 0.346 . . . . 0.0 110.541 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -90.43 -38.23 13.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.371 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.536 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 60.5 m-85 -123.92 43.87 0.9 Allowed Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 89.6 Cg_exo -38.59 -29.03 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.046 2.497 . . . . 0.0 113.014 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.474 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 0.3 OUTLIER -57.17 -37.8 72.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.692 179.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.777 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.86 152.93 21.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.137 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.637 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -97.66 123.31 41.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.751 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.435 ' CE2' ' CB ' ' A' ' 43' ' ' PHE . 4.1 m-85 -100.93 104.43 15.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.111 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.63 ' HB2' HG22 ' A' ' 23' ' ' VAL . 46.5 m-85 -113.89 -178.81 3.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.212 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 32.9 mtpt -137.62 142.92 41.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.212 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.872 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.7 tm? -107.82 138.54 43.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.803 0.335 . . . . 0.0 110.733 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.872 ' N ' HD13 ' A' ' 55' ' ' LEU . 26.4 t70 -93.03 113.39 25.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.909 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 52.6 t -73.5 -6.12 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.411 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.514 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 38.6 t70 -97.6 -46.39 6.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.085 0.469 . . . . 0.0 110.613 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.658 ' C ' HD12 ' A' ' 60' ' ' LEU . 38.2 tp10 -83.72 -32.54 25.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.101 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.707 HD11 ' C ' ' A' ' 6' ' ' LYS . 3.6 mp -119.72 59.92 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.905 0.383 . . . . 0.0 110.929 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.21 -8.07 64.65 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.708 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -83.91 -28.31 27.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.674 0.273 . . . . 0.0 111.448 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.654 HG13 ' HD3' ' A' ' 66' ' ' LYS . 7.3 t -78.01 -45.28 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.869 0.366 . . . . 0.0 110.544 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.22 -24.92 45.33 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -90.45 -40.2 12.16 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.299 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.654 ' HD3' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -57.86 -48.92 78.4 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.892 0.377 . . . . 0.0 110.458 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.6 m-80 -78.14 -3.79 44.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.963 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 66.55 40.42 3.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.225 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.876 HG13 HG21 ' A' ' 74' ' ' THR . 58.0 t -83.45 -77.39 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 120.761 0.315 . . . . 0.0 110.869 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.7 p 47.91 25.45 0.76 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.756 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.9 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -98.91 -159.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.732 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -172.74 90.4 0.4 Allowed Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.798 ' HG3' HD11 ' A' ' 36' ' ' ILE . 22.5 Cg_endo -91.99 -160.41 1.07 Allowed 'Cis proline' 0 C--N 1.349 0.577 0 C-N-CA 124.625 -0.99 . . . . 0.0 112.42 -0.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.9 ' OG1' ' HB3' ' A' ' 71' ' ' ALA . 98.5 m -156.31 155.49 32.35 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.849 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 95' ' ' ILE . 72.6 mt -120.22 121.38 38.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.935 0.398 . . . . 0.0 111.288 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.062 HD12 ' CE1' ' A' ' 25' ' ' PHE . 20.1 mt -118.99 128.57 54.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.875 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.882 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.3 mp -109.7 138.31 46.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.723 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.562 ' HA ' HG23 ' A' ' 84' ' ' VAL . 73.7 m-85 -137.51 126.91 24.87 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.542 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.468 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 59.5 mttm -109.84 128.71 55.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.728 0.299 . . . . 0.0 111.275 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 6.0 m120 44.27 58.04 3.98 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 61.64 13.55 39.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.372 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 30.8 mmmt -111.71 -156.81 0.6 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.486 ' OE2' ' CE1' ' A' ' 78' ' ' PHE . 10.9 tp10 -108.78 173.82 6.15 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.562 HG23 ' HA ' ' A' ' 78' ' ' PHE . 56.8 t -146.64 -62.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.748 0.309 . . . . 0.0 111.317 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.13 159.26 7.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.357 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -122.29 115.44 22.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.611 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.57 80.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.473 HG21 ' CB ' ' A' ' 71' ' ' ALA . 2.7 p -57.18 95.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.017 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.6 114.27 1.27 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.611 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.677 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -98.66 33.85 2.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 110.908 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -62.07 108.58 1.67 Allowed Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.968 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 17.8 Cg_exo -31.91 88.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.229 2.62 . . . . 0.0 113.216 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 176.17 -35.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.85 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.62 -43.33 2.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.577 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.977 HD13 HD13 ' A' ' 75' ' ' LEU . 4.6 tp -53.26 -15.53 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.704 -0.226 . . . . 0.0 111.277 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.437 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 64.5 pttt -91.2 -49.25 6.48 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.78 0.324 . . . . 0.0 110.642 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.437 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 72.7 mt-30 -71.85 -32.15 67.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.366 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.24 -31.53 71.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.441 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.798 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 56.5 mt -90.08 -6.57 10.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.305 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.38 -65.29 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.921 0.391 . . . . 0.0 111.036 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.82 -29.78 8.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.944 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.816 ' CB ' HD22 ' A' ' 20' ' ' LEU . 67.5 m-20 -90.07 -67.79 0.82 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.948 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.798 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.126 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.43 ' CG1' ' HD2' ' A' ' 54' ' ' LYS . 44.1 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.775 0.321 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.477 HG22 ' N ' ' A' ' 4' ' ' GLN . 87.5 m -149.95 164.84 34.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.864 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.527 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -105.61 -177.35 3.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.339 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.481 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.9 m-85 -130.33 131.43 45.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.984 0.421 . . . . 0.0 111.483 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.706 ' C ' HD11 ' A' ' 60' ' ' LEU . 34.5 mmtp -114.49 -19.74 11.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.774 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -141.23 136.96 32.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.466 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.07 -28.42 17.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.242 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.9 m -59.32 -19.83 49.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.244 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.452 ' HG3' ' CE1' ' A' ' 5' ' ' PHE . 17.6 tp10 -90.49 -37.93 13.57 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.334 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.942 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -90.2 15.83 9.64 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.06 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -89.79 -45.98 8.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.875 0.369 . . . . 0.0 110.662 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -79.6 -23.36 42.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.97 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.535 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -54.83 -50.48 68.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.205 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.7 pt -83.12 -50.02 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.334 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.457 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -40.06 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 79.9 mt-30 39.19 85.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.662 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 9.1 t70 -162.49 40.52 0.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.668 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.55 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 10.9 mptt 67.2 -156.52 0.22 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.458 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.787 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 64.3 tp -98.18 116.42 30.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.203 0.525 . . . . 0.0 110.977 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.801 HG22 ' HB2' ' A' ' 51' ' ' ASP . 54.9 t -103.12 134.69 43.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.748 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.516 HG21 ' CD1' ' A' ' 99' ' ' ILE . 49.2 t -99.7 92.32 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.65 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.942 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 48.0 t -99.83 124.34 53.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.044 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 8.1 t70 -99.98 129.17 46.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.921 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.052 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.7 m-85 -98.99 48.57 0.96 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.185 0.516 . . . . 0.0 110.348 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.547 ' HD1' ' O ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -50.14 134.55 22.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.139 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.507 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -60.72 153.04 25.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.196 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.428 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 3.3 t -76.89 2.25 15.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.514 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.452 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 5.4 p-90 -127.35 -125.3 0.23 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.746 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 48.8 t 62.49 -77.58 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.931 0.492 . . . . 0.0 111.421 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.11 -80.18 0.27 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.979 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.26 51.0 3.33 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.744 2.296 . . . . 0.0 112.523 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 99.5 m -112.5 -28.25 7.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.734 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -79.94 -15.9 56.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.495 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 66.1 mtt -74.7 4.16 6.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.764 0.316 . . . . 0.0 111.102 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.007 HG22 HG13 ' A' ' 40' ' ' ILE . 52.7 mt -83.53 -26.27 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.534 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.513 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -45.67 -45.39 34.74 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 44.1 Cg_endo -73.1 -36.36 4.36 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.773 1.649 . . . . 0.0 111.268 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 49.6 ttm -65.24 -53.11 49.21 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.007 HG13 HG22 ' A' ' 36' ' ' ILE . 79.0 mt -46.91 -30.44 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.593 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -76.79 -37.01 56.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.938 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.97 -22.74 62.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.367 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -90.1 -16.48 29.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.488 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.4 t -74.84 -6.88 51.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.236 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.404 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 44.7 tt0 -90.12 -27.94 19.3 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.785 0.326 . . . . 0.0 111.052 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -90.47 -28.33 18.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.723 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.848 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 76.0 m-85 -123.14 43.93 0.85 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.698 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 98.5 Cg_exo -39.76 -31.62 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.977 2.451 . . . . 0.0 113.098 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -62.26 -37.82 86.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.941 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.787 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.88 147.75 23.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.172 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.801 ' HB2' HG22 ' A' ' 21' ' ' VAL . 28.9 m-20 -89.84 153.67 20.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.54 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.487 ' CE2' HD13 ' A' ' 99' ' ' ILE . 6.0 m-85 -128.55 93.88 3.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.025 0.44 . . . . 0.0 111.479 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.481 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 49.6 m-85 -107.44 178.59 4.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.596 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HB2' ' HA ' ' A' ' 4' ' ' GLN . 16.5 mtpp -139.09 146.92 41.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.51 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.9 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.8 tm? -108.19 140.9 40.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.072 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.9 ' N ' HD13 ' A' ' 55' ' ' LEU . 27.8 t70 -95.43 116.04 28.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.55 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 57' ' ' VAL . 60.6 t -76.88 -1.85 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.649 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 8.1 t70 -103.5 -43.57 5.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.024 0.44 . . . . 0.0 110.575 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.492 ' C ' HD12 ' A' ' 60' ' ' LEU . 38.5 tp10 -86.12 -39.69 16.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.022 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.706 HD11 ' C ' ' A' ' 6' ' ' LYS . 4.8 mp -111.4 44.01 1.4 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.849 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.15 -28.02 53.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.379 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.51 -29.1 70.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.739 0.304 . . . . 0.0 111.158 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.705 HG12 ' HE2' ' A' ' 25' ' ' PHE . 6.8 t -79.3 -45.42 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.438 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.36 -22.85 55.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.409 . . . . 0.0 110.058 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -90.16 -38.13 13.71 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.205 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.705 ' HE3' HG13 ' A' ' 63' ' ' VAL . 15.6 pttp -60.89 -47.1 87.93 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.972 0.415 . . . . 0.0 110.084 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.401 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.6 m-20 -77.93 -4.44 46.89 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.917 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 66.94 39.51 3.27 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.034 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.709 ' CG1' HG21 ' A' ' 74' ' ' THR . 45.3 t -110.18 107.71 23.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.756 0.313 . . . . 0.0 110.97 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.5 t -121.87 -1.82 9.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.779 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.645 ' CB ' HG21 ' A' ' 88' ' ' VAL . . . -61.01 -157.75 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.575 ' O ' ' HG2' ' A' ' 72' ' ' MET . 0.0 OUTLIER -175.26 100.92 0.26 Allowed Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.79 ' HG3' HD11 ' A' ' 36' ' ' ILE . 32.6 Cg_endo -88.54 -162.06 1.92 Allowed 'Cis proline' 0 C--N 1.353 0.795 0 C-N-CA 124.701 -0.958 . . . . 0.0 112.669 -0.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.777 ' OG1' HG23 ' A' ' 88' ' ' VAL . 42.8 m -158.58 146.86 18.41 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.098 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.029 HD13 HD13 ' A' ' 95' ' ' ILE . 84.3 mt -113.97 123.04 48.75 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.804 0.335 . . . . 0.0 111.701 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.052 HD12 ' CE1' ' A' ' 25' ' ' PHE . 18.2 mt -116.94 129.87 56.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.493 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.704 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.9 mp -109.78 142.01 41.62 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.719 0.295 . . . . 0.0 111.017 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.578 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 63.8 m-85 -143.71 126.58 16.26 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.274 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.825 ' HG3' HG11 ' A' ' 84' ' ' VAL . 41.6 mtmt -118.91 136.76 53.89 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.379 178.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 78.3 m-20 50.81 60.92 3.52 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.569 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 50.04 26.19 8.5 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.849 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.578 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 98.9 mttt -132.34 -159.55 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.69 ' O ' HG13 ' A' ' 84' ' ' VAL . 28.7 tt0 -109.05 -179.75 3.94 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.825 HG11 ' HG3' ' A' ' 79' ' ' LYS . 12.2 m -163.75 -49.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.588 0.232 . . . . 0.0 111.217 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.462 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -165.14 156.54 14.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.054 0.454 . . . . 0.0 111.726 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -138.81 113.63 9.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.33 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.63 91.1 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.075 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.777 HG23 ' OG1' ' A' ' 74' ' ' THR . 7.2 p -61.66 83.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.983 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.7 113.17 0.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.236 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.646 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -95.36 37.76 1.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.355 . . . . 0.0 111.387 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 93' ' ' ALA . 5.5 m120 -73.69 131.88 81.51 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.325 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 98.7 Cg_exo -46.7 86.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.674 2.249 . . . . 0.0 112.665 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 92' ' ' PRO . . . 174.35 -35.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.425 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.39 -46.55 2.87 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.781 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.029 HD13 HD13 ' A' ' 75' ' ' LEU . 4.9 tp -53.45 -14.8 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.526 0.203 . . . . 0.0 111.278 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.415 ' HG3' ' HG3' ' A' ' 97' ' ' GLN . 21.3 ptmt -91.03 -49.52 6.37 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.883 0.373 . . . . 0.0 110.864 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.415 ' HG3' ' HG3' ' A' ' 96' ' ' LYS . 73.0 mt-30 -73.13 -32.38 64.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.447 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.454 ' HB1' HD21 ' A' ' 77' ' ' LEU . . . -61.33 -30.27 70.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.681 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.516 ' CD1' HG21 ' A' ' 22' ' ' VAL . 67.6 mt -90.19 -14.91 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.25 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.848 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.38 -70.51 0.67 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.84 0.352 . . . . 0.0 111.182 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.69 -28.69 6.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.272 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.572 ' HB3' HD22 ' A' ' 20' ' ' LEU . 5.7 m120 -83.18 -48.3 10.67 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.061 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.121 -179.953 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.851 HG12 ' HE2' ' A' ' 54' ' ' LYS . 47.4 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.838 0.351 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.8 m -147.89 154.49 40.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.03 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.565 ' HG2' ' HE3' ' A' ' 54' ' ' LYS . 16.2 mt-30 -93.74 177.25 6.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.624 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.525 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 14.4 m-85 -127.98 136.17 50.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.0 111.241 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 34.4 mmtp -115.95 -46.34 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.513 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.1 p -114.81 134.11 55.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.534 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.09 -24.68 18.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.431 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.2 m -62.37 -16.58 55.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.556 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -90.21 -58.01 2.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.347 0.594 . . . . 0.0 111.076 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.913 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -61.28 -31.47 71.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.667 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -55.54 -23.32 25.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.1 t -80.37 -45.99 16.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.191 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.96 -46.52 68.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.29 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.853 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 24.1 pt -78.16 -4.63 6.88 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.833 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.901 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.18 81.82 6.1 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.682 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 74.9 mt-30 48.14 91.76 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 63.9 t0 -168.91 39.62 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.533 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 88.0 mttt 76.12 -156.83 0.04 OUTLIER 'General case' 0 C--O 1.23 0.065 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.564 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.895 HD11 ' HB3' ' A' ' 77' ' ' LEU . 59.7 tp -98.07 116.95 31.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.216 0.531 . . . . 0.0 110.79 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.767 HG22 ' HB2' ' A' ' 51' ' ' ASP . 60.6 t -102.89 124.22 56.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.801 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.646 HG21 ' CD1' ' A' ' 99' ' ' ILE . 46.0 t -99.79 97.88 6.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.665 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.913 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 40.2 t -105.12 131.04 55.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.424 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 7.8 t70 -99.87 130.67 46.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.453 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.056 ' CE1' HD12 ' A' ' 76' ' ' LEU . 6.3 m-85 -99.06 49.48 0.95 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.975 0.417 . . . . 0.0 110.69 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.586 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -51.05 140.74 15.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.067 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.775 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -62.27 157.35 19.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.754 0.311 . . . . 0.0 110.505 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.545 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 5.0 t -83.58 4.12 29.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.406 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.449 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 18.2 p-90 -124.64 -46.6 1.87 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.431 ' HB2' ' HG3' ' A' ' 72' ' ' MET . 22.3 t -43.96 127.97 5.5 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 111.414 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . -76.41 -64.14 2.23 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.98 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -41.5 -28.26 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.389 2.726 . . . . 0.0 113.176 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.9 m -61.5 -14.57 30.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.429 ' C ' ' HD2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -78.8 -25.85 44.29 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.163 -179.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.458 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 66.0 mtm -75.39 1.52 13.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 110.301 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.856 HG22 HG13 ' A' ' 40' ' ' ILE . 28.1 mm -79.2 -44.37 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.873 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.499 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -41.7 -47.16 9.61 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.04 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 45.6 Cg_endo -73.91 -27.77 11.91 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.79 1.66 . . . . 0.0 111.233 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.406 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 14.2 tpt -74.16 -50.02 21.16 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.856 HG13 HG22 ' A' ' 36' ' ' ILE . 63.8 mt -50.96 -32.72 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.389 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -72.37 -39.56 67.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.113 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.465 ' NZ ' ' HB3' ' A' ' 42' ' ' LYS . 9.6 mtpm? -57.88 -23.94 55.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.712 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.75 ' CE2' HG23 ' A' ' 95' ' ' ILE . 6.0 m-85 -90.43 -16.88 28.18 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.1 t -72.95 -7.66 52.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.523 0.201 . . . . 0.0 111.456 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -90.15 -26.53 20.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.757 0.313 . . . . 0.0 111.081 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.07 -30.07 17.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.531 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.581 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 79.6 m-85 -125.44 51.86 5.97 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.088 0.47 . . . . 0.0 110.745 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 1.4 Cg_endo -46.79 -26.5 4.68 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.085 2.523 . . . . 0.0 112.987 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.444 ' O ' ' HD3' ' A' ' 19' ' ' LYS . 73.8 mt-30 -69.04 -29.24 67.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.122 0.487 . . . . 0.0 110.394 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.58 139.06 30.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.781 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.767 ' HB2' HG22 ' A' ' 21' ' ' VAL . 28.2 m-20 -89.56 121.69 32.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.268 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.518 ' CE2' HD13 ' A' ' 99' ' ' ILE . 6.2 m-85 -99.02 81.77 2.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.596 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.654 ' HB2' HG22 ' A' ' 23' ' ' VAL . 47.4 m-85 -94.47 -175.12 3.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.357 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.851 ' HE2' HG12 ' A' ' 2' ' ' VAL . 47.0 mtmt -148.47 138.2 22.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.994 0.426 . . . . 0.0 110.75 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.926 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.2 tm? -98.35 141.95 30.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.325 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.926 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.9 t70 -92.74 125.09 37.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.949 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 57' ' ' VAL . 92.1 t -93.14 42.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.436 0.636 . . . . 0.0 110.621 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.545 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 64.5 t0 -152.97 -48.78 0.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.035 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 6' ' ' LYS . 5.3 tp10 -75.56 -27.35 58.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.171 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.578 HD22 ' N ' ' A' ' 60' ' ' LEU . 2.5 mm? -103.16 -64.43 1.08 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.376 0.608 . . . . 0.0 111.007 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.5 -61.25 0.64 Allowed Glycine 0 C--N 1.314 -0.658 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.644 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -51.17 -36.79 42.85 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.788 HG12 ' HE2' ' A' ' 25' ' ' PHE . 6.6 t -70.51 -58.25 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 110.589 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.49 -24.84 8.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.002 0.43 . . . . 0.0 110.074 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -90.14 -37.49 14.17 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.259 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.785 ' HE3' HG13 ' A' ' 63' ' ' VAL . 17.4 pttp -60.71 -48.77 80.28 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.1 m-20 -76.71 -7.72 55.88 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.676 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 66.09 43.53 2.88 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.24 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.479 ' CG1' HG21 ' A' ' 74' ' ' THR . 49.0 t -107.37 74.6 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.885 0.374 . . . . 0.0 111.011 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.9 p -83.38 -11.32 57.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.996 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.512 ' CB ' HG21 ' A' ' 88' ' ' VAL . . . -58.14 -163.73 0.0 OUTLIER 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.728 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.775 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -178.1 106.64 0.21 Allowed Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 42.8 Cg_endo -89.72 -165.35 2.64 Favored 'Cis proline' 0 C--N 1.351 0.687 0 C-N-CA 124.485 -1.048 . . . . 0.0 112.612 -0.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 91.7 m -152.59 163.24 39.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.811 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.984 HD13 HD13 ' A' ' 95' ' ' ILE . 80.9 mt -128.02 120.73 28.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.098 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.056 HD12 ' CE1' ' A' ' 25' ' ' PHE . 21.8 mt -118.93 124.11 46.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.758 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.895 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.3 mp -109.82 135.4 50.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.692 ' HA ' HG23 ' A' ' 84' ' ' VAL . 42.4 m-85 -136.05 129.05 31.37 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.602 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.666 ' HG3' HD13 ' A' ' 20' ' ' LEU . 9.2 mtpm? -114.65 124.04 50.83 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.99 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 6.4 m120 43.9 82.46 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.652 0.263 . . . . 0.0 111.213 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.853 ' HA2' ' O ' ' A' ' 15' ' ' ILE . . . 33.83 46.77 0.45 Allowed Glycine 0 C--N 1.333 0.38 0 CA-C-N 116.024 -0.535 . . . . 0.0 114.202 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 34.5 mmtp -146.97 -158.73 0.94 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 34.0 tt0 -108.69 174.01 6.06 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.692 HG23 ' HA ' ' A' ' 78' ' ' PHE . 59.2 t -145.08 -69.08 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 0.0 111.107 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.25 155.32 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.377 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -112.65 138.26 49.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.069 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -154.6 78.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.141 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 2.5 p -58.73 90.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.093 0.473 . . . . 0.0 110.611 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 136.35 124.3 2.35 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.08 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.741 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -87.85 47.37 1.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.871 0.367 . . . . 0.0 111.468 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -53.35 110.02 1.8 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.427 ' HD2' HD22 ' A' ' 91' ' ' ASN . 18.8 Cg_exo -33.2 -31.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.167 2.578 . . . . 0.0 113.64 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -95.49 30.49 2.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.445 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -152.34 -60.13 0.15 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.984 HD13 HD13 ' A' ' 75' ' ' LEU . 4.3 tp -51.91 -11.97 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.338 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.446 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 64.8 pttt -91.13 -51.09 5.49 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.843 0.354 . . . . 0.0 110.669 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.446 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 9.7 mm-40 -69.52 -32.02 70.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.51 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.78 -32.15 73.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.613 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.646 ' CD1' HG21 ' A' ' 22' ' ' VAL . 50.5 mt -90.14 -7.92 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.488 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.581 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.09 -68.62 0.77 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.924 0.393 . . . . 0.0 111.259 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.67 -29.14 51.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.132 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.552 ' CB ' HD22 ' A' ' 20' ' ' LEU . 3.9 m120 -80.39 -52.5 7.6 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.037 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.071 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.533 HG11 ' CG2' ' A' ' 40' ' ' ILE . 55.0 t . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.763 0.316 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 4' ' ' GLN . 90.1 m -150.2 162.1 41.13 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.173 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.581 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -100.28 -177.68 3.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 179.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.511 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 23.8 m-85 -124.79 150.59 46.17 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.03 0.443 . . . . 0.0 111.671 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.687 ' C ' HD11 ' A' ' 60' ' ' LEU . 72.7 mmtt -128.52 -37.21 1.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.974 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 m -116.65 164.0 15.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 12' ' ' ASP . . . -76.13 -27.85 57.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.993 0.425 . . . . 0.0 110.933 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.2 m -64.13 -12.58 41.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.969 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -89.98 -69.35 0.73 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.226 0.536 . . . . 0.0 111.401 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.965 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -56.9 -25.88 57.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.085 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 64.2 t0 -56.38 -42.71 78.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.23 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -82.06 -24.81 35.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.321 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.679 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -56.83 -46.09 81.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.476 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.8 pt -80.21 -49.59 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.46 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.466 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -43.55 98.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 45.58 90.49 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.223 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -171.42 39.5 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.267 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.554 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 2.7 mptp? 63.54 -154.98 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.233 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.788 HD11 ' HB3' ' A' ' 77' ' ' LEU . 43.7 tp -98.05 115.99 29.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.135 0.493 . . . . 0.0 110.848 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.816 HG22 ' HB2' ' A' ' 51' ' ' ASP . 48.2 t -103.08 134.34 44.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.983 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.441 ' CG2' HG13 ' A' ' 99' ' ' ILE . 46.3 t -99.78 92.61 2.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.479 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.965 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 38.5 t -99.91 125.29 53.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.081 0.467 . . . . 0.0 111.334 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 74' ' ' THR . 38.5 t70 -99.91 130.53 46.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.916 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.057 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.7 m-85 -98.96 49.45 0.96 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.096 0.474 . . . . 0.0 110.208 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.71 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -50.68 139.8 15.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.786 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.72 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -60.59 142.12 55.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.525 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.491 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 5.8 t -69.05 -11.53 60.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.565 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.469 ' CH2' ' HG2' ' A' ' 72' ' ' MET . 21.5 p-90 -109.55 -45.3 3.71 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 24.6 t -42.38 139.54 1.45 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.657 0.265 . . . . 0.0 111.264 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.11 -57.19 1.72 Allowed Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.82 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -46.16 -27.67 4.77 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.7 2.266 . . . . 0.0 112.754 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.443 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 84.8 m -65.68 -21.1 66.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.54 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -73.45 -29.6 62.65 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -78.86 5.96 10.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.041 0.448 . . . . 0.0 110.989 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.73 HG22 HG13 ' A' ' 40' ' ' ILE . 69.9 mt -83.29 -27.44 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.119 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.542 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -49.18 -45.79 75.85 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 47.6 Cg_endo -72.04 -37.51 4.76 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 121.699 1.599 . . . . 0.0 111.134 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 58.3 ttp -62.34 -53.1 59.9 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.73 HG13 HG22 ' A' ' 36' ' ' ILE . 58.6 mt -47.61 -29.35 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.638 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.533 ' HA ' HG21 ' A' ' 2' ' ' VAL . 87.8 tt0 -78.49 -35.79 46.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.767 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 38' ' ' PRO . 72.7 mmtt -60.76 -21.97 63.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.433 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -90.12 -20.29 23.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.664 0.268 . . . . 0.0 111.632 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.4 p -74.15 -6.59 48.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.1 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.406 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 4.4 mm-40 -90.11 -29.44 18.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.82 0.343 . . . . 0.0 110.921 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.5 -29.73 17.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.676 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.54 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 71.2 m-85 -122.93 43.66 0.79 Allowed Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.654 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 93.7 Cg_exo -39.26 -31.51 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.993 2.462 . . . . 0.0 113.252 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.71 -38.13 84.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.903 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.715 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -90.04 146.52 24.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.951 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.816 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.87 148.7 23.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.72 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.49 ' O ' HG13 ' A' ' 2' ' ' VAL . 5.6 m-85 -125.27 98.35 5.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.243 0.544 . . . . 0.0 111.058 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.511 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 52.3 m-85 -113.84 -176.29 2.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.879 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.71 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 29.5 mttp -134.9 165.3 25.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.203 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.577 HD22 HD22 ' A' ' 60' ' ' LEU . 2.1 tm? -130.93 117.19 18.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.465 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.487 ' N ' HD13 ' A' ' 55' ' ' LEU . 59.3 t0 -70.26 117.59 12.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.898 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 26' ' ' TYR . 29.6 t -72.51 -8.34 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.852 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.491 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 31.9 t70 -100.97 -59.57 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.975 0.416 . . . . 0.0 110.606 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.681 ' C ' HD12 ' A' ' 60' ' ' LEU . 36.7 tp10 -66.48 -33.61 76.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.862 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.687 HD11 ' C ' ' A' ' 6' ' ' LYS . 4.3 mp -120.47 40.37 3.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.951 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.52 -20.81 32.24 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.415 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.65 -42.1 99.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.693 0.282 . . . . 0.0 111.475 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.599 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 4.4 t -69.59 -46.97 74.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.946 0.403 . . . . 0.0 110.546 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 69' ' ' VAL . . . -53.62 -25.87 19.61 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.57 -41.66 11.24 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.451 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 12.9 ptmm? -55.92 -48.81 75.01 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.853 0.359 . . . . 0.0 110.695 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.415 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.4 m-20 -80.32 0.96 30.66 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.196 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 65.06 38.8 5.98 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.895 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.727 HG13 HG21 ' A' ' 74' ' ' THR . 47.5 t -107.92 93.48 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.883 0.373 . . . . 0.0 111.024 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.2 p -112.94 21.47 15.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.609 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -77.83 -154.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.583 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.72 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -171.46 87.12 0.47 Allowed Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.653 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 3.4 Cg_endo -96.35 -156.3 0.4 Allowed 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 124.888 -0.88 . . . . 0.0 112.663 0.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.859 HG23 ' HB ' ' A' ' 88' ' ' VAL . 87.7 m -154.19 148.05 25.51 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.467 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.056 HD13 HD13 ' A' ' 95' ' ' ILE . 83.3 mt -110.02 122.18 46.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.941 0.4 . . . . 0.0 111.62 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.057 HD12 ' CE1' ' A' ' 25' ' ' PHE . 23.5 mt -116.99 129.19 55.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.525 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.788 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.4 mp -109.75 135.25 50.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.02 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.532 ' HA ' HG23 ' A' ' 84' ' ' VAL . 57.2 m-85 -136.22 124.14 22.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.991 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.686 ' HG3' HG21 ' A' ' 84' ' ' VAL . 26.0 mtpp -112.12 126.93 55.71 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.405 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.494 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.3 m120 50.3 64.58 1.74 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.846 0.355 . . . . 0.0 111.635 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 50.44 24.99 7.95 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 116.185 -0.461 . . . . 0.0 113.319 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 61.5 mttp -128.94 -157.0 0.79 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 33.9 tt0 -108.74 174.64 5.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.686 HG21 ' HG3' ' A' ' 79' ' ' LYS . 1.7 t -151.09 -55.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.973 0.416 . . . . 0.0 110.687 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.13 -164.24 0.4 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.848 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.495 ' HD3' ' N ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -164.4 125.83 2.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.027 0.441 . . . . 0.0 110.826 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.494 HG11 ' HB1' ' A' ' 94' ' ' ALA . 49.0 t -132.21 80.36 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.924 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.859 ' HB ' HG23 ' A' ' 74' ' ' THR . 7.2 p -72.54 99.17 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.02 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.74 -23.1 0.33 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.213 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.668 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . 51.2 40.4 25.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.869 0.366 . . . . 0.0 111.101 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.593 ' O ' HG22 ' A' ' 95' ' ' ILE . 75.1 m-20 -59.5 134.26 88.76 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.916 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -47.67 -25.36 5.53 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.636 2.224 . . . . 0.0 112.733 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.75 26.45 10.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.625 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -137.5 -57.32 0.69 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.362 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.056 HD13 HD13 ' A' ' 75' ' ' LEU . 3.2 tp -54.81 -11.48 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.715 0.293 . . . . 0.0 110.867 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -92.0 -59.49 2.09 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.055 0.455 . . . . 0.0 110.801 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -63.32 -33.32 75.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.101 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.44 -31.06 65.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.115 0.483 . . . . 0.0 110.664 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.88 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.4 mp -90.18 -8.29 10.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.542 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.57 -71.78 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.789 0.328 . . . . 0.0 111.34 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.2 -30.04 48.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.334 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.639 ' CB ' HD22 ' A' ' 20' ' ' LEU . 3.0 m120 -77.37 -50.02 13.67 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.986 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.577 ' HB2' HD23 ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.167 -0.921 . . . . 0.0 111.131 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 52' ' ' PHE . 14.0 p . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.683 0.278 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.449 HG22 ' N ' ' A' ' 4' ' ' GLN . 92.2 m -150.04 161.72 41.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.028 0.442 . . . . 0.0 111.702 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.672 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 51.0 mt-30 -96.19 178.7 5.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.135 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.477 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 17.3 m-85 -124.66 127.58 47.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.925 0.393 . . . . 0.0 111.133 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.749 ' C ' HD11 ' A' ' 60' ' ' LEU . 34.5 mmtp -107.92 -26.7 10.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.691 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.8 p -134.05 129.25 35.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.35 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.28 -26.02 6.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.57 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -61.62 -16.76 51.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.56 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -90.4 -41.72 11.32 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.107 0.48 . . . . 0.0 111.281 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.751 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -78.38 -27.63 46.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.055 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -51.9 -57.47 9.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.391 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 t -71.32 -23.06 61.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.499 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.651 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -56.56 -44.19 80.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.474 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.1 pt -81.08 -49.93 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.483 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -45.58 101.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 44.78 89.08 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.223 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -171.72 40.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.313 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.538 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 3.1 mppt? 62.45 -156.67 0.34 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.25 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.827 HD11 ' HB3' ' A' ' 77' ' ' LEU . 54.7 tp -98.06 116.51 30.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.089 0.471 . . . . 0.0 110.863 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 51' ' ' ASP . 45.2 t -99.96 134.78 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.638 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.614 HG21 HD13 ' A' ' 99' ' ' ILE . 40.5 t -99.82 84.24 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.951 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.799 HG22 ' HB2' ' A' ' 53' ' ' TYR . 38.8 t -101.11 120.17 50.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.098 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.532 ' CG ' HD23 ' A' ' 75' ' ' LEU . 2.9 m-20 -99.31 137.91 37.15 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.009 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.045 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.8 m-85 -99.35 53.21 0.95 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.646 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.575 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -52.64 137.38 30.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.439 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 72' ' ' MET . . . -66.1 134.82 53.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.549 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.441 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.6 t -57.59 -17.77 16.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.334 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.444 ' CZ3' ' SD ' ' A' ' 72' ' ' MET . 6.4 p-90 -109.12 -125.98 0.26 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 40.0 t 61.58 -82.24 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 122.448 0.299 . . . . 0.0 110.951 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.45 -77.77 0.29 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.067 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.03 -18.69 51.97 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.916 2.41 . . . . 0.0 112.98 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 95.0 m -52.88 -26.14 13.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.666 0.269 . . . . 0.0 111.711 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -79.47 -24.75 42.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.667 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 89.6 mmm -72.55 -2.22 18.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.729 0.299 . . . . 0.0 111.099 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.766 HG22 HG13 ' A' ' 40' ' ' ILE . 44.0 mt -85.58 -22.88 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.822 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.528 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -51.7 -44.73 91.07 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 47.2 Cg_endo -72.82 -34.42 6.8 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 121.802 1.668 . . . . 0.0 111.322 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.7 ttt -65.9 -52.21 51.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.766 HG13 HG22 ' A' ' 36' ' ' ILE . 75.9 mt -48.77 -29.34 2.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.581 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.531 ' HB2' HG11 ' A' ' 2' ' ' VAL . 37.7 tt0 -76.9 -32.71 57.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.062 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -66.73 -19.61 65.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.72 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -90.18 -26.65 20.03 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.406 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 53.9 m -59.87 -16.14 26.76 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.16 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.473 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 56.2 mt-10 -86.19 -20.32 28.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.821 0.344 . . . . 0.0 110.853 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -90.54 -37.29 13.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.552 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.586 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 72.4 m-85 -122.45 41.24 0.51 Allowed Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.723 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 75.5 Cg_exo -34.94 -33.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.5 2.8 . . . . 0.0 113.704 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -57.26 -36.8 71.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.035 0.445 . . . . 0.0 110.594 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.8 143.01 27.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.561 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.567 ' O ' HG13 ' A' ' 21' ' ' VAL . 29.9 m-20 -89.68 121.86 32.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.911 0.386 . . . . 0.0 110.694 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.662 ' O ' HG23 ' A' ' 2' ' ' VAL . 5.5 m-85 -95.21 85.79 4.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.594 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.799 ' HB2' HG22 ' A' ' 23' ' ' VAL . 34.7 m-85 -97.82 -176.87 3.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.27 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.672 ' HE2' ' HG2' ' A' ' 4' ' ' GLN . 35.1 mtmm -150.03 136.17 18.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.052 0.453 . . . . 0.0 110.982 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.4 tm? -93.04 139.94 30.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.963 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.876 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.2 t0 -95.27 112.57 24.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.856 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 53.5 t -73.2 -7.38 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.423 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.441 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 9.2 t70 -97.6 -59.84 1.69 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.972 0.415 . . . . 0.0 110.521 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.671 ' C ' HD12 ' A' ' 60' ' ' LEU . 16.9 tp10 -67.55 -32.92 74.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.882 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.749 HD11 ' C ' ' A' ' 6' ' ' LYS . 4.7 mp -120.03 58.3 0.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.928 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.35 -15.26 58.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.647 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.92 -27.05 43.7 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.68 0.276 . . . . 0.0 111.452 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.813 HG12 ' HE2' ' A' ' 25' ' ' PHE . 11.7 t -77.59 -51.49 18.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.477 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.44 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -57.21 -23.22 46.39 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.18 -37.98 13.79 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.229 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.709 ' HE3' HG13 ' A' ' 63' ' ' VAL . 17.2 pttp -59.88 -48.52 81.35 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.918 0.389 . . . . 0.0 110.131 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.413 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.0 m-20 -77.86 -6.33 53.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.871 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 66.38 42.51 2.94 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.117 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.513 ' CG1' HG21 ' A' ' 74' ' ' THR . 48.5 t -110.44 78.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.81 0.338 . . . . 0.0 111.196 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 81.4 p -90.53 10.26 26.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.096 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.645 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -61.46 -156.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.747 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.449 ' O ' ' HG3' ' A' ' 72' ' ' MET . 9.5 ptt? -176.68 86.93 0.26 Allowed Pre-proline 0 CA--C 1.53 0.185 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.613 ' HG3' HD12 ' A' ' 36' ' ' ILE . 43.0 Cg_endo -98.06 -159.58 0.46 Allowed 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 125.131 -0.779 . . . . 0.0 112.467 -0.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.645 ' OG1' ' HB3' ' A' ' 71' ' ' ALA . 83.6 m -149.9 161.22 42.71 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.825 0.345 . . . . 0.0 111.269 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.669 ' CD1' HD13 ' A' ' 95' ' ' ILE . 37.3 mt -122.1 124.1 43.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.305 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.045 HD12 ' CE1' ' A' ' 25' ' ' PHE . 22.2 mt -123.64 125.5 44.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.761 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.827 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.6 mp -109.75 136.36 49.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.635 ' HA ' HG23 ' A' ' 84' ' ' VAL . 53.2 m-85 -137.13 125.11 22.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.054 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.583 ' HG3' HD13 ' A' ' 20' ' ' LEU . 54.1 mtpt -112.43 131.21 55.68 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.514 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.4 m120 48.94 54.85 10.16 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.883 0.373 . . . . 0.0 111.719 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 58.4 17.56 32.93 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 121.276 -0.488 . . . . 0.0 113.02 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 31.0 mmmt -115.62 -153.76 0.53 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 88.1 tt0 -108.79 172.72 6.68 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 78' ' ' PHE . 44.8 t -146.45 -64.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.756 0.312 . . . . 0.0 111.276 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.08 150.08 3.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.299 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -119.3 120.25 36.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.611 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 48.6 t -145.49 94.87 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.277 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.63 HG21 ' CB ' ' A' ' 71' ' ' ALA . 4.3 p -64.56 102.33 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.735 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.99 103.07 0.54 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.42 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.615 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -96.31 36.99 1.28 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.953 0.406 . . . . 0.0 111.273 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 93' ' ' ALA . 21.2 p30 -80.06 141.52 54.52 Favored Pre-proline 0 N--CA 1.44 -0.94 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.532 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -46.95 87.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.624 2.216 . . . . 0.0 112.669 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -179.54 -38.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.407 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.69 -40.8 2.04 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.669 HD13 ' CD1' ' A' ' 75' ' ' LEU . 4.5 tp -50.51 -18.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.642 0.258 . . . . 0.0 111.441 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 18.0 ptpt -91.21 -50.18 5.97 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.894 0.378 . . . . 0.0 111.15 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.409 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 26.1 mt-30 -71.02 -31.73 68.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.464 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.82 -32.39 73.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.786 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.687 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 58.1 mt -90.1 -7.75 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.455 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.47 -74.26 0.5 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.973 0.416 . . . . 0.0 111.383 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -50.07 -30.44 10.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.53 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.686 ' HB3' HD22 ' A' ' 20' ' ' LEU . 3.9 m120 -82.38 -48.58 10.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.11 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.714 ' HB2' HD23 ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.041 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.83 HG22 HG22 ' A' ' 40' ' ' ILE . 57.5 t . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.981 0.419 . . . . 0.0 111.303 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.0 m -150.16 147.39 27.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.915 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.517 ' HG2' ' HE3' ' A' ' 54' ' ' LYS . 63.2 mt-30 -89.95 164.76 14.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.329 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.592 ' O ' HD13 ' A' ' 60' ' ' LEU . 18.2 m-85 -117.53 123.3 45.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.926 0.393 . . . . 0.0 111.448 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.679 ' C ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -103.79 -33.06 9.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.145 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.9 p -127.09 131.13 50.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.398 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.02 -24.45 9.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.657 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.1 m -61.67 -17.02 53.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.662 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.27 -39.08 12.98 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.105 0.478 . . . . 0.0 111.224 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.899 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -82.17 -30.95 30.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.911 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -55.55 -37.81 68.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.248 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.4 m -90.04 -0.13 57.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.64 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.671 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -82.6 -44.61 15.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.689 0.28 . . . . 0.0 111.39 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.2 pt -79.56 -49.67 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.551 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -41.93 97.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 85.0 mt-30 45.77 88.52 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.219 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 9.1 t70 -170.37 41.07 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.126 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 91.6 mttt 66.17 -155.49 0.25 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.699 0.285 . . . . 0.0 110.404 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.882 HD11 ' HB3' ' A' ' 77' ' ' LEU . 57.9 tp -98.06 116.12 29.63 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.29 0.567 . . . . 0.0 110.917 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.678 HG22 ' HB2' ' A' ' 51' ' ' ASP . 59.9 t -105.55 122.29 58.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.722 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.739 HG21 HG12 ' A' ' 99' ' ' ILE . 46.8 t -99.98 97.68 6.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.779 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.899 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 45.5 t -99.91 134.79 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.224 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 74' ' ' THR . 37.5 t70 -99.79 128.03 45.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.673 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.037 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.3 m-85 -99.08 51.37 0.95 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.656 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.588 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -50.9 128.65 21.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.061 0.457 . . . . 0.0 111.035 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.569 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -56.07 157.2 4.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.256 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.571 HG22 HG12 ' A' ' 57' ' ' VAL . 4.2 t -95.4 21.59 7.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.202 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.515 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 26.0 p-90 -138.53 -43.62 0.49 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.834 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.441 ' HG ' ' HG ' ' A' ' 33' ' ' CYS . 35.9 t -43.75 129.6 5.55 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.546 0.213 . . . . 0.0 110.984 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.07 -67.85 1.34 Allowed Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.786 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 33' ' ' CYS . 56.5 Cg_endo -67.76 -145.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.56 2.173 . . . . 0.0 110.937 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 32' ' ' PRO . 58.9 m 73.9 4.69 4.7 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -111.46 -29.11 7.91 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.692 0.282 . . . . 0.0 111.056 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.477 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 86.0 mmm -78.44 5.29 11.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.127 0.489 . . . . 0.0 110.538 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.909 HG22 HG13 ' A' ' 40' ' ' ILE . 71.3 mt -81.49 -24.07 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.701 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.53 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -47.36 -45.79 56.39 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 50.0 Cg_endo -72.77 -35.58 5.62 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.904 1.736 . . . . 0.0 111.199 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.5 ttt -65.12 -51.79 59.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.909 HG13 HG22 ' A' ' 36' ' ' ILE . 69.7 mt -48.88 -28.67 2.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.459 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.501 ' N ' HG21 ' A' ' 2' ' ' VAL . 38.8 tt0 -78.24 -33.32 49.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.898 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.464 ' NZ ' ' HB3' ' A' ' 42' ' ' LYS . 9.0 mtpm? -64.35 -22.36 66.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.437 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.483 ' HE2' HG23 ' A' ' 95' ' ' ILE . 4.0 m-85 -90.14 -16.97 28.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.665 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.43 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 45.8 t -74.67 -6.53 49.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.252 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -90.17 -29.07 18.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.937 0.399 . . . . 0.0 111.109 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.31 -26.41 20.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.791 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.571 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 80.1 m-85 -123.61 46.37 1.41 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.473 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 81.9 Cg_exo -37.44 -44.32 1.41 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.207 2.604 . . . . 0.0 113.64 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.415 ' O ' ' HD3' ' A' ' 19' ' ' LYS . 98.0 mm-40 -56.37 -31.29 63.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.923 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.66 133.44 34.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.803 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.678 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.55 121.91 32.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.482 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.547 ' CE2' HD13 ' A' ' 99' ' ' ILE . 4.5 m-85 -96.46 103.58 15.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.375 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.623 ' HB2' HG22 ' A' ' 23' ' ' VAL . 40.7 m-85 -114.17 -176.73 2.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.316 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.709 ' HE2' HG12 ' A' ' 2' ' ' VAL . 44.3 mtmt -145.54 130.51 18.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 111.206 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.811 HD13 ' N ' ' A' ' 56' ' ' ASP . 3.0 tm? -90.75 138.27 31.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.401 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.811 ' N ' HD13 ' A' ' 55' ' ' LEU . 25.4 t70 -94.98 108.34 20.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.422 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.571 HG12 HG22 ' A' ' 28' ' ' THR . 91.1 t -71.15 -11.29 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.547 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 9.7 t70 -88.9 -41.35 12.48 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.434 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.451 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 38.4 tp10 -93.06 -47.51 6.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.824 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.679 HD11 ' C ' ' A' ' 6' ' ' LYS . 5.2 mp -101.82 46.68 0.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.07 -20.78 36.03 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.462 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -71.35 -25.41 62.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.576 0.227 . . . . 0.0 111.517 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.738 HG12 ' HE2' ' A' ' 25' ' ' PHE . 8.0 t -79.61 -51.79 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.711 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.92 -27.4 51.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.99 0.424 . . . . 0.0 110.122 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.03 -26.31 20.37 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.756 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -70.51 -50.44 37.75 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.999 0.428 . . . . 0.0 109.96 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -76.24 -2.6 32.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.915 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 67.48 38.97 2.99 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.167 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.71 ' CG1' HG21 ' A' ' 74' ' ' THR . 48.3 t -112.04 83.49 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.868 0.366 . . . . 0.0 111.054 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.6 p -93.15 3.34 55.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.272 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.636 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -59.49 -163.07 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.612 ' O ' ' HG2' ' A' ' 72' ' ' MET . 0.0 OUTLIER -173.82 94.39 0.33 Allowed Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.51 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 18.9 Cg_endo -91.93 -161.1 1.16 Allowed 'Cis proline' 0 C--N 1.349 0.562 0 C-N-CA 124.835 -0.902 . . . . 0.0 112.513 -0.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.719 HG23 ' HA ' ' A' ' 88' ' ' VAL . 29.0 m -155.92 148.53 23.91 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.671 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.006 HD13 HD13 ' A' ' 95' ' ' ILE . 83.2 mt -109.78 125.26 52.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 111.334 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.037 HD12 ' CE1' ' A' ' 25' ' ' PHE . 21.8 mt -121.37 127.37 51.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.782 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.882 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.7 mp -109.87 140.57 43.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.024 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.626 ' HA ' HG23 ' A' ' 84' ' ' VAL . 52.5 m-85 -140.61 125.7 18.48 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.853 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.584 ' HG3' HD13 ' A' ' 20' ' ' LEU . 54.9 mtpt -109.87 129.01 55.69 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.789 0.328 . . . . 0.0 111.47 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.508 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 25.8 t-20 45.79 61.28 2.72 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.079 0.466 . . . . 0.0 111.6 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 55.59 17.89 14.73 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-N 116.088 -0.506 . . . . 0.0 113.542 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 60.0 mttp -115.18 -155.85 0.59 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 34.7 tt0 -108.78 173.0 6.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.626 HG23 ' HA ' ' A' ' 78' ' ' PHE . 47.9 t -147.79 -68.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.939 0.4 . . . . 0.0 111.038 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.63 154.99 4.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.254 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -114.52 114.99 26.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.414 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.35 82.18 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.311 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.719 ' HA ' HG23 ' A' ' 74' ' ' THR . 2.7 p -60.89 85.14 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.721 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.6 115.39 1.37 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.367 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.727 ' HB2' HD21 ' A' ' 75' ' ' LEU . . . -96.79 38.45 1.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.804 0.335 . . . . 0.0 111.186 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 93' ' ' ALA . 46.2 t30 -68.84 129.28 92.48 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.194 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 85.3 Cg_exo -45.62 88.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.667 2.245 . . . . 0.0 112.659 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 92' ' ' PRO . . . 172.52 -33.16 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.411 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.43 -44.68 2.46 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.006 HD13 HD13 ' A' ' 75' ' ' LEU . 3.8 tp -50.83 -17.9 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.298 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 7.0 ptpp? -91.63 -48.99 6.53 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.949 0.404 . . . . 0.0 110.792 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.418 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 80.2 mt-30 -69.96 -31.6 69.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.575 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.21 -31.68 72.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.023 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.739 HG12 HG21 ' A' ' 22' ' ' VAL . 46.4 mt -90.19 -8.24 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.56 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.571 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.2 -69.65 0.71 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.842 0.353 . . . . 0.0 111.174 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.99 -29.0 18.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.221 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.572 ' CB ' HD22 ' A' ' 20' ' ' LEU . 3.8 m120 -82.63 -51.76 7.45 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.032 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.616 ' HB2' HD23 ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.188 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 52' ' ' PHE . 14.6 p . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.605 0.241 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 4' ' ' GLN . 87.3 m -141.88 162.84 34.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.959 0.409 . . . . 0.0 111.51 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.596 ' HG2' ' HD2' ' A' ' 54' ' ' LYS . 19.2 mt-30 -97.29 -176.97 3.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.777 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.504 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 20.3 m-85 -135.14 101.77 4.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.328 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.559 ' C ' HD11 ' A' ' 60' ' ' LEU . 32.7 mmtp -83.19 -25.4 31.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.731 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.5 p -130.42 123.21 29.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.261 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.83 -25.77 4.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.583 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m -59.5 -18.9 43.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.572 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -90.47 -44.1 9.83 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.206 0.527 . . . . 0.0 111.452 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.885 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.2 t80 -69.39 -30.51 68.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.031 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -50.83 -66.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.404 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.9 m -60.78 -20.48 61.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.467 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 11' ' ' PHE . . . -56.41 -66.42 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.795 0.331 . . . . 0.0 111.676 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' GLY . 21.0 pt -54.6 -48.14 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.753 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.07 103.0 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.7 mt-30 45.18 92.11 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.236 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -171.51 38.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.384 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.538 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 61.61 -152.5 0.37 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.871 HD11 ' HB3' ' A' ' 77' ' ' LEU . 59.3 tp -97.55 115.92 28.78 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.244 0.545 . . . . 0.0 110.437 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 51' ' ' ASP . 58.9 t -104.05 126.97 58.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.871 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.783 HG11 HD11 ' A' ' 95' ' ' ILE . 48.6 t -99.74 93.15 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.495 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.885 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 43.4 t -99.76 128.14 51.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.114 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.7 t70 -99.72 130.73 45.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.752 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.044 ' CE1' HD12 ' A' ' 76' ' ' LEU . 3.4 m-85 -99.07 53.01 0.97 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.968 0.413 . . . . 0.0 110.406 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -50.98 124.77 12.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.301 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -51.69 154.1 2.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.25 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.468 HG22 HG12 ' A' ' 57' ' ' VAL . 7.0 t -96.47 23.82 6.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.085 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.506 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 27.3 p-90 -141.53 -38.05 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.63 ' HB2' ' HB2' ' A' ' 72' ' ' MET . 51.3 t -35.21 150.98 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.0 0.429 . . . . 0.0 111.938 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.36 -79.29 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.453 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 3.3 Cg_exo -73.01 -76.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.43 2.087 . . . . 0.0 112.021 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.9 p 37.92 31.33 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 28.3 mtpp -132.04 -35.98 1.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.214 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.491 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 15.2 tmm? -58.41 -16.03 13.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.852 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.691 HG22 HG13 ' A' ' 40' ' ' ILE . 2.4 mp -75.26 -38.13 40.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.345 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.522 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -45.6 -49.28 36.04 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 41.0 Cg_endo -70.88 -32.73 13.44 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 121.988 1.792 . . . . 0.0 110.999 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 49.3 ttm -66.59 -51.13 59.78 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.718 HG22 HG21 ' A' ' 2' ' ' VAL . 61.6 mt -49.54 -28.38 3.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.515 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.482 ' HB2' HG11 ' A' ' 2' ' ' VAL . 37.8 tt0 -79.16 -30.93 43.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.183 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.478 ' NZ ' ' HB3' ' A' ' 42' ' ' LYS . 9.1 mtpm? -69.37 -16.11 63.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.73 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.49 ' CE2' HG23 ' A' ' 95' ' ' ILE . 3.9 m-85 -90.11 -20.85 22.66 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.5 t -66.74 -14.28 62.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.777 0.322 . . . . 0.0 110.713 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.419 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 5.1 tm-20 -90.04 -20.95 22.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.295 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -90.12 -36.35 14.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.315 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.538 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 81.6 m-85 -124.11 45.4 1.22 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.373 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 75.1 Cg_exo -36.91 -33.03 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.429 2.753 . . . . 0.0 113.628 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -59.57 -37.64 79.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.652 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.83 141.26 28.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.801 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.546 ' O ' HG13 ' A' ' 21' ' ' VAL . 33.9 m-20 -90.08 123.41 33.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.824 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.799 ' O ' HG23 ' A' ' 2' ' ' VAL . 5.4 m-85 -97.09 106.58 18.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.303 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.561 ' HB2' HG22 ' A' ' 23' ' ' VAL . 40.9 m-85 -116.11 -178.45 3.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.523 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.726 ' HE3' HG22 ' A' ' 2' ' ' VAL . 69.9 mttt -142.13 145.36 34.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.393 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.677 ' CD2' HD22 ' A' ' 60' ' ' LEU . 2.7 tm? -107.25 125.13 50.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.607 ' N ' HD13 ' A' ' 55' ' ' LEU . 1.6 m-20 -81.76 108.18 15.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.693 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.468 HG12 HG22 ' A' ' 28' ' ' THR . 85.1 t -72.34 -10.12 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.44 -60.52 2.34 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.556 ' HB3' HD12 ' A' ' 60' ' ' LEU . 2.2 tm-20 -77.9 -39.83 41.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.572 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.677 HD22 ' CD2' ' A' ' 55' ' ' LEU . 4.5 mp -97.76 44.85 1.03 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.014 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.13 -19.88 40.44 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.627 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -78.93 -29.32 44.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.783 0.325 . . . . 0.0 111.432 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.86 HG13 ' HE2' ' A' ' 66' ' ' LYS . 21.4 t -73.27 -54.83 14.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.788 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.86 -25.08 10.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.918 0.389 . . . . 0.0 110.142 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -90.17 -38.36 13.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.158 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.86 ' HE2' HG13 ' A' ' 63' ' ' VAL . 51.5 pttt -60.83 -46.97 88.48 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.945 0.403 . . . . 0.0 110.185 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.402 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.8 m-20 -79.16 -2.09 39.2 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.025 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 64.72 37.7 7.36 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.456 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.746 HG13 HG21 ' A' ' 74' ' ' THR . 41.9 t -111.45 68.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.992 0.425 . . . . 0.0 110.546 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.2 t -85.01 8.24 18.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.733 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.834 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -59.76 -161.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.63 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -173.71 89.46 0.36 Allowed Pre-proline 0 N--CA 1.454 -0.228 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.545 ' O ' HG23 ' A' ' 88' ' ' VAL . 65.0 Cg_endo -96.13 -165.76 1.25 Allowed 'Cis proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.577 -1.01 . . . . 0.0 112.437 -0.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.876 HG23 ' HB ' ' A' ' 88' ' ' VAL . 29.5 m -147.35 163.63 35.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.477 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.915 HD13 HD13 ' A' ' 95' ' ' ILE . 78.9 mt -122.34 127.74 50.16 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.835 0.35 . . . . 0.0 111.191 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.044 HD12 ' CE1' ' A' ' 25' ' ' PHE . 26.5 mt -123.97 128.5 49.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.608 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.871 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.7 mp -109.64 136.9 48.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.028 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.605 ' HA ' HG23 ' A' ' 84' ' ' VAL . 51.1 m-85 -138.72 126.42 22.11 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.877 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.476 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 9.8 mtpm? -109.77 129.77 55.59 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.368 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.442 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 6.3 m120 45.78 56.75 5.64 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.865 0.365 . . . . 0.0 111.92 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 60.61 14.65 36.74 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.066 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 49.1 mtmt -110.93 -155.37 0.56 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.441 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 88.2 tt0 -109.04 172.6 6.75 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 78' ' ' PHE . 64.5 t -146.18 -68.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 0.0 111.25 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.39 -168.31 0.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 0.0 111.551 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.462 ' NZ ' ' HB3' ' A' ' 86' ' ' LYS . 9.7 mtpm? -142.51 140.03 31.68 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.994 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.7 t -154.46 82.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.532 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.876 ' HB ' HG23 ' A' ' 74' ' ' THR . 5.5 p -78.67 109.57 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.826 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.91 -25.79 0.72 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.134 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.772 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . 44.48 39.8 3.46 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 111.357 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.481 ' O ' HG22 ' A' ' 95' ' ' ILE . 24.3 t-20 -62.4 135.61 95.39 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.664 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -47.78 -25.18 5.59 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.663 2.242 . . . . 0.0 112.82 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.34 30.05 7.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.626 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -139.67 -59.57 0.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.2 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.915 HD13 HD13 ' A' ' 75' ' ' LEU . 3.9 tp -57.02 -7.28 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.337 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 14.8 ptmm? -91.3 -49.16 6.51 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.928 0.394 . . . . 0.0 110.659 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.416 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 73.0 mt-30 -69.52 -31.85 70.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.28 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.75 -28.32 69.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.695 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.8 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 59.0 mt -90.17 -10.82 10.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.523 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.84 -71.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.997 0.427 . . . . 0.0 111.349 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -47.43 -29.09 2.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.46 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.679 ' CB ' HD22 ' A' ' 20' ' ' LEU . 68.5 m-20 -90.05 -48.04 7.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.324 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.8 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.078 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.791 HG12 ' HE3' ' A' ' 54' ' ' LYS . 32.7 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.739 0.304 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 4' ' ' GLN . 95.5 m -144.25 161.19 39.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.057 0.456 . . . . 0.0 111.411 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.613 ' HG2' ' NZ ' ' A' ' 54' ' ' LYS . 55.3 mt-30 -91.71 172.55 8.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.443 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.521 ' CE2' ' CG ' ' A' ' 11' ' ' PHE . 17.1 m-85 -126.68 131.96 51.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.19 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.589 ' C ' HD11 ' A' ' 60' ' ' LEU . 47.5 mmtm -120.98 -32.61 3.92 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.2 p -126.2 148.06 49.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.908 0.385 . . . . 0.0 111.657 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 9' ' ' SER . . . -74.21 99.51 3.43 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.405 0.621 . . . . 0.0 110.337 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 31.3 t 160.55 -24.97 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.018 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -84.67 -32.68 23.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.294 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.853 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -90.34 -43.33 10.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.401 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -47.29 -37.91 11.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.12 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.7 m -74.81 -30.95 61.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.834 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.491 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -60.49 -34.9 74.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.062 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.1 pt -90.07 -49.71 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.417 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.465 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -43.62 95.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 45.23 83.17 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.177 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -164.67 42.25 0.08 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.588 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.55 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 2.7 mptp? 64.86 -157.2 0.29 Allowed 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 120.701 0.286 . . . . 0.0 110.657 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.841 HD13 ' HG3' ' A' ' 79' ' ' LYS . 65.9 tp -98.24 117.14 31.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.062 0.458 . . . . 0.0 110.856 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.657 HG22 ' HB2' ' A' ' 51' ' ' ASP . 46.6 t -113.93 124.02 70.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.742 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.72 HG22 ' HG ' ' A' ' 77' ' ' LEU . 58.8 t -99.84 111.56 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.933 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.853 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 41.5 t -109.45 137.77 40.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.197 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.45 ' OD2' HG21 ' A' ' 36' ' ' ILE . 61.8 t0 -99.84 128.96 45.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.824 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.067 ' CE1' HD12 ' A' ' 76' ' ' LEU . 6.8 m-85 -99.15 48.29 0.96 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.052 0.453 . . . . 0.0 110.175 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.582 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -48.88 132.04 18.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.243 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.563 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -60.78 145.31 50.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.808 0.337 . . . . 0.0 110.718 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.477 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 7.7 t -72.79 -21.19 61.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.391 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -95.87 -39.24 9.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.806 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 49.1 t -41.23 139.49 0.98 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.914 0.387 . . . . 0.0 111.717 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.71 -58.18 1.85 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.785 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.93 52.5 4.28 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.619 2.212 . . . . 0.0 112.755 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.442 ' O ' HD12 ' A' ' 36' ' ' ILE . 27.3 p -127.13 -13.05 5.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.38 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -78.47 -25.44 45.82 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.738 0.304 . . . . 0.0 111.251 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.409 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 65.9 mtt -73.75 3.83 5.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.828 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.797 HG22 HG13 ' A' ' 40' ' ' ILE . 62.2 mt -79.14 -38.78 20.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.933 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.572 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -42.79 -45.42 11.47 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 23.9 Cg_endo -66.36 -43.49 8.17 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.595 1.53 . . . . 0.0 111.669 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.509 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 12.2 mmt -62.1 -59.87 4.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.797 HG13 HG22 ' A' ' 36' ' ' ILE . 43.2 mt -43.08 -29.27 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.019 0.438 . . . . 0.0 110.751 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -80.42 -43.34 21.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.767 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -59.78 -29.94 68.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.183 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.605 ' CE2' HG23 ' A' ' 95' ' ' ILE . 16.0 m-85 -76.14 -22.6 55.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.473 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.401 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 98.9 p -77.31 -4.05 43.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.71 0.29 . . . . 0.0 110.711 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.424 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 50.3 mt-10 -90.08 -28.32 19.09 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.855 0.36 . . . . 0.0 110.712 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -90.24 -28.31 18.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.362 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.539 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 70.3 m-85 -123.97 45.54 1.25 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.133 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 74.2 Cg_exo -37.41 -32.43 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.376 2.718 . . . . 0.0 113.54 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -60.79 -38.45 85.37 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.674 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -90.0 138.69 31.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.956 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.657 ' HB2' HG22 ' A' ' 21' ' ' VAL . 58.2 m-20 -90.71 138.72 31.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.663 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.602 ' O ' HG13 ' A' ' 2' ' ' VAL . 2.7 m-85 -114.74 98.39 6.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.516 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.672 ' HB2' HG22 ' A' ' 23' ' ' VAL . 43.5 m-85 -102.41 -173.25 2.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.562 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.791 ' HE3' HG12 ' A' ' 2' ' ' VAL . 10.2 mtmp? -147.84 135.38 20.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.954 0.406 . . . . 0.0 111.04 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.954 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.1 tm? -98.25 145.62 26.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.698 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.954 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.9 t70 -93.85 126.04 38.82 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.7 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.759 HG12 ' O ' ' A' ' 57' ' ' VAL . 98.3 t -93.38 30.33 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 121.286 0.565 . . . . 0.0 110.814 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.477 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 65.8 t0 -137.94 -46.73 0.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.58 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.614 ' C ' HD12 ' A' ' 60' ' ' LEU . 5.2 tp10 -81.56 -32.24 32.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.414 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.675 HD22 HD21 ' A' ' 55' ' ' LEU . 4.5 mp -118.52 72.78 0.89 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.64 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -77.84 -1.72 79.32 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.88 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -90.04 -38.39 13.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.741 0.305 . . . . 0.0 111.39 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.801 HG13 ' HE3' ' A' ' 66' ' ' LYS . 6.0 t -71.73 -54.88 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.345 . . . . 0.0 110.608 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.37 -25.44 15.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.019 0.438 . . . . 0.0 110.226 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -90.24 -38.36 13.49 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.109 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.801 ' HE3' HG13 ' A' ' 63' ' ' VAL . 16.5 pttp -60.7 -48.4 81.97 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-O 120.865 0.364 . . . . 0.0 110.129 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.417 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.5 m-20 -76.81 -6.08 50.89 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.869 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 66.3 41.66 3.3 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.019 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.561 HG13 HG21 ' A' ' 74' ' ' THR . 59.6 t -104.63 84.6 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.153 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 91.3 p -95.56 -17.46 21.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.922 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.774 ' CB ' HG21 ' A' ' 88' ' ' VAL . . . -55.99 -171.01 0.0 OUTLIER 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.501 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.563 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -167.84 108.31 0.58 Allowed Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.349 -0.54 . . . . 0.0 112.372 -179.506 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.733 ' O ' HG23 ' A' ' 88' ' ' VAL . 42.1 Cg_endo -87.85 -162.15 2.07 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.394 -1.086 . . . . 0.0 112.286 -0.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.561 HG21 HG13 ' A' ' 69' ' ' VAL . 84.9 m -153.76 163.81 39.39 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.803 0.335 . . . . 0.0 110.797 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.026 HD13 HD13 ' A' ' 95' ' ' ILE . 71.0 mt -129.0 123.45 32.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 110.913 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.067 HD12 ' CE1' ' A' ' 25' ' ' PHE . 20.7 mt -121.05 129.15 53.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.803 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.79 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.5 mp -109.7 143.71 39.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.7 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.585 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 64.7 m-85 -144.41 127.09 16.15 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.001 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.841 ' HG3' HD13 ' A' ' 20' ' ' LEU . 49.3 mtpt -117.24 136.69 52.9 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.831 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.444 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.2 m120 45.78 67.69 0.7 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.569 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 46.29 33.97 5.99 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 113.048 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.585 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 68.1 mttm -141.78 -160.57 1.1 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.718 ' O ' HG13 ' A' ' 84' ' ' VAL . 28.9 tt0 -109.14 -179.91 3.98 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.811 HG11 ' HG3' ' A' ' 79' ' ' LYS . 4.6 m -164.2 -46.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.51 0.195 . . . . 0.0 111.38 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.47 158.68 24.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.046 0.451 . . . . 0.0 112.012 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.468 ' CD ' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -148.03 113.67 5.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.872 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.7 t -139.41 107.37 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.412 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.774 HG21 ' CB ' ' A' ' 71' ' ' ALA . 3.2 p -69.45 110.45 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.063 0.458 . . . . 0.0 110.659 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.2 105.14 0.91 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.164 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.667 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -94.0 38.35 1.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.847 0.356 . . . . 0.0 111.39 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' A' ' 93' ' ' ALA . 5.4 m120 -72.38 134.83 82.12 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.437 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 85.6 Cg_exo -48.48 84.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.722 2.282 . . . . 0.0 112.625 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 178.66 -38.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.43 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.33 -45.68 2.92 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.7 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.026 HD13 HD13 ' A' ' 75' ' ' LEU . 4.9 tp -52.83 -16.49 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.148 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.491 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -92.21 -49.3 6.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.982 0.42 . . . . 0.0 110.901 179.509 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.442 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 25.8 mt-30 -71.53 -32.05 67.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.661 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.679 ' HB1' HD21 ' A' ' 77' ' ' LEU . . . -57.89 -32.93 68.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.429 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.872 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.5 mp -90.24 -12.25 9.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.423 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.47 -64.42 1.14 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.911 0.386 . . . . 0.0 111.095 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.31 -30.36 38.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.064 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.78 ' HB3' HD22 ' A' ' 20' ' ' LEU . 64.9 m-20 -90.15 -66.42 0.93 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.301 -0.856 . . . . 0.0 111.117 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.848 HG22 ' NZ ' ' A' ' 54' ' ' LYS . 6.0 p . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.654 0.264 . . . . 0.0 110.668 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 4' ' ' GLN . 92.5 m -150.3 162.01 41.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.198 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.546 ' HG3' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -105.4 -173.37 2.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.878 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.51 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.8 m-85 -135.79 105.75 6.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.762 0.315 . . . . 0.0 111.698 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.661 ' O ' HD11 ' A' ' 60' ' ' LEU . 8.2 mmmm -88.93 -27.71 20.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.763 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.7 p -126.35 128.52 47.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 110.705 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.79 -24.04 20.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.415 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -62.29 -16.59 54.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.627 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -90.14 -56.74 3.1 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.246 0.546 . . . . 0.0 111.111 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.659 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -60.49 -33.1 72.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.7 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -51.46 -56.69 11.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.256 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.4 m -65.85 -25.3 67.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.526 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -56.39 -72.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 0.0 111.322 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.545 HG23 ' CE1' ' A' ' 11' ' ' PHE . 19.4 pt -52.8 -48.52 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.674 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -44.43 96.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 44.68 91.16 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.541 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -174.54 40.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.487 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.537 ' HB2' ' NZ ' ' A' ' 19' ' ' LYS . 8.1 mtmp? 69.36 -158.26 0.17 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.498 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.829 HD13 ' HG3' ' A' ' 79' ' ' LYS . 61.6 tp -98.16 113.76 25.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.205 0.526 . . . . 0.0 111.19 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.7 HG22 ' HB2' ' A' ' 51' ' ' ASP . 59.1 t -99.74 125.45 53.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.524 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.647 HG21 HG12 ' A' ' 99' ' ' ILE . 50.8 t -99.71 96.3 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.665 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.659 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 30.1 t -104.95 131.84 53.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.368 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.6 t70 -99.99 132.23 45.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.507 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.08 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.8 m-85 -99.14 54.6 0.98 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.137 0.494 . . . . 0.0 110.643 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.613 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -58.35 140.92 52.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.098 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.708 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -67.42 136.44 54.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.774 0.321 . . . . 0.0 110.253 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 3.3 t -53.39 -49.35 67.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.222 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 32.0 p-90 -68.2 -42.62 79.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.79 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 53.1 t -45.75 135.14 7.07 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 111.146 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.27 -56.3 0.94 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.117 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -48.57 -26.02 8.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.617 2.211 . . . . 0.0 112.729 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.9 p -63.92 -32.21 73.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.071 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -61.87 -25.32 67.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.383 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 66.1 mtt -68.85 -5.85 23.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.962 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.857 HG22 HG13 ' A' ' 40' ' ' ILE . 60.0 mt -86.51 -23.63 6.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.447 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.28 -44.48 81.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 45.6 Cg_endo -72.7 -36.61 4.67 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.669 1.579 . . . . 0.0 111.447 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.527 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 67.5 mtm -64.96 -51.46 61.63 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.857 HG13 HG22 ' A' ' 36' ' ' ILE . 68.0 mt -48.71 -25.53 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.716 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.404 ' HB2' HG11 ' A' ' 2' ' ' VAL . 38.0 tt0 -85.06 -23.38 28.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.972 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.447 ' HB2' ' NZ ' ' A' ' 42' ' ' LYS . 10.5 mtmp? -82.28 -15.71 52.03 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.527 ' HD1' ' O ' ' A' ' 39' ' ' MET . 3.5 m-85 -90.04 -19.27 24.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.652 0.263 . . . . 0.0 111.323 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.452 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.6 t -69.62 -8.84 50.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.484 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -87.99 -27.18 22.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.739 0.304 . . . . 0.0 111.098 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -90.6 -30.4 17.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.904 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.511 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 72.9 m-85 -123.03 47.3 1.56 Allowed Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.167 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 80.7 Cg_exo -38.01 -27.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.254 2.636 . . . . 0.0 113.594 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.491 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 13.4 mp0 -65.63 -36.22 83.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.105 0.479 . . . . 0.0 110.472 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.48 138.27 31.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.109 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.7 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.53 122.21 32.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.026 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.624 ' CE2' HD13 ' A' ' 99' ' ' ILE . 4.2 m-85 -97.37 83.96 3.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.221 0.534 . . . . 0.0 111.624 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.51 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 54.2 m-85 -102.31 -174.75 2.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.495 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.848 ' NZ ' HG22 ' A' ' 2' ' ' VAL . 28.6 mttp -141.98 148.59 38.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.307 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.727 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.8 tm? -106.21 130.23 54.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.127 0.489 . . . . 0.0 110.943 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.727 ' N ' HD13 ' A' ' 55' ' ' LEU . 56.9 m-20 -83.89 117.03 23.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.619 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 57' ' ' VAL . 69.9 t -87.22 5.56 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.111 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.492 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 11.5 p-10 -99.63 -40.73 7.65 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.92 0.39 . . . . 0.0 110.631 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.563 ' C ' HD12 ' A' ' 60' ' ' LEU . 5.4 tp10 -99.66 -28.5 13.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.979 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.672 ' N ' HD12 ' A' ' 60' ' ' LEU . 3.1 mp -114.17 41.79 2.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.032 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.51 -21.44 34.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.55 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -72.38 -25.83 61.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.687 0.28 . . . . 0.0 111.511 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.737 HG12 ' HE2' ' A' ' 25' ' ' PHE . 11.7 t -77.82 -49.56 21.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.75 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.47 -28.4 59.6 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.971 0.415 . . . . 0.0 110.321 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -90.03 -23.93 21.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.724 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -73.03 -49.54 28.19 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.98 0.419 . . . . 0.0 110.052 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -77.75 -0.75 28.14 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.146 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 68.09 37.33 2.98 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.306 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.766 HG13 HG21 ' A' ' 74' ' ' THR . 44.2 t -116.18 72.97 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.758 0.313 . . . . 0.0 110.983 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.2 p -84.12 -15.13 48.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.929 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.36 -172.62 0.0 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.524 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.708 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 1.7 pmm? -170.08 112.74 0.47 Allowed Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.513 -0.475 . . . . 0.0 112.209 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.562 ' O ' HG23 ' A' ' 88' ' ' VAL . 68.4 Cg_endo -87.64 -167.39 4.06 Favored 'Cis proline' 0 C--N 1.349 0.571 0 C-N-CA 124.151 -1.187 . . . . 0.0 112.086 -0.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.766 HG21 HG13 ' A' ' 69' ' ' VAL . 29.0 m -161.36 151.67 17.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.681 0.277 . . . . 0.0 110.837 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.988 HD13 HD13 ' A' ' 95' ' ' ILE . 81.7 mt -114.22 124.84 53.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.282 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.08 HD12 ' CE1' ' A' ' 25' ' ' PHE . 22.7 mt -120.05 128.76 53.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.282 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.787 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.1 mp -109.6 141.19 42.47 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.833 0.349 . . . . 0.0 110.838 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.611 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 55.1 m-85 -143.19 126.21 16.32 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.96 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.829 ' HG3' HD13 ' A' ' 20' ' ' LEU . 48.5 mtpt -117.04 136.11 53.21 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.701 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.2 m120 49.12 62.4 2.63 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.484 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 50.61 25.54 9.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.069 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.611 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 75.2 mmtt -132.45 -160.09 1.02 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.722 ' O ' HG13 ' A' ' 84' ' ' VAL . 32.2 tt0 -108.94 -179.93 4.0 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.792 HG11 ' HG3' ' A' ' 79' ' ' LYS . 4.6 m -164.16 -47.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -164.81 165.24 20.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.155 0.502 . . . . 0.0 111.814 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.534 ' HG2' HD22 ' A' ' 76' ' ' LEU . 36.5 mtmm -151.19 135.15 16.6 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.923 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.4 t -154.21 105.99 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.469 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.58 ' HA ' HG23 ' A' ' 74' ' ' THR . 2.8 p -68.03 78.68 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.841 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.52 106.27 0.2 Allowed Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.339 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.666 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -97.11 38.53 1.24 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.875 0.369 . . . . 0.0 111.183 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 93' ' ' ALA . 22.9 t-20 -85.8 141.08 35.6 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.147 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -45.52 87.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.657 2.238 . . . . 0.0 112.636 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -179.6 -40.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.336 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.11 -42.14 2.29 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.988 HD13 HD13 ' A' ' 75' ' ' LEU . 5.3 tp -50.39 -17.92 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.081 -0.247 . . . . 0.0 111.133 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.45 ' CD ' ' CE2' ' A' ' 43' ' ' PHE . 29.6 mmmt -90.64 -66.76 0.9 Allowed 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.787 0.327 . . . . 0.0 111.104 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.469 ' OE1' ' N ' ' A' ' 97' ' ' GLN . 1.3 mp0 -59.93 -34.82 73.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.705 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.97 -30.87 66.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.616 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.647 HG12 HG21 ' A' ' 22' ' ' VAL . 57.8 mt -90.22 -14.67 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.343 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.43 -68.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.865 0.364 . . . . 0.0 111.142 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.07 -28.76 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.148 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.591 ' HB3' HD22 ' A' ' 20' ' ' LEU . 5.8 m120 -83.15 -51.92 7.07 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.996 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.056 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.484 HG11 ' HB2' ' A' ' 41' ' ' GLU . 10.5 p . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.564 0.221 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.451 HG22 ' N ' ' A' ' 4' ' ' GLN . 85.3 m -148.67 162.59 39.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.958 0.409 . . . . 0.0 111.543 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.649 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 43.1 mt-30 -107.62 -179.92 4.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.219 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.508 ' CE2' ' CD1' ' A' ' 11' ' ' PHE . 22.6 m-85 -129.49 129.73 44.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.564 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.794 ' C ' HD11 ' A' ' 60' ' ' LEU . 47.4 mmtm -110.95 -18.77 12.99 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 8' ' ' ALA . 25.5 m -147.94 165.77 29.68 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.18 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.55 ' O ' ' OG ' ' A' ' 9' ' ' SER . . . -84.63 101.46 12.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.473 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.55 ' OG ' ' O ' ' A' ' 8' ' ' ALA . 13.2 m 160.26 -25.33 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.044 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -87.24 -30.77 20.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.481 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.911 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -90.05 -40.8 12.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.556 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -48.64 -40.35 27.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.22 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 m -76.21 -27.12 56.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.096 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.51 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -57.47 -62.16 1.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.36 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.65 HG22 ' HB2' ' A' ' 78' ' ' PHE . 19.1 pt -63.72 -48.71 85.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.602 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.48 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -40.49 94.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 24.6 mt-30 44.16 88.96 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.385 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.515 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 8.9 t70 -170.64 40.47 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.324 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 53.1 mttp 70.82 -151.47 0.1 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.729 0.3 . . . . 0.0 110.635 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.652 ' CD1' HG21 ' A' ' 84' ' ' VAL . 28.0 tp -97.47 111.49 23.73 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.15 0.5 . . . . 0.0 110.998 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.731 HG22 ' HB2' ' A' ' 51' ' ' ASP . 60.0 t -99.96 113.91 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.918 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.932 HG21 HG12 ' A' ' 99' ' ' ILE . 43.6 t -99.9 102.39 13.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.6 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.911 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 39.9 t -104.84 138.42 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.604 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -104.42 130.96 52.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.823 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.048 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.4 m-85 -99.1 49.39 0.95 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.047 0.451 . . . . 0.0 109.832 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.565 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -47.18 134.56 10.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.508 -179.106 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . . . -62.0 128.72 37.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.445 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.531 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 5.2 t -59.44 -28.02 66.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.766 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.403 ' CH2' ' SD ' ' A' ' 72' ' ' MET . 31.4 p-90 -93.83 -36.97 11.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 33.2 t -46.58 158.72 0.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.577 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.71 -66.39 0.81 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.304 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -46.77 -26.68 4.8 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.892 2.394 . . . . 0.0 113.08 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 86.3 m -60.43 -17.86 47.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -73.81 -44.34 56.12 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.406 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 65.2 mtt -70.77 1.7 5.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.796 0.331 . . . . 0.0 111.522 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.724 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 36.3 mt -75.74 -39.4 38.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.728 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.511 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -44.53 -50.39 23.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 41.6 Cg_endo -69.58 -31.26 21.69 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 121.806 1.671 . . . . 0.0 111.194 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 47.1 tpp -68.93 -51.19 42.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.779 HD12 ' CD ' ' A' ' 54' ' ' LYS . 62.6 mt -50.32 -29.07 5.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.411 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.484 ' HB2' HG11 ' A' ' 2' ' ' VAL . 43.6 tt0 -75.71 -35.63 60.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.889 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -62.42 -20.58 64.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.675 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.26 -24.54 20.91 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.414 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 50.5 m -62.21 -13.21 25.38 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.611 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -85.59 -25.2 26.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.729 0.3 . . . . 0.0 111.31 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -90.42 -30.74 17.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.556 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 80.8 m-85 -123.1 46.47 1.35 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.747 0.308 . . . . 0.0 111.482 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 79.3 Cg_exo -37.18 -33.2 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.321 2.68 . . . . 0.0 114.025 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.413 ' O ' ' CD ' ' A' ' 19' ' ' LYS . 9.6 mm-40 -66.17 -30.92 71.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.931 0.396 . . . . 0.0 110.86 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.34 138.45 31.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.475 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.731 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.49 121.59 31.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.006 0.431 . . . . 0.0 110.383 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.698 ' CE2' HD13 ' A' ' 99' ' ' ILE . 5.2 m-85 -97.44 82.99 3.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.594 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.609 ' HB2' HG22 ' A' ' 23' ' ' VAL . 43.0 m-85 -97.04 -178.16 4.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.898 178.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.779 ' CD ' HD12 ' A' ' 40' ' ' ILE . 33.4 mtmm -146.31 139.13 25.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.163 0.506 . . . . 0.0 111.398 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.831 HD13 ' N ' ' A' ' 56' ' ' ASP . 1.8 tm? -102.09 135.44 43.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.967 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.831 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.9 t0 -88.43 128.68 35.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.308 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 41.4 t -85.66 -11.17 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.531 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 2.1 p30 -105.1 -41.25 5.62 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.336 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.738 ' C ' HD12 ' A' ' 60' ' ' LEU . 15.8 tp10 -76.84 -31.17 56.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.97 0.414 . . . . 0.0 110.608 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.794 HD11 ' C ' ' A' ' 6' ' ' LYS . 4.2 mp -125.35 42.73 3.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.765 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -48.44 -27.42 5.77 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.486 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.45 -25.78 68.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.63 0.252 . . . . 0.0 111.447 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.812 HG13 ' HE2' ' A' ' 66' ' ' LYS . 11.0 t -81.16 -55.58 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.745 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.83 -26.72 6.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.069 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.427 ' N ' ' OE1' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -90.33 -37.14 14.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.669 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.812 ' HE2' HG13 ' A' ' 63' ' ' VAL . 52.6 pttt -59.74 -48.12 82.94 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.051 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.414 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 76.0 m-20 -78.41 -5.22 51.73 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.867 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 67.01 41.49 2.65 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.256 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.673 ' CG1' HG21 ' A' ' 74' ' ' THR . 41.7 t -112.63 97.6 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-O 120.805 0.336 . . . . 0.0 110.99 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.8 p -112.31 28.68 8.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.983 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.856 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -76.12 -153.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.823 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.476 ' O ' ' HG3' ' A' ' 72' ' ' MET . 16.5 ptt? -173.04 79.65 0.41 Allowed Pre-proline 0 CA--C 1.529 0.141 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.724 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 1.3 Cg_endo -97.52 -155.61 0.33 Allowed 'Cis proline' 0 C--N 1.348 0.524 0 C-N-CA 125.242 -0.733 . . . . 0.0 112.783 -0.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.856 ' OG1' ' HB3' ' A' ' 71' ' ' ALA . 86.6 m -151.22 147.09 26.57 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.027 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.047 HD13 HD13 ' A' ' 95' ' ' ILE . 88.4 mt -109.67 122.7 48.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.941 0.4 . . . . 0.0 111.458 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.048 HD12 ' CE1' ' A' ' 25' ' ' PHE . 29.2 mt -120.23 125.87 49.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.441 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 77' ' ' LEU . 3.3 mp -109.8 147.47 33.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.8 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.65 ' HB2' HG22 ' A' ' 15' ' ' ILE . 47.0 m-85 -148.45 126.83 12.28 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.339 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.832 ' HG3' HG11 ' A' ' 84' ' ' VAL . 50.3 mtpt -115.55 140.16 49.42 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.463 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 6.0 m120 49.1 52.12 14.96 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.634 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 57.62 19.32 34.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.706 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.616 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 54.7 mtpt -122.5 -155.83 0.67 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.765 ' O ' HG13 ' A' ' 84' ' ' VAL . 83.1 tt0 -108.85 177.73 4.68 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.832 HG11 ' HG3' ' A' ' 79' ' ' LYS . 4.2 m -166.55 -47.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.644 0.259 . . . . 0.0 111.369 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.452 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -163.93 174.68 11.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 111.612 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.426 ' HB2' ' CD2' ' A' ' 76' ' ' LEU . 14.3 ptmm? -170.05 115.57 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.649 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.1 p -122.88 103.82 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.129 0.49 . . . . 0.0 111.547 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.786 ' HA ' HG23 ' A' ' 74' ' ' THR . 2.1 p -59.92 88.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.838 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.636 ' O ' ' HB2' ' A' ' 90' ' ' ALA . . . 158.65 -128.93 2.15 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.169 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.675 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . 158.54 39.42 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.825 0.345 . . . . 0.0 110.894 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.626 ' O ' HG22 ' A' ' 95' ' ' ILE . 23.2 p30 -70.91 139.71 85.73 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.744 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.75 -18.41 2.74 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.764 2.309 . . . . 0.0 113.198 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.44 21.63 12.89 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.59 -60.06 0.17 Allowed 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.829 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.047 HD13 HD13 ' A' ' 75' ' ' LEU . 3.9 tp -50.69 -15.15 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.138 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.502 ' HE2' ' HG3' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -92.34 -41.03 10.58 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.0 0.429 . . . . 0.0 110.677 179.351 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.502 ' HG3' ' HE2' ' A' ' 96' ' ' LYS . 72.1 mt-30 -76.45 -32.13 58.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.18 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.39 -32.33 73.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.52 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.932 HG12 HG21 ' A' ' 22' ' ' VAL . 38.9 mt -90.25 -13.47 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.258 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.556 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.4 -72.05 0.59 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.9 0.381 . . . . 0.0 111.186 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -48.45 -29.34 3.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.264 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.509 ' OD1' HD22 ' A' ' 77' ' ' LEU . 3.7 m120 -83.82 -41.69 17.26 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.146 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 52' ' ' PHE . 49.9 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.886 0.374 . . . . 0.0 111.345 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.419 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 87.0 m -150.12 153.86 37.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.573 ' HG2' ' HG3' ' A' ' 54' ' ' LYS . 57.3 mt-30 -89.42 -179.21 5.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.178 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.543 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 17.0 m-85 -130.02 140.03 50.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.016 0.436 . . . . 0.0 111.309 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HD2' ' HG3' ' A' ' 59' ' ' GLU . 34.3 mmtp -112.72 -55.94 2.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.489 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.2 p -105.75 169.39 8.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.559 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.78 -27.84 40.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.1 m -60.85 -16.16 38.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.621 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -90.34 -62.59 1.43 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.227 0.537 . . . . 0.0 111.087 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.95 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -59.85 -24.14 63.97 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.992 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -54.96 -55.7 27.86 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.447 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.1 m -72.01 -23.41 61.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.487 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.63 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -54.98 -38.63 68.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 111.598 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 81' ' ' GLY . 21.3 pt -88.01 -48.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.437 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.37 102.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 85.1 mt-30 44.5 87.52 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.216 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 8.8 t70 -168.37 39.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.352 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.552 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 2.6 mptp? 62.54 -154.51 0.34 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.686 0.279 . . . . 0.0 110.43 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.861 HD11 ' HB3' ' A' ' 77' ' ' LEU . 62.3 tp -97.92 115.27 27.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.071 0.462 . . . . 0.0 110.882 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.688 HG22 ' HB2' ' A' ' 51' ' ' ASP . 45.8 t -106.89 130.71 58.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.632 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.684 HG11 HD11 ' A' ' 95' ' ' ILE . 56.4 t -99.81 97.96 6.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.547 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.95 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 24.8 t -101.4 126.03 55.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.053 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.573 ' HB3' ' NZ ' ' A' ' 54' ' ' LYS . 38.0 t70 -99.97 131.67 45.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.015 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.069 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.1 m-85 -99.25 50.26 0.95 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.077 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.682 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -53.79 129.58 33.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.352 -179.559 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.762 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -50.39 153.34 1.57 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.724 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.623 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 7.9 t -92.6 21.57 5.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.042 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.462 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 23.7 p-90 -143.58 -42.24 0.28 Allowed 'General case' 0 C--O 1.232 0.167 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 29' ' ' TRP . 50.1 t -29.97 -76.2 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.54 -78.92 0.38 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.446 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -46.98 -29.34 8.33 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.667 2.245 . . . . 0.0 112.217 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.46 ' HA ' HD12 ' A' ' 36' ' ' ILE . 82.5 m -60.19 -20.15 57.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.784 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -74.09 -37.27 64.22 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.6 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.44 ' O ' ' HG2' ' A' ' 35' ' ' MET . 48.6 ttm -72.21 0.88 8.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.381 . . . . 0.0 111.074 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.601 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 59.1 mt -83.2 -25.23 8.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.011 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.566 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.88 -45.84 87.31 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 38.4 Cg_endo -69.91 -37.4 8.85 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.896 1.731 . . . . 0.0 111.588 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 57.1 ttp -64.49 -51.25 63.97 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.838 HD12 ' HE2' ' A' ' 54' ' ' LYS . 55.2 mt -51.73 -27.35 8.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.652 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.635 ' HA ' HG21 ' A' ' 2' ' ' VAL . 87.7 tt0 -77.48 -29.39 52.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.336 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -66.82 -17.98 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.221 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -89.97 -18.45 26.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.425 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.5 t -67.31 -12.32 59.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.158 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.411 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 5.5 tp10 -85.71 -24.39 26.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.707 0.289 . . . . 0.0 111.042 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -90.26 -35.06 15.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.556 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.539 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 69.0 m-85 -122.33 43.9 0.78 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.539 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 90.4 Cg_exo -38.63 -32.45 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.104 2.536 . . . . 0.0 113.224 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -59.41 -38.28 80.21 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.715 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.755 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.78 145.77 24.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.688 ' HB2' HG22 ' A' ' 21' ' ' VAL . 32.7 m-20 -89.98 148.88 22.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.732 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.702 ' O ' HG13 ' A' ' 2' ' ' VAL . 2.6 m-85 -123.39 94.58 4.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.979 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.543 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 53.5 m-85 -108.8 173.78 6.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.997 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.838 ' HE2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -124.61 162.26 24.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.549 HD13 ' C ' ' A' ' 55' ' ' LEU . 2.1 tm? -127.2 108.69 11.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.753 0.311 . . . . 0.0 110.485 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -64.01 112.15 2.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.62 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 26' ' ' TYR . 55.5 t -69.27 -11.15 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.744 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.623 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 4.5 t70 -99.69 -59.92 1.63 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.138 0.495 . . . . 0.0 110.374 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.42 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -53.41 -45.45 69.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.582 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.52 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.3 mm? -81.64 -67.71 0.76 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.378 0.609 . . . . 0.0 110.83 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.11 -64.38 0.52 Allowed Glycine 0 C--N 1.314 -0.66 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.481 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -56.91 -28.82 62.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.615 0.245 . . . . 0.0 111.386 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.848 HG12 ' HE2' ' A' ' 25' ' ' PHE . 16.3 t -73.03 -52.78 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.434 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.92 -24.68 39.22 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.086 0.469 . . . . 0.0 109.806 178.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -90.34 -38.91 13.03 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.169 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.846 ' HE3' HG13 ' A' ' 63' ' ' VAL . 17.3 pttp -59.72 -48.38 81.89 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.893 0.378 . . . . 0.0 110.206 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.414 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.5 m-80 -77.55 -5.1 48.94 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.897 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 66.32 41.74 3.25 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.129 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.687 ' CG1' HG21 ' A' ' 74' ' ' THR . 53.8 t -113.87 86.16 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.122 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 93.3 p -91.46 -21.88 20.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.838 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.48 -173.64 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.762 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -172.76 119.38 0.41 Allowed Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.601 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 50.6 Cg_endo -83.89 -179.23 21.14 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.939 -1.275 . . . . 0.0 112.158 -0.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.687 HG21 ' CG1' ' A' ' 69' ' ' VAL . 37.0 m -147.03 143.65 28.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.469 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.04 HD13 HD13 ' A' ' 95' ' ' ILE . 79.5 mt -109.78 124.55 51.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.06 0.457 . . . . 0.0 111.812 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.069 HD12 ' CE1' ' A' ' 25' ' ' PHE . 25.1 mt -119.38 127.61 53.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.468 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.861 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.5 mp -109.71 134.08 52.4 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.212 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.593 ' HA ' HG23 ' A' ' 84' ' ' VAL . 53.1 m-85 -133.91 127.99 33.62 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.111 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.49 ' HD3' ' HB2' ' A' ' 20' ' ' LEU . 7.4 mmmm -109.79 127.74 54.85 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.728 0.299 . . . . 0.0 111.47 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.3 m120 45.32 56.43 5.62 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.909 0.385 . . . . 0.0 111.832 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 61.6 14.15 41.61 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.199 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 34.3 mmtp -111.74 -154.18 0.54 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 35.8 tt0 -108.77 171.37 7.47 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 78' ' ' PHE . 59.6 t -144.03 -66.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.745 0.307 . . . . 0.0 111.35 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.17 161.7 8.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.003 0.43 . . . . 0.0 111.524 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -116.69 129.14 55.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.09 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.4 t -154.49 81.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.261 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 88' ' ' VAL . 6.8 p -61.74 85.38 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.009 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.81 110.69 0.26 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.566 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.649 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -100.78 38.9 1.45 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.884 0.374 . . . . 0.0 111.318 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 93' ' ' ALA . 47.4 t30 -79.6 132.01 62.93 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.208 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.491 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 76.0 Cg_exo -44.37 87.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.737 2.292 . . . . 0.0 112.886 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 92' ' ' PRO . . . 173.26 -38.14 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.21 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.58 -46.24 3.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.643 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.04 HD13 HD13 ' A' ' 75' ' ' LEU . 5.0 tp -52.77 -16.12 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.703 0.287 . . . . 0.0 111.148 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.459 ' HB2' ' NZ ' ' A' ' 96' ' ' LYS . 10.4 mtmp? -90.78 -63.06 1.32 Allowed 'General case' 0 CA--C 1.523 -0.091 0 CA-C-O 121.024 0.44 . . . . 0.0 110.623 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -58.8 -33.39 70.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.639 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.62 -30.1 69.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.682 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 59.9 mt -89.9 -7.8 10.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.468 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.32 -72.16 0.58 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.971 0.415 . . . . 0.0 111.273 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.44 -30.73 31.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.337 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.58 ' CB ' HD22 ' A' ' 20' ' ' LEU . 3.9 m120 -80.83 -53.57 6.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.0 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.074 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.851 HG22 ' HE2' ' A' ' 54' ' ' LYS . 11.0 p . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 120.533 0.206 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.0 m -150.18 152.2 34.28 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.177 0.513 . . . . 0.0 111.803 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.412 ' OE1' ' HB2' ' A' ' 54' ' ' LYS . 9.3 mm-40 -90.13 159.03 16.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.003 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.518 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 15.0 m-85 -116.61 99.12 6.92 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.824 -0.351 . . . . 0.0 111.543 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.629 ' O ' HD11 ' A' ' 60' ' ' LEU . 30.7 mmtp -85.92 -27.51 24.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.8 p -127.74 124.23 37.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.479 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.88 -25.15 7.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.364 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.8 m -60.07 -18.69 48.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.574 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -90.33 -40.51 12.06 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.134 0.493 . . . . 0.0 111.207 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.946 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.2 t80 -75.69 -30.88 59.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.812 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -54.57 -49.57 70.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.084 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -71.93 -25.47 61.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.164 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.526 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -56.88 -67.67 0.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.311 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 81' ' ' GLY . 17.8 pt -54.13 -49.47 61.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.776 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -44.78 99.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 44.66 89.66 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.55 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 63.9 t0 -169.38 39.66 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.284 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.554 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 2.6 mptp? 65.82 -154.56 0.26 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.37 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.729 HD11 ' HB3' ' A' ' 77' ' ' LEU . 54.0 tp -97.78 115.84 28.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.14 0.495 . . . . 0.0 110.774 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.615 HG22 ' HB2' ' A' ' 51' ' ' ASP . 49.1 t -105.94 128.56 60.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.032 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.639 HG21 HG13 ' A' ' 99' ' ' ILE . 44.5 t -99.97 96.81 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.361 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.946 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 41.2 t -101.37 129.42 52.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.085 0.469 . . . . 0.0 111.678 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -99.76 130.06 45.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.327 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.049 ' CE1' HD12 ' A' ' 76' ' ' LEU . 3.6 m-85 -99.12 50.18 0.95 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.011 0.434 . . . . 0.0 110.849 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.621 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -51.05 136.79 22.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.831 179.499 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.739 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -62.09 150.3 38.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.905 0.383 . . . . 0.0 110.973 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.418 ' HB ' ' N ' ' A' ' 58' ' ' ASP . 5.1 t -78.76 -22.67 46.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.339 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.441 ' CH2' ' SD ' ' A' ' 72' ' ' MET . 21.8 p-90 -104.18 -34.91 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.868 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.607 ' CB ' ' HB3' ' A' ' 27' ' ' ALA . 42.2 t -39.47 156.33 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.727 0.299 . . . . 0.0 111.425 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 32' ' ' PRO . . . -86.98 -87.97 1.06 Allowed Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.756 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.411 ' HD3' ' HA3' ' A' ' 31' ' ' GLY . 18.0 Cg_exo -66.72 61.92 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.896 2.397 . . . . 0.0 112.645 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.8 p -129.45 -4.1 4.83 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.376 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -99.02 -24.96 14.72 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.673 0.273 . . . . 0.0 111.433 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.8 mmt -68.74 -0.25 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.318 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.89 HG22 HG13 ' A' ' 40' ' ' ILE . 64.5 mt -82.66 -27.63 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.867 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.511 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -47.54 -46.04 58.86 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 41.5 Cg_endo -72.51 -36.81 4.74 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.788 1.659 . . . . 0.0 110.763 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.653 ' HE3' ' HB1' ' A' ' 90' ' ' ALA . 1.7 tmt? -62.26 -51.88 65.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.196 178.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.89 HG13 HG22 ' A' ' 36' ' ' ILE . 55.9 mt -51.45 -29.25 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.629 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.501 ' HB2' HG11 ' A' ' 2' ' ' VAL . 39.2 tt0 -76.31 -40.02 52.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.484 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -55.36 -24.63 30.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.371 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.522 ' CZ ' ' HE1' ' A' ' 39' ' ' MET . 5.1 m-85 -90.29 -22.85 21.37 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.455 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 87.1 p -70.09 -8.36 48.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.156 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.41 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 5.4 tp10 -90.02 -25.88 20.6 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.739 0.304 . . . . 0.0 110.998 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -90.4 -29.53 17.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.582 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.53 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 78.1 m-85 -122.86 44.94 0.98 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.356 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 84.1 Cg_exo -38.18 -32.02 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.088 2.525 . . . . 0.0 113.262 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -59.01 -40.86 86.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.561 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.707 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.88 141.37 28.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.709 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.615 ' HB2' HG22 ' A' ' 21' ' ' VAL . 57.1 m-20 -89.98 125.44 35.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.909 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.455 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 4.6 m-85 -99.84 93.87 6.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.532 ' C ' ' HD3' ' A' ' 54' ' ' LYS . 47.2 m-85 -107.42 179.43 4.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.917 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.851 ' HE2' HG22 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -137.9 153.88 49.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.691 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.543 HD13 ' C ' ' A' ' 55' ' ' LEU . 2.8 tm? -112.33 118.83 36.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.445 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.1 m-20 -78.25 108.37 11.52 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.566 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 57' ' ' VAL . 90.6 t -75.46 -5.03 6.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.024 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.418 ' N ' ' HB ' ' A' ' 28' ' ' THR . 67.1 t0 -80.34 -46.8 15.48 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.795 0.331 . . . . 0.0 110.826 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.548 ' C ' HD12 ' A' ' 60' ' ' LEU . 5.5 tp10 -97.99 -24.56 15.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.115 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.672 ' N ' HD12 ' A' ' 60' ' ' LEU . 3.4 mp -113.47 52.64 0.8 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.86 0.362 . . . . 0.0 111.055 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.82 -15.55 58.04 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.707 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.36 -26.36 32.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.664 0.269 . . . . 0.0 111.486 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.839 HG12 ' HE2' ' A' ' 25' ' ' PHE . 11.7 t -78.76 -22.75 12.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.865 0.364 . . . . 0.0 110.889 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.58 -24.85 38.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -90.22 -31.72 16.89 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.779 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -59.35 -47.96 83.45 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.043 0.449 . . . . 0.0 110.077 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.411 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.4 m-80 -86.86 -0.01 55.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.064 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 62.15 41.32 10.85 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.056 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.513 HG13 HG21 ' A' ' 74' ' ' THR . 47.5 t -106.27 116.54 50.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.116 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.8 p -149.87 18.69 0.89 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.695 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 1.031 ' HB3' HG21 ' A' ' 88' ' ' VAL . . . -70.15 -16.58 63.11 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.908 0.385 . . . . 0.0 110.779 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.739 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 11.4 ptt? 43.54 93.31 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.206 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.701 ' HG3' HD11 ' A' ' 36' ' ' ILE . 13.2 Cg_endo -92.6 -156.43 0.64 Allowed 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 125.077 -0.801 . . . . 0.0 112.319 -0.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.513 HG21 HG13 ' A' ' 69' ' ' VAL . 89.2 m -164.63 162.53 21.54 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.958 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.039 HD13 HD13 ' A' ' 95' ' ' ILE . 68.5 mt -123.46 123.62 41.05 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.68 0.276 . . . . 0.0 110.796 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.049 HD12 ' CE1' ' A' ' 25' ' ' PHE . 23.4 mt -118.74 131.5 56.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.0 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.729 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.5 mp -109.75 137.04 48.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.039 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.613 ' HA ' HG23 ' A' ' 84' ' ' VAL . 67.8 m-85 -136.88 126.03 24.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.276 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.713 ' HG3' HD13 ' A' ' 20' ' ' LEU . 8.6 mtmp? -113.39 126.71 55.66 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.64 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.512 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 74.6 m-80 46.26 75.43 0.12 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.617 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 40.95 39.5 1.99 Allowed Glycine 0 C--N 1.331 0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.619 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 31.9 mmmt -143.51 -158.58 0.89 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.425 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 86.5 tt0 -108.82 175.17 5.56 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.684 HG13 ' HE3' ' A' ' 79' ' ' LYS . 14.3 t -149.14 -66.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 110.946 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.13 154.42 4.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.138 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -117.79 120.63 38.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.735 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 49.1 t -139.06 93.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.138 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 1.031 HG21 ' HB3' ' A' ' 71' ' ' ALA . 4.6 p -67.56 120.85 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.964 0.411 . . . . 0.0 110.878 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.93 102.22 1.61 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.236 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.7 ' HB2' HD21 ' A' ' 75' ' ' LEU . . . -94.41 37.58 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 111.208 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 93' ' ' ALA . 46.1 t30 -83.47 134.37 45.39 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.017 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -40.73 89.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.75 2.3 . . . . 0.0 112.693 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 179.56 -32.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.301 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.11 -42.47 0.98 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.039 HD13 HD13 ' A' ' 75' ' ' LEU . 6.4 tp -53.73 -14.76 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.471 0.177 . . . . 0.0 111.449 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.428 ' HG2' ' N ' ' A' ' 97' ' ' GLN . 14.2 tttm -92.02 -61.87 1.53 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.92 0.39 . . . . 0.0 111.004 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.512 ' NE2' ' H ' ' A' ' 97' ' ' GLN . 0.3 OUTLIER -66.64 -34.83 78.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.991 -179.531 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.42 -30.26 62.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.094 0.473 . . . . 0.0 110.646 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.917 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.5 mp -90.18 -8.43 10.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.627 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.23 -75.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.319 . . . . 0.0 111.34 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.88 -29.52 8.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.356 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.592 ' HB3' HD22 ' A' ' 20' ' ' LEU . 2.4 m120 -78.54 -50.66 11.18 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.916 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.543 ' HB2' HD23 ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.03 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 52' ' ' PHE . 13.1 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.74 0.305 . . . . 0.0 110.813 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 4' ' ' GLN . 85.6 m -150.15 161.69 41.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.964 0.411 . . . . 0.0 111.433 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.609 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 17.1 mt-30 -96.88 -179.34 4.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.375 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.52 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 18.1 m-85 -132.31 95.94 3.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.188 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.79 ' O ' HD11 ' A' ' 60' ' ' LEU . 74.6 mmtt -80.77 -19.53 44.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.6 p -134.37 122.71 22.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.375 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.47 -25.41 6.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.599 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.1 t -60.63 -17.23 45.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.769 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -90.5 -45.78 8.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.158 0.504 . . . . 0.0 111.476 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.904 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.2 t80 -69.08 -23.26 64.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.087 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -57.37 -40.09 77.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.394 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -86.48 -24.46 25.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.528 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.683 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -56.94 -38.61 73.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.542 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.542 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.1 pt -86.76 -49.41 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.543 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.505 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -44.3 100.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 84.3 mt-30 44.98 90.19 0.01 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.4 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 8.5 t0 -173.66 40.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.063 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.559 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 2.8 mptp? 63.92 -157.28 0.31 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.447 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.851 HD11 ' HB3' ' A' ' 77' ' ' LEU . 59.1 tp -98.19 117.87 33.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.112 0.482 . . . . 0.0 110.914 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 51' ' ' ASP . 53.4 t -101.66 137.58 28.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.617 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.7 t -99.93 87.5 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.368 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.904 HG21 ' CE1' ' A' ' 11' ' ' PHE . 29.0 t -99.91 121.6 50.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.357 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -100.0 134.38 43.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.61 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.041 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.2 m-85 -99.19 52.36 0.95 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.931 0.395 . . . . 0.0 110.577 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -51.81 138.15 24.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -68.23 138.08 55.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.549 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -58.41 -14.37 7.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.403 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.519 ' CH2' ' HE2' ' A' ' 72' ' ' MET . 5.7 p-90 -112.25 -123.83 0.28 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.092 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 36.8 t 60.74 -83.18 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.561 0.344 . . . . 0.0 110.824 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.64 -79.8 0.22 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.145 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.65 -22.15 73.66 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.884 2.389 . . . . 0.0 113.254 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 98.4 m -50.04 -27.66 5.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.615 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -77.7 -28.25 50.95 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.524 -179.55 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.4 mtp -76.58 4.43 9.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.859 0.361 . . . . 0.0 110.85 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.805 HG22 HG13 ' A' ' 40' ' ' ILE . 70.8 mt -86.31 -20.44 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.023 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.554 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -52.15 -44.07 91.77 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 46.4 Cg_endo -72.36 -35.15 6.83 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.835 1.69 . . . . 0.0 111.417 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.9 ttt -65.84 -52.13 53.06 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.805 HG13 HG22 ' A' ' 36' ' ' ILE . 63.8 mt -49.92 -28.41 4.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.536 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.574 ' HB2' HG11 ' A' ' 2' ' ' VAL . 88.7 tt0 -76.69 -36.55 57.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.364 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.463 ' NZ ' ' HB3' ' A' ' 42' ' ' LYS . 9.3 mtpm? -58.56 -21.45 52.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.145 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.13 -22.34 21.8 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.36 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.461 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.2 t -65.6 -11.73 46.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.312 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -86.28 -25.17 25.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.661 0.267 . . . . 0.0 111.366 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.27 -28.68 18.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.792 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.528 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 80.4 m-85 -122.78 45.2 1.02 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.5 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 86.1 Cg_exo -37.98 -32.79 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.163 2.575 . . . . 0.0 113.601 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -63.69 -37.09 86.04 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.751 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.613 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.84 138.79 31.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.789 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.611 ' O ' HG13 ' A' ' 21' ' ' VAL . 59.0 m-20 -89.76 127.11 35.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.916 0.388 . . . . 0.0 110.579 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.821 ' O ' HG23 ' A' ' 2' ' ' VAL . 4.9 m-85 -98.58 86.59 3.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.717 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.52 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 36.6 m-85 -96.48 -175.73 3.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.88 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.75 ' CD ' HD12 ' A' ' 40' ' ' ILE . 34.4 mtmm -150.1 138.78 20.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.952 0.406 . . . . 0.0 111.293 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.633 HD13 ' N ' ' A' ' 56' ' ' ASP . 3.0 tm? -95.22 129.72 42.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.07 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.633 ' N ' HD13 ' A' ' 55' ' ' LEU . 41.4 m-20 -86.98 110.46 20.06 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.888 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 57' ' ' VAL . 84.2 t -78.81 -4.51 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.012 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -84.63 -55.29 4.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.977 0.418 . . . . 0.0 110.827 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.748 ' C ' HD12 ' A' ' 60' ' ' LEU . 41.6 tp10 -87.26 -17.31 32.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.398 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.79 HD11 ' O ' ' A' ' 6' ' ' LYS . 2.3 mp -127.09 57.93 1.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.929 0.395 . . . . 0.0 111.092 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.64 -16.11 55.04 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.384 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -79.95 -29.63 39.7 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.575 0.226 . . . . 0.0 111.57 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.851 HG12 ' HE2' ' A' ' 25' ' ' PHE . 21.8 t -73.49 -27.56 23.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.961 0.41 . . . . 0.0 110.956 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.518 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -80.01 -26.83 39.7 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -90.4 -31.0 17.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.823 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 13.9 ptmm? -60.31 -48.06 83.35 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.969 0.414 . . . . 0.0 109.984 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.438 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 75.3 m-80 -84.95 1.65 46.44 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.784 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 65.41 37.74 6.07 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.332 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.674 ' CG1' HG21 ' A' ' 74' ' ' THR . 48.9 t -111.61 75.19 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.815 0.341 . . . . 0.0 111.053 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.6 p -89.35 5.59 44.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.136 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -60.68 -159.01 0.01 OUTLIER 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.575 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.61 ' O ' ' HG2' ' A' ' 72' ' ' MET . 1.5 pmm? -174.98 93.2 0.29 Allowed Pre-proline 0 CA--C 1.53 0.192 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.593 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 8.0 Cg_endo -94.04 -156.69 0.57 Allowed 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 124.904 -0.873 . . . . 0.0 112.502 -0.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.674 HG21 ' CG1' ' A' ' 69' ' ' VAL . 53.4 m -158.09 148.44 20.4 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.81 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.109 HD13 HD13 ' A' ' 95' ' ' ILE . 90.5 mt -109.89 123.31 49.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.185 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.041 HD12 ' CE1' ' A' ' 25' ' ' PHE . 20.2 mt -122.76 128.96 51.17 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.837 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.851 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.5 mp -109.96 144.66 38.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.959 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.647 ' HA ' HG23 ' A' ' 84' ' ' VAL . 65.5 m-85 -145.04 126.09 14.57 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.577 ' HG3' HD13 ' A' ' 20' ' ' LEU . 51.8 mtmt -113.46 132.96 55.46 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.694 0.283 . . . . 0.0 111.493 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.3 m120 47.96 53.34 11.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.9 0.381 . . . . 0.0 111.742 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 59.43 16.07 34.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.978 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 74.7 mmtt -111.19 -153.92 0.53 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -108.81 173.79 6.16 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.647 HG23 ' HA ' ' A' ' 78' ' ' PHE . 58.0 t -149.18 -63.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.853 0.358 . . . . 0.0 111.165 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.49 162.8 8.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.2 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -138.53 115.16 10.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.543 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.5 t -136.41 98.89 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.17 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.613 ' HA ' HG23 ' A' ' 74' ' ' THR . 2.4 p -56.92 116.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.967 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.639 ' O ' ' HB2' ' A' ' 90' ' ' ALA . . . 141.52 -140.26 10.09 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.989 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 89' ' ' GLY . . . 147.61 36.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.818 0.447 . . . . 0.0 110.867 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 93' ' ' ALA . 75.3 m-80 -86.94 143.46 35.2 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.576 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -48.87 85.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.581 2.187 . . . . 0.0 112.478 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -179.48 -37.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.487 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.46 -44.34 2.13 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.109 HD13 HD13 ' A' ' 75' ' ' LEU . 3.2 tp -50.1 -18.61 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.464 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.463 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 7.8 ptpp? -91.71 -49.52 6.23 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.971 0.415 . . . . 0.0 110.974 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.463 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 25.7 mt-30 -69.22 -32.11 71.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.48 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.65 -27.76 68.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.534 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.833 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 58.4 mt -90.22 -11.54 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.511 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.43 -74.21 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.917 0.389 . . . . 0.0 111.492 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -45.93 -29.5 1.44 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.378 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.738 ' HB3' HD22 ' A' ' 20' ' ' LEU . 69.8 m-20 -90.14 -42.34 11.12 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.269 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.833 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.081 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.541 HG11 ' HB2' ' A' ' 41' ' ' GLU . 12.5 p . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.652 0.263 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.3 m -150.26 156.54 41.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.946 0.403 . . . . 0.0 111.403 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -99.57 -173.44 2.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.621 179.368 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.527 ' CE2' ' CD1' ' A' ' 11' ' ' PHE . 21.4 m-85 -137.5 101.33 4.47 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.61 ' C ' HD11 ' A' ' 60' ' ' LEU . 43.9 mmtm -83.19 -20.41 34.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.283 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -133.03 122.84 24.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.147 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.12 -26.49 27.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.49 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -55.33 -23.41 23.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.188 0.518 . . . . 0.0 110.392 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -90.69 -35.19 15.07 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.627 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.88 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -74.76 -24.11 58.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.948 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -58.75 -68.68 0.24 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.066 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.4 t -56.74 -23.56 43.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.447 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 11' ' ' PHE . . . -52.46 -64.36 0.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.36 . . . . 0.0 111.472 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.7 pt -61.03 -47.23 94.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.486 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -40.28 97.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.7 mt-30 43.14 88.58 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.309 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.509 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 63.9 t0 -167.11 38.5 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.671 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 28.7 mtmt 70.07 -155.46 0.14 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.799 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.537 ' CD1' HG21 ' A' ' 84' ' ' VAL . 36.4 tp -97.6 112.07 24.09 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.144 0.497 . . . . 0.0 110.574 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.776 HG22 ' HB2' ' A' ' 51' ' ' ASP . 47.3 t -101.44 124.73 55.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.536 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.724 HG21 HG12 ' A' ' 99' ' ' ILE . 50.4 t -103.51 98.79 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.141 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.88 HG21 ' CE1' ' A' ' 11' ' ' PHE . 38.2 t -105.74 131.69 54.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.775 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 74' ' ' THR . 62.2 t0 -100.1 132.53 45.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.53 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.056 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.2 m-85 -99.11 49.13 0.95 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.069 0.462 . . . . 0.0 110.524 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.58 ' HB2' ' HB3' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -50.42 145.87 5.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.44 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.792 ' HB2' ' CB ' ' A' ' 72' ' ' MET . . . -59.99 164.91 3.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.77 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.441 ' HB ' ' N ' ' A' ' 58' ' ' ASP . 3.1 t -96.75 22.74 7.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.913 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -148.82 -44.77 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 39.1 t -43.3 156.11 0.05 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.836 0.35 . . . . 0.0 111.373 -179.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -93.41 -69.34 1.1 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.239 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -47.07 -25.95 4.64 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.983 2.456 . . . . 0.0 112.955 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 98.7 m -61.8 -63.07 1.38 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.704 0.288 . . . . 0.0 111.623 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 61.9 pttt -55.45 -22.02 18.68 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.602 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.418 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 44.4 tpp -76.43 1.43 16.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 110.776 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.916 HG22 HG13 ' A' ' 40' ' ' ILE . 63.1 mt -85.93 -18.08 9.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.401 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.529 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.32 -44.4 81.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 53.9 Cg_endo -73.36 -35.4 4.98 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.837 1.691 . . . . 0.0 111.438 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.74 ' CE ' HG23 ' A' ' 36' ' ' ILE . 57.3 ttp -65.33 -52.04 56.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.916 HG13 HG22 ' A' ' 36' ' ' ILE . 73.1 mt -48.18 -29.51 2.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.56 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.541 ' HB2' HG11 ' A' ' 2' ' ' VAL . 87.1 tt0 -76.92 -34.31 57.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.977 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -63.91 -22.89 67.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.62 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -90.37 -22.51 21.46 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.463 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 80.2 p -67.29 -9.17 38.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.486 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -88.62 -26.22 22.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.78 0.324 . . . . 0.0 111.174 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -90.53 -29.79 17.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.842 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.529 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 78.6 m-85 -122.79 45.63 1.12 Allowed Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.502 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 84.0 Cg_exo -38.05 -32.16 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.22 2.613 . . . . 0.0 113.952 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.498 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 3.9 mm100 -66.91 -16.83 64.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.927 0.394 . . . . 0.0 111.31 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -104.04 139.89 38.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.559 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.776 ' HB2' HG22 ' A' ' 21' ' ' VAL . 24.9 m-20 -89.44 120.99 31.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.907 0.384 . . . . 0.0 110.359 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.555 ' CE2' HD13 ' A' ' 99' ' ' ILE . 5.3 m-85 -97.92 83.88 3.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.313 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.599 ' HB2' HG22 ' A' ' 23' ' ' VAL . 46.5 m-85 -99.52 -174.53 2.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.354 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.655 ' CD ' HD12 ' A' ' 40' ' ' ILE . 32.6 mtmm -150.21 141.69 23.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.943 0.401 . . . . 0.0 110.964 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.711 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.5 tm? -100.41 130.34 46.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.866 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.711 ' N ' HD13 ' A' ' 55' ' ' LEU . 44.6 m-20 -87.87 114.07 24.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.856 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 57' ' ' VAL . 78.3 t -77.54 -3.08 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.65 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.441 ' N ' ' HB ' ' A' ' 28' ' ' THR . 64.9 t0 -82.05 -55.53 4.51 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.899 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.453 ' C ' HD12 ' A' ' 60' ' ' LEU . 41.0 tp10 -89.82 -28.46 19.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.391 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.659 ' N ' HD12 ' A' ' 60' ' ' LEU . 3.8 mp -108.23 52.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.848 0.356 . . . . 0.0 111.116 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.9 -15.21 59.9 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.447 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -82.94 -29.12 29.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.716 0.293 . . . . 0.0 111.448 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.756 HG12 ' HE2' ' A' ' 25' ' ' PHE . 15.4 t -73.33 -51.1 27.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.454 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -54.47 -26.02 28.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.114 0.483 . . . . 0.0 109.718 178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.415 ' NE2' ' C ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -90.46 -37.82 13.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.07 179.649 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -61.64 -42.53 99.02 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.903 0.382 . . . . 0.0 110.352 -179.581 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -83.68 -0.46 50.83 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 65.67 35.45 6.96 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.334 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.68 ' CG1' HG21 ' A' ' 74' ' ' THR . 31.2 t -113.16 63.51 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 121.03 0.443 . . . . 0.0 110.867 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.2 p -74.57 -13.85 60.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.074 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.79 -168.77 0.0 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.414 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.792 ' CB ' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -174.29 111.82 0.3 Allowed Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.207 -179.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.517 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 57.3 Cg_endo -88.99 -166.73 3.19 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.275 -1.136 . . . . 0.0 112.398 -0.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.747 HG23 ' HA ' ' A' ' 88' ' ' VAL . 34.1 m -159.81 150.07 18.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.604 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.052 HD13 HD13 ' A' ' 95' ' ' ILE . 71.8 mt -110.78 124.8 52.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.888 0.375 . . . . 0.0 111.591 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.056 HD12 ' CE1' ' A' ' 25' ' ' PHE . 29.4 mt -124.72 124.14 41.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.465 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.667 HD12 ' N ' ' A' ' 77' ' ' LEU . 3.3 mp -109.91 149.19 30.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.786 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.601 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 40.5 m-85 -149.29 128.55 12.87 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.128 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.823 ' HG3' HG11 ' A' ' 84' ' ' VAL . 9.8 mtpm? -114.99 137.33 52.12 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.477 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 6.2 m120 49.93 52.35 14.83 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.721 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 16' ' ' ALA . . . 57.78 18.7 33.17 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.732 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.601 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 67.1 mttm -120.01 -155.56 0.63 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.743 ' O ' HG13 ' A' ' 84' ' ' VAL . 85.8 tt0 -109.13 176.93 4.92 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.823 HG11 ' HG3' ' A' ' 79' ' ' LYS . 3.5 m -165.38 -47.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.44 0.162 . . . . 0.0 111.301 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.69 170.37 9.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.142 0.496 . . . . 0.0 112.019 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.47 ' HD2' ' N ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -160.12 132.19 6.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.355 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.4 t -146.02 109.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.147 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.747 ' HA ' HG23 ' A' ' 74' ' ' THR . 6.5 p -69.55 69.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.814 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.2 118.29 0.56 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.349 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.677 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -95.96 38.0 1.2 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.914 0.388 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 93' ' ' ALA . 5.5 m120 -65.89 132.21 94.71 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.545 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 86.5 Cg_exo -48.4 86.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.66 2.24 . . . . 0.0 112.668 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 92' ' ' PRO . . . 176.8 -36.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.267 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.04 -46.87 2.7 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 1.052 HD13 HD13 ' A' ' 75' ' ' LEU . 4.7 tp -53.58 -15.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.211 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HG3' ' HG3' ' A' ' 97' ' ' GLN . 21.3 ptmt -91.38 -50.95 5.53 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.791 0.329 . . . . 0.0 111.086 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.421 ' HG3' ' HG3' ' A' ' 96' ' ' LYS . 73.0 mt-30 -73.79 -32.97 64.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.478 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.02 -26.44 66.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.59 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.724 HG12 HG21 ' A' ' 22' ' ' VAL . 63.7 mt -90.24 -18.27 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.107 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.74 -65.49 1.01 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.007 0.432 . . . . 0.0 111.104 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -48.96 -28.26 3.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.217 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.526 ' CB ' HD22 ' A' ' 20' ' ' LEU . 50.8 m-20 -90.23 -38.71 13.26 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.34 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.197 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.798 0.332 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.492 HG11 ' HB2' ' A' ' 41' ' ' GLU . 10.7 p -167.7 135.91 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.802 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.449 HG22 ' N ' ' A' ' 4' ' ' GLN . 86.0 m -150.11 161.77 41.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.884 0.373 . . . . 0.0 111.253 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.462 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 16.6 mt-30 -102.93 -172.68 2.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.39 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.531 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.2 m-85 -137.52 129.32 28.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.059 0.457 . . . . 0.0 111.461 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.716 ' C ' HD11 ' A' ' 60' ' ' LEU . 75.2 mmtt -112.98 -28.24 7.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.498 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.0 p -128.57 132.49 48.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.515 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.44 -25.34 50.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.51 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.3 t -59.74 -18.35 42.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.621 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -90.42 -64.94 1.06 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.277 0.561 . . . . 0.0 111.031 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.897 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.2 t80 -53.54 -29.0 34.63 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.015 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -54.89 -35.29 63.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.018 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.3 p -82.5 -37.49 25.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.111 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.594 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -46.74 -49.12 20.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.66 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.522 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.5 pt -77.58 -49.91 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.501 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.48 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -40.74 95.43 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 85.1 mt-30 44.35 86.66 0.02 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.422 179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 8.1 t0 -169.54 41.14 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.407 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 10.9 mptt 67.56 -155.41 0.21 Allowed 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 120.694 0.283 . . . . 0.0 110.888 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.898 HD11 ' HB3' ' A' ' 77' ' ' LEU . 61.5 tp -98.1 115.21 27.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.222 0.534 . . . . 0.0 111.252 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.511 HG12 HG23 ' A' ' 23' ' ' VAL . 59.9 t -99.79 128.2 51.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.471 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.678 HG21 ' CD1' ' A' ' 99' ' ' ILE . 48.8 t -99.74 91.22 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 110.816 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.897 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 42.0 t -101.27 132.19 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.125 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.9 t70 -102.43 129.11 48.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.73 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.071 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.4 m-85 -98.98 51.6 0.96 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.206 0.527 . . . . 0.0 110.467 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.533 ' O ' HG23 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -50.99 139.44 17.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.111 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 71' ' ' ALA . . . -65.58 141.75 58.32 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.331 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.6 t -57.91 -18.13 21.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.069 0.461 . . . . 0.0 110.835 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.422 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 8.2 p-90 -106.61 -128.74 0.27 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.315 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 72' ' ' MET . 30.2 t 61.08 156.08 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 120.805 0.336 . . . . 0.0 110.979 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.09 -82.1 1.19 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.488 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.97 60.85 3.79 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.627 2.218 . . . . 0.0 112.33 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.7 p -107.61 -20.83 13.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.024 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -85.71 -24.11 27.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.119 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.454 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 57.7 ttp -63.44 -12.69 33.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.982 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.772 HG22 HG13 ' A' ' 40' ' ' ILE . 2.7 mp -81.99 -30.22 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.669 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -49.5 -45.72 77.95 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 37.8 Cg_endo -70.86 -37.65 6.28 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.722 1.615 . . . . 0.0 111.012 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.494 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 66.4 mtm -63.92 -54.94 26.81 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.772 HG13 HG22 ' A' ' 36' ' ' ILE . 55.7 mt -44.74 -29.08 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 121.069 0.461 . . . . 0.0 110.542 178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.492 ' HB2' HG11 ' A' ' 2' ' ' VAL . 38.3 tt0 -81.59 -40.32 23.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.176 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -59.82 -27.9 67.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.627 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.616 ' CE2' HG23 ' A' ' 95' ' ' ILE . 10.4 m-85 -78.02 -22.43 49.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.625 0.25 . . . . 0.0 111.389 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.446 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 46.9 t -66.65 -11.32 53.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.206 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -87.44 -26.09 23.44 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.64 0.257 . . . . 0.0 111.096 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -89.98 -31.73 17.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.199 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.479 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 89.7 m-85 -124.39 51.61 4.85 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.02 0.438 . . . . 0.0 110.489 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 2.9 Cg_endo -48.95 -25.43 8.66 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.034 2.489 . . . . 0.0 112.484 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -65.77 -31.49 72.49 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.054 0.454 . . . . 0.0 110.229 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.742 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -95.77 144.48 26.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.86 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.489 ' HB2' HG22 ' A' ' 21' ' ' VAL . 58.9 m-20 -89.96 129.98 36.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.709 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.479 ' CZ ' HD13 ' A' ' 99' ' ' ILE . 8.8 m-85 -105.09 90.94 3.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.391 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.628 ' HB2' HG22 ' A' ' 23' ' ' VAL . 47.5 m-85 -101.01 -178.12 3.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.559 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.493 ' HZ2' HD12 ' A' ' 40' ' ' ILE . 20.1 mtpp -141.9 141.27 33.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.395 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.911 HD13 ' N ' ' A' ' 56' ' ' ASP . 3.0 tm? -105.26 144.23 32.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.29 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.911 ' N ' HD13 ' A' ' 55' ' ' LEU . 22.9 t70 -99.9 115.5 29.77 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.075 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 26' ' ' TYR . 75.5 t -76.83 -4.0 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.919 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.442 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 38.6 t70 -96.21 -50.09 4.95 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.254 0.549 . . . . 0.0 110.215 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.494 ' C ' HD12 ' A' ' 60' ' ' LEU . 5.1 tp10 -82.16 -40.28 22.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.652 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.724 HD22 ' CD2' ' A' ' 55' ' ' LEU . 4.1 mp -111.67 43.53 1.52 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.545 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -52.6 -24.05 16.45 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.762 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 56.6 m-20 -71.04 -50.09 37.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.688 0.28 . . . . 0.0 111.256 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.756 HG12 ' HE2' ' A' ' 25' ' ' PHE . 15.6 t -56.37 -23.85 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.142 0.496 . . . . 0.0 110.244 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 69' ' ' VAL . . . -80.35 -25.2 39.33 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 62' ' ' ASP . 5.7 pt20 -90.21 -35.4 15.36 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.272 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.562 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 20.2 ptmt -57.79 -48.45 79.66 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.421 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.435 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 75.6 m-80 -85.48 2.18 45.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.048 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 63.92 38.94 8.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.905 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.765 HG13 HG21 ' A' ' 74' ' ' THR . 43.8 t -116.39 99.82 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.899 0.38 . . . . 0.0 111.398 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.7 m -121.7 13.17 10.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.816 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -60.9 -157.9 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.092 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.604 ' O ' ' HG2' ' A' ' 72' ' ' MET . 0.0 OUTLIER -169.75 88.19 0.57 Allowed Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.457 ' O ' HG23 ' A' ' 88' ' ' VAL . 40.3 Cg_endo -96.71 -164.57 0.99 Allowed 'Cis proline' 0 C--N 1.347 0.488 0 C-N-CA 124.777 -0.926 . . . . 0.0 112.793 -0.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.816 ' OG1' ' HB3' ' A' ' 71' ' ' ALA . 29.3 m -149.98 153.91 37.35 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.701 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.016 HD13 HD13 ' A' ' 95' ' ' ILE . 85.3 mt -114.33 126.58 55.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.819 0.342 . . . . 0.0 111.235 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.071 HD12 ' CE1' ' A' ' 25' ' ' PHE . 19.1 mt -121.76 128.68 52.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.014 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.898 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.6 mp -109.89 141.88 41.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.628 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.607 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 65.1 m-85 -141.88 127.13 18.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.697 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.838 ' CG ' HG11 ' A' ' 84' ' ' VAL . 8.9 mmmm -109.82 133.17 53.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.53 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 5.2 m120 42.88 65.17 0.99 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.01 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 53.96 21.02 15.65 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.155 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.607 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 28.1 mtpp -127.33 -160.82 1.03 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.633 ' O ' HG13 ' A' ' 84' ' ' VAL . 82.3 tt0 -109.47 178.06 4.55 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.838 HG11 ' CG ' ' A' ' 79' ' ' LYS . 4.8 m -162.38 -47.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 O-C-N 123.1 0.25 . . . . 0.0 111.144 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.96 162.07 17.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.125 0.488 . . . . 0.0 111.874 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -149.09 115.39 5.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.267 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.3 t -131.1 98.66 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.331 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.597 HG21 ' CB ' ' A' ' 71' ' ' ALA . 3.3 p -62.33 98.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.696 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 138.98 108.52 0.81 Allowed Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.2 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.683 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -95.68 37.13 1.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 111.259 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 93' ' ' ALA . 75.9 m-80 -72.04 131.77 85.17 Favored Pre-proline 0 N--CA 1.446 -0.644 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.237 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -45.91 86.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.689 2.26 . . . . 0.0 112.637 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 178.51 -36.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.525 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.23 -45.62 2.44 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.016 HD13 HD13 ' A' ' 75' ' ' LEU . 5.0 tp -49.94 -18.44 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.302 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 22.4 pttp -91.76 -50.97 5.46 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.903 0.382 . . . . 0.0 111.049 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.405 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 61.7 mt-30 -69.9 -32.1 70.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.599 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.1 -28.46 69.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.748 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.678 ' CD1' HG21 ' A' ' 22' ' ' VAL . 56.7 mt -90.22 -8.08 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.526 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.26 -69.39 0.73 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.866 0.365 . . . . 0.0 111.162 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.99 -29.61 30.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.177 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.623 ' CB ' HD22 ' A' ' 20' ' ' LEU . 5.6 m120 -80.75 -52.91 6.99 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.053 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.041 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.661 ' O ' HG12 ' A' ' 2' ' ' VAL . 26.5 ptt? . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.661 HG12 ' O ' ' A' ' 1' ' ' MET . 11.2 p 52.03 131.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.23 0.538 . . . . 0.0 112.048 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 4' ' ' GLN . 88.9 m -150.17 162.42 40.49 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.133 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.532 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 59.5 mt-30 -101.04 178.77 4.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.631 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.52 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 18.4 m-85 -133.17 98.48 4.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.712 0.291 . . . . 0.0 111.598 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.728 ' O ' HD11 ' A' ' 60' ' ' LEU . 45.8 mmtm -83.52 -28.31 28.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.44 178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.3 p -123.36 122.62 38.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.255 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.59 -26.4 8.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.687 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.9 t -59.22 -19.85 49.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.829 0.347 . . . . 0.0 110.426 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -90.73 -31.07 16.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.358 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.88 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -85.86 8.45 20.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.391 -179.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -87.7 -60.58 1.93 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.867 0.365 . . . . 0.0 110.923 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -67.01 -17.17 64.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.28 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.48 91.24 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.377 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.554 ' O ' ' N ' ' A' ' 81' ' ' GLY . 21.4 pt -88.89 -49.92 13.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.465 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.478 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -46.29 103.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.847 0.356 . . . . 0.0 111.955 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.9 mt-30 44.01 87.45 0.02 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.29 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -168.84 40.67 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.035 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.555 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER 64.33 -156.88 0.31 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.281 179.419 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.764 HD13 ' N ' ' A' ' 103' ' ' ALA . 3.4 tt -98.15 115.85 29.14 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.205 0.526 . . . . 0.0 110.782 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.794 HG22 ' HB2' ' A' ' 51' ' ' ASP . 47.3 t -104.73 127.87 58.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.135 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.779 HG22 ' HG ' ' A' ' 77' ' ' LEU . 61.6 t -103.69 95.21 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.552 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.88 HG21 ' CE1' ' A' ' 11' ' ' PHE . 40.5 t -99.85 136.73 29.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.204 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 74' ' ' THR . 38.8 t70 -100.01 128.1 46.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.825 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.996 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.2 m-85 -98.89 48.69 0.96 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.012 0.434 . . . . 0.0 110.683 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.521 ' HD1' ' O ' ' A' ' 26' ' ' TYR . 0.7 OUTLIER -51.48 137.04 24.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.889 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.789 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -58.39 165.01 2.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.965 0.412 . . . . 0.0 111.042 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.5 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 3.7 t -98.67 19.24 15.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.066 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.428 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 15.4 p-90 -141.76 -38.71 0.39 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.8 t -36.87 -69.06 0.12 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.781 0.325 . . . . 0.0 111.801 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.87 -74.42 0.23 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.511 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.6 -26.95 9.86 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.666 2.244 . . . . 0.0 112.421 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.417 ' HB3' ' CB ' ' A' ' 26' ' ' TYR . 77.5 m -58.25 -21.21 47.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.203 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -75.32 -19.22 59.76 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.28 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.425 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 84.4 mtp -75.3 3.8 8.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.851 0.357 . . . . 0.0 110.691 179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.039 HG22 HG13 ' A' ' 40' ' ' ILE . 55.1 mt -85.68 -17.8 9.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.487 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.592 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.51 -42.33 74.65 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 35.3 Cg_endo -68.93 -43.58 3.3 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 121.576 1.517 . . . . 0.0 111.324 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.589 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 23.9 mmt -61.23 -61.28 2.67 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.039 HG13 HG22 ' A' ' 36' ' ' ILE . 56.8 mt -43.73 -29.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.846 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.618 ' HB2' HG11 ' A' ' 2' ' ' VAL . 4.0 tm-20 -81.56 -37.8 27.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.822 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 39' ' ' MET . 99.3 mttt -71.6 -30.96 66.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.544 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.589 ' HD1' ' O ' ' A' ' 39' ' ' MET . 16.3 m-85 -73.15 -27.07 61.46 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.356 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.5 p -67.02 -9.7 41.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.147 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.409 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 56.2 mt-10 -87.26 -26.51 23.44 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.788 0.327 . . . . 0.0 111.222 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.4 -31.79 16.7 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.524 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.531 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 73.9 m-85 -122.78 45.19 1.02 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.401 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 80.3 Cg_exo -37.74 -32.32 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.286 2.657 . . . . 0.0 113.478 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -60.71 -35.1 75.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.604 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.44 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.8 138.54 31.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.543 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.794 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.68 122.32 32.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.888 0.375 . . . . 0.0 110.46 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.65 ' CZ ' HD13 ' A' ' 99' ' ' ILE . 4.5 m-85 -99.32 90.33 4.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.577 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.733 ' HB2' HG22 ' A' ' 23' ' ' VAL . 41.0 m-85 -101.02 -177.76 3.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.572 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HB2' ' HA ' ' A' ' 4' ' ' GLN . 34.4 mtpt -139.96 131.5 27.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.369 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.667 HD23 ' CD2' ' A' ' 11' ' ' PHE . 3.2 tm? -95.73 126.39 40.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.138 0.494 . . . . 0.0 111.068 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.569 ' N ' HD13 ' A' ' 55' ' ' LEU . 44.9 m-20 -85.29 113.08 21.36 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.716 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 96.4 t -81.85 -5.83 9.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.141 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.5 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 11.4 p-10 -84.52 -39.72 18.5 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.854 0.359 . . . . 0.0 110.854 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.662 ' C ' HD12 ' A' ' 60' ' ' LEU . 17.6 tp10 -100.4 -23.02 14.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.171 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.728 HD11 ' O ' ' A' ' 6' ' ' LYS . 3.1 mp -119.57 48.44 1.52 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.822 0.344 . . . . 0.0 110.995 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -60.35 -18.24 49.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.444 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.67 -27.56 55.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.694 0.283 . . . . 0.0 111.507 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.717 HG12 ' HE2' ' A' ' 25' ' ' PHE . 15.7 t -75.53 -54.69 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.758 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.428 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -53.51 -26.74 22.12 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.954 0.407 . . . . 0.0 110.218 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.06 -26.84 20.07 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.69 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.0 tptm -70.44 -49.36 49.55 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.034 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -77.61 -1.1 29.16 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.116 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 67.55 37.61 3.34 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.344 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.654 ' CG1' HG21 ' A' ' 74' ' ' THR . 40.5 t -115.25 68.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.854 0.359 . . . . 0.0 110.845 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.8 p -81.77 -7.95 59.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.15 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.56 -166.53 0.0 OUTLIER 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.537 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.789 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -174.43 107.43 0.28 Allowed Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.85 ' HG3' HD11 ' A' ' 36' ' ' ILE . 37.2 Cg_endo -89.77 -166.68 2.99 Favored 'Cis proline' 0 C--N 1.35 0.642 0 C-N-CA 124.353 -1.103 . . . . 0.0 112.366 -0.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.713 HG23 ' HA ' ' A' ' 88' ' ' VAL . 53.4 m -160.88 142.69 12.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.227 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.734 HD13 HD13 ' A' ' 95' ' ' ILE . 36.7 mt -109.79 123.75 50.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.023 0.439 . . . . 0.0 111.551 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.996 HD12 ' CE1' ' A' ' 25' ' ' PHE . 29.1 mt -115.16 127.07 55.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.853 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.779 ' HG ' HG22 ' A' ' 22' ' ' VAL . 4.5 mp -109.68 131.52 54.98 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.872 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.563 ' HA ' HG23 ' A' ' 84' ' ' VAL . 51.9 m-85 -130.94 125.52 33.65 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.298 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.481 ' HG3' HG21 ' A' ' 84' ' ' VAL . 24.6 mtpp -109.78 126.53 53.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.719 0.295 . . . . 0.0 111.087 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 6.3 m120 50.41 55.62 9.2 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.941 0.4 . . . . 0.0 111.768 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 59.58 16.39 36.78 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.072 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 27.0 mtpp -115.57 -153.55 0.53 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.44 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 35.6 tt0 -108.87 171.51 7.39 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.563 HG23 ' HA ' ' A' ' 78' ' ' PHE . 38.4 t -144.0 -59.82 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.75 0.309 . . . . 0.0 111.203 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.08 157.42 6.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.442 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -118.3 114.67 23.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.708 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.4 t -136.96 80.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.036 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.713 ' HA ' HG23 ' A' ' 74' ' ' THR . 3.8 p -59.64 85.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.998 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.54 123.41 2.06 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.703 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.604 ' HB2' HD11 ' A' ' 75' ' ' LEU . . . -84.45 55.23 3.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 0.0 110.83 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 46.6 t30 -51.59 131.89 35.86 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.725 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -44.96 -25.95 1.85 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.643 2.229 . . . . 0.0 112.776 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.403 ' HA ' ' HE2' ' A' ' 96' ' ' LYS . . . -123.32 49.19 1.72 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.724 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 91' ' ' ASN . . . -152.39 -62.02 0.16 Allowed 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.443 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.759 HD11 HG11 ' A' ' 22' ' ' VAL . 3.5 tp -58.17 -5.45 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.184 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.447 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 64.5 pttt -90.95 -47.53 7.53 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.954 0.407 . . . . 0.0 110.469 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.447 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 25.7 mt-30 -74.7 -32.47 62.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.52 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.4 -30.94 70.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.578 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.78 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 56.4 mt -90.25 -6.4 10.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.528 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.64 -77.69 0.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.998 0.428 . . . . 0.0 111.651 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.21 -29.3 5.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.883 -0.599 . . . . 0.0 112.054 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.604 ' HB3' HD12 ' A' ' 20' ' ' LEU . 73.0 m-80 -88.05 -67.4 0.83 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.672 0.272 . . . . 0.0 111.707 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.78 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.292 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.815 0.34 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.659 HG22 ' NZ ' ' A' ' 54' ' ' LYS . 9.9 p -153.73 132.98 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.56 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 4' ' ' GLN . 95.4 m -150.29 157.69 43.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.0 111.481 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.546 ' HG3' ' HE2' ' A' ' 54' ' ' LYS . 10.8 mp0 -92.23 -177.14 4.57 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.771 ' O ' HD11 ' A' ' 60' ' ' LEU . 14.7 m-85 -133.67 96.57 3.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.819 0.342 . . . . 0.0 111.073 178.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -75.54 -30.29 59.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.729 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.0 p -128.61 132.43 48.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.48 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.06 -25.32 58.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.389 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.8 m -59.08 -19.86 48.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.542 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -90.63 -35.75 14.8 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.2 0.524 . . . . 0.0 111.075 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.944 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -73.67 -29.46 62.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.888 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -53.3 -57.02 12.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.218 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.8 p -61.13 -37.61 83.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.436 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -49.56 -51.9 33.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.649 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.53 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.6 pt -75.94 -48.86 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.529 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.479 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -43.14 97.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.465 0.542 . . . . 0.0 112.465 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 84.7 mt-30 45.35 88.86 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.341 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 8.8 t70 -170.0 39.83 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.403 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 52.0 mttp 68.18 -154.35 0.18 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.731 0.301 . . . . 0.0 110.584 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.924 HD11 ' HB3' ' A' ' 77' ' ' LEU . 61.1 tp -97.8 114.28 26.28 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.089 0.471 . . . . 0.0 110.916 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.77 HG22 ' HB2' ' A' ' 51' ' ' ASP . 60.0 t -103.81 124.03 57.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.665 HG21 ' CG1' ' A' ' 99' ' ' ILE . 49.1 t -99.78 96.67 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.681 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.944 HG21 ' CE1' ' A' ' 11' ' ' PHE . 36.2 t -103.34 130.11 54.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.065 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.8 t70 -99.68 131.37 45.71 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.577 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.062 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.3 m-85 -98.9 50.88 0.96 Allowed 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.036 0.446 . . . . 0.0 110.707 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -54.05 135.61 42.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.935 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.707 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -60.88 156.42 17.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 0.0 110.894 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 3.2 t -87.35 6.09 35.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.453 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.45 ' CZ2' ' CE ' ' A' ' 72' ' ' MET . 20.1 p-90 -127.52 -37.58 1.98 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.437 ' C ' ' O ' ' A' ' 29' ' ' TRP . 53.9 t -28.51 -75.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.08 -80.81 0.35 Allowed Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.898 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.96 -21.3 33.35 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.756 2.304 . . . . 0.0 112.326 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.5 p -53.44 -33.56 54.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.124 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -64.94 -22.74 67.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.321 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.0 mtp -68.76 -7.4 33.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.735 0.302 . . . . 0.0 111.016 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.776 HG22 HG13 ' A' ' 40' ' ' ILE . 57.0 mt -88.01 -19.25 7.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.303 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.536 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -53.09 -43.74 95.45 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.893 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 38.1 Cg_endo -71.67 -36.66 6.17 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 121.747 1.632 . . . . 0.0 111.459 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.468 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 1.1 mpt? -64.64 -55.95 16.94 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.776 HG13 HG22 ' A' ' 36' ' ' ILE . 55.7 mt -44.66 -27.4 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.841 178.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.509 ' HB2' HG11 ' A' ' 2' ' ' VAL . 43.1 tt0 -80.75 -39.83 26.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.138 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -64.12 -30.98 72.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.606 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.468 ' HD1' ' O ' ' A' ' 39' ' ' MET . 10.7 m-85 -75.47 -19.18 59.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.69 0.281 . . . . 0.0 111.377 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.43 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.6 t -72.77 -6.92 48.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.382 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -90.15 -26.9 19.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.701 0.286 . . . . 0.0 111.06 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -90.3 -28.99 18.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.568 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.52 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 80.0 m-85 -123.83 47.65 1.89 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.081 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.52 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 62.9 Cg_exo -35.26 -41.58 0.35 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.6 2.867 . . . . 0.0 113.919 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.411 ' O ' ' CD ' ' A' ' 19' ' ' LYS . 85.8 mt-30 -55.4 -34.92 64.8 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.978 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.6 135.77 33.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.722 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.77 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.62 121.95 32.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.409 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.451 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . 5.6 m-85 -98.26 84.59 3.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.586 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.556 ' HB2' HG22 ' A' ' 23' ' ' VAL . 48.2 m-85 -98.86 -174.71 2.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.515 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.659 ' NZ ' HG22 ' A' ' 2' ' ' VAL . 34.4 mtmm -148.39 132.65 17.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.018 0.437 . . . . 0.0 111.033 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.748 HD21 HD22 ' A' ' 60' ' ' LEU . 2.1 tm? -91.87 130.74 37.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.187 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.838 ' O ' HD13 ' A' ' 60' ' ' LEU . 46.8 m-20 -86.44 126.32 34.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.411 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.719 HG12 ' O ' ' A' ' 57' ' ' VAL . 95.9 t -97.16 18.93 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.533 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 2.8 p30 -111.39 -38.99 4.81 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.242 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.428 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 17.6 tp10 -100.03 -13.94 18.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.805 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.838 HD13 ' O ' ' A' ' 56' ' ' ASP . 5.3 mp -104.74 -69.08 0.82 Allowed 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.295 0.569 . . . . 0.0 110.926 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 68.84 -61.58 0.5 Allowed Glycine 0 C--N 1.314 -0.661 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.591 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -52.69 -43.43 65.59 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.735 HG12 ' HE2' ' A' ' 25' ' ' PHE . 16.0 t -59.83 -53.34 49.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.719 0.295 . . . . 0.0 110.844 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -51.25 -26.09 6.66 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.969 0.414 . . . . 0.0 110.053 178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -90.39 -38.02 13.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.157 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.594 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -61.15 -42.0 97.75 Favored 'General case' 0 C--O 1.23 0.055 0 CA-C-O 120.863 0.363 . . . . 0.0 110.414 -179.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -84.95 -1.97 57.34 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.923 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 64.91 38.4 6.5 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.021 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.809 HG13 HG21 ' A' ' 74' ' ' THR . 40.2 t -114.75 69.12 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.852 0.358 . . . . 0.0 111.019 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.8 p -82.34 -11.46 58.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.067 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.524 ' CB ' HG21 ' A' ' 88' ' ' VAL . . . -55.32 -172.07 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.603 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.707 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 1.7 pmm? -171.59 107.57 0.38 Allowed Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 120.602 -0.439 . . . . 0.0 112.085 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.553 ' HG3' HD12 ' A' ' 36' ' ' ILE . 83.2 Cg_endo -93.78 171.23 18.28 Favored 'Cis proline' 0 N--CA 1.459 -0.55 0 C-N-CA 124.634 -0.986 . . . . 0.0 112.23 -0.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.809 HG21 HG13 ' A' ' 69' ' ' VAL . 34.5 m -136.16 153.69 51.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.953 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.071 HD13 HD13 ' A' ' 95' ' ' ILE . 85.3 mt -115.09 125.55 53.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 0.0 111.056 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.062 HD12 ' CE1' ' A' ' 25' ' ' PHE . 28.5 mt -122.38 128.99 51.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.061 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.924 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.4 mp -109.79 146.03 35.69 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.441 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.626 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 67.9 m-85 -145.99 128.82 16.33 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.779 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.888 ' CG ' HG11 ' A' ' 84' ' ' VAL . 27.0 mmmt -109.69 132.92 53.7 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.458 178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 5.2 m120 44.44 60.25 2.93 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.842 0.353 . . . . 0.0 111.845 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 57.29 18.61 29.28 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 121.245 -0.503 . . . . 0.0 113.072 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.626 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 96.5 mttt -122.12 -158.86 0.79 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.72 ' O ' HG13 ' A' ' 84' ' ' VAL . 32.0 tt0 -109.35 176.73 4.98 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.888 HG11 ' CG ' ' A' ' 79' ' ' LYS . 3.3 m -165.01 -46.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 O-C-N 123.169 0.293 . . . . 0.0 111.292 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -165.26 158.17 16.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.147 0.499 . . . . 0.0 111.881 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 86' ' ' LYS . 60.8 pttt -151.67 114.85 4.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.399 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.7 t -135.57 106.64 6.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.184 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.56 ' HB ' HG23 ' A' ' 74' ' ' THR . 3.6 p -66.78 97.87 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.48 104.83 0.44 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.195 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.788 ' HB2' HD21 ' A' ' 75' ' ' LEU . . . -96.98 35.87 1.5 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.927 0.394 . . . . 0.0 111.524 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 93' ' ' ALA . 13.9 p-10 -76.7 134.45 69.1 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.236 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 80.0 Cg_exo -44.79 87.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.591 2.194 . . . . 0.0 112.702 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 178.76 -36.24 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.551 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.9 -41.9 2.2 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.071 HD13 HD13 ' A' ' 75' ' ' LEU . 5.1 tp -51.02 -18.0 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.586 0.231 . . . . 0.0 111.329 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.407 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 21.4 ptmt -92.25 -50.33 5.72 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.971 0.415 . . . . 0.0 110.837 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.407 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 25.7 mt-30 -68.02 -31.92 71.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.581 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.607 ' HB1' HD21 ' A' ' 77' ' ' LEU . . . -57.38 -30.38 64.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.174 0.512 . . . . 0.0 110.772 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.874 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.5 mp -90.09 -9.72 10.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.554 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.62 -65.64 1.0 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 111.184 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.91 -26.91 27.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.452 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.662 ' HB3' HD22 ' A' ' 20' ' ' LEU . 52.4 m-80 -89.3 -59.95 2.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.536 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.102 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptp . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.846 0.355 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.434 HG22 HG22 ' A' ' 40' ' ' ILE . 49.6 t -104.54 143.89 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.9 m -149.98 147.06 27.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.977 0.417 . . . . 0.0 111.248 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.611 ' HG2' ' HE3' ' A' ' 54' ' ' LYS . 40.4 mt-30 -90.13 174.48 7.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.28 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.631 ' O ' HD13 ' A' ' 60' ' ' LEU . 16.9 m-85 -123.02 124.52 43.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.931 0.396 . . . . 0.0 111.144 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.699 ' C ' HD11 ' A' ' 60' ' ' LEU . 46.7 mmtm -109.26 -25.21 10.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.643 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.4 p -129.92 123.28 30.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.29 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.1 -26.64 4.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.426 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -57.8 -20.94 39.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.069 0.461 . . . . 0.0 110.477 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -90.42 -45.73 8.8 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.557 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.915 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -76.46 -23.38 53.87 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.695 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -63.85 -38.06 89.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.966 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.0 m -87.94 -26.39 22.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.224 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -52.38 -31.8 35.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.834 0.349 . . . . 0.0 111.423 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.538 ' C ' ' HA2' ' A' ' 81' ' ' GLY . 20.4 pt -90.18 -47.71 14.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.361 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.472 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.1 97.11 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 45.65 86.92 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.33 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -167.36 41.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.44 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.547 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 2.9 mptp? 63.31 -156.67 0.33 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.432 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.881 HD11 ' HB3' ' A' ' 77' ' ' LEU . 66.0 tp -97.98 115.81 28.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.102 0.477 . . . . 0.0 110.637 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 51' ' ' ASP . 54.8 t -102.74 133.84 45.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.126 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.412 ' CG2' HG13 ' A' ' 99' ' ' ILE . 42.8 t -100.31 103.38 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.481 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.915 HG21 ' CE1' ' A' ' 11' ' ' PHE . 23.7 t -113.93 126.36 71.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 0.0 111.462 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 74' ' ' THR . 34.6 t70 -99.76 135.19 41.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.662 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.06 ' CE1' HD12 ' A' ' 76' ' ' LEU . 6.6 m-85 -99.39 46.78 0.97 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.705 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.562 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -46.9 141.02 4.29 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.071 0.462 . . . . 0.0 111.755 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.726 ' HB1' ' CE2' ' A' ' 29' ' ' TRP . . . -69.88 133.59 47.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.084 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.7 t -63.67 -20.48 65.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.743 178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.726 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 8.4 p-90 -96.28 -126.46 0.14 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.301 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.553 ' H ' ' HE3' ' A' ' 29' ' ' TRP . 51.8 t 48.67 -88.68 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.747 0.419 . . . . 0.0 111.654 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 29' ' ' TRP . . . 150.25 -77.83 0.22 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.675 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.23 -6.77 17.05 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.77 2.313 . . . . 0.0 113.419 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 85.5 m -50.44 -34.38 24.44 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.589 0.233 . . . . 0.0 111.445 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -76.64 -5.06 46.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.62 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.437 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 27.9 ttt -81.04 2.92 24.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.895 0.379 . . . . 0.0 110.676 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.891 HG22 HG13 ' A' ' 40' ' ' ILE . 58.2 mt -86.41 -14.98 10.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.588 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.57 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -53.76 -42.04 90.59 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 37.7 Cg_endo -70.92 -41.25 2.92 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.638 1.559 . . . . 0.0 111.766 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.479 ' HE2' ' HA ' ' A' ' 36' ' ' ILE . 70.5 mtm -63.05 -54.95 30.06 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.891 HG13 HG22 ' A' ' 36' ' ' ILE . 70.5 mt -47.42 -28.01 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.81 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -79.68 -33.12 41.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.168 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -66.53 -21.98 66.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.703 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.662 ' CE2' HG23 ' A' ' 95' ' ' ILE . 4.2 m-85 -90.05 -18.13 26.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.616 0.246 . . . . 0.0 111.559 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.432 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.6 t -74.3 -6.88 50.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.187 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.402 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 95.0 mt-10 -90.07 -28.08 19.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.839 0.352 . . . . 0.0 111.069 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.51 -27.65 19.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.652 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.745 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 74.6 m-85 -123.53 44.38 0.95 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.529 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 96.0 Cg_exo -39.19 -31.85 0.33 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.093 2.529 . . . . 0.0 113.346 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -61.7 -35.68 78.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.863 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -90.01 140.82 29.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.072 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.507 ' O ' HG13 ' A' ' 21' ' ' VAL . 25.7 m-20 -89.83 127.28 35.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.639 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.432 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 4.6 m-85 -102.2 89.0 3.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.006 0.431 . . . . 0.0 111.577 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.505 ' HB2' HG22 ' A' ' 23' ' ' VAL . 39.5 m-85 -98.3 -174.56 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.207 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.611 ' HE3' ' HG2' ' A' ' 4' ' ' GLN . 42.2 mtmt -150.22 137.84 19.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.062 0.458 . . . . 0.0 111.395 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.851 HD13 ' N ' ' A' ' 56' ' ' ASP . 3.1 tm? -91.59 141.35 28.81 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.662 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.851 ' N ' HD13 ' A' ' 55' ' ' LEU . 54.1 t0 -97.74 112.84 24.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.355 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 83.4 t -77.9 -4.51 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.933 0.397 . . . . 0.0 110.563 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.501 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 38.8 t70 -95.49 -35.0 11.85 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.174 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -102.48 -46.48 4.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.613 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.699 HD11 ' C ' ' A' ' 6' ' ' LYS . 6.1 mp -102.38 35.2 2.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.743 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -51.33 -25.12 11.59 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.411 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.63 -30.01 71.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.685 0.279 . . . . 0.0 111.198 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.715 HG12 ' HE2' ' A' ' 25' ' ' PHE . 11.1 t -74.06 -52.18 21.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.576 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.76 -29.83 41.7 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.991 0.424 . . . . 0.0 110.071 178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -90.19 -28.31 18.98 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.001 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -66.15 -50.67 63.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.015 0.436 . . . . 0.0 109.948 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.5 m-80 -79.67 0.43 30.37 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.84 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 62.61 40.61 10.23 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.491 ' O ' HG12 ' A' ' 69' ' ' VAL . 29.2 t -107.72 54.2 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 110.821 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 94.1 p -74.05 -13.29 60.83 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.018 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.407 ' O ' ' CG2' ' A' ' 88' ' ' VAL . . . -88.44 62.58 6.68 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.112 0.482 . . . . 0.0 110.054 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.692 ' CG ' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -89.55 165.59 24.81 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.073 -179.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.769 ' HG3' HD11 ' A' ' 36' ' ' ILE . 56.9 Cg_endo -72.59 134.47 34.6 Favored 'Cis proline' 0 C--N 1.353 0.773 0 C-N-CA 123.288 -1.547 . . . . 0.0 112.94 0.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.792 ' OG1' HG23 ' A' ' 88' ' ' VAL . 53.0 m -117.77 154.38 31.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.565 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.982 HD13 HD13 ' A' ' 95' ' ' ILE . 75.9 mt -109.25 115.35 29.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.844 0.354 . . . . 0.0 110.813 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.06 HD12 ' CE1' ' A' ' 25' ' ' PHE . 25.6 mt -109.77 126.72 54.06 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.889 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.881 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.8 mp -109.66 142.36 40.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.568 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.638 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 54.5 m-85 -141.86 127.01 18.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.984 -179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.785 ' CG ' HG11 ' A' ' 84' ' ' VAL . 9.5 mtpm? -116.38 132.19 56.74 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.668 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.434 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 74.0 m-20 49.31 68.75 0.67 Allowed 'General case' 0 C--N 1.334 -0.084 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.38 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.538 ' HA2' ' C ' ' A' ' 15' ' ' ILE . . . 46.55 28.54 3.54 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 116.095 -0.502 . . . . 0.0 113.098 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.638 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 68.2 mttm -136.42 -161.64 1.18 Allowed 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.665 ' O ' HG13 ' A' ' 84' ' ' VAL . 30.9 tt0 -109.1 -179.52 3.87 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.785 HG11 ' CG ' ' A' ' 79' ' ' LYS . 5.0 m -162.76 -47.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.626 0.25 . . . . 0.0 111.309 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.13 166.15 13.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.098 0.475 . . . . 0.0 111.827 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.461 ' NZ ' ' HB2' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -141.76 115.42 9.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.522 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.9 t -116.05 85.42 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.13 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.792 HG23 ' OG1' ' A' ' 74' ' ' THR . 5.5 p -61.52 84.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.063 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.83 109.28 1.21 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.529 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.715 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -77.41 59.28 1.84 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.981 0.419 . . . . 0.0 111.075 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.509 ' O ' HG22 ' A' ' 95' ' ' ILE . 45.8 t30 -62.63 133.98 95.08 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.342 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -43.7 -26.38 1.18 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.534 2.156 . . . . 0.0 112.803 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.22 53.12 0.83 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.605 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -167.69 -56.7 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.549 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.982 HD13 HD13 ' A' ' 75' ' ' LEU . 3.1 tp -54.72 -9.78 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.492 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.451 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 25.3 pttm -92.04 -50.28 5.77 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.919 0.39 . . . . 0.0 110.856 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.451 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 83.8 mt-30 -70.32 -32.24 69.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.782 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.22 -37.25 77.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.217 0.532 . . . . 0.0 110.394 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.663 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.3 mp -90.21 -8.68 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.542 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.745 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.28 -62.52 1.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.941 0.4 . . . . 0.0 110.981 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.07 -28.54 58.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.073 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.643 ' HB3' HD22 ' A' ' 20' ' ' LEU . 3.6 m120 -84.64 -63.12 1.39 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.197 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.585 ' HB2' HD23 ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.056 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptp . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.828 0.347 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 52' ' ' PHE . 12.6 p -133.58 144.4 36.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.724 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 4' ' ' GLN . 97.3 m -150.08 161.27 42.69 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.147 0.498 . . . . 0.0 112.06 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.644 ' HG2' ' HD2' ' A' ' 54' ' ' LYS . 54.1 mt-30 -92.37 -170.68 2.57 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.952 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.514 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 15.4 m-85 -134.4 121.46 21.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.114 0.483 . . . . 0.0 111.488 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.625 ' C ' HD11 ' A' ' 60' ' ' LEU . 2.4 mmmp? -109.14 -16.41 14.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.621 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.7 p -139.83 125.38 19.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.374 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.56 -26.11 4.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.525 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.7 m -58.78 -20.3 48.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.344 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -90.63 -39.09 12.7 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.151 0.5 . . . . 0.0 111.025 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.877 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -84.54 4.16 33.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.22 -179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -89.88 -31.54 17.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.906 0.384 . . . . 0.0 110.738 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 79.3 p -89.92 -37.07 14.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.88 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.56 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -46.5 -40.38 12.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.499 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.593 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.1 pt -86.8 -50.93 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.353 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.495 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.69 97.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 44.52 86.84 0.02 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.231 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 64.2 t0 -169.32 40.78 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.453 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 92.2 mttt 67.66 -156.64 0.21 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.669 0.271 . . . . 0.0 110.614 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.913 HD11 ' HB3' ' A' ' 77' ' ' LEU . 63.9 tp -98.04 114.96 27.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.042 0.449 . . . . 0.0 110.9 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.774 HG22 ' HB2' ' A' ' 51' ' ' ASP . 61.4 t -102.85 132.48 48.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.966 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.525 HG21 ' CG1' ' A' ' 99' ' ' ILE . 41.1 t -102.38 107.58 22.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.68 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.877 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 34.6 t -113.91 126.75 71.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.008 0.433 . . . . 0.0 111.367 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 7.2 t70 -99.87 129.01 45.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.668 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.083 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.9 m-85 -99.08 52.09 0.96 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.124 0.487 . . . . 0.0 110.602 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.8 OUTLIER -57.48 137.41 56.27 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.961 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.838 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -61.01 143.74 54.74 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.019 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.55 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 5.2 t -63.04 -13.91 41.61 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.853 0.359 . . . . 0.0 110.948 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.443 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 11.7 p-90 -110.13 -132.33 0.33 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.644 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 40.8 t 62.2 -79.66 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.581 0.352 . . . . 0.0 111.437 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.71 -78.52 0.37 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.938 -0.648 . . . . 0.0 111.723 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -45.06 -30.55 4.82 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.637 2.225 . . . . 0.0 112.131 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 98.5 m -55.4 -36.88 66.91 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.596 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -71.12 -17.02 62.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.142 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.597 ' HA ' ' CE ' ' A' ' 35' ' ' MET . 1.7 tpt -76.16 -1.09 24.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.885 0.374 . . . . 0.0 110.68 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.743 HG22 HG13 ' A' ' 40' ' ' ILE . 65.1 mt -87.72 -12.72 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.695 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.565 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -58.41 -41.4 89.09 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 40.9 Cg_endo -71.97 -38.82 3.66 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 121.636 1.558 . . . . 0.0 111.367 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.433 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 90.1 mtp -62.87 -57.12 11.92 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.743 HG13 HG22 ' A' ' 36' ' ' ILE . 61.2 mt -46.59 -28.52 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.007 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.621 ' HB2' HG11 ' A' ' 2' ' ' VAL . 44.6 tt0 -79.95 -29.38 39.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.603 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 57.2 mtpt -74.58 -15.65 60.83 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.449 ' HB2' ' CE2' ' A' ' 52' ' ' PHE . 4.4 m-85 -90.59 -20.08 22.99 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.439 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 79.3 p -67.59 -9.32 41.79 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 42' ' ' LYS . 12.5 pt-20 -90.02 -26.17 20.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.687 0.279 . . . . 0.0 111.058 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -90.56 -28.53 18.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.383 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.635 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 86.5 m-85 -123.13 46.14 1.28 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.328 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 84.7 Cg_exo -37.63 -38.66 0.64 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.177 2.585 . . . . 0.0 113.501 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.411 ' O ' ' HD3' ' A' ' 19' ' ' LYS . 85.1 mt-30 -59.03 -33.17 70.43 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.622 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.63 134.6 34.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.853 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.774 ' HB2' HG22 ' A' ' 21' ' ' VAL . 28.0 m-20 -89.66 122.69 33.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.418 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.75 ' O ' HG23 ' A' ' 2' ' ' VAL . 4.1 m-85 -97.33 100.91 12.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.07 0.462 . . . . 0.0 111.445 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.514 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 45.6 m-85 -115.82 -177.29 3.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.363 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.644 ' HD2' ' HG2' ' A' ' 4' ' ' GLN . 29.0 mttm -141.37 157.58 45.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.245 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.776 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.6 tm? -118.39 132.77 56.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.865 0.364 . . . . 0.0 111.033 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.776 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.9 t0 -85.25 114.98 22.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.222 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 26' ' ' TYR . 55.8 t -74.12 -4.63 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.07 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.55 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 62.1 t0 -102.34 -50.89 3.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.048 0.451 . . . . 0.0 110.392 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.535 ' C ' HD12 ' A' ' 60' ' ' LEU . 38.0 tp10 -75.11 -40.66 59.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.659 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.625 HD11 ' C ' ' A' ' 6' ' ' LYS . 4.5 mp -113.44 37.75 3.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.707 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -53.12 -23.77 18.24 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.651 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -66.45 -29.79 70.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.635 0.255 . . . . 0.0 111.223 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.671 HG13 ' HD3' ' A' ' 66' ' ' LYS . 5.5 t -79.87 -27.47 12.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.051 0.453 . . . . 0.0 110.546 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.29 -26.08 60.93 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -90.17 -34.96 15.64 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.816 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.671 ' HD3' HG13 ' A' ' 63' ' ' VAL . 13.4 ptmm? -60.56 -48.53 81.37 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 121.073 0.463 . . . . 0.0 110.007 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.421 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.8 m-80 -80.93 -3.67 52.27 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.878 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 63.85 42.67 5.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.292 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.425 ' CG1' HG21 ' A' ' 74' ' ' THR . 55.1 t -103.38 109.23 26.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.754 0.311 . . . . 0.0 111.061 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -138.63 19.24 2.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.728 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 1.07 ' HB3' HG21 ' A' ' 88' ' ' VAL . . . -98.86 34.44 2.08 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.264 0.554 . . . . 0.0 109.918 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.838 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 1.2 pmm? -21.76 119.77 0.14 Allowed Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.519 ' O ' HG23 ' A' ' 88' ' ' VAL . 85.8 Cg_endo -86.42 -163.88 2.83 Favored 'Cis proline' 0 C--N 1.353 0.812 0 C-N-CA 123.81 -1.329 . . . . 0.0 111.899 -0.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 98.6 m -161.91 162.44 29.16 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.987 0.422 . . . . 0.0 111.374 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.994 HD13 HD13 ' A' ' 95' ' ' ILE . 75.8 mt -126.38 121.25 31.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.862 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.083 HD12 ' CE1' ' A' ' 25' ' ' PHE . 26.5 mt -120.05 123.94 44.65 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.576 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.913 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.5 mp -109.71 146.88 34.14 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.38 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.524 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 56.3 m-85 -143.77 129.33 19.12 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.193 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HE2' HG23 ' A' ' 84' ' ' VAL . 51.8 mtmt -109.86 129.44 55.64 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 120.891 -0.324 . . . . 0.0 111.258 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.487 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.3 m120 45.69 63.79 1.68 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.882 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 52.46 22.09 10.22 Favored Glycine 0 N--CA 1.453 -0.218 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.484 179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.524 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 97.5 mttt -125.55 -156.13 0.71 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.429 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 33.7 tt0 -108.7 174.83 5.7 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.745 HG11 ' CD1' ' A' ' 20' ' ' LEU . 4.3 p -162.19 -59.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 120.881 0.372 . . . . 0.0 111.369 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.667 ' H ' HG13 ' A' ' 84' ' ' VAL . . . -155.76 167.29 30.88 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.515 ' HG2' HD22 ' A' ' 76' ' ' LEU . 36.5 mtmm -150.5 130.42 13.36 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.414 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.1 t -145.11 90.25 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.407 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.07 HG21 ' HB3' ' A' ' 71' ' ' ALA . 2.8 p -60.71 88.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.757 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.21 101.24 0.57 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.475 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.756 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -75.5 61.16 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.861 0.362 . . . . 0.0 111.071 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.563 ' O ' HG22 ' A' ' 95' ' ' ILE . 48.2 t30 -76.7 133.33 70.41 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.057 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -44.02 -24.29 0.84 Allowed 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.547 2.165 . . . . 0.0 112.843 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.512 ' HB3' ' ND2' ' A' ' 91' ' ' ASN . . . -95.16 27.65 3.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.356 -0.384 . . . . 0.0 112.022 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -164.21 -53.05 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.994 HD13 HD13 ' A' ' 75' ' ' LEU . 4.5 tp -49.2 -16.94 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 25.6 pttm -92.47 -51.36 5.17 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.966 0.412 . . . . 0.0 111.097 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.476 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 72.5 mt-30 -69.31 -32.04 70.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.879 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.55 -33.95 70.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.17 0.51 . . . . 0.0 110.47 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.886 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.6 mp -90.4 -11.78 9.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.457 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.635 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.18 -62.92 1.36 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.806 0.336 . . . . 0.0 111.035 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.78 -27.43 51.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.011 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.619 ' OD1' HD22 ' A' ' 77' ' ' LEU . 3.7 m120 -83.66 -51.84 6.94 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.859 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.03 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ppp? . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.888 0.375 . . . . 0.0 111.397 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.796 HG12 ' HE3' ' A' ' 54' ' ' LYS . 51.2 t -132.37 126.36 55.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.911 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 4' ' ' GLN . 51.0 m -150.1 158.86 44.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.019 0.438 . . . . 0.0 111.504 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.612 ' HG2' ' NZ ' ' A' ' 54' ' ' LYS . 48.7 mt-30 -89.98 166.27 13.56 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.128 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.556 ' O ' HD13 ' A' ' 60' ' ' LEU . 12.9 m-30 -114.4 120.26 39.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.926 0.393 . . . . 0.0 110.488 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.576 ' C ' HD11 ' A' ' 60' ' ' LEU . 2.1 tppt? -97.51 -41.44 8.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.798 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.6 p -123.12 139.46 54.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.69 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.18 -24.68 43.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.4 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.5 m -63.1 -15.81 57.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.607 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -90.15 -46.69 8.29 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.158 0.504 . . . . 0.0 110.967 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.902 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -75.39 -35.41 61.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.615 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -52.36 -31.3 33.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.057 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 t -90.05 -26.22 20.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.653 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -55.27 -52.0 64.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.438 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.4 pt -73.77 -48.88 37.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.334 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.466 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -41.48 95.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 45.73 92.06 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.217 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -174.7 39.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.315 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.559 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 11.0 mptt 64.97 -155.61 0.29 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.243 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.903 HD11 ' HB3' ' A' ' 77' ' ' LEU . 65.1 tp -98.04 115.57 28.49 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.015 0.436 . . . . 0.0 111.006 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.765 HG22 ' HB2' ' A' ' 51' ' ' ASP . 49.4 t -101.26 133.48 44.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.807 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.622 HG21 ' CD1' ' A' ' 99' ' ' ILE . 48.1 t -99.78 91.44 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.586 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.902 HG21 ' CE1' ' A' ' 11' ' ' PHE . 22.3 t -100.67 123.34 53.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.904 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 7.7 t70 -99.98 133.25 44.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.095 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.019 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.6 m-85 -99.25 54.41 0.97 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.161 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.594 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.4 OUTLIER -54.19 146.48 15.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.712 -179.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . . . -63.54 146.32 53.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.896 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.519 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 2.4 t -77.32 -1.16 28.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.723 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -125.38 -33.87 2.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 30.8 t -46.96 159.19 0.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -102.93 -64.09 0.71 Allowed Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.297 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.7 -24.3 4.58 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.869 2.379 . . . . 0.0 113.305 -179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 86.8 m -58.03 -54.98 40.76 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -51.83 -28.21 15.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.687 0.279 . . . . 0.0 111.74 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.8 tpp -75.09 1.25 13.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.886 0.374 . . . . 0.0 110.72 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.868 HG22 HG13 ' A' ' 40' ' ' ILE . 61.9 mt -87.12 -18.77 8.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.705 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.563 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -51.99 -43.51 89.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 38.4 Cg_endo -71.18 -39.17 4.16 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.724 1.616 . . . . 0.0 111.611 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.463 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 1.2 mpt? -63.24 -56.23 18.3 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.868 HG13 HG22 ' A' ' 36' ' ' ILE . 56.8 mt -44.02 -28.58 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.687 178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.5 ' N ' HG21 ' A' ' 2' ' ' VAL . 43.7 tt0 -81.04 -41.35 22.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.852 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.32 -31.84 69.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.175 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.463 ' HD1' ' O ' ' A' ' 39' ' ' MET . 11.0 m-85 -74.43 -17.17 60.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.251 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.7 t -70.92 -10.41 59.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.151 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -87.05 -24.59 24.56 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.697 0.284 . . . . 0.0 111.007 179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -90.44 -34.73 15.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.585 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.579 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 67.7 m-85 -122.95 43.33 0.74 Allowed Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.706 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 95.3 Cg_exo -39.38 -31.99 0.39 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.934 2.423 . . . . 0.0 113.201 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -61.06 -37.54 83.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.834 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.754 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.85 148.84 22.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.01 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.765 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.77 148.94 22.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.64 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -125.44 85.93 2.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.425 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.47 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 45.5 m-85 -99.12 -176.02 3.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.574 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.806 ' HD3' HD12 ' A' ' 40' ' ' ILE . 9.8 mtmp? -146.43 133.84 20.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.98 0.419 . . . . 0.0 111.104 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.812 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.9 tm? -89.77 139.05 30.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.999 -179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.812 ' N ' HD13 ' A' ' 55' ' ' LEU . 61.8 t0 -95.17 101.49 13.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.467 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 71.7 t -68.23 -12.72 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.812 0.339 . . . . 0.0 110.466 178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.519 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 61.8 t0 -86.74 -31.27 21.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.44 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -103.16 -51.98 3.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.237 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.668 HD22 ' CD2' ' A' ' 55' ' ' LEU . 5.5 mp -93.62 51.86 1.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.895 0.378 . . . . 0.0 111.06 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -59.11 -19.86 47.32 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.501 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.95 -29.27 61.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.618 0.246 . . . . 0.0 111.38 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.72 HG12 ' HE2' ' A' ' 25' ' ' PHE . 5.5 t -78.45 -48.1 23.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.861 0.362 . . . . 0.0 110.343 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.41 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -56.31 -24.93 46.65 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -90.37 -38.84 13.06 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.025 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.592 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -60.99 -41.74 97.04 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.933 0.397 . . . . 0.0 110.241 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -85.31 0.6 51.51 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.736 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 61.35 39.86 14.86 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.46 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.672 ' CG1' HG21 ' A' ' 74' ' ' THR . 46.1 t -109.69 107.12 22.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.848 0.356 . . . . 0.0 111.054 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 84.3 p -124.0 20.91 9.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.032 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.542 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -73.02 -149.13 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.741 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.506 ' O ' ' HG3' ' A' ' 72' ' ' MET . 18.3 ptt? -175.88 84.73 0.29 Allowed Pre-proline 0 CA--C 1.529 0.137 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.674 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 6.9 Cg_endo -95.76 -156.28 0.44 Allowed 'Cis proline' 0 CA--C 1.534 0.509 0 C-N-CA 125.217 -0.743 . . . . 0.0 112.834 -0.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.719 HG23 ' HA ' ' A' ' 88' ' ' VAL . 91.6 m -150.68 146.77 26.68 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.362 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.02 HD13 HD13 ' A' ' 95' ' ' ILE . 77.3 mt -112.35 122.08 46.7 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.785 0.326 . . . . 0.0 111.382 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.019 HD12 ' CE1' ' A' ' 25' ' ' PHE . 27.9 mt -120.82 128.13 52.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.656 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.903 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.7 mp -109.9 145.36 36.98 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.66 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.582 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 54.8 m-85 -146.52 127.45 14.51 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.262 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.817 ' HG3' HG11 ' A' ' 84' ' ' VAL . 9.8 mtpm? -115.19 135.92 53.66 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.638 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.479 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.2 m120 48.59 59.94 4.01 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.641 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 52.37 23.02 11.78 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.022 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.582 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 52.1 mtmt -126.91 -158.48 0.87 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.713 ' O ' HG13 ' A' ' 84' ' ' VAL . 82.0 tt0 -108.97 178.41 4.48 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.817 HG11 ' HG3' ' A' ' 79' ' ' LYS . 4.3 m -164.54 -47.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.533 0.206 . . . . 0.0 111.251 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -169.98 154.37 5.13 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.038 0.447 . . . . 0.0 111.845 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -137.8 113.93 10.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.409 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.427 HG11 ' HB3' ' A' ' 94' ' ' ALA . 48.3 t -121.82 81.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.067 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.719 ' HA ' HG23 ' A' ' 74' ' ' THR . 7.4 p -50.27 94.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.18 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.04 131.35 3.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.254 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.577 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -95.6 35.86 1.32 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.919 0.39 . . . . 0.0 111.133 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -59.04 108.04 1.19 Allowed Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.97 179.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.485 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 19.5 Cg_exo -33.02 90.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.138 2.559 . . . . 0.0 113.113 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 92' ' ' PRO . . . 172.97 -30.65 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.122 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.427 ' HB3' HG11 ' A' ' 87' ' ' VAL . . . -123.99 -44.32 2.06 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.02 HD13 HD13 ' A' ' 75' ' ' LEU . 4.6 tp -49.35 -19.07 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.738 0.304 . . . . 0.0 111.179 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -91.2 -66.17 0.95 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.981 0.419 . . . . 0.0 111.22 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -60.79 -34.41 74.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.964 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.88 -31.29 68.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.06 0.457 . . . . 0.0 110.702 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.622 ' CD1' HG21 ' A' ' 22' ' ' VAL . 66.6 mt -90.25 -10.75 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.373 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.579 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.44 -68.68 0.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.839 0.352 . . . . 0.0 111.4 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.87 -28.21 34.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.367 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.683 ' HB3' HD22 ' A' ' 20' ' ' LEU . 3.6 m120 -83.48 -48.21 10.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.106 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.268 -0.872 . . . . 0.0 111.135 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.823 0.344 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.419 ' CG2' HG22 ' A' ' 40' ' ' ILE . 41.5 t -154.15 144.55 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.99 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.1 m -150.08 147.47 27.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.095 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.507 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 60.1 mt-30 -89.94 -176.9 5.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.39 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.51 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.9 m-85 -134.73 135.97 42.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.024 0.44 . . . . 0.0 111.375 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.707 ' C ' HD11 ' A' ' 60' ' ' LEU . 34.5 mmtp -112.92 -33.76 5.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.536 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 8' ' ' ALA . 11.9 m -124.54 165.55 17.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.401 ' N ' HG22 ' A' ' 7' ' ' THR . . . -77.48 -29.82 52.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.77 0.319 . . . . 0.0 111.068 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.4 t -59.35 -16.42 22.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.791 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -90.09 -58.32 2.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.299 0.571 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.866 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -66.42 -28.42 68.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.64 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -59.04 -42.73 90.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.817 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.5 m -79.23 -29.95 42.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.462 ' O ' HG21 ' A' ' 21' ' ' VAL . . . -57.78 -32.4 67.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.194 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.8 pt -90.0 -49.15 13.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.275 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.486 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -42.95 101.9 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.1 mt-30 43.78 86.1 0.02 OUTLIER 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.211 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -166.24 39.26 0.05 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.62 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER 65.37 -153.29 0.27 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.729 0.299 . . . . 0.0 110.364 179.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.882 HD11 ' HB3' ' A' ' 77' ' ' LEU . 54.6 tp -97.7 114.18 26.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.06 0.457 . . . . 0.0 110.928 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.637 HG22 ' HB2' ' A' ' 51' ' ' ASP . 52.3 t -103.28 120.17 52.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.726 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.741 HG21 HG12 ' A' ' 99' ' ' ILE . 48.1 t -99.83 98.31 6.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.622 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.866 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 44.1 t -99.74 145.45 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.167 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.458 ' HA ' ' O ' ' A' ' 74' ' ' THR . 37.4 t70 -106.97 126.06 51.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.597 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.062 ' CE1' HD12 ' A' ' 76' ' ' LEU . 7.4 m-85 -98.88 50.42 0.96 Allowed 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.152 0.501 . . . . 0.0 110.308 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.53 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -53.15 139.25 29.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.529 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.732 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -63.13 149.16 45.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.572 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.514 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.4 t -74.53 -11.91 60.33 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.79 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.538 ' O ' ' C ' ' A' ' 30' ' ' CYS . 5.4 p-90 -112.18 -60.39 1.87 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.538 ' C ' ' O ' ' A' ' 29' ' ' TRP . 50.6 t 4.07 -80.95 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.431 0.692 . . . . 0.0 112.774 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.14 -78.48 0.35 Allowed Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.582 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.02 -15.71 43.82 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.574 2.183 . . . . 0.0 112.567 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 26' ' ' TYR . 31.9 p -52.9 -26.7 15.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.138 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -75.79 -16.84 60.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.553 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 35' ' ' MET . 48.0 ttm -74.17 2.07 9.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.038 0.447 . . . . 0.0 110.779 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.017 HG22 HG13 ' A' ' 40' ' ' ILE . 55.6 mt -83.74 -25.83 7.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.639 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.524 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -45.9 -45.02 36.82 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 40.4 Cg_endo -72.32 -37.69 4.23 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 121.694 1.596 . . . . 0.0 111.096 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.434 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 88.8 mtp -64.11 -54.9 26.66 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.017 HG13 HG22 ' A' ' 36' ' ' ILE . 67.2 mt -46.79 -27.62 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.703 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -81.19 -34.05 32.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.336 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -67.0 -22.74 65.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.739 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.435 ' CB ' ' CE2' ' A' ' 52' ' ' PHE . 5.9 m-85 -84.75 -21.91 29.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.716 0.294 . . . . 0.0 111.597 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.2 m -68.65 -12.06 60.89 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.015 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.417 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 39.4 tt0 -88.63 -23.81 22.97 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.826 0.346 . . . . 0.0 110.541 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -90.43 -38.23 13.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.371 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.536 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 60.5 m-85 -123.92 43.87 0.9 Allowed Pre-proline 0 C--N 1.331 -0.207 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 89.6 Cg_exo -38.59 -29.03 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.046 2.497 . . . . 0.0 113.014 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.474 ' N ' ' OE1' ' A' ' 49' ' ' GLN . 0.3 OUTLIER -57.17 -37.8 72.63 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.692 179.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.777 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.86 152.93 21.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.137 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.637 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -97.66 123.31 41.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.751 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.435 ' CE2' ' CB ' ' A' ' 43' ' ' PHE . 4.1 m-85 -100.93 104.43 15.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.111 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.63 ' HB2' HG22 ' A' ' 23' ' ' VAL . 46.5 m-85 -113.89 -178.81 3.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.212 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 32.9 mtpt -137.62 142.92 41.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.212 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.872 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.7 tm? -107.82 138.54 43.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.803 0.335 . . . . 0.0 110.733 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.872 ' N ' HD13 ' A' ' 55' ' ' LEU . 26.4 t70 -93.03 113.39 25.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.909 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 52.6 t -73.5 -6.12 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.411 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.514 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 38.6 t70 -97.6 -46.39 6.04 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.085 0.469 . . . . 0.0 110.613 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.658 ' C ' HD12 ' A' ' 60' ' ' LEU . 38.2 tp10 -83.72 -32.54 25.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.101 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.707 HD11 ' C ' ' A' ' 6' ' ' LYS . 3.6 mp -119.72 59.92 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.905 0.383 . . . . 0.0 110.929 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -71.21 -8.07 64.65 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.708 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -83.91 -28.31 27.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.674 0.273 . . . . 0.0 111.448 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.654 HG13 ' HD3' ' A' ' 66' ' ' LYS . 7.3 t -78.01 -45.28 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.869 0.366 . . . . 0.0 110.544 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.22 -24.92 45.33 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -90.45 -40.2 12.16 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.299 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.654 ' HD3' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -57.86 -48.92 78.4 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.892 0.377 . . . . 0.0 110.458 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.6 m-80 -78.14 -3.79 44.24 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.963 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 66.55 40.42 3.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.225 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.876 HG13 HG21 ' A' ' 74' ' ' THR . 58.0 t -83.45 -77.39 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 120.761 0.315 . . . . 0.0 110.869 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.7 p 47.91 25.45 0.76 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.756 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.9 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -98.91 -159.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.732 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -172.74 90.4 0.4 Allowed Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.798 ' HG3' HD11 ' A' ' 36' ' ' ILE . 22.5 Cg_endo -91.99 -160.41 1.07 Allowed 'Cis proline' 0 C--N 1.349 0.577 0 C-N-CA 124.625 -0.99 . . . . 0.0 112.42 -0.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.9 ' OG1' ' HB3' ' A' ' 71' ' ' ALA . 98.5 m -156.31 155.49 32.35 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.849 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.977 HD13 HD13 ' A' ' 95' ' ' ILE . 72.6 mt -120.22 121.38 38.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.935 0.398 . . . . 0.0 111.288 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.062 HD12 ' CE1' ' A' ' 25' ' ' PHE . 20.1 mt -118.99 128.57 54.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.875 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.882 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.3 mp -109.7 138.31 46.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.723 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.562 ' HA ' HG23 ' A' ' 84' ' ' VAL . 73.7 m-85 -137.51 126.91 24.87 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.542 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.468 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 59.5 mttm -109.84 128.71 55.51 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.728 0.299 . . . . 0.0 111.275 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 6.0 m120 44.27 58.04 3.98 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 61.64 13.55 39.13 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.372 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 30.8 mmmt -111.71 -156.81 0.6 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.486 ' OE2' ' CE1' ' A' ' 78' ' ' PHE . 10.9 tp10 -108.78 173.82 6.15 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.562 HG23 ' HA ' ' A' ' 78' ' ' PHE . 56.8 t -146.64 -62.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.748 0.309 . . . . 0.0 111.317 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.13 159.26 7.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.357 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -122.29 115.44 22.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.611 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -133.57 80.82 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.473 HG21 ' CB ' ' A' ' 71' ' ' ALA . 2.7 p -57.18 95.11 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.017 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.6 114.27 1.27 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.611 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.677 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -98.66 33.85 2.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 110.908 179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 93' ' ' ALA . 0.8 OUTLIER -62.07 108.58 1.67 Allowed Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.968 179.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 17.8 Cg_exo -31.91 88.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.229 2.62 . . . . 0.0 113.216 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 176.17 -35.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.85 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.62 -43.33 2.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.577 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.977 HD13 HD13 ' A' ' 75' ' ' LEU . 4.6 tp -53.26 -15.53 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.704 -0.226 . . . . 0.0 111.277 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.437 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 64.5 pttt -91.2 -49.25 6.48 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.78 0.324 . . . . 0.0 110.642 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.437 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 72.7 mt-30 -71.85 -32.15 67.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.366 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.24 -31.53 71.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.441 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.798 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 56.5 mt -90.08 -6.57 10.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.305 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.38 -65.29 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.921 0.391 . . . . 0.0 111.036 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.82 -29.78 8.55 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.944 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.816 ' CB ' HD22 ' A' ' 20' ' ' LEU . 67.5 m-20 -90.07 -67.79 0.82 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.948 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.798 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.126 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptm . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.766 0.317 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.43 ' CG1' ' HD2' ' A' ' 54' ' ' LYS . 44.1 t -136.5 143.17 36.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.477 HG22 ' N ' ' A' ' 4' ' ' GLN . 87.5 m -149.95 164.84 34.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.864 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.527 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -105.61 -177.35 3.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.339 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.481 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.9 m-85 -130.33 131.43 45.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.984 0.421 . . . . 0.0 111.483 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.706 ' C ' HD11 ' A' ' 60' ' ' LEU . 34.5 mmtp -114.49 -19.74 11.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.774 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -141.23 136.96 32.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.466 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.07 -28.42 17.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.242 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.9 m -59.32 -19.83 49.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.244 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.452 ' HG3' ' CE1' ' A' ' 5' ' ' PHE . 17.6 tp10 -90.49 -37.93 13.57 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.334 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.942 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -90.2 15.83 9.64 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.06 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -89.79 -45.98 8.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.875 0.369 . . . . 0.0 110.662 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -79.6 -23.36 42.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.97 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.535 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -54.83 -50.48 68.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.205 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.7 pt -83.12 -50.02 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.334 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.457 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -40.06 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 79.9 mt-30 39.19 85.06 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.662 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 9.1 t70 -162.49 40.52 0.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.668 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.55 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 10.9 mptt 67.2 -156.52 0.22 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.458 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.787 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 64.3 tp -98.18 116.42 30.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.203 0.525 . . . . 0.0 110.977 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.801 HG22 ' HB2' ' A' ' 51' ' ' ASP . 54.9 t -103.12 134.69 43.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.748 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.516 HG21 ' CD1' ' A' ' 99' ' ' ILE . 49.2 t -99.7 92.32 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.65 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.942 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 48.0 t -99.83 124.34 53.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.044 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 8.1 t70 -99.98 129.17 46.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.921 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.052 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.7 m-85 -98.99 48.57 0.96 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.185 0.516 . . . . 0.0 110.348 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.547 ' HD1' ' O ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -50.14 134.55 22.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.139 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.507 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -60.72 153.04 25.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.196 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.428 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 3.3 t -76.89 2.25 15.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.514 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.452 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 5.4 p-90 -127.35 -125.3 0.23 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.746 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 48.8 t 62.49 -77.58 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 122.931 0.492 . . . . 0.0 111.421 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.11 -80.18 0.27 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.979 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -77.26 51.0 3.33 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.744 2.296 . . . . 0.0 112.523 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 99.5 m -112.5 -28.25 7.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.734 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -79.94 -15.9 56.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.495 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 66.1 mtt -74.7 4.16 6.73 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.764 0.316 . . . . 0.0 111.102 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.007 HG22 HG13 ' A' ' 40' ' ' ILE . 52.7 mt -83.53 -26.27 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.534 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.513 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -45.67 -45.39 34.74 Favored Pre-proline 0 CA--C 1.532 0.265 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 44.1 Cg_endo -73.1 -36.36 4.36 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.773 1.649 . . . . 0.0 111.268 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 49.6 ttm -65.24 -53.11 49.21 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.007 HG13 HG22 ' A' ' 36' ' ' ILE . 79.0 mt -46.91 -30.44 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.593 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -76.79 -37.01 56.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.938 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.97 -22.74 62.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.367 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -90.1 -16.48 29.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.488 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.4 t -74.84 -6.88 51.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.236 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.404 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 44.7 tt0 -90.12 -27.94 19.3 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.785 0.326 . . . . 0.0 111.052 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -90.47 -28.33 18.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.723 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.848 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 76.0 m-85 -123.14 43.93 0.85 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.698 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 98.5 Cg_exo -39.76 -31.62 0.46 Allowed 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.977 2.451 . . . . 0.0 113.098 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -62.26 -37.82 86.94 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.941 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.787 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.88 147.75 23.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.172 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.801 ' HB2' HG22 ' A' ' 21' ' ' VAL . 28.9 m-20 -89.84 153.67 20.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.54 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.487 ' CE2' HD13 ' A' ' 99' ' ' ILE . 6.0 m-85 -128.55 93.88 3.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.025 0.44 . . . . 0.0 111.479 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.481 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 49.6 m-85 -107.44 178.59 4.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.596 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.527 ' HB2' ' HA ' ' A' ' 4' ' ' GLN . 16.5 mtpp -139.09 146.92 41.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.51 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.9 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.8 tm? -108.19 140.9 40.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.072 -179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.9 ' N ' HD13 ' A' ' 55' ' ' LEU . 27.8 t70 -95.43 116.04 28.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.55 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 57' ' ' VAL . 60.6 t -76.88 -1.85 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.649 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 8.1 t70 -103.5 -43.57 5.36 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.024 0.44 . . . . 0.0 110.575 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.492 ' C ' HD12 ' A' ' 60' ' ' LEU . 38.5 tp10 -86.12 -39.69 16.46 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.022 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.706 HD11 ' C ' ' A' ' 6' ' ' LYS . 4.8 mp -111.4 44.01 1.4 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.849 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.15 -28.02 53.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.379 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.51 -29.1 70.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.739 0.304 . . . . 0.0 111.158 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.705 HG12 ' HE2' ' A' ' 25' ' ' PHE . 6.8 t -79.3 -45.42 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.438 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.36 -22.85 55.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.409 . . . . 0.0 110.058 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -90.16 -38.13 13.71 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.205 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.705 ' HE3' HG13 ' A' ' 63' ' ' VAL . 15.6 pttp -60.89 -47.1 87.93 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.972 0.415 . . . . 0.0 110.084 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.401 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.6 m-20 -77.93 -4.44 46.89 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.917 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 66.94 39.51 3.27 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.034 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.709 ' CG1' HG21 ' A' ' 74' ' ' THR . 45.3 t -110.18 107.71 23.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.756 0.313 . . . . 0.0 110.97 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.5 t -121.87 -1.82 9.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.779 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.645 ' CB ' HG21 ' A' ' 88' ' ' VAL . . . -61.01 -157.75 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.575 ' O ' ' HG2' ' A' ' 72' ' ' MET . 0.0 OUTLIER -175.26 100.92 0.26 Allowed Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.79 ' HG3' HD11 ' A' ' 36' ' ' ILE . 32.6 Cg_endo -88.54 -162.06 1.92 Allowed 'Cis proline' 0 C--N 1.353 0.795 0 C-N-CA 124.701 -0.958 . . . . 0.0 112.669 -0.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.777 ' OG1' HG23 ' A' ' 88' ' ' VAL . 42.8 m -158.58 146.86 18.41 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.098 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.029 HD13 HD13 ' A' ' 95' ' ' ILE . 84.3 mt -113.97 123.04 48.75 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.804 0.335 . . . . 0.0 111.701 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.052 HD12 ' CE1' ' A' ' 25' ' ' PHE . 18.2 mt -116.94 129.87 56.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.493 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.704 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.9 mp -109.78 142.01 41.62 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.719 0.295 . . . . 0.0 111.017 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.578 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 63.8 m-85 -143.71 126.58 16.26 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.274 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.825 ' HG3' HG11 ' A' ' 84' ' ' VAL . 41.6 mtmt -118.91 136.76 53.89 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.379 178.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 78.3 m-20 50.81 60.92 3.52 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.569 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 50.04 26.19 8.5 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.849 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.578 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 98.9 mttt -132.34 -159.55 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.69 ' O ' HG13 ' A' ' 84' ' ' VAL . 28.7 tt0 -109.05 -179.75 3.94 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.825 HG11 ' HG3' ' A' ' 79' ' ' LYS . 12.2 m -163.75 -49.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.588 0.232 . . . . 0.0 111.217 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.462 ' N ' HG23 ' A' ' 84' ' ' VAL . . . -165.14 156.54 14.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.054 0.454 . . . . 0.0 111.726 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -138.81 113.63 9.19 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.33 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.63 91.1 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.075 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.777 HG23 ' OG1' ' A' ' 74' ' ' THR . 7.2 p -61.66 83.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.983 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.7 113.17 0.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.236 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.646 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -95.36 37.76 1.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.355 . . . . 0.0 111.387 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.447 ' O ' ' N ' ' A' ' 93' ' ' ALA . 5.5 m120 -73.69 131.88 81.51 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.325 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.486 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 98.7 Cg_exo -46.7 86.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.674 2.249 . . . . 0.0 112.665 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 92' ' ' PRO . . . 174.35 -35.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.425 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.39 -46.55 2.87 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.781 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.029 HD13 HD13 ' A' ' 75' ' ' LEU . 4.9 tp -53.45 -14.8 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.526 0.203 . . . . 0.0 111.278 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.415 ' HG3' ' HG3' ' A' ' 97' ' ' GLN . 21.3 ptmt -91.03 -49.52 6.37 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.883 0.373 . . . . 0.0 110.864 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.415 ' HG3' ' HG3' ' A' ' 96' ' ' LYS . 73.0 mt-30 -73.13 -32.38 64.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.447 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.454 ' HB1' HD21 ' A' ' 77' ' ' LEU . . . -61.33 -30.27 70.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.681 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.516 ' CD1' HG21 ' A' ' 22' ' ' VAL . 67.6 mt -90.19 -14.91 8.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.25 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.848 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.38 -70.51 0.67 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.84 0.352 . . . . 0.0 111.182 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.69 -28.69 6.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.272 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.572 ' HB3' HD22 ' A' ' 20' ' ' LEU . 5.7 m120 -83.18 -48.3 10.67 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.061 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.121 -179.953 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.714 0.292 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.851 HG12 ' HE2' ' A' ' 54' ' ' LYS . 47.4 t -152.36 138.61 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.002 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.8 m -147.89 154.49 40.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.03 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.565 ' HG2' ' HE3' ' A' ' 54' ' ' LYS . 16.2 mt-30 -93.74 177.25 6.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.624 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.525 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 14.4 m-85 -127.98 136.17 50.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.074 0.464 . . . . 0.0 111.241 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 34.4 mmtp -115.95 -46.34 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.513 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.1 p -114.81 134.11 55.39 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.534 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.09 -24.68 18.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.431 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.2 m -62.37 -16.58 55.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.556 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -90.21 -58.01 2.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.347 0.594 . . . . 0.0 111.076 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.913 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -61.28 -31.47 71.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.667 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -55.54 -23.32 25.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.1 t -80.37 -45.99 16.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.191 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.96 -46.52 68.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.29 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.853 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 24.1 pt -78.16 -4.63 6.88 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.833 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.901 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.18 81.82 6.1 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.682 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 74.9 mt-30 48.14 91.76 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.105 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 63.9 t0 -168.91 39.62 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.533 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 88.0 mttt 76.12 -156.83 0.04 OUTLIER 'General case' 0 C--O 1.23 0.065 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.564 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.895 HD11 ' HB3' ' A' ' 77' ' ' LEU . 59.7 tp -98.07 116.95 31.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.216 0.531 . . . . 0.0 110.79 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.767 HG22 ' HB2' ' A' ' 51' ' ' ASP . 60.6 t -102.89 124.22 56.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.801 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.646 HG21 ' CD1' ' A' ' 99' ' ' ILE . 46.0 t -99.79 97.88 6.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.665 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.913 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 40.2 t -105.12 131.04 55.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.424 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 26' ' ' TYR . 7.8 t70 -99.87 130.67 46.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.453 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.056 ' CE1' HD12 ' A' ' 76' ' ' LEU . 6.3 m-85 -99.06 49.48 0.95 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 120.975 0.417 . . . . 0.0 110.69 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.586 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -51.05 140.74 15.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.067 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.775 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -62.27 157.35 19.78 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.754 0.311 . . . . 0.0 110.505 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.545 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 5.0 t -83.58 4.12 29.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.406 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.449 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 18.2 p-90 -124.64 -46.6 1.87 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.431 ' HB2' ' HG3' ' A' ' 72' ' ' MET . 22.3 t -43.96 127.97 5.5 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 111.414 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 34' ' ' LYS . . . -76.41 -64.14 2.23 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.98 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -41.5 -28.26 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.389 2.726 . . . . 0.0 113.176 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.9 m -61.5 -14.57 30.3 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.429 ' C ' ' HD2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -78.8 -25.85 44.29 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.958 -0.297 . . . . 0.0 111.163 -179.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.458 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 66.0 mtm -75.39 1.52 13.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 110.301 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.856 HG22 HG13 ' A' ' 40' ' ' ILE . 28.1 mm -79.2 -44.37 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.873 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.499 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -41.7 -47.16 9.61 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.347 -0.388 . . . . 0.0 112.04 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 45.6 Cg_endo -73.91 -27.77 11.91 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.79 1.66 . . . . 0.0 111.233 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.406 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 14.2 tpt -74.16 -50.02 21.16 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.856 HG13 HG22 ' A' ' 36' ' ' ILE . 63.8 mt -50.96 -32.72 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.389 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -72.37 -39.56 67.95 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.113 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.465 ' NZ ' ' HB3' ' A' ' 42' ' ' LYS . 9.6 mtpm? -57.88 -23.94 55.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.712 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.75 ' CE2' HG23 ' A' ' 95' ' ' ILE . 6.0 m-85 -90.43 -16.88 28.18 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.1 t -72.95 -7.66 52.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.523 0.201 . . . . 0.0 111.456 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -90.15 -26.53 20.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.757 0.313 . . . . 0.0 111.081 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.07 -30.07 17.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.531 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.581 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 79.6 m-85 -125.44 51.86 5.97 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.088 0.47 . . . . 0.0 110.745 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 1.4 Cg_endo -46.79 -26.5 4.68 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.085 2.523 . . . . 0.0 112.987 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.444 ' O ' ' HD3' ' A' ' 19' ' ' LYS . 73.8 mt-30 -69.04 -29.24 67.34 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.122 0.487 . . . . 0.0 110.394 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.534 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.58 139.06 30.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.781 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.767 ' HB2' HG22 ' A' ' 21' ' ' VAL . 28.2 m-20 -89.56 121.69 32.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.268 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.518 ' CE2' HD13 ' A' ' 99' ' ' ILE . 6.2 m-85 -99.02 81.77 2.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.596 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.654 ' HB2' HG22 ' A' ' 23' ' ' VAL . 47.4 m-85 -94.47 -175.12 3.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.357 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.851 ' HE2' HG12 ' A' ' 2' ' ' VAL . 47.0 mtmt -148.47 138.2 22.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.994 0.426 . . . . 0.0 110.75 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.926 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.2 tm? -98.35 141.95 30.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.325 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.926 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.9 t70 -92.74 125.09 37.19 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.949 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 57' ' ' VAL . 92.1 t -93.14 42.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.436 0.636 . . . . 0.0 110.621 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.545 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 64.5 t0 -152.97 -48.78 0.1 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.035 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 6' ' ' LYS . 5.3 tp10 -75.56 -27.35 58.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.171 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.578 HD22 ' N ' ' A' ' 60' ' ' LEU . 2.5 mm? -103.16 -64.43 1.08 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.376 0.608 . . . . 0.0 111.007 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.5 -61.25 0.64 Allowed Glycine 0 C--N 1.314 -0.658 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.644 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -51.17 -36.79 42.85 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.788 HG12 ' HE2' ' A' ' 25' ' ' PHE . 6.6 t -70.51 -58.25 5.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 110.589 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.49 -24.84 8.74 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.002 0.43 . . . . 0.0 110.074 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -90.14 -37.49 14.17 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.259 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.785 ' HE3' HG13 ' A' ' 63' ' ' VAL . 17.4 pttp -60.71 -48.77 80.28 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.412 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.1 m-20 -76.71 -7.72 55.88 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.676 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 66.09 43.53 2.88 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.24 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.479 ' CG1' HG21 ' A' ' 74' ' ' THR . 49.0 t -107.37 74.6 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.885 0.374 . . . . 0.0 111.011 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.9 p -83.38 -11.32 57.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.996 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.512 ' CB ' HG21 ' A' ' 88' ' ' VAL . . . -58.14 -163.73 0.0 OUTLIER 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.728 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.775 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -178.1 106.64 0.21 Allowed Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 72' ' ' MET . 42.8 Cg_endo -89.72 -165.35 2.64 Favored 'Cis proline' 0 C--N 1.351 0.687 0 C-N-CA 124.485 -1.048 . . . . 0.0 112.612 -0.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 88' ' ' VAL . 91.7 m -152.59 163.24 39.99 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.811 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.984 HD13 HD13 ' A' ' 95' ' ' ILE . 80.9 mt -128.02 120.73 28.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.098 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.056 HD12 ' CE1' ' A' ' 25' ' ' PHE . 21.8 mt -118.93 124.11 46.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.758 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.895 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.3 mp -109.82 135.4 50.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.692 ' HA ' HG23 ' A' ' 84' ' ' VAL . 42.4 m-85 -136.05 129.05 31.37 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.602 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.666 ' HG3' HD13 ' A' ' 20' ' ' LEU . 9.2 mtpm? -114.65 124.04 50.83 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.99 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 6.4 m120 43.9 82.46 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.652 0.263 . . . . 0.0 111.213 -179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.853 ' HA2' ' O ' ' A' ' 15' ' ' ILE . . . 33.83 46.77 0.45 Allowed Glycine 0 C--N 1.333 0.38 0 CA-C-N 116.024 -0.535 . . . . 0.0 114.202 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 34.5 mmtp -146.97 -158.73 0.94 Allowed 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 34.0 tt0 -108.69 174.01 6.06 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.692 HG23 ' HA ' ' A' ' 78' ' ' PHE . 59.2 t -145.08 -69.08 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 0.0 111.107 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.25 155.32 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.377 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -112.65 138.26 49.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.069 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -154.6 78.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.141 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 74' ' ' THR . 2.5 p -58.73 90.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.093 0.473 . . . . 0.0 110.611 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 136.35 124.3 2.35 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.08 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.741 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -87.85 47.37 1.49 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.871 0.367 . . . . 0.0 111.468 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -53.35 110.02 1.8 Allowed Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.427 ' HD2' HD22 ' A' ' 91' ' ' ASN . 18.8 Cg_exo -33.2 -31.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.167 2.578 . . . . 0.0 113.64 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -95.49 30.49 2.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.445 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -152.34 -60.13 0.15 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.984 HD13 HD13 ' A' ' 75' ' ' LEU . 4.3 tp -51.91 -11.97 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.338 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.446 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 64.8 pttt -91.13 -51.09 5.49 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.843 0.354 . . . . 0.0 110.669 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.446 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 9.7 mm-40 -69.52 -32.02 70.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.51 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.78 -32.15 73.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.613 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.646 ' CD1' HG21 ' A' ' 22' ' ' VAL . 50.5 mt -90.14 -7.92 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.488 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.581 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.09 -68.62 0.77 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.924 0.393 . . . . 0.0 111.259 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.67 -29.14 51.93 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.132 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.552 ' CB ' HD22 ' A' ' 20' ' ' LEU . 3.9 m120 -80.39 -52.5 7.6 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.037 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.071 179.957 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.801 0.334 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.533 HG11 ' CG2' ' A' ' 40' ' ' ILE . 55.0 t -155.24 136.56 5.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.145 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 4' ' ' GLN . 90.1 m -150.2 162.1 41.13 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.173 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.581 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -100.28 -177.68 3.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 179.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.511 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 23.8 m-85 -124.79 150.59 46.17 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.03 0.443 . . . . 0.0 111.671 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.687 ' C ' HD11 ' A' ' 60' ' ' LEU . 72.7 mmtt -128.52 -37.21 1.81 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.974 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 m -116.65 164.0 15.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 12' ' ' ASP . . . -76.13 -27.85 57.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.993 0.425 . . . . 0.0 110.933 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 66.2 m -64.13 -12.58 41.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.969 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -89.98 -69.35 0.73 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.226 0.536 . . . . 0.0 111.401 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.965 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -56.9 -25.88 57.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.085 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 64.2 t0 -56.38 -42.71 78.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.23 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -82.06 -24.81 35.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.321 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.679 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -56.83 -46.09 81.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.476 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 81' ' ' GLY . 18.8 pt -80.21 -49.59 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.46 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.466 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -43.55 98.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 45.58 90.49 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.223 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -171.42 39.5 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.267 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.554 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 2.7 mptp? 63.54 -154.98 0.32 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.233 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.788 HD11 ' HB3' ' A' ' 77' ' ' LEU . 43.7 tp -98.05 115.99 29.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.135 0.493 . . . . 0.0 110.848 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.816 HG22 ' HB2' ' A' ' 51' ' ' ASP . 48.2 t -103.08 134.34 44.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.983 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.441 ' CG2' HG13 ' A' ' 99' ' ' ILE . 46.3 t -99.78 92.61 2.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.479 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.965 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 38.5 t -99.91 125.29 53.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.081 0.467 . . . . 0.0 111.334 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 74' ' ' THR . 38.5 t70 -99.91 130.53 46.1 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.916 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.057 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.7 m-85 -98.96 49.45 0.96 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.096 0.474 . . . . 0.0 110.208 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.71 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -50.68 139.8 15.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.786 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.72 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -60.59 142.12 55.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.525 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.491 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 5.8 t -69.05 -11.53 60.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.565 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.469 ' CH2' ' HG2' ' A' ' 72' ' ' MET . 21.5 p-90 -109.55 -45.3 3.71 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 24.6 t -42.38 139.54 1.45 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.657 0.265 . . . . 0.0 111.264 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -90.11 -57.19 1.72 Allowed Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.82 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -46.16 -27.67 4.77 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.7 2.266 . . . . 0.0 112.754 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.443 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 84.8 m -65.68 -21.1 66.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.54 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -73.45 -29.6 62.65 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -78.86 5.96 10.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.041 0.448 . . . . 0.0 110.989 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.73 HG22 HG13 ' A' ' 40' ' ' ILE . 69.9 mt -83.29 -27.44 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.119 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.542 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -49.18 -45.79 75.85 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 47.6 Cg_endo -72.04 -37.51 4.76 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 121.699 1.599 . . . . 0.0 111.134 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 58.3 ttp -62.34 -53.1 59.9 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.73 HG13 HG22 ' A' ' 36' ' ' ILE . 58.6 mt -47.61 -29.35 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.638 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.533 ' HA ' HG21 ' A' ' 2' ' ' VAL . 87.8 tt0 -78.49 -35.79 46.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.767 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 38' ' ' PRO . 72.7 mmtt -60.76 -21.97 63.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.433 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -90.12 -20.29 23.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.664 0.268 . . . . 0.0 111.632 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.4 p -74.15 -6.59 48.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.1 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.406 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 4.4 mm-40 -90.11 -29.44 18.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.82 0.343 . . . . 0.0 110.921 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.5 -29.73 17.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.676 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.54 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 71.2 m-85 -122.93 43.66 0.79 Allowed Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.654 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 93.7 Cg_exo -39.26 -31.51 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.993 2.462 . . . . 0.0 113.252 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.71 -38.13 84.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.903 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.715 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -90.04 146.52 24.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.951 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.816 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.87 148.7 23.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.72 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.49 ' O ' HG13 ' A' ' 2' ' ' VAL . 5.6 m-85 -125.27 98.35 5.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.243 0.544 . . . . 0.0 111.058 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.511 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 52.3 m-85 -113.84 -176.29 2.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.879 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.71 ' HB3' ' CE2' ' A' ' 26' ' ' TYR . 29.5 mttp -134.9 165.3 25.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.203 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.577 HD22 HD22 ' A' ' 60' ' ' LEU . 2.1 tm? -130.93 117.19 18.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.465 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.487 ' N ' HD13 ' A' ' 55' ' ' LEU . 59.3 t0 -70.26 117.59 12.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.898 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 26' ' ' TYR . 29.6 t -72.51 -8.34 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.852 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.491 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 31.9 t70 -100.97 -59.57 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.975 0.416 . . . . 0.0 110.606 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.681 ' C ' HD12 ' A' ' 60' ' ' LEU . 36.7 tp10 -66.48 -33.61 76.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.862 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.687 HD11 ' C ' ' A' ' 6' ' ' LYS . 4.3 mp -120.47 40.37 3.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.951 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.52 -20.81 32.24 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.415 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.65 -42.1 99.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.693 0.282 . . . . 0.0 111.475 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.599 ' O ' ' HG2' ' A' ' 66' ' ' LYS . 4.4 t -69.59 -46.97 74.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.946 0.403 . . . . 0.0 110.546 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 69' ' ' VAL . . . -53.62 -25.87 19.61 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.57 -41.66 11.24 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.451 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 12.9 ptmm? -55.92 -48.81 75.01 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.853 0.359 . . . . 0.0 110.695 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.415 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.4 m-20 -80.32 0.96 30.66 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.196 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 65.06 38.8 5.98 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.895 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.727 HG13 HG21 ' A' ' 74' ' ' THR . 47.5 t -107.92 93.48 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.883 0.373 . . . . 0.0 111.024 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.2 p -112.94 21.47 15.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.14 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.609 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -77.83 -154.74 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.583 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.72 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -171.46 87.12 0.47 Allowed Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.653 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 3.4 Cg_endo -96.35 -156.3 0.4 Allowed 'Cis proline' 0 C--N 1.35 0.615 0 C-N-CA 124.888 -0.88 . . . . 0.0 112.663 0.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.859 HG23 ' HB ' ' A' ' 88' ' ' VAL . 87.7 m -154.19 148.05 25.51 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.467 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.056 HD13 HD13 ' A' ' 95' ' ' ILE . 83.3 mt -110.02 122.18 46.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.941 0.4 . . . . 0.0 111.62 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.057 HD12 ' CE1' ' A' ' 25' ' ' PHE . 23.5 mt -116.99 129.19 55.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.525 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.788 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.4 mp -109.75 135.25 50.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.02 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.532 ' HA ' HG23 ' A' ' 84' ' ' VAL . 57.2 m-85 -136.22 124.14 22.74 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.991 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.686 ' HG3' HG21 ' A' ' 84' ' ' VAL . 26.0 mtpp -112.12 126.93 55.71 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.405 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.494 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.3 m120 50.3 64.58 1.74 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.846 0.355 . . . . 0.0 111.635 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 50.44 24.99 7.95 Favored Glycine 0 C--N 1.33 0.241 0 CA-C-N 116.185 -0.461 . . . . 0.0 113.319 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 61.5 mttp -128.94 -157.0 0.79 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 33.9 tt0 -108.74 174.64 5.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.686 HG21 ' HG3' ' A' ' 79' ' ' LYS . 1.7 t -151.09 -55.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.973 0.416 . . . . 0.0 110.687 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.13 -164.24 0.4 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.848 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.495 ' HD3' ' N ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -164.4 125.83 2.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.027 0.441 . . . . 0.0 110.826 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.494 HG11 ' HB1' ' A' ' 94' ' ' ALA . 49.0 t -132.21 80.36 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.924 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.859 ' HB ' HG23 ' A' ' 74' ' ' THR . 7.2 p -72.54 99.17 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.02 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.74 -23.1 0.33 Allowed Glycine 0 CA--C 1.519 0.31 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.213 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.668 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . 51.2 40.4 25.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.869 0.366 . . . . 0.0 111.101 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.593 ' O ' HG22 ' A' ' 95' ' ' ILE . 75.1 m-20 -59.5 134.26 88.76 Favored Pre-proline 0 N--CA 1.448 -0.545 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.916 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -47.67 -25.36 5.53 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.636 2.224 . . . . 0.0 112.733 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.75 26.45 10.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.625 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.512 ' HB3' ' HB2' ' A' ' 91' ' ' ASN . . . -137.5 -57.32 0.69 Allowed 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.362 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.056 HD13 HD13 ' A' ' 75' ' ' LEU . 3.2 tp -54.81 -11.48 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.715 0.293 . . . . 0.0 110.867 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -92.0 -59.49 2.09 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.055 0.455 . . . . 0.0 110.801 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -63.32 -33.32 75.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.101 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.44 -31.06 65.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.115 0.483 . . . . 0.0 110.664 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.88 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.4 mp -90.18 -8.29 10.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.542 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.57 -71.78 0.57 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.789 0.328 . . . . 0.0 111.34 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.2 -30.04 48.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.334 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.639 ' CB ' HD22 ' A' ' 20' ' ' LEU . 3.0 m120 -77.37 -50.02 13.67 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.986 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.577 ' HB2' HD23 ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.167 -0.921 . . . . 0.0 111.131 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.868 0.366 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 52' ' ' PHE . 14.0 p -153.38 138.0 9.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.449 HG22 ' N ' ' A' ' 4' ' ' GLN . 92.2 m -150.04 161.72 41.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.028 0.442 . . . . 0.0 111.702 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.672 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 51.0 mt-30 -96.19 178.7 5.3 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.135 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.477 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 17.3 m-85 -124.66 127.58 47.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.925 0.393 . . . . 0.0 111.133 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.749 ' C ' HD11 ' A' ' 60' ' ' LEU . 34.5 mmtp -107.92 -26.7 10.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.691 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.8 p -134.05 129.25 35.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.35 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.28 -26.02 6.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.57 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -61.62 -16.76 51.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.56 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -90.4 -41.72 11.32 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.107 0.48 . . . . 0.0 111.281 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.751 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -78.38 -27.63 46.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.055 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -51.9 -57.47 9.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.391 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 t -71.32 -23.06 61.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.499 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.651 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -56.56 -44.19 80.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.474 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.1 pt -81.08 -49.93 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.483 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -45.58 101.97 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 44.78 89.08 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.223 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -171.72 40.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.313 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.538 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 3.1 mppt? 62.45 -156.67 0.34 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.25 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.827 HD11 ' HB3' ' A' ' 77' ' ' LEU . 54.7 tp -98.06 116.51 30.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.089 0.471 . . . . 0.0 110.863 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 51' ' ' ASP . 45.2 t -99.96 134.78 38.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.638 179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.614 HG21 HD13 ' A' ' 99' ' ' ILE . 40.5 t -99.82 84.24 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.951 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.799 HG22 ' HB2' ' A' ' 53' ' ' TYR . 38.8 t -101.11 120.17 50.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.098 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.532 ' CG ' HD23 ' A' ' 75' ' ' LEU . 2.9 m-20 -99.31 137.91 37.15 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.009 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.045 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.8 m-85 -99.35 53.21 0.95 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.646 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.575 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -52.64 137.38 30.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.439 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 72' ' ' MET . . . -66.1 134.82 53.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.549 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.441 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 3.6 t -57.59 -17.77 16.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.334 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.444 ' CZ3' ' SD ' ' A' ' 72' ' ' MET . 6.4 p-90 -109.12 -125.98 0.26 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.847 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 40.0 t 61.58 -82.24 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 122.448 0.299 . . . . 0.0 110.951 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.45 -77.77 0.29 Allowed Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.067 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.03 -18.69 51.97 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.916 2.41 . . . . 0.0 112.98 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 95.0 m -52.88 -26.14 13.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.666 0.269 . . . . 0.0 111.711 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -79.47 -24.75 42.17 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.667 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 89.6 mmm -72.55 -2.22 18.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.729 0.299 . . . . 0.0 111.099 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.766 HG22 HG13 ' A' ' 40' ' ' ILE . 44.0 mt -85.58 -22.88 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.822 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.528 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -51.7 -44.73 91.07 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 47.2 Cg_endo -72.82 -34.42 6.8 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 121.802 1.668 . . . . 0.0 111.322 179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.7 ttt -65.9 -52.21 51.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.766 HG13 HG22 ' A' ' 36' ' ' ILE . 75.9 mt -48.77 -29.34 2.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.581 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.531 ' HB2' HG11 ' A' ' 2' ' ' VAL . 37.7 tt0 -76.9 -32.71 57.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.062 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -66.73 -19.61 65.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.72 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -90.18 -26.65 20.03 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.406 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 53.9 m -59.87 -16.14 26.76 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.16 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.473 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 56.2 mt-10 -86.19 -20.32 28.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.821 0.344 . . . . 0.0 110.853 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 -90.54 -37.29 13.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.552 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.586 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 72.4 m-85 -122.45 41.24 0.51 Allowed Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.723 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 75.5 Cg_exo -34.94 -33.93 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.5 2.8 . . . . 0.0 113.704 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -57.26 -36.8 71.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.035 0.445 . . . . 0.0 110.594 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.8 143.01 27.15 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.561 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.567 ' O ' HG13 ' A' ' 21' ' ' VAL . 29.9 m-20 -89.68 121.86 32.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.911 0.386 . . . . 0.0 110.694 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.662 ' O ' HG23 ' A' ' 2' ' ' VAL . 5.5 m-85 -95.21 85.79 4.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.594 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.799 ' HB2' HG22 ' A' ' 23' ' ' VAL . 34.7 m-85 -97.82 -176.87 3.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.27 178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.672 ' HE2' ' HG2' ' A' ' 4' ' ' GLN . 35.1 mtmm -150.03 136.17 18.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.052 0.453 . . . . 0.0 110.982 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.876 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.4 tm? -93.04 139.94 30.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.963 -179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.876 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.2 t0 -95.27 112.57 24.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.856 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 53.5 t -73.2 -7.38 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.423 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.441 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 9.2 t70 -97.6 -59.84 1.69 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.972 0.415 . . . . 0.0 110.521 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.671 ' C ' HD12 ' A' ' 60' ' ' LEU . 16.9 tp10 -67.55 -32.92 74.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.882 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.749 HD11 ' C ' ' A' ' 6' ' ' LYS . 4.7 mp -120.03 58.3 0.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.928 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.35 -15.26 58.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.647 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.92 -27.05 43.7 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.68 0.276 . . . . 0.0 111.452 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.813 HG12 ' HE2' ' A' ' 25' ' ' PHE . 11.7 t -77.59 -51.49 18.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.477 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.44 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -57.21 -23.22 46.39 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.18 -37.98 13.79 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.229 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.709 ' HE3' HG13 ' A' ' 63' ' ' VAL . 17.2 pttp -59.88 -48.52 81.35 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.918 0.389 . . . . 0.0 110.131 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.413 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.0 m-20 -77.86 -6.33 53.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.871 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 66.38 42.51 2.94 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.117 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.513 ' CG1' HG21 ' A' ' 74' ' ' THR . 48.5 t -110.44 78.37 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.81 0.338 . . . . 0.0 111.196 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 81.4 p -90.53 10.26 26.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.096 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.645 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -61.46 -156.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.747 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.449 ' O ' ' HG3' ' A' ' 72' ' ' MET . 9.5 ptt? -176.68 86.93 0.26 Allowed Pre-proline 0 CA--C 1.53 0.185 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.613 ' HG3' HD12 ' A' ' 36' ' ' ILE . 43.0 Cg_endo -98.06 -159.58 0.46 Allowed 'Cis proline' 0 C--N 1.349 0.554 0 C-N-CA 125.131 -0.779 . . . . 0.0 112.467 -0.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.645 ' OG1' ' HB3' ' A' ' 71' ' ' ALA . 83.6 m -149.9 161.22 42.71 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.825 0.345 . . . . 0.0 111.269 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.669 ' CD1' HD13 ' A' ' 95' ' ' ILE . 37.3 mt -122.1 124.1 43.13 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.305 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.045 HD12 ' CE1' ' A' ' 25' ' ' PHE . 22.2 mt -123.64 125.5 44.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.761 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.827 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.6 mp -109.75 136.36 49.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.635 ' HA ' HG23 ' A' ' 84' ' ' VAL . 53.2 m-85 -137.13 125.11 22.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.054 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.583 ' HG3' HD13 ' A' ' 20' ' ' LEU . 54.1 mtpt -112.43 131.21 55.68 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.514 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.4 m120 48.94 54.85 10.16 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.883 0.373 . . . . 0.0 111.719 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 58.4 17.56 32.93 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 121.276 -0.488 . . . . 0.0 113.02 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 31.0 mmmt -115.62 -153.76 0.53 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 88.1 tt0 -108.79 172.72 6.68 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 78' ' ' PHE . 44.8 t -146.45 -64.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.756 0.312 . . . . 0.0 111.276 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.08 150.08 3.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.299 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -119.3 120.25 36.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.611 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 48.6 t -145.49 94.87 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.277 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.63 HG21 ' CB ' ' A' ' 71' ' ' ALA . 4.3 p -64.56 102.33 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.735 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.99 103.07 0.54 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.42 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.615 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -96.31 36.99 1.28 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.953 0.406 . . . . 0.0 111.273 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 93' ' ' ALA . 21.2 p30 -80.06 141.52 54.52 Favored Pre-proline 0 N--CA 1.44 -0.94 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.532 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -46.95 87.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.624 2.216 . . . . 0.0 112.669 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -179.54 -38.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.407 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.69 -40.8 2.04 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.669 HD13 ' CD1' ' A' ' 75' ' ' LEU . 4.5 tp -50.51 -18.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.642 0.258 . . . . 0.0 111.441 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.409 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 18.0 ptpt -91.21 -50.18 5.97 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.894 0.378 . . . . 0.0 111.15 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.409 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 26.1 mt-30 -71.02 -31.73 68.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.464 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.82 -32.39 73.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.786 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.687 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 58.1 mt -90.1 -7.75 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.455 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.47 -74.26 0.5 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.973 0.416 . . . . 0.0 111.383 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -50.07 -30.44 10.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.53 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.686 ' HB3' HD22 ' A' ' 20' ' ' LEU . 3.9 m120 -82.38 -48.58 10.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.11 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.714 ' HB2' HD23 ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.041 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 tpt . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.744 0.306 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.83 HG22 HG22 ' A' ' 40' ' ' ILE . 57.5 t 66.64 123.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.303 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.0 m -150.16 147.39 27.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.915 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.517 ' HG2' ' HE3' ' A' ' 54' ' ' LYS . 63.2 mt-30 -89.95 164.76 14.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.329 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.592 ' O ' HD13 ' A' ' 60' ' ' LEU . 18.2 m-85 -117.53 123.3 45.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.926 0.393 . . . . 0.0 111.448 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.679 ' C ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -103.79 -33.06 9.04 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.145 179.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.9 p -127.09 131.13 50.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.398 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.02 -24.45 9.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.657 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.1 m -61.67 -17.02 53.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.662 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -90.27 -39.08 12.98 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.105 0.478 . . . . 0.0 111.224 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.899 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -82.17 -30.95 30.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.911 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -55.55 -37.81 68.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.248 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.4 m -90.04 -0.13 57.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.64 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.671 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -82.6 -44.61 15.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.689 0.28 . . . . 0.0 111.39 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.2 pt -79.56 -49.67 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.551 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -41.93 97.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 85.0 mt-30 45.77 88.52 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.219 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 9.1 t70 -170.37 41.07 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.126 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 91.6 mttt 66.17 -155.49 0.25 Allowed 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.699 0.285 . . . . 0.0 110.404 179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.882 HD11 ' HB3' ' A' ' 77' ' ' LEU . 57.9 tp -98.06 116.12 29.63 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.29 0.567 . . . . 0.0 110.917 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.678 HG22 ' HB2' ' A' ' 51' ' ' ASP . 59.9 t -105.55 122.29 58.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.722 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.739 HG21 HG12 ' A' ' 99' ' ' ILE . 46.8 t -99.98 97.68 6.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.779 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.899 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 45.5 t -99.91 134.79 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.224 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 74' ' ' THR . 37.5 t70 -99.79 128.03 45.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.673 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.037 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.3 m-85 -99.08 51.37 0.95 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.656 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.588 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -50.9 128.65 21.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.061 0.457 . . . . 0.0 111.035 179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.569 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -56.07 157.2 4.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.256 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.571 HG22 HG12 ' A' ' 57' ' ' VAL . 4.2 t -95.4 21.59 7.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.202 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.515 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 26.0 p-90 -138.53 -43.62 0.49 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.834 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.441 ' HG ' ' HG ' ' A' ' 33' ' ' CYS . 35.9 t -43.75 129.6 5.55 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.546 0.213 . . . . 0.0 110.984 -179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -47.07 -67.85 1.34 Allowed Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.786 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 33' ' ' CYS . 56.5 Cg_endo -67.76 -145.82 0.02 OUTLIER 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.56 2.173 . . . . 0.0 110.937 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 32' ' ' PRO . 58.9 m 73.9 4.69 4.7 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -111.46 -29.11 7.91 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.692 0.282 . . . . 0.0 111.056 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.477 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 86.0 mmm -78.44 5.29 11.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.127 0.489 . . . . 0.0 110.538 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.909 HG22 HG13 ' A' ' 40' ' ' ILE . 71.3 mt -81.49 -24.07 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.701 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.53 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -47.36 -45.79 56.39 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 50.0 Cg_endo -72.77 -35.58 5.62 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.904 1.736 . . . . 0.0 111.199 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.5 ttt -65.12 -51.79 59.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.909 HG13 HG22 ' A' ' 36' ' ' ILE . 69.7 mt -48.88 -28.67 2.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.459 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.501 ' N ' HG21 ' A' ' 2' ' ' VAL . 38.8 tt0 -78.24 -33.32 49.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.898 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.464 ' NZ ' ' HB3' ' A' ' 42' ' ' LYS . 9.0 mtpm? -64.35 -22.36 66.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.437 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.483 ' HE2' HG23 ' A' ' 95' ' ' ILE . 4.0 m-85 -90.14 -16.97 28.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.665 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.43 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 45.8 t -74.67 -6.53 49.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.252 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -90.17 -29.07 18.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.937 0.399 . . . . 0.0 111.109 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.31 -26.41 20.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.791 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.571 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 80.1 m-85 -123.61 46.37 1.41 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.739 0.304 . . . . 0.0 111.473 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 81.9 Cg_exo -37.44 -44.32 1.41 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.207 2.604 . . . . 0.0 113.64 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.415 ' O ' ' HD3' ' A' ' 19' ' ' LYS . 98.0 mm-40 -56.37 -31.29 63.67 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.923 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.66 133.44 34.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.803 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.678 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.55 121.91 32.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.482 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.547 ' CE2' HD13 ' A' ' 99' ' ' ILE . 4.5 m-85 -96.46 103.58 15.49 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.375 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.623 ' HB2' HG22 ' A' ' 23' ' ' VAL . 40.7 m-85 -114.17 -176.73 2.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.316 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.709 ' HE2' HG12 ' A' ' 2' ' ' VAL . 44.3 mtmt -145.54 130.51 18.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 111.206 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.811 HD13 ' N ' ' A' ' 56' ' ' ASP . 3.0 tm? -90.75 138.27 31.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.401 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.811 ' N ' HD13 ' A' ' 55' ' ' LEU . 25.4 t70 -94.98 108.34 20.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.422 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.571 HG12 HG22 ' A' ' 28' ' ' THR . 91.1 t -71.15 -11.29 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.547 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.476 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 9.7 t70 -88.9 -41.35 12.48 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.434 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.451 ' N ' ' OD2' ' A' ' 56' ' ' ASP . 38.4 tp10 -93.06 -47.51 6.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.824 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.679 HD11 ' C ' ' A' ' 6' ' ' LYS . 5.2 mp -101.82 46.68 0.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.07 -20.78 36.03 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.462 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -71.35 -25.41 62.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.576 0.227 . . . . 0.0 111.517 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.738 HG12 ' HE2' ' A' ' 25' ' ' PHE . 8.0 t -79.61 -51.79 15.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.711 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.92 -27.4 51.98 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.99 0.424 . . . . 0.0 110.122 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -90.03 -26.31 20.37 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.756 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -70.51 -50.44 37.75 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.999 0.428 . . . . 0.0 109.96 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -76.24 -2.6 32.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.915 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 67.48 38.97 2.99 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.167 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.71 ' CG1' HG21 ' A' ' 74' ' ' THR . 48.3 t -112.04 83.49 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-O 120.868 0.366 . . . . 0.0 111.054 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.6 p -93.15 3.34 55.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.272 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.636 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -59.49 -163.07 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.612 ' O ' ' HG2' ' A' ' 72' ' ' MET . 0.0 OUTLIER -173.82 94.39 0.33 Allowed Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.51 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 18.9 Cg_endo -91.93 -161.1 1.16 Allowed 'Cis proline' 0 C--N 1.349 0.562 0 C-N-CA 124.835 -0.902 . . . . 0.0 112.513 -0.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.719 HG23 ' HA ' ' A' ' 88' ' ' VAL . 29.0 m -155.92 148.53 23.91 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.671 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.006 HD13 HD13 ' A' ' 95' ' ' ILE . 83.2 mt -109.78 125.26 52.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 0.0 111.334 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.037 HD12 ' CE1' ' A' ' 25' ' ' PHE . 21.8 mt -121.37 127.37 51.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.782 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.882 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.7 mp -109.87 140.57 43.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.024 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.626 ' HA ' HG23 ' A' ' 84' ' ' VAL . 52.5 m-85 -140.61 125.7 18.48 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.853 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.584 ' HG3' HD13 ' A' ' 20' ' ' LEU . 54.9 mtpt -109.87 129.01 55.69 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.789 0.328 . . . . 0.0 111.47 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.508 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 25.8 t-20 45.79 61.28 2.72 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.079 0.466 . . . . 0.0 111.6 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 55.59 17.89 14.73 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-N 116.088 -0.506 . . . . 0.0 113.542 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 60.0 mttp -115.18 -155.85 0.59 Allowed 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.445 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 34.7 tt0 -108.78 173.0 6.52 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.626 HG23 ' HA ' ' A' ' 78' ' ' PHE . 47.9 t -147.79 -68.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.939 0.4 . . . . 0.0 111.038 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.63 154.99 4.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.254 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -114.52 114.99 26.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.414 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.35 82.18 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.311 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.719 ' HA ' HG23 ' A' ' 74' ' ' THR . 2.7 p -60.89 85.14 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.721 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.6 115.39 1.37 Allowed Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.367 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.727 ' HB2' HD21 ' A' ' 75' ' ' LEU . . . -96.79 38.45 1.22 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.804 0.335 . . . . 0.0 111.186 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 93' ' ' ALA . 46.2 t30 -68.84 129.28 92.48 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.194 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 85.3 Cg_exo -45.62 88.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.667 2.245 . . . . 0.0 112.659 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 92' ' ' PRO . . . 172.52 -33.16 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.411 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.43 -44.68 2.46 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.006 HD13 HD13 ' A' ' 75' ' ' LEU . 3.8 tp -50.83 -17.9 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.298 179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 7.0 ptpp? -91.63 -48.99 6.53 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.949 0.404 . . . . 0.0 110.792 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.418 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 80.2 mt-30 -69.96 -31.6 69.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.575 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.21 -31.68 72.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.023 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.739 HG12 HG21 ' A' ' 22' ' ' VAL . 46.4 mt -90.19 -8.24 10.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.56 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.571 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.2 -69.65 0.71 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.842 0.353 . . . . 0.0 111.174 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.99 -29.0 18.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.221 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.572 ' CB ' HD22 ' A' ' 20' ' ' LEU . 3.8 m120 -82.63 -51.76 7.45 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.032 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.616 ' HB2' HD23 ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.328 -0.844 . . . . 0.0 111.188 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.9 tpp . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.809 0.338 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 52' ' ' PHE . 14.6 p -178.04 139.73 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.466 HG22 ' N ' ' A' ' 4' ' ' GLN . 87.3 m -141.88 162.84 34.49 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.959 0.409 . . . . 0.0 111.51 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.596 ' HG2' ' HD2' ' A' ' 54' ' ' LYS . 19.2 mt-30 -97.29 -176.97 3.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.777 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.504 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 20.3 m-85 -135.14 101.77 4.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.328 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.559 ' C ' HD11 ' A' ' 60' ' ' LEU . 32.7 mmtp -83.19 -25.4 31.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.731 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.5 p -130.42 123.21 29.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.261 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.83 -25.77 4.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.583 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.3 m -59.5 -18.9 43.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.572 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -90.47 -44.1 9.83 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.206 0.527 . . . . 0.0 111.452 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.885 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.2 t80 -69.39 -30.51 68.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.031 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -50.83 -66.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.404 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.9 m -60.78 -20.48 61.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.467 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 11' ' ' PHE . . . -56.41 -66.42 0.44 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.795 0.331 . . . . 0.0 111.676 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' GLY . 21.0 pt -54.6 -48.14 71.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.753 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.07 103.0 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.7 mt-30 45.18 92.11 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.236 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -171.51 38.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.384 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.538 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER 61.61 -152.5 0.37 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.871 HD11 ' HB3' ' A' ' 77' ' ' LEU . 59.3 tp -97.55 115.92 28.78 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.244 0.545 . . . . 0.0 110.437 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 51' ' ' ASP . 58.9 t -104.05 126.97 58.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.871 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.783 HG11 HD11 ' A' ' 95' ' ' ILE . 48.6 t -99.74 93.15 2.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.495 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.885 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 43.4 t -99.76 128.14 51.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.114 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.7 t70 -99.72 130.73 45.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.752 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.044 ' CE1' HD12 ' A' ' 76' ' ' LEU . 3.4 m-85 -99.07 53.01 0.97 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 120.968 0.413 . . . . 0.0 110.406 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.557 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -50.98 124.77 12.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.301 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -51.69 154.1 2.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.25 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.468 HG22 HG12 ' A' ' 57' ' ' VAL . 7.0 t -96.47 23.82 6.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.085 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.506 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 27.3 p-90 -141.53 -38.05 0.41 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.63 ' HB2' ' HB2' ' A' ' 72' ' ' MET . 51.3 t -35.21 150.98 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.0 0.429 . . . . 0.0 111.938 -179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -56.36 -79.29 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.453 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.432 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 3.3 Cg_exo -73.01 -76.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.43 2.087 . . . . 0.0 112.021 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.9 p 37.92 31.33 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 32' ' ' PRO . 28.3 mtpp -132.04 -35.98 1.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.214 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.491 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 15.2 tmm? -58.41 -16.03 13.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.852 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.691 HG22 HG13 ' A' ' 40' ' ' ILE . 2.4 mp -75.26 -38.13 40.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.345 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.522 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -45.6 -49.28 36.04 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 41.0 Cg_endo -70.88 -32.73 13.44 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 121.988 1.792 . . . . 0.0 110.999 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 49.3 ttm -66.59 -51.13 59.78 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.718 HG22 HG21 ' A' ' 2' ' ' VAL . 61.6 mt -49.54 -28.38 3.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.515 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.482 ' HB2' HG11 ' A' ' 2' ' ' VAL . 37.8 tt0 -79.16 -30.93 43.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.183 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.478 ' NZ ' ' HB3' ' A' ' 42' ' ' LYS . 9.1 mtpm? -69.37 -16.11 63.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.73 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.49 ' CE2' HG23 ' A' ' 95' ' ' ILE . 3.9 m-85 -90.11 -20.85 22.66 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.5 t -66.74 -14.28 62.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.777 0.322 . . . . 0.0 110.713 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.419 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 5.1 tm-20 -90.04 -20.95 22.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.295 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -90.12 -36.35 14.89 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.315 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.538 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 81.6 m-85 -124.11 45.4 1.22 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.373 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 75.1 Cg_exo -36.91 -33.03 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.429 2.753 . . . . 0.0 113.628 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -59.57 -37.64 79.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.652 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.736 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.83 141.26 28.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.801 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.546 ' O ' HG13 ' A' ' 21' ' ' VAL . 33.9 m-20 -90.08 123.41 33.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.824 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.799 ' O ' HG23 ' A' ' 2' ' ' VAL . 5.4 m-85 -97.09 106.58 18.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.303 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.561 ' HB2' HG22 ' A' ' 23' ' ' VAL . 40.9 m-85 -116.11 -178.45 3.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.523 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.726 ' HE3' HG22 ' A' ' 2' ' ' VAL . 69.9 mttt -142.13 145.36 34.15 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.393 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.677 ' CD2' HD22 ' A' ' 60' ' ' LEU . 2.7 tm? -107.25 125.13 50.74 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.607 ' N ' HD13 ' A' ' 55' ' ' LEU . 1.6 m-20 -81.76 108.18 15.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.693 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.468 HG12 HG22 ' A' ' 28' ' ' THR . 85.1 t -72.34 -10.12 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.44 -60.52 2.34 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.556 ' HB3' HD12 ' A' ' 60' ' ' LEU . 2.2 tm-20 -77.9 -39.83 41.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.572 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.677 HD22 ' CD2' ' A' ' 55' ' ' LEU . 4.5 mp -97.76 44.85 1.03 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.014 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -58.13 -19.88 40.44 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.627 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -78.93 -29.32 44.05 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.783 0.325 . . . . 0.0 111.432 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.86 HG13 ' HE2' ' A' ' 66' ' ' LYS . 21.4 t -73.27 -54.83 14.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.788 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -52.86 -25.08 10.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.918 0.389 . . . . 0.0 110.142 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -90.17 -38.36 13.54 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.158 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.86 ' HE2' HG13 ' A' ' 63' ' ' VAL . 51.5 pttt -60.83 -46.97 88.48 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.945 0.403 . . . . 0.0 110.185 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.402 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.8 m-20 -79.16 -2.09 39.2 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.025 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 64.72 37.7 7.36 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.456 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.746 HG13 HG21 ' A' ' 74' ' ' THR . 41.9 t -111.45 68.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.992 0.425 . . . . 0.0 110.546 179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.2 t -85.01 8.24 18.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.733 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.834 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -59.76 -161.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.63 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -173.71 89.46 0.36 Allowed Pre-proline 0 N--CA 1.454 -0.228 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.545 ' O ' HG23 ' A' ' 88' ' ' VAL . 65.0 Cg_endo -96.13 -165.76 1.25 Allowed 'Cis proline' 0 N--CA 1.456 -0.721 0 C-N-CA 124.577 -1.01 . . . . 0.0 112.437 -0.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.876 HG23 ' HB ' ' A' ' 88' ' ' VAL . 29.5 m -147.35 163.63 35.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.477 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.915 HD13 HD13 ' A' ' 95' ' ' ILE . 78.9 mt -122.34 127.74 50.16 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.835 0.35 . . . . 0.0 111.191 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.044 HD12 ' CE1' ' A' ' 25' ' ' PHE . 26.5 mt -123.97 128.5 49.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.608 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.871 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.7 mp -109.64 136.9 48.27 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.028 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.605 ' HA ' HG23 ' A' ' 84' ' ' VAL . 51.1 m-85 -138.72 126.42 22.11 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.877 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.476 ' HG3' ' CG2' ' A' ' 84' ' ' VAL . 9.8 mtpm? -109.77 129.77 55.59 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.368 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.442 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 6.3 m120 45.78 56.75 5.64 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.865 0.365 . . . . 0.0 111.92 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 60.61 14.65 36.74 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.066 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 80' ' ' ASN . 49.1 mtmt -110.93 -155.37 0.56 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.441 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 88.2 tt0 -109.04 172.6 6.75 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 78' ' ' PHE . 64.5 t -146.18 -68.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.824 0.345 . . . . 0.0 111.25 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.39 -168.31 0.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.015 0.436 . . . . 0.0 111.551 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.462 ' NZ ' ' HB3' ' A' ' 86' ' ' LYS . 9.7 mtpm? -142.51 140.03 31.68 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.994 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.7 t -154.46 82.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.532 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.876 ' HB ' HG23 ' A' ' 74' ' ' THR . 5.5 p -78.67 109.57 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.826 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.91 -25.79 0.72 Allowed Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.134 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.772 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . 44.48 39.8 3.46 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 111.357 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.481 ' O ' HG22 ' A' ' 95' ' ' ILE . 24.3 t-20 -62.4 135.61 95.39 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.664 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -47.78 -25.18 5.59 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.663 2.242 . . . . 0.0 112.82 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -112.34 30.05 7.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.626 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -139.67 -59.57 0.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.2 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.915 HD13 HD13 ' A' ' 75' ' ' LEU . 3.9 tp -57.02 -7.28 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.337 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 14.8 ptmm? -91.3 -49.16 6.51 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.928 0.394 . . . . 0.0 110.659 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.416 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 73.0 mt-30 -69.52 -31.85 70.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.28 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.75 -28.32 69.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.695 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.8 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 59.0 mt -90.17 -10.82 10.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.523 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.84 -71.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.997 0.427 . . . . 0.0 111.349 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -47.43 -29.09 2.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.46 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.679 ' CB ' HD22 ' A' ' 20' ' ' LEU . 68.5 m-20 -90.05 -48.04 7.44 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.324 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.8 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.078 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.826 0.346 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.791 HG12 ' HE3' ' A' ' 54' ' ' LYS . 32.7 t -142.35 141.3 28.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.867 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 4' ' ' GLN . 95.5 m -144.25 161.19 39.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.057 0.456 . . . . 0.0 111.411 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.613 ' HG2' ' NZ ' ' A' ' 54' ' ' LYS . 55.3 mt-30 -91.71 172.55 8.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.443 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.521 ' CE2' ' CG ' ' A' ' 11' ' ' PHE . 17.1 m-85 -126.68 131.96 51.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.19 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.589 ' C ' HD11 ' A' ' 60' ' ' LEU . 47.5 mmtm -120.98 -32.61 3.92 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -178.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.2 p -126.2 148.06 49.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.908 0.385 . . . . 0.0 111.657 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 9' ' ' SER . . . -74.21 99.51 3.43 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.405 0.621 . . . . 0.0 110.337 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 8' ' ' ALA . 31.3 t 160.55 -24.97 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.018 -179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -84.67 -32.68 23.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.294 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.853 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -90.34 -43.33 10.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.401 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -47.29 -37.91 11.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.12 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.7 m -74.81 -30.95 61.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.834 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.491 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -60.49 -34.9 74.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.062 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.528 ' O ' ' N ' ' A' ' 81' ' ' GLY . 19.1 pt -90.07 -49.71 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.417 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.465 ' N ' HG13 ' A' ' 15' ' ' ILE . . . -43.62 95.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 45.23 83.17 0.03 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.177 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -164.67 42.25 0.08 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.588 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.55 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 2.7 mptp? 64.86 -157.2 0.29 Allowed 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 120.701 0.286 . . . . 0.0 110.657 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.841 HD13 ' HG3' ' A' ' 79' ' ' LYS . 65.9 tp -98.24 117.14 31.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.062 0.458 . . . . 0.0 110.856 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.657 HG22 ' HB2' ' A' ' 51' ' ' ASP . 46.6 t -113.93 124.02 70.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.742 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.72 HG22 ' HG ' ' A' ' 77' ' ' LEU . 58.8 t -99.84 111.56 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.933 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.853 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 41.5 t -109.45 137.77 40.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.197 -179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.45 ' OD2' HG21 ' A' ' 36' ' ' ILE . 61.8 t0 -99.84 128.96 45.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.824 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.067 ' CE1' HD12 ' A' ' 76' ' ' LEU . 6.8 m-85 -99.15 48.29 0.96 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.052 0.453 . . . . 0.0 110.175 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.582 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -48.88 132.04 18.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.243 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.563 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -60.78 145.31 50.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.808 0.337 . . . . 0.0 110.718 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.477 ' CB ' ' HB2' ' A' ' 58' ' ' ASP . 7.7 t -72.79 -21.19 61.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.391 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -95.87 -39.24 9.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.806 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 49.1 t -41.23 139.49 0.98 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.914 0.387 . . . . 0.0 111.717 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -87.71 -58.18 1.85 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.785 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -78.93 52.5 4.28 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.619 2.212 . . . . 0.0 112.755 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.442 ' O ' HD12 ' A' ' 36' ' ' ILE . 27.3 p -127.13 -13.05 5.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.38 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -78.47 -25.44 45.82 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.738 0.304 . . . . 0.0 111.251 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.409 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 65.9 mtt -73.75 3.83 5.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.838 0.351 . . . . 0.0 110.828 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.797 HG22 HG13 ' A' ' 40' ' ' ILE . 62.2 mt -79.14 -38.78 20.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.933 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.572 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -42.79 -45.42 11.47 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 23.9 Cg_endo -66.36 -43.49 8.17 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 121.595 1.53 . . . . 0.0 111.669 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.509 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 12.2 mmt -62.1 -59.87 4.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.797 HG13 HG22 ' A' ' 36' ' ' ILE . 43.2 mt -43.08 -29.27 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.019 0.438 . . . . 0.0 110.751 178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -80.42 -43.34 21.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.767 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -59.78 -29.94 68.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.183 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.605 ' CE2' HG23 ' A' ' 95' ' ' ILE . 16.0 m-85 -76.14 -22.6 55.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.473 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.401 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 98.9 p -77.31 -4.05 43.07 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.71 0.29 . . . . 0.0 110.711 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.424 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 50.3 mt-10 -90.08 -28.32 19.09 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.855 0.36 . . . . 0.0 110.712 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -90.24 -28.31 18.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.362 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.539 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 70.3 m-85 -123.97 45.54 1.25 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.133 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 74.2 Cg_exo -37.41 -32.43 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.376 2.718 . . . . 0.0 113.54 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -60.79 -38.45 85.37 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.674 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.618 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -90.0 138.69 31.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.956 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.657 ' HB2' HG22 ' A' ' 21' ' ' VAL . 58.2 m-20 -90.71 138.72 31.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.663 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.602 ' O ' HG13 ' A' ' 2' ' ' VAL . 2.7 m-85 -114.74 98.39 6.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.516 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.672 ' HB2' HG22 ' A' ' 23' ' ' VAL . 43.5 m-85 -102.41 -173.25 2.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.562 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.791 ' HE3' HG12 ' A' ' 2' ' ' VAL . 10.2 mtmp? -147.84 135.38 20.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.954 0.406 . . . . 0.0 111.04 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.954 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.1 tm? -98.25 145.62 26.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.698 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.954 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.9 t70 -93.85 126.04 38.82 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.7 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.759 HG12 ' O ' ' A' ' 57' ' ' VAL . 98.3 t -93.38 30.33 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-O 121.286 0.565 . . . . 0.0 110.814 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.477 ' HB2' ' CB ' ' A' ' 28' ' ' THR . 65.8 t0 -137.94 -46.73 0.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.58 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.614 ' C ' HD12 ' A' ' 60' ' ' LEU . 5.2 tp10 -81.56 -32.24 32.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.414 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.675 HD22 HD21 ' A' ' 55' ' ' LEU . 4.5 mp -118.52 72.78 0.89 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.64 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -77.84 -1.72 79.32 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.88 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -90.04 -38.39 13.62 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.741 0.305 . . . . 0.0 111.39 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.801 HG13 ' HE3' ' A' ' 66' ' ' LYS . 6.0 t -71.73 -54.88 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.826 0.345 . . . . 0.0 110.608 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -53.37 -25.44 15.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.019 0.438 . . . . 0.0 110.226 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -90.24 -38.36 13.49 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.109 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.801 ' HE3' HG13 ' A' ' 63' ' ' VAL . 16.5 pttp -60.7 -48.4 81.97 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-O 120.865 0.364 . . . . 0.0 110.129 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.417 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 76.5 m-20 -76.81 -6.08 50.89 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.869 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 66.3 41.66 3.3 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.019 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.561 HG13 HG21 ' A' ' 74' ' ' THR . 59.6 t -104.63 84.6 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.153 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 91.3 p -95.56 -17.46 21.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.922 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.774 ' CB ' HG21 ' A' ' 88' ' ' VAL . . . -55.99 -171.01 0.0 OUTLIER 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.501 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.563 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -167.84 108.31 0.58 Allowed Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 120.349 -0.54 . . . . 0.0 112.372 -179.506 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.733 ' O ' HG23 ' A' ' 88' ' ' VAL . 42.1 Cg_endo -87.85 -162.15 2.07 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.394 -1.086 . . . . 0.0 112.286 -0.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.561 HG21 HG13 ' A' ' 69' ' ' VAL . 84.9 m -153.76 163.81 39.39 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.803 0.335 . . . . 0.0 110.797 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.026 HD13 HD13 ' A' ' 95' ' ' ILE . 71.0 mt -129.0 123.45 32.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.845 0.355 . . . . 0.0 110.913 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.067 HD12 ' CE1' ' A' ' 25' ' ' PHE . 20.7 mt -121.05 129.15 53.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.803 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.79 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.5 mp -109.7 143.71 39.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.7 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.585 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 64.7 m-85 -144.41 127.09 16.15 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.001 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.841 ' HG3' HD13 ' A' ' 20' ' ' LEU . 49.3 mtpt -117.24 136.69 52.9 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.831 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.444 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 5.2 m120 45.78 67.69 0.7 Allowed 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.569 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 46.29 33.97 5.99 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 113.048 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.585 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 68.1 mttm -141.78 -160.57 1.1 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.718 ' O ' HG13 ' A' ' 84' ' ' VAL . 28.9 tt0 -109.14 -179.91 3.98 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.811 HG11 ' HG3' ' A' ' 79' ' ' LYS . 4.6 m -164.2 -46.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.51 0.195 . . . . 0.0 111.38 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.47 158.68 24.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.046 0.451 . . . . 0.0 112.012 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.468 ' CD ' ' O ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -148.03 113.67 5.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.872 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.7 t -139.41 107.37 3.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.412 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.774 HG21 ' CB ' ' A' ' 71' ' ' ALA . 3.2 p -69.45 110.45 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.063 0.458 . . . . 0.0 110.659 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 133.2 105.14 0.91 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.164 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.667 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -94.0 38.35 1.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.847 0.356 . . . . 0.0 111.39 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.454 ' O ' ' N ' ' A' ' 93' ' ' ALA . 5.4 m120 -72.38 134.83 82.12 Favored Pre-proline 0 N--CA 1.446 -0.649 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.437 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 85.6 Cg_exo -48.48 84.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.722 2.282 . . . . 0.0 112.625 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 178.66 -38.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.43 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.33 -45.68 2.92 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.7 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.026 HD13 HD13 ' A' ' 75' ' ' LEU . 4.9 tp -52.83 -16.49 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.148 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.491 ' NZ ' ' HB3' ' A' ' 96' ' ' LYS . 0.5 OUTLIER -92.21 -49.3 6.25 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.982 0.42 . . . . 0.0 110.901 179.509 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.442 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 25.8 mt-30 -71.53 -32.05 67.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.661 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.679 ' HB1' HD21 ' A' ' 77' ' ' LEU . . . -57.89 -32.93 68.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.429 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.872 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.5 mp -90.24 -12.25 9.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.423 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.47 -64.42 1.14 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.911 0.386 . . . . 0.0 111.095 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -53.31 -30.36 38.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.064 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.78 ' HB3' HD22 ' A' ' 20' ' ' LEU . 64.9 m-20 -90.15 -66.42 0.93 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.154 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.301 -0.856 . . . . 0.0 111.117 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.867 0.365 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.848 HG22 ' NZ ' ' A' ' 54' ' ' LYS . 6.0 p -177.31 127.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.668 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 4' ' ' GLN . 92.5 m -150.3 162.01 41.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.198 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.546 ' HG3' ' HD2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -105.4 -173.37 2.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.878 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.51 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 19.8 m-85 -135.79 105.75 6.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.762 0.315 . . . . 0.0 111.698 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.661 ' O ' HD11 ' A' ' 60' ' ' LEU . 8.2 mmmm -88.93 -27.71 20.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.763 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.7 p -126.35 128.52 47.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 110.705 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.79 -24.04 20.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.415 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -62.29 -16.59 54.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.627 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -90.14 -56.74 3.1 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.246 0.546 . . . . 0.0 111.111 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.659 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -60.49 -33.1 72.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.7 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -51.46 -56.69 11.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.256 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 53.4 m -65.85 -25.3 67.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.103 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.526 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -56.39 -72.02 0.08 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.864 0.364 . . . . 0.0 111.322 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.545 HG23 ' CE1' ' A' ' 11' ' ' PHE . 19.4 pt -52.8 -48.52 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.674 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -44.43 96.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 44.68 91.16 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.541 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 38.6 t70 -174.54 40.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.487 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.537 ' HB2' ' NZ ' ' A' ' 19' ' ' LYS . 8.1 mtmp? 69.36 -158.26 0.17 Allowed 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.498 179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.829 HD13 ' HG3' ' A' ' 79' ' ' LYS . 61.6 tp -98.16 113.76 25.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.205 0.526 . . . . 0.0 111.19 -179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.7 HG22 ' HB2' ' A' ' 51' ' ' ASP . 59.1 t -99.74 125.45 53.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.524 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.647 HG21 HG12 ' A' ' 99' ' ' ILE . 50.8 t -99.71 96.3 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.665 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.659 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 30.1 t -104.95 131.84 53.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.368 -179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 74' ' ' THR . 7.6 t70 -99.99 132.23 45.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.507 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.08 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.8 m-85 -99.14 54.6 0.98 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.137 0.494 . . . . 0.0 110.643 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.613 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -58.35 140.92 52.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.098 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.708 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -67.42 136.44 54.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.774 0.321 . . . . 0.0 110.253 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 3.3 t -53.39 -49.35 67.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.222 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 32.0 p-90 -68.2 -42.62 79.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.79 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 53.1 t -45.75 135.14 7.07 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 111.146 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.27 -56.3 0.94 Allowed Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.117 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -48.57 -26.02 8.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.617 2.211 . . . . 0.0 112.729 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.9 p -63.92 -32.21 73.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.071 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -61.87 -25.32 67.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.383 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 66.1 mtt -68.85 -5.85 23.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.962 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.857 HG22 HG13 ' A' ' 40' ' ' ILE . 60.0 mt -86.51 -23.63 6.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.447 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.28 -44.48 81.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 45.6 Cg_endo -72.7 -36.61 4.67 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 121.669 1.579 . . . . 0.0 111.447 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.527 ' O ' ' HD1' ' A' ' 43' ' ' PHE . 67.5 mtm -64.96 -51.46 61.63 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.857 HG13 HG22 ' A' ' 36' ' ' ILE . 68.0 mt -48.71 -25.53 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.716 178.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.404 ' HB2' HG11 ' A' ' 2' ' ' VAL . 38.0 tt0 -85.06 -23.38 28.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.972 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.447 ' HB2' ' NZ ' ' A' ' 42' ' ' LYS . 10.5 mtmp? -82.28 -15.71 52.03 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.527 ' HD1' ' O ' ' A' ' 39' ' ' MET . 3.5 m-85 -90.04 -19.27 24.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.652 0.263 . . . . 0.0 111.323 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.452 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.6 t -69.62 -8.84 50.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.484 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -87.99 -27.18 22.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.739 0.304 . . . . 0.0 111.098 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -90.6 -30.4 17.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.904 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.511 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 72.9 m-85 -123.03 47.3 1.56 Allowed Pre-proline 0 C--N 1.33 -0.255 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.167 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 80.7 Cg_exo -38.01 -27.22 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.254 2.636 . . . . 0.0 113.594 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.491 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 13.4 mp0 -65.63 -36.22 83.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.105 0.479 . . . . 0.0 110.472 179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.48 138.27 31.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.109 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.7 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.53 122.21 32.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.026 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.624 ' CE2' HD13 ' A' ' 99' ' ' ILE . 4.2 m-85 -97.37 83.96 3.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.221 0.534 . . . . 0.0 111.624 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.51 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 54.2 m-85 -102.31 -174.75 2.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.495 179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.848 ' NZ ' HG22 ' A' ' 2' ' ' VAL . 28.6 mttp -141.98 148.59 38.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.307 179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.727 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.8 tm? -106.21 130.23 54.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.127 0.489 . . . . 0.0 110.943 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.727 ' N ' HD13 ' A' ' 55' ' ' LEU . 56.9 m-20 -83.89 117.03 23.06 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.619 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 57' ' ' VAL . 69.9 t -87.22 5.56 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.111 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.492 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 11.5 p-10 -99.63 -40.73 7.65 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.92 0.39 . . . . 0.0 110.631 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.563 ' C ' HD12 ' A' ' 60' ' ' LEU . 5.4 tp10 -99.66 -28.5 13.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.979 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.672 ' N ' HD12 ' A' ' 60' ' ' LEU . 3.1 mp -114.17 41.79 2.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.032 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.51 -21.44 34.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.55 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -72.38 -25.83 61.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.687 0.28 . . . . 0.0 111.511 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.737 HG12 ' HE2' ' A' ' 25' ' ' PHE . 11.7 t -77.82 -49.56 21.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.75 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.47 -28.4 59.6 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.971 0.415 . . . . 0.0 110.321 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -90.03 -23.93 21.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.724 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -73.03 -49.54 28.19 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.98 0.419 . . . . 0.0 110.052 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -77.75 -0.75 28.14 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.146 179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 68.09 37.33 2.98 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.306 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.766 HG13 HG21 ' A' ' 74' ' ' THR . 44.2 t -116.18 72.97 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.758 0.313 . . . . 0.0 110.983 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.2 p -84.12 -15.13 48.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.929 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.36 -172.62 0.0 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.603 -0.271 . . . . 0.0 110.524 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.708 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 1.7 pmm? -170.08 112.74 0.47 Allowed Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.513 -0.475 . . . . 0.0 112.209 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.562 ' O ' HG23 ' A' ' 88' ' ' VAL . 68.4 Cg_endo -87.64 -167.39 4.06 Favored 'Cis proline' 0 C--N 1.349 0.571 0 C-N-CA 124.151 -1.187 . . . . 0.0 112.086 -0.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.766 HG21 HG13 ' A' ' 69' ' ' VAL . 29.0 m -161.36 151.67 17.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.681 0.277 . . . . 0.0 110.837 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.988 HD13 HD13 ' A' ' 95' ' ' ILE . 81.7 mt -114.22 124.84 53.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.282 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.08 HD12 ' CE1' ' A' ' 25' ' ' PHE . 22.7 mt -120.05 128.76 53.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.282 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.787 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.1 mp -109.6 141.19 42.47 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.833 0.349 . . . . 0.0 110.838 -179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.611 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 55.1 m-85 -143.19 126.21 16.32 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.96 -179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.829 ' HG3' HD13 ' A' ' 20' ' ' LEU . 48.5 mtpt -117.04 136.11 53.21 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.701 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.2 m120 49.12 62.4 2.63 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.484 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 50.61 25.54 9.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.069 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.611 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 75.2 mmtt -132.45 -160.09 1.02 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.722 ' O ' HG13 ' A' ' 84' ' ' VAL . 32.2 tt0 -108.94 -179.93 4.0 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.792 HG11 ' HG3' ' A' ' 79' ' ' LYS . 4.6 m -164.16 -47.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 N-CA-C 111.582 0.215 . . . . 0.0 111.582 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -164.81 165.24 20.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.155 0.502 . . . . 0.0 111.814 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.534 ' HG2' HD22 ' A' ' 76' ' ' LEU . 36.5 mtmm -151.19 135.15 16.6 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.923 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.4 t -154.21 105.99 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.469 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.58 ' HA ' HG23 ' A' ' 74' ' ' THR . 2.8 p -68.03 78.68 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.841 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.52 106.27 0.2 Allowed Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.339 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.666 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -97.11 38.53 1.24 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.875 0.369 . . . . 0.0 111.183 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 93' ' ' ALA . 22.9 t-20 -85.8 141.08 35.6 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.147 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -45.52 87.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.657 2.238 . . . . 0.0 112.636 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -179.6 -40.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.336 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.11 -42.14 2.29 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.988 HD13 HD13 ' A' ' 75' ' ' LEU . 5.3 tp -50.39 -17.92 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.081 -0.247 . . . . 0.0 111.133 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.45 ' CD ' ' CE2' ' A' ' 43' ' ' PHE . 29.6 mmmt -90.64 -66.76 0.9 Allowed 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.787 0.327 . . . . 0.0 111.104 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.469 ' OE1' ' N ' ' A' ' 97' ' ' GLN . 1.3 mp0 -59.93 -34.82 73.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.705 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.97 -30.87 66.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.616 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.647 HG12 HG21 ' A' ' 22' ' ' VAL . 57.8 mt -90.22 -14.67 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.343 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.43 -68.57 0.78 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.865 0.364 . . . . 0.0 111.142 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.07 -28.76 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.148 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.591 ' HB3' HD22 ' A' ' 20' ' ' LEU . 5.8 m120 -83.15 -51.92 7.07 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.996 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.056 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 tpp . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.792 0.33 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.484 HG11 ' HB2' ' A' ' 41' ' ' GLU . 10.5 p -139.07 137.7 41.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.464 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.451 HG22 ' N ' ' A' ' 4' ' ' GLN . 85.3 m -148.67 162.59 39.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.958 0.409 . . . . 0.0 111.543 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.649 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 43.1 mt-30 -107.62 -179.92 4.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.219 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.508 ' CE2' ' CD1' ' A' ' 11' ' ' PHE . 22.6 m-85 -129.49 129.73 44.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.564 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.794 ' C ' HD11 ' A' ' 60' ' ' LEU . 47.4 mmtm -110.95 -18.77 12.99 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 8' ' ' ALA . 25.5 m -147.94 165.77 29.68 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.18 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.55 ' O ' ' OG ' ' A' ' 9' ' ' SER . . . -84.63 101.46 12.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.473 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.55 ' OG ' ' O ' ' A' ' 8' ' ' ALA . 13.2 m 160.26 -25.33 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.044 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -87.24 -30.77 20.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.481 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.911 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -90.05 -40.8 12.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.556 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -48.64 -40.35 27.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.22 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.5 m -76.21 -27.12 56.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.096 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.51 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -57.47 -62.16 1.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.36 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.65 HG22 ' HB2' ' A' ' 78' ' ' PHE . 19.1 pt -63.72 -48.71 85.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.602 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.48 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -40.49 94.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.746 0.646 . . . . 0.0 112.746 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 24.6 mt-30 44.16 88.96 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.385 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.515 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 8.9 t70 -170.64 40.47 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.324 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 53.1 mttp 70.82 -151.47 0.1 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.729 0.3 . . . . 0.0 110.635 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.652 ' CD1' HG21 ' A' ' 84' ' ' VAL . 28.0 tp -97.47 111.49 23.73 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.15 0.5 . . . . 0.0 110.998 -178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.731 HG22 ' HB2' ' A' ' 51' ' ' ASP . 60.0 t -99.96 113.91 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.918 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.932 HG21 HG12 ' A' ' 99' ' ' ILE . 43.6 t -99.9 102.39 13.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.6 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.911 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 39.9 t -104.84 138.42 29.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.604 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -104.42 130.96 52.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.823 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.048 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.4 m-85 -99.1 49.39 0.95 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.047 0.451 . . . . 0.0 109.832 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.565 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.7 OUTLIER -47.18 134.56 10.88 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.508 -179.106 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.548 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . . . -62.0 128.72 37.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.445 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.531 ' OG1' ' HB3' ' A' ' 58' ' ' ASP . 5.2 t -59.44 -28.02 66.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.766 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.403 ' CH2' ' SD ' ' A' ' 72' ' ' MET . 31.4 p-90 -93.83 -36.97 11.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 33.2 t -46.58 158.72 0.11 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.577 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -100.71 -66.39 0.81 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.521 -0.847 . . . . 0.0 113.304 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -46.77 -26.68 4.8 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.892 2.394 . . . . 0.0 113.08 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 86.3 m -60.43 -17.86 47.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -73.81 -44.34 56.12 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.406 ' C ' ' HD2' ' A' ' 38' ' ' PRO . 65.2 mtt -70.77 1.7 5.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.796 0.331 . . . . 0.0 111.522 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.724 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 36.3 mt -75.74 -39.4 38.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.728 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.511 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -44.53 -50.39 23.49 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 41.6 Cg_endo -69.58 -31.26 21.69 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 121.806 1.671 . . . . 0.0 111.194 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 47.1 tpp -68.93 -51.19 42.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.779 HD12 ' CD ' ' A' ' 54' ' ' LYS . 62.6 mt -50.32 -29.07 5.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.411 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.484 ' HB2' HG11 ' A' ' 2' ' ' VAL . 43.6 tt0 -75.71 -35.63 60.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.889 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -62.42 -20.58 64.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.675 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.26 -24.54 20.91 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.414 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 50.5 m -62.21 -13.21 25.38 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.611 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -85.59 -25.2 26.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.729 0.3 . . . . 0.0 111.31 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -90.42 -30.74 17.18 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.556 ' OH ' ' HB2' ' A' ' 100' ' ' ALA . 80.8 m-85 -123.1 46.47 1.35 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.747 0.308 . . . . 0.0 111.482 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 79.3 Cg_exo -37.18 -33.2 0.16 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.321 2.68 . . . . 0.0 114.025 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.413 ' O ' ' CD ' ' A' ' 19' ' ' LYS . 9.6 mm-40 -66.17 -30.92 71.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.931 0.396 . . . . 0.0 110.86 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.34 138.45 31.43 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.475 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.731 ' HB2' HG22 ' A' ' 21' ' ' VAL . 1.5 m-20 -89.49 121.59 31.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.006 0.431 . . . . 0.0 110.383 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.698 ' CE2' HD13 ' A' ' 99' ' ' ILE . 5.2 m-85 -97.44 82.99 3.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.594 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.609 ' HB2' HG22 ' A' ' 23' ' ' VAL . 43.0 m-85 -97.04 -178.16 4.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.898 178.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.779 ' CD ' HD12 ' A' ' 40' ' ' ILE . 33.4 mtmm -146.31 139.13 25.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.163 0.506 . . . . 0.0 111.398 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.831 HD13 ' N ' ' A' ' 56' ' ' ASP . 1.8 tm? -102.09 135.44 43.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.967 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.831 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.9 t0 -88.43 128.68 35.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.308 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 26' ' ' TYR . 41.4 t -85.66 -11.17 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.531 ' HB3' ' OG1' ' A' ' 28' ' ' THR . 2.1 p30 -105.1 -41.25 5.62 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.336 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.738 ' C ' HD12 ' A' ' 60' ' ' LEU . 15.8 tp10 -76.84 -31.17 56.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.97 0.414 . . . . 0.0 110.608 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.794 HD11 ' C ' ' A' ' 6' ' ' LYS . 4.2 mp -125.35 42.73 3.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.765 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -48.44 -27.42 5.77 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.486 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.45 -25.78 68.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.63 0.252 . . . . 0.0 111.447 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.812 HG13 ' HE2' ' A' ' 66' ' ' LYS . 11.0 t -81.16 -55.58 7.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.745 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -50.83 -26.72 6.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.069 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.427 ' N ' ' OE1' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -90.33 -37.14 14.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.669 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.812 ' HE2' HG13 ' A' ' 63' ' ' VAL . 52.6 pttt -59.74 -48.12 82.94 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.051 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.414 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 76.0 m-20 -78.41 -5.22 51.73 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.867 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 67.01 41.49 2.65 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.256 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.673 ' CG1' HG21 ' A' ' 74' ' ' THR . 41.7 t -112.63 97.6 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-O 120.805 0.336 . . . . 0.0 110.99 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.8 p -112.31 28.68 8.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.983 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.856 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -76.12 -153.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.823 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.476 ' O ' ' HG3' ' A' ' 72' ' ' MET . 16.5 ptt? -173.04 79.65 0.41 Allowed Pre-proline 0 CA--C 1.529 0.141 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.724 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 1.3 Cg_endo -97.52 -155.61 0.33 Allowed 'Cis proline' 0 C--N 1.348 0.524 0 C-N-CA 125.242 -0.733 . . . . 0.0 112.783 -0.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.856 ' OG1' ' HB3' ' A' ' 71' ' ' ALA . 86.6 m -151.22 147.09 26.57 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.027 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.047 HD13 HD13 ' A' ' 95' ' ' ILE . 88.4 mt -109.67 122.7 48.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.941 0.4 . . . . 0.0 111.458 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.048 HD12 ' CE1' ' A' ' 25' ' ' PHE . 29.2 mt -120.23 125.87 49.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.441 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 77' ' ' LEU . 3.3 mp -109.8 147.47 33.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.8 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.65 ' HB2' HG22 ' A' ' 15' ' ' ILE . 47.0 m-85 -148.45 126.83 12.28 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.339 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.832 ' HG3' HG11 ' A' ' 84' ' ' VAL . 50.3 mtpt -115.55 140.16 49.42 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.463 178.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 6.0 m120 49.1 52.12 14.96 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.634 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 57.62 19.32 34.49 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.706 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.616 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 54.7 mtpt -122.5 -155.83 0.67 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.765 ' O ' HG13 ' A' ' 84' ' ' VAL . 83.1 tt0 -108.85 177.73 4.68 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.832 HG11 ' HG3' ' A' ' 79' ' ' LYS . 4.2 m -166.55 -47.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.644 0.259 . . . . 0.0 111.369 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.452 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -163.93 174.68 11.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 111.612 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.426 ' HB2' ' CD2' ' A' ' 76' ' ' LEU . 14.3 ptmm? -170.05 115.57 0.52 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.649 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 87' ' ' VAL . 9.1 p -122.88 103.82 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.129 0.49 . . . . 0.0 111.547 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.786 ' HA ' HG23 ' A' ' 74' ' ' THR . 2.1 p -59.92 88.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.838 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.636 ' O ' ' HB2' ' A' ' 90' ' ' ALA . . . 158.65 -128.93 2.15 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.169 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.675 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . 158.54 39.42 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.825 0.345 . . . . 0.0 110.894 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.626 ' O ' HG22 ' A' ' 95' ' ' ILE . 23.2 p30 -70.91 139.71 85.73 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.744 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -49.75 -18.41 2.74 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.764 2.309 . . . . 0.0 113.198 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.44 21.63 12.89 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -151.59 -60.06 0.17 Allowed 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.829 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.047 HD13 HD13 ' A' ' 75' ' ' LEU . 3.9 tp -50.69 -15.15 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 121.033 -0.267 . . . . 0.0 111.138 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.502 ' HE2' ' HG3' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -92.34 -41.03 10.58 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.0 0.429 . . . . 0.0 110.677 179.351 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.502 ' HG3' ' HE2' ' A' ' 96' ' ' LYS . 72.1 mt-30 -76.45 -32.13 58.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.18 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.39 -32.33 73.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.52 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.932 HG12 HG21 ' A' ' 22' ' ' VAL . 38.9 mt -90.25 -13.47 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.258 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.556 ' HB2' ' OH ' ' A' ' 47' ' ' TYR . . . -90.4 -72.05 0.59 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.9 0.381 . . . . 0.0 111.186 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -48.45 -29.34 3.99 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.264 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.509 ' OD1' HD22 ' A' ' 77' ' ' LEU . 3.7 m120 -83.82 -41.69 17.26 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.583 ' HB2' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.146 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptp . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.704 0.288 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 52' ' ' PHE . 49.9 t 67.14 139.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.345 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.419 ' O ' ' HG2' ' A' ' 54' ' ' LYS . 87.0 m -150.12 153.86 37.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.076 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.573 ' HG2' ' HG3' ' A' ' 54' ' ' LYS . 57.3 mt-30 -89.42 -179.21 5.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.178 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.543 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 17.0 m-85 -130.02 140.03 50.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.016 0.436 . . . . 0.0 111.309 178.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HD2' ' HG3' ' A' ' 59' ' ' GLU . 34.3 mmtp -112.72 -55.94 2.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.489 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.2 p -105.75 169.39 8.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.559 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -79.78 -27.84 40.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.1 m -60.85 -16.16 38.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.621 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -90.34 -62.59 1.43 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.227 0.537 . . . . 0.0 111.087 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.95 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.1 t80 -59.85 -24.14 63.97 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.992 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -54.96 -55.7 27.86 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.447 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 54.1 m -72.01 -23.41 61.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.487 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.63 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -54.98 -38.63 68.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.765 0.317 . . . . 0.0 111.598 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 81' ' ' GLY . 21.3 pt -88.01 -48.73 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.437 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -43.37 102.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 85.1 mt-30 44.5 87.52 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.216 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 8.8 t70 -168.37 39.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.352 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.552 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 2.6 mptp? 62.54 -154.51 0.34 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.686 0.279 . . . . 0.0 110.43 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.861 HD11 ' HB3' ' A' ' 77' ' ' LEU . 62.3 tp -97.92 115.27 27.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.071 0.462 . . . . 0.0 110.882 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.688 HG22 ' HB2' ' A' ' 51' ' ' ASP . 45.8 t -106.89 130.71 58.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.632 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.684 HG11 HD11 ' A' ' 95' ' ' ILE . 56.4 t -99.81 97.96 6.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.547 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.95 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 24.8 t -101.4 126.03 55.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.053 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.573 ' HB3' ' NZ ' ' A' ' 54' ' ' LYS . 38.0 t70 -99.97 131.67 45.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.015 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.069 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.1 m-85 -99.25 50.26 0.95 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.077 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.682 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -53.79 129.58 33.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.352 -179.559 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.762 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -50.39 153.34 1.57 Allowed 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.724 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.623 ' OG1' ' HB2' ' A' ' 58' ' ' ASP . 7.9 t -92.6 21.57 5.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.042 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.462 ' NE1' ' HB1' ' A' ' 27' ' ' ALA . 23.7 p-90 -143.58 -42.24 0.28 Allowed 'General case' 0 C--O 1.232 0.167 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 29' ' ' TRP . 50.1 t -29.97 -76.2 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 128.54 -78.92 0.38 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.446 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -46.98 -29.34 8.33 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.667 2.245 . . . . 0.0 112.217 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.46 ' HA ' HD12 ' A' ' 36' ' ' ILE . 82.5 m -60.19 -20.15 57.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.784 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -74.09 -37.27 64.22 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.6 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.44 ' O ' ' HG2' ' A' ' 35' ' ' MET . 48.6 ttm -72.21 0.88 8.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.381 . . . . 0.0 111.074 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.601 ' CD1' ' HG3' ' A' ' 73' ' ' PRO . 59.1 mt -83.2 -25.23 8.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.011 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.566 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.88 -45.84 87.31 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 38.4 Cg_endo -69.91 -37.4 8.85 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 121.896 1.731 . . . . 0.0 111.588 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 57.1 ttp -64.49 -51.25 63.97 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.838 HD12 ' HE2' ' A' ' 54' ' ' LYS . 55.2 mt -51.73 -27.35 8.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.652 178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.635 ' HA ' HG21 ' A' ' 2' ' ' VAL . 87.7 tt0 -77.48 -29.39 52.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.336 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -66.82 -17.98 65.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.221 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -89.97 -18.45 26.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.425 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.5 t -67.31 -12.32 59.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.158 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.411 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 5.5 tp10 -85.71 -24.39 26.99 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.707 0.289 . . . . 0.0 111.042 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -90.26 -35.06 15.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.556 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.539 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 69.0 m-85 -122.33 43.9 0.78 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.539 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 90.4 Cg_exo -38.63 -32.45 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.104 2.536 . . . . 0.0 113.224 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -59.41 -38.28 80.21 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.715 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.755 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.78 145.77 24.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.688 ' HB2' HG22 ' A' ' 21' ' ' VAL . 32.7 m-20 -89.98 148.88 22.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.732 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.702 ' O ' HG13 ' A' ' 2' ' ' VAL . 2.6 m-85 -123.39 94.58 4.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.979 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.543 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 53.5 m-85 -108.8 173.78 6.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.997 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.838 ' HE2' HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -124.61 162.26 24.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.549 HD13 ' C ' ' A' ' 55' ' ' LEU . 2.1 tm? -127.2 108.69 11.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.753 0.311 . . . . 0.0 110.485 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -64.01 112.15 2.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.62 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 26' ' ' TYR . 55.5 t -69.27 -11.15 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.744 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.623 ' HB2' ' OG1' ' A' ' 28' ' ' THR . 4.5 t70 -99.69 -59.92 1.63 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.138 0.495 . . . . 0.0 110.374 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.42 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -53.41 -45.45 69.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.582 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.52 ' HB3' HG23 ' A' ' 63' ' ' VAL . 3.3 mm? -81.64 -67.71 0.76 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.378 0.609 . . . . 0.0 110.83 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 69.11 -64.38 0.52 Allowed Glycine 0 C--N 1.314 -0.66 0 CA-C-N 114.921 -1.036 . . . . 0.0 112.481 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -56.91 -28.82 62.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.615 0.245 . . . . 0.0 111.386 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.848 HG12 ' HE2' ' A' ' 25' ' ' PHE . 16.3 t -73.03 -52.78 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.434 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.92 -24.68 39.22 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.086 0.469 . . . . 0.0 109.806 178.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -90.34 -38.91 13.03 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.169 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.846 ' HE3' HG13 ' A' ' 63' ' ' VAL . 17.3 pttp -59.72 -48.38 81.89 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.893 0.378 . . . . 0.0 110.206 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.414 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.5 m-80 -77.55 -5.1 48.94 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.897 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 66.32 41.74 3.25 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.129 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.687 ' CG1' HG21 ' A' ' 74' ' ' THR . 53.8 t -113.87 86.16 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.122 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 93.3 p -91.46 -21.88 20.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.838 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.48 -173.64 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.762 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -172.76 119.38 0.41 Allowed Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.601 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 50.6 Cg_endo -83.89 -179.23 21.14 Favored 'Cis proline' 0 C--N 1.35 0.617 0 C-N-CA 123.939 -1.275 . . . . 0.0 112.158 -0.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.687 HG21 ' CG1' ' A' ' 69' ' ' VAL . 37.0 m -147.03 143.65 28.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.469 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.04 HD13 HD13 ' A' ' 95' ' ' ILE . 79.5 mt -109.78 124.55 51.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.06 0.457 . . . . 0.0 111.812 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.069 HD12 ' CE1' ' A' ' 25' ' ' PHE . 25.1 mt -119.38 127.61 53.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.468 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.861 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.5 mp -109.71 134.08 52.4 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.212 -179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.593 ' HA ' HG23 ' A' ' 84' ' ' VAL . 53.1 m-85 -133.91 127.99 33.62 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.111 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.49 ' HD3' ' HB2' ' A' ' 20' ' ' LEU . 7.4 mmmm -109.79 127.74 54.85 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.728 0.299 . . . . 0.0 111.47 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.3 m120 45.32 56.43 5.62 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.909 0.385 . . . . 0.0 111.832 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 61.6 14.15 41.61 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.199 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 34.3 mmtp -111.74 -154.18 0.54 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 35.8 tt0 -108.77 171.37 7.47 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 78' ' ' PHE . 59.6 t -144.03 -66.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.745 0.307 . . . . 0.0 111.35 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.17 161.7 8.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.003 0.43 . . . . 0.0 111.524 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -116.69 129.14 55.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.09 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.4 t -154.49 81.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.261 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.562 ' O ' HG13 ' A' ' 88' ' ' VAL . 6.8 p -61.74 85.38 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.009 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 161.81 110.69 0.26 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.566 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.649 ' HA ' HD11 ' A' ' 75' ' ' LEU . . . -100.78 38.9 1.45 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.884 0.374 . . . . 0.0 111.318 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 93' ' ' ALA . 47.4 t30 -79.6 132.01 62.93 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.208 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.491 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 76.0 Cg_exo -44.37 87.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.737 2.292 . . . . 0.0 112.886 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 92' ' ' PRO . . . 173.26 -38.14 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.21 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -113.58 -46.24 3.06 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.643 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.04 HD13 HD13 ' A' ' 75' ' ' LEU . 5.0 tp -52.77 -16.12 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.703 0.287 . . . . 0.0 111.148 179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.459 ' HB2' ' NZ ' ' A' ' 96' ' ' LYS . 10.4 mtmp? -90.78 -63.06 1.32 Allowed 'General case' 0 CA--C 1.523 -0.091 0 CA-C-O 121.024 0.44 . . . . 0.0 110.623 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -58.8 -33.39 70.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.639 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.62 -30.1 69.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.682 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 59.9 mt -89.9 -7.8 10.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.468 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.32 -72.16 0.58 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.971 0.415 . . . . 0.0 111.273 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -52.44 -30.73 31.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.337 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.58 ' CB ' HD22 ' A' ' 20' ' ' LEU . 3.9 m120 -80.83 -53.57 6.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.0 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.074 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.729 0.3 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.851 HG22 ' HE2' ' A' ' 54' ' ' LYS . 11.0 p -148.06 135.94 14.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.814 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 85.0 m -150.18 152.2 34.28 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.177 0.513 . . . . 0.0 111.803 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.412 ' OE1' ' HB2' ' A' ' 54' ' ' LYS . 9.3 mm-40 -90.13 159.03 16.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.003 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.518 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 15.0 m-85 -116.61 99.12 6.92 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.824 -0.351 . . . . 0.0 111.543 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.629 ' O ' HD11 ' A' ' 60' ' ' LEU . 30.7 mmtp -85.92 -27.51 24.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.8 p -127.74 124.23 37.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.479 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.88 -25.15 7.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.364 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.8 m -60.07 -18.69 48.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.574 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -90.33 -40.51 12.06 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.134 0.493 . . . . 0.0 111.207 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.946 ' CZ ' HG21 ' A' ' 23' ' ' VAL . 1.2 t80 -75.69 -30.88 59.49 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.812 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -54.57 -49.57 70.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.084 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.3 m -71.93 -25.47 61.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.164 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.526 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -56.88 -67.67 0.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.311 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 81' ' ' GLY . 17.8 pt -54.13 -49.47 61.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.776 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -44.78 99.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 44.66 89.66 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.55 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 63.9 t0 -169.38 39.66 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.284 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.554 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 2.6 mptp? 65.82 -154.56 0.26 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.37 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.729 HD11 ' HB3' ' A' ' 77' ' ' LEU . 54.0 tp -97.78 115.84 28.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.14 0.495 . . . . 0.0 110.774 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.615 HG22 ' HB2' ' A' ' 51' ' ' ASP . 49.1 t -105.94 128.56 60.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.032 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.639 HG21 HG13 ' A' ' 99' ' ' ILE . 44.5 t -99.97 96.81 5.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.361 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.946 HG21 ' CZ ' ' A' ' 11' ' ' PHE . 41.2 t -101.37 129.42 52.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.085 0.469 . . . . 0.0 111.678 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -99.76 130.06 45.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.327 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.049 ' CE1' HD12 ' A' ' 76' ' ' LEU . 3.6 m-85 -99.12 50.18 0.95 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.011 0.434 . . . . 0.0 110.849 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.621 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 1.0 OUTLIER -51.05 136.79 22.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.831 179.499 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.739 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -62.09 150.3 38.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.905 0.383 . . . . 0.0 110.973 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.418 ' HB ' ' N ' ' A' ' 58' ' ' ASP . 5.1 t -78.76 -22.67 46.1 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.339 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.441 ' CH2' ' SD ' ' A' ' 72' ' ' MET . 21.8 p-90 -104.18 -34.91 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.868 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.607 ' CB ' ' HB3' ' A' ' 27' ' ' ALA . 42.2 t -39.47 156.33 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.727 0.299 . . . . 0.0 111.425 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 32' ' ' PRO . . . -86.98 -87.97 1.06 Allowed Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.756 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.411 ' HD3' ' HA3' ' A' ' 31' ' ' GLY . 18.0 Cg_exo -66.72 61.92 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.896 2.397 . . . . 0.0 112.645 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 30.8 p -129.45 -4.1 4.83 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.376 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -99.02 -24.96 14.72 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.673 0.273 . . . . 0.0 111.433 -179.643 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.8 mmt -68.74 -0.25 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.318 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.89 HG22 HG13 ' A' ' 40' ' ' ILE . 64.5 mt -82.66 -27.63 8.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.867 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.511 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -47.54 -46.04 58.86 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 41.5 Cg_endo -72.51 -36.81 4.74 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 121.788 1.659 . . . . 0.0 110.763 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.653 ' HE3' ' HB1' ' A' ' 90' ' ' ALA . 1.7 tmt? -62.26 -51.88 65.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.196 178.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.89 HG13 HG22 ' A' ' 36' ' ' ILE . 55.9 mt -51.45 -29.25 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.629 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.501 ' HB2' HG11 ' A' ' 2' ' ' VAL . 39.2 tt0 -76.31 -40.02 52.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.484 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -55.36 -24.63 30.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.371 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.522 ' CZ ' ' HE1' ' A' ' 39' ' ' MET . 5.1 m-85 -90.29 -22.85 21.37 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.455 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 87.1 p -70.09 -8.36 48.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.156 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.41 ' C ' ' HD3' ' A' ' 48' ' ' PRO . 5.4 tp10 -90.02 -25.88 20.6 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.739 0.304 . . . . 0.0 110.998 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -90.4 -29.53 17.96 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.582 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.53 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 78.1 m-85 -122.86 44.94 0.98 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.356 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.53 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 84.1 Cg_exo -38.18 -32.02 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.088 2.525 . . . . 0.0 113.262 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -59.01 -40.86 86.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.561 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.707 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.88 141.37 28.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.709 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.615 ' HB2' HG22 ' A' ' 21' ' ' VAL . 57.1 m-20 -89.98 125.44 35.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.909 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.455 ' CE1' ' HA ' ' A' ' 44' ' ' SER . 4.6 m-85 -99.84 93.87 6.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.532 ' C ' ' HD3' ' A' ' 54' ' ' LYS . 47.2 m-85 -107.42 179.43 4.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.917 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.851 ' HE2' HG22 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -137.9 153.88 49.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.691 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.543 HD13 ' C ' ' A' ' 55' ' ' LEU . 2.8 tm? -112.33 118.83 36.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.445 ' N ' HD13 ' A' ' 55' ' ' LEU . 9.1 m-20 -78.25 108.37 11.52 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.566 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 57' ' ' VAL . 90.6 t -75.46 -5.03 6.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.024 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.418 ' N ' ' HB ' ' A' ' 28' ' ' THR . 67.1 t0 -80.34 -46.8 15.48 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.795 0.331 . . . . 0.0 110.826 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.548 ' C ' HD12 ' A' ' 60' ' ' LEU . 5.5 tp10 -97.99 -24.56 15.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.115 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.672 ' N ' HD12 ' A' ' 60' ' ' LEU . 3.4 mp -113.47 52.64 0.8 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.86 0.362 . . . . 0.0 111.055 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -63.82 -15.55 58.04 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.707 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -82.36 -26.36 32.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.664 0.269 . . . . 0.0 111.486 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.839 HG12 ' HE2' ' A' ' 25' ' ' PHE . 11.7 t -78.76 -22.75 12.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.865 0.364 . . . . 0.0 110.889 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.58 -24.85 38.89 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -90.22 -31.72 16.89 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.779 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -59.35 -47.96 83.45 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.043 0.449 . . . . 0.0 110.077 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.411 ' N ' ' CG ' ' A' ' 66' ' ' LYS . 75.4 m-80 -86.86 -0.01 55.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.064 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 62.15 41.32 10.85 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.056 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.513 HG13 HG21 ' A' ' 74' ' ' THR . 47.5 t -106.27 116.54 50.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.116 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.8 p -149.87 18.69 0.89 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.695 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 1.031 ' HB3' HG21 ' A' ' 88' ' ' VAL . . . -70.15 -16.58 63.11 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.908 0.385 . . . . 0.0 110.779 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.739 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 11.4 ptt? 43.54 93.31 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.206 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.701 ' HG3' HD11 ' A' ' 36' ' ' ILE . 13.2 Cg_endo -92.6 -156.43 0.64 Allowed 'Cis proline' 0 C--N 1.347 0.478 0 C-N-CA 125.077 -0.801 . . . . 0.0 112.319 -0.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.513 HG21 HG13 ' A' ' 69' ' ' VAL . 89.2 m -164.63 162.53 21.54 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.958 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.039 HD13 HD13 ' A' ' 95' ' ' ILE . 68.5 mt -123.46 123.62 41.05 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.68 0.276 . . . . 0.0 110.796 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.049 HD12 ' CE1' ' A' ' 25' ' ' PHE . 23.4 mt -118.74 131.5 56.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.0 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.729 ' HB3' HD11 ' A' ' 20' ' ' LEU . 3.5 mp -109.75 137.04 48.13 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.039 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.613 ' HA ' HG23 ' A' ' 84' ' ' VAL . 67.8 m-85 -136.88 126.03 24.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.276 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.713 ' HG3' HD13 ' A' ' 20' ' ' LEU . 8.6 mtmp? -113.39 126.71 55.66 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.64 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.512 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 74.6 m-80 46.26 75.43 0.12 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.617 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 40.95 39.5 1.99 Allowed Glycine 0 C--N 1.331 0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 113.619 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 31.9 mmmt -143.51 -158.58 0.89 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.425 ' HG2' ' N ' ' A' ' 84' ' ' VAL . 86.5 tt0 -108.82 175.17 5.56 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.684 HG13 ' HE3' ' A' ' 79' ' ' LYS . 14.3 t -149.14 -66.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.898 0.38 . . . . 0.0 110.946 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.13 154.42 4.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.138 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -117.79 120.63 38.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.735 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 75' ' ' LEU . 49.1 t -139.06 93.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.138 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.031 HG21 ' HB3' ' A' ' 71' ' ' ALA . 4.6 p -67.56 120.85 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.964 0.411 . . . . 0.0 110.878 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 122.93 102.22 1.61 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.236 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.7 ' HB2' HD21 ' A' ' 75' ' ' LEU . . . -94.41 37.58 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 111.208 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 93' ' ' ALA . 46.1 t30 -83.47 134.37 45.39 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.017 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -40.73 89.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.75 2.3 . . . . 0.0 112.693 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . 179.56 -32.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.301 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.11 -42.47 0.98 Allowed 'General case' 0 C--O 1.232 0.165 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.039 HD13 HD13 ' A' ' 75' ' ' LEU . 6.4 tp -53.73 -14.76 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.471 0.177 . . . . 0.0 111.449 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.428 ' HG2' ' N ' ' A' ' 97' ' ' GLN . 14.2 tttm -92.02 -61.87 1.53 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 120.92 0.39 . . . . 0.0 111.004 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.512 ' NE2' ' H ' ' A' ' 97' ' ' GLN . 0.3 OUTLIER -66.64 -34.83 78.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.991 -179.531 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.42 -30.26 62.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.094 0.473 . . . . 0.0 110.646 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.917 HD13 ' O ' ' A' ' 95' ' ' ILE . 1.5 mp -90.18 -8.43 10.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.627 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.23 -75.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.319 . . . . 0.0 111.34 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -49.88 -29.52 8.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.356 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.592 ' HB3' HD22 ' A' ' 20' ' ' LEU . 2.4 m120 -78.54 -50.66 11.18 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.916 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.543 ' HB2' HD23 ' A' ' 20' ' ' LEU . . . . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.192 -0.909 . . . . 0.0 111.03 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptm . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.845 0.355 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 52' ' ' PHE . 13.1 p -133.49 138.66 50.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.813 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.443 HG22 ' N ' ' A' ' 4' ' ' GLN . 85.6 m -150.15 161.69 41.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.964 0.411 . . . . 0.0 111.433 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.609 ' HG2' ' HE2' ' A' ' 54' ' ' LYS . 17.1 mt-30 -96.88 -179.34 4.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.375 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.52 ' CZ ' ' CG ' ' A' ' 53' ' ' TYR . 18.1 m-85 -132.31 95.94 3.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.188 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.79 ' O ' HD11 ' A' ' 60' ' ' LEU . 74.6 mmtt -80.77 -19.53 44.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 74.6 p -134.37 122.71 22.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.375 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.47 -25.41 6.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.599 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.1 t -60.63 -17.23 45.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.769 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -90.5 -45.78 8.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.158 0.504 . . . . 0.0 111.476 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.904 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.2 t80 -69.08 -23.26 64.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.087 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -57.37 -40.09 77.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.394 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.6 t -86.48 -24.46 25.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.528 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.683 ' HB3' ' HD1' ' A' ' 11' ' ' PHE . . . -56.94 -38.61 73.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.542 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.542 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.1 pt -86.76 -49.41 14.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.543 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.505 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -44.3 100.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 84.3 mt-30 44.98 90.19 0.01 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.4 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 18' ' ' ASP . 8.5 t0 -173.66 40.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.063 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.559 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 2.8 mptp? 63.92 -157.28 0.31 Allowed 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.447 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.851 HD11 ' HB3' ' A' ' 77' ' ' LEU . 59.1 tp -98.19 117.87 33.55 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.112 0.482 . . . . 0.0 110.914 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 51' ' ' ASP . 53.4 t -101.66 137.58 28.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.617 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.7 t -99.93 87.5 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.368 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.904 HG21 ' CE1' ' A' ' 11' ' ' PHE . 29.0 t -99.91 121.6 50.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.357 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -100.0 134.38 43.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.61 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.041 ' CE1' HD12 ' A' ' 76' ' ' LEU . 4.2 m-85 -99.19 52.36 0.95 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.931 0.395 . . . . 0.0 110.577 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.56 ' CE2' ' HB3' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -51.81 138.15 24.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.469 ' HB2' ' HB3' ' A' ' 72' ' ' MET . . . -68.23 138.08 55.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.549 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -58.41 -14.37 7.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.403 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.519 ' CH2' ' HE2' ' A' ' 72' ' ' MET . 5.7 p-90 -112.25 -123.83 0.28 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.092 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 36.8 t 60.74 -83.18 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.561 0.344 . . . . 0.0 110.824 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.64 -79.8 0.22 Allowed Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.145 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.65 -22.15 73.66 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.884 2.389 . . . . 0.0 113.254 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 98.4 m -50.04 -27.66 5.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.615 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.481 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -77.7 -28.25 50.95 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.524 -179.55 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.4 mtp -76.58 4.43 9.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.859 0.361 . . . . 0.0 110.85 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.805 HG22 HG13 ' A' ' 40' ' ' ILE . 70.8 mt -86.31 -20.44 7.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.023 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.554 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -52.15 -44.07 91.77 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 46.4 Cg_endo -72.36 -35.15 6.83 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 121.835 1.69 . . . . 0.0 111.417 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.9 ttt -65.84 -52.13 53.06 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.805 HG13 HG22 ' A' ' 36' ' ' ILE . 63.8 mt -49.92 -28.41 4.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.536 178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.574 ' HB2' HG11 ' A' ' 2' ' ' VAL . 88.7 tt0 -76.69 -36.55 57.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.364 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.463 ' NZ ' ' HB3' ' A' ' 42' ' ' LYS . 9.3 mtpm? -58.56 -21.45 52.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.145 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.13 -22.34 21.8 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.36 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.461 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 47.2 t -65.6 -11.73 46.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.312 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -86.28 -25.17 25.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.661 0.267 . . . . 0.0 111.366 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.27 -28.68 18.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.792 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.528 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 80.4 m-85 -122.78 45.2 1.02 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.5 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 86.1 Cg_exo -37.98 -32.79 0.23 Allowed 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.163 2.575 . . . . 0.0 113.601 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -63.69 -37.09 86.04 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.751 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.613 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -89.84 138.79 31.19 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.789 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.611 ' O ' HG13 ' A' ' 21' ' ' VAL . 59.0 m-20 -89.76 127.11 35.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.916 0.388 . . . . 0.0 110.579 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.821 ' O ' HG23 ' A' ' 2' ' ' VAL . 4.9 m-85 -98.58 86.59 3.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.717 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.52 ' CG ' ' CZ ' ' A' ' 5' ' ' PHE . 36.6 m-85 -96.48 -175.73 3.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.88 178.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.75 ' CD ' HD12 ' A' ' 40' ' ' ILE . 34.4 mtmm -150.1 138.78 20.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.952 0.406 . . . . 0.0 111.293 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.633 HD13 ' N ' ' A' ' 56' ' ' ASP . 3.0 tm? -95.22 129.72 42.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.07 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.633 ' N ' HD13 ' A' ' 55' ' ' LEU . 41.4 m-20 -86.98 110.46 20.06 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.888 -179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.52 HG12 ' O ' ' A' ' 57' ' ' VAL . 84.2 t -78.81 -4.51 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.012 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -84.63 -55.29 4.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.977 0.418 . . . . 0.0 110.827 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.748 ' C ' HD12 ' A' ' 60' ' ' LEU . 41.6 tp10 -87.26 -17.31 32.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.398 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.79 HD11 ' O ' ' A' ' 6' ' ' LYS . 2.3 mp -127.09 57.93 1.46 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.929 0.395 . . . . 0.0 111.092 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -62.64 -16.11 55.04 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.384 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -79.95 -29.63 39.7 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.575 0.226 . . . . 0.0 111.57 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.851 HG12 ' HE2' ' A' ' 25' ' ' PHE . 21.8 t -73.49 -27.56 23.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.961 0.41 . . . . 0.0 110.956 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.518 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -80.01 -26.83 39.7 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -90.4 -31.0 17.03 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.823 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 63' ' ' VAL . 13.9 ptmm? -60.31 -48.06 83.35 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.969 0.414 . . . . 0.0 109.984 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.438 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 75.3 m-80 -84.95 1.65 46.44 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.784 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 65.41 37.74 6.07 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.332 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.674 ' CG1' HG21 ' A' ' 74' ' ' THR . 48.9 t -111.61 75.19 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.815 0.341 . . . . 0.0 111.053 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.6 p -89.35 5.59 44.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.136 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HB3' ' OG1' ' A' ' 74' ' ' THR . . . -60.68 -159.01 0.01 OUTLIER 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.575 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.61 ' O ' ' HG2' ' A' ' 72' ' ' MET . 1.5 pmm? -174.98 93.2 0.29 Allowed Pre-proline 0 CA--C 1.53 0.192 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.593 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 8.0 Cg_endo -94.04 -156.69 0.57 Allowed 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 124.904 -0.873 . . . . 0.0 112.502 -0.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.674 HG21 ' CG1' ' A' ' 69' ' ' VAL . 53.4 m -158.09 148.44 20.4 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.81 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.109 HD13 HD13 ' A' ' 95' ' ' ILE . 90.5 mt -109.89 123.31 49.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.185 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.041 HD12 ' CE1' ' A' ' 25' ' ' PHE . 20.2 mt -122.76 128.96 51.17 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.837 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.851 ' HB3' HD11 ' A' ' 20' ' ' LEU . 4.5 mp -109.96 144.66 38.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.959 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.647 ' HA ' HG23 ' A' ' 84' ' ' VAL . 65.5 m-85 -145.04 126.09 14.57 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 -179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.577 ' HG3' HD13 ' A' ' 20' ' ' LEU . 51.8 mtmt -113.46 132.96 55.46 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.694 0.283 . . . . 0.0 111.493 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 82' ' ' LYS . 5.3 m120 47.96 53.34 11.68 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.9 0.381 . . . . 0.0 111.742 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 15' ' ' ILE . . . 59.43 16.07 34.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.159 -0.543 . . . . 0.0 112.978 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 80' ' ' ASN . 74.7 mmtt -111.19 -153.92 0.53 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -108.81 173.79 6.16 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.647 HG23 ' HA ' ' A' ' 78' ' ' PHE . 58.0 t -149.18 -63.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.853 0.358 . . . . 0.0 111.165 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.49 162.8 8.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.2 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -138.53 115.16 10.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.543 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.5 t -136.41 98.89 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.17 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.613 ' HA ' HG23 ' A' ' 74' ' ' THR . 2.4 p -56.92 116.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.967 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.639 ' O ' ' HB2' ' A' ' 90' ' ' ALA . . . 141.52 -140.26 10.09 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.989 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 89' ' ' GLY . . . 147.61 36.93 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.818 0.447 . . . . 0.0 110.867 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 93' ' ' ALA . 75.3 m-80 -86.94 143.46 35.2 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.576 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -48.87 85.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.581 2.187 . . . . 0.0 112.478 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 91' ' ' ASN . . . -179.48 -37.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.487 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.46 -44.34 2.13 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.109 HD13 HD13 ' A' ' 75' ' ' LEU . 3.2 tp -50.1 -18.61 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.464 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.463 ' HG3' ' N ' ' A' ' 97' ' ' GLN . 7.8 ptpp? -91.71 -49.52 6.23 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.971 0.415 . . . . 0.0 110.974 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.463 ' N ' ' HG3' ' A' ' 96' ' ' LYS . 25.7 mt-30 -69.22 -32.11 71.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.48 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.65 -27.76 68.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.534 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.833 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 58.4 mt -90.22 -11.54 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.511 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.43 -74.21 0.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.917 0.389 . . . . 0.0 111.492 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -45.93 -29.5 1.44 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.378 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.738 ' HB3' HD22 ' A' ' 20' ' ' LEU . 69.8 m-20 -90.14 -42.34 11.12 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.269 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.833 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.081 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 120.795 0.331 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.541 HG11 ' HB2' ' A' ' 41' ' ' GLU . 12.5 p -167.89 132.15 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.881 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.3 m -150.26 156.54 41.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.946 0.403 . . . . 0.0 111.403 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.471 ' HA ' ' HB2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -99.57 -173.44 2.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.621 179.368 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.527 ' CE2' ' CD1' ' A' ' 11' ' ' PHE . 21.4 m-85 -137.5 101.33 4.47 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.61 ' C ' HD11 ' A' ' 60' ' ' LEU . 43.9 mmtm -83.19 -20.41 34.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.283 178.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.6 p -133.03 122.84 24.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.147 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -54.12 -26.49 27.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.49 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.6 t -55.33 -23.41 23.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.188 0.518 . . . . 0.0 110.392 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -90.69 -35.19 15.07 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.627 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.88 ' CE1' HG21 ' A' ' 23' ' ' VAL . 1.0 OUTLIER -74.76 -24.11 58.64 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.948 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -58.75 -68.68 0.24 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.066 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.4 t -56.74 -23.56 43.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.447 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 11' ' ' PHE . . . -52.46 -64.36 0.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.36 . . . . 0.0 111.472 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.483 ' O ' ' N ' ' A' ' 81' ' ' GLY . 20.7 pt -61.03 -47.23 94.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.486 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.552 ' HA ' ' HA3' ' A' ' 81' ' ' GLY . . . -40.28 97.56 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 75.7 mt-30 43.14 88.58 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.309 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.509 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 63.9 t0 -167.11 38.5 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.671 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 28.7 mtmt 70.07 -155.46 0.14 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.799 178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.537 ' CD1' HG21 ' A' ' 84' ' ' VAL . 36.4 tp -97.6 112.07 24.09 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.144 0.497 . . . . 0.0 110.574 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.776 HG22 ' HB2' ' A' ' 51' ' ' ASP . 47.3 t -101.44 124.73 55.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.536 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.724 HG21 HG12 ' A' ' 99' ' ' ILE . 50.4 t -103.51 98.79 7.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.141 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.88 HG21 ' CE1' ' A' ' 11' ' ' PHE . 38.2 t -105.74 131.69 54.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.775 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 74' ' ' THR . 62.2 t0 -100.1 132.53 45.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.53 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.056 ' CE1' HD12 ' A' ' 76' ' ' LEU . 5.2 m-85 -99.11 49.13 0.95 Allowed 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 121.069 0.462 . . . . 0.0 110.524 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.58 ' HB2' ' HB3' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -50.42 145.87 5.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.44 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.792 ' HB2' ' CB ' ' A' ' 72' ' ' MET . . . -59.99 164.91 3.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.77 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.441 ' HB ' ' N ' ' A' ' 58' ' ' ASP . 3.1 t -96.75 22.74 7.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.913 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 15.6 p-90 -148.82 -44.77 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 39.1 t -43.3 156.11 0.05 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.836 0.35 . . . . 0.0 111.373 -179.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 34' ' ' LYS . . . -93.41 -69.34 1.1 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.806 -0.712 . . . . 0.0 113.239 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -47.07 -25.95 4.64 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.983 2.456 . . . . 0.0 112.955 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 26' ' ' TYR . 98.7 m -61.8 -63.07 1.38 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.704 0.288 . . . . 0.0 111.623 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 61.9 pttt -55.45 -22.02 18.68 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.602 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.418 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 44.4 tpp -76.43 1.43 16.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.38 . . . . 0.0 110.776 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.916 HG22 HG13 ' A' ' 40' ' ' ILE . 63.1 mt -85.93 -18.08 9.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.401 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.529 ' N ' ' HD2' ' A' ' 38' ' ' PRO . . . -50.32 -44.4 81.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 37' ' ' ALA . 53.9 Cg_endo -73.36 -35.4 4.98 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.837 1.691 . . . . 0.0 111.438 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.74 ' CE ' HG23 ' A' ' 36' ' ' ILE . 57.3 ttp -65.33 -52.04 56.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.916 HG13 HG22 ' A' ' 36' ' ' ILE . 73.1 mt -48.18 -29.51 2.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.56 178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.541 ' HB2' HG11 ' A' ' 2' ' ' VAL . 87.1 tt0 -76.92 -34.31 57.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.977 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -63.91 -22.89 67.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.62 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -90.37 -22.51 21.46 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.463 ' HA ' ' CE1' ' A' ' 52' ' ' PHE . 80.2 p -67.29 -9.17 38.15 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.486 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -88.62 -26.22 22.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.78 0.324 . . . . 0.0 111.174 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -90.53 -29.79 17.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.842 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.529 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 78.6 m-85 -122.79 45.63 1.12 Allowed Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.502 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.529 ' CD ' ' N ' ' A' ' 47' ' ' TYR . 84.0 Cg_exo -38.05 -32.16 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.22 2.613 . . . . 0.0 113.952 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.498 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 3.9 mm100 -66.91 -16.83 64.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.927 0.394 . . . . 0.0 111.31 -179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' A' ' 20' ' ' LEU . . . -104.04 139.89 38.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.559 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.776 ' HB2' HG22 ' A' ' 21' ' ' VAL . 24.9 m-20 -89.44 120.99 31.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.907 0.384 . . . . 0.0 110.359 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.555 ' CE2' HD13 ' A' ' 99' ' ' ILE . 5.3 m-85 -97.92 83.88 3.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.313 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.599 ' HB2' HG22 ' A' ' 23' ' ' VAL . 46.5 m-85 -99.52 -174.53 2.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.354 179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.655 ' CD ' HD12 ' A' ' 40' ' ' ILE . 32.6 mtmm -150.21 141.69 23.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.943 0.401 . . . . 0.0 110.964 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.711 HD13 ' N ' ' A' ' 56' ' ' ASP . 2.5 tm? -100.41 130.34 46.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.866 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.711 ' N ' HD13 ' A' ' 55' ' ' LEU . 44.6 m-20 -87.87 114.07 24.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.856 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 57' ' ' VAL . 78.3 t -77.54 -3.08 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.65 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.441 ' N ' ' HB ' ' A' ' 28' ' ' THR . 64.9 t0 -82.05 -55.53 4.51 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.899 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.453 ' C ' HD12 ' A' ' 60' ' ' LEU . 41.0 tp10 -89.82 -28.46 19.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.391 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.659 ' N ' HD12 ' A' ' 60' ' ' LEU . 3.8 mp -108.23 52.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.848 0.356 . . . . 0.0 111.116 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -64.9 -15.21 59.9 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.447 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -82.94 -29.12 29.36 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.716 0.293 . . . . 0.0 111.448 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.756 HG12 ' HE2' ' A' ' 25' ' ' PHE . 15.4 t -73.33 -51.1 27.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.454 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 57' ' ' VAL . . . -54.47 -26.02 28.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.114 0.483 . . . . 0.0 109.718 178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.415 ' NE2' ' C ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -90.46 -37.82 13.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.07 179.649 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -61.64 -42.53 99.02 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.903 0.382 . . . . 0.0 110.352 -179.581 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -83.68 -0.46 50.83 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 65.67 35.45 6.96 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.334 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.68 ' CG1' HG21 ' A' ' 74' ' ' THR . 31.2 t -113.16 63.51 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 121.03 0.443 . . . . 0.0 110.867 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 89.2 p -74.57 -13.85 60.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.074 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.79 -168.77 0.0 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.414 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.792 ' CB ' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -174.29 111.82 0.3 Allowed Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.48 -0.488 . . . . 0.0 112.207 -179.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.517 ' HG3' ' CD1' ' A' ' 36' ' ' ILE . 57.3 Cg_endo -88.99 -166.73 3.19 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 124.275 -1.136 . . . . 0.0 112.398 -0.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.747 HG23 ' HA ' ' A' ' 88' ' ' VAL . 34.1 m -159.81 150.07 18.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.604 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.052 HD13 HD13 ' A' ' 95' ' ' ILE . 71.8 mt -110.78 124.8 52.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.888 0.375 . . . . 0.0 111.591 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.056 HD12 ' CE1' ' A' ' 25' ' ' PHE . 29.4 mt -124.72 124.14 41.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.465 179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.667 HD12 ' N ' ' A' ' 77' ' ' LEU . 3.3 mp -109.91 149.19 30.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.786 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.601 ' HB3' ' O ' ' A' ' 82' ' ' LYS . 40.5 m-85 -149.29 128.55 12.87 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.128 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.823 ' HG3' HG11 ' A' ' 84' ' ' VAL . 9.8 mtpm? -114.99 137.33 52.12 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.477 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 17' ' ' GLN . 6.2 m120 49.93 52.35 14.83 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.721 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 16' ' ' ALA . . . 57.78 18.7 33.17 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.732 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.601 ' O ' ' HB3' ' A' ' 78' ' ' PHE . 67.1 mttm -120.01 -155.56 0.63 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.743 ' O ' HG13 ' A' ' 84' ' ' VAL . 85.8 tt0 -109.13 176.93 4.92 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.823 HG11 ' HG3' ' A' ' 79' ' ' LYS . 3.5 m -165.38 -47.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.44 0.162 . . . . 0.0 111.301 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.69 170.37 9.45 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.142 0.496 . . . . 0.0 112.019 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.47 ' HD2' ' N ' ' A' ' 86' ' ' LYS . 0.0 OUTLIER -160.12 132.19 6.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.355 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.4 t -146.02 109.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.147 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.747 ' HA ' HG23 ' A' ' 74' ' ' THR . 6.5 p -69.55 69.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.814 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.2 118.29 0.56 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.349 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.677 ' CB ' HD11 ' A' ' 75' ' ' LEU . . . -95.96 38.0 1.2 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.914 0.388 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 93' ' ' ALA . 5.5 m120 -65.89 132.21 94.71 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.545 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' A' ' 93' ' ' ALA . 86.5 Cg_exo -48.4 86.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.66 2.24 . . . . 0.0 112.668 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.451 ' HB2' ' O ' ' A' ' 92' ' ' PRO . . . 176.8 -36.43 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.267 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.04 -46.87 2.7 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.052 HD13 HD13 ' A' ' 75' ' ' LEU . 4.7 tp -53.58 -15.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.211 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.421 ' HG3' ' HG3' ' A' ' 97' ' ' GLN . 21.3 ptmt -91.38 -50.95 5.53 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.791 0.329 . . . . 0.0 111.086 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.421 ' HG3' ' HG3' ' A' ' 96' ' ' LYS . 73.0 mt-30 -73.79 -32.97 64.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.478 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.02 -26.44 66.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.59 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.724 HG12 HG21 ' A' ' 22' ' ' VAL . 63.7 mt -90.24 -18.27 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.107 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.74 -65.49 1.01 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.007 0.432 . . . . 0.0 111.104 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -48.96 -28.26 3.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.217 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.526 ' CB ' HD22 ' A' ' 20' ' ' LEU . 50.8 m-20 -90.23 -38.71 13.26 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.34 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 99' ' ' ILE . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.222 -0.894 . . . . 0.0 111.197 179.825 . . . . . . . . 1 1 . 1 stop_ save_